0001144204-14-031100.txt : 20140515 0001144204-14-031100.hdr.sgml : 20140515 20140515143345 ACCESSION NUMBER: 0001144204-14-031100 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 10 CONFORMED PERIOD OF REPORT: 20140331 FILED AS OF DATE: 20140515 DATE AS OF CHANGE: 20140515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: COMPETITIVE TECHNOLOGIES INC CENTRAL INDEX KEY: 0000102198 STANDARD INDUSTRIAL CLASSIFICATION: PATENT OWNERS & LESSORS [6794] IRS NUMBER: 362664428 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-08696 FILM NUMBER: 14846162 BUSINESS ADDRESS: STREET 1: 1375 KINGS HIGHWAY EAST CITY: FAIRFIELD STATE: CT ZIP: 06824 BUSINESS PHONE: (203) 368-6044 MAIL ADDRESS: STREET 1: 1375 KINGS HIGHWAY EAST CITY: FAIRFIELD STATE: CT ZIP: 06824 FORMER COMPANY: FORMER CONFORMED NAME: UNIVERSITY PATENTS INC DATE OF NAME CHANGE: 19920703 10-Q 1 v377106_10q.htm FORM 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2014

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number 001-08696

COMPETITIVE TECHNOLOGIES, INC.
(Exact name of registrant as specified in its charter) www.competitivetech.net
Delaware	36-2664428
(State or other jurisdiction of incorporation or organization)	(I. R. S. Employer Identification No.)

1375 Kings Highway East, Suite 400 Fairfield, Connecticut	06824
(Address of principal executive offices)	(Zip Code)

(203) 368-6044

(Registrant’s telephone number, including area code)

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months.

Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definition of "accelerated filer, large accelerated filer and smaller reporting company" as defined in Rule 12b-2 of the Exchange Act.

Large accelerated filer ¨	Accelerated filer ¨
Non-accelerated filer ¨ (Do not check if a smaller reporting company)	Smaller reporting company x

Indicate by check mark whether the registrant is a shell company (as defined in rule 12b-2 of the Exchange Act).

Yes ¨ No x

The number of shares of the registrant’s common stock outstanding as of May 14, 2014 was 22,463,532 shares.

COMPETITIVE TECHNOLOGIES, INC.

INDEX TO QUARTERLY REPORT ON FORM 10-Q

		Page No.
PART I.	FINANCIAL INFORMATION
Item 1.	Condensed Consolidated Interim Financial Statements (unaudited)	3

	Condensed Consolidated Balance Sheets at March 31, 2014 (unaudited) and December 31, 2013	3

	Condensed Consolidated Statements of Operations (unaudited) for the three months ended March 31, 2014 and March 31, 2013	4

	Condensed Consolidated Statement of Changes in Shareholders’ Deficit for the three months ended March 31, 2014 (unaudited)	5

	Condensed Consolidated Statements of Cash Flows (unaudited) for the three months ended March 31, 2014 and March 31, 2013	6-7

	Notes to Condensed Consolidated Interim Financial Statements (unaudited)	8-20

Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	21-28

Item 3.	Quantitative and Qualitative Disclosures about Market Risk	28

Item 4.	Controls and Procedures	28

PART II.	OTHER INFORMATION

Item 1.	Legal Proceedings	29

Item 1A.	Risk factors	29

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	30

Item 3.	Defaults Upon Senior Securities	30

Item 4.	Mine Safety Disclosures	30

Item 5.	Other Information	30

Item 6.	Exhibits	30

Signatures		31

Exhibit Index

PART I. FINANCIAL INFORMATION

Item 1. Condensed Consolidated Interim Financial Statements

COMPETITIVE TECHNOLOGIES, INC. AND SUBSIDIARY

Condensed Consolidated Balance Sheets

	March 31, 2014			December 31, 2013
	(Unaudited)
Assets
Current Assets:
Cash	$	343,748		$	57,009
Receivables, net of allowance of $101,154 at March 31, 2014 and December 31, 2013		86,317			143,330
Inventory		4,248,220			4,278,220
Prepaid expenses and other current assets		48,095			65,167
Total current assets		4,726,380			4,543,726

Property and equipment, net		8,860			7,606
Security deposits		15,000			15,000
TOTAL ASSETS	$	4,750,240		$	4,566,332

Liabilities and Shareholders' Deficit
Current Liabilities:
Accounts payable	$	650,254		$	692,251
Liabilities under claims purchase agreement		2,013,320			2,093,303
Accounts payable, GEOMC		4,183,535			4,183,535
Accrued expenses and other liabilities		803,678			582,987
Notes payable		2,596,746			2,488,691
Deferred revenue		19,687			6,400
Warrant liability		-			8,227
Series C convertible preferred stock derivative liability		66,176			80,408
Series C convertible preferred stock liability		375,000			375,000
Total current liabilities		10,708,396			10,510,802

Note payable – long-term		34,272			-

Commitments and Contingencies
Shareholders’ deficit:
5% preferred stock, $25 par value, 35,920 shares authorized, 2,427 shares issued and outstanding		60,675			60,675
Series B preferred stock, $0.001 par value, 20,000 shares authorized, no shares issued and outstanding		-			-
Series C convertible preferred stock, $1,000 par value, 750 shares authorized, 375 shares issued and outstanding		-			-
Common stock, $.01 par value, 40,000,000 shares authorized, 22,463,532 shares issued and outstanding at March 31, 2014 and 19,952,907 shares issued and outstanding at December 31, 2013		224,635			199,529
Capital in excess of par value		46,730,636			46,077,394
Accumulated deficit		(53,008,374	)		(52,282,068	)
Total shareholders’ deficit		(5,992,428	)		(5,944,470	)

TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT	$	4,750,240		$	4,566,332

See accompanying notes

COMPETITIVE TECHNOLOGIES, INC. AND SUBSIDIARY

Condensed Consolidated Statements of Operations

(Unaudited)

	Three months ended			Three months ended
	March 31, 2014			March 31, 2013
Revenue
Product sales	$	221,080		$	-
Cost of product sales		70,218			19,348
Gross profit from product sales		150,862			(19,348	)

Other Revenue
Retained royalties		2,604			13,376
Other income		3,821			48,679
Total other revenue		6,425			62,055

Expenses

Selling expenses		71,994			68,175
Personnel and consulting expenses		395,023			341,007
General and administrative expenses		193,721			400,759
Interest expense		104,786			32,767
Loss on settlement of note and warrant		132,301			-
Unrealized gain on derivative instruments		(14,232	)		(18,167	)
Total Expenses		883,593			824,541

Loss before income taxes		(726,306	)		(781,834	)
Provision (benefit) for income taxes		-			-

Net loss	$	(726,306	)	$	(781,834	)

Basic loss per share	$	(0.04	)	$	(0.05	)

Basic weighted average number of common shares outstanding:		20,036,240			15,588,693

Diluted loss per share	$	(0.04	)	$	(0.05	)

Diluted weighted average number of common shares outstanding:		20,036,240			15,588,693

See accompanying notes

PART I. FINANCIAL INFORMATION (Continued)

COMPETITIVE TECHNOLOGIES, INC. AND SUBSIDIARY

Condensed Consolidated Statement of Changes in Shareholders' Deficit

For the Three Months Ended March 31, 2014

(Unaudited)

	Preferred Stock				Common Stock				Capital					Total
	Shares outstanding		Amount		Shares outstanding		Amount		in excess of par value		Accumulated deficit			shareholders’ deficit

Balance January 1, 2014		2,427	$	60,675		19,952,907	$	199,529	$	46,077,394	$	(52,282,068	)	$	(5,944,470	)

Net loss		-		-		-		-		-		(726,306	)		(726,306	)
Common stock issued to directors		-		-		10,625		106		3,932		-			4,038
Stock option compensation expense		-		-		-		-		14,328		-			14,328
Private offering of common stock and warrants		-		-		2,500,000		25,000		475,000		-			500,000
Warrant and beneficial conversion feature on notes payable		-		-		-		-		53,338		-			53,338
Liabilities settled under Liability Purchase Agreement										106,644					106,644
Balance March 31, 2014		2,427	$	60,675		22,463,532	$	224,635	$	46,730,636	$	(53,008,374	)	$	(5,992,428	)

See accompanying notes

PART I. FINANCIAL INFORMATION (Continued)

COMPETITIVE TECHNOLOGIES, INC. AND SUBSIDIARY

Condensed Consolidated Statements of Cash Flows

(Unaudited)

	Three months ended			Three months ended
	March 31, 2014			March 31, 2013
Cash flows from operating activities:

Net loss	$	(726,306	)	$	(781,834	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization		1,824			2,336
Stock option compensation expense		14,328			111,437
Share-based compensation – common stock		4,038			7,000
Bad debt expense		-			5,000
Debt discount amortization		61,364			-
Noncash finance charges		18,434			-
Unrealized gain on derivative instruments		(14,232	)		(18,167	)
Loss on settlement of note and warrant		132,301			-
Changes in assets and liabilities:
Receivables		57,013			132,747
Prepaid expenses and other current assets		17,072			56,188
Inventory		30,000			-
Accounts payable, accrued expenses and other liabilities		178,694			(32,745	)
Deferred revenue		13,287			(1,600	)
Net cash used in operating activities		(212,183	)		(519,638	)

Cash flows from investing activities:
Purchase of property and equipment		(3,078	)		-
Cash used in investing activities		(3,078	)		-

Cash flows from financing activities:
Proceeds from note payable		120,000			505,000
Repayment of note and warrant settlement		(118,000	)		-
Proceeds from common stock and warrants		500,000			-
Net cash provided by financing activities		502,000			505,000

Net increase (decrease) in cash		286,739			(14,638	)

Cash at beginning of period		57,009			74,322

Cash at end of period	$	343,748		$	59,684

Supplemental disclosure of non-cash transactions:

In September 2013 the Company issued 1,618,235 shares of the Company’s common stock to ASC Recap. During September and October 2013, ASC Recap sold the Company’s common stock and during the three months ended March 31, 2014 paid creditors approximately $80,000 from the proceeds and retained a service fee of approximately $27,000 (see Note 10).

During the three months ended March 31, 2013, the Company transferred a rental asset with a net book value (“NBV”) of approximately $8,000 to inventory.

During the three months ended March 31, 2013, the Company issued 500,000 shares of its common stock into escrow, pending the completion of potential financing with a European investment group.

During March 2013, the Company issued 100,000 shares of its common stock at $0.43 per share for legal services.

See accompanying notes

PART I. FINANCIAL INFORMATION (Continued)

COMPETITIVE TECHNOLOGIES, INC. AND SUBSIDIARY

Notes to Condensed Consolidated Interim Financial Statements

(Unaudited)

1. BASIS OF PRESENTATION

The interim condensed consolidated financial information presented in the accompanying condensed consolidated financial statements and notes hereto is unaudited.

Competitive Technologies, Inc. (“CTI”) and its majority-owned (56.1%) subsidiary, Vector Vision, Inc. (“VVI”), (collectively, the “Company”, “we” or “us”) is a biotechnology company developing and commercializing innovative products and technologies. CTI is the licensed distributor of the non-invasive Calmare® pain therapy medical device, which incorporates the biophysical “Scrambler Therapy”® technology developed to treat neuropathic and cancer-derived pain.

These consolidated financial statements include the accounts of CTI and VVI. Inter-company accounts and transactions have been eliminated in consolidation.

We believe we have made all adjustments necessary, consisting only of normal recurring adjustments, to present the unaudited condensed consolidated financial statements in conformity with accounting principles generally accepted in the U.S. The results for the three months ended March 31, 2014 are not necessarily indicative of the results that can be expected for the full year ending December 31, 2014.

The interim unaudited condensed consolidated financial statements and notes thereto, should be read in conjunction with our Annual Report on Form 10-K for the year ended December 31, 2013 filed with the Securities and Exchange Commission (“SEC”) on April 16, 2014.

During the three months ended March 31, 2014, we had a significant concentration of revenues from our Calmare® pain therapy medical device. The percentages of gross revenue attributed to sales and rentals of Calmare devices, in the three months ended March 31, 2014, was 98%; and 13% in the three months ended March 31, 2013. Additionally, the percentage of gross revenue attributed to other Calmare related sales of equipment and training, in the three months ended March 31, 2014, was 1%; and 66% in the three months ended March 31, 2013. We continue to attempt to expand our sales activities for the Calmare device and expect the majority of our revenues to come from this technology.

The Company has incurred operating losses since fiscal 2006 and has a working capital deficiency at March 31, 2014. The Company has taken steps to reduce its operating expenses as well as increase revenue from sales of Calmare medical devices. However, even at the reduced spending levels, should the anticipated increase in revenue from sales of Calmare devices not occur the Company may not have sufficient cash flow to fund operations through 2014. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include adjustments to reflect the possible future effect of the recoverability and classification of assets or amounts and classifications of liabilities that may result from the outcome of this uncertainty.

The Company's continuation as a going concern is dependent upon its developing recurring revenue streams sufficient to cover operating costs. The Company does not have any significant individual cash or capital requirements in the budget going forward. If necessary, CTI will meet anticipated operating cash requirements by further reducing costs, issuing debt and/or equity, and/or pursuing sales of certain assets and technologies while we pursue licensing and distribution opportunities for our remaining legacy portfolio of technologies. There can be no assurance that the Company will be successful in such efforts. Failure to develop a recurring revenue stream sufficient to cover operating expenses could negatively affect the Company’s financial position.

Our liquidity requirements arise principally from our working capital needs, including funds needed to sell our current technologies and obtain new technologies or products, and protect and enforce our intellectual property rights, if necessary. We fund our liquidity requirements with a combination of cash on hand, debt and equity financing, sales of common stock and cash flows from operations, if any, including royalty legal awards. At March 31, 2014, the Company had outstanding debt in the form of promissory notes with a total principal amount of $3,277,000 and a carrying value of $3,117,000.

The Company acquired the exclusive, worldwide rights to the Scrambler Therapy® technology in 2007. The Company’s original 2007 agreement with Giuseppe Marineo (the "Scrambler Therapy Agreement"), an inventor of Scrambler Therapy technology, and Delta Research and Development, authorized CTI to manufacture and sell worldwide the device developed from the patented Scrambler Therapy technology. The original agreement was amended in 2011 to provide the Company with exclusive rights to the Scrambler Therapy technology through March 31, 2016. In July 2012, the Company attempted to negotiate a five-year extension to the agreement with Marineo and Delta (the “2012 Amendment”). However, a valid contract was never formed as the 2012 Amendment was not executed by Marineo and Delta. The Scrambler Therapy technology is patented in Italy and in the U.S. Applications for patents have been filed internationally as well and are pending approval. The Calmare device has CE Mark certification from the European Union as well as U.S. FDA 510(k) clearance. CTI’s partner, GEOMC Co., Ltd. of Korea, is manufacturing the product commercially under a ten (10) year agreement through 2017. Sales of these devices are expected to provide a significant proportion of the Company’s revenue for the next several years.

2. NET INCOME (LOSS) PER COMMON SHARE

The following sets forth the denominator used in the calculations of basic net income (loss) per share and net income (loss) per share assuming dilution:

	Three months ended		Three months ended
	March 31, 2014		March 31, 2013
Denominator for basic net income (loss) per share, weighted average shares outstanding		20,036,240		15,588,693
Dilutive effect of common stock options		N/A		N/A
Dilutive effect of Series C convertible preferred stock, convertible debt and warrants		N/A		N/A
Denominator for diluted net income (loss) per share, weighted average shares outstanding		20,036,240		15,588,693

Due to the net loss incurred for the three months ended March 31, 2014, and March 31, 2013, the denominator used in the calculation of basic net loss per share was the same as that used for net loss per share, assuming dilution, since the effect of any options, convertible preferred shares, convertible debt or warrants would have been anti-dilutive. Options to purchase 1,409,000 and 1,367,000 shares of our common stock were outstanding at March 31, 2014 and 2013, respectively, 375 shares outstanding of Series C Convertible Preferred Stock, at March 31, 2014 and 2013, outstanding convertible debt of $3,117,000 and $2,040,000 at March 31, 2014 and 2013, respectively and the warrants outstanding at March 31, 2014 were not included in the computation of diluted net income (loss) per share because they were also anti-dilutive.

3. RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

No new accounting pronouncements issued or effective during the quarter ended March 31, 2014 has had or is expected to have a material impact on the consolidated financial statements.

4. RECEIVABLES

Receivables consist of the following:

	March 31, 2014		December 31, 2013
Calmare® sales receivable	$	86,023	$	132,850
Royalties, net of allowance of $101,154 at March 31, 2014 and December 31, 2013		-		10,086
Other		294		394
Total receivables	$	86,317	$	143,330

5. AVAILABLE-FOR-SALE AND EQUITY SECURITIES

The fair value of the equity securities we held were categorized as available-for-sale securities, which were carried at a fair value of zero, consisted of shares in Security Innovation and Xion Pharmaceutical Corporation (“Xion”). We own 223,317 shares of stock in the privately held Security Innovation, an independent provider of secure software located in Wilmington, MA.

In September 2009 we announced the formation of a joint venture with Xion for the commercialization of our patented melanocortin analogues for treating sexual dysfunction and obesity. CTI currently owns 60 shares of common stock or 30% of the outstanding stock of privately held Xion.

6. FAIR VALUE MEASUREMEMENTS

The Company measures fair value in accordance with Topic 820 of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”), Fair Value Measurement (“ASC 820”), which provides a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy under ASC 820 are described as follows:

Level 1 -	Inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets that the Company has the ability to access.

Level 2 -	Inputs to the valuation methodology include:
	●	Quoted prices for similar assets or liabilities in active markets;
	●	Quoted prices for identical or similar assets or liabilities in inactive markets;
	●	Inputs other than quoted prices that are observable for the asset or liability;
	●	Inputs that are derived principally from or corroborated by observable market data by correlation or other means.
	If the asset or liability has a specified (contractual) term, the Level 2 input must be observable for substantially the full term of the asset or liability.

Level 3 -	Inputs to the valuation methodology are unobservable and significant to the fair value measurement

The asset's or liability's fair value measurement level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Valuation techniques used need to maximize the use of observable inputs and minimize the use of unobservable inputs.

The Company values its derivative liability associated with the variable conversion feature on its Series C Convertible Preferred Stock (Note 12) based on the market price of its common stock. For each reporting period the Company calculates the amount of potential common stock that the Series C Preferred Stock could convert into based on the conversion formula (incorporating market value of our common stock) and multiplies those converted shares by the market price of its common stock on that reporting date. The total converted value is subtracted by the consideration paid to determine the fair value of the derivative liability. The Company classified the derivative liability of $66,000 and $80,000 at March 31, 2014 and December 31, 2013, respectively, in Level 2 of the fair value hierarchy.

The warrant issued in connection with the Tonaquint Note (the “Tonaquint Warrants,”see Note 11) were measured at fair value and liability-classified because the Tonaquint Warrants contain “down-round” protection and therefore do not meet the scope exception under FASB ASC 815, Derivatives and Hedging (“ASC 815”). Since “down-round” protection is not an input to the fair value of the warrants, the warrants cannot be considered indexed to the Company’s own stock which is a requirement for the scope exception as outlined under ASC 815. The Company valued the warrants at $8,000 at December 31, 2013, and $26,076 upon issuance July 16, 2013, in Level 3 of the fair value hierarchy. During the first quarter of 2014 the Company executed a debt settlement agreement with Tonaquint related to the note and warrant (see Note 11).

Similarly, the conversion feature of the Tonaquint Note (Note 11) also contained “down-round” protection and therefore did not meet the scope exception under FASB ASC 815. The Company classified the derivative liability of $0 at December 31, 2013, and $19,024 upon issuance at July 16, 2013, in Level 3 of the fair value hierarchy. During the first quarter of 2014 the Company executed a debt settlement agreement with Tonaquint related to the note and warrant (see Note 11).

The methods described above may produce a fair value calculation that may not be indicative of net realizable value or reflective of future fair values. Furthermore, while the Company believes its valuation method is appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value could result in a different fair value measurement at the reporting date.

The carrying amounts reported in our Condensed Consolidated Balance Sheet for cash, accounts receivable, notes payable, deferred revenue, and preferred stock liability approximate fair value due to the short-term maturity of those financial instruments.

7. PREPAID EXPENSES AND OTHER CURRENT ASSETS

Prepaid expenses and other current assets consist of the following:

	March 31, 2014		December 31, 2013
Prepaid insurance	$	15,230	$	16,802
Other		32,865		48,365
Prepaid expenses and other current assets	$	48,095	$	65,167

8. PROPERTY AND EQUIPMENT

Property and equipment, net, consist of the following:

	March 31, 2014			December 31, 2013
Property and equipment, gross	$	180,615		$	177,537
Accumulated depreciation and amortization		(171,755	)		(169,931	)
Property and equipment, net	$	8,860		$	7,606

Depreciation and amortization expense was $1,824 and $2,336 during the three months ended March 31, 2014 and March 31, 2013, respectively.

9. ACCRUED EXPENSES AND OTHER LIABILITIES

Accrued expenses and other liabilities consist of the following:

	March 31, 2014		December 31, 2013

Royalties payable	$	155,208	$	127,708
Accrued compensation		135,000		-
Accrued accounting fees		80,000		82,141
Commissions payable		21,975		21,975
Accrued interest payable		241,487		216,518
Other payables		170,008		134,645
Accrued expenses and other liabilities, net	$	803,678	$	582,987

Excluded above is approximately $235,000 and $244,000 of accrued expenses and other liabilities at March 31, 2014 and December 31, 2013, respectively, that fall under the Liability Purchase Agreement (“LPA”) with ASC Recap, LLC (“ASC Recap”), and are expected to be repaid using the process as described in Note 10. Because there can be no assurance that the Company will be successful in completing this process, the Company retains ultimate responsibility for these liabilities, until fully paid down.

10. LIABILITIES ASSIGNED TO LIABILITY PURCHASE AGREEMENT

During the third quarter of 2013, the Company negotiated a LPA with Southridge, Partners II, L.P. (“Southridge”). The LPA takes advantage of a provision in the Securities Act of 1933, Section 3(a)(10), that allows the exchange of claims, securities, or property for stock when the arrangement is approved for fairness by a court proceeding. The process, approved by the court in August 2013, has the potential to eliminate nearly $2.1 million of our financial obligations to existing creditors who agreed to participate and executed claims purchase agreements with Southridge’s affiliate ASC Recap” accounting for $2,093,303 of existing payables, accrued expenses and other current liabilities, and notes payable. The process began with the issuance in September 2013 of 1,618,235 shares of the Company’s common stock to ASC Recap. During September and October 2013, ASC Recap sold the Company’s common stock and during the three months ended March 31, 2014 paid creditors approximately $80,000 from the proceeds and retained a service fee of approximately $27,000. As of May 14, 2014, no further shares of the Company’s common stock had been issued to ASC Recap to settle creditors’ balances.

There can be no assurance that the Company will be successful in completing this process with Southridge, and the Company retains ultimate responsibility for this debt, until fully paid.

11. NOTES PAYABLE

Notes payable consist of the following:

	March 31, 2014			December 31, 2013
90 day Convertible Notes (Chairman of the Board)	$	2,498,980		$	2,518,000
24 month Convertible Notes ($100,000 to Board member)		225,000			225,000
Tonaquint 9% OID Convertible Notes and Warrants		118,536			87,705
Southridge Convertible Note		12,000			12,000
Series A1 15% OID Convertible Notes and Warrants		100,076			81,415
Series A2 15% OID Convertible Notes and Warrants		91,127			69,571
Series A3 15% OID Convertible Notes and Warrants		37,007			-
Series B OID Convertible Notes and Warrants		34,272			-
Notes Payable, gross		3,116,998			2,933,691
Less LPA amount		(485,980	)		(505,000	)
Notes Payable, net	$	2,631,018		$	2,488,691

Details of notes payable as of March 31, 2014 are as follows:

	Principal Amount		Carrying Value			Cash Interest Rate			Common Stock Conversion Price		Maturity Date
90 day Convertible Notes (Chairman of the Board)	$	2,498,980	$	2,498,980			6	%	$	1.05	Various 2014
24 month Convertible Notes ($100,000 to Board member)		225,000		225,000			6	%		1.05	March 2014 – June 2014
Tonaquint 9% OID Convertible Notes (1)		112,500		118,536			7	%		0.30	May 2014
Southridge Convertible Note		12,000		12,000			None			75% of closing bid	June 2014
Series A1 15% OID Convertible Notes and Warrants		149,412		100,076			None			0.20	August 2014
Series A2 15% OID Convertible Notes and Warrants		134,236		91,127			None			0.25	September 2014
Series A3 15% OID Convertible Notes and Warrants		64,706		37,007			None			0.25	January 2015
Series B OID Convertible Notes and Warrants		80,000		34,272			None			0.35	March 2017
Notes Payable, gross	$	3,276,834		3,116,998
Less LPA amount				(485,980	)
Notes Payable, net			$	2,631,018

(1) Original terms noted above. The Company executed a debt settlement agreement with Tonaquint during the first quarter of 2014, cash-settled the warrant during the first quarter of 2014 and cash-settled the note during the second quarter of 2014. See further discussion below under “Tonaquint 9% Original Issue Discount Convertible Notes and Warrants”.

90 day Convertible Notes

The Company has issued 90-day notes payable to borrow funds from a director, now the chairman of our Board, as follows:

2013	$	1,188,980
2012		1,210,000
2011		100,000
Total	$	2,498,980

These notes have been extended several times and all bear 6.00% simple interest. A conversion feature was added to the Notes when they were extended, which allows for conversion of the eligible principal amounts to common stock at any time after the six month anniversary of the effective date –the date the funds are received – at a rate of $1.05 per share. Additional terms have been added to all Notes to include additional interest payments to all Notes if extended beyond their original maturity dates and to provide the lender with a security interest in unencumbered inventory and intangible assets of the Company other than proceeds relating to the Calmare device and accounts receivable.

A total of $485,980 of the aforementioned notes issued between December 1, 2012 and March 31, 2013 fall under the LPA with ASC Recap, and are expected to be repaid using the process as described in Note 10. Because there can be no assurance that the Company will be successful in completing this process, the Company retains ultimate responsibility for this debt, until fully paid down. As a result, the Company continues to accrue interest on these notes and they remain convertible as described above.

24 month Convertible Notes

In March 2012, the Company issued a 24-month convertible promissory note to borrow $100,000. Additional 24-month convertible promissory notes were issued in April 2012 ($25,000) and in June 2012 ($100,000). All of the notes bear 6.00% simple interest. Conversion of the eligible principal amounts to common stock is allowed at any time after the six month anniversary of the effective date of each note at a rate of $1.05 per share.

As of May 14, 2014 the Company has not repaid the principal due on the March 2012 $100,000 note or the April 2012 $25,000 note and as such is in default under the terms of the notes. There is also unpaid interest related to these notes.

Tonaquint 9% Original Issue Discount Convertible Notes and Warrants

During the quarter ended September 30, 2013, the Company entered into a securities purchase agreement with Tonaquint, Inc., under which it was issued a $112,500 convertible promissory note in consideration for $100,000, the difference between the proceeds from the Note and the principal amount consisted of a $10,000 original issue discount and a carried transaction expense of $2,500. The original issue discount was being amortized over the life of the note. The note was convertible at an initial conversion price of $0.30 per share at any time, and contained a “down-round protection” feature that requires the valuation of a derivative liability associated with the note. The note bore interest at 7% and was due in May 2014. Tonaquint was also issued a market-related warrant for $112,500 in shares of common stock with a “cashless” exercise feature. The warrant had a $0.35 exercise price, a 5-year term and included a “down-round protection” feature that required it to be classified as a liability rather than as equity (see Note 6).

During the first quarter of 2014 the Company executed a debt settlement agreement with Tonaquint related to the note and warrant. The warrant was settled during the first quarter of 2014 for a cash payment of $98,000, resulting in a loss of $98,000. The note was settled during the second quarter of 2014 for cash payments totaling $144,000 ($20,000 paid in the first quarter of 2014 and $124,000 paid in the second quarter of 2014). Because the execution of the debt settlement agreement in the first quarter of 2014 resulted in a significant modification of the original terms of the note agreement, the Company adjusted the carrying value of the note in the first quarter of 2014 and recorded a related loss of approximately $34,000.

Southridge

During 2013, the Company issued a six-month $12,000 convertible note payable to Southridge to cover legal expenses as part of the LPA (see Note 10). The convertible note is convertible into the Company’s common stock at 75% of the lowest closing bid price during the twenty (20) trading days prior to conversion and is due in June 2014.

Series A 15% Original Issue Discount Convertible Notes and Warrants

During the quarter ended December 31, 2013, the Company did a private offering of two tranches of convertible notes and warrants, under which it issued $283,648 of convertible promissory notes for consideration of $241,100, the difference between the proceeds from the notes and the principal amount consists of $42,548 of original issue discount. During the quarter ended March 31, 2014, the Company did a private offering of a third tranche of convertible notes and warrants, under which it issued $64,706 of convertible promissory notes for consideration of $55,000, the difference between the proceeds from the notes and principal amount consists of $9,706 of original issue discount. The notes are convertible at initial conversion prices ranging from $0.20 to $0.25 per share anytime after issuance thereby having an embedded beneficial conversion feature. The note holders were also issued market-related warrants for 958,179 in shares of common stock. The warrants have exercise prices that range from $0.40 to $0.60 and a 2-year term. The beneficial conversion feature and the warrants were recorded to additional paid-in-capital. The Company allocated the proceeds received to the notes, the beneficial conversion feature and the warrants on a relative fair value basis at the time of issuance. The total debt discount is amortized over the life of the notes to interest expense.

The beneficial conversion feature was valued at the intrinsic value on the issuance date. The intrinsic value represents the difference between the conversion price and the fair value of the common stock multiplied by the number of share into which the note is convertible. We estimated the fair value of the warrants on the issue date using a Black-Scholes pricing model with the following assumptions:

	Warrants (Tranche 1)- November 15, 2013			Warrants (Tranche 2)- December 30, 2013			Warrants (Tranche 3)- February 14, 2014
Expected term		2 years			2 years			2 years
Volatility		180.02	%		184.38	%		184.88	%
Risk Free Rate		0.31	%		0.39	%		0.32	%

The proceeds of the Notes issued during the three months ended March 31, 2014 were allocated to the components as follows:

	Proceeds allocated at issue date
Private Offering Notes	$	32,390
Private Offering Warrants		14,845
Beneficial Conversion feature		7,765
Total	$	55,000

Series B Original Issue Discount Convertible Notes and Warrants

During the quarter ended March 31, 2014, the Company did a private offering of convertible notes and warrants, under which it issued $80,000 of convertible promissory notes for consideration of $65,000, the difference between the proceeds from the notes and principal amount consists of $15,000 of original issue discount. The notes are convertible at an initial conversion price of $0.35 per share anytime after issuance thereby having an embedded beneficial conversion feature. The note holders were also issued market-related warrants for 185,714 in shares of common stock. The warrants have an exercise price of $0.45 and a 4-year term. The beneficial conversion feature and the warrants were recorded to additional paid-in-capital. The Company allocated the proceeds received to the notes, the beneficial conversion feature and the warrants on a relative fair value basis at the time of issuance. The total debt discount is amortized over the life of the notes to interest expense.

	Warrants March 20, 2014
Expected term		4 years
Volatility		151.52	%
Risk Free Rate		1.32	%

The proceeds of the Notes were allocated to the components as follows:

	Proceeds allocated at issue date
Private Offering Notes	$	34,272
Private Offering Warrants		26,811
Beneficial Conversion feature		3,917
Total	$	65,000

12. SHAREHOLDERS’ DEFICIENCY

Stock Option Plan

On May 2, 2011 the Company adopted and executed the Employees’ Directors’ and Consultants Stock Option Plan (the “Plan”). During the three months ended March 31, 2014, the Company granted 42,500 options to non-employee directors which were fully vested upon issuance. During the three months ended March 31, 2013, the Company granted 50,000 options to non-employee directors which were fully vested upon issuance.

During the three months ended March 31, 2013, the Company granted 1,000,000 stock options to its then CEO of which 200,000 vested immediately. Due to his subsequent resignation in September 2013, all options have since been cancelled.

There were no grants of stock options to employees during the three months ended March 31, 2014.

During the three months ended March 31, 2013 the Board of Directors extended the expiration dates for all options previously granted to one departing Board member in recognition for service. The Company considered the extension as a modification to the option agreements recording incremental compensation expense of $16,920 for the three months ended March 31, 2013.

We estimated the fair value of each option on the grant date using a Black-Scholes option-pricing model with the following weighted average assumptions:

	Three months Ended			Three months Ended
	March 31, 2014			March 31, 2013
Dividend yield (1)		0.00	%		0.00	%
Expected volatility (2)		118.5	%		99.2% - 100.3	%
Risk-free interest rates (3)		1.72	%		0.63	%
Expected lives (2)		5.0 YEARS			2.0-4.0 YEARS

	(1)	We have not paid cash dividends on our common stock since 1981, and currently do not have plans to pay or declare cash dividends. Consequently, we used an expected dividend rate of zero for the valuations.
	(2)	Estimated based on our historical experience. Volatility was based on historical experience over a period equivalent to the expected life in years.
	(3)	Based on the U.S. Treasury constant maturity interest rate with a term consistent with the expected life of the options granted.

During the three months ended March 31, 2014, the Company recognized expense of $11,178 for stock options issued to directors and expense of $3,150 for stock options issued to employees.

During the three months ended March 31, 2013, the Company recognized expense of $14,250 for stock options issued to directors and expense of $80,267 for stock options issued to employees.

Preferred Stock

Holders of 5% preferred stock are entitled to receive, if, as, and when declared by the Board of Directors, out of funds legally available therefore, preferential non-cumulative dividends at the rate of $1.25 per share per annum, payable quarterly, before any dividends may be declared or paid upon or other distribution made in respect of any share of common stock. The 5% preferred stock is redeemable, in whole at any time or in part from time to time, on 30 days' notice, at the option of the Company, at a redemption price of $25. In the event of voluntary or involuntary liquidation, the holders of preferred stock are entitled to $25 per share in cash before any distribution of assets can be made to holders of common stock.

Each share of 5% preferred stock is entitled to one vote. Holders of 5% preferred stock have no preemptive or conversion rights. The preferred stock is not registered to be publicly traded.

At its December 2, 2010 meeting, the CTI Board of Directors declared a dividend distribution of one right (each, a “Right”) for each outstanding share of common stock, par value $0.01, of the Company (the “Common Shares”). The dividend was payable to holders of record as of the close of business on December 2, 2010 (the “Record Date”). Issuance of the dividend may be triggered by an investor purchasing more than 20% of the outstanding shares of common stock.

On December 15, 2010 the Company issued a $400,000 promissory note. The promissory note was scheduled to mature on December 31, 2012 with an annual interest rate of 5%.

On December 15, 2010, the Company's Board of Directors authorized the issuance of 750 shares of Series C Convertible Preferred Stock ($1,000 par value) with a 5% cumulative dividend to William R. Waters, Ltd. of Canada. On December 30, 2010, 750 shares were issued. The Company converted the above $400,000 promissory note into 400 shares and received cash of $350,000 for the remaining 350 shares.

Effective June 16, 2011, William R. Waters, Ltd. of Canada converted one half of its Series C Convertible Preferred Stock, or 375 shares, to 315,126 shares of common stock.

The rights of the Series C Convertible Preferred Stock are as follows:

Dividend rights – The shares of Series C Convertible Preferred Stock accrue a 5% cumulative dividend on a quarterly basis and is payable on the last day of each fiscal quarter when declared by the Company’s Board. As of March 31, 2014 dividends declared were $70,323, of which $4,623 were declared during the three months ended March 31, 2014 and $51,575 have not been paid and are shown in accrued and other liabilities at March 31, 2014.

Voting rights – Holders of these shares of Series C Convertible Preferred Stock shall have voting rights equivalent to 1,000 votes per $1,000 par value Series C Convertible Preferred share voted together with the shares of Common Stock

Liquidation rights – Upon any liquidation these Series C Convertible Preferred Stock shares shall be treated as equivalent to shares of Common stock to which they are convertible.

Redemption rights – The redemption rights were associated with the $750,000 that had been held in escrow by the Company in the event that the funds were released and returned to CTI. However, the funds were withdrawn from escrow and paid out in accordance with the settlement agreement. Therefore the redemption rights no longer apply to the remaining Series C Convertible Preferred Stock.

Conversion rights – Holder has right to convert each share of Series C Convertible Preferred Stock at any time into shares of the Company's common stock at a conversion price for each share of common stock equal to 85% of the lower of (1) the closing market price at the date of notice of conversion or (2) the mid-point of the last bid price and the last ask price on the date of the notice of conversion. The variable conversion feature creates an embedded derivative that was bifurcated from the Series C Convertible Preferred Stock on the date of issuance and was recorded at fair value. The derivative liability will be recorded at fair value on each reporting date with any change recorded in the Statement of Operations as an unrealized gain (loss) on derivative instrument.

On the date of conversion of the 375 shares of Series C Convertible Preferred Stock the Company calculated the value of the derivative liability to be $81,933. Upon conversion, the $81,933 derivative liability was reclassified to equity.

The Company recorded a convertible preferred stock derivative liability of $66,176 and $80,408, associated with the 375 shares of Series C Convertible Preferred Stock outstanding at March 31, 2014 and December 31, 2013, respectively.

The Company has classified the Series C Convertible Preferred Stock as a liability at March 31, 2014 and December 31, 2013 because the variable conversion feature may require the Company to settle the conversion in a variable number of its common shares.

Common Stock

During the quarter ended March 31, 2014, the Company did a private offering of its common stock and warrants, for consideration of $500,000. 2,500,000 shares of common stock were issued at a per share price of $0.20. The common stock holders were also issued warrants to purchase 1,250,000 shares of common stock. The warrants have an exercise price of $0.60 and a 1-year term. The warrants were recorded to additional paid-in-capital.

During the three months ended March 31, 2014 and 2013, the Company issued 10,625 and 3,750 shares of its common stock to non-employee directors under its Director Compensation Plan. The Company recorded expense of $4,038 and $655 for director stock compensation expense in the three months ended March 31, 2014 and 2013.

13. CONTRACTUAL OBLIGATIONS AND CONTINGENCIES

As of March 31, 2014, CTI and its majority owned subsidiary, VVI, have remaining obligations, contingent upon receipt of certain revenues, to repay up to $165,701 and $198,365, respectively, in consideration of grant funding received in 1994 and 1995. CTI also is obligated to pay at the rate of 7.5% of its revenues, if any, from transferring rights to certain inventions supported by the grant funds. VVI is obligated to pay at rates of 1.5% of its net sales of supported products or 15% of its revenues from licensing supported products, if any.

We have engaged R.F. Lafferty & Co. to seek an acquisition partner from a limited number of companies for our nanoparticle bone biomaterial patents, among other assets and/or securities. The Company would pay Lafferty a 10% finder's fee in the event an acquisition partner is found, which management has deemed to be an immaterial and contingent obligation.

Contingencies – Litigation

Carolina Liquid Chemistries Corporation, et al. (case pending) – On August 29, 2005, we filed a complaint against Carolina Liquid Chemistries Corporation ("Carolina Liquid") in the United States District Court for the District of Colorado, alleging patent infringement of our patent covering homocysteine assays, and seeking monetary damages, punitive damages, attorneys’ fees, court costs and other remuneration at the option of the court. As we became aware of other infringers, we amended our complaint to add as defendants Catch, Inc. ("Catch") and the Diazyme Laboratories Division of General Atomics ("Diazyme"). On September 6, 2006, Diazyme filed for declaratory judgment in the Southern District of California for a change in venue and a declaration of non-infringement and invalidity. On September 12, 2006, the District Court in Colorado ruled that both Catch and Diazyme be added as defendants to the Carolina Liquid case.

On October 23, 2006, Diazyme requested the United States Patent and Trademark Office (the "USPTO") to re-evaluate the validity of our patent and this request was granted by the USPTO on December 14, 2006. On July 30, 2009, the U.S. Patent and Trademark Office’s Board of Patent Appeals and Interferences (“BPAI”) upheld the homocysteine patent. In September 2008, the examiner had denied the patent, but that denial was overruled by the BPAI. While the examiner had appealed that BPAI decision, delaying further action, that appeal was also denied by the BPAI on December 13, 2010. In June 2011, the examiner once again appealed the BPAI decision. In addition to responding to this new appeal, the Company petitioned the Director of the USPTO to help expedite further action on the case within the USPTO, which was to have been handled with special dispatch according to USPTO requirements for handling reexamination proceedings of patents involved in litigation.

On March 13, 2012, the USPTO issued the Ex Parte Reexamination Certificate confirming the patentability of claims examined. The company has begun collecting unpaid amounts from various obligated companies.

Employment matters – former employee (case pending) – In September 2003, a former employee filed a whistleblower complaint with the Occupational Safety and Health Administration of the Department of Labor (OSHA) alleging that the employee had been terminated for engaging in conduct protected under the Sarbanes Oxley Act of 2002 (SOX). In February 2005, OSHA found probable cause to support the employee’s complaint and the Secretary of Labor ordered reinstatement and back wages since the date of termination and CTCC requested de novo review and a hearing before an administrative law judge (“ALJ”). In July 2005, after the close of the hearing on CTI’s appeal, the U.S. district court for Connecticut enforced the Secretary’s preliminary order of reinstatement and back pay under threat of contempt and the Company rehired the employee with back pay.

On October 5, 2005, the ALJ who conducted the hearing on CTI’s appeal of the OSHA findings ruled in CTI’s favor and recommended dismissal of the employee’s complaint. Although the employee abandoned his position upon notice of the ALJ’s decision, he nevertheless filed a request for review by the DOL Administrative Review Board ("ARB").

In May 2006, the U.S. Court of Appeals for the Second Circuit vacated the order of the district court enforcing the Secretary’s preliminary order of reinstatement and back pay. The employee also filed a new SOX retaliation complaint with OSHA based on alleged black listing action by CTI following his termination. OSHA dismissed the complaint and the employee filed a request for a hearing by an administrative law judge. Ultimately, the employee voluntarily dismissed the appeal.

In March 2008, the ARB issued an order of remand in the employee’s appeal of the October 2005 dismissal of his termination complaint, directing the ALJ to clarify her analysis utilizing the burden-shifting standard articulated by the ARB. In January 2009, the ALJ issued a revised decision again recommending dismissal and once again the employee appealed the ruling to the ARB. On September 30, 2011, the ARB issued a final decision and order affirming the ALJ’s decision on remand and dismissing the employee’s complaint. The employee has appealed the ARB's decision before the U.S. Court of Appeals for the Second Circuit which has ordered the employee to file his opening brief by May 31, 2012. Response briefs by the Solicitor's Office of the U.S. Department of Labor and CTI were submitted in August 2012. In March 2013, the U.S Court of Appeals for the Second Circuit upheld the ARB’s decision dismissing the former employee’s complaint and denied the employee’s appeal from that order. In April 2013, the Second Circuit terminated proceedings in that court.

Summary – We may be a party to other legal actions and proceedings from time to time. We are unable to estimate legal expenses or losses we may incur, if any, or possible damages we may recover, and we have not recorded any potential judgment losses or proceeds in our financial statements to date. We record expenses in connection with these suits as incurred.

We believe that we carry adequate liability insurance, directors and officers insurance, casualty insurance, for owned or leased tangible assets, and other insurance as needed to cover us against potential and actual claims and lawsuits that occur in the ordinary course of our business. However, an unfavorable resolution of any or all matters, and/or our incurrence of significant legal fees and other costs to defend or prosecute any of these actions and proceedings may, depending on the amount and timing, have a material adverse effect on our consolidated financial position, results of operations or cash flows in a particular period.

14. RELATED PARTY TRANSACTIONS

Our board of directors determined that when a director's services are outside the normal duties of a director, we compensate the director at the rate of $1,000 per day, plus expenses, which is the same amount we pay a director for attending a one-day Board meeting. We classify these amounts as consulting expenses, included in personnel and consulting expenses.

At March 31, 2014, $2,598,980 of the outstanding were Notes payable to related parties; $2,498,980 to the chairman of our Board and $100,000 to another director.

15. SUBSEQUENT EVENT

On April 8, 2014, Mr. Giuseppe Marineo, an inventor of the Calmare® pain therapy device, and Delta Research and Development (“Delta”), Mr. Marineo’s research company, and Delta International Services and Logistics (“DIS&L”), Delta’s commercial arm in which Mr. Marineo is the sole beneficiary of all proceeds as its founder and sole owner (collectively the “Group”), issued a press release (the “Group’s Press Release”) regarding Competitive Technologies, Inc. (“CTI” or the “Company”) stating that the Company did not have authority to sell, distribute and manufacture Calmare as an exclusive agent of the Group. CTI issued a corporate response in a press release dated April 11, 2014 stating that the Group’s Press Release was inaccurate and has since been purged by the overseeing body of wire services.

As disclosed in the Company’s Annual Report on Form 10-K on April 16, 2014, this dispute between the Company and the Group is over the validity of a 2012 Amendment to a Sales and Representation Agreement (the “Amendment”) which, if valid and enforceable, would have compromised its rights to sell, distribute and manufacture Calmare as an exclusive agent of the Group in the global marketplace, especially in the European, Middle Eastern and North African (“EMENA”) territory which was responsible for approximately 70% of gross Calmare sales in 2011. However, the Company believes that the Amendment is neither valid nor enforceable as it was never duly signed or authorized and subsequently deemed null and void as disclosed on April 16, 2014 in the Form 10-K filing. Therefore, the parties’ rights are determined by an earlier agreement whereby the Company still possesses the authority to sell, distribute and manufacture Calmare as a world-wide exclusive agent of the Group.

On April 16, 2014, counsel for the Group (“Group Counsel”) sent a cease and desist letter (“Cease and Desist Letter”) to the Company, requesting a confirmation that the Company would no longer hold itself out as an agent of the Group permitted to sell, distribute and manufacture Calmare world-wide including the EMENA territory.

The Company responded on April 25, 2014 to the Cease and Desist Letter, disputing Group Counsel’s interpretation of the events surrounding the execution of the Amendment. At this time the Company is pursuing a reasonable and amicable resolution to the situation.

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

Forward-Looking Statements

Statements about our future expectations are “forward-looking statements” within the meaning of applicable Federal Securities Laws, and are not guarantees of future performance. When used in herein, the words “may,” “will,” “should,” “anticipate,” “believe,” “intend,” “plan,” “expect,” “estimate,” “approximate,” and similar expressions are intended to identify such forward-looking statements. These statements involve risks and uncertainties inherent in our business, including those set forth in Item 1A under the caption "Risk Factors," in our most recent Annual Report on Form 10-K for the year ended December 31, 2013, filed with the Securities and Exchange Commission (“SEC”) on April 16, 2014, (subsequently amended in a Form 10-K/A, filed with the SEC on April 30, 2014) and other filings with the SEC, and are subject to change at any time. Our actual results could differ materially from these forward-looking statements. We undertake no obligation to update publicly any forward-looking statement.

Overview

Competitive Technologies, Inc. (“CTI”) was incorporated in Delaware in 1971, succeeding an Illinois corporation incorporated in 1968. CTI and its majority-owned subsidiary (collectively, "we,” “our,” or “us”), is a biotechnology company developing and commercializing innovative products and technologies. CTI is the licensed distributor of the non-invasive Calmare pain therapy medical device, which incorporates the biophysical “Scrambler Therapy” technology developed to treat neuropathic and cancer-derived pain.

Since 2011, the Company has controlled the sales process for its Calmare^® medical device. We are the primary obligor, responsible for delivering devices as well as training our customers in the proper use of the device. We deal directly with customers, setting pricing and providing training; work directly with the inventor of the technology to develop specifications and any changes thereto and to select and contract with manufacturing partners; and retain significant credit risk for amounts billed to customers. Therefore, all product sales are recorded following a gross revenue methodology. We record in product sales, the total funds earned from customers and record the costs of the device as cost of product sales, with gross profit from product sales being the result.

Sales of our Calmare device continue to be the major source of revenue for the Company. The Company initially acquired the exclusive, worldwide rights to the Scrambler Therapy^® technology in 2007. The Company's 2007 agreement with Giuseppe Marineo ("Marineo"), an inventor of Scrambler Therapy technology, and Delta Research and Development ("Delta"), authorizes CTI to manufacture and sell worldwide the device developed from the patented Scrambler Therapy technology. The Scrambler Therapy technology is patented in Italy and in the U.S., effective in February 2013. Applications for patents have been filed internationally as well and are pending approval. The Calmare device has CE Mark certification from the European Union as well as U.S. FDA 510(k) clearance.

In 2011, the Company negotiated an extension to the agreement Marineo and Delta. This agreement extended the Company’s exclusive, worldwide rights to the Scrambler Therapy^®technology until March 31, 2016.

Dispute with Marineo and Delta

On April 8, 2014, Mr. Giuseppe Marineo, Mr. Marineo’s research company, and Delta International Services and Logistics (“DIS&L”), Delta’s commercial arm in which Mr. Marineo is the sole beneficiary of all proceeds as its founder and sole owner (collectively the “Group”), issued a press release (the “Group’s Press Release”) stating that the Company did not have authority to sell, distribute and manufacture Calmare as an exclusive agent of the Group.

As disclosed in the Company’s Annual Report on Form 10-K on April 16, 2014, and in a Current Report on Form 8-K on April 29, 2014, this dispute between the Company and the Group is over the validity of a 2012 Amendment to a Sales and Representation Agreement (the “Amendment”) which, if valid and enforceable, would have compromised its rights to sell, distribute and manufacture Calmare as an exclusive agent of the Group in the global marketplace, especially in the European, Middle Eastern and North African (“EMENA”) territory which was responsible for approximately 70% of gross Calmare sales in 2011. However, the Company believes that the Amendment is neither valid nor enforceable as it was never duly signed or authorized and subsequently deemed null and void. Therefore, the parties’ rights are determined by an earlier agreement whereby the Company still possesses the authority to sell, distribute and manufacture Calmare as a world-wide exclusive agent of the Group.

Presentation

We rounded all amounts in this Item 2 to the nearest thousand dollars.

The following discussion and analysis provides information that we believe is relevant to an assessment and understanding of our financial condition and results of operations. This discussion and analysis should be read in conjunction with our Consolidated Financial Statements and Notes thereto.

Results of Operations – Three months ended March 31, 2014 vs. three months ended March 31, 2013

Summary of Results

Our net loss, for the quarter ended March 31, 2014, decreased to $726,000 or $0.04 per basic and diluted share as compared with a net loss of $782,000 or $0.05 per basic and diluted share for the comparable quarter of 2013. This net loss decrease is largely attributable to a $221,000 increase in sales and a $207,000 decrease in general and administrative expenses, partially offset by a $72,000 increase in interest expense, a $54,000 increase in personnel and consulting expenses and a non recurring $132,000 loss on settlement of note and warrant.

Revenue and Gross Profit from Sales

Revenue from the sale and shipment of Calmare® pain therapy medical devices (the “Devices”), in the three months ended March 31, 2014, increased $221,000 to $221,000 as compared with $0 for the comparable quarter of 2013.

Cost of product sales, in the three months ended March 31, 2014, increased $51,000 to $70,000 as compared with $19,000 in the three months ended March 31, 2013. This increase in cost of product sold is attributable to CTI’s limited unit sales in the prior quarter.

Device sales, in the three months ended March 31, 2014, increased significantly with the sale of three (3) Devices as compared with zero (0) Device sales for the comparable quarter of 2013.

Due to the relatively long sales cycle for a Device, Device sales and related revenues and expenses can vary significantly from quarter to quarter.

Other Revenue

Retained royalties, in the three months ended March 31, 2014, decreased $10,000 to $3,000 as compared with $13,000 in the three months ended March 31, 2013.

Other income, for the three months ended March 31, 2014, decreased $45,000 to $4,000 as compared with $49,000 in the three months ended March 31, 2013. Other income includes:

	Three Months Ended March 31, 2014		Three Months Ended March 31, 2013
Training payments and the sale of supplies such as electrodes and cables for use with our Calmare® devices	$	2,000	$	3,000
Rental income from customers who were renting Calmare® pain therapy medical devices from CTI	$	2,000	$	8,000

In addition to the above mentioned items, the Company received a one-time payment of $38,000 in the first quarter of 2013 from one of our insurance companies related to its conversion to a stock insurance company.

Expenses

Total expenses increased $59,000 or 7% to $884,000 in the three months ended March 31, 2014 as compared with $825,000 in the three months ended March 31, 2013.

Selling expenses increased 6% or $4,000 to $72,000 in the three months ended March 31, 2014 as compared with $68,000 in the three months ended March 31, 2013 and reflects increased commissions as a result of increased Devices sales offset by reduced patent and other direct costs related to the Calmare pain device.

Personnel and consulting expenses, in the three months ended March 31, 2014, increased 16% or $54,000 to $395,000 as compared with $341,000 in the three months ended March 31, 2013. This increase is primarily related to differences between periods in executive compensation. The three months ended March 31, 2014 includes an accrual for estimated bonus compensation whereas no such accrual was recorded in the three months ended March 31, 2013. However partially offsetting this difference was stock option expense for employees of $3,000 for the three months ended March 31, 2014 as compared to $80,000 for the three months ended March 31, 2014. The significant stock option expense in the three months ended March 31, 2013 was associated with stock options issued to the Company’s then CEO. As part of his compensation package, 1,000,000 options were granted in March 2013, 200,000 of which vested immediately and as such resulted in expense during the three months ended March 31, 2013.

General and administrative expenses, in the three months ended March 31, 2014, decreased 52% or $207,000 to $194,000 as compared with $401,000 in the three months ended March 31, 2013. The decrease reflects:

$34,000 decrease in Directors fees and expenses, primarily related to share-based compensation;

$44,000 decrease in investor and public relations expenses, primarily as a result of terminating certain management consulting arrangements;

$73,000 decrease in legal expenses, primarily related to corporate counsel matters; and

$33,000 decrease in accounting and tax expenses.

Interest expense, in the three months ended March 31, 2014, increased $72,000 to $105,000 as compared with $33,000 in the three months ended March 31, 2013. This large increase is due to an increase in the use of debt financing.

Loss on settlement of note and warrant, during the three months ended March 31, 2014 the Company cash settled the warrant previously issued to Tonaquint for a loss of $98,000 and also recorded a $34,000 loss related to modification in terms to the original note agreement, which was cash settled in the second quarter of 2014 (see Note 11 of the Notes to Condensed Consolidated Interim Financial Statements).

Unrealized gain on derivative instruments, in the three months ended March 31, 2014, was $14,000, as compared with the $18,000 gain recorded in the three months ended March 31, 2013. This reflects the impact of the movement in CTI’s share price on the Class C Preferred Stock at the end of each period.

Financial Condition and Liquidity

Our future cash requirements depend on many factors, including results of our operations and marketing efforts, results and costs of our legal proceedings, and our equity financing. To achieve and sustain profitability, we are implementing a corporate reengineering effort, which commenced on September 26, 2013 under the direction of CTI’s new president & CEO, Mr. Conrad Mir. This plan design will change the inherent design of the current distributor network and focus on opportunities within the US Departments of Defense (the “DOD”) and Veterans Affairs (“VA”), and set out to upgrade CTI’s current U.S. Food and Drug Administration (“FDA”) clearance designation for the Calmare Pain Device to approval. Although we cannot be certain that we will be successful in these efforts, we believe the combination of our cash on hand and revenue from executing our strategic plan will be sufficient to meet our obligations of current and anticipated operating cash requirements.

In fiscal 2010, the Company incorporated revenue from the sale of inventory into its revenue stream. That source of revenue is expected to continue as sales of its Calmare pain therapy medical device continue to expand and other products are added to the Company's portfolio of technologies.

At March 31, 2014, cash was $344,000, as compared with $57,000 at December 31, 2013. Net cash used in operating activities was $(212,000) for the three months ended March 31, 2014 as compared to $(520,000) for the three months ended March 31, 2013, primarily reflecting the decrease in the current period net loss between periods, non cash interest expense and loss on settlement of the note and warrant in the current period and favorable changes in current assets/liabilities. There was minimal investing activity year to date in 2014 and 2013. Net cash provided by financing activities was $502,000 for the three months ended March 31, 2014 as compared to $505,000 for the three months ended March 2013, primarily as a result of the Company’s debt and equity financing activities in both periods.

We currently have the benefit of using a portion of our accumulated net operating losses (NOLs) to eliminate any future regular federal and state income tax liabilities. We will continue to receive this benefit until we have utilized all of our NOLs, federal and state. However, we cannot determine when and if we will be profitable enough to utilize the benefit of the remaining NOLs before they expire.

Going Concern

The Company has incurred operating losses since fiscal 2006 and has a working capital deficiency at March 31, 2014. During the three months ended March 31, 2014 and 2013, we had a significant concentration of revenues from our Calmare® pain therapy medical device technology. We continue to seek revenue from new and existing technologies or products to mitigate the concentration of revenues, and replace revenues from expiring licenses on other technologies.

Although we have taken steps to significantly reduce operating expenses going forward, even at these reduced spending levels, should the anticipated increase in revenue from sales of Calmare® medical devices and other technologies not occur, the Company may not have sufficient cash flow to fund operations through 2014. These conditions raise substantial doubt about the Company’s ability to continue as a going concern.

Debt Financing

Details of notes payable as of March 31, 2014 is as follows:

	Principal Amount		Carrying Value			Cash Interest Rate			Common Stock Conversion Price		Maturity Date
90 day Convertible Notes (Chairman of the Board)	$	2,498,980	$	2,498,980			6	%	$	1.05	Various 2014
24 month Convertible Notes ($100,000 to Board member)		225,000		225,000			6	%		1.05	March 2014 – June 2014
Tonaquint 9% OID Convertible Notes (1)		112,500		118,536			7	%		0.30	May 2014
Southridge Convertible Note		12,000		12,000			None			75% of closing bid	June 2014
Series A1 15% OID Convertible Notes and Warrants		149,412		100,076			None			0.20	August 2014
Series A2 15% OID Convertible Notes and Warrants		134,236		91,127			None			0.25	September 2014
Series A3 15% OID Convertible Notes and Warrants		64,706		37,007			None			0.25	January 2015
Series B OID Convertible Notes and Warrants		80,000		34,272			None			0.35	March 2017
Notes Payable, gross	$	3,276,834		3,116,998
Less LPA amount				(485,980	)
Notes Payable, net			$	2,631,018

90 day Convertible Notes

The Company has issued 90-day notes payable to borrow funds from a director, now the chairman of our Board, as follows:

2013	$	1,188,980
2012		1,210,000
2011		100,000
Total	$	2,498,980

A total of $485,980 of the aforementioned notes issued between December 1, 2012 and March 31, 2013 fall under the liabilities purchase agreement with ASC Recap, and are expected to be repaid using the process as described in Note 10. Because there can be no assurance that the Company will be successful in completing this process, the Company retains ultimate responsibility for this debt, until fully paid down. As a result, the Company continues to accrue interest on these notes and they remain convertible as described above.

24 month Convertible Notes

Tonaquint 9% Original Issue Discount Convertible Notes and Warrants

During the quarter ended September 30, 2013, the Company entered into a securities purchase agreement with Tonaquint, Inc., under which it was issued a $112,500 convertible promissory note in consideration for $100,000, the difference between the proceeds from the Note and the principal amount consisted of a $10,000 original issue discount and a carried transaction expense of $2,500. The original issue discounted was being amortized over the life of the note. The note was convertible at an initial conversion price of $0.30 per share at any time, and contained a “down-round protection” feature that requires the valuation of a derivative liability associated with the note. The note bore interest at 7% and was due in May 2014. Tonaquint was also issued a market-related warrant for $112,500 in shares of common stock with a “cashless” exercise feature. The warrant had a $0.35 exercise price, a 5-year term and included a “down-round protection” feature that required it to be classified as a liability rather than as equity (see Note 6 of the Notes to Condensed Consolidated Interim Financial Statements).

During the first quarter of 2014 the Company executed a debt settlement agreement with Tonaquint related to the note and warrant. The warrant was settled during the first quarter of 2014 for a cash payment of $98,000, resulting in a loss of $98,000. The note was settled during the second quarter of 2014 for cash payments totaling $144,000 ($20,000 in the first quarter of 2014 and $124,000 in the second quarter of 2014). Because the execution of the debt settlement agreement in the first quarter of 2014 resulted in a significant modification of the original terms of the note agreement, the Company adjusted the carrying value of the note in the first quarter of 2014 and recorded a related loss of approximately $34,000.

Southridge

During 2013, the Company issued a six-month $12,000 convertible note payable to Southridge to cover legal expenses as part of the LPA (see Note 11 of the Notes to Condensed Consolidated Interim Financial Statements). The convertible note is convertible into the Company’s common stock at 75% of the lowest closing bid price during the twenty (20) trading days prior to conversion and is due June 2014.

Series A 15% Original Issue Discount Convertible Notes and Warrants

During the quarter ended December 31, 2013, the Company did a private offering of two tranches of convertible notes and warrants, under which it issued $283,648 of convertible promissory notes for consideration of $241,100, the difference between the proceeds from the notes and the principal amount consists of $42,548 of original issue discount. During the quarter ended March 31, 2014, the Company did a private offering of a third tranche of convertible notes and warrants, under which it issued $64,706 of convertible promissory notes for consideration of $55,000, the difference between the proceeds from the notes and principal amount consists of $9,706 of original issue discount. The notes are convertible at initial conversion prices ranging from $0.20 to $0.25 per share anytime after issuance thereby having an embedded beneficial conversion feature. The note holders were also issued market-related warrants for 958,179 in shares of common stock. The warrants have exercise prices that range from $0.40 to $0.60 and a 2-year term. The beneficial conversion feature and the warrants were recorded to additional paid-in-capital. The total debt discount is amortized over the life of the notes to interest expense.

Series B Original Issue Discount Convertible Notes and Warrants

Capital requirements

We continue to seek revenue from new technology licenses to mitigate the concentration of revenue, and replace revenue from expiring licenses. We have created a new business model for appropriate technologies that allows us to move beyond our usual royalty arrangement and share in the profits of distribution.

For 2014, we expect our capital expenditures to be less than $100,000.

Contractual Obligations and Contingencies

Contingencies. Our directors, officers, employees and agents may claim indemnification in certain circumstances. We seek to limit and reduce our potential financial obligations for indemnification by carrying directors’ and officers’ liability insurance, subject to deductibles.

We also carry liability insurance, casualty insurance, for owned or leased tangible assets, and other insurance as needed to cover us against claims and lawsuits that occur in the ordinary course of business.

Many of our license and service agreements provide that upfront license fees, license fees and/or royalties we receive are applied against amounts that our clients or we have incurred for patent application, prosecution, issuance and maintenance costs. If we incur such costs, we expense them as incurred, and reduce our expense if we are reimbursed from future fees and/or royalties we receive. If the reimbursement belongs to our client, we record no revenue or expense.

We have engaged R.F. Lafferty & Co. to seek an acquisition partner from a limited number of companies for our nano particle bone biomaterial patents, among other assets and/or securities. The Company would pay Lafferty a 10% finder's fee in the event an acquisition partner is found, which Management has deemed to be an immaterial and contingent obligation.

As of March 31, 2014, CTI and its majority-owned subsidiary, VVI, have remaining obligations, contingent upon receipt of certain revenue, to repay up to $165,701 and $198,365, respectively, in consideration of grant funding received in 1994 and 1995. CTI also is obligated to pay at the rate of 7.5% of its revenues, if any, from transferring rights to certain inventions supported by the grant funds. VVI is obligated to pay at rates of 1.5% of its net sales of supported products or 15% of its revenues from licensing supported products, if any.

Critical Accounting Estimates

There have been no significant changes in our accounting estimates described under the caption “Critical Accounting Estimates” included in Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” in our Annual report on Form 10-K for the year ended December 31, 2013.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Not applicable.

Item 4. Controls and Procedures

(a) Evaluation of disclosure controls and procedures

Management evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Securities Exchange Act Rules 13a-15(e) and 15d-15(e)) as of March 31, 2014. Our disclosure controls and procedures are designed to ensure that information required to be disclosed by the issuer in the reports that it files or submits under the Act (15 U.S.C. 78a et seq.) is recorded, processed, summarized, and reported, within the time periods specified in the Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Act is accumulated and communicated to the issuer's management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Based on this evaluation, management concluded that our disclosure controls and procedures were effective as of March 31, 2014.

(b) Change in Internal Controls

During the period ending March 31, 2014, there were no changes in our internal control over financial reporting during that period that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II – OTHER INFORMATION

Item 1. Legal Proceedings

None.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

During the quarter ended December 31, 2013, the Company did a private offering of two tranches of convertible notes and warrants, under which it issued $283,648 of convertible promissory notes for consideration of $241,100, the difference between the proceeds from the notes and the principal amount consists of $42,548 of original issue discount. During the quarter ended March 31, 2014, the Company did a private offering of a third tranche of convertible notes and warrants with 3 investors, under which it issued $64,706 of convertible promissory notes for consideration of $55,000, the difference between the proceeds from the notes and principal amount consists of $9,706 of original issue discount. The notes are convertible at initial conversion prices ranging from $0.20 to $0.25 per share anytime after issuance thereby having an embedded beneficial conversion feature. The note holders were also issued market-related warrants for 958,179 in shares of common stock. The warrants have exercise prices that range from $0.40 to $0.60 and a 2-year term. The beneficial conversion feature and the warrants were recorded to additional paid-in-capital. The total debt discount is amortized over the life of the notes to interest expense.

During the quarter ended March 31, 2014, the Company did a private offering of convertible notes and warrants with one investor, under which it issued $80,000 of convertible promissory notes for consideration of $65,000, the difference between the proceeds from the notes and principal amount consists of $15,000 of original issue discount. The notes are convertible at an initial conversion price of $0.35 per share anytime after issuance thereby having an embedded beneficial conversion feature. The note holders were also issued market-related warrants for 185,714 in shares of common stock. The warrants have an exercise price of $0.45 and a 4-year term. The beneficial conversion feature and the warrants were recorded to additional paid-in-capital. The Company allocated the proceeds received to the notes, the beneficial conversion feature and the warrants on a relative fair value basis at the time of issuance. The total debt discount is amortized over the life of the notes to interest expense.

During the quarter ended September 30, 2013, the Company entered into a securities purchase agreement with Tonaquint, Inc., under which it was issued a $112,500 convertible promissory note in consideration for $100,000, the difference between the proceeds from the Note and the principal amount consisted of a $10,000 original issue discount and a carried transaction expense of $2,500. The original issue discounted was being amortized over the life of the note. The note was convertible at an initial conversion price of $0.30 per share at any time, and contained a “down-round protection” feature that requires the valuation of a derivative liability associated with the note. The note bore interest at 7% and was due in May 2014. Tonaquint was also issued a market-related warrant for $112,500 in shares of common stock with a “cashless” exercise feature. The warrant had a $0.35 exercise price, a 5-year term and included a “down-round protection” feature that required it to be classified as a liability rather than as equity (see Note 6 of the Notes to Condensed Consolidated Interim Financial Statements).

During the quarter ended March 31, 2014, the Company did a private offering of its common stock and warrants to 8 investors, for consideration of $500,000. 2,500,000 shares of common stock were issued at a per share price of $0.20. The common stock holders were also issued warrants to purchase 1,250,000 shares of common stock. The warrants have an exercise price of $0.60 and a 1-year term. The warrants were recorded to additional paid-in-capital.

The above securities were issued to the individuals identified in connection with a transaction made in reliance upon exemptions from registration pursuant to Section 4(2) under the Securities Act of 1933, as amended (the “Securities Act”) and/or Rule 506 promulgated under the Securities Act. The investors are accredited investors as defined in Rule 501 of Regulation D promulgated under the Securities Act.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None.

Item 6. Exhibits

Exhibit No	Description	Filing Method
3.1	Unofficial restated certificate of incorporation of the registrant as amended to date filed.(1)	Incorporated by reference

3.2	Bylaws of the registrant as amended effective October 14, 2005.(2)	Incorporated by reference

10.1	Securities Purchase Agreement with Tonaquint, Inc. dated July 16, 2013.(3)	Incorporated by reference

10.2	Equity Purchase Agreement with Southridge Partners II, L.P. dated September 10, 2013.(4)	Incorporated by reference

31.1	Certification by the Chief Executive Officer and Chief Financial Officer of Competitive Technologies, Inc. pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (Rule 13a-14(a) or Rule 15d-14(a)).	Filed herewith


32.1	Certification by the Chief Executive Officer and Chief Financial Officer of Competitive Technologies, Inc. pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350).	Filed herewith

101.INS	XBRL Instance Document	Filed herewith

101.SCH	XBRL Taxonomy Schema	Filed herewith

101.CAL	XBRL Taxonomy Calculation Linkbase	Filed herewith

101.DEF	XBRL Taxonomy Definition Linkbase	Filed herewith

101.LAB	XBRL Taxonomy Label Linkbase	Filed herewith

101.PRE	XBRL Taxonomy Presentation Linkbase	Filed herewith

	(1)	Filed as Exhibit 4.1 to the registrant’s registration statement on Form S-8 with the SEC on April 1, 1998.
	(2)	Filed as Exhibit 3.2 to the registrant’s Quarterly Report on Form 10-Q filed with the SEC on December 12, 2005.
	(3)	Filed as Exhibit 10.1 to the registrant’s Current Report on Form 8-K filed with the SEC on September 5, 2013.
	(4)	Filed as Exhibit 10.1 to the registrant’s Current Report on Form 8-K filed with the SEC on September 11, 2013.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	COMPETITIVE TECHNOLOGIES, INC.
	(the registrant)

	By	/s/ Conrad Mir
		Conrad Mir
		President, Chief Executive Officer, and interim CFO
May 14, 2014		Authorized Signer(Duly Authorized Officer, Principal Executive Officer, and Principal Financial and Accounting Officer)

EX-31.1 2 v377106_ex31-1.htm EXHIBIT 31.1

Exhibit 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER,

PURSUANT TO EXCHANGE ACT RULE 13a-14(a)/15d-14(a)

AS ADOPTED PURSUANT TO SECTION 302 OF THE

SARBANES-OXLEY ACT OF 2002

I, Conrad Mir, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Competitive Technologies, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;

disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting;

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

a) all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

Dated: May 15, 2014

By:

/s/ Conrad Mir

Conrad Mir

President, Chief Executive Officer and interim Chief Financial Officer (Duly Authorized Officer, Principal Executive Officer, and Principal Financial Officer and Principal Accounting Officer)

EX-32.1 3 v377106_ex32-1.htm EXHIBIT 32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.SC. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE

SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Competitive Technologies, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2014 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Conrad Mir, chief executive officer of the Company, certifies, pursuant to 18 U.S.C. section 1350 of the Sarbanes-Oxley Act of 2002, that:

(1)	The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 15, 2014

By:

/s/ Conrad Mir

Conrad Mir

President, Chief Executive Officer and interim Chief Financial Officer (Duly Authorized Officer, Principal Executive Officer, and Principal Financial Officer and Principal Accounting Officer)

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

GRAPHIC 4 tlogo.jpg GRAPHIC begin 644 tlogo.jpg M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$" M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,# M`P,#`P,#`P,#_\``$0@`4@#.`P$1``(1`0,1`?_$`+$``0``!@,!```````` M```````!`@4&!P@#!`D*`0$``04!`````````````````0(#!`4&"!````4$ M`0(#!@$'!PT!`````0(#!`4`$08'""$2,1,405$B,A4)87&!D4(C,Q:AL5)B M1#87P>%R0V,T5'24E=;7&`H1``$#`P,"!`,'`P,%`0````$``@,1!`4A$@8Q M05%A(A.1,A1Q@:%"4M('L=$6X6(5P7+"(R07_]H`#`,!``(1`Q$`/P#[^*(E M$2B*!K=HWMX#\WA^?\*(K5RS*(/#H*4R/)I9M"P40U6=296N?N=8/F.Y)7#9J._AS7SYVG%8=ESM3]JJ](J"1W,NC M_J6#XX_L1_5O<:(O5)NY0>(IJHJ)K-ETBK)+$4*NW7;GMVJ)K$'M,!@$!HB[ MU$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1%`P7`0L(_@`V']/ M2B*U,NR_'<%QZ6RG+)AK"0,2T6=`B`=P`6#>)*I@`7N*H$[B"4`O?V6O1%Z3\*.;&0ZY>1^D M]_#+,8+S$V6+9;-H.FKF&.4X)EAYU=TD5%PP((]I#D'N]]$7NLV/40`/Y:(K;RC)H?$X5[.3[Y"-8,R&[EE MU.WS3#8"(HDZB=98X@4H``C<;T1:+9S`AOB692.V2+H:]9*>?!ZS2E8I&/=K M)GNUG%FV*Z[H]@,FV.44Q`;"%$668!+#L<9I1.-Q4+$L&21$HYA$?PZW; M-$0``5$!)/%#O.6_<(=1HBN`TTP$HE`Y!&WPE];!]1]@?WB]]$5AYMBFL-AQ MJT-F.*PDRU%(/@?J8\#QHZZ`*[)T6>%5%6_6Y!`;T1534F/9KJ=RQQ-FVR3( M=6OCD^B*R"C9:5PL5+BB@14LC)+2L`^`>@G-W(!1%M[1$HBX+G[A]UQMX^^J MMT=*5%?M"Q/_`';SH=M?-DMVR.W[G M#[#HK<7NAE"!7S4>OX_I&J/I&_K?\5`4![^EK_RU=C9'"""XFOB58E]XD4'PJIRC[!&W\_\`+59+>Q"N M1[Z>H*<+>^_Y[U"NE1HH2B)1$HB412G$0*-KW]E@[AO^2B*S.0CX411]0J4O15S8O4``\P'AU]F041=ABF_D7:;9LJ[,HH)1L*LR M!2W$+]0GSB!0`>HV'I1%GB"QEE&-P.<57"RA0]0=VZB+EHB41:@;=YR\5='9I%ZYVINS$ ML+SBWS5LK/BV1OHW3P,>64W5H M=1_MT-5S=UR_%64IAE<-['%I&G4&AKJK=VC]Q'AMI3,66OMH<@-?XCF+Q-FK M]"D))=9TV)(=OHS2"C%HZ;QY%^\O;YQDQZ]0"LBWXQE)8S)'#,Y@%=&.U!\/ M3JL.7G.):X#>RI-.H_'U*]-F\RN-FG6^`O=C[@Q;%F>SCIA@:[MT=RWROSO+ M!$8IRQ0>(+$4.L0"CWD#KUK!;Q7(S74D>V30`=IK4]/R]SHK$/.\1+*8PYIW45'3\?4K78?=1X&3#V98Q')C! M)!SCS26D)ML@>7`\>U@B&/+KN!&($2)LDR"8;#VF`.EZ@\,SW3V[FM:?*[]O M16?_`-`Q!%0]M:5[?N4D5]U?@+D4?,2L/R9P5]'8ZQ3E)ETBI,()QS)P_;P[ M=9T*D20W:M*O$VX>P%!`:D\+SW0QW.KJ?*[]O13_`)_B-:O;H*]OW*:9^ZKP M$QZ00BYOD[@D9)+MH]ZW:K?6U#*,Y9))Q'K"4D190KQL@VM5C(8 MB\Q6T7<;V%Q(&X$`T\*@+88;D-EG72-M""8P*].]:="?!;=IG`XB!1[@*)B' M&X#VJ%$.X@C8+]MZUJWJY:(E$2B)1%9.=Y[C.N<6EXPH&FY("=O[98@C^Q-\H=?91%ZVZ=9IX9K#!<;:BP2"/QF'!9(%&1SBX%F0 MYS&!)J8?-'OZF.-Q$.HWHBR8$ZX'H!V]Q\+BU\?9_9J(IC33X2F`#-+V'VM/ M=_RU$6:]0)`]"2DW)6YU$W1&R"A3-S@F4I>I2B5,@A MM$4U$2B*3NN)K]`+;\]NM_R#1%\=.W=#[)T9]RGD)L3?7"[*.96$[OF69]59 MI&`61CL10D%V:+!PKYBGEP[G'A*5`Q$P*L"1/,#YJ]#X[+V;^"VS;-_T]Y!( MW7\S;M;SJXMI`'6[]QVGI4GYM.ZU=W'Q[2/\`6JJ6 MV^`G,/+\0X1\<,DQ7-Y*5U9I;8F8/Y])%P\B,2RYX[_B'"9V>-;%G*>)"XOLM%;0GWKJ,5HZFGI<0:Z[JZ^%%B'C.;FQL+#/(V396 ME6]U3N/7%3E_KW>6H^1VP=<[#FX^Q7_P`%?L][YVIA^-[FVD[;ZI@-995L;(8C6Q,0?0FU)J25 M:2'H41G""5N]@WKDI/)(KT%)2U<=R?\`EC%XQ\&-QUBPOZN<-XZTZ]:TU.BZ M[`_QYDLB9[Z]NG&(M:&@EFA%:T_!4_[6_&C8T5O/.L,WQQ]VF.%9W&;?8RC+ M)]>1J6MG:+N'E#,32T^[*GD+9=RL5,B1$3>4H(AV]*R><\]L[W`P'CT;;>]] MQARTW%N+W=KEYVYF1T]J&NVAY%*[M*4IV5.P/@OL%A]NKG, MK_\`..2--SRVX8G'L&(EC#A/+977*>6Q4L:,QM-R8JBL&B:/*KW=O<;LO6MN MN:!F;MV-?_\`.RP+WM!):Y]*5/F.JVD?%);RP-U$[83?F,=!Z?#7LMA\^X(J M3_)#[4C]QQO=R.*R^F<*0Y*.5L=4C(=^T42S]R4P"V=M?*13[![>B9: MU&%Y]<38;(.N)"Z[]U_M.ZN8W9H&CR.HKW6ZS/!709:TAA=M@=&W>!0!QW&I M/W*Y-1\!,XVUM?[N^L]L>Z:FIW&AJ/$JUA>%W+LM?P/F=[#"[8T;:" M@J/@L0\.>'')3-=)\VM[96GM7&^-$WQTTCCDW'*#+2B$5CKU@H[A45Q, MX5GP6Q7_Y]];[4TUEF6XOM+4^WL%=JX8\.@ZS+"XZ M)Q1JFE-K.ET(^<$@3;F7?JN^J"HF*4J?P]+UK/YSRV)SMK8-Q4$4;H7/+ME: MG>&TK6O@NF_B""\P#IY,E,Y_U&@W$=&$^'VKZITW)KK%*H5,"G$!$3W,8#@" M@*B8+"0XAT$!KS8T2%_R=/(KT#=7]NZ,>R\`GP/^JJJ"@F^$3=Q@(`CX^`^` MW]MZP6W39+EUM0B1HKT(_JLV&I@:\FI/==FLE5I1$HBU/Y8\:V?)36I\6^K/ M(B:BSJ26/O$'!R1RKTMS%;2+4AR@LDM8"W$+D$;AUHB^738^M\OU#F,EA.;1 MBT-.Q:@@IZHBA4'S4BP`1]'6[?-;'(6_ M%BG"0I/FQDCE-'H$[#`38")DR@8GZR1?R417-_$!/^,2_P"O;?\`L"B*4<@* M4.X'Z91+U`PR#6P"'4!&^P2A8!]XA^6B+9?14XC(PLFU]0FX=(/"+G*15)83 M=YK>8(H34^(!^0]J(MAJ(E$2B+AN8PJ@'B``!+^`VN/\]$7QQ[4T;MF.^\JT MX[(4>2XW)L_D*=["1"X$UTT%25J- M]O#>VZ7/(G:>1N]B[%SS*\*+NAQA^.3&\EG+1W+PD#++0D4&J)1RZ>9&!UD1 M4%1,Y0+V`F!0&NNY'QOBT6`L7PM9$9?:WGU'J02-7=^BYOC<^2.CK+OIL+G=`RM35(PIQR]W@TWYO35M2/F[G758MQE.00@ M$[M#7J.OP6(U.8O,'`^/7(QK*;%V5+ZOVOLF7PS#<\3R2>"6P/8>(2@S1(EG M+B]65B(Z=@71""'FI%,*5@`*[+&<`_C_`"-R)+E[&W\,%7LVN)=O`VN)W"E" M#2G6JTEWRWF./@C]C=]-*\ZU;VZ_E*VFV3O/8NXMU8GJGD=RSV7Q?U1A'&K& M,BUS,P\E-Q"^=SRF+%E1DWFN M'G&;)-B[8SAMCV+\M'^/1FSDY2:AWN8:\8M&CY9286*JT7E6<:"A?VBIC")5 M1(-Q+>K5EQ3C4&7OX&!K:6I;LUTH3K\WYO\`HLN^S>7;C+-UM4PON&NK4=2- M>RWC^XGS#/R)Y)\9M:QG*C(=(\+\OP95[*[HP1S(,67\D#)LVR9VQI<104`INK3I4ZCR6TY M'R'-.S]I'NG6I\JK2C'^&3D6:??W"90[8A;@>PWK;9/B'%8V8JZ#6QR/B#I& M@..YQPQ,MYI-X/S&H9(&MZN_,/A5:#B/(,\XY&(EQ&YO<=P[R6GF:\B-[ MI\0.*\HOO':'U67W_N"'G'Y=IRV//9.'05Q\46*\^K,+E8-4@>72=+&5*V[S M&[+6KH\3P[ADK\DZ:)@=';1%NCN]0?S>2P+G+9Z/'V3B7"LLO<>/V+:#F)M; M<>/Z2XG%B^060+ZNA-42F1Y[KS&>3B*NV)*?+,Q,0J?D) MJ%*4!`Q"E^*N2XUQGAV0O9HPP"5IHW1VNE33U>'BM]!R+-4CC>XT!'A_9?7- M]O?84F7CSFC'JTN_5`BCUPY=M3J`I:QDS M%'I>U>FNFE2O3?$+JZNL:UUQ6E/Q^"W5KEUUJ41 M*(N(R90+\)>WX@$>P"@-KAW=1M8!#QHBU&Y8<4,,Y+8>JU=HIQF<1;993&,I M02(#A-;M'L8O%@*)U6:_RFO?M`W<'7P(O.W2SK,\&B9#3^?MUF&9ZZ73BBMU M$'2_U2)[3%CY",4:QDJ*R"#<``YA,0>\;"-$6:_K$G_1?_\`;I?_`,AT7-,IEDUDHU<'+%ZB15NN":B9A*<+@*R"Y4EFQOZIP` M0]U$58HB410$`'Q]@WHBT.S.(U@GR$GL_<\=H^>VUC.,/6;'9+;'1/DTC`*M M&[9G$MPO2W%[7F70.R\5X30&+YRM.1!8S)(3#&[>>B MSY-!LI:VS+.XN"ZVCIM%`*4Z M:C7\5K+;B''K2YDNX(-MQ+7<=SC7=UT)I\%3&^EN+TAL)_E!.$&.-YO8^*[) MC,GRK^#$"$=_378L58*:(G&IB8N<,3'.F8"@"H#81$.M5'E&?-H+-UP3"'!V MH%:MU%32IH?-2WB/'VOWL@`)_P!SO[KOY3C?%K"6F&)9%Q&@XR'TO-8]!ZA5 M4QACZ;'CYH8\^[<8B*;$RL;Z61:&!P0@$[G9BE$;FO3_`"CD&^9PN7;[BADT M'JVB@[:4\E5)Q/`3-VR0`C_N=_=79LCC[QZQ;#,DM&YVA.IUK55-_I#B_R)+*8EL'B7!/X[2,* MP981_&N'L09BQ"-(_1@,74.W*JC'MA*5(4BCY0&`;!48SE&?P<[[K&W!CFEK MN.UIK4]:.!'7PHIRO#..YR!EKDX/<@C^4;G-I04ZM(/16L[UOI?.==:KUYMS MA;BHXD24DU<0PE7&HR1QG$(X6[8Z,J=BBS.RCQ>+/!!5-04KE*8P]QK`,1\F MSL%Q+>1W+OJ)A1Y(#B1W&H-%+>'<>9:Q6;;>EO$06#<[0CH:UJ?O5HN=;\:< MBU:75\UP8C'F'85BC'.8[`QPMM]!8SF9.TG4G`8R4\4FJ@Y(X=&47$A4Q`2= M2A5NVY!F;4N=!.YID!#AH0?N.E?N61<<9PMU(R6>`&2,4::D4^!666,'J'6F MJG1H`Z=@`#T'58EAPWCN,,KK.W##*:N]3C7XDTZGHK6@>* M_%G.L4#'9/AIKIGKK%\=-G6*0$MB#44?XJGB/F^0QZ,4>/\`3I.W*4 M_?S5I9#QPXE/AC<;FN!N'2C?7^-8M+XT5'#&2D0S7R!XHLY@HXI8T`.K"G3\ MU8IKAU`;5BX_DV=QA>;&X,?N?-1K3_4&GW*C_".,U!^F]3>GJ?\`WU6UD#N1 MIB<8^A\@/,\X M5LGBI?*HN`?3S>[4$BI1L<]5>F`+AV(C[*IVMKT634+;40N%KB'4!Z#:]O8/ MX#5E%(*90()2D#M$;B4.@#<0O?\`-1%K]NW1T)M"-+)-4VT9FL(FI]%GCMDU MO.*?XO02*)NU*0:J#T`JH&*4P@-$7DWE$Y(X1DLAAV5QZ$+DL<ERV&B+>+2G*_,=OY&RQ>%UV@_18@F.798WR1F:/Q](U MQ[WC((]N<[I]BVZ>ZF[2B;5'TZ5NWM"W>"GMOY@#?OO?YK^VHJ5&P(#=(MNTH%MW`%KA8 M#&[C!X^!A'K3<5.U0!N0H)@43`"8`!0`P@%B@8`*8+V,%C>VIW%-JAZ5(+B4 M#$$1`>XIC`8!M:X#?I<.@_A0N)3:IP1(`B(!U'V^T.MP`/<`#X>ZHW&E.R;0 MI/2H]W>!;&L`!U&Q;&,8#`%[`;N.(WJ=Q3:GIDKG$P"<%"%(][C5'N*JBY:K4)1%QG"Q1L`F#M M[>P!``$!Z#U\0L%$6L/)3C/B_(##UXE193'\NC4U5<9RIBHJU>,G)DQ%-JZ6 M0,51['JJ``*)J"8!`:(OG!VB.Z-(9JYP3/FX(2$8HLFW,8-A"B*U%MQR'I0!!F\3>6&ZBD@MY136^8P`?H4H]1Z^%$ M6;N-VJ=TRP419 M2HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2HTWS4U4:N*$H MB41<:A"G*8#`)BB6PD#H`_DM80&B+6+D]Q?PCDIAAH.<108Y/')JJXSE2:)` M?QKH2&*1,ZI2"*[0YQ#O3'I8>EAZT1>$&M_M\;ERG=$GK/)HIQC\#C+L%<@S M(4C'BWL-YG[`\(MZ(O71[B.R-"Y'J[7/'W$V++635N09 M(4VA'+O)Y0PE*^'(9#N#TA@)B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB#X#_E\/ MST1=;^SAX^WY?'Q-\O\`6]WXT1<9_D`?-_6HBD0_?#^[^0?E\? LE+X?[?\`I?A1%4*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(O_]D_ ` end EX-101.INS 5 cttc-20140331.xml XBRL INSTANCE DOCUMENT <div> <div> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> <strong>9.           ACCRUED EXPENSES AND OTHER LIABILITIES</strong></p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> Accrued expenses and other liabilities consist of the following:</p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </p> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="2">March 31,<br />  2014</td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt"> </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center" colspan="2">December<br /> 31,<br />  2013</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center" colspan="2">  </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt" colspan="2"> </td> <td style="FONT-SIZE: 10pt"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; WIDTH: 72%; TEXT-ALIGN: left">Royalties payable</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; FONT-WEIGHT: bold">  </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; FONT-WEIGHT: bold; TEXT-ALIGN: left"> $</td> <td style="FONT-SIZE: 10pt; WIDTH: 11%; FONT-WEIGHT: bold; TEXT-ALIGN: right"> 155,208</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; FONT-WEIGHT: bold; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">$</td> <td style="FONT-SIZE: 10pt; WIDTH: 11%; TEXT-ALIGN: right"> 127,708</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">Accrued compensation</td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold"> </td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right"> 135,000</td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">-</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">Accrued accounting fees</td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold"> </td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right"> 80,000</td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">82,141</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">Commissions payable</td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold"> </td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right"> 21,975</td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">21,975</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">Accrued interest payable</td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold"> </td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right"> 241,487</td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">216,518</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"> Other payables</td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; FONT-WEIGHT: bold; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; FONT-WEIGHT: bold; TEXT-ALIGN: right"> 170,008</td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt"> </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> 134,645</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"> Accrued expenses and other liabilities, net</td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 2.5pt">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 2.5pt double; FONT-WEIGHT: bold; TEXT-ALIGN: left"> $</td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 2.5pt double; FONT-WEIGHT: bold; TEXT-ALIGN: right"> 803,678</td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt"> </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"> $</td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"> 582,987</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left">  </td> </tr> </table> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">   </p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> Excluded above is approximately $235,000 and $244,000 of accrued expenses and other liabilities at March 31, 2014 and December 31, 2013, respectively, that fall under the Liability Purchase Agreement ("LPA") with ASC Recap, LLC ("ASC Recap"), and are expected to be repaid using the process as described in Note 10.  Because there can be no assurance that the Company will be successful in completing this process, the Company retains ultimate responsibility for these liabilities, until fully paid down.</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in">  </p> </div> </div> 4183535 4183535 235000 244000 0.1 53338 53338 0.75 1000 0.2 223317 60 2100000 -98000 <div> <div> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> <strong>10.          LIABILITIES ASSIGNED TO LIABILITY PURCHASE AGREEMENT</strong></p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in">  </p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> During the third quarter of 2013, the Company negotiated a LPA with Southridge, Partners II, L.P. ("Southridge"). The LPA takes advantage of a provision in the Securities Act of 1933, Section 3(a)(10), that allows the exchange of claims, securities, or property for stock when the arrangement is approved for fairness by a court proceeding. The process, approved by the court in August 2013, has the potential to eliminate nearly $2.1 million of our financial obligations to existing creditors who agreed to participate and executed claims purchase agreements with Southridge's affiliate ASC Recap" accounting for $2,093,303 of existing payables, accrued expenses and other current liabilities, and notes payable. The process began with the issuance in September 2013 of 1,618,235 shares of the Company's common stock to ASC Recap. During September and October 2013, ASC Recap sold the Company's common stock and during the three months ended March 31, 2014 paid creditors approximately $80,000 from the proceeds and retained a service fee of approximately $27,000. As of May 14, 2014, no further shares of the Company's common stock had been issued to ASC Recap to settle creditors' balances.</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in">  </p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> There can be no assurance that the Company will be successful in completing this process with Southridge, and the Company retains ultimate responsibility for this debt, until fully paid.</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in">  </p> </div> </div> 2013320 2093303 2093303 18434 2498980 2518000 225000 225000 118536 87705 12000 12000 100076 81415 91127 69571 37007 3116998 2933691 34272 3117000 485980 505000 0.09 0.15 0.15 0.15 80000 0.075 0.015 0.15 341007 395023 0.85 375000 375000 7765 3917 32390 34272 14845 26811 10086 <div> <div> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> We estimated the fair value of the warrants on the issue date using a Black-Scholes pricing model with the following assumptions:</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in">  </p> <table style="WIDTH: 80%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt"> </td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="2">Warrants<br /> (Tranche 1)-<br /> November 15,<br /> 2013</td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt">  </td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="2">Warrants<br /> (Tranche 2)-<br /> December 30,<br /> 2013</td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt">  </td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="2">Warrants<br /> (Tranche 3)-<br /> February 14,<br /> 2014</td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">Expected term</td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">2 years</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">2 years</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">2 years</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt; WIDTH: 49%">Volatility</td> <td style="FONT-SIZE: 10pt; WIDTH: 2%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; WIDTH: 13%; TEXT-ALIGN: right"> 180.02</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">%</td> <td style="FONT-SIZE: 10pt; WIDTH: 2%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; WIDTH: 13%; TEXT-ALIGN: right"> 184.38</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">%</td> <td style="FONT-SIZE: 10pt; WIDTH: 2%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; WIDTH: 13%; TEXT-ALIGN: right"> 184.88</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">%</td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">Risk Free Rate</td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">0.31</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">%</td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">0.39</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">%</td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">0.32</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">%</td> </tr> </table> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </p> </div> </div> <div> <div> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> We estimated the fair value of the warrants on the issue date using a Black-Scholes pricing model with the following assumptions:</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in">  </p> <table style="WIDTH: 60%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="PADDING-BOTTOM: 1pt"> </td> <td style="PADDING-BOTTOM: 1pt"> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center" colspan="2"><font style="FONT-SIZE: 10pt"><strong>Warrants</strong></font> <br /> <font style="FONT-SIZE: 10pt"><strong>March 20,</strong></font> <br /> <font style="FONT-SIZE: 10pt"><strong>2014</strong></font></td> <td style="PADDING-BOTTOM: 1pt"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt">Expected term</td> <td> </td> <td> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">4 years</td> <td> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt; WIDTH: 84%">Volatility</td> <td style="WIDTH: 1%"> </td> <td style="WIDTH: 1%"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right; WIDTH: 13%"> 151.52</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%">%</td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt">Risk Free Rate</td> <td> </td> <td> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">1.32</td> <td style="FONT-SIZE: 10pt">%</td> </tr> </table> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in">  </p> </div> </div> <div> <div> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> The proceeds of the Notes issued during the three months ended March 31, 2014 were allocated to the components as follows:</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in">  </p> <table style="WIDTH: 70%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td nowrap="nowrap"> </td> <td style="PADDING-BOTTOM: 1pt" nowrap="nowrap"> </td> <td style="BORDER-BOTTOM: black 1pt solid" colspan="2" nowrap="nowrap"><font style="FONT-SIZE: 10pt">Proceeds allocated</font> <br /> <font style="FONT-SIZE: 10pt">at issue date</font></td> <td style="PADDING-BOTTOM: 1pt" nowrap="nowrap"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ccffcc"> <td style="FONT-SIZE: 10pt; WIDTH: 87%">Private Offering Notes</td> <td style="WIDTH: 1%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%">$</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right; WIDTH: 10%"> 32,390</td> <td style="WIDTH: 1%"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt">Private Offering Warrants</td> <td> </td> <td> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">14,845</td> <td> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ccffcc"> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt">Beneficial Conversion feature</td> <td style="PADDING-BOTTOM: 1pt"> </td> <td style="BORDER-BOTTOM: black 1pt solid"> </td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 10pt; TEXT-ALIGN: right"> 7,765</td> <td style="PADDING-BOTTOM: 1pt"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt">Total</td> <td style="PADDING-BOTTOM: 2.5pt"> </td> <td style="BORDER-BOTTOM: black 2.25pt double; FONT-SIZE: 10pt"> $</td> <td style="BORDER-BOTTOM: black 2.25pt double; FONT-SIZE: 10pt; TEXT-ALIGN: right"> 55,000</td> <td style="PADDING-BOTTOM: 2.5pt"> </td> </tr> </table> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> <strong> </strong></p> </div> </div> <div> <div> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> The proceeds of the Notes were allocated to the components as follows:</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in">  </p> <table style="WIDTH: 70%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td nowrap="nowrap"> </td> <td style="PADDING-BOTTOM: 1pt" nowrap="nowrap"> </td> <td style="BORDER-BOTTOM: black 1pt solid" colspan="2" nowrap="nowrap"><font style="FONT-SIZE: 10pt">Proceeds allocated</font> <br /> <font style="FONT-SIZE: 10pt">at issue date</font></td> <td style="PADDING-BOTTOM: 1pt" nowrap="nowrap"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; WIDTH: 87%">Private Offering Notes</td> <td style="WIDTH: 1%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%">$</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right; WIDTH: 10%"> 34,272</td> <td style="WIDTH: 1%"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt">Private Offering Warrants</td> <td> </td> <td> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">26,811</td> <td> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt">Beneficial Conversion feature</td> <td style="PADDING-BOTTOM: 1pt"> </td> <td style="BORDER-BOTTOM: black 1pt solid"> </td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 10pt; TEXT-ALIGN: right"> 3,917</td> <td style="PADDING-BOTTOM: 1pt"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt">Total</td> <td style="PADDING-BOTTOM: 2.5pt"> </td> <td style="BORDER-BOTTOM: black 2.25pt double; FONT-SIZE: 10pt"> $</td> <td style="BORDER-BOTTOM: black 2.25pt double; FONT-SIZE: 10pt; TEXT-ALIGN: right"> 65,000</td> <td style="PADDING-BOTTOM: 2.5pt"> </td> </tr> </table> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in">  </p> </div> </div> 98000 1618235 8000 112500 P5Y P2Y P1Y P4Y false --12-31 Q1 2014 2014-03-31 10-Q 0000102198 22463532 Smaller Reporting Company COMPETITIVE TECHNOLOGIES INC

294

394

650254

692251

86023

132850

803678

582987

80000

82141

155208

127708

135000

21975

171755

169931

46730636

46077394

106644

14328

101154

61364

1367000

1409000

375

4750240

4566332

4726380

4543726

343748

57009

74322

59684

-14638

286739

0.60

0.45

0.35

0.40

0.60

1250000

185714

958179

<div> <div> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> <strong>13</strong>.            <strong>CONTRACTUAL OBLIGATIONS AND CONTINGENCIES</strong></p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> As of March 31, 2014, CTI and its majority owned subsidiary, VVI, have remaining obligations, contingent upon receipt of certain revenues, to repay up to $165,701 and $198,365, respectively, in consideration of grant funding received in 1994 and 1995.  CTI also is obligated to pay at the rate of 7.5% of its revenues, if any, from transferring rights to certain inventions supported by the grant funds.  VVI is obligated to pay at rates of 1.5% of its net sales of supported products or 15% of its revenues from licensing supported products, if any.  </p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> We have engaged R.F. Lafferty & Co. to seek an acquisition partner from a limited number of companies for our nanoparticle bone biomaterial patents, among other assets and/or securities.  The Company would pay Lafferty a 10% finder's fee in the event an acquisition partner is found, which management has deemed to be an immaterial and contingent obligation.</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in">  </p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> <em>Contingencies - Litigation</em></p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> <em> </em></p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> <strong><em>Carolina Liquid Chemistries Corporation, et al</em>. (case pending)</strong> - On August 29, 2005, we filed a complaint against Carolina Liquid Chemistries Corporation ("Carolina Liquid") in the United States District Court for the District of Colorado, alleging patent infringement of our patent covering homocysteine assays, and seeking monetary damages, punitive damages, attorneys' fees, court costs and other remuneration at the option of the court. As we became aware of other infringers, we amended our complaint to add as defendants Catch, Inc. ("Catch") and the Diazyme Laboratories Division of General Atomics ("Diazyme"). On September 6, 2006, Diazyme filed for declaratory judgment in the Southern District of California for a change in venue and a declaration of non-infringement and invalidity. On September 12, 2006, the District Court in Colorado ruled that both Catch and Diazyme be added as defendants to the Carolina Liquid case.</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in">  </p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> On October 23, 2006, Diazyme requested the United States Patent and Trademark Office (the "USPTO") to re-evaluate the validity of our patent and this request was granted by the USPTO on December 14, 2006. On July 30, 2009, the U.S. Patent and Trademark Office's Board of Patent Appeals and Interferences ("BPAI") upheld the homocysteine patent. In September 2008, the examiner had denied the patent, but that denial was overruled by the BPAI. While the examiner had appealed that BPAI decision, delaying further action, that appeal was also denied by the BPAI on December 13, 2010. In June 2011, the examiner once again appealed the BPAI decision. In addition to responding to this new appeal, the Company petitioned the Director of the USPTO to help expedite further action on the case within the USPTO, which was to have been handled with special dispatch according to USPTO requirements for handling reexamination proceedings of patents involved in litigation.</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in">  </p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> On March 13, 2012, the USPTO issued the Ex Parte Reexamination Certificate confirming the patentability of claims examined. The company has begun collecting unpaid amounts from various obligated companies.</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> <em> </em></p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> <strong><em>Employment matters - former employee</em> (case pending) <em>-</em></strong> In September 2003, a former employee filed a whistleblower complaint with the Occupational Safety and Health Administration of the Department of Labor (OSHA) alleging that the employee had been terminated for engaging in conduct protected under the Sarbanes Oxley Act of 2002 (SOX). In February 2005, OSHA found probable cause to support the employee's complaint and the Secretary of Labor ordered reinstatement and back wages since the date of termination and CTCC requested de novo review and a hearing before an administrative law judge ("ALJ"). In July 2005, after the close of the hearing on CTI's appeal, the U.S. district court for Connecticut enforced the Secretary's preliminary order of reinstatement and back pay under threat of contempt and the Company rehired the employee with back pay.</p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> On October 5, 2005, the ALJ who conducted the hearing on CTI's appeal of the OSHA findings ruled in CTI's favor and recommended dismissal of the employee's complaint. Although the employee abandoned his position upon notice of the ALJ's decision, he nevertheless filed a request for review by the DOL Administrative Review Board ("ARB").</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in">  </p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> In May 2006, the U.S. Court of Appeals for the Second Circuit vacated the order of the district court enforcing the Secretary's preliminary order of reinstatement and back pay. The employee also filed a new SOX retaliation complaint with OSHA based on alleged black listing action by CTI following his termination. OSHA dismissed the complaint and the employee filed a request for a hearing by an administrative law judge. Ultimately, the employee voluntarily dismissed the appeal.</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in">  </p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> In March 2008, the ARB issued an order of remand in the employee's appeal of the October 2005 dismissal of his termination complaint, directing the ALJ to clarify her analysis utilizing the burden-shifting standard articulated by the ARB. In January 2009, the ALJ issued a revised decision again recommending dismissal and once again the employee appealed the ruling to the ARB. On September 30, 2011, the ARB issued a final decision and order affirming the ALJ's decision on remand and dismissing the employee's complaint. The employee has appealed the ARB's decision before the U.S. Court of Appeals for the Second Circuit which has ordered the employee to file his opening brief by May 31, 2012. Response briefs by the Solicitor's Office of the U.S. Department of Labor and CTI were submitted in August 2012. In March 2013, the U.S Court of Appeals for the Second Circuit upheld the ARB's decision dismissing the former employee's complaint and denied the employee's appeal from that order. In April 2013, the Second Circuit terminated proceedings in that court.</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in">  </p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> <em>Summary</em> - We may be a party to other legal actions and proceedings from time to time. We are unable to estimate legal expenses or losses we may incur, if any, or possible damages we may recover, and we have not recorded any potential judgment losses or proceeds in our financial statements to date. We record expenses in connection with these suits as incurred.</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in">  </p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> We believe that we carry adequate liability insurance, directors and officers insurance, casualty insurance, for owned or leased tangible assets, and other insurance as needed to cover us against potential and actual claims and lawsuits that occur in the ordinary course of our business. However, an unfavorable resolution of any or all matters, and/or our incurrence of significant legal fees and other costs to defend or prosecute any of these actions and proceedings may, depending on the amount and timing, have a material adverse effect on our consolidated financial position, results of operations or cash flows in a particular period.</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in">  </p> </div> </div>

0.01

40000000

22463532

19952907

22463532

19952907

224635

199529

0.13

0.98

0.66

0.01

375

315126

3117000

2040000

<div> <div> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> The Company has issued 90-day notes payable to borrow funds from a director, now the chairman of our Board, as follows:</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in">  </p> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; WIDTH: 87%">2013</td> <td style="WIDTH: 1%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%">$</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right; WIDTH: 10%"> 1,188,980</td> <td style="WIDTH: 1%"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt">2012</td> <td> </td> <td> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">1,210,000</td> <td> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt">2011</td> <td style="PADDING-BOTTOM: 1pt"> </td> <td style="BORDER-BOTTOM: black 1pt solid"> </td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 10pt; TEXT-ALIGN: right"> 100,000</td> <td style="PADDING-BOTTOM: 1pt"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt">Total</td> <td style="PADDING-BOTTOM: 2.5pt"> </td> <td style="BORDER-BOTTOM: black 2.25pt double; FONT-SIZE: 10pt"> $</td> <td style="BORDER-BOTTOM: black 2.25pt double; FONT-SIZE: 10pt; TEXT-ALIGN: right"> 2,498,980</td> <td style="PADDING-BOTTOM: 2.5pt"> </td> </tr> </table> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in">   </p> </div> </div>

19348

70218

400

<div> <div> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> <strong>11.           NOTES PAYABLE</strong></p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> <strong> </strong></p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> Notes payable consist of the following:</p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </p> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold"> </td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="2">March 31, <br /> 2014</td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center" colspan="2"> December 31, <br /> 2013</td> <td style="FONT-SIZE: 10pt"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; WIDTH: 74%; TEXT-ALIGN: left">90 day Convertible Notes (Chairman of the Board)</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; FONT-WEIGHT: bold">  </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; FONT-WEIGHT: bold; TEXT-ALIGN: left"> $</td> <td style="FONT-SIZE: 10pt; WIDTH: 10%; FONT-WEIGHT: bold; TEXT-ALIGN: right"> 2,498,980</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; FONT-WEIGHT: bold; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">$</td> <td style="FONT-SIZE: 10pt; WIDTH: 10%; TEXT-ALIGN: right"> 2,518,000</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">24 month Convertible Notes ($100,000 to Board member)</td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold"> </td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right"> 225,000</td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">225,000</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">Tonaquint 9% OID Convertible Notes and Warrants</td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold"> </td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right"> 118,536</td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">87,705</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">Southridge Convertible Note</td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold"> </td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right"> 12,000</td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">12,000</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">Series A1 15% OID Convertible Notes and Warrants</td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold"> </td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right"> 100,076</td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">81,415</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">Series A2 15% OID Convertible Notes and Warrants</td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold"> </td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right"> 91,127</td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">69,571</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">Series A3 15% OID Convertible Notes and Warrants</td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold"> </td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right"> 37,007</td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">-</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"> Series B OID Convertible Notes and Warrants</td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; FONT-WEIGHT: bold; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; FONT-WEIGHT: bold; TEXT-ALIGN: right"> 34,272</td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt"> </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">Notes Payable, gross</td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold"> </td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right"> 3,116,998</td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">2,933,691</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"> Less LPA amount</td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; FONT-WEIGHT: bold; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; FONT-WEIGHT: bold; TEXT-ALIGN: right"> (485,980</td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"> )</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt"> </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> (505,000</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"> )</td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"> Notes Payable, net</td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 2.5pt">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 2.5pt double; FONT-WEIGHT: bold; TEXT-ALIGN: left"> $</td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 2.5pt double; FONT-WEIGHT: bold; TEXT-ALIGN: right"> 2,631,018</td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt"> </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"> $</td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"> 2,488,691</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left">  </td> </tr> </table> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">    </p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px 0pt 1in; TEXT-INDENT: 0.5in"> Details of notes payable as of March 31, 2014 are as follows:</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in">  </p> <table style="WIDTH: 93%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif; MARGIN-LEFT: 0.5in" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td nowrap="nowrap"> </td> <td style="PADDING-BOTTOM: 1pt" nowrap="nowrap"> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center" colspan="2" nowrap="nowrap"><font style="FONT-SIZE: 10pt">Principal</font> <br /> <font style="FONT-SIZE: 10pt">Amount</font></td> <td style="PADDING-BOTTOM: 1pt" nowrap="nowrap"> </td> <td style="PADDING-BOTTOM: 1pt" nowrap="nowrap"> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center" colspan="2" nowrap="nowrap"><font style="FONT-SIZE: 10pt">Carrying</font> <br /> <font style="FONT-SIZE: 10pt">Value</font></td> <td style="PADDING-BOTTOM: 1pt" nowrap="nowrap"> </td> <td style="PADDING-BOTTOM: 1pt" nowrap="nowrap"> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center" colspan="2" nowrap="nowrap"><font style="FONT-SIZE: 10pt">Cash</font> <br /> <font style="FONT-SIZE: 10pt">Interest</font> <br /> <font style="FONT-SIZE: 10pt">Rate</font></td> <td style="PADDING-BOTTOM: 1pt" nowrap="nowrap"> </td> <td style="PADDING-BOTTOM: 1pt" nowrap="nowrap"> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center" colspan="2" nowrap="nowrap"><font style="FONT-SIZE: 10pt">Common</font> <br /> <font style="FONT-SIZE: 10pt">Stock</font> <br /> <font style="FONT-SIZE: 10pt">Conversion</font> <br /> <font style="FONT-SIZE: 10pt">Price</font></td> <td style="PADDING-BOTTOM: 1pt" nowrap="nowrap"> </td> <td style="PADDING-BOTTOM: 1pt" nowrap="nowrap"> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center" nowrap="nowrap"><font style="FONT-SIZE: 10pt">Maturity</font> <br /> <font style="FONT-SIZE: 10pt">Date</font></td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; WIDTH: 32%">90 day Convertible Notes (Chairman of the Board)</td> <td style="WIDTH: 1%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%">$</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right; WIDTH: 10%"> 2,498,980</td> <td style="WIDTH: 1%"> </td> <td style="WIDTH: 1%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%">$</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right; WIDTH: 10%"> 2,498,980</td> <td style="WIDTH: 1%"> </td> <td style="WIDTH: 1%"> </td> <td style="WIDTH: 1%"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right; WIDTH: 10%">6</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%">%</td> <td style="WIDTH: 1%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%">$</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right; WIDTH: 10%"> 1.05</td> <td style="WIDTH: 1%"> </td> <td style="WIDTH: 1%"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center; WIDTH: 15%">Various 2014</td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt">24 month Convertible Notes ($100,000 to Board member)</td> <td> </td> <td> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">225,000</td> <td> </td> <td> </td> <td> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">225,000</td> <td> </td> <td> </td> <td> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">6</td> <td style="FONT-SIZE: 10pt">%</td> <td> </td> <td> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">1.05</td> <td> </td> <td> </td> <td style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt">March 2014 -</font><br /> <font style="FONT-SIZE: 10pt">June 2014</font></td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt">Tonaquint 9% OID Convertible Notes (1)</td> <td> </td> <td> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">112,500</td> <td> </td> <td> </td> <td> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">118,536</td> <td> </td> <td> </td> <td> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">7</td> <td style="FONT-SIZE: 10pt">%</td> <td> </td> <td> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">0.30</td> <td> </td> <td> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center">May 2014</td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt">Southridge Convertible Note</td> <td> </td> <td> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">12,000</td> <td> </td> <td> </td> <td> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">12,000</td> <td> </td> <td> </td> <td> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">None</td> <td> </td> <td> </td> <td> </td> <td style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt">75% of closing</font> <br /> <font style="FONT-SIZE: 10pt">bid</font></td> <td> </td> <td> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center">June 2014</td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt">Series A1 15% OID Convertible Notes and Warrants</td> <td> </td> <td> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">149,412</td> <td> </td> <td> </td> <td> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">100,076</td> <td> </td> <td> </td> <td> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">None</td> <td> </td> <td> </td> <td> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">0.20</td> <td> </td> <td> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center">August 2014</td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt">Series A2 15% OID Convertible Notes and Warrants</td> <td> </td> <td> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">134,236</td> <td> </td> <td> </td> <td> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">91,127</td> <td> </td> <td> </td> <td> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">None</td> <td> </td> <td> </td> <td> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">0.25</td> <td> </td> <td> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center">September 2014</td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt">Series A3 15% OID Convertible Notes and Warrants</td> <td style="PADDING-BOTTOM: 1pt"> </td> <td> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">64,706</td> <td style="PADDING-BOTTOM: 1pt"> </td> <td style="PADDING-BOTTOM: 1pt"> </td> <td style="PADDING-BOTTOM: 1pt"> </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: right"> 37,007</td> <td style="PADDING-BOTTOM: 1pt"> </td> <td style="PADDING-BOTTOM: 1pt"> </td> <td style="PADDING-BOTTOM: 1pt"> </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: right"> None</td> <td style="PADDING-BOTTOM: 1pt"> </td> <td style="PADDING-BOTTOM: 1pt"> </td> <td style="PADDING-BOTTOM: 1pt"> </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: right"> 0.25</td> <td style="PADDING-BOTTOM: 1pt"> </td> <td style="PADDING-BOTTOM: 1pt"> </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center"> January 2015</td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt">Series B OID Convertible Notes and Warrants</td> <td style="PADDING-BOTTOM: 1pt"> </td> <td style="BORDER-BOTTOM: black 1pt solid"> </td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 10pt; TEXT-ALIGN: right"> 80,000</td> <td style="PADDING-BOTTOM: 1pt"> </td> <td style="PADDING-BOTTOM: 1pt"> </td> <td style="BORDER-BOTTOM: black 1pt solid"> </td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 10pt; TEXT-ALIGN: right"> 34,272</td> <td style="PADDING-BOTTOM: 1pt"> </td> <td style="PADDING-BOTTOM: 1pt"> </td> <td style="PADDING-BOTTOM: 1pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">None</td> <td style="PADDING-BOTTOM: 1pt"> </td> <td style="PADDING-BOTTOM: 1pt"> </td> <td> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">0.35</td> <td style="PADDING-BOTTOM: 1pt"> </td> <td style="PADDING-BOTTOM: 1pt"> </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center"> March 2017</td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt">Notes Payable, gross</td> <td style="PADDING-BOTTOM: 2.5pt"> </td> <td style="BORDER-BOTTOM: black 2.25pt double; FONT-SIZE: 10pt"> $</td> <td style="BORDER-BOTTOM: black 2.25pt double; FONT-SIZE: 10pt; TEXT-ALIGN: right"> 3,276,834</td> <td style="PADDING-BOTTOM: 2.5pt"> </td> <td style="PADDING-BOTTOM: 2.5pt"> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right">  </td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 10pt; TEXT-ALIGN: right"> 3,116,998</td> <td style="PADDING-BOTTOM: 2.5pt"> </td> <td style="PADDING-BOTTOM: 2.5pt"> </td> <td style="PADDING-BOTTOM: 2.5pt"> </td> <td style="PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: right"> </td> <td style="PADDING-BOTTOM: 2.5pt"> </td> <td style="PADDING-BOTTOM: 2.5pt"> </td> <td style="PADDING-BOTTOM: 2.5pt"> </td> <td style="PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: right"> </td> <td style="PADDING-BOTTOM: 2.5pt"> </td> <td style="PADDING-BOTTOM: 2.5pt"> </td> <td style="PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: center"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt">Less LPA amount</td> <td style="PADDING-BOTTOM: 1pt"> </td> <td style="PADDING-BOTTOM: 1pt"> </td> <td style="PADDING-BOTTOM: 1pt; TEXT-ALIGN: right"> </td> <td style="PADDING-BOTTOM: 1pt"> </td> <td style="PADDING-BOTTOM: 1pt"> </td> <td style="BORDER-BOTTOM: black 1pt solid"> </td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 10pt; TEXT-ALIGN: right"> (485,980</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt">)</td> <td style="PADDING-BOTTOM: 1pt"> </td> <td style="PADDING-BOTTOM: 1pt"> </td> <td style="PADDING-BOTTOM: 1pt; TEXT-ALIGN: right"> </td> <td style="PADDING-BOTTOM: 1pt"> </td> <td style="PADDING-BOTTOM: 1pt"> </td> <td style="PADDING-BOTTOM: 1pt"> </td> <td style="PADDING-BOTTOM: 1pt; TEXT-ALIGN: right"> </td> <td style="PADDING-BOTTOM: 1pt"> </td> <td style="PADDING-BOTTOM: 1pt"> </td> <td style="PADDING-BOTTOM: 1pt; TEXT-ALIGN: center"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt">Notes Payable, net</td> <td style="PADDING-BOTTOM: 2.5pt"> </td> <td style="PADDING-BOTTOM: 2.5pt"> </td> <td style="PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: right"> </td> <td style="PADDING-BOTTOM: 2.5pt"> </td> <td style="PADDING-BOTTOM: 2.5pt"> </td> <td style="BORDER-BOTTOM: black 2.25pt double; FONT-SIZE: 10pt"> $</td> <td style="BORDER-BOTTOM: black 2.25pt double; FONT-SIZE: 10pt; TEXT-ALIGN: right"> 2,631,018</td> <td style="PADDING-BOTTOM: 2.5pt"> </td> <td style="PADDING-BOTTOM: 2.5pt"> </td> <td style="PADDING-BOTTOM: 2.5pt"> </td> <td style="PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: right"> </td> <td style="PADDING-BOTTOM: 2.5pt"> </td> <td style="PADDING-BOTTOM: 2.5pt"> </td> <td style="PADDING-BOTTOM: 2.5pt"> </td> <td style="PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: right"> </td> <td style="PADDING-BOTTOM: 2.5pt"> </td> <td style="PADDING-BOTTOM: 2.5pt"> </td> <td style="PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: center"> </td> </tr> </table> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in">   </p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px 0pt 0.5in; TEXT-INDENT: 0.5in">   (1) Original terms noted above. The Company executed a debt settlement agreement with Tonaquint during the first quarter of 2014, cash-settled the warrant during the first quarter of 2014 and cash-settled the note during the second quarter of 2014. See further discussion below under "<strong><u>Tonaquint 9% Original Issue Discount Convertible Notes and Warrants"</u></strong>.</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in">  </p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px 0pt 0.5in"> <strong><u>90 day Convertible Notes</u></strong></p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> The Company has issued 90-day notes payable to borrow funds from a director, now the chairman of our Board, as follows:</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in">  </p> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; WIDTH: 87%">2013</td> <td style="WIDTH: 1%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%">$</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right; WIDTH: 10%"> 1,188,980</td> <td style="WIDTH: 1%"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt">2012</td> <td> </td> <td> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">1,210,000</td> <td> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt">2011</td> <td style="PADDING-BOTTOM: 1pt"> </td> <td style="BORDER-BOTTOM: black 1pt solid"> </td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 10pt; TEXT-ALIGN: right"> 100,000</td> <td style="PADDING-BOTTOM: 1pt"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt">Total</td> <td style="PADDING-BOTTOM: 2.5pt"> </td> <td style="BORDER-BOTTOM: black 2.25pt double; FONT-SIZE: 10pt"> $</td> <td style="BORDER-BOTTOM: black 2.25pt double; FONT-SIZE: 10pt; TEXT-ALIGN: right"> 2,498,980</td> <td style="PADDING-BOTTOM: 2.5pt"> </td> </tr> </table> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in">   </p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> These notes have been extended several times and all bear 6.00% simple interest.  A conversion feature was added to the Notes when they were extended, which allows for conversion of the eligible principal amounts to common stock at any time after the six month anniversary of the effective date -the date the funds are received - at a rate of $1.05 per share.  Additional terms have been added to all Notes to include additional interest payments to all Notes if extended beyond their original maturity dates and to provide the lender with a security interest in unencumbered inventory and intangible assets of the Company other than proceeds relating to the Calmare device and accounts receivable.</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in">  </p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> A total of $485,980 of the aforementioned notes issued between December 1, 2012 and March 31, 2013 fall under the LPA with ASC Recap, and are expected to be repaid using the process as described in Note 10.  Because there can be no assurance that the Company will be successful in completing this process, the Company retains ultimate responsibility for this debt, until fully paid down.  As a result, the Company continues to accrue interest on these notes and they remain convertible as described above.</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in">  </p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px 0pt 0.5in"> <strong><u>24 month Convertible Notes</u></strong></p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> In March 2012, the Company issued a 24-month convertible promissory note to borrow $100,000. Additional 24-month convertible promissory notes were issued in April 2012 ($25,000) and in June 2012 ($100,000). All of the notes bear 6.00% simple interest. Conversion of the eligible principal amounts to common stock is allowed at any time after the six month anniversary of the effective date of each note at a rate of $1.05 per share.</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in">  </p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> As of May 14, 2014 the Company has not repaid the principal due on the March 2012 $100,000 note or the April 2012 $25,000 note and as such is in default under the terms of the notes. There is also unpaid interest related to these notes.</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in">  </p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px 0pt 0.5in"> <strong><u>Tonaquint 9% Original Issue Discount Convertible Notes and Warrants</u></strong></p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> During the quarter ended September 30, 2013, the Company entered into a securities purchase agreement with Tonaquint, Inc., under which it was issued a $112,500 convertible promissory note in consideration for $100,000, the difference between the proceeds from the Note and the principal amount consisted of a $10,000 original issue discount and a carried transaction expense of $2,500. The original issue discount was being amortized over the life of the note. The note was convertible at an initial conversion price of $0.30 per share at any time, and contained a "down-round protection" feature that requires the valuation of a derivative liability associated with the note. The note bore interest at 7% and was due in May 2014. Tonaquint was also issued a market-related warrant for $112,500 in shares of common stock with a "cashless" exercise feature. The warrant had a $0.35 exercise price, a 5-year term and included a "down-round protection" feature that required it to be classified as a liability rather than as equity (see Note 6).</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in">  </p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> During the first quarter of 2014 the Company executed a debt settlement agreement with Tonaquint related to the note and warrant. The warrant was settled during the first quarter of 2014 for a cash payment of $98,000, resulting in a loss of $98,000. The note was settled during the second quarter of 2014 for cash payments totaling $144,000 ($20,000 paid in the first quarter of 2014 and $124,000 paid in the second quarter of 2014). Because the execution of the debt settlement agreement in the first quarter of 2014 resulted in a significant modification of the original terms of the note agreement, the Company adjusted the carrying value of the note in the first quarter of 2014 and recorded a related loss of approximately $34,000.</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in">  </p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px 0pt 0.5in"> <strong><u>Southridge</u></strong></p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> During 2013, the Company issued a six-month $12,000 convertible note payable to Southridge to cover legal expenses as part of the LPA (see Note 10). The convertible note is convertible into the Company's common stock at 75% of the lowest closing bid price during the twenty (20) trading days prior to conversion and is due in June 2014.</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in">  </p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> <strong><u>Series A 15% Original Issue Discount Convertible Notes and Warrants</u></strong></p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> During the quarter ended December 31, 2013, the Company did a private offering of two tranches of convertible notes and warrants, under which it issued $283,648 of convertible promissory notes for consideration of $241,100, the difference between the proceeds from the notes and the principal amount consists of $42,548 of original issue discount. During the quarter ended March 31, 2014, the Company did a private offering of a third tranche of convertible notes and warrants, under which it issued $64,706 of convertible promissory notes for consideration of $55,000, the difference between the proceeds from the notes and principal amount consists of $9,706 of original issue discount. The notes are convertible at initial conversion prices ranging from $0.20 to $0.25 per share anytime after issuance thereby having an embedded beneficial conversion feature. The note holders were also issued market-related warrants for 958,179 in shares of common stock. The warrants have exercise prices that range from $0.40 to $0.60 and a 2-year term. The beneficial conversion feature and the warrants were recorded to additional paid-in-capital. The Company allocated the proceeds received to the notes, the beneficial conversion feature and the warrants on a relative fair value basis at the time of issuance. The total debt discount is amortized over the life of the notes to interest expense.</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> <strong> </strong></p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> The beneficial conversion feature was valued at the intrinsic value on the issuance date. The intrinsic value represents the difference between the conversion price and the fair value of the common stock multiplied by the number of share into which the note is convertible. We estimated the fair value of the warrants on the issue date using a Black-Scholes pricing model with the following assumptions:</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in">  </p> <table style="WIDTH: 80%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt"> </td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="2">Warrants<br /> (Tranche 1)-<br /> November 15,<br /> 2013</td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt">  </td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="2">Warrants<br /> (Tranche 2)-<br /> December 30,<br /> 2013</td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt">  </td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="2">Warrants<br /> (Tranche 3)-<br /> February 14,<br /> 2014</td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">Expected term</td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">2 years</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">2 years</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">2 years</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt; WIDTH: 49%">Volatility</td> <td style="FONT-SIZE: 10pt; WIDTH: 2%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; WIDTH: 13%; TEXT-ALIGN: right"> 180.02</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">%</td> <td style="FONT-SIZE: 10pt; WIDTH: 2%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; WIDTH: 13%; TEXT-ALIGN: right"> 184.38</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">%</td> <td style="FONT-SIZE: 10pt; WIDTH: 2%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; WIDTH: 13%; TEXT-ALIGN: right"> 184.88</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">%</td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">Risk Free Rate</td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">0.31</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">%</td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">0.39</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">%</td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">0.32</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">%</td> </tr> </table> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> The proceeds of the Notes issued during the three months ended March 31, 2014 were allocated to the components as follows:</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in">  </p> <table style="WIDTH: 70%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td nowrap="nowrap"> </td> <td style="PADDING-BOTTOM: 1pt" nowrap="nowrap"> </td> <td style="BORDER-BOTTOM: black 1pt solid" colspan="2" nowrap="nowrap"><font style="FONT-SIZE: 10pt">Proceeds allocated</font> <br /> <font style="FONT-SIZE: 10pt">at issue date</font></td> <td style="PADDING-BOTTOM: 1pt" nowrap="nowrap"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ccffcc"> <td style="FONT-SIZE: 10pt; WIDTH: 87%">Private Offering Notes</td> <td style="WIDTH: 1%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%">$</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right; WIDTH: 10%"> 32,390</td> <td style="WIDTH: 1%"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt">Private Offering Warrants</td> <td> </td> <td> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">14,845</td> <td> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ccffcc"> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt">Beneficial Conversion feature</td> <td style="PADDING-BOTTOM: 1pt"> </td> <td style="BORDER-BOTTOM: black 1pt solid"> </td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 10pt; TEXT-ALIGN: right"> 7,765</td> <td style="PADDING-BOTTOM: 1pt"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt">Total</td> <td style="PADDING-BOTTOM: 2.5pt"> </td> <td style="BORDER-BOTTOM: black 2.25pt double; FONT-SIZE: 10pt"> $</td> <td style="BORDER-BOTTOM: black 2.25pt double; FONT-SIZE: 10pt; TEXT-ALIGN: right"> 55,000</td> <td style="PADDING-BOTTOM: 2.5pt"> </td> </tr> </table> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> <strong> </strong></p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> <strong><u>Series B Original Issue Discount Convertible Notes and Warrants</u></strong></p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> During the quarter ended March 31, 2014, the Company did a private offering of convertible notes and warrants, under which it issued $80,000 of convertible promissory notes for consideration of $65,000, the difference between the proceeds from the notes and principal amount consists of $15,000 of original issue discount. The notes are convertible at an initial conversion price of $0.35 per share anytime after issuance thereby having an embedded beneficial conversion feature. The note holders were also issued market-related warrants for 185,714 in shares of common stock. The warrants have an exercise price of $0.45 and a 4-year term. The beneficial conversion feature and the warrants were recorded to additional paid-in-capital. The Company allocated the proceeds received to the notes, the beneficial conversion feature and the warrants on a relative fair value basis at the time of issuance. The total debt discount is amortized over the life of the notes to interest expense.</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> <strong> </strong></p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> The beneficial conversion feature was valued at the intrinsic value on the issuance date. The intrinsic value represents the difference between the conversion price and the fair value of the common stock multiplied by the number of share into which the note is convertible. We estimated the fair value of the warrants on the issue date using a Black-Scholes pricing model with the following assumptions:</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in">  </p> <table style="WIDTH: 60%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="PADDING-BOTTOM: 1pt"> </td> <td style="PADDING-BOTTOM: 1pt"> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center" colspan="2"><font style="FONT-SIZE: 10pt"><strong>Warrants</strong></font> <br /> <font style="FONT-SIZE: 10pt"><strong>March 20,</strong></font> <br /> <font style="FONT-SIZE: 10pt"><strong>2014</strong></font></td> <td style="PADDING-BOTTOM: 1pt"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt">Expected term</td> <td> </td> <td> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">4 years</td> <td> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt; WIDTH: 84%">Volatility</td> <td style="WIDTH: 1%"> </td> <td style="WIDTH: 1%"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right; WIDTH: 13%"> 151.52</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%">%</td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt">Risk Free Rate</td> <td> </td> <td> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">1.32</td> <td style="FONT-SIZE: 10pt">%</td> </tr> </table> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in">  </p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> The proceeds of the Notes were allocated to the components as follows:</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in">  </p> <table style="WIDTH: 70%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td nowrap="nowrap"> </td> <td style="PADDING-BOTTOM: 1pt" nowrap="nowrap"> </td> <td style="BORDER-BOTTOM: black 1pt solid" colspan="2" nowrap="nowrap"><font style="FONT-SIZE: 10pt">Proceeds allocated</font> <br /> <font style="FONT-SIZE: 10pt">at issue date</font></td> <td style="PADDING-BOTTOM: 1pt" nowrap="nowrap"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; WIDTH: 87%">Private Offering Notes</td> <td style="WIDTH: 1%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%">$</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right; WIDTH: 10%"> 34,272</td> <td style="WIDTH: 1%"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt">Private Offering Warrants</td> <td> </td> <td> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">26,811</td> <td> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt">Beneficial Conversion feature</td> <td style="PADDING-BOTTOM: 1pt"> </td> <td style="BORDER-BOTTOM: black 1pt solid"> </td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 10pt; TEXT-ALIGN: right"> 3,917</td> <td style="PADDING-BOTTOM: 1pt"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt">Total</td> <td style="PADDING-BOTTOM: 2.5pt"> </td> <td style="BORDER-BOTTOM: black 2.25pt double; FONT-SIZE: 10pt"> $</td> <td style="BORDER-BOTTOM: black 2.25pt double; FONT-SIZE: 10pt; TEXT-ALIGN: right"> 65,000</td> <td style="PADDING-BOTTOM: 2.5pt"> </td> </tr> </table> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in">  </p> </div> </div>

55000

65000

0.35

1.05

0.30

0.20

0.25

1.05

0.20

0.25

75% of closing bid

2014-01-31

3276834

2498980

225000

112500

12000

149412

134236

64706

296099

283648

100000

25000

100000

400000

80000

3277000

monthly

100000

2498980

1210000

1188980

0.05

0.06

0.07

0.06

2014-03-31

2012-03-31

2012-04-30

2012-06-30

2013-09-30

2013-12-31

2017-03-31

2014-05-31

2014-06-30

2014-08-31

2014-09-30

2015-01-31

2012-12-31

Various 2014

2014-06-30

2014-03-31

P90D

P24M

P6M

10000

42548

9706

15000

2500

19687

6400

2336

1824

66000

80000

19024

66176

80408

81933

66176

80408

4623

70323

51575

2010-12-02

100000

-0.05

-0.04

-0.05

-0.04

0.3

20000

124000

144000

P2Y

P4Y

1.8002

1.8438

1.8488

1.5152

0.0032

0.0132

0.0031

0.0039

27000

18167

14232

-132301

-34000

400759

193721

-19348

150862

-781834

-726306

-32745

178694

-1600

13287

-30000

-56188

-17072

-132747

-57013

32767

104786

241487

216518

4248220

4278220

<div> <div> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> <strong>5.    AVAILABLE-FOR-SALE AND EQUITY SECURITIES</strong></p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in">  </p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> The fair value of the equity securities we held were categorized as available-for-sale securities, which were carried at a fair value of zero, consisted of shares in Security Innovation and Xion Pharmaceutical Corporation ("Xion").  We own 223,317 shares of stock in the privately held Security Innovation, an independent provider of secure software located in Wilmington, MA.</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in">  </p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> In September 2009 we announced the formation of a joint venture with Xion for the commercialization of our patented melanocortin analogues for treating sexual dysfunction and obesity.  CTI currently owns 60 shares of common stock or 30% of the outstanding stock of privately held Xion.</p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </p> </div> </div>

4750240

4566332

10708396

10510802

34272

0.561

505000

502000

-3078

-519638

-212183

-781834

-726306

2631018

2488691

2596746

2488691

2498980

2598980

100000

824541

883593

170008

134645

165701

198365

48679

3821

32865

48365

62055

6425

3078

0.05

1.25

1000

0.001

750

35920

20000

750

375

350

2427

1000

750

2427

375

60675

Holders of these shares of Series C Convertible Preferred Stock shall have voting rights equivalent to 1,000 votes per $1,000 par value Series C Convertible Preferred share voted together with the shares of Common Stock

48095

65167

15230

16802

350000

500000

505000

120000

100000

241100

55000

65000

485980

180615

177537

8860

7606

<div> <div> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> Property and equipment, net, consist of the following:</p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </p> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT: bold 10pt Times New Roman, Times, Serif">  </td> <td style="TEXT-ALIGN: center; FONT: bold 10pt Times New Roman, Times, Serif" colspan="2">March 31, <br /> 2014</td> <td style="FONT: bold 10pt Times New Roman, Times, Serif">  </td> <td style="FONT: 10pt Times New Roman, Times, Serif"> </td> <td style="TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif" colspan="2">December<br /> 31, 2013</td> <td style="FONT: 10pt Times New Roman, Times, Serif"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="WIDTH: 72%; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> Property and equipment, gross</td> <td style="WIDTH: 2%; FONT: bold 10pt Times New Roman, Times, Serif">  </td> <td style="WIDTH: 1%; TEXT-ALIGN: left; FONT: bold 10pt Times New Roman, Times, Serif"> $</td> <td style="WIDTH: 10%; TEXT-ALIGN: right; FONT: bold 10pt Times New Roman, Times, Serif"> 180,615</td> <td style="WIDTH: 1%; TEXT-ALIGN: left; FONT: bold 10pt Times New Roman, Times, Serif">  </td> <td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif">  </td> <td style="WIDTH: 1%; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> $</td> <td style="WIDTH: 10%; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"> 177,537</td> <td style="WIDTH: 1%; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="PADDING-BOTTOM: 1pt; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> Accumulated depreciation and amortization</td> <td style="PADDING-BOTTOM: 1pt; FONT: bold 10pt Times New Roman, Times, Serif">  </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left; FONT: bold 10pt Times New Roman, Times, Serif">  </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; FONT: bold 10pt Times New Roman, Times, Serif"> (171,755</td> <td style="PADDING-BOTTOM: 1pt; TEXT-ALIGN: left; FONT: bold 10pt Times New Roman, Times, Serif"> )</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif">  </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif">  </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"> (169,931</td> <td style="PADDING-BOTTOM: 1pt; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> )</td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> Property and equipment, net</td> <td style="PADDING-BOTTOM: 2.5pt; FONT: bold 10pt Times New Roman, Times, Serif">  </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left; FONT: bold 10pt Times New Roman, Times, Serif"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right; FONT: bold 10pt Times New Roman, Times, Serif"> 8,860</td> <td style="PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left; FONT: bold 10pt Times New Roman, Times, Serif">  </td> <td style="PADDING-BOTTOM: 2.5pt; FONT: 10pt Times New Roman, Times, Serif">  </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"> 7,606</td> <td style="PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif">  </td> </tr> </table> <p style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in">  </p> </div> </div>

5000

86317

143330

118000

750000

-53008374

-52282068

13376

2604

0.20

221080

<div> <div> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> Receivables consist of the following:</p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </p> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT: bold 10pt Times New Roman, Times, Serif">  </td> <td style="TEXT-ALIGN: center; FONT: bold 10pt Times New Roman, Times, Serif" colspan="2">March 31, <br /> 2014</td> <td style="FONT: bold 10pt Times New Roman, Times, Serif">  </td> <td style="FONT: 10pt Times New Roman, Times, Serif"> </td> <td style="TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif" colspan="2">December <br /> 31, <br /> 2013</td> <td style="FONT: 10pt Times New Roman, Times, Serif"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="WIDTH: 72%; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> Calmare® sales receivable</td> <td style="WIDTH: 2%; FONT: bold 10pt Times New Roman, Times, Serif">  </td> <td style="WIDTH: 1%; TEXT-ALIGN: left; FONT: bold 10pt Times New Roman, Times, Serif"> $</td> <td style="WIDTH: 10%; TEXT-ALIGN: right; FONT: bold 10pt Times New Roman, Times, Serif"> 86,023</td> <td style="WIDTH: 1%; TEXT-ALIGN: left; FONT: bold 10pt Times New Roman, Times, Serif">  </td> <td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif">  </td> <td style="WIDTH: 1%; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> $</td> <td style="WIDTH: 10%; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"> 132,850</td> <td style="WIDTH: 1%; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT: 10pt Times New Roman, Times, Serif">Royalties, net of allowance of $101,154 at March 31, 2014 and December 31, 2013</td> <td style="FONT: bold 10pt Times New Roman, Times, Serif">  </td> <td style="TEXT-ALIGN: left; FONT: bold 10pt Times New Roman, Times, Serif">  </td> <td style="TEXT-ALIGN: right; FONT: bold 10pt Times New Roman, Times, Serif"> -</td> <td style="TEXT-ALIGN: left; FONT: bold 10pt Times New Roman, Times, Serif">  </td> <td style="FONT: 10pt Times New Roman, Times, Serif"> </td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif">  </td> <td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"> 10,086</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif"> Other</td> <td style="PADDING-BOTTOM: 1pt; FONT: bold 10pt Times New Roman, Times, Serif">  </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left; FONT: bold 10pt Times New Roman, Times, Serif">  </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; FONT: bold 10pt Times New Roman, Times, Serif"> 294</td> <td style="PADDING-BOTTOM: 1pt; TEXT-ALIGN: left; FONT: bold 10pt Times New Roman, Times, Serif">  </td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif">  </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif">  </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"> 394</td> <td style="PADDING-BOTTOM: 1pt; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left; FONT: bold 10pt Times New Roman, Times, Serif"> Total receivables</td> <td style="PADDING-BOTTOM: 2.5pt; FONT: bold 10pt Times New Roman, Times, Serif">  </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left; FONT: bold 10pt Times New Roman, Times, Serif"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right; FONT: bold 10pt Times New Roman, Times, Serif"> 86,317</td> <td style="PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left; FONT: bold 10pt Times New Roman, Times, Serif">  </td> <td style="PADDING-BOTTOM: 2.5pt; FONT: 10pt Times New Roman, Times, Serif">  </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"> 143,330</td> <td style="PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif">  </td> </tr> </table> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </p> </div> </div>

<div> <div> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> Accrued expenses and other liabilities consist of the following:</p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </p> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="2">March 31,<br />  2014</td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt"> </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center" colspan="2">December<br /> 31,<br />  2013</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center" colspan="2">  </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt" colspan="2"> </td> <td style="FONT-SIZE: 10pt"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; WIDTH: 72%; TEXT-ALIGN: left">Royalties payable</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; FONT-WEIGHT: bold">  </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; FONT-WEIGHT: bold; TEXT-ALIGN: left"> $</td> <td style="FONT-SIZE: 10pt; WIDTH: 11%; FONT-WEIGHT: bold; TEXT-ALIGN: right"> 155,208</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; FONT-WEIGHT: bold; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">$</td> <td style="FONT-SIZE: 10pt; WIDTH: 11%; TEXT-ALIGN: right"> 127,708</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">Accrued compensation</td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold"> </td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right"> 135,000</td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">-</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">Accrued accounting fees</td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold"> </td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right"> 80,000</td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">82,141</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">Commissions payable</td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold"> </td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right"> 21,975</td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">21,975</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">Accrued interest payable</td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold"> </td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right"> 241,487</td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">216,518</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"> Other payables</td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; FONT-WEIGHT: bold; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; FONT-WEIGHT: bold; TEXT-ALIGN: right"> 170,008</td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt"> </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> 134,645</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"> Accrued expenses and other liabilities, net</td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 2.5pt">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 2.5pt double; FONT-WEIGHT: bold; TEXT-ALIGN: left"> $</td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 2.5pt double; FONT-WEIGHT: bold; TEXT-ALIGN: right"> 803,678</td> <td style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt"> </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"> $</td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"> 582,987</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left">  </td> </tr> </table> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">   </p> </div> </div>

<div> <div> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> We estimated the fair value of each option on the grant date using a Black-Scholes option-pricing model with the following weighted average assumptions:</p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </p> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td> </td> <td style="FONT-WEIGHT: bold"> </td> <td style="FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="2"> Three<br />  months<br />  Ended</td> <td style="FONT-WEIGHT: bold"> </td> <td> </td> <td style="TEXT-ALIGN: center" colspan="2">Three<br /> months<br />  Ended</td> <td> </td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="PADDING-BOTTOM: 1pt"> </td> <td style="FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt"> </td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="2">March 31,<br />  2014</td> <td style="FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt"> </td> <td style="PADDING-BOTTOM: 1pt"> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center" colspan="2">March 31,<br />  2013</td> <td style="PADDING-BOTTOM: 1pt"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="WIDTH: 54%; TEXT-ALIGN: left">Dividend yield (1)</td> <td style="WIDTH: 1%; FONT-WEIGHT: bold"> </td> <td style="WIDTH: 1%; FONT-WEIGHT: bold; TEXT-ALIGN: left">  </td> <td style="WIDTH: 20%; FONT-WEIGHT: bold; TEXT-ALIGN: right"> 0.00</td> <td style="WIDTH: 1%; FONT-WEIGHT: bold; TEXT-ALIGN: left">%</td> <td style="WIDTH: 1%"> </td> <td style="WIDTH: 1%; TEXT-ALIGN: left"> </td> <td style="WIDTH: 20%; TEXT-ALIGN: right">0.00</td> <td style="WIDTH: 1%; TEXT-ALIGN: left">%</td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="TEXT-ALIGN: left">Expected volatility (2)</td> <td style="FONT-WEIGHT: bold"> </td> <td style="FONT-WEIGHT: bold; TEXT-ALIGN: left"> </td> <td style="FONT-WEIGHT: bold; TEXT-ALIGN: right"><font style="FONT: 10pt Times New Roman, Times, Serif"><strong>  118.5</strong></font> </td> <td style="FONT-WEIGHT: bold; TEXT-ALIGN: left">%</td> <td> </td> <td style="TEXT-ALIGN: left"> </td> <td style="FONT: 10pt Times New Roman, Times, Serif; TEXT-ALIGN: right">  99.2% - 100.3</td> <td style="TEXT-ALIGN: left">%</td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="TEXT-ALIGN: left">Risk-free interest rates (3)</td> <td style="FONT-WEIGHT: bold"> </td> <td style="FONT-WEIGHT: bold; TEXT-ALIGN: left"> </td> <td style="FONT-WEIGHT: bold; TEXT-ALIGN: right">1.72</td> <td style="FONT-WEIGHT: bold; TEXT-ALIGN: left">%</td> <td> </td> <td style="TEXT-ALIGN: left"> </td> <td style="TEXT-ALIGN: right">0.63</td> <td style="TEXT-ALIGN: left">%</td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="TEXT-ALIGN: left">Expected lives (2)</td> <td style="FONT-WEIGHT: bold"> </td> <td style="FONT-WEIGHT: bold; TEXT-ALIGN: left"> </td> <td style="FONT-WEIGHT: bold; TEXT-ALIGN: center"><font style="FONT: 10pt Times New Roman, Times, Serif"><strong>5.0 YEARS</strong></font> </td> <td style="FONT-WEIGHT: bold; TEXT-ALIGN: left"> </td> <td> </td> <td style="TEXT-ALIGN: left"> </td> <td style="TEXT-ALIGN: center"><font style="FONT: 10pt Times New Roman, Times, Serif">2.0-4.0 YEARS </font> </td> <td style="TEXT-ALIGN: left"> </td> </tr> </table> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </p> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 7%"> </td> <td style="FONT: 10pt Times New Roman, Times, Serif; WIDTH: 7%"> (1)</td> <td style="FONT: 10pt Times New Roman, Times, Serif; WIDTH: 86%">We have not paid cash dividends on our common stock since 1981, and currently do not have plans to pay or declare cash dividends. Consequently, we used an expected dividend rate of zero for the valuations.</td> </tr> <tr style="VERTICAL-ALIGN: top"> <td> </td> <td style="FONT: 10pt Times New Roman, Times, Serif">(2)</td> <td style="FONT: 10pt Times New Roman, Times, Serif">Estimated based on our historical experience. Volatility was based on historical experience over a period equivalent to the expected life in years.</td> </tr> <tr style="VERTICAL-ALIGN: top"> <td> </td> <td style="FONT: 10pt Times New Roman, Times, Serif">(3)</td> <td style="FONT: 10pt Times New Roman, Times, Serif">Based on the U.S. Treasury constant maturity interest rate with a term consistent with the expected life of the options granted.</td> </tr> </table> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in">  </p> </div> </div>

<div> <div> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> The following sets forth the denominator used in the calculations of basic net income (loss) per share and net income (loss) per share assuming dilution:</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in">   </p> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="BACKGROUND-COLOR: white"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="TEXT-ALIGN: center; FONT: bold 10pt Times New Roman, Times, Serif">  </td> <td style="TEXT-ALIGN: center; FONT: bold 10pt Times New Roman, Times, Serif" colspan="2">Three months<br /> ended</td> <td style="TEXT-ALIGN: center; FONT: bold 10pt Times New Roman, Times, Serif">  </td> <td style="TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif">  </td> <td style="TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif" colspan="2">Three months<br /> ended</td> <td style="TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="BACKGROUND-COLOR: white"> </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="PADDING-BOTTOM: 1pt; TEXT-ALIGN: center; FONT: bold 10pt Times New Roman, Times, Serif">  </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: bold 10pt Times New Roman, Times, Serif" colspan="2">March 31,<br /> 2014</td> <td style="PADDING-BOTTOM: 1pt; TEXT-ALIGN: center; FONT: bold 10pt Times New Roman, Times, Serif">  </td> <td style="PADDING-BOTTOM: 1pt; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif">  </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif" colspan="2">March 31,<br /> 2013</td> <td style="PADDING-BOTTOM: 1pt; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="WIDTH: 10%; BACKGROUND-COLOR: white"> </td> <td style="WIDTH: 64%; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> Denominator for basic net income (loss) per share, weighted average shares outstanding</td> <td style="WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif">  </td> <td style="WIDTH: 1%; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif">  </td> <td style="WIDTH: 10%; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"> 20,036,240</td> <td style="WIDTH: 1%; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif">  </td> <td style="WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif">  </td> <td style="WIDTH: 1%; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif">  </td> <td style="WIDTH: 10%; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"> 15,588,693</td> <td style="WIDTH: 1%; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="BACKGROUND-COLOR: white"> </td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> Dilutive effect of common stock options</td> <td style="FONT: bold 10pt Times New Roman, Times, Serif">  </td> <td style="TEXT-ALIGN: left; FONT: bold 10pt Times New Roman, Times, Serif">  </td> <td style="FONT: bold 10pt Times New Roman, Times, Serif; TEXT-ALIGN: right"> <strong>N/A</strong></td> <td style="TEXT-ALIGN: left; FONT: bold 10pt Times New Roman, Times, Serif">  </td> <td style="FONT: 10pt Times New Roman, Times, Serif"> </td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif">  </td> <td style="FONT: 10pt Times New Roman, Times, Serif; TEXT-ALIGN: right"> N/A</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: white">  </td> <td style="PADDING-BOTTOM: 1pt; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> Dilutive effect of Series C convertible preferred stock, convertible debt and warrants</td> <td style="PADDING-BOTTOM: 1pt; FONT: bold 10pt Times New Roman, Times, Serif">  </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left; FONT: bold 10pt Times New Roman, Times, Serif">  </td> <td style="BORDER-BOTTOM: black 1pt solid; FONT: bold 10pt Times New Roman, Times, Serif; TEXT-ALIGN: right"> <strong>N/A</strong></td> <td style="PADDING-BOTTOM: 1pt; TEXT-ALIGN: left; FONT: bold 10pt Times New Roman, Times, Serif">  </td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif">  </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif">  </td> <td style="BORDER-BOTTOM: black 1pt solid; FONT: 10pt Times New Roman, Times, Serif; TEXT-ALIGN: right"> N/A</td> <td style="PADDING-BOTTOM: 1pt; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="PADDING-BOTTOM: 2.5pt; BACKGROUND-COLOR: white">  </td> <td style="PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> Denominator for diluted net income (loss) per share, weighted average shares outstanding</td> <td style="PADDING-BOTTOM: 2.5pt; FONT: 10pt Times New Roman, Times, Serif">  </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif">  </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"> 20,036,240</td> <td style="PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif">  </td> <td style="PADDING-BOTTOM: 2.5pt; FONT: 10pt Times New Roman, Times, Serif">  </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif">  </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"> 15,588,693</td> <td style="PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif">  </td> </tr> </table> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in">  </p> </div> </div>

<div> <div> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> Prepaid expenses and other current assets consist of the following:</p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </p> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT: bold 10pt Times New Roman, Times, Serif">  </td> <td style="TEXT-ALIGN: center; FONT: bold 10pt Times New Roman, Times, Serif" colspan="2">March 31,<br />  2014</td> <td style="FONT: bold 10pt Times New Roman, Times, Serif">  </td> <td style="FONT: 10pt Times New Roman, Times, Serif"> </td> <td style="TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif" colspan="2">December<br /> 31,<br />  2013</td> <td style="FONT: 10pt Times New Roman, Times, Serif"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="WIDTH: 72%; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> Prepaid insurance</td> <td style="WIDTH: 2%; FONT: bold 10pt Times New Roman, Times, Serif">  </td> <td style="WIDTH: 1%; TEXT-ALIGN: left; FONT: bold 10pt Times New Roman, Times, Serif"> $</td> <td style="WIDTH: 10%; TEXT-ALIGN: right; FONT: bold 10pt Times New Roman, Times, Serif"> 15,230</td> <td style="WIDTH: 1%; TEXT-ALIGN: left; FONT: bold 10pt Times New Roman, Times, Serif">  </td> <td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif">  </td> <td style="WIDTH: 1%; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> $</td> <td style="WIDTH: 10%; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"> 16,802</td> <td style="WIDTH: 1%; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif"> Other</td> <td style="PADDING-BOTTOM: 1pt; FONT: bold 10pt Times New Roman, Times, Serif">  </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left; FONT: bold 10pt Times New Roman, Times, Serif">  </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; FONT: bold 10pt Times New Roman, Times, Serif"> 32,865</td> <td style="PADDING-BOTTOM: 1pt; TEXT-ALIGN: left; FONT: bold 10pt Times New Roman, Times, Serif">  </td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif">  </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif">  </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"> 48,365</td> <td style="PADDING-BOTTOM: 1pt; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> Prepaid expenses and other current assets</td> <td style="PADDING-BOTTOM: 2.5pt; FONT: bold 10pt Times New Roman, Times, Serif">  </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left; FONT: bold 10pt Times New Roman, Times, Serif"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right; FONT: bold 10pt Times New Roman, Times, Serif"> 48,095</td> <td style="PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left; FONT: bold 10pt Times New Roman, Times, Serif">  </td> <td style="PADDING-BOTTOM: 2.5pt; FONT: 10pt Times New Roman, Times, Serif">  </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"> 65,167</td> <td style="PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif">  </td> </tr> </table> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </p> </div> </div>

15000

68175

71994

7000

4038

655

4038

P5Y

P2Y

P4Y

1.003

1.185

0.992

1.185

0.0063

0.0172

1000000

50000

42500

200000

16920

0.43

2427

22463532

19952907

-5992428

-5944470

60675

224635

199529

46730636

46077394

-53008374

-52282068

-5992428

-5944470

2500000

500000

2500000

100000

10625

3750

10625

25000

475000

500000

3932

106

4038

111437

14328

14250

11178

80267

3150

8227

8000

26076

15588693

20036240

15588693

20036240

iso4217:USD xbrli:pure xbrli:shares iso4217:USD xbrli:shares 0000102198 cttc:TonaquintOriginalIssueDiscountConvertibleNotesAndWarrantsMember 2014-04-01 2014-06-30 0000102198 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2014-03-01 2014-03-31 0000102198 cttc:SeriesbOriginalIssueDiscountConvertibleNotesAndWarrantsMember us-gaap:WarrantMember 2014-03-01 2014-03-20 0000102198 cttc:SeriesaThreeOriginalIssueDiscountConvertibleNotesAndWarrantsMember us-gaap:WarrantMember 2014-02-01 2014-02-14 0000102198 cttc:TonaquintOriginalIssueDiscountConvertibleNotesAndWarrantsMember 2014-01-01 2014-06-30 0000102198 us-gaap:SeriesCPreferredStockMember 2014-01-01 2014-03-31 0000102198 us-gaap:SeriesCPreferredStockMember 2014-01-01 2014-03-31 0000102198 cttc:SeriesbOriginalIssueDiscountConvertibleNotesAndWarrantsMember 2014-01-01 2014-03-31 0000102198 cttc:SeriesbOriginalIssueDiscountConvertibleNotesAndWarrantsMember 2014-01-01 2014-03-31 0000102198 cttc:NonEmployeeDirectorsMember 2014-01-01 2014-03-31 0000102198 cttc:SeriesaThreeOriginalIssueDiscountConvertibleNotesAndWarrantsMember 2014-01-01 2014-03-31 0000102198 cttc:TwentyFourMonthConvertibleNotesMember 2014-01-01 2014-03-31 0000102198 cttc:TonaquintOriginalIssueDiscountConvertibleNotesAndWarrantsMember 2014-01-01 2014-03-31 0000102198 cttc:SupportedProductsMember cttc:VectorVisionIncMember 2014-01-01 2014-03-31 0000102198 cttc:SouthridgeConvertibleNoteMember 2014-01-01 2014-03-31 0000102198 cttc:SeriesaTwoOriginalIssueDiscountConvertibleNotesAndWarrantsMember 2014-01-01 2014-03-31 0000102198 cttc:SeriesaOriginalIssueDiscountConvertibleNotesAndWarrantsMember 2014-01-01 2014-03-31 0000102198 cttc:SeriesaOriginalIssueDiscountConvertibleNotesAndWarrantsMember 2014-01-01 2014-03-31 0000102198 cttc:SeriesaOneOriginalIssueDiscountConvertibleNotesAndWarrantsMember 2014-01-01 2014-03-31 0000102198 cttc:SalesOfSuppliesAndTrainingRentalPaymentsAndSaleOfRentalAssetsMember cttc:CalmarePainTherapyMedicalDeviceTechnologyMember 2014-01-01 2014-03-31 0000102198 cttc:NinetyDayConvertibleNotesRelatedPartyMember 2014-01-01 2014-03-31 0000102198 cttc:LicensingSupportedProductsMember cttc:VectorVisionIncMember 2014-01-01 2014-03-31 0000102198 cttc:LiabilitiesPurchaseAgreementMember 2014-01-01 2014-03-31 0000102198 cttc:DebtIssuanceTwoMember cttc:TwentyFourMonthConvertibleNotesMember 2014-01-01 2014-03-31 0000102198 cttc:DebtIssuanceThreeMember cttc:TwentyFourMonthConvertibleNotesMember 2014-01-01 2014-03-31 0000102198 cttc:DebtIssuanceOneMember cttc:TwentyFourMonthConvertibleNotesMember 2014-01-01 2014-03-31 0000102198 us-gaap:AdditionalPaidInCapitalMember 2014-01-01 2014-03-31 0000102198 us-gaap:SalesRevenueNetMember cttc:CalmarePainTherapyMedicalDeviceTechnologyMember 2014-01-01 2014-03-31 0000102198 us-gaap:RetainedEarningsMember 2014-01-01 2014-03-31 0000102198 us-gaap:PrivatePlacementMember 2014-01-01 2014-03-31 0000102198 us-gaap:PreferredStockMember 2014-01-01 2014-03-31 0000102198 us-gaap:PreferredStockMember 2014-01-01 2014-03-31 0000102198 us-gaap:EmployeeStockOptionMember 2014-01-01 2014-03-31 0000102198 us-gaap:EmployeeStockOptionMember cttc:EmployeesMember 2014-01-01 2014-03-31 0000102198 us-gaap:EmployeeStockOptionMember cttc:NonEmployeeDirectorsMember 2014-01-01 2014-03-31 0000102198 us-gaap:EmployeeStockOptionMember 2014-01-01 2014-03-31 0000102198 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2014-01-01 2014-03-31 0000102198 us-gaap:CommonStockMember 2014-01-01 2014-03-31 0000102198 2014-01-01 2014-03-31 0000102198 cttc:SeriesaTwoOriginalIssueDiscountConvertibleNotesAndWarrantsMember us-gaap:WarrantMember 2013-12-01 2013-12-31 0000102198 cttc:SeriesaOneOriginalIssueDiscountConvertibleNotesAndWarrantsMember us-gaap:WarrantMember 2013-11-01 2013-11-15 0000102198 cttc:SeriesaOriginalIssueDiscountConvertibleNotesAndWarrantsMember 2013-10-01 2013-12-31 0000102198 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember cttc:LiabilitiesPurchaseAgreementMember 2013-07-01 2013-09-30 0000102198 cttc:NinetyDayConvertibleNotesRelatedPartyMember 2013-01-01 2013-12-31 0000102198 us-gaap:SeriesCPreferredStockMember 2013-01-01 2013-03-31 0000102198 cttc:NonEmployeeDirectorsMember 2013-01-01 2013-03-31 0000102198 cttc:SalesOfSuppliesAndTrainingRentalPaymentsAndSaleOfRentalAssetsMember cttc:CalmarePainTherapyMedicalDeviceTechnologyMember 2013-01-01 2013-03-31 0000102198 us-gaap:SalesRevenueNetMember cttc:CalmarePainTherapyMedicalDeviceTechnologyMember 2013-01-01 2013-03-31 0000102198 us-gaap:EmployeeStockOptionMember 2013-01-01 2013-03-31 0000102198 us-gaap:EmployeeStockOptionMember cttc:EmployeesMember 2013-01-01 2013-03-31 0000102198 us-gaap:EmployeeStockOptionMember cttc:NonEmployeeDirectorsMember 2013-01-01 2013-03-31 0000102198 us-gaap:EmployeeStockOptionMember us-gaap:MinimumMember 2013-01-01 2013-03-31 0000102198 us-gaap:EmployeeStockOptionMember us-gaap:MaximumMember 2013-01-01 2013-03-31 0000102198 us-gaap:EmployeeStockOptionMember us-gaap:ChiefExecutiveOfficerMember 2013-01-01 2013-03-31 0000102198 us-gaap:EmployeeStockOptionMember 2013-01-01 2013-03-31 0000102198 2013-01-01 2013-03-31 0000102198 cttc:NinetyDayConvertibleNotesRelatedPartyMember 2012-12-01 2013-03-31 0000102198 cttc:NinetyDayConvertibleNotesRelatedPartyMember 2012-01-01 2012-12-31 0000102198 cttc:WilliamrWaltersLtdOfCanadaMember us-gaap:SeriesCPreferredStockMember 2011-06-01 2011-06-16 0000102198 cttc:NinetyDayConvertibleNotesRelatedPartyMember 2011-01-01 2013-12-31 0000102198 cttc:NinetyDayConvertibleNotesRelatedPartyMember 2011-01-01 2011-12-31 0000102198 us-gaap:SeriesCPreferredStockMember 2010-12-16 2010-12-30 0000102198 cttc:ConvertibleNotesPayableFourMember us-gaap:SeriesCPreferredStockMember 2010-12-16 2010-12-30 0000102198 cttc:SouthridgePartnersIiLpMember us-gaap:SeriesCPreferredStockMember 2010-12-01 2010-12-15 0000102198 cttc:ConvertibleNotesPayableFourMember 2010-12-01 2010-12-15 0000102198 2014-05-14 0000102198 us-gaap:BoardOfDirectorsChairmanMember 2014-03-31 0000102198 us-gaap:SeriesBPreferredStockMember 2014-03-31 0000102198 us-gaap:SeriesCPreferredStockMember 2014-03-31 0000102198 cttc:SeriesbOriginalIssueDiscountConvertibleNotesAndWarrantsMember 2014-03-31 0000102198 cttc:SeriesaThreeOriginalIssueDiscountConvertibleNotesAndWarrantsMember 2014-03-31 0000102198 cttc:VectorVisionIncMember 2014-03-31 0000102198 cttc:TwentyFourMonthConvertibleNotesMember 2014-03-31 0000102198 cttc:TonaquintOriginalIssueDiscountConvertibleNotesAndWarrantsMember 2014-03-31 0000102198 cttc:SouthridgeConvertibleNoteMember 2014-03-31 0000102198 cttc:SeriesaTwoOriginalIssueDiscountConvertibleNotesAndWarrantsMember 2014-03-31 0000102198 cttc:SeriesaOriginalIssueDiscountConvertibleNotesAndWarrantsMember us-gaap:MinimumMember 2014-03-31 0000102198 cttc:SeriesaOriginalIssueDiscountConvertibleNotesAndWarrantsMember us-gaap:MaximumMember 2014-03-31 0000102198 cttc:SeriesaOriginalIssueDiscountConvertibleNotesAndWarrantsMember 2014-03-31 0000102198 cttc:SeriesaOneOriginalIssueDiscountConvertibleNotesAndWarrantsMember 2014-03-31 0000102198 cttc:PromissoryNotesMember 2014-03-31 0000102198 cttc:NinetyDayConvertibleNotesRelatedPartyMember 2014-03-31 0000102198 cttc:GrantFundingReceivedInNineteenNinetyFourMember 2014-03-31 0000102198 cttc:GrantFundingReceivedInNineteenNinetyFiveMember 2014-03-31 0000102198 cttc:EquityMethodInvesteeOneMember 2014-03-31 0000102198 cttc:DebtIssuanceTwoMember cttc:TwentyFourMonthConvertibleNotesMember 2014-03-31 0000102198 cttc:DebtIssuanceThreeMember cttc:TwentyFourMonthConvertibleNotesMember 2014-03-31 0000102198 cttc:DebtIssuanceOneMember cttc:TwentyFourMonthConvertibleNotesMember 2014-03-31 0000102198 us-gaap:AdditionalPaidInCapitalMember 2014-03-31 0000102198 us-gaap:RetainedEarningsMember 2014-03-31 0000102198 us-gaap:PrivatePlacementMember 2014-03-31 0000102198 us-gaap:PreferredStockMember 2014-03-31 0000102198 us-gaap:PreferredStockMember 2014-03-31 0000102198 us-gaap:FairValueInputsLevel2Member 2014-03-31 0000102198 us-gaap:EquityMethodInvesteeMember 2014-03-31 0000102198 us-gaap:DirectorMember 2014-03-31 0000102198 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2014-03-31 0000102198 us-gaap:CommonStockMember 2014-03-31 0000102198 2014-03-31 0000102198 us-gaap:SeriesBPreferredStockMember 2013-12-31 0000102198 us-gaap:SeriesCPreferredStockMember 2013-12-31 0000102198 cttc:SeriesbOriginalIssueDiscountConvertibleNotesAndWarrantsMember 2013-12-31 0000102198 cttc:SeriesaThreeOriginalIssueDiscountConvertibleNotesAndWarrantsMember 2013-12-31 0000102198 cttc:TwentyFourMonthConvertibleNotesMember 2013-12-31 0000102198 cttc:TonaquintOriginalIssueDiscountConvertibleNotesAndWarrantsMember 2013-12-31 0000102198 cttc:SouthridgeConvertibleNoteMember 2013-12-31 0000102198 cttc:SeriesaTwoOriginalIssueDiscountConvertibleNotesAndWarrantsMember 2013-12-31 0000102198 cttc:SeriesaOriginalIssueDiscountConvertibleNotesAndWarrantsMember 2013-12-31 0000102198 cttc:SeriesaOneOriginalIssueDiscountConvertibleNotesAndWarrantsMember 2013-12-31 0000102198 cttc:NinetyDayConvertibleNotesRelatedPartyMember 2013-12-31 0000102198 us-gaap:AdditionalPaidInCapitalMember 2013-12-31 0000102198 us-gaap:RetainedEarningsMember 2013-12-31 0000102198 us-gaap:PreferredStockMember 2013-12-31 0000102198 us-gaap:PreferredStockMember 2013-12-31 0000102198 us-gaap:FairValueInputsLevel2Member 2013-12-31 0000102198 us-gaap:FairValueInputsLevel3Member 2013-12-31 0000102198 us-gaap:CommonStockMember 2013-12-31 0000102198 2013-12-31 0000102198 cttc:LiabilitiesPurchaseAgreementMember 2013-09-30 0000102198 us-gaap:FairValueInputsLevel3Member 2013-07-16 0000102198 2013-03-31 0000102198 2012-12-31 0000102198 us-gaap:SeriesCPreferredStockMember 2011-06-16 0000102198 us-gaap:SeriesCPreferredStockMember 2010-12-30 0000102198 cttc:WilliamrWaltersLtdOfCanadaMember us-gaap:SeriesCPreferredStockMember 2010-12-30 0000102198 cttc:SouthridgePartnersIiLpMember us-gaap:SeriesCPreferredStockMember 2010-12-15 0000102198 cttc:ConvertibleNotesPayableFourMember 2010-12-15 We have not paid cash dividends on our common stock since 1981, and currently do not have plans to pay or declare cash dividends. Consequently, we used an expected dividend rate of zero for the valuations. Estimated based on our historical experience. Volatility was based on historical experience over a period equivalent to the expected life in years. Based on the U.S. Treasury constant maturity interest rate with a term consistent with the expected life of the options granted. Original terms noted above. The Company executed a debt settlement agreement with Tonaquint during the first quarter of 2014, cash-settled the warrant during the first quarter of 2014 and cash-settled the note during the second quarter of 2014. See further discussion below under "Tonaquint 9% Original Issue Discount Convertible Notes and Warrants".

EX-101.SCH 6 cttc-20140331.xsd XBRL TAXONOMY EXTENSION SCHEMA 105 - Disclosure - AVAILABLE-FOR-SALE AND EQUITY SECURITIES link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40501 - Disclosure - AVAILABLE-FOR-SALE AND EQUITY SECURITIES (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 305 - Disclosure - AVAILABLE-FOR-SALE AND EQUITY SECURITIES (Tables) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 109 - Disclosure - ACCRUED EXPENSES AND OTHER LIABILITIES link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40901 - Disclosure - ACCRUED EXPENSES AND OTHER LIABILITIES (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 309 - Disclosure - ACCRUED EXPENSES AND OTHER LIABILITIES (Tables) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 101 - Disclosure - BASIS OF PRESENTATION link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40101 - Disclosure - BASIS OF PRESENTATION (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 002 - Statement - Condensed Consolidated Balance Sheets link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 003 - Statement - Condensed Consolidated Balance Sheets (Parentheticals) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 006 - Statement - Condensed Consolidated Statements of Cash Flows link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 005 - Statement - Condensed Consolidated Statements of Changes in Shareholders' Deficit link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 004 - Statement - Condensed Consolidated Statements of Operations link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 113 - Disclosure - CONTRACTUAL OBLIGATIONS AND CONTINGENCIES link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 41301 - Disclosure - CONTRACTUAL OBLIGATIONS AND CONTINGENCIES (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 001 - Document - Document and Entity Information link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 106 - Disclosure - FAIR VALUE MEASUREMEMENTS link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40601 - Disclosure - FAIR VALUE MEASUREMEMENTS (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 110 - Disclosure - LIABILITIES ASSIGNED TO LIABILITY PURCHASE AGREEMENT link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 41001 - Disclosure - LIABILITIES ASSIGNED TO LIABILITY PURCHASE AGREEMENT (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 102 - Disclosure - NET INCOME (LOSS) PER COMMON SHARE link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40201 - Disclosure - NET INCOME (LOSS) PER COMMON SHARE (Calculation of Net Income (Loss) Per Common Share) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40202 - Disclosure - NET INCOME (LOSS) PER COMMON SHARE (Narrative) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 302 - Disclosure - NET INCOME (LOSS) PER COMMON SHARE (Tables) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 111 - Disclosure - NOTES PAYABLE link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 41105 - Disclosure - NOTES PAYABLE (Narrative) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 41103 - Disclosure - NOTES PAYABLE (Summary of Fair Value Assumptions) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 41102 - Disclosure - NOTES PAYABLE (Summary of Issuances of Notes Payable) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 41104 - Disclosure - NOTES PAYABLE (Schedule of Note Allocation) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 41101 - Disclosure - NOTES PAYABLE (Schedule of Notes Payable) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 311 - Disclosure - NOTES PAYABLE (Tables) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 108 - Disclosure - PROPERTY AND EQUIPMENT link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40801 - Disclosure - PROPERTY AND EQUIPMENT (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 308 - Disclosure - PROPERTY AND EQUIPMENT (Tables) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 107 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40701 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 307 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS (Tables) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 104 - Disclosure - RECEIVABLES link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40401 - Disclosure - RECEIVABLES (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 103 - Disclosure - RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 114 - Disclosure - RELATED PARTY TRANSACTIONS link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 41401 - Disclosure - RELATED PARTY TRANSACTIONS (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 304 - Disclosure - RECEIVABLES (Tables) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 112 - Disclosure - SHAREHOLDERS' DEFICIENCY link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 41201 - Disclosure - SHAREHOLDERS' DEFICIENCY (Narrative) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40001 - Disclosure - Supplemental Disclosure of Non-cash Transactions link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 41202 - Disclosure - SHAREHOLDERS' DEFICIENCY (Schedule of Weighted Average Assumptions) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 312 - Disclosure - SHAREHOLDERS' DEFICIENCY (Tables) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 115 - Disclosure - SUBSEQUENT EVENT link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink EX-101.CAL 7 cttc-20140331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 8 cttc-20140331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 9 cttc-20140331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE AVAILABLE-FOR-SALE AND EQUITY SECURITIES AVAILABLE-FOR-SALE AND EQUITY SECURITIES [Abstract] AVAILABLE-FOR-SALE AND EQUITY SECURITIES Legal Entity [Axis] Equity Method Investee [Member] Schedule of Available-for-sale Securities [Line Items] Security Innovation, Inc. [Member] Equity Method Investee One [Member] An entity that issued voting stock held by an investor and that is accounted for under the equity method of accounting by the investor. Xion Pharmaceutical Corporation [Member] Equity Method Investment Ownership Number Of Shares Owned The number of shares of common stock or equity participation owned in the investee accounted for under the equity method of accounting. Number of shares held Entity [Domain] Available-for-sale securities, fair value Equity Method Investment, Ownership Percentage Schedule of Available-for-sale Securities [Table] NTRU Cryptosystems, Inc. [Member] NTRU Cryptosystems, Inc. [Member]. NTRU [Member] Percentage of shares outstanding owned Available-for-sale Securities [Table Text Block] Schedule of Available-for-Sale Securities Accounts Payable Accrued Liabilities And Other Liabilities Disclosure Current And Noncurrent [Text Block] ACCRUED EXPENSES AND OTHER LIABILITIES The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current and noncurrent at the end of the reporting period. ACCRUED EXPENSES AND OTHER LIABILITIES [Abstract] Accrued Liabilities And Other Liabilities Liability Purchase Agreement Amount of accrued and other liabilities that fall under the Liability Purchase Agreement but are still considered a liability since no full assurance can be made the agreement will be fulfilled. Accrued expenses and other liabilities - LPA Accrued expenses and other liabilities, net Accrued Professional Fees, Current Accrued accounting fees Royalties payable Accrued Royalties, Current Accrued Salaries Accrued compensation Commissions payable Accrued Sales Commission, Current Accrued expenses and other liabilities Accrued interest payable Interest Payable, Current Other Accrued Liabilities, Current Other Schedule of accrued liabilities Schedule of Accrued Expenses and Other Liabilities BASIS OF PRESENTATION [Abstract] Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] BASIS OF PRESENTATION Concentration Risk, Percentage Debt Instrument, Face Amount Debt Instrument, Name [Domain] Calmare Pain Therapy Medical Device Technology [Member] Calmare pain therapy medical device technology [Member] Calmare Pain Therapy Medical Device Technology [Member]. Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Axis] Percentage of revenue Debt, Current Principal amount Debt Instrument [Axis] Noncontrolling Interest, Ownership Percentage by Parent Ownership percentage Notes Payable Gross Including the current and noncurrent portions, aggregate gross carrying amount of all types of notes payable, as of the balance sheet date,with initial maturities beyond one year or the normal operating cycle, if longer. Carrying amount Organization Consolidation And Presentation Of Financial Statements [Line Items] Organization Consolidation And Presentation Of Financial Statements [Line Items]. Products and Services [Axis] Products and Services [Domain] Promissory Notes [Member] Promissory Notes [Member]. Sales Of Supplies And Training Rental Payments And Sale Of Rental Assets [Member] Sales Of Supplies And Training Rental Payments And Sale Of Rental Assets [Member]. Sales of supplies and training, rental payments and the sale of rental assets [Member] Sales Revenue, Net [Member] Schedule Of Organization Consolidation And Presentation Of Financial Statements [Table] Schedule Of Organization Consolidation And Presentation Of Financial Statements [Table]. Outstanding debt Vector Vision, Inc. [Member] Vector Vision, Inc. [Member]. Revenues [Member] CONTRACTUAL OBLIGATIONS AND CONTINGENCIES [Abstract] CONTRACTUAL OBLIGATIONS AND CONTINGENCIES CONTRACTURAL OBLIGATIONS AND CONTINGENCIES Details pertaining to employment case matters. Obligation Expenses Amount of contingent obligation expenses recognized, based on the occurrences of an event or condition. Increase (Decrease) in Restricted Cash for Operating Activities Litigation Case [Axis] Loss Contingencies [Line Items] Loss Contingency, Damages Awarded, Value Acquisition Partner, Finders' Fee, Percentage Finders' fee Finder's fee, expressed as a percentage, for the party who finds the company a compatible acquisition partner. Employment Matters Case One [Member] John B. Nano vs. Competitive Technologies, Inc [Member] Grant Funding Received In Nineteen Ninety Five [Member] Grant Funding Received In Nineteen Ninety Five [Member]. Grant funding received in 1995 [Member] Grant Funding Received In Nineteen Ninety Four [Member] Grant Funding Received In Nineteen Ninety Four [Member]. Grant funding received in 1994 [Member] Refers to additional awarded amount of loss continency damaes. Percentage of revenues obligation Refers to percentage of reveune obligation. Litigation Case [Domain] Loss Contingencies [Table] Amount (placed in) released from escrow Licensing Supported Products [Member] Licensing Supported Products [Member]. Estimated Litigation Liability Accrued litigation costs Loss Contingency Damages Additional Awarded Value Additional damages paid to plaintiff as statutory interest Total damages paid to plaintiff Loss Contingency, Damages Sought, Value Damages sought Obligation recognized Other Commitment Funding repayment obligation Related Party [Domain] Related Party [Axis] Scenario, Unspecified [Domain] Scenario [Axis] Supported Products [Member] Supported Products [Member]. VVI [Member] Accounts payable, GEOMC. Accounts payable, general Assets Assets, Current Total current assets Cash Common stock, $.01 par value, 40,000,000 shares authorized, 19,176,789 shares issued and outstanding at September 30, 2013 and 15,237,304 shares issued and outstanding at December 31, 2012 (see Note 12) Deferred Revenue Inventory, finished goods Liabilities Total Liabilities Liabilities and Equity TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT Liabilities and Shareholders' Interest (Deficit) Liabilities, Current Total current liabilities Notes Payable, Current Preferred Stock [Member] 5% Preferred stock [Member] Accumulated deficit Security deposits Series B Preferred Stock [Member] Class of Stock [Axis] Condensed Consolidated Balance Sheets [Abstract] Shareholders' interest (deficit): Accounts payable Accounts Payable Geomc Accounts payable, GEOMC Accrued expenses and other liabilities ASSETS Current Assets: Cash Commitments and contingencies Common stock, $.01 par value, 40,000,000 shares authorized, 22,463,532 shares issued and outstanding at March 31, 2014 and 19,952,907 shares issued and outstanding at December 31, 2013 Deferred revenue It reprsent as liabilities claims purchase agreement current. Preferred stock liability Additional Paid in Capital Capital in excess of par value Assets [Default Label] TOTAL ASSETS Current Assets: Class of Stock [Domain] Commitments and Contingencies Conversion derivative liability Series C convertible preferred stock derivative liability Current Liabilities: Long Term Notes Payable Preferred stock value Prepaid expenses and other current assets Property and equipment, net Receivables, net of allowance of $101,154 at September 30, 2013, and December 31, 2012 Series C Preferred Stock [Member] Series C convertible preferred stock [Member] Statement [Line Items] Statement [Table] Stockholders' Equity Attributable to Parent Total shareholders' deficit Inventory EX-101.PRE 10 cttc-20140331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 11 R39.htm IDEA: XBRL DOCUMENT

LIABILITIES ASSIGNED TO LIABILITY PURCHASE AGREEMENT (Details) (USD $)			3 Months Ended		3 Months Ended
	Mar. 31, 2014	Dec. 31, 2013	Mar. 31, 2014 Liabilities Purchase Agreement [Member]	Sep. 30, 2013 Liabilities Purchase Agreement [Member]	Sep. 30, 2013 Liabilities Purchase Agreement [Member] Common stock [Member]
Liabilities Assigned To Liability Purchase Agreement [Line Items]
Financial obligations to existing creditors				$ 2,100,000
Liabilities under claims purchase agreement	2,013,320	2,093,303		2,093,303
Common stock issued in accordance with liability purchase agreement, shares					1,618,235
Payment to creditors			80,000
Service fee retained			$ 27,000

XML 12 R48.htm IDEA: XBRL DOCUMENT

RELATED PARTY TRANSACTIONS (Details) (USD $)	3 Months Ended
RELATED PARTY TRANSACTIONS (Details) (USD $)	Mar. 31, 2014
Related Party Transaction [Line Items]
Director's service charges per day	$ 1,000
Notes payable to related parties	2,598,980
Chairman [Member]
Related Party Transaction [Line Items]
Notes payable to related parties	2,498,980
Board of Directors [Member]
Related Party Transaction [Line Items]
Notes payable to related parties	$ 100,000

EXCEL 13 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0`!@`(````(0#0P^C!"0(``*\=```3``@"6T-O;G1E;G1?5'EP97-= M+GAM;""B!`(HH``"```````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````#,F4MNVS`41><%N@>!T\*B M^6F:%I8SZ&?8!FBZ`$9ZM@1+)$$RJ;W[4G(2%('KP(B!WHD%2^2[1QR<@>[B M:COTQ3V%V#E;,5'.64&V=DUGUQ7[=?-M=LF*F(QM3.\L56Q'D5TMW[Y9W.P\ MQ2+OMK%B;4K^$^>Q;FDPL72>;'ZR;E$GYO6V>I

$LJ\H-,8U[H8V+:]13/_`UU/_2EY-8$:GZFD(O#LP/\/?L81Z[5 MKH/S,1>,@4X_A<<&<=P]\WD0A=314X=XJ(M[2LSEY.F!S\I`&NO/AIH#V7RJ M6Y=_````__\#`%!+`P04``8`"````"$`M54P(_4```!,`@``"P`(`E]R96QS M+RYR96QS(*($`BB@``(````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M`````````````````````````````````````````(R2ST[#,`S&[TB\0^3[ MZFY("*&ENTQ(NR%4'L`D[A^UC:,D0/?VA`."2F/;T?;GSS];WN[F:50?'&(O M3L.Z*$&Q,V)[UVIXK9]6#Z!B(F=I%,<:CAQA5]W>;%]XI)2;8M?[J+*+BQJZ ME/PC8C0=3Q0+\>QRI9$P4P>J/OH\ M^;*W-$UO>"_F?6*73HQ`GA,[RW;E0V8+J<_;J)I"RTF#%?.$8B^,`(``.X<```:``@!>&PO7W)E;',O M=V]R:V)O;VLN>&UL+G)E;',@H@0!**```0`````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````"\F'K@V5.X7H[EAU/E\60Z78[C5JS&+QW7EAL>U MF"N>3GV>^NW!N\UFWX2'KOE^#&WZQQSESVYXCKL04AZT'K8A56Z\%G!Q;A".+LDXND0X=DO&L5N$HT+&44$XYLDXYA&.5S*.5XASS<:Y M1CB+;,+I-GI,IT,VYRB=/]=H?O9JP,5@5PHL%&$[3Z#SE.T\AYP8X"X3#IH$P MPJ81B*/LE*XPI2L[I2M,Z<;N6`8[EI^T8Z5\U@LO>^I\69X_86,0MFL$ND8F M79-WN$9@%S=V%S?X8WEV%_>PB]-I4%M@%PZL&V$OC<`?2MEQ2V'<4G;<4ABW MC*U`@PHT=J0P&"D\.U)X&"D\.U)X&"G8-!!F,6FWBKMZ".NO: M1D)FUPTL&V$;4*`!A6U`@094MG(4*L?HI0-KQ]B;W.`N]^Q3C(>G&&5W3X7= MTT_JP'<<(#Q,[&P:",,NG+%NRE?_4JY^`P``__\#`%!+`P04``8`"````"$` M0"":HG,$``#L#@``#P```'AL+W=OW]DED=I,M;TKP.M)Y-U&D;)\UA;!O,OW[1>7H@D%'&:R+'V*G/M M^]V__]P>T^SWKS3]W0.!)!]KVZ+8W_3[^7HK=R+_FNYE`G(>F*_=\4.?+_$6B\6>4'"J)#A6+N"97J4C0O983\Y1#'ME-!%\R&NJE<:PR39-0)KD,.7S+TS@*!22+ M3T0LDK5$*@92,?Y.!0S49DPD4^7[$V98`9YVV(R%5*Q/FGE3P68@^75FKOY. M!M)1QS1$,A49.*:)S2CCWIPO?,*(&]@!]5RTV;I&NT=M$RX).'6GWB/ACL<8 M7Q"?P^K1.3*3S:>>*4L269<7LZ]99N0-U[L.5A&0S+ M]249NK(G#F%X#T9#'[0WV2N;.N6>N><_+>DP1-G!.M@-G2%U+E- M?;ZRG27AC\1F2Y\\PI\;-*Q@,'0%4RC!PJ;P])\+XC+"*BM>\%`F=>EC*Y@, M7>$4<@:%`/_G4!:E$;P?(Z$KA$+Z_;(,%WPXM%'5$:JJKB`*/YY0AP:T#(4Q M>N^":.#QTW7L!X[TF@Y=8=3U`E!8V$]EF?`VS*:NP`D$^N3!A]U1RGLDPQED.,I7Z!2\<.(/2%718% M)%T&JM!GF(TAQA1.YM9!R)83!E1"'3E9-:LYQ&`:"IC=/0K.WP\*C*>AX%EV MZ5M[\4#\BF'NHKT82>,"DEUH-TQ@-@V%SL($1-3Z+J*HSPJ0:"JGLL-_',(.20L1\%N7K.,T/F>3IAKLI_#]3EWB$ M23444B].`SZ3A8AB7.T1AM548.U&#O;6?DSL!Q8MZKN%@/MWH8:C3G;5<$S< M0;!HN>@>$1@6$W<0+%I"'\Z(*L4HFE'#D$)O]Z!HY!=WDZF3J8#-5"LD-_N2K;=N8@RCG1&^""U%)!;?EIQX019F"%8=`;F MBBR#5Y8_\JW9L2&,D*4P_<&4Y2=%K(,1LA2F/](YE0[I6`T_"M+=0[N1H(8A MA6F??#2URQQA0QAIJT*Z7YU+\$:T%O$:7M7*C_)=I\*K?WY1O?L?``#__P,` M4$L#!!0`!@`(````(0"."'B5UP0``,L2```8````>&PO=V]R:W-H965T&ULE)A=;ZLX$(;O5]K_@+A/P.8[2G)4J+I[I#W2:K4?UY0X"2K@ M"&C3\^]WS#B`31/!31O@87C]>CP#WG[[+`OC@]5-SJN=2=:V:;`JXX>\.NW, M?_Y^686FT;1I=4@+7K&=^9,UYK?]K[]LK[Q^:\Z,M09$J)J=>6[;R\:RFNS, MRK19\PNKX,J1UV7:PF%]LII+S=)#=U-96-2V?:M,\\K$")MZ3@Q^/.89>^;9 M>\FJ%H/4K$A;T-^<\TMSBU9F<\*5:?WV?EEEO+Q`B->\R-N?75#3*+/-]U/% MZ_2U@'%_$C?-;K&[@TGX,L]JWO!CNX9P%@J=CCFR(@LB[;>''$8@;#=J=MR9 M3V234,^T]MO.H']S=FU&OXWFS*^_U?GAC[QBX#;,DYB!5\[?!/K]($[!S=;D M[I=N!OZLC0,[IN]%^Q>__L[RT[F%Z?9@1&)@F\//9]9DX"B$6:.,C!<@`/X: M92Y2`QQ)/[O_U_S0GG>FXZ^]P'8(X,8K:]J77(0TC>R]:7GY'T)$B.J#4!G$ M`?7R.IT;Q$)!W?B>TS;=;VM^-2!IX)'-)14I2#80^#8PE-$/]=Y(09T(\B2B M[$S(=AA$`]/SL??#K?4!CF82B:<(48GD1HB)`'6]1!CW6.+7GM^4"%@H$<8) M:3&>@-B]-*H]=TKX48\H2L"@^4H$O#/=T8,#NP^+VA"!#.BUN2J1/"(4:?"< M^=($#"DX>FZ@34:,2-3-):7$#C7M"0**]L%811HP\Z4)6),VA$77$`DZ:8%- MB99IR?@ZB1QWN*[(\I?($K`FRU&G*D8$91'/#GU-=S(&5@^$!4N$"5C+,BV' M8D3`E;M9]HA0/!/];%0M'B]%`6N>>9IGB*!GU+QH[6DNQ84E)95B['^68#/,UHLI;5/`)EF^EF`TS(N4A@\8% M)(KT1)-!I+,A">XY)^KQ?.>P>H^EZ64T)LC(9(L\FVIU)5$)E]CVD!>J;XMZ M`)DV@5#+]%@R*`XJ5C!9"PKA@C1O\%X5)ZKR?.<$K:Z&4"NGL7C_`D:*L]T@ MU-9QHA`.#?Q[QBUJ!63:"T)MSF+)2&T.=6S-VD02RG(81JA:IS4$\8[F0'%Y M7'T)%G4E^;2TCR6#,E?$IB)?U#!AJJ^)99V>O)JXF,,B*&_%6]$P5^5/CFK5Z*;6'L8:2]@<>2P1R$ M#0''IZ[&)`I#/"\,_=$R4H4N:A]TVCZB8?5)%Y$9>30L`)F#$^*>BZ+8+W<1 M6X3BHE;A8O$!WK>1>RZ.F3LNXMX!?EN7K#ZQA!5%8V3\7>P+4$BD_FR_9_%$ MQ7>J=CZ&O8SNP]_J+\!6PB4]L1]I?W`_&5W6]#[?\'``#__P,`4$L#!!0`!@`(```` M(0")Z&<+'0,``-D(```9````>&PO=V]R:W-H965T?_:U,X+X8*R-D7^Q$,.:7-6T':7HI\_'N]FR!$2MP6N64M2 M]$8$NE]]_+`\,/XL*D*D`X16I*B2LENXKL@KTF`Q81UI8:9DO,$2'OG.%1TG MN-"+FMH-/"]V&TQ;9`@+?@N#E27-2<;R?4-::2"=BWC>%M#W*_^%.<]6S]`3LX$#G M@7'18=7'_@+(?7I,,$/"_I8O2)2"/"A*BF#+0"H$U/AE-8WCI?L"AV]*K+SUU+49`/9@-C@S3>9"LTT?SEDFX M4_3/"OY"$#@4O0F(2\9D_Z!>,/PI6?T!``#__P,`4$L#!!0`!@`(````(0"/ MR]7/&P,``)D)```9````>&PO=V]R:W-H965T4\4R$9;]8NFOFN0YN,YZS9K]U?/Q]NYJXC%6ER4O&&KMU7 M*MW;S<W.KO$KB;B M\:F]R7C=@L6.54R]=J:N4V?++_N&"[*K8-XO*"39T;N[.+.O62:XY(6:@9UG M0,_GO/`6'CAM5CF#&>C8'4&+M7N'EBGR76^SZ@+ZS>A!CLX=6?+#)\'RKZRA MD#;425=@Q_FCEG[)]5\PV#L;_=!5X+MP6.8$9Z8LO\ M]9[*#!(%FQF.M%/&*P"`7Z=F>FE`(N2E.QY8KLJU&\2S*/$#!')G1Z5Z8-K2 M=;(GJ7C]QXA0;V5,<&\"Q]X$X:M-@MX$CB<3/(]0%/\?Q3/3ZE*Z)XIL5H(? M'%AZ`"Y;HA`D-^.!W+18^[TH&XHJ"74]'D3QO.5]PQUR'K-]ER# M;47ZAB(<)![P#9"0V_60>M#:#5UG@,1X,?AW$]D:#11RT)P(.D7ZGL)BA/#& MC.\'J,40].BY.)C$LS6:11()E]'T7"$*YXDM2"T!BB-T6H86 MF6Z8HXWD_?6OQ3892B8/WAI-O\H2J.3IP>;5M`1!&(>G3"VRA4UVV1:G!]F$ M.)@`;(WFN-:".)D(TK$@FN/%*%R+$!J@%=YEB-THFS&,ISM<+S+;"'[K9;45 M83A^9PRE::ZF;;1D3[\1L6>-="I:P+[ISQ)XJ81IK>9"\;9K#SNNH"5VIR5\ M`E'H'?X,Q`7GZGBAF_?P4;7Y"P``__\#`%!+`P04``8`"````"$`6-QGF8\# M``#L#```&0```'AL+W=O134:).1I'=37:3S68_GBL4:08H:>LX\^_WEBI*=6#T`>1Z>KCGW%NX MSA]?R\)XP8P36BU,9V2;!JX2FI)JMS#__(X?IJ;!!:I25-`*+\PWS,W'Y>=/ M\P-ESSS'6!C`4/&%F0M1AY;%DQR7B(]HC2OX):.L1`(NV<[B-<,H;1:5A>7: M]L0J$:E,Q1"RCW#0+",)CFBR+W$E%`G#!1*0/\])S4]L9?(1NA*QYWW]D-"R M!HHM*8AX:TA-HTS";[N*,K0M0/>KXZ/DQ-U<7-&7)&&4TTR,@,Y2B5YKGEDS M"YB6\Y2``FF[P7"V,)^<,)Z9UG+>^/.7X`._^&[PG!Z^,))^)Q4&LZ%,L@!; M2I\E]%LJ0[#8NEH=-P7XR8P49VA?B%_T\!6372Z@VF,0)'6%Z5N$>0*&`LW( M'4NFA!:0`!R-DLC.`$/0:W,^D%3D"].;C,:![3D`-[:8BYA(2M-(]ES0\I\" M.4(>2>!\)''DXA]9)BW+Q_58RIO&Z@@)M)PS M>C"@?4$]KY'<#$X(Q">/E2.MZ^^9#FY+DB?)LC!AWX&?'!KE9>D']MQZ@>HF M1\SJ&N-V$>L;"+\+B10$CNV--)+--<)W-9:X'V.!-:T_4'?='P\Z^78/GNR0 MBZ0=LB>E/RL]L-8#D0I<"O-=7=H','$_IB,-NO%26K\D">Y(T@-K/1"I@-I. MTH6-'HA/@7,U?==K*]Y)%IK_,EG9I\-UD(L6)AS;;O$#I^57I5$8>""<,5W$ M>A`1#2(V@XBX#]%Q`E*]WPFY"!R[5!EH[;52F#XG!A'1(&*C$+/F(>$ZMOQT M_8[[.#I.P//J?B?DHJX3WJ2;P$I!`I6B[7B>JZ6X[B)FGF>?V[9IJT@A0,I[ M;;49Y(C[.#I&!-=&^'#K_ATM%W6-\-VQYH3"]*A8#R*B0<1F$!$KA*J(,W&F MKG?.M..$'/TN7F?]#DBP[H#>"PK3Y\`@(E((E?WTNN$W@PQQ'Z*C?W:/?@G6 M]0=:!RA,G_Y!1*00QRT?7&WXS2`#3)DRT]M9*/UJBE2C38G9#J]Q47`CH7LY M(7JPE]MH.[P^>?(-K<573KBZ%5\[(;SBY+S:+H!ALT8[_`.Q':FX4>`,;F6/ M`LB3J7%570A:-X/6E@H8,YNO.?RKP/!.M$<`SB@5IPMY@_9_RO(_````__\# M`%!+`P04``8`"````"$`[;;,R;L*``!B.@``&0```'AL+W=OX!0HBGY<.XZ2 M&&M;@>5L=O]]2<[P:TB+%-";S89Y.7XY&LY#V=;];S]/Q\6/_C(>AO-VF:PV MRT5_W@_/A_/K=OGO?WW[4B\7XW5W?MX=AW._7?[JQ^5O#W_^T_WGQ:33L=U MNMF4Z]/N<%Y"A+M+3(SAY>6P[Q^'_<>I/U\AR*4_[J[,__AV>!]EM-,^)MQI M=_G^\?YE/YS>68BGP_%P_26"+A>G_=WOK^?ALGLZLG7_3/+=7L86OSCA3X?] M91B'E^N*A5N#47?-S;I9LT@/]\\'M@*>]L6E?]DNOR9WCU6]7#_'V[LLM=L!7QA=T]_WKLQSW+*`NS2@L>:3\H),3,QP(ON)$\M5DF]*_MH3TW*2N=+(\\R%<>9;MD6XIE:F0U\.,AK[+[ M]0]VW?:H:5U-8BLZJ>`7B8=]A`&1ZC7SJTRS-/\?3/,HW+1\N58.Z%6DQ*%4 MR"F/,,!\JH6GN9IC>697V/3L+T^93R[>+MGU4&'S2L<5R6E!P^I$:]0K"T4G M%"9ED* MXLURL6TV+6IB%C05F$V2LFF(H@.%8=:A`89BUIA2;8K/14RRSU1RS7$S,EF3_M*`!LVF9)9N$9A84AEEK M2E[7-S/+@4XZ6<9H,KW1^"3;=%Z5=OY:T+`K?'.C287::'+`-\7*<&.;GC;+ MQ:&N`)HILU*AS,J!H-F$I=-,\;1;H::YI7T!15@1>5.[Y8L2HR342-@Q)XA1 M%`''P!NSD[G-(0'1I&.0F(ZM2452W]QR"2=*O&/@C^DXKRI2OR+D=MEDHJ%M M5AM2X!T*3+\0UU]&5@$GG"GQ?KF:U@1I`:T(RT<&OCAV":ZUI3"0X1*/(G M#DX12J*=0V3_)+LZ.&KBLPU@8NG4G=8Y]B029X;(+OA.2;3CJ4FV8\Z;>,=` M)[L^2+FVB86PU,(MIA@49D'+$=\J;<.<-?&&@4RF84^+`Q&V.*]A"3B=X8DY MME^.FWB_`"?3KZ?!@6BBP4G$:;MR))C?=!;TA#K4X%!TN\&AP*@'-1+VRU$3 MG=\4P&3EMZ:G-A25HA_G2962#MBAP/0K$1CV.PMXJ0=X-;W31)'T6Z?Z>`O[ M#06FWVC@I2Q7,_++U>3,5I-;GU:$W"[]_10=0QS3L1P)9W@6\E(/\FK:TE`$ M'2)AAQGC#@(-2RBJ+8=S_*NT6@1_\\-,<1SOQ"RR]6IRU&E1Y#>!SOFK\ZNA MG@:"SHU^0(^X@OYD^"73N<0\9ZID_\*5#+7(2+0Q3)1=1%1JJJ M0X59,B8.ZZHRSK"V7+M`+=.N2\,41$C#:B5VI_ZG^LL7TM\[G&':C\8C M/X?&+T"HR1ZMZ/D?18C'S8JT]P[_;MA5(T8MJC.AE>]L%AV%FMBM';N`.DF; MJJ&TP2BFWV@Z9K/H*-0AVJ#(OY>@!2J):BAJ))QASJ7HBLZXFF:8'"]:%.GS M'1%T*#`S#'']B[0K@M`Q#C:9AY+TPK!9V2:JTEM.#=7 M&8@F'4N)K@TY$JZ-67C,`&)VMZ.$01$V9_;9F[/[)`JU7SD2]DO@.`V3S"6B M"Q,43?B%*&8MPXAOBET/L]"7N>AS68(BJQXH/91&)QA"6[-NM&."O\C-Y\&@ M\7Z[V%EMYD%8XWB7(NU=C@2+(Y]%/J&FC8ZB!$42)>Z-"PJ,XE`C8;^ST)<# MHNQC&;UQ09'_0D.#4Q*58342=DS@QZLC9R\VO0USSRUB0\X0+8H44N@'5AT* MS$Q'WR+F!(%Q52UFD0IIG(Q/<0TS+B4ZXW(DG'$"PT"F`5Y6C3A(R4$T62-2 MHAW+D;!C%C@>@KQZZ'OH61=AO\R9/:-M`A5D<$-B_2JM+Y[,8*-1V4;A, M01$:9@BD'V%UJ#`-`P1A3IWDB0:K;7<6`G,7@2Y44&3ERLFP0T'?+#]4\ED< M%&H[P[ES2X(B=4OBV)7$TQ4L1\(5S(D3?6#.@4]L1^O;;N>6!$6*(_0=O0X% M9CU$-H M4:3X86P?]"MO\;1?.1+VZ^$>O\6=[L:%CWMZ5PM;+8HF,RTYIYW+D;!S3IKH M6BZ`2]/\0-&D8\DW[5B.A!USTL0[!BZQZ'KW.?PH0(3M.,M3Y_TB5!C;3XT8 M@6\4,\O$#,-<;1>SRX\"1&"X29*4O/W6H<#T:TXIFZ+2'RS:6V\6[0J`DIU> M8J9%$3.@KP'MQTJC*P)"6[-N)'@6\0H?\>BY'D4:'V1;=B@P$RP!:*SRAM]9 MN"N`2U:*'7Z@2/*C<0Y`*##]1O.NF,4[H0[R8PI>V(^E1%>$'`EFN)Q%/*&V MMUSN\`-%M_F!`B/#:B3LE_`N[OZC!#Y9E=&0=[I;%/FW$61:252FU4C8.2'? M-/%*X-(T/U`TZ5CR33N6(V''+%_Q[;CD:E(;#C]0!.VXS"OG^SHH,&L#XOH7 M:37D`WJ]CMAVI46!$`1-.O'#'RJWNX;9@M:D:"N=HV[-Z` ME""RLJ5?'3U+C:X).6)X5@NU+<^"7NF#'B4(BFX3!`5FCJ.)5\XBGE"3%#L$ M01$2)-UDE'@H,/U&$Z^<13RA#A$$159)J(N+%2$)IRM"CH0K8A;S2B"3U8E= M@H!H@B"2;]JO'`GZK0CQX@@B9I'*:$@S:%$TE6DE4<[52-@Y8=\T02I@WC1! M4#3I&.(8U3PYR>H6U2SF"37)L4,0%$%'YM\UI1^*H,#T&TV\:A;QA-KVZQ($ M1?AX0)Y6M!NCP/3K(9Z>92=X%O(J0).U^9ROU*+(*@G]ZM`OE$97L8=ZJLG8 MEEGD>.A57&WGV'T+"T6*($Y'1H&98XAKK?*&WUG$JSS$(/E%V#F/`$V:F_O/9=?SR.B_WPP1^Q*]@W!-6H>OSO M:\KGD_$VN6//>WG&T[O.I_]:5>PYPLHWHZKE$X9K]2+L";_WW6O_]]WE]7`> M%\?^A=G;K'B*+_",(/QR'=[%,W!/PY4]VR?^^\:>Y>S9TV>;%1._#,-5_L*3 MH)X.??@?````__\#`%!+`P04``8`"````"$`3;=`RXT"``"%!@``&0```'AL M+W=OSLDIK?/HL&[9C27+8Y MCH(0(]86LN3M)L>_?ZUN)AAI0]N2-K)E.7YA&M\N/G^:[Z5ZTC5C!@%#JW-< M&]/-"-%%S035@>Q8"Y%**D$-;-6&Z$XQ6KHDT9`X##,B*&^Q9YBI:SAD5?&" M/\TZ]LHKB&3E#UM.UN"BDZH%CSAIL71XJ1*&:/FU8J MNFZ@[N=H1(M7;K>YH!>\4%++R@1`1[S0RYJG9$J`:3$O.51@;4>*53F^BV;+ M%)/%W/GSA[.]/GE&NI;[+XJ7WWC+P&QHDVW`6LHG"WTL[5^03"ZR5ZX!/Q0J M646WC?DI]U\9W]0&NIU"0;:N6?GRP'0!A@)-$#L9A6Q``/PBP>UD@"'TV:U[ M7IHZQTD6I.,PB0".UDR;%;>4&!5;;:3XZT&1%=63Q`<26`\D4?QADN1``NN1 M))ZD49K]7PKQ93F7'JBAB[F2>P23!\)U1^T<1S-@MO8D8/+;]D!)-N?.)KE4 M0&MHZ6XQRM(YV4$?B@/F_A(3#Q'+-Q"C'D)`7R\2?/NX2)N4XQ%&O<@XG/;\ MKI![CX%&]IBC`H=8OH<8:`3S3C6^;Z`%@]$G[XVC[$R;QTR=O5$:)^$POAS$ MLTEXM'>@"PRX7I<%#W5%X_'PO?<>,W:ZDGARWOCE:7PT24[B`UU@^JFNZP;/ M)@WUQ>P8')0P`7$EI7C?VINH_((M_````__\# M`%!+`P04``8`"````"$`&O99K"<#``"W"0``&0```'AL+W=OLX\^_WEBH".N*\`+T]/;WWW-M>9H]O1:Z]8L8)+>>Z;5BZALN8)J34T%0;0F^-9[1PX:1Y#LI,8@-:9()V%+Z(J'/B33!8O-B=50GX"?3$IRB?2Y^T<,W M3':9@&Q[$)",*TC>0\QC$!1H#*=V(Z8Y.`!/K2"R,D`0]%:_#R01V5P?^88W MMD8VP+4MYB(BDE+7XCT7M/BG0+9TJB%QCB3P/I+8SJ=)1D<2>)])G(EG>_XG M7'&/+.,SBV],/,_U)^/!@$PE3JUUB`1:S!@]:%"_$#ZOD#P-=@#,)Y&5)(WL M'ZD.2DF2)\DRU^'@@:`<*N5UX7K3F?D*Z8V/F.4EQNDB5E<0;A<2*@@\FXUZ M).LKB!Y)-`S97$)<_[R3">(U"D)IM!6\7IXGH218"B5K3"JW[!M6?4.H#.V0 M7=_JRK*^`Q-=P]A=GLUM3"=L*.9VV+)PW`]/YRE\N0APK?2Y_JCKPU)A@*I) M<2]_JT%$.(A8#R*B0<3F%J*C%03`DN%N:71(")4B&E] M6GW?LOHUU9Z?P'1O/FK/]^8V[3E[:CEG_SNZ0`#WZR+!/5UZY;M4D(XLYT-; MG[>5@JBH)XXS[A9?>(6ABU@/(J+.%A>Z0+NTK.X!;!NQFLP#Z9H5V^`=B M.U)R+<(TD!LTOUR+ M_P```/__`P!02P,$%``&``@````A`"8A/Y"&`@``%@<``!D```!X;"]W;W)K M&ULG%7+;MLP$+P7Z#\0O$?4P[(3PW*0($@;H`6* MHH\S35$6$5$42/J1O^^2=&39#E*U%TN49V=G9D5J<;N7#=IR;81J"YQ$,4:\ M9:H4[;K`/W\\7EUC9"QM2]JHEA?XA1M\N_SX8;%3^MG4G%L$#*TI<&UM-R?$ ML)I+:B+5\1;^J926U,)2KXGI-*>E+Y(-2>-X2B05+0X,@'\$VCDE=TT]CO M:O>9BW5M8=HY&'*^YN7+`S<,`@6:*,T=$U,-"(!?)(5[,R`0NO?7G2AM7>!L M&N6S.$L`CE;2))T+`D)@KR_!VKI:\`N@X5O-_9@4$A1H/.DY[7J[L/&,CUB.D1)YV!9MAYG'=75.#)D#W/ M>_Z@(&!&*`":H8+WO3OPN??I6>>`F?F9I&F6);,><&(=M`T;C[/NBLX%'/F# M]8`987WZ/PI?- MKWO^$'S`W&2^>QP=MV.8>SC:PM;OZ)I_I7HM6H,:7L$VB:,9!*;#P1865G5^ MBZ^4A0/)W];P_>&P_^,(P)52]G7ACL[^B[;\`P``__\#`%!+`P04``8`"``` M`"$`6&:Z@[X"``"H!P``&0```'AL+W=O([.\?JXK],2DXJ)),?$"C%B3B9PWVQ3__G5_-<-(:=KDM!(- M2_$+4_AZ]?G34-]@I+.0E&J(H>,;N1+:K6:.=B&05U>!?E;Q51[4ZNT2N MIO)QUUYEHFY!8L,KKE^L*$9UMGC8-D+2305U/Y,)S8[:]N%$ON:9%$H4V@,Y MWQD]K7GNSWU06BUS#A68V)%D18IOR&(]Q?YJ:?/YP]E>]>Z1*L7^B^3Y-]XP M"!O:9!JP$>+1H`^Y^0LV^R>[[VT#?DB4LX+N*OU3[+\ROBTU=#N&@DQ=B_SE MCJD,`@49+XR-4B8J,`"_J.9F,B`0^FRO>Y[K,L51XL73("*`HPU3^IX;28RR MG=*B_NL@(X9A#>J8>V0J:V!!,$LZ20&%D&C;_'\T!EX;&W<5\?$]KWA?-S3_FK46QUX M2C[BR78UP6LR0B(\_K_CJ91%'T3C^G'S%FX*&Q>#[RY1`W9R0@ M)!['=09PB;G#UATC+=VR[U1N>:-0Q0H8ML";0N#2';7N08O6'AL;H>&(M+&ULG)9=;YLP%(;O M)^T_(-\W?`1"$R6IFE3=)FW2-.WCV@$3K`)&MM.T_W[GX$!Q6$FTFP3,Z]?/ M.W!)':5JEM!`56Y%7ILC= M^N.'Y5'()Y4SIAUPJ-2*Y%K7"]=52-W-+RBMB'!;R&@^193QA#R(YE*S2QD2R@FK@5SFO5>M6)M?8E50^'>J; M1)0U6.QXP?5K8TJ<,EE\V5="TET!<;_X(4U:[^9F8%_R1`HE,CT!.]>`#F.> MNW,7G-;+E$,$F'9'LFQ%[OW%UO>(NUXV"?K-V5'UKAV5B^,GR=.OO&*0;:@3 M5F`GQ!-*OZ0X!)/=P>S'I@+?I9.RC!X*_4,.EL1)#DJ+ M\H\1^27&OB&J`FO@>JZ7HIQ=&!30-+JIKB%O078-P&9C"Z M4-^+%$)$DWMT61'8[1"$@O(\K\-PMG2?(:7)2;,9:GQ;L6T56`G`ZQ@A\#[C MOY/>HJ`84;`(R+8Q`^#=L05GZPX5LWDGL4@@0WT2S%;X[C9HB7`2Z'H`81AW M_@;2:,"J@PQMQ79,83'"0GW&\6RA C?]WPUEYY8S1Q4]:I[\>>Y]F*;5\1 M>"$(WA06&P1X/1N*S]G>ZF+R9C1C>1M36&PSF^VZVN*D2[4UFC'&,87%&`\9 MIW"8C=<8)YWE,7JKC\FCT9@:^Z$W[U>P46PMQ71F[0*+$7O>V8ERF1$GV8S1 M^?EA)&-I'%-8B/,AXN77&"==*K71C#&.*2Q&:&?_D<=FEIW(<%#LDR@R;W0< MG;W-[SXV?*9)FB92,KEG6U84RDG$`1M@`*;=:-><[P,\C\_&-]BT<=SM'D#/ MK.F>?:-RSROE%"P#2V\20T:EZ;KF1HNZ:5T[H:%;-I&ULC)5;;YLP%,??)^T[6'XOMT!N"JF: M5-TJ;=(T[?+L&`-6`2/;:=IOOV,<")"5]H5P^9\_OW/)87/[4A;HF4G%115C MW_$P8A45":^R&/_^]7"SQ$AI4B6D$!6+\2M3^';[^=/F).23RAG3"!PJ%>-< MZWKMNHKFK"3*$36KX$DJ9$DT7,K,5;5D)&F"RL(-/&_NEH17V#JLY4<\1)IR MRNX%/9:LTM9$LH)HX%HMBQ`;%-,&P[>P-\.[8 M@M%[KQ7S52<9D$"%^B1MM::)3%",PQZ`'RX[?PMI-3`+'60X5.RG%`-&>-&8 M,7QS5-NJF2#H?/_]X8A@9S6+IKVP?F;S(/1&D'V)'T7+Y7QU&8,!)1"-*U(RH)Q?4[Y?2Q,TIKS,D^VWU4Q23DH&E(MK MRO=K:8*&E&$8C6II-9,=[TO>Z+C=JG;KE$QF;,^*0B$JCF9C!C!/W=UNF=\% MY@\\NK^#)=^L1+=[`$NV)AG[3F3&*X4*EH*EYRR@LM*N:7NA1=WLNH/0L%Z; MTQR^I@P6A.>`.!5"MQ=F_73?Y^T_````__\#`%!+`P04``8`"````"$`U=-S M4.D"```>"```&0```'AL+W=O)-8GNU:B#:$9ZPI$NO7SX>;I86DPDV&*][0Q'JCTKI= M?_ZT.G#Q+$M*%0*&1B96J50;.XXD):VQM'E+&UC)N:BQ@J$H'-D*BK-N4UTY MONO.G1JSQC(,L;B&@^K%V#2#$_J:$<$ESY4-=(X1>NHYKR\YO1@SQZ1[+DAR^"94^LH9!L*),NP([S M9PU]S/04;'9.=C]T!?@N4$9SO*_4#W[X2EE1*JAV"(:TKSA[2ZDDD%"@L?U. M!N$5"(!_5#-],B`A^+5['EBFRL2:S>UPXJ!:4H+D;U4O/YC0)X6 M-9#X[R0!J']?]VU_&7KA_#]8(%XG!9X]R]P._'"QO$*+8WQU:4JQPNN5X`<$ M1P^4RQ;K@^S%P*SS$\#3N!DR]J^$@4E- M,9M33.BZ8\Q]C]'9T\3I=&)K)N!_B!2ZWL#B@*O!&J3]V-K')>\=:+!VT$?> MF(GC0'XPQ.G$W9]"0M,ZAFXXJ:/!1-T5]+SE,EI.K]@(X7LN_,8VX@L;&PO=V]R:W-H965TTT[=OO&#<$F[1-EXLHD&_^S#]C>UC=/%6E M]8@9)[2.;-_Q;`O7*(.;7`-O^2454C`+=N[O&$896U05;ICSYNZ%2*U MK126[!H-FNS@THY16#4CL2$G$ MHIL"#F23!21'4R=<.8%/N#6#G-Q1Z2D;:4'+FCU5T%^FY32 M:E.+D4#K%:-'"]H--&^07#S^$E1..2F%+LO7DH3LI,BM5(EL6*?P_QP*^[@. MO>G*?81JI"_,1C'PV6-F.K,=,I.QKS/QD`D]0R<9,GT=%[QW!1CK!;C76@G;S)( M\Z8>Z-X6W1^V_K<7&-_3F?@2,]:99,A,_'-3-7.3_S$G@Z`(_<7G&TW8*`;J MU"U0@]B^2\3O$LE;A.83$NGOS+<7IH3A/.CE'IB;8J.8OK_0#_4^;*]@XBN8 MY!)S/A`TG]./^)2PZ=-8DQO%+(+V'/*=N><9JVUK$I,`H.XR-EX\H.?&#D\, M`LH*D[6[SGJ:[]E'?$O8\&WNLXUB7GP'CK?0KV1T/BW4YC4"YCH_'P3$1D#? M)+@=#P)@FLJTNU8$@)Q[H:JAQJ6:215F>[S%9,X-5R-2<53>"-NW$VU$!\[']6L#K$(:3W',` MSBD5IQLYR;L7K/4_````__\#`%!+`P04``8`"````"$`;W<*S00#``!Z"0`` M&0```'AL+W=OWEVP`2K@)'M-.W?[]A.2(`T95^2$,Z<,V<\S+"Z?:TK MYX4*R7B3(CSSD$.;C.>LV:;H]Z_'FP5RI")-3BK>T!2]48ENUY\_K?9-W=KPAID M&99B"@F4*](?1O3S[[ M,8N9T&=)/X/KQC7XHPZWF`G*&(;)N?GKT@;==SWN\0/(ECT(_?CT^/7*C@>S M[0-I.[#.1TJ$AVUN*%-DI?WY`N.N(_K2%X;:A+$ZGFK1J-.Q!1W<)V<]T<_@ MOX8:[,YAMXV:_8"QLV5^H=OM]K3;I25;^IV(+6ND4]$")K`WBZ%=A-V=]D+Q MUFR1#5>P\\S/$MYQ**P8;P;@@G-UO-#;N7MK6O\#``#__P,`4$L#!!0`!@`( M````(0#$?D?\W0P``!A^```-````>&POV_;R!'_OT"_ M`\&T10^HHQ=E23[+AT@QVP!I>KBX:(%>45`29?/"AXZB$ON*?O?.+%^SDD@N MQ:56N1J]B)1VYC>/G<>27-Y^]^RYVF<[W#J!/]5[K[NZ9OO+8.7XCU/][P_F MU5C7MI'EKRPW\.VI_F)O]>_N?ON;VVWTXMH?GVP[TH"$OYWJ3U&TN>ETMLLG MV[.VKX.-[<,WZR#TK`@.P\?.=A/:UFJ+@SRWT^]VKSN>Y?AZ3.'&6XH0\:SP MTVYSM0R\C14Y"\=UHA=&2]>\YLPR#;;". M7@.Y3K!>.TO[$.6D,^D`I;M;?^>97K35EL'.CZ9Z/SNEQ=^\6TWU:UV+19X' M*P#QAY]W0?3M[^)_7OWIU:ON?[[Y]E\_V*M___C'P^]^_$;OI&P(3;!!.[#GPBB`%J0FW=?/*#+[Z)WX$S@'CXL[O;[2_:9\N%,SV$ MMPS<(-0BL#+(Q\[XEF?'OYA;KK,('?S9VO(<]R4^W<<3S#&2WWD.F`E/=F(. MY^6S0#2I3&.$P-BJILFQ)!>MXMJI09KB=EDW@5^9V-V/3R;9`-S8(ZD2L;Y MXJ'=D.'`E*G*"H;FF]';LZE3/K,BZ9(P?*X9@!-.KA8=F+HE\WMDXM\Y_.3, M":T=BS&J7-!G4R^/C0^.9V^U#_87[8?`LWQ4+$UJ[-=<3N8<3SYYSOSRR2/Z M'?6P=EBT+`74Y]$;UWGTXVIJN]M`P;X,G4V$]CLV>^0Z,W.(+7B*X[I9]3L8 M8GT(9^YNH1"/[-`WX4!+/C^\;*`Z]*%G0(B=^'<5OWX,K9=>G]5(8@.V@>NL M$,7CG-6D24TPO[XWY_>,+T$FBJ*`J&G.1RT0O9]-YO*1SB<3V43[)OQ))OIF MB'^2B9KPO[DTG283R9`%,J.G10[VD-W7H\ED,NY=C\?CB3'H&093\B+Q:,=? MV<\VMI72U'2(8`@()H/QY+H/0+K&F+$Z*X(!`!@-A^-A;](WX/\L#;6/0+9. MA[IJJQ($BJQ*$"BR*FMC.A(B?S)38$5'\5PE"!19E2!09-61Y`@\4FY5@D"1 M50D"159EBV\2YRJLE"J>JP2!(JL2!(JL*JWX3"+P1+E5"0)%5B4(SFW5I*W" MPMID2S&'E9FT^CAMX>9I$5^'%^L:H4]=!.$*.N3T.DUO`#UB?.[NUK77$72D MH?/XA/]&P0;^NPBB""X`W=VN'.LQ\"T7/G;2$>F_)2/A$AE<#9OJT9.S_`3, MN!686#F>/:"8!*?\*)(?%E$.-SQXA[PV1-%%A]A,8AV`=NQM)CD1TBW M2]MU/V("_.]*.4/SB7,7Z8_X(T_ MB5.#":A3E^&1B0#:^10!&$$%`KQ1*=$!N*<*!-`FI0C`07,$`*?$*YK,@QZ) M9N`#.4O@WQ9+B#&IE!S+%J4L"K_`OT1*DPN_C=1,XBTX>JYF."@!T(AE48A5 M%6*(V6&FY2J`@Q(5F)!UY:2\7E',5Z80$G0!0ZX1"`-E&I'GE23F`L\<0+E& M9A+K$.(4&(I40P`X2B`00_04Y=\>Q:`H`U-O4)2"*00N!Y]Q3E!+5VYD-HK:IJ`5CH\[I[BSA%LP7HITDKCHV$6WI", M:Z?:4Q`ZOT"3B8^(+>&$'>KX2&'D+.F9+Z&U>;"?H16-K_,\K_<$9-UELD(L MCI%?9DVQGA/PD#1(%1B:Y[:8K#?%?'!DC>& MR=8QTYQ7"$VI7U#3I,7!J8`&^^V:!.50?'C_1#V_X4S7`KI*39'T4P/+\01T MDG-1_;&[21HHL`7?I_!.,"\)T_4K+:Q+M01TEZS1\=5BH#1I_3JKWBP!5A?.3 MW.DDA&02#U/.C+3.74,7X5J1QL MT3Q;25JU4XZEV+H5<9!?0CPIAPJ6[73"UX!;?\:?)(1HV*(1H#!L514":I1> M`^X%*YVZ#M^@7F0'50/N!2N=NLY7H/0:<"]8Z=1U^(S=?DS_VL)A0[Q2\G?3 M*KC0W@?FKN^T4DOW@AS(*1'OP>=[3;[Y.RE)R^W692$\M5VMZ,]X??$EP]G- M>>""/#HA/(GUX!'?SL&]7T(N50&BB4O5`=6VW9IZ.=^-5BCM!+\2QL>>ATD7 MB6A.YK+9`<"6HEMSV%SE5X&AG2MV4L_>AYNK[ MZ4D1ZBRE35YHFB M@%L1-OC*B<^_P@&B,J85@>/\5%7`+0#'19?#>,LK+E>5JMAUN.ZIX7;-^+`] M@*]347*"PT'CL%H"+=[SN*P`A]V7!2\?\A81"OB7BTS\>AMU7]*T2[=B8T1M M=RJB`;Y`86WG'^&*G^##YX/7,N^+;W"%2?I$/#5K2/?LDB@0[PA<&I]DFX@N MW)TTY_!I:JE.NM#=+C`[9):,>Q/'%SG%A\VAL;?`1V"4\1Q)XL_AD M\M!B&:UL.1'%IK2@'JQ+"RC$-4`?'XLFN*`]K4L+V,>T!B`MH04[]-6F!8^J M)[3PH?4@(*T81'<5426`GI$(@.^$)]E>`[B(0`3"6DB(TI.]_*3-8>O8C!`_'S"-BA"Z?]ZXEF]%0?BBX?X"&3G> MZ$-!GZR!7F(-\3Z,#^G7(9/-!5X]N&A6APR, MCM'P_H>KNW7(P.B8#!]4L7X2(?/.W^PR"_&Q%%.W"(GWCO_)7O&>PVNX#R!% M*'VP=U%H9?['3ZF^H&(^X(;#&0T^1,0O&TQW1T[JSP^POW"J1-S!@,P=+.!% M@/]M%Q$UXBA"!+M&$2(/3@3[L*>3F".!L(1(!+#G1T9B+Z((TOB'%?HX6[BI MN^>C!1+E.ZA`];]ZSC>?9GJ/\"W@;%OJK!\`1:WLM;5SHX?LRZF>?_XK>\,! M.%/RJ^^=ST'$2$SU_/-[?'4$S&)8X8-P\WX+KR.`?[5=Z$SU_][/1I.W]V;_ M:MR=C:^,@3V\F@QG;Z^&QGSV]JTYZ?:[\_^!RO"5Z3?PSNT&KR1GKTZ'/51Z MQLW6A1>7AXFP"?B/^;FI3@YB^&Q]$F##Q?A4B,XV>Z7[W?\!``#__P,`4$L# M!!0`!@`(````(0`Q]N)S'%0``%8-`0`4````>&PO2A&*__RPW_]+]^/1N.,L?W1'U9NQ^/[?_KNNU'[MKC+1QN#^Z+/D^O!\"X? M\^?PYKO1_;#(.Z/;HAC?];[;VMS<^^XN[_97LO9@TA__867KU<[V2C;I=_\Z M*0[\I[VMS94?OA]U?_A^_,/AH#VY*_KCC'UD1_UQ=_R0'?=]`?;]_7?C'[[_ M3J_ZZ]O9SX/^^';$JYVB4W_Z_S? MZR.?U7\(^SPO;KH:PNY/\KNB_M:S@].?SXXNCR^/WQ]EET<'/YV;CQN!],-0Q++WIY3?U69Y=Y[U18\S!9#CD,-F;[JC- M@?Y7C@O[@?#,=2= M'0SN[O-^X\T(X\'=W:"?78P'[5_7LHO;?%B,LM/)V'B!X?5=)+B&HP1@O8%R M1_5WG_VI<8CZ<(/$[,&SR/9@`"GT1T6'4_5'@UZW`QPZV>N\E_?;!=N'\4;9 MZKN+P^S)\_IV#HMV8HCM^L.(H?W1B"G^J?$X']W6?SLOVD7W0W[5*T9K6;\8 M9X/K#.`//MI>^.-):[.UUMK=R?)Q!C>V;Q,[KAF'LZ'B[@ID!2YM;.JX_P&J MF8'FLV%QGW<[6?$)&30"8Q(8@_$M<[4#J>5VD/J>+P=CZ&_Q.V=#)-L0T:-) MB[].NO>B=CMB?;J+@JDDI3J0VZ@[;I#`Y>GE_MML_^+BZ/*B/CB"_&TWO^KV MNN-NT83[?MLDYRB[SQ\$Z?H'W4R6`,5N9L^K"X+I`'G6Q8@-])XU"_Y$.3 MHW'^!N\^^_+YR^?ZDA>(+=8\0-=`-O`^X,K01V&MD3@:.GJ:P^!H[J^]7((H0RM;7,_3NS?JX&-[57T2`W77'0J'3.>>38$-]SYC5 M)-CMH,=!1\\X[G6WW1TWV!G^J8)EUHH(10/96O9D8[/%1H?9A[PW*=:RGV]W>BD^[HY$(R%BT%*Q-H6!OM%ZM MO=K=6GNU^>+QX8_*CX/\OBM^[_8AWW8Q&DE$I9/43PU#3.XF/9.H`7#U5QRY M=NHZC!NO&N>_/=Y_??P6K8^BWS\YS"Y^VC\_^NGT[>'1^<6S[/#HS?'!\65] M:"#`UUF))M-/V;__;/*R89,L1;'S!N\^K:SC7#+OU275SQE*%+NL&'=1]J/G M\_31?M(56'A99S"Y&E]/>ED>1%X=*F*#DB@3%K-5L-L9]'KY$(&#`#3L-)3? M].@&W=HL_NMR0P-1:_&O&3:H,,""L27B`P]^[7$;$WS5B>>-?OS0\T8N>>XY M!'8QABE=`,+`IV`9$8X!-(^RJJ;_=IV.SF9Z,<>Z8^YF"`%R39 ML>BE'X<#)`RO7'?'V?5P<+?X]5,S5^;LYKP8XS=)10X>\IY,@_J6?'@7'Z[I M;+B83U1S5??TY]NYHT.\7\"G6$:IH-&%["P;\6/1! ME[^>=^ZZ??.23`//6^.XCQHL@'AXH;Z'MX*S1$$Q'O>,+H2;OO2I-O71S8?Z MJ'=]?-.>E%1V`VPU0<4:Z/9QWLSY;$#:H3D/8+:9JP(15J!GA(ULG']JX@OZ M^M"5]YVM7@$2:.1Y)KFW:,P)1G6/P]:/\CH?==OVI)1XL]_Y6'1O;N4BY)A$ M^4V1]2=F<0,OMFKRU%5XA4'K,QUV>Q--H9W,7R^^]2TK-NR3I>3`P6V.%322 M=K_0(9)&QKZ4U3-/.A@^ZXCRX=KM="O M"^^M16OJL??#^=P."/)^/,@ZW6'1QA-KD.)C[\>%Z_!V``[N)<=%BO+C3*C/ M8_HS,]P+.!W+50*G0L)FVE=8O['+KQH\;\O!+7$CW'FXW94W:?Z&L?9UD8\G M"`+.U%_D`;TM/:<@Q3K!?8M/'K*SZ,'MS_/@*C10U7B-8-<,&ECX_G+<1T0@ M>X.W/U<+'^B-:WO#M*&\:E`,ZHBK=3_,<7@[?YF,@K,#W4%U`_PZKE.9J"6_4XCH;_9#@SXE4=:O\*"EY2KDN9X$ MIZBN/NQUWD&K7,U578=ZUB$*IN#GP@V<<&X#8+=O\90V&T+:U1>L"$&/>)@* MK+B=#=E:"=O4)VN&!##&O\7[7P8_]<7KY-+%BQ\]1BZ12=RSFQFXJ:\CI3I% M/+,6J@^J;^[:L/((+:/RVT71&;DQV*_X^_7IB5;F#S)P9QDR%3NG/FYZ!>@T M>4A52ZA!-`D$]S)*B)UG5P_9K"/5U]-`#!8,*2)+JYW"__5<+"B0UE\WJ*%Q MKHB-]_M!:,.JA)?GO4IL63"8_=+K_8OCB^ST379V?G1Q='*Y?WE\>E*?:>9+ M"P+ZK0U%D_2?F2/KTU_>RL[#0.W>2?*'<"S_*L.Q`9(6>$C)"X6B1F#8!1:V MOSFZ%IH68!Z=BH!T]($DN_JF7@AX%LC#[@CMD4\Z76;?J&\8#7V/*VX6]V71 MONT/>H,;'(HU\@H$A%=7#BZ/5YX;O1#`S.[ROQ#*&3^L#S[*_UC=W=MH/7V> MC297HVZGFP\?UK+W9@ID[\V<3=.\?\\T:]EJ&U^<%PBQ]7A7!UW1%@C!KZQE M*Q^+E0RK=V4R8DWVG6=778X2MO5@LI97$:*,']P;AW%#AN6XN5I.,W'`C8R3:0WMH==M>^`=J\F&#,B-#WK#_KK"`&,:L*" M!WGO#M'_Y7\1*(*L>3[,[Q^RNZ*C:(;VQ4QKV]#$@V@QI?A,/>W M#UCGO+IRT1[F=T0AA]FES[+"K&F'Z8Q`&1R.8:HQFFV"$,O'S&X8:4OV#]?- M4>$];:F!8":'&^=08(5LV&QOTL$]";2'!C*Q*2B)I$"@L8*Y7^M`7#A+X1A[ M1?FMD;2WG.];?`I8NR"XUNOBV%G@3)(@\0*O-7;[B\;TNJ`W^UCX''W`92=*Q)_.`<+\123D4HAM$;K/#)M[0UA8S M[!2X]+KX5P'^C]WQ;82%UKMGU7;WGEA!1B16'BX;0UL6]Q4.?[=Q81`%0VQ5 MGC*Z`+H3!L:WQ.4SY+42F$@]L(M1!DW%E&4&%8K-H0F'1)<5NGV1H?%R(-XX M[_@6\H%<@*Z9T&WM(RY&7*V7/2CKQDK:_F$M];+3P)/V'.7OQO*!.J0I4$D&!$??<*6PG-49O`.%\=\\I6+HP,D$FOM@]I>UMKS MQ'$#+H<3H[>E4(B8$(EC:6:C[DV_BUNJ_#!DA3""E\SY`8\A1A,,!4%@*2F4 M:`MMJ0GQ[XVA;RP0%28ESN[R#HC`%R.%MPP,BM$2GA4WQ=4^NW0;K0DSRYXP M'WWY_.KETW^V25O;3Y<=NVW;W^^@M<"`^,>U17D8;6W163S`%38/$#UT[R=D M:$K=1=%%[*E_\Y5GRUKA9'M[7WDR!!V(1FI-8/:!T%#AGQB$D]>Z^R#MN0QN39Q\'P5[W:#D$/3YV0 MG4(>UO.^B6*KRX[S7]$AHW%QSV[E\J'.D3U23FD?(1+(>B-X2JK"MNN&:*1T M\S(3^@,$OWR>5MTCV\-/@X]HH.%:IF"P]BFH^LJ=;$0PPJ1D3T8(W!#$EMZ! M?XDMW0==%RQAN.61/03&,GD^(,_D.B!"X2Y_L">F44>3:X6OX$YW4^1!"R[7 M$]&,0T3J%P4RF-S<6GE+A*O;`&@/%*X,6Q*OD-5FA.1GE)G!VT6;XL9/4FYTZCT3 M;A5?F-E!M:#M6C.R"0&;R;@MOK$=F#G-<16"'S\L8AL`%Z#E^VI"3/8GQ0%2 M\"!T'Q.`M@21-8[1@+'A-M+ M^TP&Y,R3ZL=B)XR$0K:AT2/0,GHUN06R!@;W M*AZB3$V)%Q/)+F15RZ8!O>(F1[SII6N*<`9&-E'.RO.0-PE6,.""1=9'`7`H MS&=$FU&A"#WROP$/HV@TP8`)%")1&&1]3F1NVQ9[KQ8V1]47KJT5NGD)U/I0@ M"B:S6$&1$77OT%3"1CI:O(EA+[$'1_!P,&$E_H<-T%3R5%%RT[P978ER& M(#8K2)';&7U%(R/]Q0M&8=C%P!G<:&:9O>;#BD]X"9FK$RF3HJU5:'\C0\N[ M8)Y_>G<=I)>OY"09@9%^47`/6L,4I6HB4GH@\PAOF2LE@=?#.S9%,\"**VDAGR?03H`L#M1/A"2&4V9E@2/ M.,U\)J^PRO!#L?(##)\5_=[Z@R_9OV0[7LY@I_$=>`@GCYCE5;^F7X!OO.7[GL MWG'P$TCN?'"7]_7T.K^3Q^8SZ(?O;.+Q#XVP0&/QWV?AV5";#DF`6LR[%QN* M6$1@POY$A(C@@4T]+$O*'-,_=@G#W]\7\E_)60^R54&T&?W(4B)#<2(\505> M5=XG?#=@\/\-`DHAY=H-?[8WSG%^1_CK:`!QR*&;"XH0`[E4;64!+B@8BIM< M$Y:1#OH$)5LX)TCU"O:DDJ)\;Z1)?*P=AO+.ZW]@^U@.[E)21#!7L>8#L0/D&7$?@JE$IH[IXXOIE0;I;[D&HH MVD-_%KAT6\L#LS%J(&L#(1D=_/Q>_)OW@K[ST'^4E0IO'!P);;]FZJ`>D&8#S&Y$P61=MT$)?Y?<$*U8["F*/ M,T4'%M:PO?:+3Q34B5LP'<2BHV#,86!5[O'(6W(N*._VG!Q=ZF;,Z<]'V>K; MTXN+Y]G9T7G&WS^?GG@5[=>/6)`$W#*731OY^H4O@0%N(&$:XCM>5EO9BWD;F?_+2LJA#CU3;/4?;0`!-$M2U!^:Z/[RF73%S"?*8]0?'%:` M(1IY]-!K7SXWZLE&RQ6L*9=7AI7$+3"HES5YU5$S*_[=?F/#!LJIF2[(_&+J M+[QFL"9]`=7['83DVX7"Q,;"=;`8`B&5!=A69J%6V;<$7#P2+;+4U%9-`[7I MPDR9*D)4+,Y+N>]LV(^YJFU7U4O0NJ1;B77;`=ZU%Z>9TM3F1MA9KE>)UAG3 MB%C2EM,`=E*G>=QE3N3F6(E]A<$"TJ=1@_-X[5=1''K33PUQK!SQADFM6$F9 M]U14==W9[0."_=2JV2R(38R))!/"M;6VL_DJ>;JMM>T]]WLCMCQ^/T6>'Q4W MJCK=0&$*W#LF"Y#EP!WO5UD!J%WYD^T7N['0KSH!0$]D>U"AS+-T?"O'`YX+ M5JI.V"!O5L"I#QZ[;>_)UMJFWQ19.&MU_S9.!)``7EVSN3<#5+^,.)?"E:3& MA'J)H*26X"=2DNT<4I/,)MDK#)`;(V@WA>&Z>#@_.J`*Y>V?L^.+BW='A]G^ MP<'INY/+XY,?J5`Y/>'?!T<_\\;%-P]WGXA*18X"]D`SS@S"2AVBD3H'^=8,3`ONX5U6A4YI.%CPBHD>&VY!5S M89I[:!K;1E4T6`9=4E"*_KNE!VW-*J4I\PRU@-#X!YW_^/W^Z[=',P$='BT` MY4>%=%@J29Z#5I_X;*+95DT\0Y##GXYA-49_/'@U28XA%! M`K]A/W7J>E+_X3Q>(OC:>YK&D7&?2=K7IU^O_V!W$^H_7EHXL-QU0PWNO]\_ M?BLLKK\Y/5^_V'][9%>FCO[T[OCRSQGY^7?G=I&J/O&RXQ80P&XB@&4GJV_B M4F20=\,EN4@8GK3`)D3)>C)!!0$%2L1$#*Z,;C';G02X)?]`@%^W/-?1=^O" MZK'H?Z*3DM^$3_ M)DEYAF%U1TP5XQ'K%+/>*YOT:'5%;^`9RT(FY$UM&!?]MM>V6^F:GM:Q.NS@ ML!'WI4`+K>3GG;&R#`FLW3([%AP.BP<:R#C_X'J,-B!;,Q"P3,+_TNW)SAT/ M^FO9S_L-:7"L8]Z3;-?-8N*5KX`U*[E8\X`PX$7X!.V09W\AQ4D<%XFG`)I% M;PP@LCK$WM+.L?@L#5.BP-U/=G5'[4%_0"T80I2UZ*%P,PF9(ZOK_-II+2JI@Q6 MKB+S4SC0H1K@>K-_?)Z]WW_[#D_W:/_BW3D::Z;.FO4BJFT!5\T946>=O<1\ MLP;,W(NX[2!4+MQ1C`K>"`B4?"`LH-2&'O*0R:^:NGUL&S,R M"5Q,G!XMSZ6F&A2"RLE43-B7KDSL08YR]ANTN4]YBRNA^U9A*:L"H.;+2NJ8 M[:\3TCH4'PZI?%39!;"5P8D"'_ZJ5*OXA!@H%H3D1IF8KV;>5]\JA)VUXK[, MOGANPD/B)1L1QQ62*,_MP1*09=0@ MX=(I1FUJ0CDC4MB5>?,J?CQ`0]L=)X3H)"52[@IN17,S5>$MK3(7HLO`KPGU M1A99!I=V$.LF(`*8@'QR@^?]*%O9-QW%4[-%P]3YW__S?]0Y^T]3A*-CCB@4 MY:;N'")I'/*?'Y^Q)+QEIH?GIVBWL4!`II>6`>)^C?H-ZL)FA3BCGC#*E[$< M"?]AWO1IEE38Z^6DE=PX">[!<#BXLN)BBQ]75G3.RSHY,6PBRWI3U6^FT5"? M4,%0+-)OHI[*#:,1%4E,;16K7')(WB0R#5:@D-MCWFBMYT06AW?NY4?B,9;, M[KBMHWK.RN8,SV71$9I,*UH)JF:)O-F$UAPZW?XV.G66J^Q+VK9:#!.2!!49 M$62F9%.=\"[%6`*:94-+#//G[`G(LTO@2?=`U@:!4C^5P@C7R"\9!>\G"$(? MC,I7Z,(A;33#ZTL?8<.4T&P%H7H*TQ+Y)SCR;QXPD?_+DA60VDWWFW@4("+JEJR41H$G6&$S]Y0(XE;!."!+FBQ-]/9@MH'DLJF`B!'0FKU M:W:::YG81K9Z@A++6EO/I^$=.,ETFPZO^:IFEMDF;^#I(B<72]L9L_%PE'%= M:9*D'<;3H?PLI!N4JI>E:5[S)#Z[`,!0[ M12Q5D$D]6'P.D`;L$MOCSX7@&>,,M5FMU$ZZ!&3FFEEUQ35065!"6!`\A M3H60T4X?@Y;[\!RK!!0RJC`@7C)^[.UW/`3%[+XO$37-'Y1?X[>P%%O@P@F6 MD$DUZ_;#\3N%1`A5!K:="N9"PU(/*7,+-&R!`/=G;2U&[)R^] MVPGG^KE6H@]C--SC>E`.]H\R,^RRLN\D"68R3@B$Q3@,,P$6*N\,)HE%+BF? MIMP%'\9HW).:Y8^_^'WXT=K*B,BNLT'KN7N@0>*9)UG9E1@^L>5Z++X4?F<%NQ'Z]RUK7J!.V%'7Y3M>+VI5@\+%J$TR3=4Z MN&]296ZHR0#/S%IK[:X![=C`Q\723T6'RI0;#/7PBM*W%Q8#GK<)R*U/T-"< M3ZQ*B4&M7CE^0%,,0[K>BW^II$_C47J11@&,_-A/_/\P6:`V*0M<97?(PI4A M:=E*=9Q9S[-.CSK&J:,9`[-63-:6QRHNV7$D:>,B`VP9.856G[QT"K8;XM.- MMN1Z=[(G6]#XB[U0E4JHS[PER[^'ZP_;*B`+U+LMMJ@!JJ3>[)`(!WBP%[I# MC((8'&04H>H=>Q)WG-+B.1Q+C2=Z-79R*).6P6V+M!WK^P.$08'<>C1%Z!:U M6J7N!C==N.$9+QF`N88R\=.55&V<$M0&_&+QX$#@H&0>==5(G-H!$).)-8FPH'S9!&AFKZ*FUN[=10S?O_.;$M[G#W2Y9&Y#N\?&O,EL0&R)8'T03K"J11=AY@$<%"C%F3B0<`:(R#.NKIPK%**C@F,9V&B>N4]@9U+14\TC7[ZBRJ/AB MD4F''?C-'.FMYN"]9<)VU9Z M^L'-R_;_6&V]:*V]V-VM3]CH#K?:VJ-E8;-=[<)N(Y8.I7$IQLN(-JEK+U'- MIJ:WUK:W]ZHIUD?+,6S$RO@'LM3GRE;/X.9*N\+ZP9<;M8"H M7LTAJN4F;FRGO4QCDN4Y.*5(HT:8MV";M$/L533OG:!O9`]?%S-ZMI!/\GO' M2?_,F\D*&2TR/KO_JV5:XY:;&=6E@#2SLRV7I-4L`,?0C*9H>KC"(Z3W9&M[ MMW20MW9V[`\$)6=?HF/,G)J0*#%3JGF:E&7$8$5<$R8-+I$,BK>AF=*LEDGX MA6_/]LG?F'4D%_$<#_:>4LNW!\%GM!_\1@*GQ2VMEBI@^@5MP062X-Y@/"JJ MCJE4L2TQ@4[DD;0VC9O'W/V=G[\X/?MJ_(%W_X_F1)0_KY!Q1)"-SG_#+C9S:R\%BU,WOP1Z` M/&T/?/D<=V3-5K]QIQ4WEL`M&`4=>C22.(JWO:`B;U)-,5RJ3!A3<8_ MJ_E=-POA6S;_XRTEQ1IN7O:-6_)1&GP`BWI5]F]?+$'LCLM[;B5""?AP?Y)NWG(+DKA9B1Z(:00`IN*X5Y1/;%I0)6TL.".PY@(I M&@H$IEE9QD._ZM!,`9U8U0WAKA0P5%F7Q7J`>K56HF7;::WMM5ZN(=]C\#>8 MOT':<$2$4EE-"U[203=B&*B<53L[;8\I%G'-F5IC.V5< MZ7%;R*18B5XCM5)EA3!NJMX/)`K*6,=E*(1`#HRL,ZENZ6[CPGM>+&?9\EN) MR#$]_)EH0FO'>X7(IT2<^IWFLL!SP0%5'V<==$*A7166"B5Z7"Q+)WI&_-]: M_3<3>Y>_];HQ2)VE:9HB3="JG"E`[C'M@\SH$.IK:IV&PCDYO<3%/-O_LVK! MZIIDZN$":[-5MO6:5A-3$S1FK[+0\L9C-%NL&CXZ[.5=AE>;9&H?(/*R)OS$ M%EH]N$5R)40O?1\*VOM?M-28?S6;QR__=O&O_X&*#E:SV), M::9+^E:*4@K?@UMUZ*WNO-Q=>_5RL_'[[J89W/7?:TL2FJR_X?1?__50-J.W M_^E/4;WR#I)KC5Y4/)A7&W,6RQ?JJ^Q;;X[ZKP?ANG?]]_?*#]=_/%:S/5R@ M^N_GJ-CZ;^@1.*7^Z\6L3IU._DHGUU_G,.W&S#^'"%[]Y<,9NWA:?^D].>S! M9&1YD/HS![3"1\TRAR5X=K75X'0ZAS:V_P).-+N/KY0T/VISU>U,;RM$'K]\ M9OKL-%[^!@]T)>E#+<$MG,ZL)G/I*Y(Z%>U^/2MK1,"(".ZZZT%7.S'?\]A0 MT^J-T=I]U:;``B:67+/R=T@AHONC*E>_U@E>"WD!`O1TX_%TW(K#K!:8G?Q^ MP=EI\HN%NO-/?].@>2@U0%.)8X\3Q%.$]_X!VP9M$RE,96. MV,E>;:Y+CPJ%*7`B*XD:J2%8\4XA9MTI&T&L#QM?-AE]0)@0[R?I6A7OFK;$ MTIXOU=@&+K,O5U[ZX4YC8;?`X\5&?&XY;E"1XA)7>";9WL;FYE,5NV%1X=JX M`+/`P+ZLBGKJT>Z6=Q1MX33:ZXD=,?I>X4)*7#A6CP;?3@Y89%O=H61MU/P>H@W4U&:SBB%V.T4RJW M0>3HK+/G+Y]5Z6%#'1$*I8`#[B@4G2^?UXGX?/E,YELOL<"LW*QZK3>/T!&('3H<(Y0BXC3')G()V(J)68VI0%H.HGE+!".8>A#KLW?J M==.-_Y2JT7$$?FZ%>9>3X$*K2LO1S#\0$/0_LT[[X#2VN<`W M9CE>H_F@H89P1+6Y=3>KM/(/(VYD!$?!"KCU7W8#;41J+Z,2TK&+%;$O#-##D)N:D;[M+ M4G:Z'"@R18/*_P-LICHX*R'B&!QV@Z`,>FUOFH0DV&72.@":@@MHUU0`S%T) MOLZ(++IZ2;OW+ML*GICJ\>;3U'S`YXD%G[3@SEV^RK:(!8$^CRN5E3(?(CI] MN[&0@PA8E/PZ18J6I?C9B5&B2Z$*R83"5UN&TA2N."F2S1J>(HIVJ^U;??>( M%U.)8CK,*C]4?%YI-)URI4Q#W)0#NMN1-'9M(L'DJE"DE8T0T-4'?]1.TE#1 MZUZ;^:$#B79]*J-BC:M"SC@6:N7J#<:3/S$Y`',`&NUFOT*0T3\98IFM4!?H`?NR_L<`".(;GRZ<63%=.Q<2M[1! MM<<73PW8.J^X&XJ0:)`'"C12*:D>&^,E^KJSJJ+UR'C1#W,""J3'9&7@<\K* M#.;2BCPR6A"/5L"K+M7!N0$$CHLXK;=-%HAWRS<-],`VV_6./Q(;=IA@"7XM MH.'%L6DEW(.R+E@G3^%UU"OMV(U\L,AX%.YTEN6&>\\;4JX" MU4!)WX02*_CS&CO-6'2VOYUJM>*:LG]H`:1UGK1"E*Z^/GMYC()*PE;D1M,FN?N<3))"@>L`0:]DBU_D$1#TPNQ=N($']QNH MJO:FS0T2.G4TA=J5R8O(4ZBU9%92HTZDC44P3:J_86@$7\NU=SWM)4'J M035!/US;:0,VT2P!-2E$U$2%WW"B:">&IQ\GA0:$ M%G84!'0T9)MM^L/=D7V/=4?=>OPU,:$Y*-.QINV;Y/]1FR5]4<-HAT,K8VUW MCH$^]90ZHLC[(Z!4]RL"*OJ["FF`_;O9VU%[1U MKR%G2=#NFMOUS9!=#-57<6-S@7H)K,)1,76JQ`63SC/@U!Z=.`P$:O8LA@97 MPV%Y_:,2F((R'RJ1,>'3,N?@9UA0P4!<4'-@&BCM9E&JA9^&JVC(\+U"=VBK MIM9L0TMQRF'V:O?E6NO%*\GTV8;6E.H/(;1D:0%I7>%V6].^@1$/OQ,/3\,! M,2,>?6EB^9P+SV6#1+21TOQ82;,`V4J43BIYO=M?#\W'??Y([G*9O=F#YDMN M1XPE"DEZ8!AWFOO*G:'8%7WI$5*C4K]2O*W.5,@B3$+F-ZS##Q'EODD/H)E! MD%P7C7G@],N4R9^N%:9:G_+KHT:\4#'( M]'M1&BV42NM56-@Z;)/]L[JV>:LFF@N1BB!U%6KVLKT\>]W+V[^N7[1A.AA` M?""VQ0X+=W3]/+'`6WY5O`;1*/;^)=RG^[YFZJQ>NHK+6L\;%^M/\$"M(0EW MV.:.VVJ.*U7NYOQQV\UQ;XJK(^.?LW>J&?'!!`,U1[&A$#&O, M3U&'C_$E\5(_B92%V4WBE_K#LV#6G$:SQD[QZ%OS:.6U?0+8NH\<-/)!]5F# MC4=!PN]KWWV;#5)AUJB%ES'F0C'6MQD<>[^GP0&+;A)%8V??9G%@"\PS.LQ, MM)!&:F+X]V9@M"@_>4$QPE<9&#)_8C3';(QPT)W=8$SL_,.8,)\\ZN3_.\:$ M,S11D[I$V9DMY>=+Z]\B>2]^VC\_^NGT[>'1^<6S[/#HS?'!\=')P9_KFYKW MWJ(JORTJ-9:=WNJ9O4=G=D8597W]TQ`(-=^V909!,DD[M`]5?`3)YM$A_I#% M0ZPKO47-3'[7D@V.VNU0-H8IG?;?2T.F%__K(+A/XEXF"=_-5.ZI%`>*. M=D.X_S]H1W5D?07(YFRP)2EODGYDZ*G`3DU`P&Z?]M^GDF0.-'K)V>L!8EV: MPG54Y]U[$+QP&.ALB?&J[VT1(\8>P<=0T,\JT"5/R_R0!T^P1!+&K+Z$V)$% M)%B9*R-M?82F^3U7F!0OUS!(N;&!V$/C5-$["N*9)$8$>RC]-7P2.J0COV@ M9W7]W#:F\#I4X)98`J8)13/:`[Y/EZ"Z`JQ>9&$QYPHP<$H^J&"."O](3@`7 M&X](K!7I8[I7BUT%7'F:?&+19M5\H8A[(_NB+S&E6`K6BL6%`O_:OLRSP73, MY0^4#=U84KMUNBACL':+F'"I_`?PY543N?5V21?#=$1];M;4(+T47A%;T*:6 MPO7X7;(W!6Q[NOV(SW*"*+3Q!IUT6@3D$Z3+$TI8'2`GRZ`.YQV:9& M&A_E7L-(9OVI"S7_CB^GX@3U(TVTGU*:S?L+1XG"4XLC'0:)2A6?-1843U%9 MSGGH;%5B6?&0-&3FZY[^)33-<'HV*8''1B2@`XMK9MN]I8<1)M5O%93E4Z]S MG3:PF'W@X9(N$%S-5@>VOGUDL;SI/T4HL5C,\I4F@E"ZK)]NY$SO`-%92AX^ M,.Q*OB$7ZI+9Z_5F?TUXVFP(PE*I<:V<)!41\A>=9&=MZY'=S#$KNG6WHN%8)A_E+/4,>)"9D6= MQ7_BRA.UE%(,9(]0=&1)5!/B,+.R."K`:(:#?:EOH5K])%UXKF'?D;.PE84& M#DV1M:;.Y48?S8U8Q\LQ+4D&VZ5*VEU$S?PEGKJDD8R M:Y0_O!:20*M_PE@6@WTLW/2]-;[71C2GQQ/YHQJ!="]K!IPQTP!Z0=T*NK<@73,2"G]Y*U=^_"1WJ9G(&*!H:BQ"<4C*KG5/LH__1.+9CTY M3\!]X'@H+Z_M(A+@A+4<0V8:KMLQ.F8)"O-'!N]IVMRJ"#7K*5)`K!=[ MD)/)VD3K,W>%#H/G"56J`/S"OJ42;R&GO4FE1A:>QK?$+9>B>1ZF5<;;I,&5 M(NVZVL2T#2!Y2[IS'WR(_-"2QS&7%J9*RP>I`,_?W!B&R+-94$V>%Z`(']?P M`#Y6BM5*;VT^C7N:ZH4=OA93$PQU4CVM;%IMY@RU5;`%#4@=VTYP`VNYT4AM M4[EH*]`;D?;N3()$M_)R`%99+V33MX*10'(*(8H+>7@3F`<92(VGEI4<]"[FL@Q@H/)D.\0S MHA?G-='?295`"U],= M/GT,!HH8T%)C=ZVUM1>/R6Q5P='8^R60QU*8F=97(+S(;-28&_=,)U22[%=M?C!XC(2?O-A_9HH#C*$"KC=UMHN1)"PK-@5X1FE])8WQ M.B$J@R5&2GFNFC_IHE!F#*2%15R7C40!PP?$9HM4VY690?(`^/PZ5GKI)Y9[ MCAJ\=#*F[]JU9R'DK7V?VT-O?Q]8>7LFQ M=9DU]8D/3>(EQ]-5NK;49?1V;<]-T!!+[PWZV)OJ["@WP*._I9Y?AAQG$DPQ MBV"<^2WR_/=!,"X>D6^XQG([!(#`"JX'C8&DHI8!Q)0G;196R7]"4ZDPJT:( MC0JK5LJ-DON3MC`U"#['6F:[+S$WV9_F5SVN?4=(%]CU0ZS,O0NM4:TX-SCL M2D)H('YAN-GA![4Q=S;*L&P MB*OHC5DKN0F[J-T]N09VJLA;66Q(,"G>"C$.M&AHEYOK7D'GD0M67`IIM9TF MMT`'T\3N_8F?U80M?NS*-U[92+0,E2_G>O9`>4%F8E&&%MKJ&Y#\J@@Z MH>T-J]+H('#X2`^?=PJ!DE.4K"DTX&*@F?0!$ZUYV>:-KD6&#ZFR5F6+9=/5 MF2Q[ZI(MHJQ*#DY?I6V]-$<([X'L<2O"IP*<8$+9GD]=V64)2*@;,#XABD^W MKXW,M&:Y*_?XPM/J,]II$0CGRU-U7_BRLM$$>K7U2GJQ$6B: MN6>81%WT6W08%P&IB_[.YDL"&S/TSS?`L^KE-^Q36S&%(-I58E(TL*+&N;I@V99'A)-=CD]N3S?/[A\M_\V.WW]]OC'_W1"X5,CZ:N'2PV<6P=EOG9LE/S_R,$V&]L[357_.W.RJVSJ=VQ>OC0DTZ8J MO6GV9T1LUC)]D5&$+;J\R_]")EI-W#_*C5&=3Y<"H"')K??OC]<\-%#Z"Y7N MD];V6B$#V2R6VX)VB^Z]97K:A%5EIX2^\\@[F$1W\1]X5?]^TJ+<]<5FRZF: M5#X?D29$755EEL)JB$BO`I$_9M&*T(M%GE/KU:L=FXY_^/=$[*"Z9T]$+.S< M737M(]C),?'W8L,-;0&EW#6M5?#CD=9(OH32CZ-_0N[5#6/O-1O:65J`@]R'[ M;_G=_3\CSC:$3CY3\BOS$''#_.+3GTIJ$CD?]W%8#':R'^ZZ@DBIKB6T\K[: MZDD9JC""CU<.-(R<%3=&%"2^Z@[4_'>H'.X]_S#=R<443N,1O9#-@YZ_8Y+0 MN(8YHW^0%P'14>N*;FI*7GC6VW!9YVFPN/_0]RY[K:1 M)7?\51I&%M(`EC.V=R=8!#!`4[1'&XDD1-D[@9$/%$792F2*("5?%GFF/$2> M++]_59WNP]-L2G:\LU]\87>?2YVZ5YVJ*/NZ>4K&)BD]=\.U8JKUFBNLZG^8 M?\G?VE MV$"I(N^?%1"C_*`R?BANRXG)'""Y%+X%F&1F8?$^$+040"[>),(9N/2&!#Y& M-P./6*L=S(R107@L3I!6>GC],R3W"BH? M+6:J0&W_`^Q:GH-T^C?*94'NUF\2,0$M^#Z6OWGW<5[8P-Q\G:O>[XBY)<. M7:>+'<^'BROZ]/`]2.<.`;XA3X*46ZU?51,437&O-E])P4R`LBGT%A*'P2@3 M1K+NQGI5T0CD9L$;N.4HQT0)PZJ5AW!5@/Z<:VQMRDE[$Q?5L25]%(-,'757%A M24XMC\"_F8S/1IP[2UK-#^:>CJ<`NO6M-?!(,&:TXA@"&X^)S0\4"6E)8MNH M&R%MKXC\\R\&:VLQY15Q?H:3V+J?3)Y0&MURX#1#N=P42--BXK7>?A6S2>4FU:%6$LA>]D]M3K,^8WW9K)N`-X2A/CZ47I>_(N"\ ML<\;I80:UY:O.ZULOKDP&R'9DXXPZBE@JJ1A-#BQF'^.$7R&9)DM:5B@/=B. MQ;!1=Y6XP6G:Z0L+-23'M;0$1.A2@0.OG.W[U[;TLLE$>02#41BR)75"1Z%Q MIC!D"V["'RX$:',A6B];#HQ4&\Y2Q$J-/$_1XOTO'0+3U%M!(3U7GN^D-3R&0##"J\H'Q)(?5&[-)8*LDGG MHA;\G8I`(2]!-(:)REI>M@D@2'^7&UH5:QM3H-9`B\W!NVY?#.RBB3%;%#B( M4WH8+/LC5)52)7]'7:HC!KRI7VTW3:_^?N5;XU+P/TJC@R%L<#\PT<1J?D:U M=D=,=$U:WKG'41I=S^A*F#JBL1*X!Y%#8)/IY1PS1YS\5]@)PK%W`89*DM=2 M61_1$PF+Q=`$3#5EH]H?<8$+322I;\;U]'+"&V/+1MS@%:/"S+WKA-E:0F!H M#TM!UAW>10+OELJ-T0'R::#)='4^)36M&GVYIEIBC]>8'?[_K-J?C'Y3)MJB MJB],NZ*K1;GEHB'/O0'QE&QWL9NP#9VIQA4K)%8#)1>:\A@3LO$DSK1=^(^E MM*W0.4GEBSB&/CCG@CI\'BTSDO:U]A2!2%N7L:B7^V?]?A+)@.-"(:5/$NJ? MKL23>6,*=X6(`4^=WXEVTIP*'/-Z^MGT,+2#1[WCOUA.GJ0&T4^'0E,-MD[S MTZ+2P*P%MP$[=RGB,L#RXN&XF%0`VG5A*6_]:%Q+9:5JON"7&>NVXTE`8J`E M$6-LWX7GO>H`.:D.4)F#)`Y9@3&]*H-1*:$&`0V>)-)J3IV4F+!&+$-F`SMC MW:>*65*@;"`-"[1(&[``J=`N!NZ`2Q)[CE/J)"DAXMH#J.L@O)Q^DH;+P?HIHJ6M&V^>_]AXQ7RWAC.A+"NI2VI3&2^!O,_ M+>I09VR'`1N5A(D6F/42QRK55G.%I`/J/`/50A$Y'!UOT#S8=>JXZ-F'(-CI M2Q!LTR*_?0'E>?&YI(`;^KCRS99[H?1I0BT4@E+)WO[5:D;H"BGE44X],L)* M8"KPS_%-M!"#.%5^.\*Y-$V'X/7QDD$L90AV`F!4N,SY7L,2#-<,`^J[*L;R M0)WS:U'^-22C%8;V`USEDO,\.OVN,\RX`)JU6%0@2"!@,YT027NMEYI6F1]A MQB+$O#O9`_'&:"R5VN?6PZ:\]"MXQN9:G"=L/W"U%FCT;S##,E#9!(NHSU&> M5'8!A>0;XFE@%C#G]&Y32--""%JAJW+B+RZ1$F"[>"F MNOZJ8C#4@2.6G-X\OX-]+P[6'ZXN[;`L&7NJA&@YXI3GJO,D>030LRW7PJ=D M\ZZ,I8;UH_E2.,KH2"DRB?I",:^Y@*9NV(`@DJGO.60V=7G8BRW:;4];"TIH MHP!$A=(P#?(C@-HETYOU:$I)+>MLU&B>[")C&E+7X\2TQEAQ@EO"%SZH<;2@ M):FF?K*!S*PI'S^DF';\33S"L[LT>A*]&T#CW$4:1EXTOUIHQ>>X/RYUC&)- M*3O["0S-FJIA:>BY-;O24!/\B3.UDV*U86P'L[9U;M-Y!"%1M\7OB"/@[17B M@.K)XX:)8,CC5D,3>F-(9)K\2_=SQ\P<+F!9G`[<-5<"\T,RB939Q-E!!AE& MAHGDKY#$5EU7`G[NXK)@VXF-L>7K%).P?&\D/!W_P.5P3:8WQ4H0YN[9Y.LZ'5@/.#.Q M71H`HCC[_:_:-1<3,G7L0O:N.8>:'FNU#FN&N-15VY0/;;8]EPOM.R3W0A8G MC")9$:C3:^0XD-(;=C4UW7??=(D!\G,T0W026"LHPBYFZB&#R%+V%\Z#)M,% MO=J;Y28VKT9OQC?-$\9_LC?P+MQAL`B<]5=2-CS$)Z![`F-1L]]AF7RR\:5V ML:"5G/B75$-@SOW8VCW>`%B+`4>8.%GK^@5MW(%A.[S!OK(+:&(QG)+KQ"(- M@`;MRT67KMSHOM1GZ6M:%KADNJ0A%#%"[I$9S/E&Q\R6E,8<5KKM0\$@#15VT0-HS!G-(^"1 M'#[NA[")N&H'/X[(*K?S.6B+;M$D$1<#VHW=K]"'6C$QFZOA(,8B`",4HV` M."F^J7:M^6_4Y]!4-(D%^9@^5)?8NH:H3M4FSMD2,]XDI&SB?:>#X]X9?3#' M/75?)GX_G!#[5\"_U'"[W^R,Y]^^H!1S'D5O_MT]6CGO2`AR(]V$PTPI$%+R MG?L*28V25.9"U]*@6)=A:^]^QU$K\L"%,V[>FT*S0$Q(,0"?0`3A4_V912,D MV2U=PU]/0U;0JY`8>!MBI83X.0$!(<#R&B*)%(YU6;M<5`K(>4:-YB MT?6D'A-`S*U!C)L<'^=X(>D^*>#!/R*9RW0SX:0-RB:MVIPJM4CR M-\N`&+S_+1P/'%B+>5T;4@K-BM<+846+Y?*^Q&,K74[HGLY>`IU1=7:9SS2! MH5\:\.YAXB%6HY"3DI0!YO^J0?X8@_!8@Q`1:7>UL76FHNX:B%@Q+P/P..;6 M@B=O7D[H'T[S\&KPEC]+;"J?[$=3RAH<#;]JQRCG`/]U!4'_/)H/!1!/4&= M>'V%UP4S4`Y4O/2*].G"BN[)BF\Y*`D4H1G,__=_`)6I$5#W$HL$$]0NYL)> M#^<4XY$.AU%1.J)]F#BM526^#3WM3N])$W@A%`;B2JD+\_"U\MNW31Y]'IU<[?4:FHS M9,D^M5F3=Q$MLK=8ZMB>G?HSXBS/0%#K/>,Z2MQ2=`5K334<2?2XH"P1E M-BA3,0>)BQ5'T*>83<+0]CZV@LRB-\@CB71-HY7+(,G*_9!!J+01;`ZM4JH# M(6A!Z/SFPL[[,Y1+6-H:D[:+9_1@[#12T%WFI9UI*6K^#D MY',<_)O^$UNRN*V(CDB+C;:4'#^/UC]:53HC+;^&I7#4-!W]DD*L+AP4YZAZ M\F09A8D-X8M58HY&8#7`EZ-Q3TFO+JGNDPE*G5?\UOB;Z+UUB",7H'I!9O M#>[45GE*1._DZH+H5#7@?H!"W0+#D-PGW.7D*NB2_?ZCP+(3#>)KIB?EYAF8M M7A.BN@:^3GPN)N9?. M7[I,IOI`9^(1])"^8F?6`=IPE,N=5M4Y!P]<7+S6C"^9,GKV_9RI^GRSNKXX M^"RE:B>/ZI2.<8L82L4:@%G1P3T8K#$?<,C_QDV@I^*V8H`D3\B4,4A?4)=L M?8MMHU`='_3K)X?^Y-B>"`U=RPC2EPIMZ0?B3$H!6B@4Z01<(T]B$TZ4S;4J M95*+).>ZRDP0@)/F#-K<6>I6.$2^A6HSN+KNYO(%:A-%-?344GW..,^T9J

S4QXN>7)BVEP'P(V;KY#0F"^6CG0C0$?=7)$Z(CNV%66H.Q&4(" M6,],UH+*<'!6'0W[HY-!M7\\FDQ^JL:#TXK_GXR&7G*QVC_3J.OB=MOM"WB/ MN4)C#T,RZ093DG@4]1B#;Q/=-RC1^W30'QR][='Q>=(Y,-6;K9""('-JV:RV M@'*H\>E@W*/!\>"W\6`X8;S>\+`:G?VJ];\Y/96.VYM,!F]ET?'1V>DF3]HPIYUF-NZN>,K3RI`FRL7,,P;='?.P]C@ MM>YO#&774-_A1D7&M+57;IR#K,TQ5N^.E85W1/QN_1_EC/G)VVBD27S5X>]Z M\:'=1M';9=#^?UIH5.].K+SWSH4W%Z>[DUO0 M-:_F[EUB$J0)VF49\2T)*%-N/7JLNBSBUC^P`GI^'.#L#*>7.01B)UZ_'_)O MG8Y#^GL+67=#N:,$;"=NYAO(`._E[."-Z:BJS9,RSE6-K'Y3ZY0F)+)?6[HI M*N&A:^.R2V!60U74DH^)/+?%.KG#]M],#JM_:K'/I]4)4>P/ZVJ@$'`)PHPL MJS&W/+$C"#75RG,7'B+@=)G+[[QWO41TZ`E5K4S>/2\GWA@A;"?T2D^ILI88 MYM5M_+#UI:A:O7H<)1?*H:'E9"&0+T$N&![;\ITPKBWQ7)(47M&"C4'W$L8, MR,D-)`R+D@&+EA:3/`81/6@\>0_<5[J"GB#=M9!"%C5XZJ_6CM_E/5@6').-CP ME:B8[0R(N<\$?2FL^:^=5$>`7TFXZ\X7)F9\:0,YRX,AUFE5D%#<[9UO3A:O>>ZQ=]< MM>W7CF6I-#T$&$I!8[J.+I-``WP3E#QC`BQXAT`;R3-#&'DI;9<[)[?HP>7I MHBO%$P>&0;OU$DZQO+US^9RLXY5EE[K#LWS\$#4/="GU.8!\0[KX_C%6$9HA M^!EX;_@+XB44+.<[G"\X`5QF4(2H0I5X9IB.MQ"H#ZF@TT^"BJ.\/,LJ1R`# M$J\(8*KKMC3NT_MFV3D^+.).808\*!XJ*4=["(R&DK]R@V5[[R*_'F$VGPOO M%*'1NQ4.-(AC()>5;`^+$P)0S`E'0$BHK4'OQJ\&.#+3@)R7[KJ@DUVYOXE= MN0VIUDDZ6O5!O6R%>6+99L76R^80\V5C8KOB7Q]H.?N&XI_0I@MTH*+\O'&_ MBY`%W<6WJ8&]M[VC8QD3!Z]&IP>3WO&@UL91S"<#[(!0DM.,Y;+B7+Z2&TAF MG1U#.#6[6,:&3O%I>G6MA1V`Y`?&S[*#WL48AG?6)D9,TT6(4MK+Q?TF/C3F M^4=<3MB<,QA/=GFI\PPW.4I,D-^CM[!G.=NKWM%I];9W_&90G0QZDS>G6-0R M:3`Q$O2ZSNM8'O;J6>>"_/GSSN?D(CZIPN'1TD@:W>QQF&)F7.0:T@F6,#J8 MF?.8&IC:I@O#P5')0)_X@<*^6-"[CN40S558`,76&DX)IV^P.^^#V_ATNPUY MWW#S%PN220?O_W:OSFM/]K;P(AOSX=&/X]`/VR:5'SJ<4/*IS=ZE8UKA6$GH4\2\AW6!8Q$QC-6MS:!8MXP0 MES->12NC MD"?'ER+&XKW=.RR61!`+VI+BP`K+F8MW"8)TO3G,3[_:'R/?,/^(JL'5?VH= M9S2:\`6[TZ&_>TY<[8V%4Y+U,] MC@+]2/L.I7:"N/FPNKI`CRN7U8U9N_!F%VI$@]94^^G\JB5)#]79UQ4DH2(7 M_G?/%1N30KYCU.11>NI=6;__"-)`SW[40,]_T$"X<+Y_5R."!# MN3>?HADK13V5Q0%1Q)B>H.@W-]P4J[U#'L$,";Y1 M6`__/P;/HV8;HMP$I2,Y`\RC)']JBVS<;D[4_*CMR=_TUD82I3!8`\MSD_GN MM@FA[Y80C[ECM]7#]6RGB^OY+SL?'\XQ\%-6;LF#\H=/RX<30I&W!T(ZLC#` MIUT*WS#GRN1\>`X2MZ.I@PBV!IK!#L@.*^S=$?AQD MS0Q;_L&?=T*'1I-HS!ZS:FG,B9T$7_HN!*L75NXZ#1Z\ZL<.SO4LMD7,[WE)FJ$,!!>[" MQ;V.IIQ['6W<2OS+PF9":ZX+60=-V,\&YFTGUMJ_3TJ#M^7U@$YY_-O>2TSI M(>^^I,(`V5K*V'3%P-CC*RYV8<"5`Q0[_!;ORQ]WDL]NUM/)";M4J!WZ9]#Z/IR$+?/N[>F#I9=7^,:PJ?)7?Y4 MBK/K1?/8I$J8RDO!+;-+84FQA*@34$E/?9&FN538DM<)%1(+%I1R:\$8?K= M`I26\@,C\]R&#\>V>'H[2#RN71-FQ&_I3K*-[Q+P([#,HJ2?J,#0K/WANMHG M('Y!LO447(-IN0N_I<#[6/)*KRWRPK_`5>/3SA6^;YB\@#Y>8%ON+#&:APVI MBD]<]K/+J&Q"$6@Q9P$*$N(64@GZ,W3M]VQ4H;Q:A/+V10P$UP4.610S#S8D M9NMQCI0NT)JC]CEMDQ,%+%-8/25HDG=:+KGU!:FBRFW%Q-X*I'9^6VN$W?B6 M\F-,KB[M8)JS[\#1XBU';KPDY6;PE#1I'3Z6UY=5ZLUA@8L'.9J"6`\L2\_K)/-:IOC& M1$6SB']<$X\F,:7G+@VQ M5"BLYEOEXV3,17**U,A$L]DI)*(69RM'V'MJ.DOY,W4,MO8'ISI+9KG^-:4! M]`@;*`V@RX$2-&$R*^5JU2*PQ8PGXCX'7I.!+VLA4_644!?E`U$!\_?&D:_4 M0W>[V"D($RFX6[SLY8S?_KE;.^7G M'0ULR]?>/>^>Q=K9EA\\N.3N`X)UTD&Q;Q120?-71L0N'6.\(5>H1N*Y2$U< MKEPJL3NOZ(MX`,` M`(X0```8````>&PO=V]R:W-H965T&ULG)A=;Z,X%(;O1]K_ M@+AOP!!(B9*,)G0[,]*NM%KMQS4!)T$%C+#;M/]^CGUH&IN/)O2BA)[7+X^/ M?3AQ5U]?R$ZH0W/6;6VR_?5F=6//$CY0*"QPJOK:/0M1+Q^'ID98)G[&:5A#9LZ9,!-PV!X?7#4TR M-:@L',]U0Z=,\LI&AV5SC0?;[_.4/K#TN:250).&%HD`?G[,:_[N5J;7V)5) M\_1Y>%.FME6FRY^'BC7)KH!YOY)YDKY[JYN.?9FG#>-L+V9@ MYR!H=\Z1$SG@M%EE.I/1G)O\$@YW.Z$>U`G\U5D;WR7,A_F:G'S0_'`4L=P`S MDA-;9F\/E*>04;"9>8%T2ED!`/#;*G.Y-2`CR:NZGO),'->V'\Z"A>L3D%L[ MRL5C+BUM*WWF@I7_HTC-Z&SBM29P;4V(=[.)WYK`] M$I%L5@T[6;#U`)S7B=S(9`G.,CT^)+D_/9`7.>:;'*2&@IK#FKYL@ON5\P++ MD+:2;5?BZ8JX1S$_2QS`.S-"VBX9Q]FD&.9@6Q]LT=E6X6]1$BEPXA(2?#Q7 M">(1@08&3[D$NRYY#P/P6)0M% M-W?QQR`]R)*!F%O)2,0RYTR/$RD6(=+@@,.)1`DLZ59-;)F$++G^RF-[]E MY"`=,30`MBAI"X7\?F?D-QZ.:WC1%#PYR,`S,XB2=GEEG>@9CH?C&A[,;T+Z MU"@#,-0!MJTFP!>-'HP'@CK:M/Z![WYXC9VW5OA1>5@:!#4#:/U!'] MG4E/_^AD#35CE=':]$MT3/DRO[DV"+8`+8-F<;2:]S[7V7W#<1UP4ALA/7W$ M+(]6@TN\",SJ&`SK>/(M?GO^Y*C/B@,UB.J MPTUJ&^2*OM%JL''X0>1U2N.R<^@"#=&;U#G4J$^*H]6TO6WN&=L@'H[K@)/Z MAW=%_V@UPX#HT1-'0#Q1XEFI3@[TSZ0YY!6W"KJ'IN7.%E#^#9XG\4:P6IV) M=DS`.5!]/,*YG\*!R9V!>,^8>+^1)];S?Q(VOP```/__`P!02P,$%``&``@` M```A`)6:>,DQ!@``K!L``!@```!X;"]W;W)KF#YRB.*.!T>R.M".M5GNX)C:.T=C&`C*9>?NMIMIT M5V-C/OPX[+WO9=-6]7'ELT7@>^5Q76^JX^O*_^?OSP^) M[[5=<=P4^_I8KOR?9>M_>/[UEZ?WNOG6[LJR\R#"L5WYNZX[/2Z7[7I7'HIV M49_*(QS9ULVAZ.!C\[IL3TU9;/J3#OLE#X)H>2BJHX\1'IM[8M3;;;4N/]7K MMT-Y[#!(4^Z+#OC;775JS]$.ZWO"'8KFV]OI85T?3A#BI=I7W<\^J.\=UH]? M7H]U4[SL8=T_F"S6Y]C]AU'X0[5NZK;>=@L(MT30\9K39;J$2,]/FPI6H-+N M->5VY7]DC[E(_>7S4Y^@?ZORO;7^]MI=_?Y;4VW^J(XE9!OJI"KP4M??E/3+ M1OT+3EZ.SO[<5^#/QMN4V^)MW_U5O_]>5J^[#LH=PHK4PAXW/S^5[1HR"F$6 M/%21UO4>`.#5.U2J-2`CQ8_^_;W:=+N5+Z)%&`>"@=Q[*=ONWJ MPW\H8CH4!N$Z"+SK((S/#B)T$'@W07@2LC"ZC;+$9?59^E1TQ?-34[][T'H` MWIX*U`-C)`VFW&:38E7OO0]PQ8.87O\#"50OD%B+MPK\BD%08.4W8^FQ)!> MZ[H\;7KSV55)SE\\1`>4X>2 MN.=+(L&=.26F6%9!$`LE&BOF MD4C1RV8?C*#!;B4"E!273].L!@,V?N3U:L=L-'$51%7_KF28<"ERZ;#:$D814*8 MY5$\QQ>F:\EPEL/F'R:J<$9JIC6P#0>-(\DG)11OEB4P'.?VX!7.[LNT!E,3 M0?+"$1U&T8J4\]#T*X53,]K:!_=-$(:3G4":EL8-H36(P`,&Y1N5&,.<)2E, M8-,H%%/-:@OS1HEQLA,\,Z$TGCW])4M$Z*8Y9U,2BJ<&]OUX.-X)GNL1ZK9O MV"!)(*+84>1$$28\3]M:5[G36&MU^01PD(G53Z&A"%B2!:00*.,L^ M^-@^W+V9:8W.GN2QN3*VH!9<:5-*IT;XW9./*[536]/?V'Y:<^7B&A#C7-%0 MP%G.P7'DPZLQ?M/=&A`UY.+TOBO782Y+*!YH9N1/J9W\N<-9?;\>G`/N-&.G M/_,)`45S?$-MW_3FUVT^]H_0\?U,:[`!.9?1R'J)@J5IR,TR*>0L]^!C][!N MC'1Y48-P,HI%$(G1]J6:((Y%:F84!9QE(GQL(J&S.S.M0<"'4`0P8&)S=;U# M;!=Y"#E/>!"93J:(CI5,WR#PL86$KH5HS1DQ3;GDYN*:T':1AS"54L:F40B@ M^I''WB3W&4E_%MTL[GURIC6ZV&`DX^\A5#+U/43,LI)>[>`Y6S73FLMS!-,X M*:%9G&4D`HUDAKDLH7BSG$1<&W-Z-PNEIC]!NC_C95I#\N@8WJ2$XCFN M<@-O["9R5&;4$+Q1F2T6@-`73SAV$N2RC>+#\1:`/3NQ@U MEZ^MA\R4A.+-\A)XF'+S?D9K\&?F2_&PO=&AE M;64O=&AE;64Q+GAM;.Q93V_;-A2_#]AW('1O;2>V&P=UBMBQFZU-&\1NAQYI MF9984Z)`TDE]&]KC@`'#NF&7`;OM,&PKT`*[=)\F6X>M`_H5]DA*LAC+2](& M&];5AT0B?WS_W^,C=?7:@XBA0R(DY7';JUVN>HC$/A_3.&A[=X;]2QL>D@K' M8\QX3-K>G$COVM;[[UW%FRHD$4&P/I:;N.V%2B6;E8KT81C+RSPA,S*A/D%#3=+;RHCW&+S&2NH!GXF! M)DV<%08[GM8T0LYEEPETB%G;`SYC?C0D#Y2'&)8*)MI>U?R\RM;5"MY,%S&U M8FUA7=_\TG7I@O%TS?`4P2AG6NO76U=VJ^>?__J^5/TZOF3XX?/CA_^=/SH MT?'#'RTM9^$NCH/BPI???O;GUQ^C/YY^\_+Q%^5X6<3_^L,GO_S\>3D0,F@A MT8LOG_SV[,F+KS[]_;O')?!M@4=%^)!&1*);Y`@=\`AT,X9Q)2"M.69EN`YQC7=70/$H`UZ?W7=D'81BIF@)YQMAY`#W.&<= M+DH-<$/S*EAX.(N#UO5D"53,+2L?VW9`X8NXS'"L< MD)@HI.?XE)`2[>Y1ZMAUC_J"2SY1Z!Y%'4Q+33*D(R>0%HMV:01^F9?I#*YV M;+-W%W4X*]-ZAQRZ2$@(S$J$'Q+FF/$ZGBD".S1P1%H$B)Z9 MB1)?7B?-AOZ'&(KA\1JCX_M\+H>SHX;.1DC M56#.M!FC=4W@K,S6KZ1$0;?785;30IV96\V(9HJBPRU769O8G,O!Y+EJ,)A; M$SH;!/T06+D)QW[-&LX[F)&QMKOU4>86XX6+=)$,\9BD/M)Z+_NH9IR4Q>Q,O91&\\!)0.YF.+"XF)XO1 M4=MK-=8:'O)QTO8F<%2&QR@!KTO=3&(6P'V3KX0-^U.3V63YPINM3#$W"6IP M^V'MOJ2P4P<2(=4.EJ$-#3.5A@"+-2[\JIB4 MOR!5BF'\/U-%[R=P!;$^UA[PX7988*0SI>UQH4(.52@)J=\7T#B8V@'1`E>\ M,`U!!7?4YK\@A_J_S3E+PZ0UG"35`0V0H+`?J5`0L@]ER43?*<1JZ=YE2;*4 MD(FH@K@RL6*/R"%A0UT#FWIO]U`(H6ZJ25H&#.YD_+GO:0:-`MWD%//-J63Y MWFMSX)_N?&PR@U)N'38-36;_7,2\/5CLJG:]69[MO45%],2BS:IG60',"EM! M*TW[UQ3AG%NMK5A+&J\U,N'`B\L:PV#>$"5PD83T']C_J/"9_>"A-]0A/X#: MBN#[A28&80-1?F#R`Y+<&ULE%9; M;YLP&'V?M/]@^;V`24A"%%*UJ[I5VJ1IVN79,0:L8HQLIVG__3[CA*:D%_+" M]7#.=XXO'ZO+1UFC!ZZ-4$V&21!AQ!NFX2=N M\.7Z\Z?53NE[4W%N$3`T)L.5M>TR#`VKN*0F4"UOX$VAM*06;G49FE9SFG@R'*@K!^(UB6\D;ZTDTKZF%^DTE6G-@DVP,G:3Z?MM> M,"5;H-B(6MBGCA0CR99W9:,TW=3@^Y%,*3MP=SY``$KLKPF!(?K51?07\%WYN@:F4KMOFJ1?Q<-A[1AG-P( M;)2Z=]"[W#V"C\.3KV^[$?BI4D>DJ?(!,V1YS[3%P[#&D1X1035\2E'%< MTNLA'Y0=V"F[T%TIU_[!L4S\NLSD'!D'SO#TJ/@927I>K^PQ,*"]P><(7A@$ MFO$&'1CFRQ'KC,P&RAZ3=L&3*(KZUR]DH;+QL@X\E)WWO-ZPQ\P[V3A)%^GB M#>79.#)0]9D34\W.4'?BC0?:8$>AZF[3'[M*?O MI)V>H^S`0^5TD+;'C/!,8&<=;[I#?Y3W'C1&W&TPHQ.'=G%J?!CY'O2\L$Z6 MEF\9?D>57)?\"Z]K@YC:NG9`8>3_M6=15WS:9_`9VBI27_074I&H-J7L"G M43`'S]KW&G]C5=OMUQMEH4=TEQ7\$W#8]:(`P(52]G#CNEG_E['^#P``__\# M`%!+`P04``8`"````"$`E)?KE%T#``#3"P``&0```'AL+W=O';`!*N` MD>TT[;_?-28D.$WBYB$)Y/C<<\^]W-SE[4M=.<^$"\J:U$5>X#JDR5A.FTWJ M_OG]>#-W'2%QD^.*-21U7XEP;U4LEWXOLA*4F/A ML98T\$O!>(TE7/*-+UI.<-X=JBM_$@217V/:N)IAP6TX6%'0C#RP;%N31FH2 M3BHL0;\H:2OV;'5F0U=C_K1M;S)6MT"QIA65KQVIZ]39XMNF81RO*\C[!4UQ MMN?N+D[H:YIQ)E@A/:#SM=#3G!,_\8%IMY1[/JK96?0 M7TIVXNB[(TJV^\)I_ITV!-R&.JD*K!E[4M!ON;H%A_V3TX]=!7YR)R<%WE;R M%]M])7132BCW##)2B2WRUP(@1`!WUD3(1ZHH72?;"LGJ?QJ$>BI-,NE)X+,G03-O.IG%A`M@'F?F=8QY'HN514% MLZ7_#)YF/>9>8^!]P*`!X8.:01+(.);TMLG[R`JL(BO3E91[?>,XS.3M,.%[ MPBAPZDZ/Q$=!-/#JR!H#!1T2G`Z(48)`8Y^@`D._'+%&03SPZL@:DX2=\[$W M34:O^//-&0M`J[T0!3:%S`TA&M,+";PS!8[&857/A?!,7BZT.F2&3XSP&F-1 M@7BLX')D!;Y6>XVQB*S^$HZ>M\N1%=C,V:R]QO26([/VR=G:)V,A=D50APQ! M*#"*H#$65B"HN;T7'?I:&7J037`UCJP+@?3PNOP4]J!#]Q\FX.CQ1\:`L[.^ M.V5Z?WC`]"#H03;YJVEEG[^>;9?G'](@F^#OFH#HC1&(#A.MSUR#XFX$H@C^ M7`_>C-T'?<>)6[JO3IGNAT;GJY4`0#8&&"/P\AA`>JY=<=]Z^,&F-'+@2G`] MVD:M?^J^!O7N)_,P,GM?[U9Z]:@)WY!/I*J$D[&MVIL0E&VX.^QT=Y-N*QM^ M@)6JQ1OR`_,-;813D0*.!EX,AG.]E.D+R=INL5DS"A!X`"X8 MD_L+M?8-Z_CJ/P```/__`P!02P,$%``&``@````A`)NZ"$'Q!```NA,``!D` M``!X;"]W;W)K&ULK%A=;Z,X%'U?:?\#XKV`DY"$ M*,FH$+H[TJRT6NW',R5.@@HX`MIT_OW>BS'@2THRU?2A))=SCWWNA^UX_>4] M2XTW7I2)R#>*\,H`A+S?FJ:K.*]LNXQ//HM(29Y[#FX,HLJB"K\71+L\%C_:U4Y;: M$\>9VUF4Y*9D6!7W<(C#(8GY3L2O&<\K25+P-*I@_N4I.9>*+8OOH]L%L6*N_XRH,^2N!"E.%06T-ER MHD/-GNW9P+1=[Q-0@&$W"G[8F(]L%;*E:6_7=8#^3?BE['TVRI.X_%8D^V]) MSB':D"?,P+,0+PC]ND<3.-L#[ZT^DM,'SQ\; M$&AKN?"\9T!;1JL._BZJHNVZ$!<#*AKB49XC[`^V`BZ,^JR=2 M1V39F-"*X%Y"[;QM76^^MM\@WW&#\8<8IB,"A<#D(NV.&L*>P08!K0K(%U6! MM2,#?[<*9$$5:GQ?&3I9$S)EA5`N.V7H7.:>[A,J"/AH(J!VJ`A,Q?4&4)%' M)TB9%OF%/J`O,4#59F>F(P*%:&4HPX)%UO MJ4_3EQAO6E>8H[\,FI?PZ&0N22AV8PSA#08M6:#G4S+1C\HD!>)+3".366SI M.KT_VC4-NJ][[I#@[#1*Q_(\YFE_>BS#&YQ:).:?C`3ZZ9&8.T2;+S'W1J)! MCT>"4#K.9"P0-RBU0"P^&0CTHX$@ZXPO,6T@%I/P@4""!J*KG^J)W6D\(-&4XQG+[)YW-7KZ$<5DR7)EQ@HQ+:;79?,-9`83Y=,2W](1(8*%8(N M99XN;WPA1K"NR9V2%/D2T]=$IA(H1+L0*T,7!N(2*@2=/8,C&,W.[?VD]KJU MH32@,2$MI%726CZ6TD(&6G#C_TRE,7EBZ&\K1SI*U.63AF)6-CR#A*% MQX*>!G6>O*%%'B;Z?>QZ9.OVF02-:E&0KNB4942+@@RTP'RHEKN6-X:.>FJN M%)T$C4-ZVRUD1@^$?@/"F+6HZ8ST4="ANE1(=G!4IE!# MZ8IP5_T)BN3FW%''G`T[0T8O&*UPU+^+'1 M6N55"(08[D(6F/C!FZ6Z)2%OX/KD<7+5`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`CSJ3^J M(CTNG\4&B#\O7IZJ4T,?'X:[U9OA0UTII0=9!^$V0@MKY9WC\[R+`)(OY^"]*_'6FCZS,V16ST=G^N M]U$&8JM.W(^;YL4B.9I-Z-]\NM%Z=X.;TP_&71-$$T>EB?*!0ZJ)K:[?F+># MVA^=?5"UW5'5Q+[]/[9&')%Z:PX.S>"3-NR=\]YHNT/3KT[SYFP[_=WI[\[5 M_L$A.7LC^KLC4OUC]RZ/3MR5JSI[MLFHSS?S+Y]7R]\7X@HG-FW]NDV2?F>WDI$K**\D<5YN%2'&.1&S,^-AH MLICL1)7M55B];JASMFHP=N)M/4H,-L?95N3G=BM)54;,K4A M5QL*M:$\:+@29]?^%!.7$^D4:[_"[\ZD2E=GTF[3QKN&M[WIR^_-Y%AO+7.L5%6-&L1RHK< M8S*Z5DX5K\THJ_+;C++!09M1XH1M1MF>J,THZXJ/C?I&)<=$V9CT6*A!LF.B M!,F/A1JD8%(>D[?U2*DF^A8*Q6HQR*9XRL5O(M9)`3&9,7"9>&QG(&^.?8((6,U"2(VPQUTK21R>8 M^-@,A\J[F9Q@TA-,=H+)3S#%":8\-J/KM]-+2B5Q+_2!5*I>):62VC!1&W2U MP:@;WOIS4VVPU(:IVF"K#8[:,%,;7+7!4QO\7<-;#SE2LBI@$C*)F,0[LKM- M2'8-!QNG7H#2$TS68JY'>]=&_+DWRF5A@D)'8:`P45@HIBAL%`Z*&0H7A8?"1Q&@"%%$*&(4 M"8H4188B1U&@*+N$E&9BJ.6,-*NTN)LZ2*&1>B\WKHW8@'?3#(6.PD!AHK!0 M3%'8*!P4,Q0N"@^%CR)`$:*(4,0HDEK<;(=0AOU13_EHDQXN%TO5Y1FN(4=1 M'*Y#J]:AKJ7LBB&EF!B\.R/%*JVDV(UR`,:UZ4HQ%#H*`X6)PD(Q16&C<%#, M4+@H/!0^B@!%B")"$:-(4*0H,A0YBJ(6=:J+R:?C+.L*(669&%($\LJK6:9 M\D%R7)NN+$.AHS!0F"@L%%,4-@H'Q0R%B$#X:,(4(0H(A1Q+>ZVW91V?==7 MKM()1DA19"AR%`6*LDM(22;F@,Y(LDK+2:;UE%&?<6WJ"X`V'/25#VT3:;DF MQ-M013T]4H..+#50F"@L%%,4-@H'Q0R%B\)#X:,(4(0H(A0QBJ06S>FC:3?* MZ9-*RZM[27D4(SM_V"<;'OR%?7RCI.O[!)2:FEBB/J,W-IR M.;F&-\H8S;A!]>$9]&^N;P?JD$=#.G9!9V(P,9E83*9,;"8.DQD3EXG7D/H- M&+;Z)5&0F[> M)J2V5X=Q@SIR:\)$9V(P,9E83*9,;"8.DQD3EXG'Q-^3JEY#9*C^. M9H5,(B8QDX1)RB1CDC,IF)2=1,Z]:F[W,/=.F[*M:K24^\O1C7I_V:#.'*SC M=!"=HQA,3"960^X&VT\5O4\]I4N?<@R;B4.KF7$,EXG'Q&<2-.3=8Q)RC(A) MS"1ADC+)F.1,"B9E)Y$SL)H4_D`&UG/)J1]!$X:W<)4PYALW$83)CXC+QF/A,`B8ADXA)S"1ADC+)F.1,"B9E M)Y&SL)H+_T`6UE/HT2F&P3%, M)A:3*1.;B<-DQL1EXC'QF01,0B81DYA)PB1EDC')F11,RDXBIV`UZWZ8@C`8 M6D_2'Z;>Z$:9IQM7WV&CW@^)SE$,)B83JR'7=1%2;Z0I'VNG',-FXC"9,7&9 M>$Q\)@&3D$G$)&:2,$F99$QR)@63LI/(V5=-QQ]F7S4<.A1]$F1A/8LO9Z$R M'SK6NJ;ZM[,6$R8Z$X.)R<1JR'[H3YEAF7((FXG#9,;$9>(Q\9D$3$(F$9.8 M2<(D99(QR9D43,I.(B=A-7%_F(20?/4\OYQ\RK>%QM57J*D+1*)S%(.)R<1B M,F5B,W&8S)BX3+R&-)VZUK]1.G6?8P1,0B81DYA)PB1EDC')F11,RDXB95_U MC($SLF_+E>&7@9I]#>KX;#=AHC,QF)A,+"93)C83A\F,B?5PE2/]E`'/V^50HIQ@SJSKX[3072. M8C`QF5@-:2KG1D?%O5,"-J_$V9-JIO%&+3Z<=2]V]XO?':ORF/A,`B8ADXA) MS"1ADC+)F.1,"B9E)Y%S[F,U,/V6&IA;951SW*".Q)HPT9D83$PF5D/>F7CH M7&IS>$<*4'VU2Y[?G\%REU?A,?&9!-*&'%T>0HX0,8F9)$Q2)AF3G$G!I.PD M[^\4=/1P>;I^C!`VIC\+Q)2'D$-&>M/;E\7[QN[N2 M,$F99$QR)@63LI/(:595:YP^E%(]@>THS=2RS@9U=FE8)*)S%(.)R<1B,F5B M-V1W4WK\;4F'@\R8N$P\)CZ3@$G()&(2,TF8I$PR)CF3@DG92>3T$TER3OI5 M7.WEE'&R_!H MO_C=?BUFDC!)F61,ALD$BS]VI5)DQT)@83 MDXG%9,K$9N(PF3%QF7A,?"8!D[`A3;^OC;2^4EH8<9"82<(D99(QR9D43,I. M(J?A>?4L_99ZEEOED(\;U)E^7,_"40PF)A.+R92)S<1I2'VRBD>1]Y5;]QG' M<)EX3'PF`9.02<0D9I(P29ED3'(F!9.RD\C9I]:S=$^E]UOJ6&Z5<8EQ@SJS M#TM==(YB,#&96$RF3&PF3D/J[!M>'R74L_98ZEENUB*Q!GI(K0D3G8G!Q&1B M,9DRL9DX#:D[P>MK37T>P$P"M[UA3_F<[;X7/)&`2,HF8Q$P2 M)BF3C$G.I&!2=A(Y\]0BF-.><38X+H91'T(Z;DQG`G(M#$=%2 M<@;+;5Z%LR>MD]:S[L7N?O&[$ZL>$Y])P"1D$C&)F21,4B89DYQ)P:3L)'+B MB;PX&H*I/C;""$SU,GD$1NL=W7C6J#/SD.@#)$9#ZIS1JM]ME8N630F('[Q5 MACLL7L>4BK.\(X4-*<3Q*LQ]B*JWN1XIJ6GM M%[_;G4R9V$P<)C,F+A./B<\D8!(RB9C$3!(F*9.,29N0<-YB83"PF4R8V$X?)C(G+ MQ&/B,PF8A$PB)C&3A$G*)&.2,RF8E`UIS0`Y#=42F!/3\+@41E._-3T>8$G' MA(G.Q&!B,K&83)G83!PF,R8N$X^)SR1@$C*)F,1,$B8IDXQ)SJ1@4C:D&5%0 M>B(Y#\^KAAFT5,/<*8-PXP9)G9S<@4V8Z$P,)B83B\F4BK,/ZZ$X2@&$Y.)Q63*Q&;B,)DQ<9EX M3'PF`9.02<0D9I(P29ED3'(F!9.R(?M.\.W[0G+RJ74PW=,0PY;ZE]%;_UK_ MSEB#.I./ZU\XBL'$9&(QF3*QF3A,9DQ<)AX3GTG`)&02,8F9)$Q2)AF3G$G! MI&PAH[NW@?@Z`Z_6/Q:+C3[?S+]\?EFLOB\FB^?G]<7C\M>K^`;MK7C2\[[U M8K7X]G#YAW;_Q_#RZJA]K-U/M)9V0[NWVMH][3YL:X^U^[*M?=R_'[>M=]*_ MG[2UZ_U[?=M^M=^!]9?//^??%]Y\]?WI=7WQO/@F=K'WZ49<(U9/WZO1I_H_ MF^7/ATO1,?^YW&R6+]M__EC,ORY6%1#XVW*YV?U''(BKW\O57]O#^.7_!``` M`/__`P!02P,$%``&``@````A`,`1UJ[T#```WE8``!D```!X;"]W;W)K&ULK)Q=<^(Z$H;OMVK_`\7])-A@OBK)J0%_8P(V]NXU M0TA"G1!2P,R<\^]70K:,6L8OG-JYF"3MQZ_E5K7ALOA^/7\/[^\/J?;U='NYV7^M/=N1UM]\NC^S/_=O]X6N_ M7KZ<3MI^W)NM5O=^N]Q\-H7"<'^-QN[U=;-:V[O5S^WZ\RA$]NN/Y9&U__"^ M^3H4:MO5-7+;Y?[/GU_?5KOM%Y/XL?G8'/\^B38;V]4P>/O<[9<_/MA]_V5T MEJM"^_2')K_=K/:[P^[U>,?D[D5#]7L>W`_NF=+3P\N&W0%W>V._?GUL?C>& MF=EOWC\]G!STG\WZ]^'L]\;A???;VV]>HLWGFGF;]1/O@1^[W9\<#5ZXB9U\ MKYWMGGI@OF^\K%^7/S^.R>ZWO]Z\O1]9=UOLCOB-#5_^MM>'%?,HD[DS+:ZT MVGVP!K#_&]L-#PWFD>5?IY^_-R_']\=FNWMG]5IM@^&-'^O#T=UPR69C]?-P MW&W_*R`CEQ(B9B[29JW/CYLWBW1R$?:S%#'[EF%U;V@*:_3I?KI2I=V^ZYA6 MKW_+#?4*K_#^D&ZYN3&&]"[[I=2YU;U&X5_^2X5,3<\8K$M$_RI]8W1:)Z?6 MG5GTAU%VR#\(#1Z+H@'LE[SM9NOFX#!8?YYDS'_BR7L1]*<[ MP08F)G;X6O)ASAARY2)[A%]D/EU*)Y9'7.4[EWELLB&59+C_ MQ?)VE3,CG2'$N"!XDG)96QA$JGQC*ZQ`-5R!8&]O^9U]IJ6V?%225#[GA>$$5;8VI(J&%!#6EAN'B5K"#8 M5>Y9[,@`8@GY_P@@+L,#J+B)46$H6T1Z<:P3W8'J/%M'S(Z*.`)A=R?[@%S' MU0EZ'4]'B(@/B0`2(20F.F&9Q">18,Y3E;1U6A!%7SQ?(3O3&2([AT1<09#N M2BH0M4,7D$@AD=412O2S.46+_@X;YZL7'\5HR<]2@IT:QM1@4X,C#.=Q:]'8 M=J]@O"K&4EWJ7\$$5S#A%_YQ(153%_5F11,$4B1,)13U90:GNDI M,VJ84T-,#4EA.+O%-NG6115#0C$MF*+YV9E!Z7@V:MW0\9Q^;#(M.6U:+3)6 MCP3#_I<,(<:0L"'A0,*%A`<)'Q(!)$)(3"`106):$$6'/Q>&B]TP@\0<$C$D M$D@L()%"(JLCE'AGSU,WQ#NGV9N!LUBVVB2:1X)A#;@8[Y"P(>%`PH6$)XCN MZ4&MTQH,R!K1!\<#Y;C1HFO,D!P?D`E\(H[7>"I2%:P.&;FGA8*,\L)PT?DS M2,S5BW;;Q"TQ5$@@L8!$"HE,$'GW&;TS]RL1SM[AW!#AG*813A:"(\'4]-L8 M$C8D')VPVF1V=W6&9*.G$U:;1)%_!1-%RU.N$ MU29+G+G.D*;%D$@@L8!$"HFLCE!BG[_=/W^O5;^,Y32-?9+\(\'4Q3XD;$@X M@ABT3T-SZZY%XQXJ>$#!!\<#<#P$QR?B>(V?(D6A=]=2__6<;V2=.RTD9=@7 MALMA7T$0U7D%HB[]8T@DD%A`(JT@2%.S6D2)^P&)^]/[W!ZO?(!W$OQ$-04Z M'?+H.Q+,X!2;;;/7[=,ET%@0-9UO0\(YOXK9&?0'?;)\<*&&IVB8%HLPM6O] M<\`X!:`*!.=`A4!X?KQ*8"*`&E=$B@0KSM!&3G/@_"FKTR=SV#.\SDRY#JM. M$E_,SX^;@RY;#ZJ^B!6@W^YVR`22P#8L()&>7Z3;Z=&1+SL_WN<])ANI)(#! M"E8WC/PG7(U[JU-*GUX3C'*HIB_'&+$QXN0(^\%+**QH319@+M;PD(:/@``! M(0(F.5#CL$C5:-V1]Q93*2$'?6FY/.IC9(Z1&"-)CK`?O*-895D&XREB%MIQ MTI$I`C(*M$L%-=YY8>9\I<-'_#9+@OH5#R_,DO'>TL;['.J=;K+3M[21>)P3 M-1UM*R)62Q^+'2SB8L3#B(^1`",A1B88B3`RE4B9`J+7:MP]DR==S)(Y1F*, M)!A98"3%2%:+J+G`ZS;GN0!R0)1YE)PK)R9-J8A^JQ%@EP<@" M(RE&LEI$'?_9*'U+"G"1@Q,6(AQ$?(P%& M0HQ,,!+EB*SCT#+95&J4.0!=.2.J?9.L6^92]6*2Q!A),++`2)HCN0O,UME3 M[BD",P+TS3)$U>CG-;$;)@!10E,G`/*N?<0_5)-#D"5&*LD&%E@),5(5HNH.<#+9>-WL/!G`.U%19E.2P"(CTL@04.UC`41LK.)@Q,6(AQ$?(P%& M0HQ,,!)A9"J1,@N@OV?RI)HL$"HB_P96W^B1\2_&(@E&%AA),9+E2#Y:]*V> M4;["47+`O*TF?,+)H[%%/PN10W4Y@!$;(PY&7(QX&/$Q$F`DQ,@$(U&.R/HJ M?2Z<2@V9`=)R,;QG&)EC),9(DB.R^65/%-\B8Q*="X\&/,O==XP M_I]P&ONT)I9#M;$/*Y4V5G$PXF+$PXB/D0`C(48F&(DJ$,LBE9FIA,KXAQZ? MR9,NILB\`F'?/U=7N'$%1"(\P<@"(RE&L@K$,LI\4N=R7/*;B6S^QPC,482 MC"PPDF(DJT74#&`C\2T9P'$Z#9!/I(_XEPT8)+XG\,UHF^T6>7H>YX@R#9"G M#+N*46=]!R,N1CR,^!@),!)B9(*1*$=R][;U@)Y*D3()1)>=R`GSB_CDBKRT-9-CFYR=9.GFWS=%.BF4#=-=%.DFZ:ZZ5DWS733 M7#?%NBG130O=E.HFOK,F7VLQWS.OBA`0.V6*7?ZVZ_W;>KS^^#@T5KN??!=, M1CX]2+/8HC-J#]E^24R`VCM#MKF-;O]N]MB>GKV*(RP6BMT^B1;;!O1[E=;( M&+)]__1K>,:0;9BGVV?&,*ZR)\:0;6NG\RG;?K3*/C*'HZKVC,TAV[-(U['- M(=NZ2+='YI!MF,;L]_*&V>ZB7\NW]72Y?]M\'AH?ZU?F]]9=CZ7?7NQ/*OXX M[KY8?[`]1G='MJ_HZ==WMH_LFFUTR/:';#9>=[MC\0>_@-R9]NE_````__\# M`%!+`P04``8`"````"$`!>$?+(@#``"Y"P``&````'AL+W=OP74C:+(!!902HL!JPA M-;S9,%YA";=\&XB&$YRW'U5E$(7A)*@PK7WML."7>+#-AF;DGF6[BM12FW!2 M8@G\HJ"-.+A5V25V%>9/N^8F8U4#%FM:4OG:FOI>E2T>MS7C>%W"N%_0"&<' M[_;FQ+ZB&6>";>0`[`(->CKF>3`/P&FUS"F,0*7=XV03^W=HD:*A'ZR6;8)^ M4[(7QK4G"K;_Q&G^A=8$L@WS)/'Z!RE))DD.,^=[:D;6C#VI3Q_A40A!1"M0 M0<3?0YB[2$4)^C#F]2'D0SMMW[B7DPW>E?([VW\F=%M(B#2&-*AL+/+7>R(R MF`:(-8C&RC5C)5C`KU=1M9X@C?A%T]%<%K$_G`S&TW"(0.ZMB9`/5%GZ7K83 MDE5_M`AU5MHDZDS@?]^9H,$H&D]GU[@,.Q?X[UP00,_&:#SY/TN@Q]6F[!Y+ MO%IRMO=@P0*Y:+!:_F@!SF_G!1*BM'=*'/M04#!D`9/SO`J7P3.D/^L4B5;` M;Z]`MB(]*-0,`D,/`LFY'$2)%8B:,$66Z`=FW,B)JQ512SU"T^FP?V]A0`Y, M#+5>AK!4W\^+^BCV1\:HC^Z:3RM@R?1Y&?7Q6T7ZGL(BA#`FX?MD2@PC,.*. M[;B)5IAD$UN1GBJ.[!89F%Q.IL0VV=2.FVB%23:S%>FIX@S9Y!HR);;)YG;< M1"M,,N040GHJ.8,VO09-B6TTY-17HB63PSJ/'/94OS?9SX"I<_/BG4&)'3"G M`!,M,0,CITK24\D9MODU;$KLL!UM=7EJB<7FU$EZ*CF:6%6`8+NX/'&MVJ%S M"C#I-!:>4RSI&YIS?&H'-B;VLBT.Z7W;W$F04XY)IS$YCPQZE^LDTW9Y1M%H M,AP/CPO%SN-5)P+2^[O%YRS]I-.8?)%;MV]HCF.P^=2.;>3Q_8T8.B-W%49N MZ78:B^^8G"Z!VL?4N'RZ,=*G?$7XEJ2D+(67L9UJ=!"DOG_:=VY=2]6_@!ZH MP5OR%?,MK857D@U\&@ZF$)?K+DK?2-:T/<2:2>A^VLL"6F0"9W(X`/&&,7FX M42=^WW2O_@$``/__`P!02P,$%``&``@````A`!A8&%'I`P``C@\``!D```!X M;"]W;W)K&ULG)==KZHX%(;O)YG_0+@_?"J*44\V M(A_)3#*9S,G3;JWW\%WY:J0FA294F!*[11OQ!1OV]__65]QFD;E"2M9W*0K<,P]'+)*]4 MKK!JIFC@XS%/D8_32XDJRD4:5"04XB?GO"8WM3*=(E-IC@(]5`3N>!/H[9U5T=E+;K M+(<1,-N5!ATWZINYBI>JOEVW_OR3HRNY^ZV0,[Z&39[]EE<(S(8TL00<,'YG M:)RQ)NBL/_0.V@3\T2@9.B:7@OZ)KQ'*3V<*V9[#@-BX5MF7CT@*AH*,9LV9 M4HH+"`"N2IFSR@!#DL_V?LTS>MZHMJ/-%X9M`JX<$*%!SB15);T0BLM_.61V M4ES$ZD3@WHF8ULLB=B<"]Q\BUG)NSIT70IEU*HM>Y7^,!^9&:PK.)GS*)G!C;";!9MG/UT>;I5+NLT ML%%LV(D-/F\8VBC4Z7X"$SQCYOW0VJ2&$YCHQMPJ(;YK&!@$"];K!K%.&Q6N M=T6S'$;I<0:\_L$,B9V4\*7$7DH$4B*4$I&4B,>(@=]@R+W?X_.9P3#O[SVT MA87+X\R8SU+"EQ)[*1%(B5!*1)QP[?:_A:'-'=.X_Q,F0CPF.##=><5T!@NF MSXQAZ7J<@>__M+BEA,^)?K"N,('VPGM36)4#X;UA#F,,A?>.L(I&_/W(&.(Q M8N`O[':F%S6#17^%V#W.N&T=V-;"6=K"8KKCQ$CTOI382XE`2H12(I(2,2?Z MT2Z@YOM<#GQFAZ;)^R\&BSX+VQ&/,]V73=-QQ2KV>N?*>M>_,%6P>@-?[#G`*ZW8' M?L`4#D+MSS.<>Q'L\V"I5)4CQO3VP#[0GZ2W_P$``/__`P!02P,$%``&``@` M```A`"'4ESU+!P``H!P``!D```!X;"]W;W)K&UL MK%G;CJ,X$'U?:?\AXGV2<$E(4*='S1VT*ZU6>WFF">F@3D($]/3,WV\97[!= M3'JRFI>FJ,SX^__O+PWK2OW;&J^ADP7+J=<>S[J[=8=.6Q.A?= MO+E6%WAS:-ISTSE MTK3%\PGZ_=5TBI)S#S\0_;DNVZ9K#OT3"^WEL;B\6$0Z)^Z>N^D_V?=L7E/VGK_6WVI0&T8)S("STWS2DRS/8'` M>8&\XV$$_FAG^^I0O)WZ/YOWM*I?CCT,]PIZ1#KF[;^%55>"HD`SMU:$J6Q. M$`#\G9UKDAJ@2/%U>+[7^_ZX,^SU?.4N;1/,9\]5U\[Y9K9SUQ@66&YXV\X0G]YR[YG)K?^#G,#]X_O^P(;2A[_!D M)*8Y-YWEFG3]1M!KY@=/WO@HV0T_E_G!W./M+>>.M7(W@]@W/+?,$Y[ZDJ%P@C[A8B)$)( MC)`$(2E",H3D,J+(`KN.(LOT3L]76V*M]ITBSE!6#$MG@)`0(1%"8H0D"$D1 MDB$DEQ&EH[!=WM%18JUVE")R1REB;\7Z&C($Q)820=MK(F'$$R%&1`E%I,92 M9@/I_7WJ3!AQZEPF4N0@%;N\_=X>=V*MRD$1*<*`(K(<#%'ET':<2!CQF&-$ ME%!$:BQE-JH2)0^O6.3EA],>Z?/4; MF*!@-#&A;*A/6=5**S_8;'F3ODDA*?R`08I@U,J&94ZL`Y:ISRGNN!;T,8=D MP5"+*;>"94.B7VGS:K3BT><,HM&K@I':3A9L0A@X(0EE:"FH*,,@.2C;UH(* M3&H%5#RHD$-C!1PQ:+,>C@K:'AV/#E+W75?M?L*LS)$VY9`K&L\8M+:F6LI' MA^F65`E)Z7>'A+125"2D$%P=C,W9]EKM6&`R*WH2^RBWJ$H*7/=(2LRU M!8Y!:E9J]7)`RFEP5+*206/Z1,R*9:4Y=[4)'7,:V+]NJ&+.U]H^D8\^TXVI0L*Z=X^0Q%P3DD)J;CK:U`S(+1014LY-!LFY2:&-,BB. M5H'%G&MT3!BD)**(B^=FQJS6\NIK.]I@Y9R>7K7)YWJ35*=W3&1:S,)X\`C\ M@0&.LN/L"#`48BC"4(RA!$,IAC(,Y0JD)@B,A=)GLF&Z<"LXN47*.P%QU%*% M0LZXKP60V<0*('+W\TD;ZG!\/>:R[8P9KX9*RD-Y>$BH*]@E/]BR:%6I#!,K M-.5`!30$JB5-"+L)ZX<6$O^<4#C@M+82Z!"PSY0(7ND_IUZ8\*;*1\HCB&"J3?P=>)I M6%.U]GWX:C%E[UL0\$3;ONW!;1>.Z#BQ_LD+@>')8PGKH>G)4G M\(T'A\8)?.O!Z0GCN>O!&0KC/DA$"GK\!@Y!'JGK\9L0WI"3SM0;$]Y,^<`Q MR".5/?;Q7<^?BBQP/3B98OO0]>!B8@+?>'!"G\"W'AQ5,1Z['AQ8`5^('(#O M0]?BI?J]:%_J2S<[50>8"LOAP-32+TST1]]<8=[#5Z*FAR]#P[]'^!)8P77\ MDNP6AZ;I^0_2@/BV^/@?````__\#`%!+`P04``8`"````"$`!PM`(L0"``"8 M!P``&0```'AL+W=OKW^^&&UU^;! MED(X`@RU36GI7),$@>6E4,R.="-J>)-KHYB#HRD"VQC!LO:2JH(X#&>!8K*F MGB$QEW#H/)==LT5UZH!BJVLI'MN M22E1/+DO:FW8M@+?3]&$\2-W>SBA5Y(;;77N1D`7>*&GGI?!,@"F]2J3X`#+ M3HS(4[J)DILHI,%ZU1;HMQ1[VWLFMM3[ST9F7V4MH-K0)^S`5NL'A-YG&(++ MP8V8$8V8L%TJY\8%^FOA\FO$P#3H?0T_? M3H>74CKIFUB$';]7X#'0DL[HI$,,C`+-Y481#$T:I#ZIL0==D!H@_=1H/I[A MV+WC'^^U*KIZ'R+]@D>+Z+SAV3#KVZ5&\##5(3)N![H_,?,A;SO$T73TKAN\ M-TQQB$`+N^9%BU<&"/=R[Z_SMAL$#U,=(J=NED->=+-\=S#QTI#_$!E:&9]O M#*R]__#2HH?)CJ'XI3=^#_IEHX0IQ"=1599PO<,=%\.6Z*+=_MVT]_^-3Y*- MW\M!]P;V8L,*\8V90M:65"('SG`TAY8;OUG]P>D&A,)VU`XV8OM8PA=0P*8( M<3YRK=WQ@+N[^Z:N_P(``/__`P!02P,$%``&``@````A`"-RYI"W!@``-QT` M`!D```!X;"]W;W)K&ULK%E=CZ,V%'VOU/\0\;XA M?.132583[&U7:J6JZL5 M\W'[XP_KUZ+\4IW2M!Y!ADNU<4YU?5VY;I6\O12JR1E>HYKX%^=LFO5 M9LN3]Z3+X_++R_5#4N172/&Y/4&>7)ZO/Q4I3Q\QET?_/".&ES-S]8 M^CQ+RJ(J#O48TKF**->\=)B^(+AG[>(P2=7=;[4S,"OY6C?7J(7\[U M[\7KSVEV/-4PW%-0A,)6^^\BK1*H**09^U/,E!1G(`!_1WF&4P,J$G]KKJ_9 MOCYMG&`VGLXG@0?AH^>TJC]EF-(9)2]57>1_JR!/IU))?)T$KCJ)-Q\OIM-P MMIA#EAL]`]T3KFW/Z)C=0`R-B-H('&-,*VQ`&H`+`CH5,&S_@PK,@BK:^^]:H)?E M6Y3;B+:+L`%I`(0RS!>;<@#/SO"L;^N,G38.3!.CSE-*::=B`G,PK*&(NI". M-D.DB1#B<'>;.#ZN=\X8S`)SCDJ965)4T$TI74@GA2'21(@4H&U*N5U[#&X8 MMW?:*218DN&84PU1%]1V$PR1)D((SNXAB,&4H$)"M=3A$Q4Q1#!$F@AA,Z=L M<*U8+'%1OG?P,1%EJA!@:L[LA57*+J@K)4.DB1#RN%TP%KK;8XW!E*!"*,'0 MFJ]1%]019(@T$4(0II%)$*L[A7K<^5QA%LI<(>&L6]:B#C&+O:3%%CH(ZMFO M-/<4\)37P`K5#N9. M0X23B@+(+)-'RR3:CK28EI?(/HI5$TW$8(YSPY^.X<%[HZ[*?(@&!1$-#!)> M!YFR`BI+#D?U9D.KCX;RB`9E1$2#@H@&!@FO@VYJ&(SJ/95J0"=Y1(-R(*)! M040#@P3TP,?9FEYL'`:C^L6):D"SL34$CZSBZ/K66J.A<-X]-!&'1`_='!F5 M'G*94;V]4E5H6H:J-YX+97%D/+3KF-"M#`EOE%5Y&RFKMCO#?3P&"0Y)`M&RHND8 MG/Y#695]$;[:T4R^'636T+9+3T>9E8:#!'O%[*+L2OMW&68332>$ALS-'H<$ MAR2!2*5]RS`?W)(T:2RRVC;ATLU+?V+99J0[&I($AR2!*']T,6.FW)Z]OO(\ MG#.]^Z?:5=1'"VLUH7:V-1J0[&K($ MAR2!J`;T&T/#&W55[D1H:L,R7DQ\!@D.20)13@.VYOESW"/=N8/&]QEKL=40 M%,R=S-4J*%SRA M!UW;=0>KSP>[8`+?#YI19BWX9:'Q`-;BM]\<[!8_7*$+`&W6,H66Y@,!:YE! M2[.C8RUS:&FV_*QE`2W-43!K64++*`%=JZ\!3[Z/`W>!8@-\X*;#^39`:DA3D_A MZDE]5+++"^,[.+PPNH.#"V,[-+0"E`T)@[,84#`HP9NN=O`VQXL![["K:+`% M7F57^%+(^TAHP7=#:'$[B?#9ZAH?TU_C\IA=JM$Y/&PO=V]R:W-H965TY_ M?V-L$]O#1JVT+Z7Y,!Y[OAZ;L5=?OU<7XZUHVK*^KDTRF9I&<O57'MF).FN&0=C+\]E[=6>*ORC[BKLN;E]?8EKZL;N'@N+V7WHW=J&E7N M)Z=KW63/%XC[.YEEN?#=_T#NJS)OZK8^=A-P9[&!XI@]R[/`TV9U*"$"*KO1 M%,>U^43\E+BFM5GU`OU;%N^M]+_1GNOWJ"D/?Y37`M2&>:(S\%S7+]0T.5`$ MC2W4.NQGX*_&.!3'[/72_5V_QT5Y.G"[:+BRI2]/(7]NNKOYC1H0. M:G!B9MP+/+D7\/>@5_#<#QV>W'X^69"IY]`^'[2# MU._;P?-#_7C<'IY#/_;2)>Z<2H0[LIC$_8SMLR[;K)KZW8!E`"*VMXPN*N(3 MF&DQ5\S%,'L_FSP0G'IYHF[6)HP>YJ6%C'O;V-/ERGJ#+,FYS1;;$-5B)RSH M/%*W>QT$.@AU$.D@UD&B@U0"%L@R:`-3_2NTH6ZH-B*JK0"26)H0PD(TV>L@ MT$&H@T@'L0X2':024(1P1H1P(%G&%[3("=IJ;<+*D7+"4P/=,AM'3IR9:K(; M3`8Q$`D0"1&)$(D121!)9:)H`G']BN2@;F#MJ2KI*X<9/51I,!E40B1`)$0D M0B1&)$$DE8FB$FQ&BDJ/,X9:]V*((+:,.+#-W9.(3+4,&8Q$LSTB`2(A(A$B M,2()(JE,E-CGGXJ=6JNQ,S+KO[7]=KA#9(](@$B(2(1(C$B"2"H3)=#%IP*E MUFJ@C,Q@&Y8F6?\V#$;#)",2(!(B$B$2(Y(@DLI$B1UVKD\D.+568V=$GF1$ M]H@$B(2(1(C$B"2(I#)1`H4E^(E`J;4:*"-RH(S`VAYFE!-844,B$%?['@2# MD6@6(D<1(U)G,;>!C6IP;1-'W4B2P4BX3F5'BART5OJ$'KVY*@A'TB!W',F2 M""1K8A-;'7APMQ(C#P6ZRQMQ)/48"RM5%TWRY&XEW*>*+U496D[))>7C/9^P MZ@N^@,+WEB-IG#N.%&580X>=(&BY&`BK.PH%DF5@#27WL;!297!5E9.[E1AJ MRA'SIQ0/(P46^)L/)8;_/E5,OA5%@L:"*H4M(B3):2 M'5(F]$S5G[OO>UJ20G:^="CCY*3FY%I^]M,UM./:0FL[#O M4Q#QWI3DY'[@\?/>$M[0=?O>YBZ9:SF0"MHL"5A+:8Q1@%&(4811CE&!$KX[N@V`+E5T%L8N%JFA.Q:ZX7%HC MKU_I-0]D_&8U8'8'M9WY<&J`E:YSUX>*>H3/?2A`1_C"A^)LA"]]J&5&.($. M(`+\)O+\"+9S_"+V?*@,1CB9^O33./:&P)LQ7ZD'O8^]@#NYIWYCT/6@=W4C M76QM'X[KN.NMX\.9%?.GF?\T&O;6\^D'%[?8>3[][.(7>\^'(FR$@QZT$AE[ M0^#-F*_0\^DG&II80^!P%7C+3L6?67,JKZUQ*8Z00]-^MV_892+[T?&%]5QW M<`G8K[$S7/H64`E,)Y"CQ[KNQ`_:P7"-O/D?``#__P,`4$L#!!0`!@`(```` M(0`+(5VL.@8``,$8```9````>&PO=V]R:W-H965TL/.37T]K\ZUOP964: M=9->#^FEO-*U^8/6YM?-K[\\O)75F^>FN7F656=G6J3UI+S1 M*[PYEE61-O"S.EGUK:+IH6U47"Q[.EU819I?3>[!J][CHSP>\XSNR^REH->& M.ZGH)6U@_/4YO]7"6Y&]QUV15L\OMR]96=S`Q5-^R9L?K5/3*#(O/EW+*GVZ M0-S?R3S-A._V!W)?Y%E5UN6QF8`[BP\4Q^Q:K@6>-@^''")@LAL5/:[-1^(E M9&%:FX=6H+]S^E9+_S?J<_D65OGAM_Q*06V8)S8#3V7YS$SC`T/0V$*M@W8& M_JB,`SVF+Y?FS_(MHOGIW,!T.Q`1"\P[_-C3.@-%P/,%ZLEN'FB=1/DS*=I9"]U4Q;_<"O2^>)>[,X+ M/(67Q<193F<$.KW7<-8UA&?7D,S>U7#>-81GU]"6AGUGJ#">-F!XBA[)^UHN MNI;P[+NT5PYQ%O\1Y+)K"$_1Y?N"A$7:CA6>?8]+,G5G;&KNQ.AV[>`I.IR^ M2U4"^;UN;+)\L%YA262=S1;;$-5B)RQ8_C.W>QWX M.@AT$.H@TD&L@T0"%LC2:P/+Y#.T86Z8-B*JK0"26)H0PD(TV>O`UT&@@U`' MD0YB'2024(2`9?\90C`W:Q.V`BE)5FKD6VXSDS-IKIKL>I->'41\1`)$0D0B M1&)$$IDH(D%T1\1`)$0D0B1&)$$IDHL<.) M]('8F;4:.R?SMM)H]\<=(GM$?$0"1$)$(D1B1!*9*('""?J!0)FU&B@G<]B7 MATFVI]HD]T;])"/B(Q(@$B(2(1(CDLA$B1UVK@_$SJS5V#F1)QF1/2(^(@$B M(2(1(C$BB4R40&$)?B!09JT&RHD<*">PMOL9[0BLJ#X1R%)+!+\W$LT"Y"CD M1.HLZFQ@H^I=VV2FYEC<&PG7B>Q(D8,53Q_0HS57!>F0-,A=AV1)!')XE34E MVO'H#P9BT(%`@[)AAZ3.(F&E2&)K-5H\6`GWB>)+%8655G)Y>7^[)[P2@\-/ M^-X*!.MMF"?;5N=IUUEUGTZ\=.2^;,C?OB%9(K&XU=QNU22KZ8(XJN]`^!X* MN%`,:D"10/(X47>QL')Y=\NE,]..]D28+)D&JIBL/)/%Y+7ZA'UE-.<\>]Z6 M$"D$-"+R##KL*G5>Y"D:+=(B$^^$,C`62E;?MA3J+B>A1C7'H456:%7G_7VE> M*BI*=T@>ZTQ;83O"C91DYLB1]4+9Y7<-'3;9KYO5:J'ME('P/,Q7V"$RH$BX MD?)]K"B1675X3]YOY>UGB0RJ])G,W&A;*$?.$,V.5=)@ M):$]1CY&`48A1A%&,4:)@M148]6BKH7M3`!_]!.<>=+DX$@KI+0=9\?NH:`A M6(EEML?(QRC`*,0HPBC&*%&0JA`K,V6%1K8W.2MX50J*BVBV<+&G!;C#:(^1 MCU&`48A1A%&,$;MP',;%8^87B/R&IJ#5B>[HY5(;6?G"+@=M=DSUF-]<;A<> M%.(0J\Z7'A2I(WSE04TWPLD%$\CG$P] M5D+@-XD+KL9>P-7LHSW28,NN;,>X[<%%!NY@._/@XQWSQ[GW.!K#%@09U0/D M&%7#];:C$>Q!Z[%J#K\(78_5=/#"ZB<)+I!O MZ8G^GE:G_%H;%WJ$')JV]4+%KZ#YCZ;;;I_*!FZ.VYWW#'\JH'`#!_>1IG$L MRT;\8!WT?WS8_`L``/__`P!02P,$%``&``@````A`""'*,PO!@``Q!<``!D` M``!X;"]W;W)K&ULK)C;CJ,X$(;O5]IW0-Q/..8` M2C+J)!RU*ZU6L[O7-"$)ZA`BH*=GWG[+V`;;14?34M],IC^7RZ[?95/V^NN/ MZJI]+YJVK&\;W9J9NE;<\OI8WLX;_9]OX9>5KK5==CMFU_I6;/2?1:M_W?[^ MV_JM;E[:2U%T&GBXM1O]TG5WWS#:_%)463NK[\4-6DYU4V4=_-F%-FQ M[U1=#=LT%T:5E3>=>O";7_%1GTYE7ASJ_+4J;AUUTA37K(/YMY?RWG)O5?XK M[JJL>7F]?\GKZ@XNGLMKV?WLG>I:E?O)^58WV?,5XOYAN5G.??=_(/=5F3=U M6Y^Z&;@SZ$1QS)[A&>!INSZ6$`&176N*TT9_LOS46NC&=MT+]&]9O+7"_[7V M4K]%37G\H[P5H#:L$UF!Y[I^(:;)D2#H;*#>8;\"?S7:L3AEK]?N[_HM+LKS MI8/EGD-$)##_^/-0M#DH"FYF]IQXRNLK3`#^U:J2I`8HDOWH?]_*8W?9Z+:M M:\]%VX4E<:5K^6O;U=5_M-%B+FAGL.P[PR_K["QF\Z7I6##6KSIQF1/XY3.8 M6:ZY("X>C`VM_=CPR[HM']I#PO?V\,OLK=EJ/G<7J^7C@3S6$7Y9Q\7#C@95 MN%^P0]9EVW53OVFP"T#+]IZ1/67Y%BPT7RH:Y+!X[ZT=+!KQ\D3<;'0(`Y:G MA83[OK46B[7Q'9(D9S:["1O98L\M2$80MP<5!"H(51"I(%9!HH)4``;(,F@# M&?09VA`W1!L>U8Z#42Q;$8);\"X'%00J"%40J2!60:*"5`"2$,[G"$'<;'38 M4D*2+.7(=]3&$3/)E4WV@\F@#B(!(B$B$2(Q(@DBJ4@DD2"NS\@6X@8VHZR2 MNI6HT4.5!I-!)40"1$)$(D1B1!)$4I%(*L&Q)JDT_4G@QPJQ[L7@0>PH<>#< M$Y)HI63(8,2['1`)$`D1B1")$4D0244BQ;[X4.S$6HZ=$K?_]O;GXQZ1`R(! M(B$B$2(Q(@DBJ4BD0.&C]X%%)M9RH)2X<"X+B^PIBSP8#8N,2(!(B$B$2(Q( M@D@J$BEV.+D^$#NQEF.G1%QD1`Z(!(B$B$2(Q(@DB*0BD0*%+?B!0(FU'"@E M8J"4P-X>5I01V%%C(BQ-.1&"P8AW"Y&CB!)AL)C9P$$EN+9DU\E@Q%VGHB-) M#E(\?4"/WEP6A"%ADGN&1$DXFO=5EFU:RN7EX^/>HI48?/RX[QU#PCSW#$FBT(X.O4R0TC'@5B,* M.1)EH!T%]S&W&8`<+'5&Z4"O7[L-=+4Q;<1URUV,%&S%DC2CF2)ZF,EK"K3QZ1W#L MU5S9SBDW69(DD+4DM9>H);FLV`MRAWSG:LGK"(M6;9*L#,EGRUQ>ZSWK:-,K M)I65=H0;*5_^@%M!BZ"T4K2%W&KL&/%YC4D:(/&@(N:)6L.2UA.@FYAU%+D0I=%2D"EA'EWX>5@O'4I8DY*[%-&33 M%-.0(@'Y3J.@[8SBX2^&(G7:WB!>BSQM_K^7FI"0@VY2]9[AICGMHC]$!HP"C$*,(HQBC!"/RYD965?Q,T#5S'ZX>$WSA0Z4^P9<^5+$3?.5#T3?! M+7`$$>"6R/,C^`+BAMCSH82:X);IDT)BJL6"EBE?J0>C3S7`8^93G\NJ'N21 MW#0P<>>N?X<+G'_,GUGR;#WGD^*4]PC[WGDR(%-QP\'ZK5"0YZD+IM MJL6"EBE?H>>3@@:Z&$/@\(9ZS\[%GUES+F^M=BU.D$-F?]8W]!66_M&QC?5< M=_"*VN^Q"[R6%U`WF3/8KZ>Z[O@?9(#A_7W[/P```/__`P!02P,$%``&``@` M```A`'!KUJ.E`@``QP8``!@```!X;"]W;W)KR&0A+8HI$I7=:NT2M.TCV?'&+"",;*=IOWO=X<3`DL_ M\H+P1)&"MUD]$HF%`B&JYSV909_?WK_N**$NM8D[-:-R*C M+\+2F^7G3XN=-AM;">$((#0VHY5S;1J&EE=",1OH5C3PI=!&,0=+4X:V-8+E MW295A_%DDH2*R89ZA-2<@Z&+0G)QI_E6B<9Y$"-JYD"_K61K#VB*GP.GF-EL MVPNN50L0:UE+]]*!4J)X^E`VVK!U#;Z?HQGC!^QN<0*O)#?:ZL(%`!=ZH:>> MK\/K$)"6BUR"`RP[,:+(Z"I*;Z]HN%QT]?DCQH.I#SF&8'-XLON^:\`/0W)1L&WM?NK=-R'+RD&WYV`(?:7YRYVP'`H* M,$$\1R2N:Q``3Z(DG@PH"'O.:`S$,G=51J=),+^<3"-()VMAW;U$2$KXUCJM M_OJDJ!/EL3II=\RQY<+H'8%V0[9M&1Z>*`7@@R:/T*M\2R2H0Y`5HF04SBGP M6RCLTS)*XD7X!-7@^YQ;GP//8TZ?$8*:7A+(&$IZO3P'9DQ&9BP72KGU@2'- M4=3Z.G[=+@IH[.AB63:V_`*?`ZTI#6J?=`8UI`RIT7RG1C!\<_G8J M84KQ1=2U)5QO<2C$<*WZ:#^O5ETQ_H_/TE5W(\+^`\R1EI7BD9E2-I;4H@#( M27`)-3)^$OF%TRW(A&FB'4R0[K6"'X:`FS7!@A9:N\,"9UW_"UK^`P``__\# M`%!+`P04``8`"````"$`[JJ['CD'``#K'0``&````'AL+W=O]N]>4D`8U M"1'0[?;;WQC;^&%HMCG=F^WFYYFQ_?<8C^'^ZX_3\G9:7\HSM.SKYI1W\+-Y-MM+4^:[WNET-.W9;&F>\NILT`A> M\YD8]7Y?%:5?%Z^G\MS1($UYS#L8?WNH+BV/=BH^$^Z4-R^OER]%?;I`B*?J M6'7O?5!C;]PYKG!8_=_T#A3U71U&V][Z80SJ0#Q7-V3=>$ M2`_WNPIF0&2?-.5^;3Q:7F:YAOEPWPOT=U6^M=+_)^VA?HN::O=;=2Y!;5@G ML@)/=?U"3),=0>!L(N^P7X$_FLFNW.>OQ^[/^BTNJ^=#!\N]@!F1B7F[=[]L M"U`4PDSM!8E4U$<8`/P[.54D-4"1_$?_]ZW:=8>UX2RGB[N98X'YY*ELN[`B M(8U)\=IV]>D?:F2Q4#2(S8+`7Q;$B\HRAZS3DT$!#D(=1#J(=9#H(-5!)@%%&=BS2!D' M\GK\P<.SAGBM#=BR4M:LU)EOJ(TCI]9<-=D.)H,ZB`2(A(A$B,2()(BDB&0R M452"F2*5R./YQLU&PL!^5773=QLUNJK;8#+HADB`2(A(A$B,2()(BD@F$T4W MD$C1[7I6$>M>'CZM#24./*&E1'.U+!J,N)N/2(!(B$B$2(Q(@DB*2"8310TX MHFY0@UBK:E`R[RN)_C&[1<1')$`D1"1")$8D021%)).),G4X:V^8.K%6IT[) M')[O(A$6,RT1!J,A$1`)$`D1B1")$4D021')9**H0:IV^>R^OBV(M:H&):H: M\Z6FQF`TJ(%(@$B(2(1(C$B"2(I()A-%#=C=-ZA!K%4U*'&,C(?B,\( M+9U)A1(,1,XH2]4P'(RXAA$B,2.BLV0@$X&NA$^%%0^?*4@5B]2`G]]< MI'36\HDA12QJY8BA^]Q*%HM9P0$@/:6THB?$CA%&,4>BQT0@.?Q"RRMA)<22 M1Z^*1D2D7`;8'=(6AQ"74-[W)C4:1HR)"P M\KF5K"&S6O9W$7MF(?D&`]Y9A,/$'(G.$H[N>&1]1PH#'CGCJ`^C*D=J15TY M>TENYV-B`1[4HE6FHA9#0H>MQ1"<(5(N:<]XGUN)*TG`T=VP&"%'+IOYS%G: M<^WPC+B1\(LY$M$3CH15RA&-;BT6J]72U;3-N%'OIPI)BD=9R)%4D]6CM::B M'D.R>A39\."4U-,J;9\4XK#W;?H6I#\5.+(E]9@5+(@42[OM1-@Q9@CN"3R? M$FXE2KB4(^CEX_`9MZ)OD>2K+;F&*/J1+>RXMVYA$D4[,Q@2P]_V?8&5FI1: M/>XS*U@T/N^`H^6`0H[46$A6.@A;I&#,!R%0PF/U+^CZ9U+*$+G*7I.5S7$D M+4DI*Z-Q9"09LN0FJI+;7?ZV#%@R!'9&W)D7]WH M=`S0(1]6C*,G/)2(GG)$HW^TT>7HZD8'\9"BUD(DZK?Z\M%9(S\`2!@M4RF" M>IC/:$M2%*PDY&,48!1B%&$48Y1@E&*4*4B5A]3'>L(MX.B]\1V#1>ML)>N& MTEO:"TNMUMTR1T6RP9$+&V"K$*,(HQBC!*,4HTQ!JF2D8I8E^\G100ML11F* MI#EOX2T_RAR$`FP58A1A%&.48)1B1+X^B'%1&>C7!/I6^%0VS^6V/![;25&_ MDB\%4'L]W`^8?L;86"[_CJ&W+#QX<0'+K/.E![?Z$7[GP?UVA*\\N.F-<`L< M(/O'6L`%%AFW0!'LD4H.MT`M[*50Z8ZUV-`RYI.!#RGHL`]\W'D*1VQSX; M%X8V-NBM"R,;:_!=&-A80^!Z<(O'702@&+FWXI;(A5'U#>:@/GQJN^3/Y>]Y M\UR=V\FQW,,&F_5'5T,_UM$?'3O"GNH./K+UI]D!/JJ6\,)A-H5:8U_7'?\! M/9O#9]J'?P$``/__`P!02P,$%``&``@````A`+8"CZ3``P``9`X``!@```!X M;"]W;W)K;*%+9B954S43-*OCG(&1)-3S*8Z1JR6AN!I5%%,_GRZBDO`HM MPD:.P1"'`\_8H\C.):NT!9&LH!KFKTZ\5BU:F8V!*ZE\.=??,E'6`/',"Z[? M#6@8E-GFQ[$2DCX7H/N-I#1KLRBKGX'ZB0NOTJ>_\XK!M6&/F$'GH5XP=0? M.89@<-0;_60Z\*<,%Y_JT"Y-XMEC-$P+IP3-3^HDC9!AD9Z5%^9]-(@V4 M!8D;$/AN099C02([(:/OD6JZWTIQ"6#1`*6J*2Y!L@'@84&@!'/O,7D7PJ*& MN2KHPNN>),DV>H7*94W.@\V!SX^<+B,"THX9V,8S8S(R8VEQ*@\V<$T3#],D M4V@P>1>FUY-/T@[7,ML<:%LG\"/#$0@PXP5B,O3`I?9K:Y-&4$/*>&I,-M1= M<9O(=75)LNCJX*A<3J'"9)>JB<1F^UTOCY6+BSMN068KF-KG:Q3'N11-!/K6 M=8PDRV$U:-BCMP,FNU1-I*]F[>):_TA&R,&!+D<3<>6LAN40<+KQ>DRV2]:& M^HH(;O2K4HUND!GHL2`6A%Q-=S?;"$\WGZ().8+2^0U!DWR! M](VA#0T(&K"&F*QF7S>I[PUDR!Q2RF]<3C&D_S!9+L[MPWUNQ0/^,,(16:8QS'D#NG'V>@<1_$D=S#9'EMC M&/T>Q;C'O8U$5NL1[F!&>C0(!B%W,]VX2<23W,%D>VR-.PR(&G"'='XWXF1" M4_0+JYM^\84?F1_4'GDE0H*=@#,N2F>M&\)]D&+ M&N8.-WVAX79O?I[@;8[!37:.OG400KTV&3'W=H>3HF7)Z4+Z^G25KD)PCQG!VR^K,):EMYNOB^.Q9E\GR` M?7\P+TG/L9LO@_!YEI9%56SK*81SD.APSW-G[D"D]7*3P0Z4[%8IMRO[@2UB MP6QGO6P$^C>3[U7O?ZO:%^^_E=GFC^PH06W(D\K`ZK^*]]]EMMO7D.X9[$AM;+'Y?)15"HI"F"F?J4AI<0`"\&GE MF2H-4"3Y:/Z^9YMZO[*%/YT%KF``MYYE53]E*J1MI:]57>3_(:C941N$ZR`" MV.OK?&P0!PDU^WM,ZF2]+(MW"XH&EJQ.B2I!MH#`YXTAC7:KUW8*6U1!'E24 ME0W5#INH(#UO:\;BP"O;ZRW,&&OC(CG$0`VTY#P3$=]"&-Q@ MH?'<%!B*L+=N&)H+1PB9-]F@C2)1=ZO2&! MG="LN;)'T2-6,&Z2,!SP?9HAT2C2&&0Y81X7-+\$$3*_VZFIH1K9XS54:#/% M(6U:AA@MH>#")3X2:\0H#>\R"H9#'CY;AV*,-&6D0<;J9@/%-R&F?!#F#OD4 MVI2/LDR6,#,1$\\+HY;[*\RT#8T$&\`;F^/3#PW:[`M(9]P(3Y/9$- M:OPN`VG0I#TX&1Z1!J%P$\XX/,F1]C4A,S;W>\YL\KO+03B:@S%>>%7>?"A>3#Z MI!EIT`UZ&,6@U^IKLKO+._@%[^!=Q^GD(NCRXM@:.LYEB,D/,..]0[U[4^_@ M].E*@_14@7.77F-J>A@&$3/W^K,?_Y)Y-'?1%B;3(](@G6-PZ`LTT3\,%:\5 M(;&0<2['AU;"!EZB06>Q+LDYWDSXE\RDN8L*2NU8@\X\5=[;EM!I[[^*W$S[ M76;"AV;"!%D[TB!DQT,_$(1_;"#@>?;JO%9O;>-;ID$3[03U$PW2VL%;&B5G M`N9^[VG<:&#UUJ/#VD`$\(K$J(IVBY+')SV@MP:'A* M=O)'4NZR8V4=Y!9"NM,`NK;$8T?\4A>GYNSNN:CAN+#Y=P_'PQ(.O-PI@+=% M49^_J..T]L!Y_3\```#__P,`4$L#!!0`!@`(````(0#?3F8<=P0``)H1```8 M````>&PO=V]R:W-H965T&ULG)A=DZ(X%(;OMVK_`\6]DO`I MECHU(.Q.U6S5UM9^7"-$I5J(!73;_>_WA*!R(@/V](5(\^9-SG-.0N+JRWMQ MTMY85>>\7.MT3G2-E2G/\O*PUO_Y.YXM=*UNDC)+3KQD:_V#U?J7S:^_K"Z\ M>JF/C#4:.)3U6C\VS7EI&'5Z9$52S_F9E?!DSZLB:>"V.ACUN6))UC8J3H9) MB&L425[JTF%9/>/!]_L\95N>OA:L;*1)Q4Y)`^.OC_FYOKH5Z3-V15*]O)YG M*2_.8+'+3WGST9KJ6I$NOQU*7B6[$\3]3NTDO7JW-P_V19Y6O.;[9@YVAASH M8\R^X1O@M%EE.40@L&L5VZ_UKW094TLW-JL6T+\YN]2][UI]Y)??JCS[GI<, M:$.>1`9VG+\(Z;=,_`L:&P^MXS8#?U9:QO;)ZZGYBU]^9_GAV$"Z'8A(!+;, M/K:L3H$HV,Q-1SBE_`0#@$^MR$5I`)'DO;U>\JPYKG7+G3L>L2C(M1VKFS@7 MEKJ6OM8-+_Z3(MI921.S,X%K9T+IITVLS@2NG8EISSU*?,M[?B1V9P+7NPFU MB?N):*"W%@E<.X^?0.)V)G"]#F0Q7SB.[2ZFPS%DDMJ<;Y,FV:PJ?M%@(D$: MZG,BIB5=@K-(M@W#'$XV9%FT^2H:M4U!74.%OFU\:V6\05&EG208D-A8$@Y( M'"S9#DA<+(D&)!Z6Q`.2Q4UB`(@;#2BW/HUQ"D(,Q:UK=PK^S;8%%4B)WR*: M.;YMVQ[!DK`O<8GKJ0CZSZGO.Z;21]07V"[Q/,M72,=]R M)R#$F``E2GR!U$!)W2@IHPNEPFLAF;:I9&_;?RP!$$423?81CRE0!<`T?SY^ M(<;Q+^Y8905(B0QNYIFN190"#J4"`3)QC6RG)=&T)!X;"F(`8WF>@1!C!I10 M//Y`:B0$FU@*HU`^AL][B:@$KA*QUE`58=3WMWQ+:1Q?&P_ZH\AA!>Q'+E9# M"UZ@X^N`:*024(802`T*$3,*!Q2*R59*)$:`8"I+131@@3N)QQ0(A(=!C`,0 M8A6`^CZ0FF[LMF6J-2"?(T!J^-.2:**7>-0"`1"[6>6].%T)HI$*0EGM`JF1 M(!PB_G".0BD8)='W,(4)MHCZSVWO41"/]H$X^#_#0312.2C%&D@-"A-'$0XH MU)*0$@FS!?&`8L`$=Q./*1`*"BO!YVNB;:7"4-X!02?JJL*R'I;(3H!PJ3"> MT$13'<7C)IB'V%=]>HY0N1N#%_)MM:?J"SWH1-UR05S75J91V"G&@$^8B-AH]8B,+YM4;LLP"65=##K1;0OIPPY)T81(,[2'1`+3M%U+F8T1 M4MBN!]L42RG2&&EFCD7(PO+N><$DQ(;K>1)R>X9)*/O<`,Z\8E5!V<13.>PD MW7KPN)7$SUL.ZF8AFNY&G+Y_/!*)09ZNY4GKG!S8'TEUR,M:.[$]E#V9BQ-; M)<_6\J;AY_9$M>,-G(G;KT?X#83!<8O,0;SGO+G>B-/[[5>5S?\```#__P,` M4$L#!!0`!@`(````(0`L*<3QY0,``"@/```9````>&PO=V]R:W-H965TQ/7MG"9THR4 MQXW]S]_)UR?;X@*5&-_>RM$L^S MG>VZ3M"_!%]X[W^+G^CE.R/9[Z3$D&VHDZS`GM(7B?[,Y!!,=FYF)W4%_F16 MA@_HG(N_Z.4')L>3@'+/P)$TMLK>(\Q3R"C(3/R95$II#@'`IU40V1J0$?16 M7R\D$Z>-/9U/9@MWZ@%N[3$7"9&2MI6>N:#%?PJJ'74B?B,"UT;$\S\M,FU$ MX/K_(PD:$8B]$?%AZ$$;\V8R7#\=@:/R6I+.A]R!ROD%Q)W@J$ MV_JH;'85^ZA@4"DI\BQ5-C8L6J@%ARY[W0:^NW9>H3/2A@EO&4\G=BTAVT#* M1FH`/GNRQJ2XG71E#")I"=FGX+JS#NW0MWZ_)5N'$I8.V]C"=N#Z7-^PHXA^ M]`81C1+Q*)'<$H$?=)%HAJ%U^X9EK:>PHH>-RTF:<7-@IP;Z/@/?='J/F791 MUM6.'V"2849S"POK\V[E),VM.;!3`^H%4S>I.1";`TD[<&V5?H*TH.'%8`8= M?/BZ;'M33H)2:LMDIB23NQ&B6B4B$>)1!&+^AWAS;TG?WJ-5,L$ MO(SZF1AN4@F;&9CK_D+%P/,_S(`BEG5L3R[\Z0K1J$(\2B1#A.9_\1G_$C;] M+_3H0\4,^5>$JHV_N/4_JA"/$LD0H?F7.\#>#]-P_25L^G\R_"OF6EW]ZYWZ M>B`]T2@1CQ+)$*'97^KV'WM7RTEF&I:ZSU`Q`SYWHT0T2L2*4*TTDTO)6$O) MD(26"`]^H?J-\%@FZEE&*J9&#&$##>5B'(D:I'FEW?$:CXLD@XB>#[F=>7AA MP-[^IB6FQ@8I;*#!/"B=`21J5,")W/^YD\#\?1\#Y$%$!GO_(2H)ZJ"A=K`% M9D>\PWG.K92>Y2$B@$=WH]T!YSF0NS9C//16L-^\'8_E@>C.>.BOPEK'Z83@ MG%*A(_X#L2,IN97C`X3@3A80/U,G'74C:%7OL_=4P`FE_O<$)U(,.UQW`O"! M4M'>R#UJ=\;=_@(``/__`P!02P,$%``&``@````A`"?GG'3`!P``=Q\``!D` M``!X;"]W;W)K&ULK)G;;N,V$(;O"_0=#-^O;>K@ M@Q"GB&4=T0)%L6VO%5N.A=B6(2G)[MMW*'(DDJ-U8[0WZ\VGF1'GYY`:B0^_ M?#N?1N]Y51?E93UFD]EXE%]VY;ZXO*S'?WX-ORS'H[K)+OOL5%[R]?A[7H]_ M>?SYIX>/LGJMCWG>C"#"I5Z/CTUS]:;3>G?,SUD]*:_Y!:X[5NG\VEJS6;SZ3DK+F,1P:L^$Z,\'(I=OBUW;^?\TH@@57[*&AA_?2RN M-48[[SX3[IQ5KV_7+[OR?(40S\6I:+ZW0<>C\\Y+7BYEE3V?(.]OS,EV&+O] M@X0_%[NJK,M#,X%P4S%0FO-JNII"I,>'?0$9<-E'57Y8CY^8EUK6>/KXT`KT M5Y%_U,K_1_6Q_(BJ8O]K< M3LT?Y4><%R_'!J;;A8QX8M[^^S:O=Z`HA)E8+H^T*T\P`/AW="YX:8`BV;?V M]Z/8-\?UV)Y/W,7,9F`^>L[K)BQXR/%H]U8WY?EO8<1D*!'$DD'@=R#(#4=; M.L*O=+2_X>E(3_B5GN[$L=S%LAWW#4<(VR8,OWC+V80YLSG/ M]X;?7/HM>K]/#A666GM'^,6AWKS32MK#K[1GB\^)PJ!\Q&SR.A(S]2^"3D4] MM.6US9KL\:$J/T:P9F'&ZVO&=P#F\;A86$*BKM1^5&E08CS*$P^S'D/J4$0U M+(_W1\M:/DS?H:1WTF9#;9ANX:,%KU\>=FN"P`2A"2(3Q"9(3)`J8`JR=-I` MG?\?VO`P7!O,:H-`$IB96>Z$;8V&KA.+J)WYET8A`2$!(2$A$2$Y(0DJI$TP3R(IKP M'?G.AV1?1/;,J)#."-VVA`2$A(1$A,2$)(2D*M%RAT?)';ES:SUW09RV M,6BW0Y^0+2$!(2$A$2$Q(0DAJ4JT1.%9>4>BW%I/5!`'MF%EDLUG0V?433(A M`2$A(1$A,2$)(:E*M-QAY[HC=VZMYRZ(.LF$;`D)"`D)B0B)"4D(256B)0I+ M\(Y$N;6>J"!JHH+`VNYF5!)845TA,-=X'@2=$;J%)%`DB'*S6-K`1M6%MIBM M;R1)9X2A4S60)@?OE>[0HS77!9%(&:0OD2H)(E43BUGZP(/>"D<>(NKEC212 M[ABCE:Z+(7G26V'X5(NE*\/;*=I23GBGWQR+W>NFA"D`HX%G@0VMHVPH15,& M#T:\Y88)I`S?ET@33%C9\\XQ0*L>A8A4=4CX&*U@]2M5X^KB)[T5#C652`Q5 M5X?W6*HZ`RK`*THG@VC)-!DDZK/QF43M"ZCLG`6:]T^/0%HI**2.$44Q.HJW M0=Z8)Q2EFJ.>,V^B[LA9]%Q:SA)I$V$;J\!GP@KDPXG8(H)MK9M!MC#J.Y!6 MCM6^N3#7M69&"Q;V@3!V)!'K._L8D3I.O[T/ M*-5GLT74ET8@D:RQ)>A$A!)WLWJG2#II)=:-";5+T$I,PM)BCM$\I6@Q4$Z\ MJ[NCG$03"*+CW3=,(*.24*)-)*J1L4"I>@E2@EB\U=9NR$*9H,U!)O'M5:$A^3[GWR MBQ94*S&!C!(SDO8A-;)C">3T.@32RI$[U@+6H9%AB('4&I.#4FM,(%>M,8F8 MV-AM9^X8]9MB[('MBO>:_UT]T;%JZDFDUYZ1M,^$E59[`KG02B@;L+']!=+1 M%0MK.;/G"R-VB+'[:8@D`CFP]F(,I._WQNT2M.(]TONCN[169O6G&)M6**^@ MFQI_+:\_ZDU!&>S*VC#Z`I<(.CY%*\=RF,O^9'"O=^UVE"&1++!AI^NG"S;^"+H2T?X&M!+U#DB"JA52%%$44Q1 M0E&J(5TBWE>KJ_1V_PYG0N:C0"(E09^B+44!12%%$44Q10E%_/B*#U6,2^0L MCJ/$><$YKUYR/S^=ZM&N?.-'3=8<%D2'Q3G8QIK!05B[N9$K_(BLG55RQ<+# M,^,*G*H]M9NPP3<0:C@2!.)U8]K;'GS(I?S)@?B##HX'WS2IP\;UX'O?`)][ M\'EL@"\\^'0TP)<>?&FA/%IY$;P[T@OQRH.O$P.CYTA<&5H5CI"M0; MNK!EEL??$H>"61!LZ,IFY?$7<^KBKSS^>DXO;%<>?,,9X)`*_Y`Q=(7!E:%8 MXG3*#U"KL[8)J<3!J?BCD5O]<]G`@6>[ MZQ_A@#N'U]O9!#:\0UDV^`>_07=D_O@/````__\#`%!+`P04``8`"````"$` M6JV(KODA``".Q```&0```'AL+W=O2Q]\W8K^#@N]#L?KN#DD39M=]7[O[3$N4Q;`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`(]I>+W3I8;U0H/==@#H/`Q,$K:^4X M4/.&1^F513D2`A,*Z\M7>2;@8%#_H6NU9\US7>5P""RWOJ[!"W:K^@^N=?'L M='D[K1BG!2B\>;KY\.[A_L\WM*R3GQ]_W*B+1'!0YGCIF5H^+T9_M1;1(J2L M_*+,O+^@+M$R\T@KZ+\^+%;K=V__18O>1ZUSC3J!U#BRAEKAE-G0!9$+8A""T0)OR8&S%VF2_AU>5&:4%WG\ MKQE8;G5M:SL\KL62`1 MD!A(`B0%D@')@11`2B`5D!I(`Z0%T@'I@0Q`1IL(S]+.0GC6OSWG2Z+2/CF0 M!_YZ(DNZWEN3=>O,Q%F)BX5`(B`QD`1("B0#D@,I@)1`*B`UD`9("Z0#T@,9 M@(PV$?ZB[=P9_E+:TE\3(7^Q*XY`0B`1D!A(`B0%D@')@11`2B`5D!I(`Z0% MT@'I@0Q`1IL(Y]"&^0SG*&WIG(FL:,MJ3::=,YEF)?9@""0"$@-)@*1`,B`Y MD`)(":0"4@-I@+1`.B`]D`'(:!/A+]H]G.$OI2W]-1'R%[OB""0$$@&)@21` M4B`9D!Q(`:0$4@&I@31`6B`=D![(`&2TB7`.75+.<([2ELZ9B.VSD&0\E$K,I2K4,7WMGT8K67IK-9B4WGMB$Q'"KO<<9X MG-3E@&AD-?*HD3TDC-;3B?,S%4ET.J-A%-AR M+LS(\5#G1O>4O]BH9.)?Y!AY$Z/R0$ZL,**5PGAK[03"46M1#=R^D!%%\5PP MV,*0336N%CJ+L-_M=X[QV%ABXPFWRAQ>4T9V0Z&^C+7V4WWK8'=UY=27L\Y6 M=4:.K#K>_=S(3@=#VN!S'ZXIQ:P&6Z5AY@%:K"%)HK6F[.V4)M'HE*(^94XB M;6NMN[580Z]BKLZ42C2B'!HW*F4MLW!G&JV6TY!Y;.>BE!PQ=7#ZN1&;CEQB MQ#2R7;Q8+^1<.:I$I!I7TZN0D0F72",=>$&P6R^=@W2,I1*-`F,H972*EI,W M,D:3-W;;[95SDLM9PQ-BZCQB#]CSQPYU8G1G[(2FK&4'V%2;#K#-?KUUUM9<%)(!1L'PD^.E2CJ["XUD M@#EQ<53QI\;+="ID9.(BTD@'V')+`2:7OQ@+)1J)56MN$P]AIK4V='69KT>! M&[XYV_*L7&J_"C&F.OWE[N/OU_=DE"[VGN5,75CT?85IRRN";4).L#F=/E+7 M(-@FM+('3Z-I!BU7BZUS[8C9CAUL4R$1;!-:V\&FD>UCS^!-6M09F*!J=VL/ MGF><*#3F@9HVPV*@-+);L%B[1V1U^\F-,HWL@9H01UD0;/9[QU+,EDRQ1",1 M9W.K3)QII/9:1<3,U,%@ABHZ1;6I;IO_/I`.UF1LU0C]6<._\7: M.98<6(8'WN2..1@BX)IR52MM69BD>M9:^'&JWM`8,M?L1:>K^Z6097 M@1N\;-P*7HWLX&5+M%.9W0CU9:RECX6KW0[CF8WCJKE0FWE[XKOQ/-[_^*N% MTUH03F:<@%:6Z6:1H1#8A&@:3'U#GH#(_I8Y-U)J25 M5:V=6[,//"(*&=&TM2:GYSS,CT.4&4,I+FG:U-9K38?,[(F"\0E8RD M>6<#7!DM-E\S,N8;1"TC8=X]@'5&B\WWC(SY`=&HD1,09NQE0-#6\YR`4.K. MYFI"(B``A0N-EG.B(D(4,S(=3!"EC(RM#%'.R-@J$)6,I"^<\TEEM-@7-2-C MOD'4,I+FG9UG9[38?,_(F!\0C1J1JZF@]*LZ7]L3W=U,ORH+00D]$A+L! MA;K@UEQ((D0Q(]/)!%'*R-C*$.6,C*T"4)8^>YJL8Y]!-4--2@U6L_4E['6,_7EK&.,%XA*1)5&E!=4#_J: M%?64LJM-`=/`Q=;9I#1&BT>R-<@4A)'L9.7T5HRYQ)_J[XT9MCP@&MF,2A+- MCRQOS:531-K233$]O^$_J&,$R`Z)1HPUMXJP8 M,?L?&2-N"A%%C*8%G.Z"T0U\>1*+6<6LWPFB%%'&B&WCG>Z<58SM`E&)J-)( M7QNPX/*RDO`P/6KK%;N.% M\%#JSC5@0LXUP&GV48FIH+4*A(@BC?0UP'.O/,9"":(44?:BZ1P+%8A*1!6; M%@OJSKDG46/!!E&+J--(I8',>KUS;B/T6'!`-&JT?7G94*D\>Q?Z0EQ,F3^Q M;$R(:N1P/RX!A8@BC<2Z#P43+)@BRM!6CEH%HA)1Q;;L=1_:U6#!%E&GD>-3 M9]+T6'!`-&I$/J6!EI/;S0^^^O&1):8*&8G+P-K-T!LM]GJ(*&*DE^K5?A4X M\1RSBEFJ$T0IHHR1MNUY-"5G%6.[0%0BJC02CPXL<*;KP3/F&[35(NJ,>;4% MIK>BY:6QQR(#HI&M\-J_LYX$P)0#'=-1(GC[5SBCDN9RT3 M'H`BK<6/3-$##/#,&AI*$*6(,FG;\R!.CH4*1"6B2B-G4L-U`/K;H*T646?, MZ^AP!K?',@.B4:-YY[C;F65'AH=*ZOU<>$SI0!$>&LG5PSED'Y>SE@D/0!%K M33-\L]I>.79BUC`S,$&4(LH83:8]CQWEK&%,%XA*1)5&+ZT=T-T&;;6(.F/^ MKZ(#+`]H9F0S>O&@!R%-E,GH($]B=%`=KW\X1;W@YVXF-9*KB+.3/G)!TX%U(Z!OF^B5 M@Q\#>OTRCYI2;36GJI M6?B>X\O1>(&H1%1I9+6]1JT&48NH0UL]:@V(1B[H60W<[*3K?UX.GD\_T`.\ M[O5!(U7U'`#!RMDH'HV6"8#)%A5D%*%6C"A!E"+*$.6("D0EH@I1C:A!U"+J M$/6(!D2C0')RGY=;I.,>.'%".W+)[,3%SKD.'W5!TF*/A8@B1#&B!%&**$.4 M(RH0E8@J1#6B!E&+J$/4(QH0C0)))ZH4EWT*?&$F3ADQ^^BWFI`UH8Z(0D01 MHAA1@BA%E"'*$16(2D05HAI1@ZA%U"'J$0V(1H&DQVC7W,#E]OGV8M,^T`12M`,:($48HH0Y0C*A"5B"I$-:(&48NH0]0C&A"-`DDG MJBS1&=-.)Y7,)O5Z-2%Q`5SLX`(X:QDG`HJ,+=:*$26(4D09HAQ1@:A$5"&J M$36(6D0=HA[1@&@42#I1I5S.<*+.T-A.G)!8.P&%*T`1HAA1@BA%E"'*$16( M2D05HAI1@ZA%U"'J$0V(1H&DQU1>Y0R/Z32,[3&-I@3:XBHPV56];,X*/)=" M>J7JM`33GWF]Q90$:^D;&\'.\PD!UCGE.V3/W$3,"]=QS+BL--(/Z%RYMVR. M1L'T;"[#*-):M.-0&:A@$7@2<\*2Z`:]BR@=Y!X87O7DX\F*O.8QFOWFY.V/ M1H&[$FJT-=FEB-&4VCGUSQD0# MHE$@Z=_S3H=K/!UJ9/GBB"A$%"&*$26(4D09HAQ1@:A$5"&J$36(6D0=HA[1 M@&@42'I,G<=>O\.AK"0LJQ-RIIUYQGC:YNB"EE]#1!&B&%&"*$64(H1#8A&@:03U1'M#"=.)SH[*:->V:?+I>6>(Z(0480H1I0@ M2A%EB')$!:(2486H1M0@:A%UB'I$`Z)1(.DQ=40[PV/3B4YX;$).4L:]IZ5N M+9%?2H1#8A&@:03U9'T#"?J$ZSMQ`F)M1-02)]Z`P3,.I9QVDS8M)' MB[W[$(;1,M-N+L@H0JT848(H190ARA$5B$I$%:(:48.H1=0AZA$-B$:!I!/_ MM@2,^N*`DV#3R%E6W82WT6)GAH@B1#&B!%&**$.4(RH0E8@J1#6B!E&+J$/4 M(QH0C0))_YZ7@*'WS<&)$Q++*J!0%[2T(D0QH@11BBA#E",J$)6(*D0UH@91 MBZA#U",:$(T"28^Y"9B?3HEN,#>CD3,CW4R_T3(SW<#*((48PH090BRA#EB`I$):(*48VH0=0BZA#UB`9$HT#2B>?E9C:8F]'( M63O=!V:,%B^4(:((48PH090BRA#EB`I$):(*48VH0=0BZA#UB`9$HT#2B2IG M*H<^ M_P9.U!D9\\KE46OM#`H118AB1`FB%%&&*$=4("H158AJ1`VB%E&'J$F':8@:'/UIPVH.9UWZ-&]$ZLF6.3 MEOI4Q[SI6;KOIT=M9\9;38?,WH M9%X._'E9DRUF332B=TVYNJ-&8N"G@L[`.W<"(RYH#[PN:$8F82V#4D9R9)R, M>&:TN*DY(V.K0%0RDN:=/$-EM-A\S<@S\.7(/-SUF9$8F090RDN:=Q&=FM-A\SLB8+Q"5C*1Y)S=0&2TV7S/R#+R; ML/BI)]GIV7/PQX2$/R8D_*'1]-E*?$\ATI;I.0M5S"K4[ME=\#G@!*M+ M34&N+F/$U:TNEX[?2D!]:"PZ['Y9&\"A+X^ M)+\R>-0%[0,FH@A1C"A!E"+*$.6("D0EH@I1C:A!U"+J$/6(!D2C0-*)YZ4$ M5%;<=2*F!+26\!AH1:@5(TH0I8@R1#FB`E&)J$)4(VH0M8@Z1#VB`=$HD/08 M[2C.2.)0.A0\-B%*]O&%XZBU+!0:9$].9XV/C!;;B@62371V`2[/Y]\ MW,U:IG.`(JW%[VFO=BLGSQ`+.[(G[M'JYP(/3UR[^2QEG+`,G'/XT6B9#DX% MZ33(*-):=-=$[12WVPWT;ZZ,RHC^[2FDA:=^JG\G*_(4P\AV(+RH;92X+Z%& MZH`U1S4&I];2+VJOZ=O[SAX[%J9EE]U=OMOEUWVI:X^[?XUH&>/N'!&%B")$ M,:($48HH0Y0C*A"5B"I$-:(&48NH0]0C&A"-`DE/GK?SW^/.7R-US9RC;1FX M>0^CQ7X-$46(8D0)HA11ABA'5"`J$56(:D0-HA91AZA'-"`:!9).=`\#:CHN M?N;%^CV>$S2B_:3M7R=)<#1:QK_S`8-1A%HQH@11BBA#E",J$)6(*D0UH@91 MBZA#U",:$(T"2?^J_?OK]P+[:;MO[P4T$LOJI&6A$+4B1#&B!%&**$.4(RH0 ME8@J1#6B!E&+J$/4(QH0C0))CZE=_AD>FPX%PF,3$M-NL7=22L?]K,5S+$04 M(8H1)8A21!FB'%&!J$14(:H1-8A:1!VB'M&`:!1(.M$],3V?R]SCT4@CZRQ^ M1!0BBA#%B!)$*:(,48ZH0%0BJA#5B!I$+:(.48]H0#0*)#UVWHEPCR="C:RD MY1%1J)%SX]C9/T=&BR=G+&S)IJM#UQDKACZC66\B[R3MPX81;S&H!)A." M*_?`]E*G\&0VV:".TB7'ZI03.4=+S>J4-F=.==2IB=''R)7;@G5PN:8?F)C_ M<1+1U+O9AJG>OLGF>/&\;F0DOPITH2\WJL#9G91A83]^,"BZ73CJ/ MNCB7>E47W5W_2S[%O7UPI??HYGXG.1`8124PPPL-* M#ZL\K/:PQL-:#^L\K/>PP<-&R9Q(/6]S'USA[IZ9V"PN%\X4(L].1:WM"'D6 M&'D6&'D6&'D6&'D6&'D6&'D6&'D6&'D6&'D6&'D6&'D6&'D6&'D6&'D6&'D6 M&'G69HYGU>;^'VCZ5F=FCVJJ>T\=I:RO[J!D%N=FZP:V@X&I6L_H(C,)O8OINT&*S MX&^^>B\63&V7&6(5. M`Q"Q@=K&/M?SU]T=HA^$)CNNAR=F;6&.K&>QT,,B#R,'@KW$PU(/RSPL][#" MPTH/JSRL]K#&PUH/ZSRL][#!PT;)IOG[]O'+[>U3>/-T\^'=M]N'WVZ/MU^_ M/K[Y>/_'=UI4`OIVD,7?/-Q^?G]Q3=?5P^GB2D$REV%9L"`9.<`CVR\/*A_N MDZQ(P#:OGIQX?? M76O;*^K/Z1`($FH!+8`>:UMJP72-AS+44WH1RE-F0V7H`.R34!GZLHU/0J-# M7U#Q2DUEZ)N=GC)K*D,?@O1):*SIZX(^ M"8TU?<7.(]G06-.GT7P2&FN:1A[)BMI&/RWADU#;Z"<,/)(UC35]C-LGH;&F MSSC[)#36]+E@GX3&FKY!ZY$LR-K":VU!UJ8?FW/'>D5MH]^*\EA;D37:6/@D M9(U^Z,8GH;;1KZ?X)"3P<=49'U=AX^,TR-XQ)O=[O;^@_BV\_:-]^H&619\U MVF1N#O0OGXPVFYO#:>./O2395LE\Y=2YX$#_\LE^"0Z_^-M(ZYYO%%2G?)Q< MYO/8+ZO#+W^UOF\/UY26Q;Y0MOUP]$HHZ7Y0*74L0SEMDOC\0+EADOCJH4S\ M(?9*Z+VT@WI1!.NYWJT/U_2$&DKH$;Z#>N@-)?0DWT$]I^>3D$.]9>@AOD/L ME=`K>0?U>@Q:HS?S#NHM&930"WH']?J=3[(AB:_5](H327QC3:_=D,173T@2 M]9X0UD/O*1[4ZT(HH=<5#^JM(9306XL']4ZB3[(AB:_5]-X727RMIM>02.*K MIUDN#\W2MT:T)&F]DIXDO5E?T:V\]1Y(24*2Q"M) M29)Z)07UI_#VIR1)Z954)*F\DIHDM5?2D*3Q2EJ2M%[)L%@?AH5O9EU3F6MO MF2-)CEY)2)+0*XE($GDE,4EBKR0A2>*5I"1)O9*,))E7DI,D]TH:&H/&.P8M M2;J%;YZVBPU)?*M8N]B2Q#=/V\6.)+ZQ[JF>WBLI2%)X)25)*F_;2FI;Y6U; M26VKO&TKJ6V5MYZ:ZJF]DH0DB5>2DB3SMBVEMF7>MJ74MLS;MI3:EGGKR:F> MW"M)]X?,MV^@S/B!,N&>533?'R@=[A%<4R77WDJ.)#EZ)2%)(N\`A#0`D7<` M0AJ`R#L`(0U`Y*TGIGIBK^1ZK[:IGNX<]VJ/ZA&$:J_EXS1DM#OU2.*]VIIZ M!,G^0+&ULK)C;CJ,X$(;O5]IW0-Q/.(<$)1EU#IRT*ZU6 ML[O7-'$2U"&.@.[TO/V4L4U\8*)N[=P,DZ_+OUV_RU"P^/I>GXTWU+05OBQ- M9V*;!KJ4>%]=CDOSGV_QEYEIM%UQV1=G?$%+\SMJS:^KWW];W'#STIX0Z@Q0 MN+1+\]1UU\BRVO*$ZJ*=X"NZP%\.N*F+#GXV1ZN]-JC8]X/JL^7:]M2JB^IB M4H6H^8@&/ARJ$FUQ^5JC2T=%&G0N.EA_>ZJN+5>KRX_(U47S\GK]4N+Z"A+/ MU;GJOO>BIE&747:\X*9X/D/>[XY?E%R[_Z')UU79X!8?N@G(672A>LYS:VZ! MTFJQKR`#8KO1H,/2?'*BW/%,:[7H#?JW0K=6^+_1GO`M::K]']4%@=NP3V0' MGC%^(:'9GB`8;&FCXWX'_FJ,/3H4K^?N;WQ+474\=;#=`61$$HOVW[>H+<%1 MD)FX`5$J\1D6`/\:=45*`QPIWOOKK=IWIZ7I32=!:'L.A!O/J.WBBDB:1OG: M=KC^CP8Y3(J*N$P$KES$F\R"P)_.PH^K^$P%KDP%]![,"LK]TN'*XJ>3T+'G M'IGSP3@H_7X<7#\TSYS%PW68QYT%3C`E%ND36=3B?L>V15>L%@V^&7`,P,3V M6I!#Y40.[#3?*RHQ[-[/-@]VC:@\$9FE":N'?6FAXMY6ONTMK#>HDI+%K/48 M1X[8\`A2$D1VJX*="F(5)"I(59"I(!>`!;8,WL!6_PIOB`SQAF>UYN!NEJL8 MP2/XD*T*=BJ(59"H(%5!IH)<`)(1WH@1'A3+^('F-4%&+4TX.4--N/9<3G1- M8SRI<.20S1`RF*&1G49BC20:2362:207B>0)Y/4KBH/(P-D37?)M7[9@38,> MNC2$#"YI9*>16".)1E*-9!K)12*Y!#S-X$FM*?#BA]R)RU-O& M$,2';36RTTBLD40CJ48RC>0BD7*??BIW$BWG3HG?/VO[V^%&(UN-[#02:R31 M2*J13".Y2*1$PT\E2J+E1"D1$Z7$FP_WS"TC8/90"$Z@G)/=$,0+(=:$$DJ$ MR5(6`S4\2+N.\O#*AB`NG8M"DAUP,_M$S9-HV0Y*A!5N*!'M8$2TPW64I\AN M".)KCC6AA!)ALI3%R'8H3F=#$)?.12')#FA1/F$'B9;MH$18X882T0Y&:#-) M.H>=1F)M5$*)H)RR&#GW0+X;9T/0D+LH).5..JI/)-^'R]ES!-4F5.=47M*& M1;%NFK9.9.JEZ<*^#`.=4-G''1OHNWW/Y@2N9\O2,9>^]R\)7],=I1R)R]1F MRWC4G,XVG=E*R>8\(B0G7[:2=&EZISHAC75WJLJ7-88\(6CD$>/!?*Q/I;T> M/&_YYJT=AL2SY(2A;,.&1;GT)8,Z3`?Z=QMV+,JG"7KN;*H43\QUW&$!R7T! M?$TI0\']WI]QY-#N>N:ITCF7IB]G8B/KD,;N_WM'VT/).X;$;7>5'F_3SPZ5 M>#^=6X8"&/ZH.*EZ0+8/7BAF]EQSDT9`D7/K$B;MW%'*9Q./]4AQLMF"?K9I MX$R5&LBY]$AQDC;QD<'?\/5GQ0F^#-5)NTW)88J$F]0&7MW)R1;05D<['<4Z M2G24ZBC3$?E^<%\$/:CT>P!]NZQ1&.Q[]H*$I)&,%M7A^1AA$\TD?X+()GVPB?1W#?UWD> M1OD8AT\L3_T15]:S)I]>1G36;@1O7[K^&A+KO]0H.D]^]`1;,#(@C-9C"]J$ M$3PW]?AM&$';-,)G$?0/(WP>P;-5YW$8P1,6N#6L%#[I7(LC^K-HCM6E-<[H M`&5@]S?LAGX4HC\Z=C:><0X_8$[LH'C#O^@TPP?`Y<_0`` M`/__`P!02P,$%``&``@````A`#>"I]%J!0``$!0``!D```!X;"]W;W)K&ULK)C;CJI(%(;O)YEW(-QO$02QB;K3J)PRDTPF>V:N M:2R5M%@&Z+;[[6<5=;`.[AU-^J9I/U;]5>NO157!_/M'<[3>4=O5^+2PW='8 MMM"IPMOZM%_8__Q(OLULJ^O+T[8\XA-:V)^HL[\O?_]M?L'M:W=`J+=`X=0M M[$/?GR/'Z:H#:LINA,_H!'=VN&W*'GZV>Z<[MZC<#HV:H^.-QU.G*>N3316B M]AX-O-O5%5KCZJU!IYZ*M.A8]C#^[E"?.Z[65/?(-67[^G;^5N'F#!(O];'N M/P=1VVJJ*-^?<%N^'"'O#]5\ M6T,&Q':K1;N%_>Q&A>O9SG(^&/1OC2Z=]+_5'?`E;>OM'_4)@=LP3V0&7C!^ M):'YEB!H[!BMDV$&_FJM+=J5;\?^;WS)4+T_]##=`61$$HNVGVO45>`HR(R\ M@"A5^`@#@+]64Y/2`$?*C^%ZJ;?]86%/@M$L"/SI+`29%]3U24TT;:MZZWK< M_$>C7*9%53RF`E>NXC^NXC,5N#(5T+MS!##6(0^XLK90X7>VG;*V<&5MW5$0 MCB>)71DA!U][.R@WHC*L]$9F!0'3PK M[TM_',R==ZCOBL7$9HRK1JQX!"EF(KO6P48'B0Y2'60ZR'502,`!6X0W4*-? MX0V1(=[PK&(.KF9YFA$\@C=9ZV"C@T0'J0XR'>0Z*"2@&#'Y&B.(S,*&-4`4 MB>?.U,QC&C-1*DD-68D0X8Y!-@9)#)(:)#-(;I!")HI)D-=75`N1@8=1=@G6 M"=6"F`;]TB41(EPRR,8@B4%2@V0&R0U2R$1Q"=9=Q:7;NQE?5DCT8`9/(J;$ MAT?V6D3>6+5G)8)XL[5!-@9)#)(:)#-(;I!")DKNL`L]D#N)5G.GQ!^.#O,^/IFR<-8F?BX1C!"`Q+-'-#W2$:Y'N#@^YL/'6U`TPB9'BB*27N M=6_/&)%':'25LZ`GVE48!I-0G:Y"R$!7BH/DC*982`]L(W*D[P]U]1ICR!&6 MQQL+ZP3Z8\[GG'YZT*8KB$_9P//W89DLM\I0S) M=\/?/Y9(8,KHI+IF57QEZ+@ MFN`*WM-)O4MH;:*-B1(3I2;*3)2;B'PLN`Z">D%?_ND+68/:/5JAX[&S*OQ& M7NQA/I9S@>E7AW@:P;X+9NK<]?CG".U.%D:P69DMLED$2[?)BS""!=SD\+WC M>?CG'Y#O(C?@8!G0S?A+!(?J&OA\]@T7FC=B/X#QY@P<1G+5N\#"*;R6P M"B/8.,WX=1C!0>$>6P;9H\"2/8/$V>AA%LH<`=X1!\CSF7>_1GV>[K4V<= MT0ZF=3PL(2W]HD-_]*S67W`/'V*&LC_`ES<$[\#C$:SL.XQ[_H-T(+[E+?\' M``#__P,`4$L#!!0`!@`(````(0"-(BTSV08``'<:```9````>&PO=V]R:W-H M965T-XFY!((F64T(5[5256W; M9X:0"9H0(F!F=K]]C_$%7]CMI-J7S>:7XX/]]]_FV//P^6MS,=ZJKJ_;Z]9$ MBY5I5->R/=;7YZWYUY?XDV\:_5!AENP7/;EN6J*?M'>JBO\\[&]=51S'1LUE::U6ZV53 MU%>39`BZC^1H3Z>ZK`YM^=I4UX$DZ:I+,4#_^W-]ZUFVIOQ(NJ;H7EYOG\JV MN4&*I_I2#]_&I*;1E$'V?&V[XND"X_Z*G*)DN<-Q!O[HC&-U*EXOPY_M>UK5S^&! M!<=OAZHO05%(L[!XQBE-HWSMA[;YAP0AFHHDL6@2^&1)G`\WALBQ!_!)&T.:#SX8NCBVA4_: MUELXENOY]_0>EL*8!#YI$K3P7==9^][')=C0)/!)DWQ8QB69DG&&#\50[!ZZ M]MV`90.B][<"+T(4('`&FULR$WRVOS?9,,LXRR-.LS5A=#"//3CT;>>LO(?E M&[BJI#%[/0;)$2&+P!;":0\JB%00JR!10:J"3`6Y`)8@"]<&//(SM,%IL#9L M5'L&)K$L10@6P9H<5!"I(%9!HH)4!9D*<@%(0M@S0MA@EOD-@'D"M]J:L.2X M)RQK(P]T3V)LR3AR2,A#N!@:B302:R312*J13".Y2"1-8%P_PQPX#:P]425G MYA2##6)/B`,K M=#*1K6X;/(@U.V@DTDBLD40CJ48RC>0BD<:^OFOL.%H>.R'.^&X>M\-0(P>- M1!J)-9)H)-5(II%<)-)`O;L&BJ/E@1(B#I00>\/WS`,E(#8W`G(=>9U$/(@9 M(=82)80(#TMI#'B8I[:0+:?.>!!+G8N))#E@,[O#\SA:EH,0H8B=,:#6.I<3"3)`=6*)`>I,!:X[AG.=?FR M;T%V6.`S6X,-E02I+W`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`/9U&\1Y'L/670(2)1DO<(M;&]7].!`N==[0%SJ.8MP^@`)XPH>:,=!3K M*-%1JJ-,1_B^>'HBJ2W(_2^Y'6RJ[KD*J\NE-\KV%=_M6K@NXIA?/#^.ZT/A M>WPAC5>NRJT`[IAFN!W`18O.'YW@$3JJ_[!W`KASF.%N`.?Q&;X.X/@ZPY'/ MKLZ5KB9>``B&;X)LKD\N1?D&ULK)U9AY'[AT3BR`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`]0?W#9!V] ML7_9&0;6&X;#-^9E?Q@X=GU;C8=L5O4/;NSBW6QPNQC-@KYTH\?X:1TL:3A7;'?OKXJ]F#1KS2\DFI^7!-+:*)X9FF MO']^'-\NWM_\DZ:I>R.S1)F!E(A90DTD2FWB@]0'F0]R'Q0^*'U0^:#V0>.# MU@.#U@:C&E,]X-U.)Y[([$7XFP)D!1(!B0'4@`I@51`:B`-D!;("L@:R`;(%L@. MR!Y(YQ)A+UJ]76`O)2WMI0G9BTT1`TF`I$`R(#F0`D@)I`)2`VF`M$!60-9` M-D"V0'9`]D`ZEPCCT/KX`N,H:6D<35SC:#):].9*#"$'Z0?<8.8]'=->B*V< M@:)<$Z>PPLC07-&K'HZ]!6[9"['JRE4DNH,>SA=TAY*6W:&)4\-8$[<[#)F< MEN/#V\%83CUIG\[5S4!'KHE33F%DQJQU)+66?3IKK5P=HA,H[A&=H&*/X51M M2KRR"E(997\80OUM[3/Q3!]K(5+/54L,H1KVV08SOY^TT'BH6SQ>S!=S3W/6 MZV'-N28#NY8N#'&K"&651FBARYH,YK>W7EE5KX?*$MVI8OQ?Z\]33MFA!JF0 ML.^:X<1;D,0LI?=^=,BF:D%V'/:]G!JIB6G5<`*-REB1S94;1&LI[M2"I>P4 M71HT'ND>"^BN1"[98RJ>\J/?-WF@VA[Q7)"1:^#AQ(^7C)3KA(RLKZ0&&9\; M#.:3T52.LPQSY0:Y3L=HUG=BR4A;8SZ;W4ZDZHHE3IEDAZEHQNVP\VLBM7?D M]Y)&GE]YDTAL,@Y=OS(9K8>D1LKXU8"VF;VQDK$>FRGG.KENU=>)/:TT4L:M M`JHK5JWW8MU@7&U[B4YZ\[QVRNF-0QUXJ/TE9QQZ4U1L,@JOTAF'KE=IQ%Y% MW34#KX)<.5?**BH8N5YEZFF\:C`>@%<9B8!7J26XZU5O[S"]>*>PB2VW5"&4 MFG_DQ.55)F8IU\%,1NLKJ9$R#K88#(8S.50RUF,SY0:)>:NO$U>S-%+&P::+ MR)JUD:J2D-U7X<#'SWK5A7P,?4RA3Z3#7ZV\/][\LC*:4I M/3"=J0>+V>/4BUO1>1IYSN8U.E;[RLHE76?3:&P;G1JIL1Y!H_%PYCT[,M;C M.INIDSN;:31Q'Y(&N38.=)Z6HL90K\MIGS**S@OT$[E&WU%*W)O&#')K,)SX MP;!R0M51MC4)([>CM!1[V6`P72P\31EFRPT23\>^5M;/##)KE<5H-%W`R'2S MR8Y2:UW?RP:3=VI3_@)'TRMFX6@:>8[F!2`QM0T<32/A:!I-R-S]4!I.X=%I M=+D#;CCTYM'F?C>ZI&$[?#8(&?FHP3LUZ=C@:W`W!>H]SZ?&ZR">]4**_D\DP4.)[/`_ZL-=$`\0>^\K>SO=P=?_[5Q.E,""AY) MXYZ?U4_BGA%U%#2G/[T+#J?^XM1D)"EKQ#XCHQ2E,D0YH@)1B:A"5"-J$+6( M5HC6B#:(MHAVB/:(.H&D$57LXLZ#KQA1B7M&U&ALS1-3\*ZD')0@2A%EB')$ M!:(2486H1M0@:A&M$*T1;1!M$>T0[1%U`DF+J3CH`HN9L,EY1`TUFMEU8(PH M843"SN#T'N"IE>*1F#&RZG-$!2.IWEOZEE:*U5>,K/H:4<-(JI?11&N%6/N* MD=6^1K1A)+3[$=C62K'Z'2.K?H^H,V@JU=NNE_Z@@L,+_$''DN[B<*B1\`=` M"4N)2DV]0"^U4MSFC)%MTN;TDJQ^HJ155\C:AA)]=X"N+52K'[% MR*I?(]HP$NK]`&QKI5C]CI%5OT?4&>0YA.U[Z1`J^KW`(4RP[$X0&@F'`)30 M`DW-\K-1_UQ.$66,;`-S1`4CJZM$5#&RNFI$#2-I"R\^::T4VV+%R*I?(]HP MDNJ]E>?62K'Z'2.K?H^H,XA,31FE755\[=I5G[6Z,#@;*F*ZT&@D)D!XM4?[NNKI0%)<]011:A#M;ZGNI_TA?`># MN7)$!:+R==T5YJH1-8A:UCT-NTW?=M<@X#:]%/?0!DO:RI)"/@)J]JBF,VA* M\Y3C(W;](WU$;>A=@C1RK!\/`26(4H/((;A3,I3*$16(2M15H52- MJ$'4LJYI7Z\52JT1;1!M4=<.I?:(.H.FLY/7C0R_N*?6XBM%%LK090RTA,XO06C42XCL8Q%[/R=(RH0E8Q8-[[IKEC$ZJX1 M-8A:@\RSP1N^*YO!Z2%X-E@I[J$-HJTLZ?:=MYK<898]HHZUS-D]G$UYZ1Z7 M[=R-]&Z;^PPPR'L&>-6.K10W/D&4&F2>`8%WY1EFRA$5B,I755>8J4;4(&I9 MM9A0Y]X[B15F7"/:(-H:I`(_9_QYKQ%VF'&/J#-H]OJT<=EFX`@W`PURYWU$ M":+4('?>1ZD<48&H1%T52M6(&D0MZW+F?91:(]H@VAKDV=0;-#O,N$?4&40V MI:$E!S>MR\3<_^;3$&HT>YN[C,1C8.+OT%LI.\Z-+COIIBQEINKQ8CSP_#EC M$9LK1U0@*AD9W8&C*16+6-TUH@91:Y`X.C#$D0X-7J.N#:*M5:^6P/1-I7PT M[C#+'E''6GCNGSLGQZ1[J)T]=VWW=O?0>X+B,6"0B#PF7A03CWHIZQZ`4B/% M1Z;H``.<64-%.:("42EU!P[B5)BI1M0@:@WR!C4\!Z"]:]2U0;2UZHUW>)V[ MPSQ[1)U!_Q@D9P\OR(Y'O91U#T`I2^D1/AW/ M;CT]&4O8`9XC*A"5C+3JP+&CBB6LZAI1@Z@UZ+6Y`YJ[1ET;1%NK_J^\`S3O M44W':LSD00TD6%B MT-2>X4\-F@Q.:V!U_!E"C;XT=K<<51>HNI2J`P>L*M13(VH0M0:]-HE`S=>H M:X-H:]5K-QE9\^I])LRS1]09Q)/(<+:P>J2;A'8S+S[&-,*=349R0K$[7:?6 MQ%:*+9P8-'./B\!^7&JD)GHW:C2<3>C8 M686::D0-HM8@FF>XO!5*K1%M$&U1UPZE]H@ZSG@:H=(AR&`P;ZB?`S`S!Q\# MNF`:41J]+0N#Y#1BM[B,<_12W%.)^B!2Z;(S2VH0#4B6RE`J1U08Y$Q)I4$3 M-4WRU^UP7JZRNAPIY_3:J?:UE>)Z-8A:@YS:KU!JC6B#:(NZ=BBU1]091#N. M5%7I#?[VXB^]R*)/E<`##")[.CWM+:ACSF@?Y@FBU"!G1&4HE2,J##H_U91& MRDPU='(-S_%5J+Q&U"!J#7+JOD*I-:(-HBWJVJ'4'E''&7$V4(?V<#9P3KGR M='#^U<1)C9P"#**#1]8!!F-OH1A;*1Y$":(4488H1U0@*A%5B&I$#:(6T0K1 M&M$&T1;1#M$>42>0&-RJ[\&XPXF:ZB_]I!VW'4_*Z1A,,Y M/$5[*;988C,R2A%EB')$!:(2486H1M0@:A&M$*T1;1!M$>T0[1%U`DDCTO"\ MQ(A*W%L*:21F64#)&%"**$.4(RH0E8@J1#6B!E&+:(5HC6B#:(MHAVB/J!-( M6DQMSEPP[,Q>CCOL#-*[NXUZ`AU=BD1VJN*_!4N;MR&`>^`D" MECE%1;)E_F[.*Q,*;MN,#3*G?&[]]SZQ%;`MZ_,P2HT437UJ&VLP'`1V]X0F MV0P5Y;L&^J6HDSZ$@Y%F4&\W;_,_YCQ.P&G0S**4D=X?.K7-W[H4BF3C_I:0 MFKX=A<891/-$_RQ8P/.\%V);)4;5C%+Z?`''U!GI9::R*/TB2L@Q7>6BT?2) MX'F+OBV./*F1DZ=!X@F(<:25ZIN-*$64(J#VA?"T"LC#5NGXU1BE(9HAQ1@:A$5"&J$36(6D0K1&M$&T1;1#M$ M>T2=0-*X?U.\2=\XFZ>1:V[OV;,T4F?C32O#MDT0I8@R1#FB`E&)J$)4(VH0 MM8A6B-:(-HBVB':(]H@Z@:2Y51SHKJM>&<,Z;'3?_T[Z2-(UM'VWJ%>_5LH: ML<_(*$6I#%&.J$!4(JH0U8@:1"VB%:(UH@VB+:(=HCVB3B!I1!4'7F!$'38* M(VKDQIOT,K/H:4MGQEX7#ZK6OW_$:B8[72'2\0;+J7FR9 M&O5T@H>KGC&R/9,C*AA)]=Z60VFE6'W%R*JO$36,I'IO3F^M%*M?,0ITO!_` MO_*@P4A]HI'H>(U$QQLDJ^Z]14Z-+M'QH"MG*=M9!2.IWEO6E%:*>Z9B9'75 MB!I&4KVW>=M:*5:_8A3H>!6!NP^'7]HYH5]!@X&@D;"'1L(>!NEOK7!?+#6: MZ7@2-R9C9/LJ1U0P^BO-I15@S14CJ[E&U##J-7OV;:T`:UXQ0@-,_8V.\YY_ M$I<;&HQH3G%FL87>,W!72B<-9!XY0OUS2E:*'20Q MB'Z1AU'*2/^<+OWT0[1%U`DESTY-,K`]? M&:!*W%N>:"3>M]`):?DE5#SMI:P1`:4HE2'*$16(2D05HAI1@ZA%M$*T1K1! MM$6T0[1'U`DDC7C9?H+Z(0'?B!HYVSVQD7)0@BA%E"'*$16(2D05HAI1@ZA% MM$*T1K1!M$6T0[1'U`DD+:8V"-RP[)5AI_<3Q&I&(_>'?^CC#F57!R46V5F8 M[G*4@S.U4CPX,X%DU56D[%;]ER+*J8ZW18LT(4H/X&,AX/O;T M9"*3;(D?O?V2X]$W//[DQTA:SUNJQ%;*-E#K3K?*^=`3$9S#F02^!4@H5J:U`\/ M_":_[10(_8P=V%2CN=U;C8V4@Q)$*:(,48ZH0%0BJA#5B!I$+:(5HC6B#:(M MHAVB/:).(&G)4-CP^I$/^D4Z93DR5C^UT$_CR,?3DH7<\>GMR<56QKJOT6VG MVQ2E,D0YH@)1B:A"5"-J$+6(5HC6B#:(MHAVB/:(.H&D<=5*W9^97C_R03$ MHHQ+9G",ZSVYED;H;`1H9:QQM6[*QBA%J0Q1CJA`5"*J$-6(&D0MHA6B-:(- MHBVB':(]HDX@:5P_>-!S\,4!_ZR/*EQS>^-T::3.FUMKY&.*+$(/6K(/U#%X]\6"F>3C.A2U1=A=H7.-M)7$:0!KE5 M1Y08)*L^\-YUI%:JK[K0):O^MX2,ZHX+SQ@&B19I*0;I^.R`>NX=1Y MW+??0K-LC!\?GA_TZD-;O]8&N0OID7]/5\P9[=(J090:I-X&64<;>JN[3&24 MK?%#OU=:@R'>W"#IZIZ_Q%:*_25!E!I$O[J@+#68#-Y-U)6"_#]O-SNS&FSC MW?>RLJ5^:/1*2W78XFXOS0T2=H,WEU;*MK3/R"@U4F2W4TO?C;S-P,RJ>4O; MU#+\[0\BBKW!)S5RADULI!R4($H198AR1`6B$E&%J$;4(&H1K1"M$6T0;1'M M$.T1=0));_R;EOOSX'+?VS1;&JFSRWTKPTZ:($H198AR1`6B$E&%J$;4(&H1 MK1"M$6T0;1'M$.T1=0)) M/3&BQ"+[L,;W>U:*=64"B:HO_.6^OR?_I@M33UID%&"0VR)$B4%J36_7E?!^ MSTKU+1*Z9(O\*.#\`FR!RWU&-&2<2GE[6[&5XDHE%MF,^'Z/I:.&_K,B$&MD^/P[XM?9A>+`PR#4@ MO-^S0MR6Q"`5^?=>'7!.K=V\WYL&WN$U;+):G'O/KC\)K_M_=Y"QPCN`\T@ M]X&&*$&4(LH0Y8@*1"6B"E&-J$'4(EHA6B/:(-HBVB':(^H$TI:\>?YV.+PD M=R]W']\_'IZ^'N+#]^_/5_?'/WZ0TPQ.5U;W_.KI\.7#]:?Y-/I$JLC1O!2* M!R*U6`VES"CE=`X5\LPIY30$_93%)%)5#FB;40J]\L"43S.J&T5'F$*O)BA/ ML&XSJAMMQH;R4-WT].#7;4XU");S:3J./M&+U(`V2E%']4(II(W.?X52J-9T MSBB0,AM1W8+ES*@<>ML7R#,91.K3[U#*D%).BQ&OI9\FH^@3G2<-Y:$:T,>G MH12J`7W1&$JAEM*7H[P:KT<4WOH=[Q*$^P/6-J#_TB4"@/M8?>@P=2)E3KORB'L@1S4(805RX0XD,J M07]QX+=^2/U"%\L&:C6D?J$+3`,I\T6TI$46IM#"-(J#*;0^C5)::F(>6N=% M:3`/+4VC+)CR:1!]"M:,&A-N"S4E4/:2S!BRXB<:F$&76,ZHZ;0QB\V(*24. MIM!.?)32HQ7ST$8W=4JH(VG#F%)"Y=#V?)0%4^AKQTA]?H3E+*>S:$D'X3`E MIA1UM@Y3Z,!@I(X#AE+FE!+*0V<%HRR80A]Z1NJC*]1&WWM&ZMLK3*'//B/U M46,V2@F50S?01.K&$BR'+J*)U,4EF$(WS43J M9A),H0MG(G5!":;0O3,T1D(I2VKI,E@W^@(YBH,I]"$R]76H=Y()^5NP=Q+J M'?6A)M:-;@:*U#TQF$(W`D7JNAA,H8N!(G5K#*;0_4"1NCP&4^B:H$C=(8,I M=#50M`JFT)5OD;HC#//L*$5=%88I=.5;I&X,PY0EE;,,ED/7,T5Q,(5N:8K4 M)3VHC2YKBM1=/9A"ES1%63"%[FJ*U,T]F(>N;(K4!3Z80M?P1>IF-DRAV_@B M=4$;IM"E?)&ZIPU35I2BKFO#E#6EJ%O;,(7NXHO4Y6V80C9;! M/#&EJ!OP4!O=BABIB_`PA2Y'C-1]>)B248JZ%@]3Z&K$2-V.ARET0V*D+LG# M%+HH,5)WY6$*W8\8J2OS,(4NQ:9^"_4!W8U-WAMZ--(ER9026I30G;J4$EJ6 MT(VLE!(JAZ[2IK$02J'KP,EW0BET*SAY2*AN=#\TI83J1M<)4TJH;G3S+*6$ MRJ%;Q,G?0BET$SK9)Y1"%Z*3%4)UHZNQ*254-[HVF5)"=:,;=BDE5`[=GTXV M#:44])`)/F/(/4)S:#6+JA!?4@G+8`ETS3R-@E#9=-L\^7JH]73O.*6$6D\7 M4%-*J/5T5S&EA,JAR^EIY(12EK30";4FIF5.B"?TT`GU5D*#-B2?T0(GQ/-9 ME)_X3;^^?O[X_N?=UT-[]_3UX7X_&%_X.&\,V?QZ??3Y'XQ_\3````__\# M`%!+`P04``8`"````"$``S$0FJPHI$I7=9NT2=.TCV?'&+`* M&-E.T_[WN\,)@R9MLY<('^??Q]WE6%X_-C5YD,8JW68T"D)*9"MTKMHRH[]^ MWEU\H,0ZWN:\UJW,Z).T]'KU_MURI\V]K:1T!!!:F]'*N2YES(I*-MP&NI,M MO"FT:;B#HRF9[8SD>7^IJ5D.KI=$[`OV&;-MQG)XH!>"#)H\P MJ'Q))*A#D#6B9!0&%?@M5/9A%2?ADCU`-<0^Y\;GP.^0$PT9#-0,DD#&6-+I M\AR8,1F9L5PHY<8'QC3Q:9K9E`:=SZ"GK]/AI8PF(Q-Q\L^&5^!SH"6#T>2T M`H`YWR@F0Y.FU,]K[)/.H(:4,36:C^^\BDX,D+)9]/65\O M-29/J?:163_0XXE93''[5B["X$TW>&]*L8]`"X?FQ0I MU3YR[.9JBHMNYLG;9O#:E&$?F9IY819A\?V'FSY[2G8(C?SX3>C732--*3_* MNK9$Z"UNN1CVQ!`=-O`ZQNX^CR?IVF]F-KR!S=CQ4G[CIE2M);4L`#,,%M!T MXW>K/SC=@5#8C]K!3NP?*_@&2M@5_8046KO#`9C9\%5=_04``/__`P!02P,$ M%``&``@````A`+>(&ULK)C;;JLX%(;O1YIW0-SO<`PDJ.E60\)),])HM&?FFA(G00UQ!/2P MWWXO8YOX0*-6TYNF^;+\V^OWPBRX^_[6G(P7U'8U/J],9V:;!CI7>%>?#ROS MGQ_)MX5I='UYWI4G?$8K\R?JS._WO_]V]XK;I^Z(4&^`PKE;F<>^OT26U55' MU)3=#%_0&7[9X[8I>_C:'JSNTJ)R-PQJ3I9KVX'5E/79I`I1^Q$-O-_7%=K@ MZKE!YYZ*M.A4]K#^[EA?.J[65!^1:\KVZ?GRK<+-!20>ZU/=_QQ$3:.IHOQP MQFWY>(*\WQR_K+CV\$63;^JJQ1W>]S.0L^A"]9R7UM("I?N[70T9$-N-%NU7 MYH,3%8YO6O=W@T'_UNBU$_XWNB-^3=MZ]T=]1N`V[!/9@4>,GTAHOB,(!EO: MZ&38@;]:8X?VY?.I_QN_9J@^''O8[CED1!*+=C\WJ*O`49"9N7.B5.$3+`#^ M&DU-2@,<*=^&S]=ZUQ]7INO.%O.Y'RQ"D'E$79_41-,TJN>NQ\U_-,IA6E3% M92KPR52\8#8/;<^!23\JXC,1^.1+F3F^'1")&W/#KT,&\,F&A3?CH?*'>/AD M\8Z0\(V)EFP@?+*!P!R`"^[2TDN+B=R8,?YGM&Y MQUU\;Q-A]XC*`Y%9F9`&;$\'E?=R[]O.G?4"U5*QF+4>HT3$/(*4!I'=J&"K M@D0%J0HR%>0J*`1@@2VC-U!!7^$-D2'>\*S6'%S-B MD&0''&:?L(-$RW90(JPPID2T@Y'Y<.]U;<=7G!A_Y\M--(V4$F&>C,7(3BB' M43X&<>E"%)*<@';E$TZ0:-D)2H05QI2(3C!"&TS216PUDFBC4DH$Y8S%^-Q1 M3W8T'W\?TQ8UI+1)8_6)O(=P.7&.H,:$FE26%+,HUES3#HI,#8TT;(DP4*T. M-M!WAV07@>TJT@F7OK8Q*5_3%64$I(+7O:2 M=&MJQ^H&Y(GBG0<-?C-Q:)]'GX"&\W/-D7R*S.6=CEF42Y\SJ*U4RW7'`VG+ MHZ!!$)P.9*V$1UT'IM=%\$K*>-3UJ,\9\CUJFFTO%.E"&B1[1AH[U3-G/B-/ M5?VQKI[6&)8,*4WG[:'D'T-R=2D]7>S0**DL&0H$_Q@*AP3=I5(U M"5>YEEO*D'-%&8^ZWBERACQ[$/94X8*K3-0::?;^OV^T991\HPC*1ZR5A5PK ML<.BQ+JCR)=/9,6J+1OHT[O!(O`<94L2+BV6(5OF]>#,6)0'E2&4M#);SJ/H MX>'XGN=IES/+A+X_$)^Q2*-[T^(?^/)>:4)!C;5)9)0CDR+A2(^'R>`)Y'I9 M;72TU5&BHU1'F8YR'9$W,&2I=!'T,J5O5.AS>8/:`XK1Z=09%7XF;TM<4K@C MIJ]RUGX$/3:<%RJ?1]!_3O`@@G9M@CL@!"O2?TG#"&Z*.L_""'J?";Z(H!.8 MX,L(;I4Z+\*HF.+PDNIAJ$HU,_+R:D)G[4;PW*KKK[T(GM5T_N!'#Y,)K\-H M/;6@.(R@R]"%-F$$_>4$7T3;*2,VRP@Z$3T^"2/H1X!;8\;P4NQ2'M"?97NH MSYUQ0GLH`WLXKEOZ6HU^Z=FU\8A[>!LV7"9'>/V)H.FQ9W"V[S'N^1TK(%_"B%KJN%1;CS52D9S4,L0B+'8(BBX!F[ M$]FV9HVV())55$/\JN2MVJ/5V1BXFLJG;7N5B;H%B#6ON'XUH,2IL^1ATPA) MUQ7H?@DF--MCFX<3^)IG4BA1:!?@/!OHJ>;8BSU`6BYR#@HP[8YD14I607(; M3(BW7)@$_>%LIPY^.ZH4NZ^2Y]]YPR#;4">LP%J()W1]R-$$A[V3T_>F`C^D MD[.";BO]4^R^,;XI-91["HI06)*_WC&5048!Q@VGB)2)"@*`3Z?F>#4@(_3% M?.]XKLN4A-?N//#C:`XH:Z;T/4=(XF1;I47]USH%'90%"3L0^.Y`HID[G?M1 M`)S_`?%L0$;?'=5TN9!BY\"E`4K54KR"00+`YP6!$O1=H7-*X%)#K`JJ\+R, MXG#A/4/FLL[GUOK`9^\3]!X>D/;,P#:>&9V1&5.+H=Q:PR'-6R`#FN@2&G1. MR>0@^"B.^O`ML_6!C/<")[W'@!E@Q@M$9ZC!D/I-DJ6V3B.HP64\-3H;ZCZY MG>4PNU'\CLK9)53H/*3J+*%IO\/K,1_B8L>%TZF+_?+Q)<6#0X[.`H7K2Q;% MT_-%PXD]NA_0>4C56:(3.?$0%^5$_FR$'#PXY.@L0SFS\W("&'7C]1CO(=G> M=*HHP$X_2)69B7XX0I(Y>42#8&`:BIJ_(^JBT1%TH\*L!]M'>],94=C=1Z)B MR.''5P[#/BK2WC04=/V.H(M&!0Z)8[;.="#([C([ZVLF-^P+JRKE9&*+>RJ$ MZ=U;^QVZ,FUX;)\D*[M;O?X?V&TMW;!'*C>\44[%"L#T3>FEW8[V08L6B@K+ M26C8:N9G"6\Q#":X[T(G%T+H_0/NW_Z]:/D/``#__P,`4$L#!!0`!@`(```` M(0!32\O0F`\``)56```9````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`*(!**`:"`&B,T)\YU.*R-\ M=];<=T_F_B3MCH\MD`Z(`"*!*"`:B`%B<\(=-7?4DPN>Y$5Q&!B, MAB0#$4`D$`5$`S%`;$Z8[TYYYR?4UPO<67/?/Q]07@*(.D0"D42D$&E$!I%EB/OL%%1>]#]<"U.OQ>CT%[-Z M$U!1#:NB&I)5[-@A$H@D(H5((S*(+$,\0DY:Y1%ZHRJ\$F-A\(A5!:!N"D@@ MDH@4(HW((+(,<9^=5!KALU=6S&>/BM1?E*D?K%+J`8DI((E((=*(#"++$`^# MTT(CPN"E$PN#1RSU@#KJX8ZCF95`)!$I1!J10609XCX[#93[_.,'!*^F:%,Q MN3?N^H=W-#\]7)95,5C%CEWJ&)%`)!$I1!J10609XA%RXBF/T!L'!*^U6!B" M_.HO(/7+Y78*J$,D$$E$"I%&9!!9AKC/3C2-\-EK+.:S1_R`T)R7J1^L8IZ[ M*2"!2")2B#0B@\@RQ,/@)-6(,'@%QL(01%F>>D#=%)!`)!$I1!J10609XCX[ MO33"9R^OF,]!<>4^>T2+P93G@&CG3^O#IKC.)*:#5>PH(TICJ8#F:8LZ6M&A M]J^'-\DJ#F_96"PRLW%ZL3?G>C&@;)YM0'ED(N*1*2XLB&05IRXCRB(34+9% M':UX9(J%N4E6<7C+QN*1*57EZX?(&4K'@+)YM@&QR/B.#8],<6%*Q([^*KM; M?U-`V3S;@%AD?$<6 MF>FB2*J('?/(A(YY9#S*MJACQSPR,+Q)5BDR^5@\,D[EY9'QU[-/5RZY#]O; MKS<[VG$IL)5::NBZM;^:/?-:D04LR,=T,&B#%0N8MW+W6(;CPVP*.]E@%3V2 M.)8*B`4L=*23639\<6'$Q+%6PV'1LK%XP"CX+&"5P-!-FR$RSKPX_`243ZII MBDFU,V]%0T6?NXC2E7$1T,6ROX50G-=EZI"YORI6@BI8T;DH;DE'E")B`EK. M:ENRJ4-]2SR$5%MC0NC,BQ!ZY`Z%0UZ;IKS@X>Z=44]G^&A"ORG*1,/-6-+<4TH!2^8A@%:IR>KHJ=F@9AR'!-40@]ZT_JJA@ MQ0ISF&7`W- MO/=HOARRU,X&Y.X)_U*DNDO-><92Q;.I-J52=E-=U,_EV43[;KRF`\HGFE`_ MT:)HNM2<3S0I(3Y1)]S*F#87[@F-FN[(Y^HE7Q[4QB,VUP'U/M(U77FR"08RE7;\-5MFEJ`Z10"01*40:D4%D&>(^.QDU MPF>ONIC/'O'K$//RA-T,5O&HU2$2B"0BA4@C,H@L0SP,3I*-"$/0>=F5N,:C M+,\MH@Z10"01*40:D4%D&>(^.T4SPN<@@'*?/2I27^BKUBV9Z$2:1:9#)!!) M1`J11F00689X&)SN&!&&(%/R,'B4.=BZ54_I,R"!5A*10J01&426(>ZS4PD`"K20BA4@C,H@L0SP,XT2.>\:D4(0!90O3 M%E&'2""2B!0BC<@@L@QQGVLBQRF'D7>J::D/P0@"AP;+-&>YS@@=L[VE0R00 M240*D49D$%F&6'PHE6-VC=Z<*ZJ`,@=;1!TB@4@B4H@T(H/(,L1]=B+J_8<# M\JQ,?4#N)Z5^4:Z,DM5P.$`D$$E$"I%&9!!9AG@8QNF_.>J_@&@3T<$648=( M()*(%"*-R""R#'&?2_WG%A)!GX\\(LQ1&P;D0IZ51;'R:9-5C%J'2""2B!0B MC<@@L@SQ$(W3AG/4A@&QL@"YV*&50"01*40:D4%D&>(^C].&<]2&`16I+]:2 M;;)*J0>Y*-!*(E*(-"*#R#+$P^`TVX@#HY=XN4ZBM6HA!%M$'2*!2")2B#0B M@\@RQ'UV`BWWV1T1?NAAMKF7>BP<'A554:S:V]`QVU\Z1`*11*00:40&D66( M1VB<;)RC;`PH<[!%U"$2B"0BA4@C,H@L0]SG4C:^?FUDCNHPH"+UZ;*1?VPC M6:4#PB`K(Q)H)1$I1!J106098F%8C%.'O3E7AP'EJ4?4(1*()"*%2",RB"Q# MW.=QZM"M)8I54D!%ZM-5.)_Z9!7SW"$2B"0BA4@C,H@L0SP,X]3A`M5A0"SU MWBI#'5H)1!*10J01&426(>YS31W2RUSON'R[0#48$)UZ8H+;A'*!6%P\[.I6 MZ3H3G_,XN;9`N1;09;J=TB+J$`E$$I%"I!$91)8A[G,IU]Y[YV*!PBT@EJ4@ MR4C+9#*^N-C3A8X7=+K+K-+RG\]XG+):H+(**-MU6D0=(H%((E*(-"*#R#+$ M?:XIJV73/Y#Q^NET@4HJ():F(*Y8FI;%(KP+'7F:EFE-QJ<\3NHL4.H$Q-+D MK3+4H95`)!$I1!J10609XCZ74L?M3-/9ZNW[@`M4/0&Q-`4]P]-4K(RZT+%( M4U+*;,K+<;*D-^>R)*`L)RVB#I%`)!$I1!J10609XCZ7LJ1?I\PNWT[3$A5* M0'F:$LH.9\M"KW;!JDA3DC9\RN,D!#WW4"JI@%B:4$*@E4`D$2E$&I%!9!GB M/MH*`*B<.0Y*N1#FZRB[N@0"402D4*D$1E$EB$>H7&"98F")2!6 M%=XJ0QU:"402D4*D$1E$EB'N(^UP32CU4% M"J9E4$>\*@H1VR:K6`(=(H%((E*(-"*#R#+$(S1.CRU1CP7$J@+U&%H)1!*1 M0J01&426(>YSJ<=>U\I+%&$!\9O5R[0R"0<$WY&L4NH!B316M)*(%"*-R""R M#+$PK,9IO-Z<:[R`*/7I;#F%)W62572P0R00240*D49D$%F&>!AH]C_G\O3* MC51$R",6H695K*#:T#';A3I$`I%$I!!I1`:198A':)S*7*'*#"ASL$74(1*( M)"*%2",RB"Q#W.>?IC)7J#(#*JHBK9C]X2-9I?W&CY7%4:"51*00:40&D66( M1VB<'.`9*R#5:9@QTB@4@B4H@T(H/(?7/,3=5/POOLOR'F/^[TM-E_ MV;2;Q\?#R>WNF_L^V.J2GMP=L/]XVUE_Q@Q;W7;/^CCZTS*BE?S0; M6AIJ:=R)!%KFU-(_/%:V+*F%%'.ESW)!+?WSWM!G22W]]51H65%+_Y('M%Q0 M2_](/[1<4DM_^BM;%C0WNOQ8F=N"9D"7O&HMM!VZRE)I65*L:6%?:Z&(TEJR MUD(1I354I65.GM+-NEH+S8!N:=5:R%.ZRU-I6=#TM,(M1;*`MVSK[50A=!M[%H+Y<=?UBAGT%`? M>BRRTJ>A/O3P8*V%8DW/T]5:*-;TU%FMA6)-SUM56N84:WHJJ=(RI>W06\.U M%MJ.?VVD]&=&+?1P?Z5/0[&F1Z!K+11K>BJXUD*QIF=G*RU3RBE]W:+60MNA M;T#46F@[]%F$6@MMQ]\A+_V94G[\6Q[00OFA5\LKHU&7:D:I0]6>PER-,H6R M&DE*93634\HD?1,%9Z1FLROW^AZVT"N/5^Z%QEI+0RVU/I;ZN!?XL`]]?/)3 M;:P;EZR*_8T;J,9=053XI_G5I_IAV^V3E0[TRC0Y7MLTO3E]Y=Z+1B?HS6%R MO!9&>G.66FJCT>O4Y$FMY8:"=5,-%KW?>N5>V<09=-3B7F*MM3344NLCJ8][ M:1/[W-#<;JIS:ZG%O7^,?3IJ<2^E5UHH.NZE[%K+E%IJH]&[[#2WON5LV(OH MHZ`OZR^;?Z[W7[;/AY/'S3V)@O/^-LS>?U;4_W',?-*FSX8.R'_\$``#__P,`4$L#!!0`!@`(````(0"S M!"?[%@0``-,/```9````>&PO=V]R:W-H965T#OG7T.>Y@#Q&B>Q_%2@MI6&VV_'C!?!:P*\/\@B""ML]:,#G\9A MP04_R!G`.3K1+N>-LW$`:;^+8F"`VVX5[.#;CV3[Y,YM9[]3&_0K9A?1^&Z) M$[_\5<31/W'&8+>A3EB!5\[?T/5;A"98['16OZ@*_"BLB!V"_67P\ M22CW$A@AL6WT^F9`O,4+:5G@6DJ>_M1-126DLE=IS((/]KN`7"^H-WB(/L'O(%H"K MG#1"G>50DI`=@CPBBF]#HT)\`3O[OG<]NG/>83?"TN=)^\!G[4-J#P>RJ5." M-)HI]6]/%1F=,3)N%Z;RI`W-,-=$C#"N&0:90_4'JE&%PT6^O6B0<#VWIJ$S MT#Y0DIKHHO8P,@"8\431&8IDAKY2TZ&UTXC0X-(,C>3I"MON#G]G\\'>5M!JM,;J<\ M!$=_]$XI[Q8T`OCVQFPR;X#()/T@I5XLK@I2FB`:JGFSSPB.=H.(&IO-B-*H MA2U.6B8V$+_1:NL!3I.D`D6BU0F5J:Z-4IDZ16MD*@V!@,DE=[QHFJ4GZ0+OZ4)EZ2/7H@^O2 M$7<%O$VT^Z%/(M8#MP4Z22*4=VL+2]7H(=4C$63,&4N[&E&:S,-I/7!GH),T M0GFW.)6RT<.I1R,(SOEM(:==C:A,9NL-W!OPSMQL^MO1E+?)J#(U&.DGE'ZG MI*PXLC]9D@@KY&=\'E%X8-36^NGVJ#2F;5]L'P$?S_'Z'WA2Y<&1?0^*8YP) M*V$'P)RK(2WTHTS_D#R'1.%AQ24\IM37$SR>&3PRYGB8'#B7U0\,4#_']_\# M``#__P,`4$L#!!0`!@`(````(0`ST58G>@8``!H9```9````>&PO=V]R:W-H M965T6 M/9Y:H^*:5_OR>MQ8?WT)/JVM4=-FUWUVKJ[%QOI>--;GQU]_>7BKZI?F5!3M M"!2NS<8ZM>V-3"9-?BHN63.N;L45?CE4]25KX6M]G#2WNLCV7:/+>>),I\O) M)2NO%E,@]7LTJL.AS`N_RE\OQ;5E(G5QSEH8?W,J;XU0N^3OD;MD] M76X@\5R>R_9[)VJ-+CF)C]>JSI[/,.]O]CS+A7;W!-]623U%Y8D\>'SJ"_R^*M4?X_:D[56UB7^]_* M:P%NPSK1%7BNJA<:&N\I@L83U#KH5N"/>K0O#MGKN?VS>HN*\GAJ8;D7,",Z M,;+_[A=-#HZ"S-CIAI%79Q@`_#NZE#0UP)'L6_?Y5N[;T\::+<>+U71F0_CH MN6C:H*22UBA_;=KJ\@\+LNF@I(C#1>"3B[AC9[VP%TLJ$S__>^YR+ M0%KQ>+^7*]NC_L%6_HRH;OG*\-Z\OLI@O-K'QGG[9<*?C/ MN^8Y84O=98Z?M=GC0UV]C6`[@D!SR^CFM@F5%3G#%DIFT8^2"!:>JCQ1F8T% M!PGD1P.9__5QYKH/DZ^0K3F/\7",K4=L103-)RKKFV!G@L`$H0DB$\0F2$R0 M*F`"/DFS(*?_#[.H##5+3-,3H'?/,9P1$:*);X*="0(3A":(3!";(#%!J@#- M&=BTR)D9Y/7PT2.RAK;:6+!G9=;8\[4^T!_<;%0&]JOJVWPZU4WQ6-!=WV2(]`V1'2(!(B$B M$2(Q(@DBJ4HTW\`BS;?[646C.WO$M#Q&YK"M^T1;&(9M99!HYB.R0R1`)$0D M0B1&)$$D58GF!CRB/N`&C=;=8$1W8[[4TVB#:2>)FE'&XRR00<+#$)&(D[ZS M6!)5>J8O3R*#A'2J$LT@6MVK3_C[FX=&ZP8QHAK$23]FGQ/%($G461A/M4`& MB5F$B$2<])W%DMR13F20D$Y5HAD$E=L'#*+1ND&,J`9QTH_9YT0Q2!)U%L:3 M+9!!8A8A(A$G?6>Q)*KTPL@@&22D4Y5H!M%*57.(%8EC6AFWIS)_\2IV+1A( MK1D4@[Q$I"JZE,;=.X/D!,+Q2HEXD$ZCN+ M!5H)97/G]0%".16HD]&=HY6DNOFH<\Z27K]^4AK16MQTBZ-^`EL1!9M?>;(9 M9[DOHOJ*TV@ MWEQL6I.J_M%$G+D?W<*LLM5LY4BUE2,]*8W;H-^-"#9#WW`GT%*QE6DYNA:R ME4?U*1AQ+;M'L9!WI7S"$;VIW+-53@BR24]+6K*:MG:#??^QR*I>S5..>FNV MM-B'XT!/U:6Q.WT>I>32CJ-9G[V!0,[=C2X[%#LHPNJQD.K5$X&8^H\VNJJN M.TK+7M-1>]$GZI?J!@^1GQZ?K'J&P8CA>_2B!19"W2O0%B,?HQU&`48A1A%& M,48)1O0E83]49@][Z<=>W5R*^EALB_.Y&>75*WVAY]!C56+VMM%;$+A#P%Q- MOB1030]P&QI`S_B7R"7T48E_B%V2=+O)Z`*>HB09;)&ZT,>0%+P;?>I.14/* MH^],![KV'`(O(_"0O!F!^S?F3W/R-#@Y;T[@XHD;1"L"M2?F\8I`]3W`UP2* M3LS3%8'2$W//)=Z@$UN7;`=_\%U":R$LM7,)5(H#')8A&&P1NH360[B)MR+> MT&BW*[(=XOZ*0/&/=78K`M>?`;XF4/5C'JX(U/[`)W+]XJQ;>27=GPPG^!E'`-6TZAHUTJ*I6?*$=R+]J M//X+``#__P,`4$L#!!0`!@`(````(0",1$K6N0(``(('```9````>&PO=V]R M:W-H965T!'$UG-G9)5>KVY>Z(L]"&ZF:E(9>0(EH MN,ID4Z3TU\^'FP4EQK(F8Y5J1$I?A:&WZX\?5GNEGTPIA"7`T)B4EM:VB>\; M7HJ:&4^UHH$ON=(UL[#4A6]:+5C6;:HK/PJ"F5\SV5#'D.AK.%2>2R[N%=_5 MHK&.1(N*6.E)*:)X]%HS3;5N#[ M)9PP?N3N%B?TM>1:&95;#^A\E^BIYZ6_](%IO M=07Z+<7>#-Z)*=7^LY;95]D(J#;T"3NP5>H)H8\9AF"S?[+[H>O`=TTRD;-= M97^H_1N],!PJ"C1>-$4FKBI(`)ZDEG@TH"+L):41",O, MEBF-9]YT'L0AP,E6&/L@D9(2OC-6U7\<*.R2#%?^<]@FA\P=PX#SQX3]@@?1'ME4+M> M&<&HC%7!5.Y<8"@3G9>)QS)8]!A:][Y1W)32R@*:8`,I=%\-,/3=<$_[NNRZ.M]B`P+'B^6YPW/QJKO MEQK!8ZE#).K.[?#$S,>\W?T)I]Y%-[AO+'&(0`O[YL7+X+P;'+]7WQ`$CZ4. MD?C$S7+,BVZFH3>_Z`;WC24.D;&;?]PZ&'#_8:=#C\6.H8$A-_'<6*F%+L0G M456&<+7#:1;!H.BC_:3==.U]&Y\D&S>!_?X+3,"6%>(;TX5L#*E$#IQ!5R?M M9JA;6-5"HC`'E879U[V6\*\3,"P"/"*Y4O:XP"G=_SW7?P$``/__`P!02P,$ M%``&``@````A`$(ADC0R`0``0`(``!$`"`%D;V-0$+ZUQ$()H-W^O:SKZHR>/)+WY>'Y/HKE M7C?))SBO6E,BDN4H`2-:J4Q5HN?-*EV@Q`=N)&]:`R4Z@$=+=GU5"$M%Z^#1 MM19<4."32#*>"ENB.@1+,?:B!LU]%ALFAKO6:1[BT578`T_[/"WURT=0J'&R<:="] M9$MQ"L?VWJNQV'5=UDU[C>A/\';]\-2/FBISW)4`Q([[:;@/Z[C*G0)Y>V#[ M-]#?Q#.`]=X__YQ]`0``__\#`%!+`P04``8`"````"$`8/HA M>9@#```-#```$``(`61O8U!R;W!S+V%P<"YX;6P@H@0!**```0`````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````"<5M]OHS@0?C]I_X>(]RUIMSJM*L+* M(4YCB0"'(;=]LKS@-&@)CFPG:O>OOR$T;=(S:+O*B^WY]G00 M2E>RF3C75V-G))I"EE7S.''R;/[YJS/2AC.!MC=G>NJXN-V')]!>(&)&NIMMS`53VZC,=_ MN^+)B*84Y>?=JT.G\WAW,'_JM)1%BT^OLN<=`/8]M-O55<$-9.DOJT))+==F MA)\*47ONN=`#=%04>U699W_LN>=7CQ:\%@$X]M>\UL)SWQZ\A>`M:0FOE/:] M@[D[B,)(-=+5+Z#MQAG]X%JT<";.@:N*-P9@M6K=Y7BN=]HH_U^I?NJ-$$9[ M+BATC\?CN>[YN;KU;[\>->!TJ=EZZ)"`X!)C5IE:Z'B=<&4LD&^A\F^8CR@Z MQ!V@4Q49]`;#C0&^&&FZ:E?R'/EK#H&$0C=:E`Q.6M95R0U,1$&\ MQ"R,*64)3AG:I-0#D`F0`@!.6I'5O504&TI8)B_>0V$F$]RD)249: M+)22^PCLLYAU[]8H49R!6J*L&E"Q%"_B<(93RF9X3@*"H^#!JAO$49:B M(,M1R.)I2.Z//=(1$_15,409P$Q02PM81Q0<0&?9.:?YE$(-@32&5WW4#?>? M_1_1-N!+-[&,_X#A8LUPN.9VU_:B#T49KKT]RD4EAYSW%'309`^?()@_C>$U MFU6ZJ*7>*\'DFD6RL1)EG19L)@RO:CNUPU6SSZ1AFR]69.>5'L(S/#_L1>@= M(,?,K7"&.\J>=D]'#68S.$[L88;GB9V!RS:DL$^5^_JE4XS]`_;.9+_=L^MI/6:S&&%8;]C\@[8[R03<:5@"SN(ES:VANG[=W7&'S+IR+.:#`]: M>S(I[INT;3[G82[VKG>;5E@U/W6^R^0,-I+3*GGYZ-$-5Z*$)>LD?WOP%K!% MJKIU$FQX\RC*D\[_!>WBN^JV>__Z]FK\90P[[=F;Y[[M\?Y_````__\#`%!+ M`0(M`!0`!@`(````(0#0P^C!"0(``*\=```3``````````````````````!; M0V]N=&5N=%]4>7!E&UL4$L!`BT`%``&``@````A`+55,"/U````3`(` M``L`````````````````0@0``%]R96QS+RYR96QS4$L!`BT`%``&``@````A M`-X1B+XP`@``[AP``!H`````````````````:`<``'AL+U]R96QS+W=OAG"QT#``#9"```&0`````````` M``````"%%```>&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`%C<9YF/`P``[`P``!D` M````````````````*QL``'AL+W=O&PO M=V]R:W-H965T&UL4$L!`BT`%``&``@````A`!KV6:PG`P``MPD``!D````````````````` MIRP``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``& M``@````A`$N=SY\4`P``M`D``!D`````````````````MS4``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`-Z_HBW@`P`` MCA```!@`````````````````%J<``'AL+W=O&PO=&AE;64O=&AE;64Q+GAM M;%!+`0(M`!0`!@`(````(0#]&K;4U`(``*H(```9`````````````````%BX M``!X;"]W;W)K&UL4$L!`BT`%``&``@````A`)27 MZY1=`P``TPL``!D`````````````````8[L``'AL+W=O&PO=V]R:W-H965T;281```*:6```9`````````````````!_$``!X;"]W;W)K&UL4$L!`BT`%``&``@````A`,`1UJ[T#```WE8``!D` M````````````````M]0``'AL+W=O$?+(@#``"Y"P``&`````````````````#BX0``>&PO M=V]R:W-H965T&UL4$L!`BT`%``&``@````A`!A8&%'I`P`` MC@\``!D`````````````````H.4``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`"-RYI"W!@``-QT``!D````````` M````````/?0``'AL+W=O&PO=V]R:W-H M965T&UL4$L! M`BT`%``&``@````A`""'*,PO!@``Q!<``!D`````````````````O0&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`.ZJNQXY!P``ZQT``!@````````````````` M_A`!`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@` M```A`-].9AQW!```FA$``!@`````````````````'"(!`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A``'+J)O!`@``F@<``!D` M````````````````/88!`'AL+W=O&PO M=V]R:W-H965T&UL4$L!`BT`%``&``@````A`%-+R]"8#P``E58``!D````````````````` M?I(!`'AL+W=O&PO=V]R:W-H965T@8``!H9```9```````` M`````````)JF`0!X;"]W;W)K&UL4$L!`BT`%``& M``@````A`(Q$2M:Y`@``@@<``!D`````````````````2ZT!`'AL+W=O9@#```-#```$`````````````````"DL@$`9&]C4')O<',O =87!P+GAM;%!+!08`````.0`Y`($/``!RMP$````` ` end XML 14 R46.htm IDEA: XBRL DOCUMENT v2.4.0.8

SHAREHOLDERS' DEFICIENCY (Schedule of Weighted Average Assumptions) (Details) (Common Stock Options [Member])
3 Months Ended

Mar. 31, 2014

Mar. 31, 2013

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Dividend yield 0.00% ^[1] 0.00% ^[1]

Expected volatility, minimum 118.50% ^[2] 99.20% ^[2]

Expected volatility, maximum 118.50% ^[2] 100.30% ^[2]

Risk-free interest rate 1.72% ^[3] 0.63% ^[3]

Expected lives 5 years ^[2]

Minimum [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Expected lives 2 years ^[2]

Maximum [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Expected lives 4 years ^[2]

[1] We have not paid cash dividends on our common stock since 1981, and currently do not have plans to pay or declare cash dividends. Consequently, we used an expected dividend rate of zero for the valuations.

[2] Estimated based on our historical experience. Volatility was based on historical experience over a period equivalent to the expected life in years.

[3] Based on the U.S. Treasury constant maturity interest rate with a term consistent with the expected life of the options granted.

XML 15 R33.htm IDEA: XBRL DOCUMENT

RECEIVABLES (Details) (USD $)	Mar. 31, 2014	Dec. 31, 2013
RECEIVABLES [Abstract]
Calmare sales receivable	$ 86,023	$ 132,850
Royalties, net of allowance of $101,154 at March 31, 2014 and December 31, 2013		10,086
Other	294	394
Total receivables	86,317	143,330
Allowance for doubtful accounts	$ 101,154	$ 101,154

XML 16 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 17 R25.htm IDEA: XBRL DOCUMENT

PROPERTY AND EQUIPMENT (Tables)

3 Months Ended

Mar. 31, 2014

PROPERTY AND EQUIPMENT [Abstract]

Schedule of Property and Equipment

Property and equipment, net, consist of the following:

	March 31, 2014			December 31, 2013
Property and equipment, gross	$	180,615		$	177,537
Accumulated depreciation and amortization		(171,755	)		(169,931	)
Property and equipment, net	$	8,860		$	7,606

XML 18 R42.htm IDEA: XBRL DOCUMENT

NOTES PAYABLE (Summary of Fair Value Assumptions) (Details) (Warrant [Member])	0 Months Ended	1 Months Ended	0 Months Ended	1 Months Ended
	Nov. 15, 2013 Series A1 15% Original Issue Discount Convertible Notes and Warrants [Member]	Dec. 31, 2013 Series A2 15% Original Issue Discount Convertible Notes and Warrants [Member]	Feb. 14, 2014 Series A3 15% Original Issue Discount Convertible Notes and Warrants [Member]	Mar. 20, 2014 Series B Original Issue Discount Convertible Notes and Warrants [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Expected term	2 years	2 years	2 years	4 years
Volatility	180.02%	184.38%	184.88%	151.52%
Risk Free Rate	0.31%	0.39%	0.32%	1.32%

XML 19 R37.htm IDEA: XBRL DOCUMENT

PROPERTY AND EQUIPMENT (Details) (USD $)	3 Months Ended
PROPERTY AND EQUIPMENT (Details) (USD $)	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2013
PROPERTY AND EQUIPMENT [Abstract]
Property and equipment, gross	$ 180,615		$ 177,537
Accumulated depreciation and amortization	(171,755)		(169,931)
Property and equipment, net	8,860		7,606
Depreciation and amortization expense	$ 1,824	$ 2,336

XML 20 R47.htm IDEA: XBRL DOCUMENT

CONTRACTUAL OBLIGATIONS AND CONTINGENCIES (Details) (USD $)	3 Months Ended
	Mar. 31, 2014
Loss Contingencies [Line Items]
Percentage of revenues obligation	7.50%
Finders' fee	10.00%
VVI [Member] \| Supported Products [Member]
Loss Contingencies [Line Items]
Percentage of revenues obligation	1.50%
VVI [Member] \| Licensing Supported Products [Member]
Loss Contingencies [Line Items]
Percentage of revenues obligation	15.00%
Grant funding received in 1994 [Member]
Loss Contingencies [Line Items]
Funding repayment obligation	$ 165,701
Grant funding received in 1995 [Member]
Loss Contingencies [Line Items]
Funding repayment obligation	$ 198,365

XML 21 R9.htm IDEA: XBRL DOCUMENT

RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS	3 Months Ended
RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS	Mar. 31, 2014
RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS [Abstract]
RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS	3. RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS No new accounting pronouncements issued or effective during the quarter ended March 31, 2014 has had or is expected to have a material impact on the consolidated financial statements.

- Definition

The entire disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 270

-SubTopic 10

-Section 45

-Paragraph 13

-URI http://asc.fasb.org/extlink&oid=6372559&loc=d3e765-108305

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 01

-Paragraph b

-Subparagraph 6

-Article 10

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 250

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=28359718&loc=d3e22499-107794

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 250

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=28359718&loc=d3e22580-107794

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Direct Effects of a Change in Accounting Principle

-URI http://asc.fasb.org/extlink&oid=6510796

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Indirect Effects of a Change in Accounting Principle

-URI http://asc.fasb.org/extlink&oid=6515603

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Accounting Change

-URI http://asc.fasb.org/extlink&oid=6503790

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Change in Accounting Principle

-URI http://asc.fasb.org/extlink&oid=6507316

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 270

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.10-01.(b)(6))

-URI http://asc.fasb.org/extlink&oid=27015980&loc=d3e46468-122699

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Retrospective Application

-URI http://asc.fasb.org/extlink&oid=6523989

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 250

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=28359718&loc=d3e22583-107794

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 270

-SubTopic 10

-Section 45

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=6372559&loc=d3e725-108305

+ Details

EXCEL 22 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\V93)E-#8Q85\W.3,W7S1A9#9?.60R,E\Y,S'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-O;F1E;G-E9%]#;VYS;VQI9&%T961?4W1A=&5M M93$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I7;W)K#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DQ)04))3$E424537T%34TE'3D5$7U1/7TQ)04)) M3#PO>#I.86UE/@T*("`@(#QX.E=O#I.86UE/@T*("`@(#QX.E=O M#I%>&-E;%=O#I.86UE/D-/3E1204-454%,7T]"3$E'051)3TY37T%. M1%]#3SPO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E)% M3$%4141?4$%25%E?5%)!3E-!0U1)3TY3/"]X.DYA;64^#0H@("`@/'@Z5V]R M:W-H965T4V]U#I%>&-E;%=O#I.86UE/@T* M("`@(#QX.E=O#I% M>&-E;%=O#I.86UE/DY%5%])3D-/345?3$]34U]0 M15)?0T]-34].7U-(03$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I7 M;W)K#I%>&-E;%=O M#I7;W)K#I%>&-E M;%=O#I7;W)K M#I7;W)K#I7 M;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DY% M5%])3D-/345?3$]34U]015)?0T]-34].7U-(03(\+W@Z3F%M93X-"B`@("`\ M>#I7;W)K#I%>&-E M;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D%604E,04),149/4E-!3$5?04Y$7T5154E465]3 M13$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I7 M;W)K#I%>&-E;%=O M#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/DQ)04))3$E424537T%34TE'3D5$7U1/7TQ)04))3#$\+W@Z3F%M93X- M"B`@("`\>#I7;W)K#I7;W)K#I7;W)K#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E)% M3$%4141?4$%25%E?5%)!3E-!0U1)3TY37T1E=#PO>#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M6QE#I!8W1I=F53 M:&5E=#X-"B`@/'@Z4')O=&5C=%-T#I0#I0#I0&UL/CPA6V5N M9&EF72TM/@T*/"]H96%D/@T*("`\8F]D>3X-"B`@(#QP/E1H:7,@<&%G92!S M:&]U;&0@8F4@;W!E;F5D('=I=&@@36EC'10 M87)T7S9E,F4T-C%A7S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO2!296=I'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)V9A;'-E/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N M/CPO'0^)RTM,3(M,S$\'0^)SQS<&%N/CPO'0^)U$Q/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO3PO=&0^#0H@("`@("`@(#QT M9"!C;&%S2!D97!O6%B;&4\+W1D/@T*("`@ M("`@("`\=&0@8VQA3PO=&0^#0H@("`@("`@(#QT9"!C;&%S6%B;&4@+2T@;&]N9RUT97)M/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$;G5M<#XS-"PR-S(\'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPOF5D M+"`R,BPT-C,L-3,R('-H87)E&-E'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P M.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPOF5D("AI;B!S:&%R97,I/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,"PP,#`\'0^)SQS<&%N/CPO'0^)SQS<&%N/CPOF5D("AI;B!S:&%R97,I/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$;G5M<#XS-2PY,C`\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N M8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'!E;G-E'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO&5S/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$;G5M/B@W,C8L,S`V*3QS<&%N/CPO'1087)T7S9E,F4T-C%A7S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P M.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO2!0=7)C:&%S92!!9W)E96UE;G0\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)R9N8G-P.R9N8G-P.SQS<&%N M/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPOF%T:6]N M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV,2PS-C0\'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO M'0^)SQS<&%N/CPO6%B;&4L(&%C8W)U960@ M97AP96YS97,@86YD(&]T:&5R(&QI86)I;&ET:65S/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$;G5M<#XQ-S@L-CDT/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^ M)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA'0^)SQS<&%N/CPO&AT;6PQ+T141"]X:'1M;#$M=')A;G-I M=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I=CX\(2TM4W1A#L@5$585"U)3D1%3E0Z(#`N-6EN)SX@5&AE(&EN=&5R:6T@8V]N9&5N6QE/3-$)T9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE"<^("9N8G-P.SPO M<#X@/'`@3L@1D].5#H@,3!P M="!4:6UE2P@5F5C=&]R(%9I2!C;VUP86YY(&1E=F5L;W!I;F<@86YD(&-O M;6UEFEN9R!I;FYO=F%T:79E('!R;V1U8W1S(&%N9"!T96-H;F]L M;V=I97,N($-422!I7-I8V%L M(")38W)A;6)L97(@5&AE2(F"<^("9N8G-P.SPO<#X@ M/'`@3L@1D].5#H@,3!P="!4 M:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&IU#L@5$585"U)3D1%3E0Z(#`N-6EN)SX@5V4@8F5L:65V92!W92!H M879E(&UA9&4@86QL(&%D:G5S=&UE;G1S(&YE8V5S2P@8V]N6QE/3-$)T9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M#L@5$585"U)3D1%3E0Z(#`N-6EN M)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&IU#L@5$585"U)3D1%3E0Z(#`N-6EN)SX@1'5R:6YG('1H92!T:')E92!M M;VYT:',@96YD960@36%R8V@@,S$L(#(P,30L('=E(&AA9"!A('-I9VYI9FEC M86YT(&-O;F-E;G1R871I;VX@;V8@2!M961I8V%L(&1E=FEC92XF;F)S<#LF;F)S M<#M4:&4@<&5R8V5N=&%G97,@;V8@9W)O#L@5$585"U)3D1%3E0Z(#`N-6EN)SX@)FYB2!A="!-87)C:"`S,2P@,C`Q-"XF;F)S<#LF M;F)S<#M4:&4@0V]M<&%N>2!H87,@=&%K96X@2!N;W0@:&%V92!S=69F:6-I M96YT(&-A2!T;R!C M;VYT:6YU92!A6QE/3-$)U1%6%0M04Q)1TXZ(&IU#L@5$585"U)3D1%3E0Z(#`N-6EN)SX@5&AE($-O;7!A;GDF(S,Y M.W,@8V]N=&EN=6%T:6]N(&%S(&$@9V]I;F<@8V]N8V5R;B!I2!F=7)T:&5R(')E9'5C:6YG(&-O2P@86YD+V]R('!U6QE/3-$)U1%6%0M04Q)1TXZ(&IU#L@5$58 M5"U)3D1%3E0Z(#`N-6EN)SX@)FYB2!R97%U:7)E;65N=',@=VET:"!A(&-O;6)I;F%T:6]N(&]F(&-A2!L96=A;"!A=V%R9',N($%T($UA M2!H860@;W5T6QE/3-$)U1%6%0M M04Q)1TXZ(&IU#L@5$585"U)3D1%3E0Z(#`N M-6EN)SX@)FYB2!W:71H M(&5X8VQU3PO96T^('1E8VAN;VQO9WD@=&AR;W5G:"!-87)C:"`S,2P@,C`Q-BX@26X@ M2G5L>2`R,#$R+"!T:&4@0V]M<&%N>2!A='1E;7!T960@=&\@;F5G;W1I871E M(&$@9FEV92UY96%R(&5X=&5N2!I2!A;F0@:6X@=&AE(%4N4RX@ M07!P;&EC871I;VYS(&9O65A7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA&AT;6PQ+T141"]X:'1M M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I=CX\(2TM4W1A3L@1D].5#H@,3!P="!4:6UE6QE/3-$)U9%4E1)0T%,+4%,24=..B!B M;W1T;VTG/B`\=&0@6QE/3-$)U1% M6%0M04Q)1TXZ(&-E;G1E6QE/3-$ M)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ M(&-E;G1E6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T M;VTG/B`\=&0@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1) M3D6QE M/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z M(')G8B@R,#0L,C4U+#(P-"DG/B`\=&0@6QE M/3-$)U=)1%1(.B`Q,"4[(%1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4.B`Q,'!T M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)U=)1%1(.B`Q)3L@5$585"U!3$E'3CH@;&5F=#L@1D]. M5#H@,3!P="!4:6UE6QE/3-$ M)U9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z('=H M:71E)SX@/'1D('-T>6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z('=H:71E)SXF M;F)S<#L\+W1D/B`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`@("`\=&%B;&4@8VQA M'0^)SPA+2U$3T-4 M65!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I M=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78^/"$M+5-T M87)T1G)A9VUE;G0M+3X@/'`@3L@1D].5#H@,3!P="!4 M:6UE'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SPA+2U$3T-465!% M(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO M;F%L+R]%3B(@(FAT='`Z+R]W=W&AT M;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78^/"$M+5-T87)T M1G)A9VUE;G0M+3X@/'`@#L@5$585"U)3D1%3E0Z(#`N-6EN)SX@4F5C96EV86)L97,@8V]N6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)FYB6QE/3-$)T9/3E0Z(&)O;&0@,3!P="!4:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&-E;G1E6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VT[ M($)!0TM'4D]53D0M0T],3U(Z(')G8B@R,#0L,C4U+#(P-"DG/B`\=&0@6QE/3-$)U=)1%1(.B`R M)3L@1D].5#H@8F]L9"`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M6QE/3-$)U=)1%1(.B`Q)3L@5$58 M5"U!3$E'3CH@;&5F=#L@1D].5#H@8F]L9"`Q,'!T(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-E6QE/3-$)U=)1%1(.B`Q)3L@5$585"U!3$E'3CH@;&5F=#L@1D].5#H@8F]L M9"`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)U=)1%1(.B`R)3L@1D].5#H@,3!P="!4:6UE M6QE/3-$)U=)1%1(.B`Q,"4[(%1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4 M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT.R!&3TY4.B!B;VQD(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0Z(&)O;&0@,3!P="!4:6UE6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M M0T],3U(Z(')G8B@R,#0L,C4U+#(P-"DG/B`\=&0@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P="!S M;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#(N-7!T(&1O=6)L93L@5$585"U!3$E'3CH@;&5F=#L@ M1D].5#H@8F]L9"`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#(N-7!T(&1O=6)L93L@5$585"U!3$E'3CH@;&5F M=#L@1D].5#H@,3!P="!4:6UE3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%\V93)E-#8Q85\W.3,W7S1A9#9?.60R,E\Y,S'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R6QE/3-$)T9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE"<^(#QS=')O;F<^-2XF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#M!5D%)3$%"3$4M1D]2+5-!3$4@04Y$($5154E462!3 M14-54DE42453/"]S=')O;F<^/"]P/B`\<"!S='EL93TS1"=415A4+4%,24=. M.B!J=7-T:69Y.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L M(%-E3L@ M1D].5#H@,3!P="!4:6UEF5D(&%S(&%V86EL86)L92UF;W(M2!H96QD(%-E8W5R:71Y($EN;F]V871I;VXL(&%N(&EN9&5P M96YD96YT('!R;W9I9&5R(&]F('-E8W5R92!S;V9T=V%R92!L;V-A=&5D(&EN M(%=I;&UI;F=T;VXL($U!+CPO<#X@/'`@3L@1D].5#H@,3!P="!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&IU#L@5$585"U)3D1%3E0Z(#`N-6EN)SX@26X@4V5P=&5M8F5R M(#(P,#D@=V4@86YN;W5N8V5D('1H92!F;W)M871I;VX@;V8@82!J;VEN="!V M96YT=7)E('=I=&@@6&EO;B!F;W(@=&AE(&-O;6UEF%T:6]N(&]F M(&]U2!O=VYS(#8P('-H87)E3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\V93)E-#8Q M85\W.3,W7S1A9#9?.60R,E\Y,S'0O:'1M;#L@8VAA'0^)SPA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1- M3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^ M(#QD:78^/"$M+5-T87)T1G)A9VUE;G0M+3X@/'`@6QE M/3-$)U1%6%0M04Q)1TXZ(&IU#L@5$585"U) M3D1%3E0Z(#`N-6EN)SX@)FYB2!G:79E2!T;R!U M;F%D:G5S=&5D('%U;W1E9"!P3L@1D].5#H@,3!P="!4:6UE6QE/3-$)U9%4E1) M0T%,+4%,24=..B!T;W`G/B`\=&0^)FYB6QE/3-$ M)T9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2!T;R!A8V-E6QE/3-$)U9% M4E1)0T%,+4%,24=..B!T;W`G/B`\=&0@6QE/3-$)U=)1%1(.B`P+C(U:6XG/B9N8G-P.SPO M=&0^(#QT9#XF;F)S<#L\+W1D/B`\+W1R/B`\='(@6QE/3-$)T9/3E0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2!I;F-L=61E.CPO=&0^(#PO='(^ M(#QT6QE/3-$)T9/3E0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)U9%4E1)0T%,+4%,24=..B!T;W`G M/B`\=&0^)FYB6QE/3-$)T9/3E0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE3L\+W1D/B`\+W1R/B`\='(@6QE/3-$)T9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M6QE/3-$)T9/3E0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE"<^($EN<'5T6QE/3-$)U9%4E1)0T%,+4%,24=..B!T;W`G/B`\=&0^)FYB2!T:&4@9G5L;"!T97)M(&]F('1H92!A6QE/3-$)U9%4E1) M0T%,+4%,24=..B!T;W`G/B`\=&0^)FYB6QE/3-$)U9%4E1)0T%,+4%,24=..B!T;W`G/B`\=&0^)FYB6QE/3-$)T9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE3L@1D].5#H@,3!P="!4:6UE2!I2!I M;G!U="!T:&%T(&ES('-I9VYI9FEC86YT('1O('1H92!F86ER('9A;'5E(&UE M87-UF4@=&AE('5S92!O9B!O8G-EF4@=&AE('5S92!O9B!U;F]B3L@1D].5#H@,3!P="!4:6UE M6QE/3-$)U1% M6%0M04Q)1TXZ(&IU#L@5$585"U)3D1%3E0Z M(#`N-6EN)SX@5&AE($-O;7!A;GD@=F%L=65S(&ET2!A2!C86QC=6QA=&5S('1H92!A;6]U M;G0@;V8@<&]T96YT:6%L(&-O;6UO;B!S=&]C:R!T:&%T('1H92!397)I97,@ M0R!02X@5&AE($-O M;7!A;GD@8VQA2X\+W`^(#QP('-T>6QE/3-$)U1% M6%0M04Q)1TXZ(&IU#L@5$585"U)3D1%3E0Z M(#`N-6EN)SX@)FYB&5D('1O('1H92!#;VUP86YY M)B,S.3MS(&]W;B!S=&]C:R!W:&EC:"!I2`Q-BP@,C`Q,RP@:6X@3&5V96P@,R!O9B!T:&4@ M9F%I3L@1D].5#H@,3!P M="!4:6UE2!C;&%S M2!O9B`D,"!A="`\9F]N M="!S='EL93TS1"="04-+1U)/54Y$+4-/3$]2.B!W:&ET92<^1&5C96UB97(@ M,S$\+V9O;G0^+"`R,#$S+"!A;F0@)#$Y+#`R-"!U<&]N(&ES2!E>&5C=71E9"!A(&1E8G0@3L@1D].5#H@,3!P="!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&IU#L@5$585"U)3D1%3E0Z(#`N-6EN)SX@5&AE(&UE=&AO M9',@9&5S8W)I8F5D(&%B;W9E(&UA>2!P2!N;W0@8F4@:6YD:6-A=&EV92!O9B!N970@ M6QE/3-$)U1% M6%0M04Q)1TXZ(&IU#L@5$585"U)3D1%3E0Z M(#`N-6EN)SX@5&AE(&-A3L@1D].5#H@,3!P="!4:6UE M7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^ M/&1I=CX@/&1I=CX\(2TM4W1A6QE/3-$)T9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE"<^("9N8G-P.SPO M<#X@/'`@3L@1D].5#H@,3!P M="!4:6UE6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E M6QE/3-$)T9/3E0Z(&)O;&0@,3!P="!4:6UE6QE/3-$)U=)1%1(.B`Q,"4[(%1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4.B!B M;VQD(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)U=)1%1(.B`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`\<"!S='EL93TS1"=&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-E6QE/3-$)U1%6%0M04Q)1TXZ(&IU#L@5$585"U)3D1%3E0Z(#`N-6EN)SX@4')O<&5R='D@86YD(&5Q=6EP;65N M="P@;F5T+"!C;VYS:7-T(&]F('1H92!F;VQL;W=I;F6QE/3-$)U9%4E1) M0T%,+4%,24=..B!B;W1T;VTG/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T9/3E0Z(&)O;&0@,3!P="!4:6UE6QE/3-$)T9/ M3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)U=)1%1(.B`W,B4[(%1%6%0M04Q)1TXZ(&QE9G0[($9/3E0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2!A;F0@97%U:7!M96YT+"!G6QE/3-$)U=)1%1(.B`Q)3L@5$585"U!3$E'3CH@;&5F=#L@1D]. M5#H@,3!P="!4:6UE6QE/3-$)U=)1%1(.B`Q)3L@5$585"U!3$E' M3CH@;&5F=#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P M="!S;VQI9#L@5$585"U!3$E'3CH@;&5F=#L@1D].5#H@8F]L9"`Q,'!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P="!S;VQI9#L@5$58 M5"U!3$E'3CH@6QE/3-$ M)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE M/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z M(')G8B@R,#0L,C4U+#(P-"DG/B`\=&0@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#(N-7!T(&1O=6)L93L@5$585"U!3$E'3CH@;&5F=#L@1D]. M5#H@8F]L9"`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E#L@5$585"U)3D1%3E0Z(#`N-6EN)SX@ M)FYB6QE M/3-$)T)!0TM'4D]53D0M0T],3U(Z('=H:71E)SY-87)C:"`S,3PO9F]N=#XL M(#(P,30@86YD($UA7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M&AT;6PQ+T141"]X:'1M;#$M=')A;G-I M=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I=CX\(2TM4W1A6QE/3-$)T9/3E0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE"<^("9N8G-P.SPO<#X@/'`@3L@1D].5#H@,3!P="!4:6UE6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`\ M=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ(#%P M="<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!415A4+4%,24=..B!C M96YT97(G(&-O;'-P86X],T0R/D1E8V5M8F5R/&)R("\^(#,Q+#QB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M4$%$1$E.1RU"3U143TTZ(#%P="<^)FYB6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@5TE$5$@Z(#6%B;&4\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#$E.R!&3TY4+5=% M24=(5#H@8F]L9#L@5$585"U!3$E'3CH@;&5F="<^("0\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#$E.R!&3TY4+5=% M24=(5#H@8F]L9#L@5$585"U!3$E'3CH@;&5F="<^("9N8G-P.SPO=&0^(#QT M9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[(%=)1%1(.B`Q)2<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#$E M.R!415A4+4%,24=..B!L969T)SXD/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@5TE$5$@Z(#$Q)3L@5$585"U!3$E'3CH@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$ M5$@Z(#$E.R!415A4+4%,24=..B!L969T)SX@)FYB6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]5 M3D0M0T],3U(Z('=H:71E)SX@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@5$585"U!3$E'3CH@;&5F="<^06-C6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U714E'2%0Z(&)O;&0[(%1%6%0M04Q)1TXZ(&QE9G0G/B`F;F)S M<#L\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z(&)O M;&0[(%1%6%0M04Q)1TXZ(&QE9G0G/B`F;F)S<#L\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@5$585"U!3$E'3CH@;&5F="<^06-C6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U714E'2%0Z(&)O;&0[(%1%6%0M04Q)1TXZ(&QE9G0G/B`F M;F)S<#L\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z(&)O;&0G M/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/ M3E0M5T5)1TA4.B!B;VQD.R!415A4+4%,24=..B!L969T)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z M(&)O;&0[(%1%6%0M04Q)1TXZ(')I9VAT)SX@,C$L.36QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z(&)O;&0[(%1% M6%0M04Q)1TXZ(&QE9G0G/B`F;F)S<#L\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$58 M5"U!3$E'3CH@;&5F="<^)FYB6QE/3-$ M)U9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z(')G M8B@R,#0L,C4U+#(P-"DG/B`\=&0@6%B;&4\ M+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U714E'2%0Z(&)O;&0[(%1%6%0M04Q)1TXZ(&QE9G0G/B`F M;F)S<#L\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z M(&)O;&0[(%1%6%0M04Q)1TXZ(&QE9G0G/B`F;F)S<#L\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52 M+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!&3TY4+5=%24=(5#H@8F]L9#L@ M5$585"U!3$E'3CH@;&5F="<^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=& M3TY4+5-)6D4Z(#$P<'0[($)/4D1%4BU"3U143TTZ(&)L86-K(#%P="!S;VQI M9#L@1D].5"U714E'2%0Z(&)O;&0[(%1%6%0M04Q)1TXZ(')I9VAT)SX@,3

6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@4$%$1$E.1RU"3U143TTZ(#%P="<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+4)/5%1/33H@8FQA8VL@ M,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+4)/5%1/33H@8FQA M8VL@,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(#$S-"PV-#4\+W1D M/B`\=&0@6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]5 M3D0M0T],3U(Z(')G8B@R,#0L,C4U+#(P-"DG/B`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`N-6EN)SX@)FYB M3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\V93)E-#8Q85\W M.3,W7S1A9#9?.60R,E\Y,S'0O:'1M;#L@8VAA6QE/3-$)T9/3E0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE"<^ M(#QS=')O;F<^,3`N)FYB3L@1D].5#H@,3!P M="!4:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&IU#L@5$585"U) M3D1%3E0Z(#`N-6EN)SX@1'5R:6YG('1H92!T:&ER9"!Q=6%R=&5R(&]F(#(P M,3,L('1H92!#;VUP86YY(&YE9V]T:6%T960@82!,4$$@=VET:"!3;W5T:')I M9&=E+"!087)T;F5R&-H86YG92!O9B!C;&%I;7,L('-E8W5R:71I97,L(&]R('!R M;W!E&5C=71E9"!C;&%I;7,@<'5R8VAA&ES=&EN9R!P87EA8FQE'!E;G-E6%B;&4N(%1H92!P28C,SD[&EM871E;'D@)#@P+#`P,"!F2`Q-"P@,C`Q-"P@;F\@9G5R=&AE3L@1D].5#H@,3!P="!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&IU#L@5$585"U)3D1%3E0Z(#`N-6EN)SX@5&AE2!R971A:6YS('5L=&EM871E(')E7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`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`Q,SPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-) M6D4Z(#$P<'0G/B9N8G-P.SPO=&0^(#PO='(^(#QT6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$ M5$@Z(#6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#$E.R!&3TY4+5=%24=(5#H@ M8F]L9"<^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P M<'0[(%=)1%1(.B`Q)3L@1D].5"U714E'2%0Z(&)O;&0[(%1%6%0M04Q)1TXZ M(&QE9G0G/B`D/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M5TE$5$@Z(#$P)3L@1D].5"U714E'2%0Z(&)O;&0[(%1%6%0M04Q)1TXZ(')I M9VAT)SX@,BPT.3@L.3@P/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@5TE$5$@Z(#$E.R!&3TY4+5=%24=(5#H@8F]L9#L@5$585"U!3$E' M3CH@;&5F="<^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z M(#$P<'0[(%=)1%1(.B`Q)2<^)FYB6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#$E.R!415A4+4%,24=..B!L969T)SXD M/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#$P M)3L@5$585"U!3$E'3CH@6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@;&5F="<^)FYB6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VT[ M($)!0TM'4D]53D0M0T],3U(Z(')G8B@R,#0L,C4U+#(P-"DG/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U714E'2%0Z(&)O;&0[(%1%6%0M04Q)1TXZ(&QE9G0G/B`F M;F)S<#L\+W1D/B`\=&0@6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z(&)O;&0[(%1%6%0M04Q)1TXZ M(&QE9G0G/B`F;F)S<#L\+W1D/B`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`F;F)S<#L\+W1D/B`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`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ M(#(N-7!T.R!415A4+4%,24=..B!L969T)SX@3F]T97,@4&%Y86)L92P@;F5T M/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U714E' M2%0Z(&)O;&0[(%!!1$1)3D6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@0D]21$52+4)/5%1/33H@8FQA8VL@,BXU<'0@9&]U8FQE.R!&3TY4 M+5=%24=(5#H@8F]L9#L@5$585"U!3$E'3CH@6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@4$%$1$E.1RU"3U143TTZ(#(N-7!T)SXF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+4)/5%1/33H@8FQA8VL@ M,BXU<'0@9&]U8FQE.R!415A4+4%,24=..B!R:6=H="<^(#(L-#@X+#8Y,3PO M=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[(%!!1$1)3D6QE/3-$)T9/3E0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE"<^("9N8G-P M.R9N8G-P.R9N8G-P.SPO<#X@/'`@6QE/3-$)U1%6%0M04Q)1TXZ(&IU#L@5$585"U)3D1%3E0Z(#`N-6EN)SX@)FYB6QE/3-$ M)U!!1$1)3D6QE/3-$)T9/3E0M4TE:13H@ M,3!P="<^06UO=6YT/"]F;VYT/CPO=&0^(#QT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,7!T)R!N;W=R87`],T1N;W=R87`^)FYB6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#%P="!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R)R!C;VQS M<&%N/3-$,B!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@,3!P="<^4F%T93PO9F]N=#X\+W1D/B`\ M=&0@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P="!S;VQI9#L@5$585"U!3$E'3CH@ M8V5N=&5R)R!C;VQS<&%N/3-$,B!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#%P="!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R)R!N;W=R87`],T1N;W=R M87`^/&9O;G0@3PO M9F]N=#X@/&)R("\^(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^ M1&%T93PO9F]N=#X\+W1D/B`\+W1R/B`\='(@2!#;VYV97)T:6)L92!.;W1E6QE/3-$)U=)1%1(.B`Q)2<^)FYB6QE/3-$)U=) M1%1(.B`Q)2<^)FYB6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@5TE$5$@Z(#$E)SXD/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@5$585"U!3$E'3CH@6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VT[ M($)!0TM'4D]53D0M0T],3U(Z('=H:71E)SX@/'1D('-T>6QE/3-$)T9/3E0M M4TE:13H@,3!P="<^,C0@;6]N=&@@0V]N=F5R=&EB;&4@3F]T97,@*"0Q,#`L M,#`P('1O($)O87)D(&UE;6)E6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@6QE/3-$)U9%4E1)0T%,+4%,24=..B!B M;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z(')G8B@R,#0L,C4U+#(P-"DG/B`\ M=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M5$585"U!3$E'3CH@6QE/3-$)T9/3E0M4TE:13H@ M,3!P="<^)3PO=&0^(#QT9#XF;F)S<#L\+W1D/B`\=&0^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@6QE/3-$)T9/3E0M4TE:13H@,3!P="<^-S4E(&]F(&-L;W-I M;F<\+V9O;G0^(#QB6QE/3-$ M)U9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z(')G M8B@R,#0L,C4U+#(P-"DG/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@5$585"U!3$E'3CH@6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T], M3U(Z('=H:71E)SX@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^4V5R M:65S($$R(#$U)2!/240@0V]N=F5R=&EB;&4@3F]T97,@86YD(%=A6QE M/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z M(')G8B@R,#0L,C4U+#(P-"DG/B`\=&0@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$1$E. M1RU"3U143TTZ(#%P=#L@5$585"U!3$E'3CH@8V5N=&5R)SX@2F%N=6%R>2`R M,#$U/"]T9#X@/"]T6QE/3-$)U9%4E1)0T%,+4%,24=..B!B M;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z('=H:71E)SX@/'1D('-T>6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ(#%P="<^4V5R:65S M($(@3TE$($-O;G9E6QE/3-$)U!!1$1)3D6QE/3-$ M)U!!1$1)3D6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ(#%P=#L@ M5$585"U!3$E'3CH@8V5N=&5R)SX@36%R8V@@,C`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`Q,'!T.R!415A4+4%,24=..B!R:6=H M="<^("@T.#4L.3@P/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@4$%$1$E.1RU"3U143TTZ(#%P="<^*3PO=&0^(#QT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,7!T)SXF;F)S<#L\+W1D/B`\=&0@6QE/3-$ M)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$ M)U!!1$1)3D6QE/3-$)U9%4E1)0T%,+4%,24=..B!B M;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z(')G8B@R,#0L,C4U+#(P-"DG/B`\ M=&0@6%B;&4L(&YE=#PO=&0^(#QT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,BXU<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,BXU<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,BXU<'0[(%1%6%0M04Q)1TXZ(')I9VAT M)SXF;F)S<#L\+W1D/B`\=&0@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1% M6%0M04Q)1TXZ(&IU#L@5$585"U)3D1%3E0Z M(#`N-6EN)SX@)FYB6QE/3-$)U1%6%0M M04Q)1TXZ(&IU#L@5$585"U)3D1%3E0Z(#`N M-6EN)SX@)FYB6QE/3-$)U=)1%1(.B`Q,#`E M.R!"3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E.R!&3TY4.B`Q,'!T(%1I;65S M($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)U9%4E1)0T%, M+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z(')G8B@R,#0L,C4U M+#(P-"DG/B`\=&0@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D3L@ M1D].5#H@,3!P="!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&IU#L@5$585"U)3D1%3E0Z(#`N-6EN)SX@5&AE3L@1D].5#H@,3!P M="!4:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&IU#L@5$585"U) M3D1%3E0Z(#`N-6EN)SX@02!T;W1A;"!O9B`D-#@U+#DX,"!O9B!T:&4@869O M2!C M;VYT:6YU97,@=&\@86-C2!N;W1E2!T:6UE(&%F=&5R M('1H92!S:7@@;6]N=&@@86YN:79E3L@1D].5#H@ M,3!P="!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&IU#L@5$58 M5"U)3D1%3E0Z(#`N-6EN)SX@07,@;V8@36%Y(#$T+"`R,#$T('1H92!#;VUP M86YY(&AA6QE/3-$ M)U1%6%0M04Q)1TXZ(&IU#L@5$585"U)3D1% M3E0Z(#`N-6EN)SX@)FYB3L@1D].5#H@,3!P="!4:6UE2!E;G1E2`R,#$T+B!4;VYA<75I;G0@=V%S(&%L&5R8VES92!F96%T=7)E M+B!4:&4@=V%R&5R8VES92!P2!R871H97(@=&AA;B!A3L@ M1D].5#H@,3!P="!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&IU#L@5$585"U)3D1%3E0Z(#`N-6EN)SX@1'5R:6YG('1H92!F:7)S="!Q=6%R M=&5R(&]F(#(P,30@=&AE($-O;7!A;GD@97AE8W5T960@82!D96)T('-E='1L M96UE;G0@86=R965M96YT('=I=&@@5&]N87%U:6YT(')E;&%T960@=&\@=&AE M(&YO=&4@86YD('=A&5C=71I;VX@;V8@=&AE(&1E8G0@2!A9&IU2`D,S0L,#`P+CPO<#X@ M/'`@3L@1D].5#H@,3!P="!4 M:6UE6QE/3-$ M)T9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE"`P<'0@,"XU:6XG/B`\2!I6%B;&4@=&\@4V]U=&AR:61G92!T M;R!C;W9E'!E;G-E28C,SD[7,@<')I;W(@=&\@8V]N=F5R6QE/3-$)U1%6%0M M04Q)1TXZ(&IU#L@5$585"U)3D1%3E0Z(#`N M-6EN)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&IU#L@5$585"U)3D1%3E0Z(#`N-6EN)SX@1'5R:6YG('1H92!Q=6%R=&5R(&5N M9&5D($1E8V5M8F5R(#,Q+"`R,#$S+"!T:&4@0V]M<&%N>2!D:60@82!P2!D:60@82!P6QE/3-$)U1%6%0M04Q)1TXZ(&IU#L@5$585"U)3D1%3E0Z(#`N-6EN)SX@)FYB6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z(&)O;&0[(%!! M1$1)3D6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U714E'2%0Z(&)O;&0[(%!!1$1)3D6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z M(&)O;&0[(%!!1$1)3D6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@;&5F="<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@ M;&5F="<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@5$585"U!3$E'3CH@65A6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#(E)SXF;F)S<#L\ M+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#$E.R!415A4 M+4%,24=..B!L969T)SX@)FYB6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@5TE$5$@Z(#$S)3L@5$585"U!3$E'3CH@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#$E M.R!415A4+4%,24=..B!L969T)SXE/"]T9#X@/"]T6QE/3-$ M)U9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z(')G M8B@R,#0L,C4U+#(P-"DG/B`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`@3L@1D].5#H@,3!P="!4:6UE3L@1D].5#H@,3!P="!4:6UE6QE/3-$)U!!1$1)3D6QE/3-$ M)U!!1$1)3D6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]5 M3D0M0T],3U(Z("-C8V9F8V,G/B`\=&0@6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T], M3U(Z('=H:71E)SX@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$ M1$E.1RU"3U143TTZ(#(N-7!T)SY4;W1A;#PO=&0^(#QT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,BXU<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS M1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!&3TY4+5-) M6D4Z(#$P<'0G/B`D/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#(N,C5P="!D;W5B;&4[($9/3E0M4TE:13H@,3!P=#L@5$585"U! M3$E'3CH@3L@1D].5#H@,3!P="!4:6UE'!E M;G-E+CPO<#X@/'`@3L@1D]. M5#H@,3!P="!4:6UE3L@1D].5#H@,3!P="!4:6UE6QE/3-$ M)U=)1%1(.B`V,"4[($)/4D1%4BU#3TQ,05!313H@8V]L;&%P6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M4TE:13H@,3!P="<^/'-T6QE M/3-$)T9/3E0M4TE:13H@,3!P="<^/'-T6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]5 M3D0M0T],3U(Z(')G8B@R,#0L,C4U+#(P-"DG/B`\=&0@'!E8W1E9"!T97)M/"]T9#X@/'1D/B9N8G-P.SPO M=&0^(#QT9#XF;F)S<#L\+W1D/B`\=&0@6QE/3-$)U=)1%1(.B`Q)2<^)FYB6QE M/3-$)U=)1%1(.B`Q)2<^)FYB6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@3L@1D].5#H@,3!P="!4:6UE6QE/3-$)U=) M1%1(.B`W,"4[($)/4D1%4BU#3TQ,05!313H@8V]L;&%P6QE/3-$)T9/3E0M4TE: M13H@,3!P="<^870@:7-S=64@9&%T93PO9F]N=#X\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#@W)2<^4')I=F%T M92!/9F9E6QE/3-$)U=)1%1(.B`Q)2<^)FYB6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M M0T],3U(Z('=H:71E)SX@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^ M4')I=F%T92!/9F9E6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@5$585"U!3$E'3CH@6QE M/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N M,C5P="!D;W5B;&4[($9/3E0M4TE:13H@,3!P="<^("0\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&IU M#L@5$585"U)3D1%3E0Z(#`N-6EN)SX@)FYB M3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\V93)E-#8Q85\W M.3,W7S1A9#9?.60R,E\Y,S'0O:'1M;#L@8VAA6QE/3-$)T9/3E0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE"<^(#QS=')O;F<^,3(N(%-(05)%2$],1$524R8C,SD[($1%1DE#245. M0UD\+W-T6QE/3-$)U1%6%0M04Q)1TXZ(&IU#L@5$585"U)3D1%3E0Z(#`N-6EN)SX@)FYB3L@1D].5#H@,3!P="!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&IU#L@5$585"U)3D1%3E0Z(#`N-6EN)SX@ M3VX@36%Y(#(L(#(P,3$@=&AE($-O;7!A;GD@861O<'1E9"!A;F0@97AE8W5T M960@=&AE($5M<&QO>65E2!G2!V97-T960@=7!O;B!I65E(&1I3L@1D].5#H@,3!P="!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&IU#L@5$585"U)3D1%3E0Z(#`N-6EN)SX@1'5R:6YG('1H92!T M:')E92!M;VYT:',@96YD960@36%R8V@@,S$L(#(P,3,L('1H92!#;VUP86YY M(&=R86YT960@,2PP,#`L,#`P('-T;V-K(&]P=&EO;G,@=&\@:71S('1H96X@ M0T5/(&]F('=H:6-H(#(P,"PP,#`@=F5S=&5D(&EM;65D:6%T96QY+B!$=64@ M=&\@:&ES('-U8G-E<75E;G0@3L@1D].5#H@,3!P="!4:6UE65E6QE/3-$)U1%6%0M04Q) M1TXZ(&IU#L@5$585"U)3D1%3E0Z(#`N-6EN M)SX@)FYB2!G2!C;VYS:61E'1E M;G-I;VX@87,@82!M;V1I9FEC871I;VX@=&\@=&AE(&]P=&EO;B!A9W)E96UE M;G1S(')E8V]R9&EN9R!I;F-R96UE;G1A;"!C;VUP96YS871I;VX@97AP96YS M92!O9B`D,38L.3(P(&9O6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`\=&0^)FYB6QE/3-$)T9/3E0M5T5)1TA4.B!B;VQD)SXF;F)S<#L\ M+W1D/B`\=&0@6QE M/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z M(')G8B@R,#0L,C4U+#(P-"DG/B`\=&0@6QE/3-$)U=)1%1(.B`Q)3L@1D].5"U714E'2%0Z(&)O;&0G/B9N8G-P M.SPO=&0^(#QT9"!S='EL93TS1"=724142#H@,24[($9/3E0M5T5)1TA4.B!B M;VQD.R!415A4+4%,24=..B!L969T)SX@)FYB6QE M/3-$)U=)1%1(.B`R,"4[($9/3E0M5T5)1TA4.B!B;VQD.R!415A4+4%,24=. M.B!R:6=H="<^(#`N,#`\+W1D/B`\=&0@6QE/3-$)T9/3E0M5T5)1TA4 M.B!B;VQD.R!415A4+4%,24=..B!R:6=H="<^/&9O;G0@6QE/3-$)T9/3E0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)U9%4E1) M0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z(')G8B@R,#0L M,C4U+#(P-"DG/B`\=&0@6QE/3-$)T9/ M3E0M5T5)1TA4.B!B;VQD.R!415A4+4%,24=..B!L969T)SXF;F)S<#L\+W1D M/B`\=&0@6QE/3-$)T9/3E0M5T5)1TA4.B!B M;VQD.R!415A4+4%,24=..B!L969T)SXE/"]T9#X@/'1D/B9N8G-P.SPO=&0^ M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)SXF;F)S<#L\+W1D/B`\ M=&0@6QE/3-$)T9/3E0M5T5)1TA4.B!B;VQD.R!415A4+4%,24=..B!C96YT97(G M/CQF;VYT('-T>6QE/3-$)T9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B9N8G-P.SPO=&0^(#PO='(^(#PO=&%B;&4^(#QP('-T M>6QE/3-$)T9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE"<^("9N8G-P.SPO<#X@/'1A8FQE('-T>6QE M/3-$)U=)1%1(.B`Q,#`E.R!"3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E.R!& M3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E2P@=V4@=7-E9"!A;B!E>'!E8W1E M9"!D:79I9&5N9"!R871E(&]F('IE6QE/3-$)U9%4E1)0T%, M+4%,24=..B!T;W`G/B`\=&0^)FYB6QE/3-$)T9/ M3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2!C;VYS M=&%N="!M871U2!I;G1E6QE/3-$)U1%6%0M M04Q)1TXZ(&IU#L@5$585"U)3D1%3E0Z(#`N M-6EN)SX@)FYB2!R96-O9VYI>F5D(&5X<&5N'!E;G-E(&]F M("0S+#$U,"!F;W(@3L@1D].5#H@ M,3!P="!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&IU#L@5$58 M5"U)3D1%3E0Z(#`N-6EN)SX@1'5R:6YG('1H92!T:')E92!M;VYT:',@96YD M960@36%R8V@@,S$L(#(P,3,L('1H92!#;VUP86YY(')E8V]G;FEZ960@97AP M96YS92!O9B`D,30L,C4P(&9O3L@1D].5#H@,3!P="!4:6UE6QE/3-$)T9/3E0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE"<^ M(#QS=')O;F<^/'4^4')E9F5R2!B92!D96-L87)E9"!O2!T:6UE(&]R(&EN('!A M7,F(S,Y.R!N;W1I8V4L M(&%T('1H92!O<'1I;VX@;V8@=&AE($-O;7!A;GDL(&%T(&$@6QE M/3-$)U1%6%0M04Q)1TXZ(&IU#L@5$585"U) M3D1%3E0Z(#`N-6EN)SX@)FYB3L@1D].5#H@,3!P="!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&IU#L@5$585"U)3D1%3E0Z(#`N-6EN)SX@070@:71S($1E8V5M8F5R M(#(L(#(P,3`@;65E=&EN9RP@=&AE($-422!";V%R9"!O9B!$:7)E8W1O2`H=&AE(")#;VUM;VX@4VAA2!A;B!I;G9E3L@1D].5#H@,3!P="!4:6UE2!I6QE/3-$)U1%6%0M04Q)1TXZ(&IU#L@5$585"U)3D1%3E0Z(#`N-6EN)SX@)FYB28C,SD[2!N;W1E(&EN=&\@-#`P('-H87)E M3L@1D].5#H@,3!P="!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&IU#L@5$585"U)3D1%3E0Z(#`N-6EN)SX@169F96-T:79E($IU M;F4@,38L(#(P,3$L(%=I;&QI86T@4BX@5V%T97)S+"!,=&0N(&]F($-A;F%D M82!C;VYV97)T960@;VYE(&AA;&8@;V8@:71S(%-E3L@1D].5#H@,3!P="!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&IU M#L@5$585"U)3D1%3E0Z(#`N-6EN)SX@5&AE M(')I9VAT3L@1D].5#H@,3!P="!4:6UE6QE/3-$)U9%4E1)0T%,+4%,24=..B!T;W`G M/B`\=&0@6QE/3-$)TU!4D=)3CH@,'!T(#!P>"<^1&EV:61E;F0@6QE/3-$)T9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE2!B87-I6QE M/3-$)U=)1%1(.B`X)2<^)FYB6QE/3-$)T9/3E0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)T9/3E0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE3L@1D].5#H@,3!P="!4:6UE6QE/3-$)U9%4E1)0T%,+4%,24=..B!T M;W`G/B`\=&0@2!A3L@1D].5#H@,3!P="!4:6UE6QE/3-$)U9%4E1)0T%,+4%,24=. M.B!T;W`G/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&IU#L@ M5$585"U)3D1%3E0Z(#`N-6EN)SX@)FYB6QE/3-$)U=)1%1(.B`X)2<^)FYB M6QE/3-$)T9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE6QE/3-$)T9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE28C,SD[2!W:6QL(&)E(')E8V]R9&5D(&%T(&9A:7(@=F%L M=64@;VX@96%C:"!R97!O2!C:&%N9V4@6QE/3-$)U1%6%0M04Q)1TXZ M(&IU#L@5$585"U)3D1%3E0Z(#`N-6EN)SX@ M)FYB3L@1D].5#H@ M,3!P="!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&IU#L@5$58 M5"U)3D1%3E0Z(#`N-6EN)SX@5&AE($-O;7!A;GD@2X\+W`^(#QP('-T>6QE/3-$)U1% M6%0M04Q)1TXZ(&IU#L@5$585"U)3D1%3E0Z M(#`N-6EN)SX@)FYB3L@1D].5#H@,3!P="!4:6UE65A6QE/3-$)U1%6%0M04Q)1TXZ(&IU#L@5$585"U)3D1%3E0Z(#`N-6EN)SX@)FYB2!I'!E;G-E(&EN('1H92!T:')E92!M;VYT:',@96YD960@ M36%R8V@@,S$L(#(P,30@86YD(#(P,3,N/"]P/B`\<"!S='EL93TS1"=415A4 M+4%,24=..B!J=7-T:69Y.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L M+F1T9"(@+2T^/&1I=CX@/&1I=CX\(2TM4W1A#L@5$585"U)3D1%3E0Z M(#`N-6EN)SX@07,@;V8@36%R8V@@,S$L(#(P,30L($-422!A;F0@:71S(&UA M:F]R:71Y(&]W;F5D('-U8G-I9&EA#L@5$585"U)3D1%3E0Z(#`N-6EN)SX@5V4@:&%V92!E;F=A9V5D(%(N M1BX@3&%F9F5R='D@)F%M<#L@0V\N('1O('-E96L@86X@86-Q=6ES:71I;VX@ M<&%R=&YE2!,869F97)T>2!A(#$P)2!F:6YD M97(F(S,Y.W,@9F5E(&EN('1H92!E=F5N="!A;B!A8W%U:7-I=&EO;B!P87)T M;F5R(&ES(&9O=6YD+"!W:&EC:"!M86YA9V5M96YT(&AA3L@1D].5#H@,3!P M="!4:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&IU#L@5$585"U) M3D1%3E0Z(#`N-6EN)SX@/&5M/D-O;G1I;F=E;F-I97,@+2!,:71I9V%T:6]N M/"]E;3X\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU#L@5$585"U)3D1%3E0Z(#`N-6EN)SX@/&5M/B9N8G-P.SPO M96T^/"]P/B`\<"!S='EL93TS1"=415A4+4%,24=..B!J=7-T:69Y.R!&3TY4 M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E7-T96EN M92!A7,L(&%N9"!S965K:6YG(&UO;F5T87)Y(&1A;6%G97,L('!U;FET M:79E(&1A;6%G97,L(&%T=&]R;F5YGEM92!B M92!A9&1E9"!A6QE/3-$)U1%6%0M04Q)1TXZ(&IU#L@5$585"U)3D1%3E0Z(#`N-6EN)SX@)FYB2!O9B!O=7(@<&%T96YT(&%N9"!T:&ES(')E<75E&%M:6YE6EN9R!F=7)T:&5R(&%C M=&EO;BP@=&AA="!A<'!E86P@=V%S(&%L&%M M:6YE6QE/3-$)U1%6%0M04Q)1TXZ(&IU#L@5$585"U)3D1%3E0Z(#`N-6EN)SX@)FYB"!087)T92!2965X86UI;F%T:6]N($-E2!H87,@8F5G=6X@8V]L;&5C=&EN9R!U;G!A:60@ M86UO=6YT6QE/3-$)U1%6%0M04Q)1TXZ(&IU#L@5$585"U)3D1%3E0Z(#`N-6EN)SX@/&5M/B9N8G-P.SPO96T^/"]P/B`\ M<"!S='EL93TS1"=415A4+4%,24=..B!J=7-T:69Y.R!&3TY4.B`Q,'!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E65E(&9I;&5D(&$@=VAI2!A;F0@2&5A;'1H($%D;6EN M:7-T2X\+W`^(#QP('-T>6QE/3-$)T9/3E0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE"<^("9N8G-P.SPO<#X@/'`@3L@1D].5#H@,3!P="!4:6UE2!T:&4@1$], M($%D;6EN:7-T3L@1D].5#H@,3!P="!4:6UE M6QE/3-$)U1% M6%0M04Q)1TXZ(&IU#L@5$585"U)3D1%3E0Z M(#`N-6EN)SX@26X@36%Y(#(P,#8L('1H92!5+E,N($-O=7)T(&]F($%P<&5A M;',@9F]R('1H92!396-O;F0@0VER8W5I="!V86-A=&5D('1H92!O2!A;B!A9&UI;FES=')A=&EV92!L87<@:G5D9V4N(%5L=&EM871E;'DL('1H M92!E;7!L;WEE92!V;VQU;G1A2!D:7-M:7-S960@=&AE(&%P<&5A;"X\ M+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU#L@5$585"U)3D1%3E0Z(#`N-6EN)SX@)FYBFEN9R!T:&4@8G5R9&5N+7-H:69T:6YG M('-T86YD87)D(&%R=&EC=6QA=&5D(&)Y('1H92!!4D(N($EN($IA;G5A65E(&%P<&5A;&5D('1H92!R=6QI;F<@=&\@=&AE($%20BX@3VX@4V5P M=&5M8F5R(#,P+"`R,#$Q+"!T:&4@05)"(&ES65E)B,S.3MS M(&-O;7!L86EN="X@5&AE(&5M<&QO>65E(&AA65E)B,S.3MS(&%P<&5A;"!F3L@1D].5#H@,3!P="!4:6UE3PO96T^("T@5V4@;6%Y(&)E(&$@<&%R='D@=&\@ M;W1H97(@;&5G86P@86-T:6]N2!I;F-U2!R96-O=F5R+"!A;F0@=V4@:&%V92!N;W0@ M'!E;G-E3L@1D]. M5#H@,3!P="!4:6UE2!C;W5R2!O2P@9&5P96YD:6YG(&]N('1H92!A;6]U;G0@86YD('1I;6EN M9RP@:&%V92!A(&UA=&5R:6%L(&%D=F5R3L@1D].5#H@,3!P M="!4:6UE'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M'0^)SPA+2U$3T-4 M65!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I M=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78^/"$M+5-T M87)T1G)A9VUE;G0M+3X@/'`@3L@1D].5#H@ M,3!P="!4:6UE3L@1D].5#H@,3!P="!4:6UE'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'0^)SPA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z M+R]W=W&AT;6PQ+71R86YS:71I;VYA M;"YD=&0B("TM/CQD:78^(#QD:78^/"$M+5-T87)T1G)A9VUE;G0M+3X@/'`@ M#L@5$585"U)3D1% M3E0Z(#`N-6EN)SX@3VX@07!R:6P@."P@,C`Q-"P@37(N($=I=7-E<'!E($UA M6QE M/3-$)U1%6%0M04Q)1TXZ(&IU#L@5$585"U) M3D1%3E0Z(#`N-6EN)SX@)FYB2!W:&EC:"!W87,@&EM871E;'D@-S`E(&]F(&=R;W-S($-A;&UAF5D(&%N9"!S=6)S97%U M96YT;'D@9&5E;65D(&YU;&P@86YD('9O:60@87,@9&ES8VQO6QE/3-$)U1% M6%0M04Q)1TXZ(&IU#L@5$585"U)3D1%3E0Z M(#`N-6EN)SX@)FYB2!W;W5L9"!N;R!L;VYG97(@:&]L9"!I='-E M;&8@;W5T(&%S(&%N(&%G96YT(&]F('1H92!'3L@1D].5#H@,3!P="!4:6UE M6QE/3-$)U1% M6%0M04Q)1TXZ(&IU"<^(%1H92!#;VUP86YY M(')E7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T M9"(@+2T^/&1I=CX@/&1I=CX\(2TM4W1A3L@1D].5#H@,3!P="!4:6UE6QE/3-$)U9% M4E1)0T%,+4%,24=..B!B;W1T;VTG/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE M/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U9%4E1) M0T%,+4%,24=..B!B;W1T;VTG/B`\=&0@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)! M0TM'4D]53D0M0T],3U(Z(')G8B@R,#0L,C4U+#(P-"DG/B`\=&0@6QE/3-$)U=)1%1(.B`Q,"4[(%1%6%0M04Q)1TXZ(')I M9VAT.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)U=)1%1(.B`Q)3L@5$585"U! M3$E'3CH@;&5F=#L@1D].5#H@,3!P="!4:6UE6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM' M4D]53D0M0T],3U(Z('=H:71E)SX@/'1D('-T>6QE/3-$)T)!0TM'4D]53D0M M0T],3U(Z('=H:71E)SXF;F)S<#L\+W1D/B`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`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA&AT;6PQ+T141"]X:'1M M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I=CX\(2TM4W1A"<^("9N8G-P.SPO<#X@/'1A8FQE('-T>6QE/3-$)U=)1%1( M.B`Q,#`E.R!"3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E.R!&3TY4.B`Q,'!T M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)T9/3E0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE M/3-$)T9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)U=)1%1(.B`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`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M'0^ M)SPA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q M+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD M:78^/"$M+5-T87)T1G)A9VUE;G0M+3X@/'`@3L@1D].5#H@,3!P="!4:6UE6QE/3-$)U9%4E1)0T%,+4%,24=. M.B!B;W1T;VTG/B`\=&0@6QE M/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T9/ M3E0Z(&)O;&0@,3!P="!4:6UE6QE/3-$)U=)1%1(.B`Q,"4[(%1%6%0M M04Q)1TXZ(')I9VAT.R!&3TY4.B!B;VQD(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$)U=) M1%1(.B`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`N-6EN)SX@4')O<&5R='D@86YD(&5Q=6EP;65N M="P@;F5T+"!C;VYS:7-T(&]F('1H92!F;VQL;W=I;F6QE/3-$)U9%4E1) M0T%,+4%,24=..B!B;W1T;VTG/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T9/3E0Z(&)O;&0@,3!P="!4:6UE6QE/3-$)T9/ M3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)U=)1%1(.B`W,B4[(%1%6%0M04Q)1TXZ(&QE9G0[($9/3E0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2!A;F0@97%U:7!M96YT+"!G6QE/3-$)U=)1%1(.B`Q)3L@5$585"U!3$E'3CH@;&5F=#L@1D]. M5#H@,3!P="!4:6UE6QE/3-$)U=)1%1(.B`Q)3L@5$585"U!3$E' M3CH@;&5F=#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P M="!S;VQI9#L@5$585"U!3$E'3CH@;&5F=#L@1D].5#H@8F]L9"`Q,'!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P="!S;VQI9#L@5$58 M5"U!3$E'3CH@6QE/3-$ M)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE M/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z M(')G8B@R,#0L,C4U+#(P-"DG/B`\=&0@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#(N-7!T(&1O=6)L93L@5$585"U!3$E'3CH@;&5F=#L@1D]. M5#H@8F]L9"`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E#L@5$585"U)3D1%3E0Z(#`N-6EN)SX@ M)FYB3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\V93)E-#8Q M85\W.3,W7S1A9#9?.60R,E\Y,S'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'!E;G-E6QE/3-$)U1%6%0M04Q)1TXZ(&IU#L@5$585"U)3D1%3E0Z(#`N-6EN)SX@06-C'!E;G-E6QE/3-$)T9/ M3E0M4TE:13H@,3!P="<^)FYB6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z(&)O;&0[(%!!1$1)3D6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@5$585"U!3$E'3CH@8V5N=&5R)SXF;F)S<#L\+W1D/B`\=&0@6%L=&EE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#$E.R!&3TY4 M+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4 M+5-)6D4Z(#$P<'0[(%=)1%1(.B`Q)3L@1D].5"U714E'2%0Z(&)O;&0[(%1% M6%0M04Q)1TXZ(&QE9G0G/B`D/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@5TE$5$@Z(#$Q)3L@1D].5"U714E'2%0Z(&)O;&0[(%1%6%0M M04Q)1TXZ(')I9VAT)SX@,34U+#(P.#PO=&0^(#QT9"!S='EL93TS1"=&3TY4 M+5-)6D4Z(#$P<'0[(%=)1%1(.B`Q)3L@1D].5"U714E'2%0Z(&)O;&0[(%1% M6%0M04Q)1TXZ(&QE9G0G/B`F;F)S<#L\+W1D/B`\=&0@6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z(&)O;&0G/B9N8G-P.SPO M=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4 M.B!B;VQD.R!415A4+4%,24=..B!L969T)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z(&)O;&0[(%1% M6%0M04Q)1TXZ(')I9VAT)SX@,3,U+#`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`L,#`P/"]T9#X@/'1D('-T>6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z(&)O;&0[(%1%6%0M04Q) M1TXZ(&QE9G0G/B`F;F)S<#L\+W1D/B`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`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA6%B;&4\+W1D/@T*("`@ M("`@("`\=&0@8VQA6QE/3-$)T9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M#L@5$585"U)3D1%3E0Z(#`N-6EN M)SX@3F]T97,@<&%Y86)L92!C;VYS:7-T(&]F('1H92!F;VQL;W=I;F6QE M/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z(&)O;&0[ M(%1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)FYB6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VT[ M($)!0TM'4D]53D0M0T],3U(Z(')G8B@R,#0L,C4U+#(P-"DG/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#$E.R!&3TY4 M+5=%24=(5#H@8F]L9#L@5$585"U!3$E'3CH@;&5F="<^("0\+W1D/B`\=&0@ M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#$E)SXF M;F)S<#L\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z(&)O;&0G M/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/ M3E0M5T5)1TA4.B!B;VQD.R!415A4+4%,24=..B!L969T)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z M(&)O;&0[(%1%6%0M04Q)1TXZ(')I9VAT)SX@,C(U+#`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`P+#`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`F;F)S<#L\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U714E'2%0Z(&)O;&0[(%!!1$1)3D6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED M.R!&3TY4+5=%24=(5#H@8F]L9#L@5$585"U!3$E'3CH@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ(#%P=#L@ M5$585"U!3$E'3CH@;&5F="<^("9N8G-P.SPO=&0^(#PO='(^(#QT6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@5$585"U!3$E'3CH@;&5F="<^3F]T97,@4&%Y86)L92P@9W)O6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U714E'2%0Z(&)O;&0[(%1%6%0M04Q)1TXZ(&QE9G0G/B`F M;F)S<#L\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U714E'2%0Z(&)O;&0[(%!!1$1)3D6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+4)/5%1/33H@8FQA8VL@,7!T M('-O;&ED.R!&3TY4+5=%24=(5#H@8F]L9#L@5$585"U!3$E'3CH@6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M M0T],3U(Z(')G8B@R,#0L,C4U+#(P-"DG/B`\=&0@6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@0D]21$52+4)/5%1/33H@8FQA8VL@,BXU<'0@9&]U8FQE M.R!&3TY4+5=%24=(5#H@8F]L9#L@5$585"U!3$E'3CH@;&5F="<^("0\+W1D M/B`\=&0@6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ(#(N-7!T.R!415A4+4%, M24=..B!L969T)SX@)FYB3L@1D].5#H@,3!P="!4:6UE6QE M/3-$)T9/3E0M4TE:13H@,3!P="<^4')I;F-I<&%L/"]F;VYT/B`\8G(@+SX@ M/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M4TE:13H@,3!P="<^0V%R6QE/3-$)U!! M1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M M4TE:13H@,3!P="<^4W1O8VL\+V9O;G0^(#QB6QE/3-$)U!!1$1)3D6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#,R)2<^.3`@9&%Y($-O;G9E6QE/3-$)U=)1%1(.B`Q)2<^)FYB6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#$E)SXD/"]T9#X@/'1D('-T>6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#$E)SXE/"]T9#X@/'1D('-T>6QE M/3-$)U=)1%1(.B`Q)2<^)FYB6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@5TE$5$@Z(#$E)SXD/"]T9#X@/'1D('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@6QE/3-$)U=)1%1(.B`Q)2<^)FYB6QE/3-$)U=)1%1(.B`Q)2<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@8V5N=&5R.R!7 M24142#H@,34E)SY687)I;W5S(#(P,30\+W1D/B`\+W1R/B`\='(@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)3PO=&0^(#QT9#XF;F)S M<#L\+W1D/B`\=&0^)FYB6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@5$585"U!3$E'3CH@6QE/3-$)T9/3E0M4TE:13H@,3!P="<^ M36%R8V@@,C`Q-"`M/"]F;VYT/CQB6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@8V5N=&5R)SY-87D@,C`Q-#PO=&0^ M(#PO='(^(#QT6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@6QE/3-$)T9/3E0M4TE:13H@,3!P="<^8FED/"]F;VYT/CPO=&0^ M(#QT9#XF;F)S<#L\+W1D/B`\=&0^)FYB6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@8V5N=&5R)SY*=6YE(#(P M,30\+W1D/B`\+W1R/B`\='(@6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@5$585"U!3$E'3CH@6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U14 M3TTZ(#%P=#L@5$585"U!3$E'3CH@6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ(#%P M=#L@5$585"U!3$E'3CH@6QE/3-$ M)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U9%4E1)0T%, M+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z(')G8B@R,#0L,C4U M+#(P-"DG/B`\=&0@6%B;&4L(&=R;W-S/"]T9#X@/'1D M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N,C5P="!D;W5B M;&4[($9/3E0M4TE:13H@,3!P="<^("0\+W1D/B`\=&0@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P="!S;VQI9#L@1D].5"U325I%.B`Q M,'!T.R!415A4+4%,24=..B!R:6=H="<^(#,L,3$V+#DY.#PO=&0^(#QT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,BXU<'0G/B9N8G-P.SPO=&0^(#QT M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,BXU<'0G/B9N8G-P.SPO=&0^ M(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,BXU<'0G/B9N8G-P.SPO M=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,BXU<'0[(%1%6%0M M04Q)1TXZ(')I9VAT)SXF;F)S<#L\+W1D/B`\=&0@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE M/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#(N,C5P="!D;W5B;&4[($9/3E0M4TE:13H@ M,3!P=#L@5$585"U!3$E'3CH@6QE/3-$)U!!1$1) M3D6QE/3-$)U!! M1$1)3D6QE/3-$ M)U!!1$1)3D6QE M/3-$)U!!1$1)3D3L@ M1D].5#H@,3!P="!4:6UE6QE/3-$)T9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE"`P<'0@,"XU:6X[(%1% M6%0M24Y$14Y4.B`P+C5I;B<^("9N8G-P.R9N8G-P.R@Q*2!/3L@1D]. M5#H@,3!P="!4:6UE2!#;VYV97)T:6)L92!.;W1E'0^)SPA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T14 M1"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM M/CQD:78^(#QD:78^/"$M+5-T87)T1G)A9VUE;G0M+3X@/'`@3L@1D].5#H@,3!P="!4:6UE2!H87,@:7-S=65D(#DP+61A>2!N;W1E M3L@1D].5#H@,3!P="!4 M:6UE6QE/3-$)U9% M4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z(')G8B@R M,#0L,C4U+#(P-"DG/B`\=&0@6QE/3-$)U=)1%1(.B`Q)2<^ M)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$ M5$@Z(#$E)SXD/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M5$585"U!3$E'3CH@6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ(#%P="<^,C`Q,3PO=&0^(#QT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,7!T)SXF;F)S<#L\+W1D/B`\=&0@ M6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#(N,C5P="!D;W5B;&4[($9/3E0M4TE:13H@,3!P="<^("0\+W1D/B`\ M=&0@6QE/3-$)U1%6%0M M04Q)1TXZ(&IU#L@5$585"U)3D1%3E0Z(#`N M-6EN)SX@)FYB'0^)SQS<&%N/CPO6QE/3-$)U1%6%0M M04Q)1TXZ(&IU#L@5$585"U)3D1%3E0Z(#`N M-6EN)SX@5V4@97-T:6UA=&5D('1H92!F86ER('9A;'5E(&]F('1H92!W87)R M86YT6QE/3-$)U=)1%1(.B`X,"4[($)/4D1%4BU#3TQ,05!313H@8V]L;&%P M6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ(#%P="<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z(&)O M;&0[(%!!1$1)3D6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z(&)O;&0[(%!!1$1)3D6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U7 M14E'2%0Z(&)O;&0[(%!!1$1)3D2`Q-"P\8G(@+SX@,C`Q-#PO=&0^(#QT M9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD M.R!0041$24Y'+4)/5%1/33H@,7!T)SX@)FYB6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M M0T],3U(Z(')G8B@R,#0L,C4U+#(P-"DG/B`\=&0@'!E8W1E9"!T97)M/"]T M9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@;&5F M="<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M5$585"U!3$E'3CH@65A6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@;&5F="<^)FYB6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)! M0TM'4D]53D0M0T],3U(Z('=H:71E)SX@/'1D('-T>6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@5TE$5$@Z(#0Y)2<^5F]L871I;&ET>3PO=&0^(#QT9"!S='EL M93TS1"=&3TY4+5-)6D4Z(#$P<'0[(%=)1%1(.B`R)2<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#$E.R!415A4 M+4%,24=..B!L969T)SX@)FYB6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@5TE$5$@Z(#$S)3L@5$585"U!3$E'3CH@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#$E M.R!415A4+4%,24=..B!L969T)SXE/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@5TE$5$@Z(#(E)SXF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$58 M5"U!3$E'3CH@;&5F="<^4FES:R!&6QE/3-$)U1%6%0M04Q)1TXZ(&IU#L@5$585"U)3D1%3E0Z(#`N-6EN)SX@5&AE('!R;V-E961S M(&]F('1H92!.;W1E6QE/3-$)U1%6%0M04Q) M1TXZ(&IU#L@5$585"U)3D1%3E0Z(#`N-6EN M)SX@)FYB6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VTG M/B`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P="!S M;VQI9"<@8V]L6QE M/3-$)T9/3E0M4TE:13H@,3!P="<^4')O8V5E9',@86QL;V-A=&5D/"]F;VYT M/B`\8G(@+SX@/&9O;G0@6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]5 M3D0M0T],3U(Z("-C8V9F8V,G/B`\=&0@6QE/3-$)U=)1%1(.B`Q)2<^)FYB6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#$E)SXD/"]T9#X@/'1D('-T M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$1$E. M1RU"3U143TTZ(#%P="<^0F5N969I8VEA;"!#;VYV97)S:6]N(&9E871U6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P="!S M;VQI9"<^)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#%P="!S;VQI9#L@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=. M.B!R:6=H="<^(#6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D3L@1D].5#H@,3!P="!4:6UE'0^)SQS<&%N/CPO6QE/3-$)U1%6%0M04Q)1TXZ(&IU#L@5$58 M5"U)3D1%3E0Z(#`N-6EN)SX@5V4@97-T:6UA=&5D('1H92!F86ER('9A;'5E M(&]F('1H92!W87)R86YT6QE/3-$)U=)1%1(.B`V,"4[($)/4D1%4BU#3TQ, M05!313H@8V]L;&%P6QE/3-$)U!!1$1)3D6QE/3-$)T9/ M3E0M4TE:13H@,3!P="<^/'-T6QE/3-$)T9/3E0M4TE:13H@,3!P="<^/'-T M6QE/3-$)U9%4E1)0T%,+4%, M24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z(')G8B@R,#0L,C4U+#(P M-"DG/B`\=&0@'!E8W1E9"!T M97)M/"]T9#X@/'1D/B9N8G-P.SPO=&0^(#QT9#XF;F)S<#L\+W1D/B`\=&0@ M6QE/3-$)U=)1%1(.B`Q)2<^ M)FYB6QE/3-$)U=)1%1(.B`Q)2<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@ M'0^)SPA+2U$3T-465!%(&AT;6P@4%5"3$E# M("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT M='`Z+R]W=W&AT;6PQ+71R86YS:71I M;VYA;"YD=&0B("TM/CQD:78^(#QD:78^/"$M+5-T87)T1G)A9VUE;G0M+3X@ M/'`@3L@1D].5#H@,3!P="!4 M:6UE6QE/3-$)U=)1%1(.B`W,"4[($)/4D1%4BU#3TQ,05!313H@8V]L M;&%P6QE/3-$)T9/3E0M4TE:13H@,3!P="<^870@:7-S=64@9&%T93PO9F]N=#X\ M+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$ M5$@Z(#@W)2<^4')I=F%T92!/9F9E6QE/3-$)U=)1%1(.B`Q)2<^)FYB6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T M;VT[($)!0TM'4D]53D0M0T],3U(Z('=H:71E)SX@/'1D('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3!P="<^4')I=F%T92!/9F9E6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#(N,C5P="!D;W5B;&4[($9/3E0M4TE:13H@,3!P="<^ M("0\+W1D/B`\=&0@6QE/3-$ M)U1%6%0M04Q)1TXZ(&IU#L@5$585"U)3D1% M3E0Z(#`N-6EN)SX@)FYB3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%\V93)E-#8Q85\W.3,W7S1A9#9?.60R,E\Y,S'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^)SPA+2U$3T-465!%(&AT;6P@4%5" M3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@ M(FAT='`Z+R]W=W&AT;6PQ+71R86YS M:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78^/"$M+5-T87)T1G)A9VUE;G0M M+3X@/'`@3L@1D].5#H@,3!P M="!4:6UE6QE/3-$)T9/3E0M5T5)1TA4.B!B;VQD.R!415A4+4%,24=..B!C M96YT97(G(&-O;'-P86X],T0R/B!4:')E93QB6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T M;VTG/B`\=&0@6QE/3-$)T9/3E0M5T5)1TA4.B!B;VQD.R!0041$24Y' M+4)/5%1/33H@,7!T)SXF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T9/3E0M5T5) M1TA4.B!B;VQD.R!0041$24Y'+4)/5%1/33H@,7!T)SXF;F)S<#L\+W1D/B`\ M=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P="!S;VQI9#L@ M5$585"U!3$E'3CH@8V5N=&5R)R!C;VQS<&%N/3-$,CY-87)C:"9N8G-P.S,Q M+#QB6QE/3-$)U!!1$1)3D6QE/3-$)U=)1%1(.B`U-"4[(%1%6%0M M04Q)1TXZ(&QE9G0G/D1I=FED96YD('EI96QD("@Q*3PO=&0^(#QT9"!S='EL M93TS1"=724142#H@,24[($9/3E0M5T5)1TA4.B!B;VQD)SXF;F)S<#L\+W1D M/B`\=&0@6QE/3-$)U=)1%1(.B`Q)3L@1D].5"U7 M14E'2%0Z(&)O;&0[(%1%6%0M04Q)1TXZ(&QE9G0G/B4\+W1D/B`\=&0@6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T M;VT[($)!0TM'4D]53D0M0T],3U(Z('=H:71E)SX@/'1D('-T>6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/D5X<&5C=&5D('9O;&%T:6QI='D@*#(I/"]T9#X@ M/'1D('-T>6QE/3-$)T9/3E0M5T5)1TA4.B!B;VQD)SXF;F)S<#L\+W1D/B`\ M=&0@6QE/3-$)T9/3E0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4.B`Q,'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/E)I6QE/3-$)T9/3E0M5T5)1TA4.B!B;VQD.R!415A4+4%,24=..B!R:6=H M="<^,2XW,CPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5=%24=(5#H@8F]L9#L@ M5$585"U!3$E'3CH@;&5F="<^)3PO=&0^(#QT9#XF;F)S<#L\+W1D/B`\=&0@ M6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SXP+C8S/"]T9#X@/'1D('-T>6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B4\+W1D/B`\+W1R/B`\='(@6QE/3-$)T9/3E0M5T5)1TA4.B!B M;VQD)SXF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T9/3E0M5T5)1TA4.B!B;VQD.R!415A4+4%,24=. M.B!L969T)SXF;F)S<#L\+W1D/B`\=&0^)FYB6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS M1"=415A4+4%,24=..B!C96YT97(G/CQF;VYT('-T>6QE/3-$)T9/3E0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)U9%4E1)0T%, M+4%,24=..B!T;W`G/B`\=&0@6QE M/3-$)T9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)T9/ M3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'!E'!E8W1E9"!L:69E(&EN M('EE87)S+CPO=&0^(#PO='(^(#QT7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M2!;365M8F5R73QB2!M961I8V%L(&1E=FEC92!T96-H;F]L M;V=Y(%M-96UB97)=/&)R/E-A;&5S(&]F('-U<'!L:65S(&%N9"!T6UE;G1S(&%N9"!T:&4@2!;365M8F5R73QB'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6EN9R!A;6]U;G0\+W1D/@T*("`@("`@("`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`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\V93)E M-#8Q85\W.3,W7S1A9#9?.60R,E\Y,S'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA'0^ M)SQS<&%N/CPO'!E M;G-E'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA'0^)SQS M<&%N/CPO2!A;F0@97%U:7!M96YT+"!G'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%\V93)E-#8Q85\W.3,W7S1A9#9?.60R,E\Y,S'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M6%B;&4\+W1D/@T*("`@ M("`@("`\=&0@8VQA'!E;G-E'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO6UE;G0@=&\@8W)E9&ET;W)S/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%\V93)E-#8Q85\W.3,W7S1A9#9?.60R,E\Y,S'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R6%B M;&4Z/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO6%B;&4L(&=R M;W-S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#0Y."PY.#`\ M'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO6%B;&4Z M/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO6%B;&4L(&=R M;W-S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,C4L,#`P/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S2!$871E+"!S=&%R=&EN9R!D871E/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$=&5X=#Y-87(@,S$L#0H)"3(P,30\2!$871E+"!E;F1I;F<@9&%T93PO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^2G5N(#,P+`T*"0DR,#$T M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6%B;&4Z/"]S=')O;F<^ M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!$871E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X M=#Y-87D@,S$L#0H)"3(P,30\6%B;&4@*%!A'0^)SQS<&%N M/CPO6EE;&0@<&5R8V5N M=&%G93PO=&0^#0H@("`@("`@(#QT9"!C;&%S6%B;&4Z/"]S=')O;F<^/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)S'0^)SQS<&%N M/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^075G(#,Q+`T*"0DR M,#$T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6%B;&4Z/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO2!$871E/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$=&5X=#Y*86X@,S$L#0H)"3(P,34\6%B;&4@ M*%!A'0^)SQS<&%N/CPO6EE;&0@<&5R8V5N=&%G93PO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^ M)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^36%R(#,Q+`T* M"0DR,#$W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO M2!E>&5C=71E9"!A(&1E8G0@'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA2!#;VYV97)T M:6)L92!.;W1E'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)S(@>65A'0^)S0@>65A M7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`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`@("`@("`\=&0@8VQA M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^2G5N(#,P+`T*"0DR,#$T/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO6UE;G0\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3QS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6UE;G1S+"!S=&%R="!D871E/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^2F%N(#,Q+`T* M"0DR,#$T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)S(@>65A'0^)SQS M<&%N/CPO'0^ M)S0@>65A'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6UE;G0@9F]R M('-E='1L96UE;G0@;V8@;F]T93PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!E>&5C=71E9"!A(&1E8G0@'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA65E(&1I65E'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'!E;G-E M/"]T9#X-"B`@("`@("`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`T*"0DR,#$R/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)TAO;&1E'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)S$@>65A7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2!3:&%R92UB87-E9"!087EM96YT($%W M87)D(%M,:6YE($ET96US73PO'0^)SQS<&%N/CPO2P@;6EN:6UU;3PO=&0^#0H@("`@("`@(#QT9"!C M;&%S&EM=6T\+W1D/@T*("`@("`@("`\=&0@8VQA'!E8W1E9"!L:79E'0^)S4@>65A'0^)SQS<&%N M/CPO'0^ M)S(@>65A'0^)SQS<&%N/CPO6UE;G0@07=A'0^)SQS<&%N/CPO2P@=V4@=7-E9"!A;B!E>'!E8W1E9"!D:79I9&5N9"!R M871E(&]F('IE'!E'!E8W1E9"!L:69E(&EN('EE87)S+CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$:6YN97)&;V]T;F]T93X-"B`@ M("`@("`@/'1D('9A;&EG;CTS1'1O<#Y;,UT\+W1D/@T*("`@("`@("`\=&0@ M8V]L'!E8W1E9"!L:69E(&]F('1H M92!O<'1I;VYS(&=R86YT960N/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T M86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T M7S9E,F4T-C%A7S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6UE;G0@ M;V)L:6=A=&EO;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^ M)SQS<&%N/CPO'0^ M)SQS<&%N/CPO3X- M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\V93)E-#8Q85\W.3,W7S1A M9#9?.60R,E\Y,S'0O:'1M M;#L@8VAA&UL;G,Z;STS1")U'1087)T7S9E,F4T-C%A7S XML 23 R43.htm IDEA: XBRL DOCUMENT v2.4.0.8

NOTES PAYABLE (Schedule of Note Allocation) (Details) (USD $)

Mar. 31, 2014

Series A 15% Original Issue Discount Convertible Notes and Warrants [Member]

Proceeds allocated

Proceeds allocated, Note $ 32,390

Proceeds allocated, Warrants 14,845

Proceeds allocated, Benevicial Conversion Feature 7,765

Total 55,000

Series B Original Issue Discount Convertible Notes and Warrants [Member]

Proceeds allocated

Proceeds allocated, Note 34,272

Proceeds allocated, Warrants 26,811

Proceeds allocated, Benevicial Conversion Feature 3,917

Total $ 65,000

XML 24 R29.htm IDEA: XBRL DOCUMENT

Supplemental Disclosure of Non-cash Transactions (USD $)	3 Months Ended		1 Months Ended	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2014 Liabilities Purchase Agreement [Member]	Mar. 31, 2014 Common stock [Member]	Mar. 31, 2014 Common stock [Member]	Sep. 30, 2013 Common stock [Member] Liabilities Purchase Agreement [Member]
Common stock issued in accordance with liability purchase agreement, shares					1,618,235
Payment to creditors		$ 80,000
Service fee retained		27,000
Transfer of rental asset to inventory	$ 8,000
Common stock issued in accordance with escrow agreement, shares				500,000
Common shares issued for legal services, shares			100,000
Shares issued, price per share			$ 0.43	$ 0.43

XML 25 R28.htm IDEA: XBRL DOCUMENT

SHAREHOLDERS' DEFICIENCY (Tables)

3 Months Ended

Mar. 31, 2014

SHAREHOLDERS' DEFICIENCY [Abstract]

Schedule of Assumptions used to Estimate Fair Value of Share Options

We estimated the fair value of each option on the grant date using a Black-Scholes option-pricing model with the following weighted average assumptions:

	Three months Ended			Three months Ended
	March 31, 2014			March 31, 2013
Dividend yield (1)		0.00	%		0.00	%
Expected volatility (2)		118.5	%		99.2% - 100.3	%
Risk-free interest rates (3)		1.72	%		0.63	%
Expected lives (2)		5.0 YEARS			2.0-4.0 YEARS

	(1)	We have not paid cash dividends on our common stock since 1981, and currently do not have plans to pay or declare cash dividends. Consequently, we used an expected dividend rate of zero for the valuations.
	(2)	Estimated based on our historical experience. Volatility was based on historical experience over a period equivalent to the expected life in years.
	(3)	Based on the U.S. Treasury constant maturity interest rate with a term consistent with the expected life of the options granted.

XML 26 R44.htm IDEA: XBRL DOCUMENT

NOTES PAYABLE (Narrative) (Details) (USD $)

3 Months Ended

4 Months Ended

3 Months Ended

6 Months Ended

3 Months Ended

Mar. 31, 2014

Mar. 31, 2013

Dec. 31, 2013

Mar. 31, 2014

90 day Convertible Notes [Member]

Mar. 31, 2013

90 day Convertible Notes [Member]

Mar. 31, 2014

24 month Convertible Notes [Member]

Mar. 31, 2014

24 month Convertible Notes [Member]

Debt issuance, March 2012 [Member]

Mar. 31, 2014

24 month Convertible Notes [Member]

Debt issuance, April 2012 [Member]

Mar. 31, 2014

24 month Convertible Notes [Member]

Debt issuance, June 2012 [Member]

Jun. 30, 2014

Tonaquint 9% Original Issue Discount Convertible Notes and Warrants [Member]

Mar. 31, 2014

Tonaquint 9% Original Issue Discount Convertible Notes and Warrants [Member]

Jun. 30, 2014

Tonaquint 9% Original Issue Discount Convertible Notes and Warrants [Member]

Mar. 31, 2014

Southridge [Member]

Mar. 31, 2014

Series A 15% Original Issue Discount Convertible Notes and Warrants [Member]

Dec. 31, 2013

Series A 15% Original Issue Discount Convertible Notes and Warrants [Member]

Mar. 31, 2014

Series A 15% Original Issue Discount Convertible Notes and Warrants [Member]

Minimum [Member]

Mar. 31, 2014

Series A 15% Original Issue Discount Convertible Notes and Warrants [Member]

Maximum [Member]

Mar. 31, 2014

Series A3 15% Original Issue Discount Convertible Notes and Warrants [Member]

Mar. 31, 2014

Series B Original Issue Discount Convertible Notes and Warrants [Member]

Short-term Debt [Line Items]

Note issuance date

Mar. 31, 2012

Apr. 30, 2012

Jun. 30, 2012

Sep. 30, 2013

Dec. 31, 2013

Mar. 31, 2014

Notes payable, term

90 days

24 months

6 months

Interest rate

6.00%

7.00%

Principal amount

$ 3,276,834

$ 2,498,980

$ 225,000

$ 100,000

$ 25,000

$ 100,000

$ 112,500

^[1]

$ 12,000

$ 296,099

$ 283,648

$ 64,706

$ 80,000

Conversion price

$ 1.05

$ 0.30

$ 0.20

$ 0.25

$ 0.35

Notes payable, portion attributable to LPA

485,980

505,000

Proceeds from notes payable

120,000

505,000

485,980

100,000

241,100

55,000

65,000

Debt discount

10,000

42,548

9,706

15,000

Transaction expenses

2,500

Note maturity date

May 31, 2014

Jun. 30, 2014

Jan. 31, 2015

Mar. 31, 2017

Frequency of periodic payment

monthly

Debt payments, start date

Jan. 31, 2014

Value of common stock called by warrant

112,500

Number of shares called by warrants

958,179

185,714

Exercise price of warrants

$ 0.35

$ 0.40

$ 0.60

$ 0.45

Term of warrant

5 years

2 years

4 years

Cash payment for settlement of warrant

98,000

Loss on settlement of warrant

(98,000)

Cash payment for settlement of note

124,000

20,000

144,000

Loss on settlement of debt

$ (132,301)

$ (34,000)

Debt conversion, Common Stock Conversion Price, percent of closing bid

75.00%

[1]

Original terms noted above. The Company executed a debt settlement agreement with Tonaquint during the first quarter of 2014, cash-settled the warrant during the first quarter of 2014 and cash-settled the note during the second quarter of 2014. See further discussion below under "Tonaquint 9% Original Issue Discount Convertible Notes and Warrants".

XML 27 R30.htm IDEA: XBRL DOCUMENT

BASIS OF PRESENTATION (Details) (USD $)			3 Months Ended
BASIS OF PRESENTATION (Details) (USD $)	Mar. 31, 2014	Dec. 31, 2013	Mar. 31, 2014 Calmare pain therapy medical device technology [Member] Revenues [Member]	Mar. 31, 2013 Calmare pain therapy medical device technology [Member] Revenues [Member]	Mar. 31, 2014 Calmare pain therapy medical device technology [Member] Sales of supplies and training, rental payments and the sale of rental assets [Member]	Mar. 31, 2013 Calmare pain therapy medical device technology [Member] Sales of supplies and training, rental payments and the sale of rental assets [Member]	Mar. 31, 2014 Vector Vision, Inc. [Member]	Mar. 31, 2014 Promissory Notes [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Ownership percentage							56.10%
Percentage of revenue			98.00%	13.00%	1.00%	66.00%
Principal amount	$ 3,276,834							$ 3,277,000
Carrying amount	$ 3,116,998	$ 2,933,691						$ 3,117,000

XML 28 R31.htm IDEA: XBRL DOCUMENT

NET INCOME (LOSS) PER COMMON SHARE (Calculation of Net Income (Loss) Per Common Share) (Details)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
NET INCOME (LOSS) PER COMMON SHARE [Abstract]
Denominator for basic net income (loss) per share, weighted average shares outstanding	20,036,240	15,588,693
Dilutive effect of common stock options
Dilutive effect of Series C convertible preferred stock, convertible debt and warrants
Denominator for net income (loss) per share, assuming dilution	20,036,240	15,588,693

- Definition

Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method.

+ References+ Details

XML 29 R8.htm IDEA: XBRL DOCUMENT

NET INCOME (LOSS) PER COMMON SHARE

3 Months Ended

Mar. 31, 2014

NET INCOME (LOSS) PER COMMON SHARE [Abstract]

NET INCOME (LOSS) PER COMMON SHARE

2. NET INCOME (LOSS) PER COMMON SHARE

The following sets forth the denominator used in the calculations of basic net income (loss) per share and net income (loss) per share assuming dilution:

	Three months ended		Three months ended
	March 31, 2014		March 31, 2013
Denominator for basic net income (loss) per share, weighted average shares outstanding		20,036,240		15,588,693
Dilutive effect of common stock options		N/A		N/A
Dilutive effect of Series C convertible preferred stock, convertible debt and warrants		N/A		N/A
Denominator for diluted net income (loss) per share, weighted average shares outstanding		20,036,240		15,588,693

- Definition

The entire disclosure for earnings per share.

+ References+ Details

XML 30 R32.htm IDEA: XBRL DOCUMENT

NET INCOME (LOSS) PER COMMON SHARE (Narrative) (Details) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Outstanding convertible debt	$ 3,117,000	$ 2,040,000
Stock Options [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive securities excluded from computation of earnings per share	1,409,000	1,367,000
Series C convertible preferred stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive securities excluded from computation of earnings per share	375	375

- Definition

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

+ References+ Details

XML 31 R40.htm IDEA: XBRL DOCUMENT

NOTES PAYABLE (Schedule of Notes Payable) (Details) (USD $)

3 Months Ended

Mar. 31, 2014

Dec. 31, 2013

Composition of Notes Payable:

Principal Amount

$ 3,276,834

Notes Payable, gross

3,116,998

2,933,691

Less LPA amount

(485,980)

(505,000)

Notes Payable, net

2,631,018

2,488,691

90 day Convertible Notes (Chairman of the Board) [Member]

Composition of Notes Payable:

Principal Amount

2,498,980

Notes Payable, gross

2,498,980

2,518,000

Cash Interest Rate

6.00%

Common Stock Conversion Price

$ 1.05

Maturity Date, narrative

Various 2014

24 month Convertible Notes ($100,000 to Board member) [Member]

Composition of Notes Payable:

Principal Amount

225,000

Notes Payable, gross

225,000

Cash Interest Rate

6.00%

Common Stock Conversion Price

$ 1.05

Maturity Date, starting date

Mar. 31, 2014

Maturity Date, ending date

Jun. 30, 2014

Notes Payable (Parenthetical):

Due to Board Member

100,000

Tonaquint 9% OID Convertible Notes and Warrants [Member]

Composition of Notes Payable:

Principal Amount

112,500

^[1]

Notes Payable, gross

118,536

87,705

Cash Interest Rate

7.00%

Common Stock Conversion Price

$ 0.30

Maturity Date

May 31, 2014

Notes Payable (Parenthetical):

OID, yield percentage

9.00%

Southridge Convertible Note [Member]

Composition of Notes Payable:

Principal Amount

12,000

Notes Payable, gross

12,000

Cash Interest Rate

Common Stock Conversion Price, narrative

75% of closing bid

Maturity Date

Jun. 30, 2014

Notes Payable (Parenthetical):

Debt conversion, Common Stock Conversion Price, percent of closing bid

75.00%

Series A1 15% OID Convertible Notes and Warrants [Member]

Composition of Notes Payable:

Principal Amount

149,412

Notes Payable, gross

100,076

81,415

Cash Interest Rate

Common Stock Conversion Price

$ 0.20

Maturity Date

Aug. 31, 2014

Notes Payable (Parenthetical):

OID, yield percentage

15.00%

Series A2 15% OID Convertible Notes and Warrants [Member]

Composition of Notes Payable:

Principal Amount

134,236

Notes Payable, gross

91,127

69,571

Cash Interest Rate

Common Stock Conversion Price

$ 0.25

Maturity Date

Sep. 30, 2014

Notes Payable (Parenthetical):

OID, yield percentage

15.00%

Series A3 15% OID Convertible Notes and Warrants [Member]

Composition of Notes Payable:

Principal Amount

64,706

Notes Payable, gross

37,007

Cash Interest Rate

Common Stock Conversion Price

$ 0.25

Maturity Date

Jan. 31, 2015

Notes Payable (Parenthetical):

OID, yield percentage

15.00%

Series B OID Convertible Notes and Warrants [Member]

Composition of Notes Payable:

Principal Amount

80,000

Notes Payable, gross

$ 34,272

Cash Interest Rate

Common Stock Conversion Price

$ 0.35

Maturity Date

Mar. 31, 2017

[1]

XML 32 R2.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets (USD $)	Mar. 31, 2014	Dec. 31, 2013
Current Assets:
Cash	$ 343,748	$ 57,009
Receivables, net of allowance of $101,154 at March 31, 2014, and December 31, 2013	86,317	143,330
Inventory	4,248,220	4,278,220
Prepaid expenses and other current assets	48,095	65,167
Total current assets	4,726,380	4,543,726
Property and equipment, net	8,860	7,606
Security deposits	15,000	15,000
TOTAL ASSETS	4,750,240	4,566,332
Current Liabilities:
Accounts payable	650,254	692,251
Liabilities under claims purchase agreement	2,013,320	2,093,303
Accounts payable, GEOMC	4,183,535	4,183,535
Accrued expenses and other liabilities	803,678	582,987
Notes payable	2,596,746	2,488,691
Deferred revenue	19,687	6,400
Warrant liability		8,227
Series C convertible preferred stock derivative liability	66,176	80,408
Series C convertible preferred stock liability	375,000	375,000
Total current liabilities	10,708,396	10,510,802
Note payable -- long-term	34,272
Commitments and contingencies
Shareholders' deficit:
Preferred stock	60,675	60,675
Common stock, $.01 par value, 40,000,000 shares authorized, 22,463,532 shares issued and outstanding at March 31, 2014 and 19,952,907 shares issued and outstanding at December 31, 2013	224,635	199,529
Capital in excess of par value	46,730,636	46,077,394
Accumulated deficit	(53,008,374)	(52,282,068)
Total shareholders' deficit	(5,992,428)	(5,944,470)
TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT	4,750,240	4,566,332
Series B Preferred Stock [Member]
Shareholders' deficit:
Preferred stock
Series C convertible preferred stock [Member]
Shareholders' deficit:
Preferred stock
5% Preferred stock [Member]
Shareholders' deficit:
Preferred stock	$ 60,675	$ 60,675

XML 33 R45.htm IDEA: XBRL DOCUMENT

SHAREHOLDERS' DEFICIENCY (Narrative) (Details) (USD $)	3 Months Ended			3 Months Ended				0 Months Ended	3 Months Ended			0 Months Ended					3 Months Ended
SHAREHOLDERS' DEFICIENCY (Narrative) (Details) (USD $)	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2013	Mar. 31, 2014 Non-employee directors [Member]	Mar. 31, 2013 Non-employee directors [Member]	Mar. 31, 2014 5% Preferred stock [Member]	Dec. 31, 2013 5% Preferred stock [Member]	Dec. 30, 2010 Series C convertible preferred stock [Member]	Mar. 31, 2014 Series C convertible preferred stock [Member]	Dec. 31, 2013 Series C convertible preferred stock [Member]	Jun. 16, 2011 Series C convertible preferred stock [Member]	Dec. 15, 2010 Promissory note [Member]	Dec. 30, 2010 Promissory note [Member] Series C convertible preferred stock [Member]	Dec. 15, 2010 Southridge [Member] Series C convertible preferred stock [Member]	Jun. 16, 2011 William R. Waters, Ltd. of Canada [Member] Series C convertible preferred stock [Member]	Dec. 30, 2010 William R. Waters, Ltd. of Canada [Member] Series C convertible preferred stock [Member]	Mar. 31, 2013 Stock Options [Member]	Mar. 31, 2014 Stock Options [Member] Non-employee directors [Member]	Mar. 31, 2013 Stock Options [Member] Non-employee directors [Member]	Mar. 31, 2014 Stock Options [Member] Employees [Member]	Mar. 31, 2013 Stock Options [Member] Employees [Member]	Mar. 31, 2013 Stock Options [Member] CEO [Member]	Mar. 31, 2014 Private Offering [Member]
Stockholders Equity [Line Items]
Options granted																		42,500	50,000			1,000,000
Options vested																						200,000
Incremental non-cash compensation																	$ 16,920
Stock option compensation expense	14,328	111,437																11,178	14,250	3,150	80,267
Principal Amount	3,276,834											400,000
Debt conversion, shares issued													400
Percentage of cumulative dividend rate						5.00%			5.00%					5.00%
Preferential non-cumulative dividends (in dollars per share)						$ 1.25
Preferred stock redemption price (in dollars per share)						$ 25
Preferred stock liquidation preference price (in dollars per share)						$ 25
Common stock, par value (in dollars per share)	$ 0.01		$ 0.01
Dividend declared, date of record						Dec. 02, 2010
Trigger for issuance of dividends, percentage of outstanding common shares purchased						20.00%
Maturity date												Dec. 31, 2012
Interest rate												5.00%
Preferred stock, shares authorized						35,920	35,920		750	750
Preferred stock, par value (in dollars per shares)						$ 25	$ 25		$ 1,000	$ 1,000				$ 750
Preferred stock, shares issued						2,427	2,427	350	375	375				1,000		750
Proceeds from preferred stock issued								350,000
Preferred stock converted															375
Common stock issued upon preferred stock conversion															315,126
Dividends declared									70,323
Dividends declared during period									4,623
Dividends declared and unpaid									51,575
Preferred stock, voting rights									Holders of these shares of Series C Convertible Preferred Stock shall have voting rights equivalent to 1,000 votes per $1,000 par value Series C Convertible Preferred share voted together with the shares of Common Stock
Amount held in escrow									750,000
Preferred stock, threshold percentage of stock price trigger									85.00%
Derivative liability									66,176	80,408	81,933
Preferred stock, shares outstanding (in shares)						2,427	2,427		375	375
Common stock issued to directors, shares				10,625	3,750
Share-based compensation - common stock	4,038	7,000		4,038	655
Proceeds from common stock and warrants	$ 500,000																						$ 500,000
Private offering of common stock and warrants, shares																							2,500,000
Price per share																							$ 0.20
Warrants issued to purchase shares of common stock																							1,250,000
Exercise price of warrants																							$ 0.60
Term of warrant																							1 year

XML 34 R6.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Cash Flows (USD $)	3 Months Ended
Condensed Consolidated Statements of Cash Flows (USD $)	Mar. 31, 2014	Mar. 31, 2013
Cash flows from operating activities:
Net loss	$ (726,306)	$ (781,834)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	1,824	2,336
Stock option compensation expense	14,328	111,437
Share-based compensation - common stock	4,038	7,000
Bad debt expense		5,000
Debt discount amortization	61,364
Noncash finance charges	18,434
Unrealized gain on derivative instruments	(14,232)	(18,167)
Loss on settlement of note and warrant	132,301
Changes in assets and liabilities:
Receivables	57,013	132,747
Prepaid expenses and other current assets	17,072	56,188
Inventory	30,000
Accounts payable, accrued expenses and other liabilities	178,694	(32,745)
Deferred revenue	13,287	(1,600)
Net cash used in operating activities	(212,183)	(519,638)
Cash flows from investing activities:
Purchases of property and equipment	(3,078)
Net cash used in investing activities	(3,078)
Cash flows from financing activities:
Proceeds from note payable	120,000	505,000
Repayment of note and warrant settlement	(118,000)
Proceeds from common stock and warrants	500,000
Net cash provided by financing activities	502,000	505,000
Net increase (decrease) in cash	286,739	(14,638)
Cash at beginning of period	57,009	59,684
Cash at end of period	$ 343,748	$ 74,322

XML 35 R35.htm IDEA: XBRL DOCUMENT

FAIR VALUE MEASUREMEMENTS (Details) (USD $)	Dec. 31, 2013	Mar. 31, 2014 Level 2 [Member]	Dec. 31, 2013 Level 2 [Member]	Dec. 31, 2013 Level 3 [Member]	Jul. 16, 2013 Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability		$ 66,000	$ 80,000	$ 0	$ 19,024
Warrant liability	$ 8,227			$ 8,000	$ 26,076

ZIP 36 0001144204-14-031100-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001144204-14-031100-xbrl.zip M4$L#!!0````(`#UTKT36ZS M>V(F0FT>(MBSL^@U4/ZVCVB+X9EJU M;]>U]XV&7W+MV/I&@Z*VA02.;S4XJ<%+Z%^(YRX%"76_LI(/,\=$`,ER+S7/ MTS[6EIZWOKRXT.S5&GN&9]QA#VO+IH6]"](,)XI\S:\`_?ZYJW!_?]\DC35M M9P$E.?&"O)ZI+MX6)V^-E/*&18C6@O)+;V5&RM^+M#3?Z70NZ-M=T0,HD:+D M[;:HC@,,M'\7:\V%?7Q4-7UKLI<=6>T9?]%3!7#M5L" M+Z=1RDKX%;*P!$2%T"^$CDM76^*5.L9S1.FZ]![7,$9<8[4V">OHLZ6#YQ]K M1*"-K=":#ZY>0Q>L(?+FLJMI]L;RW)'ZJ,Y,##^=#=9O#'4&(\HSL-NU]*&W MQ$[HT97A:J;M;AS)]/6_D2&_K%68?M-A5-@Z@3_ MU9!F6QZ\'A/"YXZ]:K!!SY/_/=O_)8*8#NI"[5__87H?8-)<#7O3/T9]1,86 M&OWVZ6;00[7&Q<5WL7=Q<36]0K]_F7Z]05`=31W5<@&S;:GFQ47_MH9BAM]T MS,8I3RK[?S:\4,VF[H%4&HU_++P/!(-NW)$_4>AO']K$4QWOVE$7*V`$JT!+ MK6&I>#1A!%P/;Z>7,+O7'IH:*^RB6WR/QO9*M>KL01U-L&/,/Z"OW?'GP>TE M(D6Y]4-MUY;K.;:U(#\[S7^HJ_4':^:N/YSBKVZO-_ZM?X7ZOX_ZMY/^!'5O MK]!P^J4_1C>#[J?!S6`ZZ$\(QHL`)/VY+I\3`;Z$#J;]WZ>-[LW@,U3]WXWK M&?/'#^CH7C\@VM[@]JI/6N":DF$Q)/Z40?AAC2T7FH0]`=EDRB`SF#-DZ+N& MZR%[CN`=FMNF:=_#GG!Y:@9Y9)YO._D^N)I^(;UP/W]`GX;CJ_ZXT1O>W'1' MD_XE8#9-=>WB['R#*8Y-TUVK&MTJ.?9[K>JZ_SN`X6PQ?.N/IX->]V8KK)GM M>?8J5%(/LZ0Q&?Q/GT&A1?;H]/2GZS%R&M_[@\]?IJ0_4_^`1MVKJ\'MY\:G MX70Z_`H%_?;W&9FM`Y^5V\9FI@KK+32)7-LT]%@`X?&JP?*!';)>$EZ""B)0 M+%]51UL&>$2^3F#,''2QAY0LI.?$CJ36*N%M!D9>80VO9MB)L"^5G6*EU%YX M3ID3(Y8'1_+[>#EED,,QH^G4A!R`+K_O/.*'\=_M_?OS>/C;[159JH?C2^0L M9N\$KE47)*D._[[/-$3\I5\6?HZ*RL1SAG=L/ZHFW;O63#G,(?OMOO)SS.)2 M8!U):S:!"O33$>UGZ,`Q%DN_!YZR7:F8CF(,.WX:A[#&`CN6OTG,%.2Z?"PS M\W*NZ,2[7QH>SKT@[Y!M54=JQUNN2LR-(MMVJ0I1B:,PQU02I3K'<6>"O)R] M;P>A<$L!HQK587F6S2AU>JCLC`(L"#3'V/VQ9XC"O4V0#!-$$>I\BS_?65)P MY^C9JY7ADN/I8[2S5S@M!+[>D:4S`7Z^TR(WFU[\YF$0PQ.[WMLTH=.DQ==; MBGPFR,]YGK3K$I_'"CG;_2/F-"I)A-31LYTHA?2L,SM/+3B_"O8>MF]DHK[E M&5?96%LJN<]V6ENQF!)MSE:]W1"TTI&7LVSU8=6=@K=T!3 M5&4/!-HHTNT-K&T5'1\6[S=BZ(GUMESR4I$J[U(6BT!V58GN)')*$(H$=F4G ME_Y4D@3"J\4%=>'N?E;@,3X;YWK_03,W.CD#FMEW&!FP!JW7COU@K%0/FX_H M)X$=&-*EZ2>AU:(_[#DY,\KBE5<]1)VJQ/E'([!HN:U[4NH.%=-$VTL'\-; MHNZDA\984]=U='/3@W>[![7W=0I`=3!%KI$P,L]&,PP`UJJAHXU+CL%(?\`& M#;M`@HMT[&J.,:/6#KJU/0Q"B(T-^02=;``8X0-&FFJ1EBT;VG`W#HEA8I21 MYGOV:JU:CX`8J(12[D8CWV/7RZJCNI*CAW[C.V5%A?T15\T%4Y6DJ.U5+=ASZ,!6M'BI,+&,ECIWR97 M-1B5&HC==$G8QZ\M7A$E48JGGP(H`KR3`;C8X`4?>*="X$\+)8)GP M:2S21L5RA/465MB`&T6@GA_C*AQ'L#=5P[B_-@8+5!RICF=AY]H@6Y)[C?$( M.R3N@L0?,_YD*5IVU&;`DS4L76&F\+5?N2:_XT@6<&'"=;+:$VZX4[NKZWZL MY@@VC('54]>&IYK?50=V-8\PMV=;=]CQ#)BT5WCF?8=]F#TB9^C76/4`'.-2 M^>TRMK04J2GQ[4X!OAXVD3+@)%$4E2UWRR?J18N"Z\A[C'QPC4O+,#_6/)B8 MQXCFL,FH;/P8>->(BX`7.(Z_^/WKS82&C3>"(/N+E\QFGE/*9G-,DS\\FUMM M22A[-!\V^<.SN8HM\3E7[;WB0=&18VBA/;<'1@?8>9_`$"/\S5^-J9BM#B\I M35YL\_%<3%),X^HEJA0"42GDK;*>'VJ(/5>&`^:W[8"=>`>E>TO568`A25@0 M_^J4HX0/5,EX,!%"[@P=6_K69IDZQF*!G8#\X7RX\>BG;,"$"=3'[E;CU'UZ M"[00V7%EL8CV<]A&NFXI[%A4`'^(DWU04;W'K]A;VC`![S";F\-[4%;=I;&^ MW9`SH^&<-4`>,_;EK\;&/J]($AGX^>;+8:T=DUS:P[Y=(H@B+_NO_!<,DA6L_!L+K;#EM? M,I8E\X*NJUR[*8G*4WP0&URG(7*L%A=;+\U\)4O.;M')B#!$_V=R$GACNRZP MQII@SS.I)3N<;S]_M?^[=3>MK\].>7SWYL?G(D5QMGZSKQEH:CH[\V M,&2P0[Q%S,<3]EU8>&%[!OV,7T4WHR[SW$SLC;=T#'V!Z\@_IG+18%!'-\U1 M$[VK!>]K[YMH2KQ"4-53_R2N)OU.98=QQ#U%/"9W!E%&B3N%]#S!&B"D7JFN M1K\3Y3NB2.C4R&1`XCOU_3N>>^][GU3R_:A+:^('6`]`C["'$P85-8P5[BH>! M\:I#'7M-'JT,TR2D`UW0%)IO=QUD!]L.K>UO/$C;[:/W2QNI9&&D_K,UR,K0 MC#7I@/C7\`.PA\B6L0NMMQX[=;N6NOL"IP/Y[V+G`W!H/H=%F;05..XB0>K` MN)^$.M<1ZR(G$O0[@-O8JGJ:@])WZ42]8N2U!2S;Q?M&F(]F>*%:##-AKN&Z M&^K/`^Y/\-IC[DPB`#JPZFU>J0NBA)C&L_THV1_\(5(U>[4"`;`1`XS<$=S< MSJ>@=8)P"*;(MJ=Z4)I$X.A9NB!MZ.&)"N)`\-I;N@@T>.#7GKN6.@@#L>]Y MAUFP/"(;7N`SQ3IC-G-/T@GN,N.)?%Y`9^>>CUDFK311ES+JJ_J(^!;KODZ< MIW,8Y41LN7BY5&&:8)B!1%)LD`;<@A\N52H"RG;MH)EJ$LFZY^L1/3F2:47N M[,-%GXR;_"YN@[CH9]ZA:_M\97B,5_M(;35>5^[1E?F@EN_[WM>.TTM7[1.% MQ4X4N$,NI*,Z#=U5NC1AAX,-[BSI/J%E7)@+)(I#=9?,J,9]IA!0BF/?$)Q[ M0LIPWB]&C#TQ,/:X=(D7/^D_@KR3G:,J+;'E2RX63(0,4+ZV<1\.V/X^"7M/ M=Z?=8",>==I]4"\UJ*"C=!1N1\$>EN/0=[*CWULX\J*7^-"92DGH*>]EX3C> M']1+0R](I8/O9`=_R/KG!J\\>2Z7POD\1W$\KTABNP+.9P-_R/D\X!59YJ0* M&%^^MN^.M&M%'G:VCE*V')[&>ZP]"H98NU/!F&\SCW'N M,7]8+XW;+4$6RA_SAQB.&O-/D7+B,0]KH7CDQGM0+WT&R/G5AI'M$-=$U_,< M8[:A\4?;<[#$X/4"]:O^@VXE%`"6`C!,9BC""IWCMB1.$',3:*#Y]B!Y6M"(C-"'PU,EPYVEW9X#1_.:2'Z`8$?1LYX M4*P-1BB`5XH&R<>TD3[JE=VH+T9"(D.#>Q$.&;5[5_5)AAQ2RQ,@%">@0KLB M-P$LSJEKFK9&@A@_80O/#1([%__55)X*@69YI(?SH%X*X;+<#@9H=HRGYL5I M3H@ZNP\URN)%V$2-)SY[T1?S/&;GRW)`FWTC+'XRFY.: M"K=!T&"5K1\TIO<09D*0OC%!4^F[+#13OU8-YYMJ;N`9G5Y=L-57:_;M$OTL M,/+I39$&=D8-S!M1Y`M]]'C8R&OX&N=4\:W?,<);\;&\6R!#=$>$N`W4OM\N M-[:U"YW'2"?!O.RR+15](A?$-6!$V":)OP>MESQ?V3HV@Y#[748O&G[LCXO$ M[%[/'N`;EP9,>8E9P$J^K_3-(+K!KDW:9Q<&N*>-*[QS-FH#OW(9U\:IT^J M=SX7ZO=W]U%B9_4:KGA'CUAU\MQR7A:B-YZ\\>194@'X:EZKP]+!?;--U:-' MASF(\]L0*LPH5RS5G9B26XXX3(02D?[\PS"NU13+S,GW(S%.J91QYZ,@C`WW M3W1-/M@>@_'\"E9^KBD6SB"6?:"?-1\Z;WR@?,BS>>2?O]5?[!\]`SKF(^\B MYZ+G=CY+?`"%SV^#77DCL,/!JCK9G6XEM%^FS)Y!9\URA/74 M0"M9G6@E'2RH/V!LVS7P[3.*;TE&6_]E879ELK!,/ M83Z/1OP,^N^)+CXJ72?>QI@,Y^2B*=LBH?:DF5W,2:I"G+/V6[3"N6C#T_`5 M=;[Z2T?/]I:X7%?CW9-+T=2MS,FEVQ;Z:IP1.V-[2*#]CC:7:6X'6$%U5'5"YEV!53/?#PKNI'_7=/F M;CT\4'^7RGMJ>:V8G*EP@X(26O<)`[>6_^IN7]/:+-Y,2_-,ULN=1G M,7U.IH!%#H/V,"=>)U_,6,IIIYR/I?3F-SA?2^G-ZGFS>MZLGO,[@'_]Y@^P M0TXY#7TS?_*%7;;K"A\3?G.&`_O-#DK2FL5ZAY??[*!79`>U7[L=5(U?J("I M$Y-=KKLBUTLQ6R;Q]?.ER@MGRDO&%Z:1W&-!K\[265:A$4C-UEDFQ2?N`CRR M+B%-)NFD%9;G.'H75N(U/'+D&IYMU@BYR:4TE9Y>DF_SBB!N/Y@_DIH0+ZE) M")OYU"8Y*BW/=MB])3'/3WDU3VA(Q"`)X?<'">.![T'MTUL_S7D?1'%#SI,R>RU$LG-X:8]CK41D.C8NN["0Z&0QN3;5 M!4NE'GY2>D[1.$Q$?NF$JCL=11PI-=#N-/'=10E>5`Z.)YK_"<*BW03H.E;'B@0 M/7CNJ.;`TO'#OS%3$&+?E(Z/W"'*S:0;KV,/:48DU% M#.[$2]_NI0;?.BC^M"('NT!;E$0A0E<*HGTBKPT3.ST8.HNMRA;SO'1Y3%9$ MZW#0&*_)#=7`3S^U89B,"(1]W&.\,%SB3O!NU14.`8^^*!UY;_AUU)\.IH-O M?;#F>E]NP<+_3#(E#VY[8?!1&`S]QFTL5'5]V65)6]VNI0])#L_@*B'W%D=R MSV4J6?$MAD('ELA6.$&*(2D*H@0:*I1) MNR,($G\<#8'(:.Z$.%KBBU0L%Z5-[XS-!K<"TJJ\+DT4%(D[FC:2GSJ!60%J%$E,$OL47(FUW:V$,3?OO*I83+TD"=SB7]E&40D:5BYP@R\>2,5%- MU0G*@'9!LL`>DI16KFHIB5+<=$I#5"FI>Y(\(IE4"N6%[BH])!BH``/,H%,S M9J#&EZA:B><[),M$)K"ETU5E\K4B=&U6&Y-XP:[PVH%&:9X%^-O$-&>2I7=7 MQ#C]/_H<5MLU=KS'D:G2X=G_:V.L5R$6E-)8U;-:YF4IRJY28+\0SE:Y';0[ M'9&OG+.Z[@=/CE1#'U@]=6UXJLD8%?^NZC1M;5GDVB0M\A,82R&D0@&VVIPL M1XW_;(20L``_*5%"#7ITX).6L;3ODU$DYMN-I3B;1^:@B=1[KMOM5H0#&>&> MDB=<1]ZC*$49R,:CPR:KT`^JY`I/H@'*Y4I,DR^-*ZVV))0]5@Z;?&E<25Q" M2XV\..%:0GT<,]7%.G$B8,NE6^H8PQ[J&AZ>8.?.T##SDXVQ9B\LV@H-AN7VFG><%R*#5[V_O1`9O.K=](7(X$1[][/N'.0C M.2+':]NYLC#[B:LV.[*0LJ#134EDL"!V.#.=7 M>.9MTQN/'+PR-BL_5/")4LW#3*<9UJQC$Y^6LUJ51_FIUHLV+[;#0G\*VQ[! MEF?HAKGQC#M8)[2-0WV0_0?-W.A8OP:@9$G9>'Y[?=6Q#&OAPEI"%YW05PFE MM,3DS"LDF%Y^0EE/'2B'33P1DB^VY:C/I0QRSI[7?$9>IRMS>7D-&O@/R.MM MHMY"X_JPB71>BQ$'S0_!9SXCGS/D5#XC/KLN]M-CLC^K=BW(P(%6>([27C.` MJM)-(+7;(HFV?1I41$,+/ZF<;T);5`[X%J]F/8VT4F:V1`";"6E/=99E8$MD-H`$T@$8#XR*9]Y'-+3OS/J5!.+C( MZK[AVR^`KQJL;_SQ=>L[&8[[->#+(P(7UM1AFLO.&/\W!^WT%U+\O"H=NQ@I MCI4^Z-=UM$B'LV&2-.4`JN/AJ+=6_`N1Q-1<-[BS?>7<8`V`\Q_,F1HNNW:, M*0LO=(M?^>Z_R8OB3F[^CY&ZI0U\%<"G%/`[>;D].[[R:5T!:ORZ\G=Q=6W6^GDVYF$OUU\ M^_7\V^G%^6U^]>C:^ULV7CWNA(H1Q_NP=*33NPM)LW3)@-UEKOVO#=KW1;*? M+:9+[O+>-71#@:^>F+5$T#T;/BRT%W@4_WZG#`>=D:P0(.^4R;@#1F0' M'G&Q)9KQQ$R```:`.0`@YM"<./(#E=F:+7FQ#9KR"0"'1Y7)I$_#P1^#5(8D MQ$W7E@S7QX279$:X-(\J,SM8O`7F&74'[_%?)%*(A3&#&0`R5"&2)PJ'4:%2 MA^_6,)B/NT'5Q)!40-8%EK.`R>Y?:)80"S<54J!]%I`(("VK$H'08I[DXMTF M_"*<;>'8^G**O2H=25G%AZ-A@HUM4>?*U1=]C-/E^[6+SQ^,\S^S'K0'H,I- M]TM7NM2P-BU(#,&)_R^=VEU<()>Q/X%8DC;ER4W(L0M0RQ9S.*4UH#5L8S"2 M1<8/20J5-\&]?0:+9"\=R=(L&U\SIB:3[FT+_F/8V,3+PF3IP5H*5A"6%I9E@@=?32WWJ3 MGP$ZQE#(D'F1>[PL1`U$!/BZ@[5-0>T`_8%V=&OK47/!3H2_B9WO&0YAS`/, M4'0C*B54-=U=\\'^<"1.RN:TY\7LPF/I$I:!DXM@Y`_M#[@)$NX/>'%K0-!6 MY#2I[8#.I((W9%`ZXK2N_S%KO1ABB'Y!:/MZ6/" MWH!ENK*DD^4#X"2I$]R/9=CTGAF(&W@^('JH#4S8/&#?UNDPHC@[+Q2.O@0\'7H)-.;1.&U>T.EI5G#[@U<+4# M(\YPM^/R#$^BOA(_3>TG7K+[T9[;TQ?78P:H+M!,V@MJ*Q!NU(^\$3)L5V!B M2+HV!]T`OR[0RX!]//Q&\SS;L=B+&Z@@U$!D="#44]OE^DXH0+!0EI9O)8B= MW%[X-@/ON`#O==$B`G+?LRG6AM*>P7DE-/B5&8&Q@YQ#-<%-)>F MZQ*ILAD\0*V@3S5O^MB1+JQIEQ8"/@'Y$3Q.6NT_+S#=I7:/JV73VIT93X8K MX/N5(>RF=.+9286[;P&&T80^(9^*\_)F<<7$3PP$V-AG\! MH=$?^$59S@&W]A(QM.*KK)D&O&@9&KT/S/>H`?;X#ID'!+\6C"M@M6SK.,8% M9$E:3S"8#G9D`EY%]0&.\1AG/9C(YS3)69K4<1O6[AY6@U.4QO8QQ?U"Q_6( MDUXTU$B*"8IANV\$D,"B7$T]&Y=$[25YR&%_@3'H=SR/:XMK+MRX$.#2ZN`( M.']B=7ZP&:4/^/C1]]OKNRO@=C+PCQGV2D<3&G_SF2*A*;A<&*X_L?0,2TH6 M<6@@TZC88OT,+'S.2GT.-W'8/Y;FB]23Z9L)9Z[OW=MN'K@16^:SK3DZ`B4> M/UDL&/@%]-H%-N(&2P@V5H:2^/GZY`*P6RX>F@!JS(%B M/[2Y@6;1HZ8#UX*=Q\?@KW6D^Z7'F1Y_`PV`E$`]RL5!T`)!Z$I_/(*HKPZJ M$>R^[."C%(MS:7_2F:GAJ3MX&@XW%*=\XZ*'^:LT)WE%`K[(K/$%(,919$+V M'Z!N\9.2P-,&LO&]*PH9BP-&(VCBO@!G'!<<2/+H2)X-]&B>Q0A\!M]B73"/ M7F.^;@47T+,=7\USOH%!8+D6`-:"P2PL@3^B17L"[M7/!LQGA2_[ABN2!<=! M!^">,0O^LG1$!U^0T$W%!=,-=\%5U71J.SX&'`ID;P"/HE:D8FD$[K9R@G&M M*AH'89H=HB$L?%2JMBE\6S.P[EJE%E5J/+0A.%/M1%A`=*C%+\Y_@*"#6RO= MQ,A^"NZ.`9H!M17X'3/#F?O-;/D2B.KFY*7!YC]W?3;7N]3P:2I8$OV:>_:P MM*C[$88O8)BEM=!@'](H7U)XVD^:8]C+J%L?>'^[7];#--7/P2ZS7\@0`4<2 M5#?Z0B!KF_ZU68,G6[8>7X#70>/G.C`8E0A-&J^GC%TL'VSFRQ) MZ8\]V80*!X"P"'O MJ7/85%L"U3%$PB-,,2@C&W/$_1&V\RTF`Y&S$*`-:A:V9QV4*)TP>*$9>H^- M1)[1@9!<`SG$=-'9V#:/N%6]&3@UD.V[R/3R*6Y M9T`UBE=HD=6!C<'4GLG8!F/HZ.3R'T9H^M309IZ@)1Y2,'\Y_8%1#=U= M1"@0W?+(HM%]FWD:N&O@^ENH9:9@/#`+OIFR!+$B`RX"07#T[FBW!%_(W888^&(R8.&(Z8W!\K4Z>]F@!AQ*P>^-X\T@-8 M`?2`[$FS4]P&UUD*Z;SR!=NU[P_6&]"S1^7B+. M-6D+[EC#\O@NC1_>`=5@H](SG.G2\,`2$>TH,4[B:P72EG%UP]6+;Q95H%^X MY13R&OH=/GN@R0^[BH1SF+PL5G+_)-F@V\0H1;3SH<="':1,`!TA%38^ M]_#>FA27`FZ.;`)=/I@0&4&+U0UH97^/,G%DAWC)VQVZTG?3,S#2C<=:L6'! MQ@<#$0:!+2,."]<*+"?D#?&OR/'W10(V/9W]8K'(&+@'ZFF#?O;@PP-(#/^(__I/W2X#2.G8? MC1F]3?7W4K14"/&Q2:Y5M8DW"'\1$G7>J2#<,UL'#`@YT!IPG1 MHJAIZ*;'=7_49X>M)_#(!2RQX!Z/O_@A@.A2X/:%SG$`#TY)BZ/-HGY6^@8B MT5DRK2#^OX#\_["[OYX;G<4/"/W^@B2,RA5ZT&+(P!2)AL0S:)E8OZ9IEV?Z16%FV M^/)3>/1ZB/Z$SJW)2HP.UR/L>=/^)+'^,! M^1SX&$/S=`#\@CS/#U-@9T9=,^4)$)H5IS=?.8")M`O\V\6Q\#1F:9''"%_# M)DM;IA@*8WD@(93+`*Z42[VU:7H#ZP&'N1GP.QBMKH'#B/,D_TG4B&"7\N.H M9W&Z#S8M_>#0X0*&&&V,_F!T+SA'$1/BT'['96`9C&FCIK,H%!@8/!0W1+>3 MD.)#A^!SEYL<.!`//RK@HI`:O!VXP>L;ZRT?1C,Q[L'.!*>"R^DSQA08N-3/^%B5B4#H4LAHC:Q,V MZ0?B*)YJT8F2 MD+EQ:S!-/UC6\7-&;)J,U]7FNXMK/%@4'D7V)PG$`]@(WOP,%EF=3N.$<&#R MBT%O4#YF&N0"Y]#Y:RRY:F1T%VK*K+\]@0;N""1VD&?@*))]=E9(L!2G0W M;7]%L60?V,UR<%?S=T47J6O-N7+HJ)`WD/3+!`1)NVN>J_JV=/%^[JFX\1_JW^=PB9T:\"L!)=ZUP;3BM6)/-H6EV2SP/PV@7NP0BM-`BM# M;><+5@2U2+V%Q)=UM^:@I4F%/JV,0E&(ZZSR1Q0O#C&8FI8XZ+PQW#]A($O MP&-3!/39#_#B#/U1O]=5%/A/'Q8:_JNJ^0W3LZL\9`\5(+Q8IFRR2B^*;S;` M%>.NE,0]O]SJAKA/QCO!G>XD]M6J%CY[K'SLA\-=K7PY[-?U,M\,^[AQ60)[ M=-VHMEA$#_.OP2`-2)#_5'>LJ'V$'13J&*NA44DTA??(3:<"D&`84H$^*4,^ MCIP]4HG*:FN!+D0);D+DDD$\LB\T4`:*.EQ+!@%T&@T\#*Q@-=`(TL%W==?C M4I11PMZ.3;$O'66EU+E?M(_*`[O'<:$DA=KGES?GO]$69C: MPF7%`02^9J;I+C1,=4`YH\\+3%'FGT,P'!^&W\]O[BY.3RY]JMS;GF?/`9R3 MT__^]>;J^[;C_`'+;40>##OS[,3*:'DV).KZ]^+_G'-R?)8'B M>/2>'D>-013Q])2W?7KP9Q,T3'TC:SXQQ+L2;T99@V[!AH/)?#1)Z2CC<6K)?"`Y9ZBUQRLA3$J1-^N[LYO8"OOCC_.+7W^YP/K.X+;Q^J+BIA+%> MYJ!"0ZI8&"'&42FS-)ROIW3BD]\[TB=N7X&FVP5BFQ.D`/;!S>F"%,CQ[\N! MO1._3\C8J/\^3AR3S3B\$UG"R%7$&A2ZX\-I)"I%=\4Q*O5QD]A%%FLD]<3V MPV8@F>>09(XOKY^@G"]2"2851)&VI7HJ8)M2.).<`V6<[["7!C&'=LVY\JF0 MJ7VLOH/U55;%\)V(7&`XF=^ZFY/Z*B.)S6TY6S)J"7E3!R79HT[(J]FQ`A`J M#%.6IU-)B':RK:7">`=NT%]+O*HR>2]=79RE2!-F+_MUC-^V_"B@7@>]X9Y` MOK_R,QYU1O)@?\5GRYV'2I`Y!I9*2$K+&YBIR"E273P>XN&&*`'>1$ MH9*][?:R1GS0:!VUV\O:[47I])57O+T(H5%;H2D@-!.EHZBC/0%\?V5F..D, M1CE9"[N6F>KWG%XK/@7$IS<"6Z05GW7B<[R_DK-Y1HR2":TDA.ASS?*3G6.U M&=\72GRJ3>JVG#TJE:`(1RGI>EM2ME)LM\ES*TVZ!EN[9D=1AIW)9+PGL._OQJEV)KU>9SC98].SE@WT$HM%7EZ? MB!(@[299_2;YH3\>E#P\WFZ;+'-Z^,9VQP\#N>R1V3:$WXOK`)06G05R8L^T M6,4J(,S)KG"=:=!X1GG5B2+;SQM+>!CVE(ZL;+D-EUK82FSE-4FO/GS'E^=?`G#J282U[&='6_S]B/];6.33S(=-QRJSI:?D M?Z9."Q/,;,O+N'<.:&@MQTPJ?#F`+4D6+C',2&M#^(,W0[16LP2D6E@3^ MW7()J.!-NP*;K8#[N"7UJ8T7<[TMA[G1O'8--UM#*OVT)?FI?LB68X17O+8< M"'3S]"TRPX8,\%7SL`OQRY94/ULG@;N\[=!3>:)[=7<;]KV20X';!^51:)%N MBDSKD2V3214'Z/WA+K#2SO+; M]/;WS82B1PKM-DS.(MGSNV)HI"[O1I6O\36+[3" MR^ZW^E+7>)KF_XPK(GO&_@<"YC?;JF%)-]D]0YB*;'FCP7O>L=MVMP_BWAMZ M[L[9O!:([^A[L(EO?UVI:?GK3SK].NHZ5@UGULVF/8-SMXJB\!:N[L$6'K9> MW/$NOO5MJ:9E`9.[#\"TS;I8M6=@'HK(UNB>%Q79L-WMGFRZV6F2U5WBVB01 ML^+5'_8[(SDGI+1-KNBNWBV?SEGBTMF;(TBZ$MLU2CLC1[JZ/#R4(KHWTO=\ M]>KZ3F\P1/7M=O?]7E'E\W'EA<]?)9G6W5-\%9JKC-VY*^`KMU=[KTX!!R=1 M*X;'7EB^X96`W@A[HEV%GW,LIJ;L=`6H@W_K;4HVJZ/5757=)P1K> MSB+%02+3DB(#F6@>0J'K0+LQK`O?`]XC4ZE*KGFCAO$&=Y.SL,_)L&UY9I_> M?24DV(&:K=>`SKU[O>>[W.%LV?ON212X*[YWO/`V.:DE1:UV\`%TYZOHUCQ- M6@Z0#\I'Z0KXP[`T4P*ZSEVZ4Z]+VKW]Q+JQ5L;L!YLNZ3=)QP[:+O,\DV%_ M,$E[/0[UESID!#?UKZPT;:?W6S6&/G!0JJ M9-+0X$FA;]:-O$R:[9ID;;_O."0'TL"M[??=]OO>>`TR]&QO(9<+6>=2>&%C2S`*7P6-@2P/E&=ARZ&+0=&@*:Z8)SVB.-.R" M:2"YQGP!1H,A:K^DM@,^P1ZUHB"(-&-8I`+=!1A/QSG`M$+#B5O;SX\P/7Q\ MD9YAP`"0#@K8]!%G!Q,*3"DG.J8H],!,L.G1A%GX)9W$:8:+BI46``1UT$ZG(=A)O!>T(>N3WO?2K?)[_,>P;R&6:>,`:T=9FH>N8VT;V\UON2KQRGTH4CQ7SZTDSY#+NG>.P>,Y(+')R>RK=L*FVZ/!U(HE?@)AQ MAKY'*5IHABXM73\P0.ONNNA0ZHRF/).V:.73"J(=?4Z0K17:B(F.X M?",7\P+#G<#N;')-\>$=K[/Q46A_R;]IJ89%3#["C*;I*R0^8H[](9UN8Q:` M4)*%@13:VD*`;YD&BT"4Q.&R-_R]%[+&]B)1"O9%PA@SA8N]1)0.R.GO"GP_ M\!=5!ZW'E5V$^P/&Y`(W4VTT#?1C8O;GY% M^9'"[<3CP#VN#<\2=($&)@LE,'1]37P`JUZW:JT@(K^W.O@L/,OP#S&X:1W> M;NO)W#R*:V@Z)R-5B9NY;T/CK8?%$KA:`_[).K;I@.:?=CN"6;G'9'CD:@5Z M_YTHK9*K][E=X()5#RJ+O#80'%^2.+BZ`=K.86@\^99@8)XQ/T#N^W6^U;&B M@ODT+DH'2!1"QX4U<#D(;CKIH<=)0,&"D_`(;XZF9.2 M7PRE&SDG)"\>=5[`7^![_"G($$Z\%@1`M2H[$-6#B.1W@^:()E M?82GE\[4@(45).`P^\,^:L33>`\@?))(#[25!LHV,K-'YM1]&(2&?C+EJY.X9#@%,#OQANV[D]X0B M29DT_=R;![PB<[K<9\>WWBG]/NE,L*:Y\A36QYHC^'>*VE]Y/'UZL,$C+K18 MD(B%G;TLN5!P6G&O`#8ZX\$"R9KBBLQMG?Z,3F+'TQTBZCF<+[Z3:CKRL$@P MF(H2XZ0P8]I]/:D0BFW]Q#N1_(!(G2[R*]&:,-D#<*RP32AHM0#V\KD/ MXV#A#J&@KXOZ8642(VYSD&48`9A6^V^]R<_N2I!;5&8BHP;<6N!O4:1)NC=T M8:-$M`_8<1;N6BJXY&!B-L3A(G]H'!;#/WIHV\OQJ7#C6[L M[HKS(X3YG3KN=8;]<7*$E6B5.%J*^#[D4?25CE+:]8E%7#-]'VX@],$TYN!E MN"S=;-K&6^<4):R&46A']XF[!6UYX9`-23L8;.!4AL#E4W7B`Y9)U+MP-(R`,%[Q5$ M0^<';Q8#RR`4B$LQ,:`5F%P9"PJ@SVJO'AG4\U18& MV,#Q9%<,WTXUW^B+'!+RP]BH0R".;4I"AAN?.',$XLPTPQ$6Y;WF8@"0'R/1 MJ@-Q_27G0/)S-K*6@T`$OK,^`B&.=(5[+NR)W>^T\?TMON_NSYZTGO_0&:-5 MU/T%!%J#8G&-J>\O<$T4B#!&^/FB)I]TV`(6B?MHV2IM)5+D,UJ$H\3ZQVRZ M.7J7"Q,#$*!`B#WH+!T?YCJ'K$.NHD,/)V9`=J4_0*Q=?CJ9-6N4X7W,Q<$& M/XS5I,^8[W-\.P5=Q,A$Q-1.]-V8&<:9>-8KO0`CS!6`SO>NQ38K=($ M-\J;I"_VN-MO2ALEG#5J+P=5:#_<"8M'^7@<^^$;Z%^>RC#HQ'[(3PUNGEBO ME=!RSRGD4QM$+4U:FNPD(U^8>?V)Z/%DHW-G^GWT2MWM M4:NX'E1I2V]_U-[[K)64E+'UL; MQX7V[9SP+AJJ%O&W;]&[%M$CVD=4)70J[:8>__A'`D$TU7TF3\VN?3@,,(G,W[/6E>)+8<&ZM.FFUK'_QM.IW-IM--Z@Q< MB[/8*_\L-KQ,]SD\8SM= M.6,K)\P5*;QJABE^B7W4&0TK+4C>EB78<5F"048CZ%=3D\`\B"/\!)AF/)/N M\YO)HMLLTVO#M*ZQN(NS45K7L,ZT+F7@0[997E>!*SM[G,:EC`>=$3AZI=*X M$+I8)I=`M#\0*5O]-F6K3=G:%P78IFRU*5O;A(J&^QTJJL#SJ<]K*I0\4B2R M$],D8?Y_\OTT[C*_):FDX)-+/RC78%^?9 MC_#UBV<0E(_J51`'S(GF]?PZH@.E.]@H&6!O#F(+';LV'=4K[9'7_MD2K__L:TUCV?;LJUQ2Z;`S3JMAO8>,W1Z"97?RG*SV MKFT/P0[X$&SXV@_!LDRR_W-\?&[I7QSM`:O+'!\'6[1N/(70BP__]6GI'C]H MVN*G,W;OX1&4:;L@]'?LA_<9#(<_?_G__S])^J_H0Q>6ZSE+'/M4E*434QF/"&S?Y^I+G']NP8XQ7'W8DZ6QJS#731=/PE\$`5C^.719<-:`XG/0W0G'UO1P4 MAQ6A&$9L0^5_C<%B)0W?[*?K1?[?"^;\FT+/43)?&72(1O>1HFB M*!LR__%1YI[KX@H\KA/_U42RK,H<;+??T6*5QX/ MMR12UONOBDB#+8F4]?XK(E+@J?1Z8[7;[PT'&_DYB;=?UNYI]P6JU-Z)`]36O"IS&03E/!P3)M9*+$B0YR"_^ M.STEBQ`YL.41X(LV99E!A/!'G\GE=+RR9"+V0D[(H*>.AN->/PNW$([*4*G+ M\TT@IO8GX\DX4^_5@U@MWFL2,34ORE,/7K4XH`F\%`41:Q:O7!V:M]TDW\O# M2VU\N6IQC9-H]2=]16UXN>KP;I-X]?IJ;]@H7O4XJ,G8<'\D-XM6(U%]=3*4 M)Y/&\)H4QZMWK*@"K\D&>(U[P_ZXT?5J)B20%#=9;EH]-N/5)]>S\4V[&;]\ ME\NIJ"I".!H4$4<9Q5$9\+?DU/=R\.HWSZ:-G!B.&T=+Z6UHG*R\E^_5C+9' M#!LG,6OZ/_ M?K$=_O8WEH9\WN,`^Z2WUNGST5=BZ"O!%@I#E/8`\W51'LP-DJ:_(6E"ZP*& MJ-HYWA/:#`K31HW11@UI,]B`;51E[_D&7.7"M.FE\PT.49XVRK@>ON'W2_&. MP[G??A;>Q%M;VD-:H'3-&S7:!HME/("L8O@X^P!B#:!%J7+K8<)V89(D'\^V M*7ZXQD^68?[]"$9A%9@8G#P_YJ;E_@1C__WHT?,6/WWZ]/S\W'WN=6WGX1.X MK+/U2/K4,#5JB$,FN4,<+V1[WGEP-DV.ZJ.7!TV. MZH.>6>08'0(Y5F*>&ZF.G-#I0:F.E5#I9M3(CK@>%#56`JP;\D9FG/:0J+$: MEMV(&CG1W4.B1@-1Q4/>91H(1AXV>6H/8C9''E'"!?,%TG(<8K_[4:/\*&#! MJ-'*(+^$3V5B&86F\$'4["*_ES_=C#*5RA18"K&J=;$O<&.<*HG.Y,_E:%U4E)QRM-]->*4GTY4$*>501"G07XB;"TX*6IO;2#? MQXGB^`%.D:@^/SU<&>27\+"H2IS.F#MU#"HXN`:]R),!1Q8ZU%G'DL93S:" M3^2S+$1P^FVAKF<1KM7^UQJA;LC'K!V+1ES( MVK%HQ$.L&8N:C-7KX<9`?[>"TM1!$?Q5'%*>:O;&0EZ>2`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`\6D5/3+X1M),"T":.CHI".^S'(^ZYP"X<>)7:+\/?)L,_8'E.^*&# M%LFH6?\@QK[E;+2RKD<'<7.Y!(YJ+UXR:CUT-2->Y8%!+BN.U?YVB%,7'^.) M?=$,YW?L`WLU"[^\-+1[ZD`HD"_V,)Y@X+2L& M84-$F!0F0D*VRQ%AI8C,WA%!W8P(*Z_E$&%O"3`>EB"`/#I6AOREL@10)G)< M%VQ'!/\!@[D)C"._<*$=R"K\1QGURDEZRFNYDJZ,AFGH1<#9&I=)85P2O%H. ME['UQ.15.;29*XH&:3;LB7"8@J1BI M&BW`(NR6CI3A>HYQO_28?JXYEF$]")Y;_9X;+FLXKI#I4X[]^D,URGVK@"4Q M>C)T9ND^'N+3KJ`?R;TX^`*>#*"OM1=T^,1:@6'WS;:F41XK\&"#*GN@#$:# M%.QRH,M'G%?ZOF%3V]'/M)>O6'H-7O\7TYQ4_'.>%QE0\F2T[8JOCO%+2IGY:YLC67..I%HX1_+;^9UT\>WTZNNY].'RZO;VHW2- MB8U77[]>?9-N?SNY.7]K:8UWT0Q%B?(79[;C/5+J(FS)]MRP-,]VI*6+8FS1 M]U/-G"Y-BIBYF.9X3YK9PEJ1UM2>,^F#:;ON1PF$3R+AHP.ZW-]==SE'"'04 M/!@W,UER!PUK7V%^95YVR=;-QGF"7P6Y@0>0QWGWZ#`F49UC-Y9_"-8LT_<< MZ;V9)96JX:Q5DK?9Q(E&9&]MXDA$(#?/^FF08\NDXC22CIV?A+UKA:Q%\&*7&\7=D((GQEFH("- MJ3TQ!VORT0-@7BX]K`Z)5D^A_-V]SG:^YCJ6%36#HM^O+MTTE:T&0?$*WI`EM=VJ1X%"-C8?RE:!B#7622DQV7 MKWJJL)PKTC+X*[QVBH%?OR^QM'!$NB'7/IW8CSJ[]RAJ]JPYCF:5265O+^?H M):>M0=.UUW;VY-I.O4KUP.[L%+Y"*#+U*U>P%=T`2#J:NCAFS',UI:T\S-=T M:Z0&,&IS3AN_0M(N>9U+7L3'WP!ZMF229]-Y+ZI55*>H6Y=D ML:+2Q5^\R/$7/Y.1@B@M1*Q0XS^P:[]&POP:Q[ MA-U&NF?,@G$]XU@7SD%7NN)3((T72R"/YC))Z?3E24>69:*:TND-1_3)WZEF ML%DY\9C%,P-:1+8P":@07P(:B],=!EGP+G_F2T?JC08I>V#,7SF-('@=H'_+ M_96\F:(#KE)I)KWK=11E%*#Z3NW(?9E_+`@_?8TK%Q`\GPI$*,LF`\%+I1LO?&#-=.W$"N]:@*N^J9B9X)3(DOIK:7@O7YGW M:.L7L/"NA[-;+ZH'%4"NR?>J\Q^H?9D>E.U=]Q!V.8[U MX!L,AG)750=J7A9KM$Y^I)5TH@]??*A?KM5_A4BN@ZLF5"?1'A+%4(UW/U:H M)0`.)&H]D;#:*W:`J@"$ZLQEE:/E3X?2,X>:B]0C56W+89J+Z&259D/ M)&O2Y2'($&Z=2,GEM' MIWYOO-=T:DISK*73>-_IU(S:64.G@3*H2>YN#/?/+PYCT8:5F51*>WA/>`D> MD'MK:)0&?D,4V@,N@@>4O:707NQOQ$/*WE)H#W8VHM"D,@J%=93<^"6NW"?: MBURKP:Q*+W(-"U_D^G)R<2/]?G+Y_5SZ>GYR^_WF_"O\[[?"9>EW'H/;R46O M4WN^P.CVG&G$V=(,V%UZ0G['8*@VQ?O66`Q:>C:\1^G.7AA3::S*?BG[+X8% MOQJ:*9U,J;\&1EIO,>2J.;HK?;;A'^G#T9>3V\]''].?.;5U8V9,>;3UP]') M[>G1QXZ$8B>1W$E?.6S(;_QW!`"?>7XTIH_2PK'QJK@K:5'@'PWF8+3WA9\" M+!S#=@SL!,*/"`QKL?0HTHZ/\[D]-GVTC+^6\`@=&L"/@BR1@;M$MG#T!^-) M#/EH/#R"CO&G>L'WEY:FXQ+":'\M;?P'?IUB*1*D+:4$S37G3W''3L(;[QZ0 MPO0;!\!W9J2`R8=+]L1,2?'A0I*X'X.PMVD_KP)@W[O,>:)[:0)I,4HO/@I' MC)_>F/B`&[0K2*/JTM*9(XG%D#`"KE,+OGL\37?%!4*WO;-7P9T]SUY$$S2* MYB>6.@OU&>LX9;S(G8N-QI8N`F%#=@H%;DX1=-NT'UZ(@S*EI8ALK$H4";X7 M47*/XGS0KTP%`(&"8Z[;W2RK)K$P"1X*N;!$WKC<'6WTEEKDK?S?-\*Y1F94 M=\>,XCSPIT9(5`L):<"_38:C254C_L^*1+K&W#`UIZ@\-L-P!TO-4+\5(2V8 M72UQLT84(L[+?\,N8"6V$]H8<,.)V$9^^@I1/$KPE]=*VLH]-U^S^M35L7`: MISJX"`O--%\D](B1NN!6./:][6!5(^G^);H2G*,E7?,T_`6?9'[RCR,6%2Q7 MR]W?=(K=<\NVV^3%+$,:R(C2)$RZ`:\-%N\#!CP8WZ.9Q!SD+.Q-$T:Q?<^5D&HQEK;EL2OR]CJ[=KRCS`& MNK.N\6!15`!\?O%VQ`V-.*YMYF;14`\)$M\1>I.?8T;%2^3K=#+SD``%@42. M7&I4P'`Q.Q.T@FU%(Q+\99%(R14"[1+P>.&%[E(T*#U28S$1KM%^@.'T'YZ^ MB=EXF!ZY$O]`_IH;ULJ3*;&2_=UB=AHMI,4!.Q2(J0?542-[!+":C775854H M;,B%WS&(LCSWT\5UG#'-P_`:5HN'L8KDF$H?OH$I)RGJQSBG":N!+#Q<3(/: M;H99L:EQY"\@`TR;/DH.6V#)=^L!,SH-6X^%#?ST8Q'GTWAV%\RQ`$AH[XKG MWP9QAP"?)`Y3R@,62;#`:L"Z,62B)+*=.4PN?<#$4V>!%A."*=#E4I*2!,R# M@O"F9RQ,@R"W77]@+\A71@.K"/4X8(!62"@=CX+2B$IA1-LCJOBSB8"RBQL^ M&0OZI^UG%)*'X$GX9253VFU-&LMWC6=>@47UK*2?DVNJB MF"X2.=[`5.Z29VX#)UE(5&"C0.O.7,;X M(XKRD>=OB[U'1W:(K`>N:,!!QQ$NBV2`2ZLST+F@!E`>Z?:S=>R`#M&/\.S" M$R"+(#YH"AM])YL2T^>,<57B3NT%D]B/*:.331%^QV,5'H-7!ATI+%3-][C? MF/Z`DBK.3)3!T<>N=$O7&[*```G%:37+WZ57=F3!H'Z&?2>>;P_;.+Y_'XHU M+8W.?O`-.J)6HY;(7#0XN[2!_1VZ02Q^B7)^I7UZU*KGED394P\F=US=.9JF:)%`6=,]#2#?0 MNJ!\PS974L#7\G31':_T!A>1A=4]SA<,9=*1U7Y",&"BURT;;W/OY>Z[&SWR MO;FC"QN]P4=V)#XI=@K8'NCT_XE$#>]8.0P;GI&S(#8=![Z; MF=QBPJ=F2R]^+.]VI2]+!^5K;M/-[D?#9#$>N6=@!S\)KR49B:`M9P&@@P6L M"4:@')R M[P!,1+#>Z1@E,FB&=RX^$?==_$< MWBJ.J\5$19>HCXSL]L.8([M%5E4/[]BZCP#S,<5"Y[@5"?W-/;E9D'AC6*[G M+"F)8\_45"3I*LX>F=E8&]Y#S,W12R3\,>:>6#IHA3GL4BB+U$R1I_JE_Q9< MOY.'W4%OG''1L.CUNY5!\J[?C6(7M3+@BR/X*Y@AE[;K7EFA/W`1LL@WYET[ MS--^$,9%'VZR.:$R5H:1=I%%06R("HUU*NRKT0SIS:G@XFL,7DR[YA>@G_M4 MRNK_<(V?+,/\^Q%`P*IEAA]STW)_@@G^GI+(JLJR\NF?7R]OIX]LKAVC[D.- M?21]J@WSIE;\6.FI/5F)KWDN=#6BO(O+QL>]^+W4LO@S"[P'$_MWZAC>!^$@ M,3GG+<$Y]OG/-*GF`-?1()*_O@:T6G!M3)E->B-5V117!UC@VK%GAN#@\'.3 MZW4,2/0C-\0B8)2"MS&:#^3Q4"T`[P55M$`Y^P+S@ST,@@8>\L/50@3EW<\4 ML^#/W6D_F`O"Z&BVHX,-ZKQ<>&SN8B,JS`.P31->]>];$/XUCM_H^H_&RK@7 M:1!4(UZO:H$:VS]'ZK`G#W>V0#"`T%^?0;WYTI_QVP&:5!MBJ93&[61S M?N2)P]P;ML6X,3.A%Z]IE0O8.BRO'889*SXWB-T/E``%YDYX]GXZ^D5>;53& M!T,E6@%C,XCW@&#-Q6M&\DBMFV`WP8E#%ETB3S2[)Z`QD:LD(Y!5CF9CJSP8 M`8DVQQ*C59IY2KET5"/1/?%XSW5\X\X^U4Q3U/T$Q@BRA0(:;/9^8UL(3R.L M5J%B2B\CS4XD3+'.,U0^.)YBF6W+:\&`KQG_PRMQF89%7%+0J\VE?Z MXQ3"QX&H`(=)`1S"/F"IQ:/3/_5QCPHCD/:3S6O M0U_MCU4UYLVD05$!$C4N1%\=;88$K[OLHC=^[\%F_I5RLW#Q>(7F6S;%K!F# M9TTP!S,T[QP-2V]PXSM,%XG7?*IK\+9<5.67CN-Y1NE)LFE_G?Q^>S!=HS_\"I!VI-FF"A2QS/;.78UK,,3O.G7=Q(O.H[! M[V)HB6G_PQR[$V1KZOB5N-QD6)*0TA?IPK+L)RW(Q/XG_G$-C\VU*5ORN@NG M_OTJJD.%3QQ]3.6G/QA=65#57J>GC"*M&'B.G[@@N:`\'6Q+0/BG0-+A%RUT MML`^&9;GE[*B)&$46](07."" M+SR>K`XF[02Y#Z^D+,&6Y5GQ>)].\QL[:-+_VI@+CML-$IOR?/\IKMWYG2#F MS,$\2^,_P6N80;K0,#,8!ITS4[/L*>7=PER::3\L14D/SV'\MI[+?BR!P?07 M=P:0!$QHWS.7[K.G\-CIW84TY28(=R;#%/Q2'4M2D%>XP(H\D`! M)SQ]!=(AM\$PQ)LR+DI<$-^.Q$6S[.R-WFR-Z)J-Z'YA(_KF_/3\XG>THHO: MR75M+8V;&M$#"V%[!A?:J/8E[#R9U2_KHL+>E[+D?4C3BB8B%,>W%__WG(-2 MN`)B`_W7L9D3<\IVYHT6SPFJ!(13]Y1.'(Y[1_I$@*"V:AS?6KNCQPFX`>W\ M"Z@9%,NE94Y;R8J0;J+9N1#FD?I^^[:7IYHY!S>"$'+8P\\2.M[1NVW9%!-@ M(!0U,:*OM7+P+#7GN_53R8FY8FU,2TTV'G9D-8?AJD:N!$'#)6MXM9I:J,+] M9GMJ9SS(Z2]<(4X[:-M="L`;^T4S>:P-[UUC1`1-%[H#BY4"%%GI*(-^1@/. ME1(9.]VE:Q6B:M1#6HF]IC&I=:.OJP_U]D(O=^3Q>"[\5:%P6B M5]DR[UXG91H?23S4[J`RAKVCDH*AD^(6)Z<`HTDU05-*NKT$2.OW9$J"L)6# MTU-&I2F_,XT56_D]6?0=KW=ADZG?Z_1Z.7Y2R;6N5FUEE7;>LZ/+C0XXDJ7XW>>$B#8$O@$P=;.1FQ&YQS59(!^]6PJ+N6 MGRYX]6PQQWTT%M?,P4"G]L`^OUQKP0%>B>?YJN8_7/'-%__SRW67ZA27ZPED/)UBSC9\=IES`)@IM M-T23Z<8#>1"[.[8=Y'M(R*:2GP>RVC0A>1;)5H0L.$3#MQE'X[5T+`AX(3J* MQ[>A8\$AFKW]J$R&O?64+`CZ'E*R,8Y4%549]VJC9%C5PR=,^,U.Z\'$("D- M]LZJI&P+=G\X`,L?"WUM#GS*&(VB($]&B>FWO8J5,F0-MF@A[!1Y7#5V*4/N M"KO^>%#UTJV,6`MNSV$S9%"-/$69HB9J9;$]>Q4!M M1EW-&76]4AEUW^XN_R5=W-Y^/S^33DY/K[Y_N[OX]JMT?7/U#?X^+=75O/9\ MNXSH\/8Y=\DI\T.RJV%LPZ;[WVQ^/A1"D+9C0E/>7[NFD[F`Q'_6$ZT*DY MZ25AWQ7!U\)^P[M47&.[@2#]'J0#RQ)FH+7^%4[^40_404\=EUNRU;=R<9^, M)V,Y'??U<.Z$+'4R\<$10QFJR@9,DO):[HV3>$6N;>@21!5$&07N-ZQ\VV2@ M8*SV!_V(_*\`LS$&3<4,QN/>8-(KCH'SH%GBNF387@,^P+I=.\S%XP2/*J)\ M\2VCV\`PRKHJ5/6@K<]3L\^C%/9Y/I_<7MQ*5U_`PSF_!3OUY.[BZMN^^#=- M7J<^?G-<.I/"O8RM3Q"#V?M4*%+0CF]O*D- MMBD#'P=&_8G@_6BR36&!0U MO&\OJ-D1-:T*[ZOC=X8H-O#$1&,NL!,&NA)?-#=[=UC2FG%]TK,J/A:QL MQ[_89MG6L6$]:2X.MW*+9*%Q!G2TQ8LT9SK55`#P8$"_E$/8PU;TT@6<%H\O M+CUZ=#MUM#GL^0X*`XYR%`X>P5Q@+%JWX15[R6)+QUYH'DS"J8`Q-^>8.N#! MI[1'L'9)R,-7.R@`0OWS%G2^LBZE]OG2X(:" M)0"H!$8LF.;'7*0'WK7#I,7',AO!EO.]>YO9G9+WL7.#BAK>H\.`%&!K/;KI M03>L=H*]`7W*&.9+HDF@%QF7V@F"P&,KP2!`YT\V6P*U7YA&X3U$)WEGI?]V MF^3YUL9F7!,:"QZW%CK8KPX;%][CVFB^R/^O7_"$]U!<.M*)96$QE!MJR8H#>\7\'R^:O&$NY9`3@F-&^\F'E#X+I_,>4`H=2V"4-]MS;\U/81N'/ M$^!GTV]'^D87/]):=:TP=KCRPLZJKO%@&3.00M`VL+"8%2:*)8%$BJ:'(.;@ M./$6BR7L@TSEL0BRSVB+>L`>-OYG&_^A!]0?GF;%BPX"5QI@N0^/YPN"6F?Y!5@ID=U-H24&'S!?46!WU-=9"` M7<3R!;D@@2[PL>0K1Q!Q-4^_^E:X7Y8IX$,/>S+/&>=',`S=B`FYOX-AE\+`:K(D?XY%,ZL`&XH^W0F>&BV*KRO*0E@+?T:1GV_F3O$UM87@D MU:`G#&9-7U:OCJYM8XU#>MJ?#(M;L06M)`"$+871[0KA8GY\3,,BB5NL`F2<6WQ M%L'<4!*`@205A$W`1*:0/85EB;4S]ALHDV'I+F>OPHV,O'QYSUX'[$%PW@?[1#)>14^LA.D@J>WGO8;_GI1<%B,;X6V_R,ZR' MZ'#KV:'<$YL\V"(D`:&;A.VON\2-:")/Z@Y-->BP*X&'JR)'M'\ MT#>T&J=1=$V?1IL9AIO0X`MF^>ADQ-_CM;,C#2T"=I:B\;-0O%0 M.3;21`0!A52FO#Z9EZV(7HT7=)?*(8(M.,%760-C$6%11-Y1'GD@#'6$_I`O M3"Y&`N9N5!2(_YZPFF*@,Z:VZZ5+>50#Z;80.W[(#]]$;1]T19X,'6U8$C;J M$LWUGH,[KQ/Z513B6.H/S!,(PJ;VK#EZNG\]B_J"Z(T_&Z#5YMB*.JI*(MC@ M]+$Y[U^`[:D-.M=0`==D4B0R>(:X0?'I$%0&SIL_P M13-,5"/4L)WX#[@UB_W6<%^P8_$.[Q9@S,-_DL:55+H^#14BZ#8C-WKR]@R8 M*V`BTP`^UE&?QX1!^%MX%&ACX MIG^B&A,#7LR3)`5SD6*_H5R)R*O?$A[CN-PV9QAWP6(;,#+ZXQ011LT"#P'; M($9X=P]!BVB'+@:7^-Z>C3T/Y*`1?(\Q.+&U<8UE@6:S]$Z@"_RRO3/_OD4G MH@*BA49Y<%58&+ZS%]@7!"7P;I20#I48>2'Q!A,-M9_;E4Z25F$G)JN4T-1&_]YV7D0<0B#LT3WA8-7%%D[E3'H==33JR+),>&A45)A. M28):PO"(HM`CK8BE^@C:E%B,&[CL!ZPR'@9T4*!,_=D`TXPS+,7FX1$$F,UQ MF)7H/J'%?TN-\\-Z@YLQZF;8$.#V/0"[DB\RDK0'\$S)Y24V^-58NFRQ8,AE MAL5LZ0.=KZS`()WX[^&1#%5CYJ7GD1F*P1X!N2/*XIB>)MV`(4T6WJ,H@8V;/!`*%F;:J8;'(E=%:@=\,%&BQ]=<]]!B2F'81<+._]C"0H%*,(O/(^'B<6[!R:03I`-G MD*X4N((:J@R#XJ2>@WF?2#(+?R/]Q*N;XR#Q,?AC8%BR'V!!(-!@L*U,S]>E M//'`:@Z8`9;M`O0@]W`B47KI9+$P`Q<&K3#^2O38A@=8*3S,-PX>\_>];%2= M#D:KN&[6%L@7FBGD-!ZM05_^]!Q1_)-LR=#-"OCW'(_N&(C>=TMX`[XS3_!^ M.3N1!HK\X<^/X(#!:J)Q1P>6$56PT!S/PF7Y]?SJZRFP1K:P;SK?F=.,O"!:(<)@%W`P*`GU8?K*Q5ZG$%5^?KSKI M)Y&G1%WX5KJU1M-%\Q^INX;T".R02$)Q/C`UX%9GE>E>?QCM1%P:-SK>H0A0 MB$SX77"37E;P+H]:;H'2WLO#98@]`A.XA+!L`;R\(?#)]_*`GXQ[P^1"Y`+/ M;V"%@///3694]L?#T20!,H>B%+A-I4_VQFJ2.S*A%2U#16+EBKBF_EQWT0]U MO,(@J7!4B$Z=#092^+TH.K3;BY;/WU@$D<0/30K#4)4'27P2X&R)25-R,NRK MI1"YUEYHH[^S3[A7>BV")M>F1DGBY\$Y**)7_/$#;,!=*RT:4Y2Q6A;%84R0 M(M9F\PQC]>"JW(!9&-:RX40H\&#L@OBHMP414L;(K,^C8GT>.2(,14"MG0H# M61UO2X64,0Z("HK:0_MJ,.F.$8TH+NFTD'&/"FA!GY0!'T?.'JEYBKCP.+6O M/6-34\/X7C915IYM1D9`7?P;Q/_?U`(K012EJZXER@K8>72YI)@Z^9;\![P` MFT*3U.>$_9Y/CTSS?1,2T.VR+`*DPIB'_+7F7#GD1^MTV]&#I/"=$APPRNC`_'#9#-^ M2+ZVG@Y4[E".AFCVAA"3PH1898A71`A%58L95@$Y(K:46LB6RI.2T:!2(;EA M.IY)T89K3/,HDO'DGFV?&5#FD8`><$_"H\Y5W)./U(8T;YJ:]#4'$S5ST9.@ MU8!I+7;!7F):BZY/Q525I?774.%,V9:HUCEP#?EO>&&WU+^J>V'"-K.A^F'2-K.E^ M6'@%4:6P7PIZ]'W-N5=#>9B-!0&P%>0UIEG5#'FJ#BS2+:K<>4)5V3EEEV5# MY,J=$>P&N;KBVDU+3CW'NCN0HJ16W4R*\DXG=RA%FR!7[NBU'N1LO#!\PV]3 MI>`8^;G.W*Q??K--G3F1"RY\I\7/>$L$_L+K-M837NW!F@L!F!+!B8^;)K]: M]$0P^S?$\,+IDV:*B](*7SF>T-7X:&IS@>=J-AOZ8WD25QOK`*H5 MTSK-C($R'&V/Z87EUPV(H!5\6?<]GX':DU=P"&;?$.`Z+^\,Q[):'&![BK?K MOX`*PF`'/G$UB\LY6X-]?8L@`3Q*"K%>F^,AQV!ZK: MWP+UE#$:(L!*GY2L'YN\;Y/L`9L%4T5H-<6XRDI*0#-E MD!*=)FI%4E&&=#PB%T`2-F(YRIEB6\8AY-1!.(61 M3+\)EM4]I,P+;6>0FCN#C`MW!JGFK^N;J^OSF[M_22??SJ3S__E^<8T=%-]: M@Q%?!()Z7Z(7)]>_Z3A/TSM(5;HM4D"#(S37>A88DS5#_T>:'INO@<@N'X M,/P.G'-Q>G+I+]&][7GV//*D'B7)\>W%_SWGH!P%A:U"/#T]XSTD3`8+ZL'%\"S-! MT77))N`&M//+V,?H%*,@;J6U8_?)H#)K#K@1%PS5K>+F:6JG"BS0:=0:]42,XU:#&Q;*JFPE43 MRPN3QI_JWM3`78$))2ITUJ#LE0%D<[7S01DIG=$@1^^48HI2./5;<+.26*B=@=5X)+CIQ6GJH"E275!4U)W")/5;Q25 M!&%SI37NC(=R:<(WIKES%WY/UGS'RUUT^E%G*`\K6^EJ3:]/%!?)#QZ51/H@ M2Y&?Y1EU?G\%JK+\3NF,U3X]\T[M]'I#2<]M>X;HS."+@.-R3%F_.C51`U_" M+_WFA5:R)U8'.\(L_$ZO^U2M=Z5&K_3%8*;^DW2M/8!$W<+N@WD)`(#ZLT1Y M=<#V4B0^O&%9WS+1^(*!_U^I6UINJ)\>J3N59RR#8UT`4P*F!MSJS/H9C<`? MK1@WO_9DW@,UK]D8-O@"6*V6G]P6IQK7:@1;6:4X%3Q.:P_1<@[1VI.>]J2G M/>EI3WK:DY[VI*<]Z6E/>MJ3GO:DISWI:4]Z=@U#>]+3GO2T)SWM24][TM.> M]%3(@&<^T.PML,35C$RH*D8P M$50M<(EST^MAE5SBO&%39CPA2[O?F!>].Y[Z2]VA_F%/B9Q@I(*P-?QU'L'T M>[WH5?%"")"3=*V!%%)$7)M2[]>LFS(EGF]C_-5'R\WH11FEW_!-F9OSRY.[ M\S/I^@2OR]S=G'R[/3F]N[CZ=DOJ_0W=EKE:.F#":8Z.!R6ZX;"I9SLN2*/' MG+EA40-TS9.>'YDE:<$#D;Z]+G/"5L#8R][OG&W9#LBSI"^QORF.'K[>D9X9 M-B/&+`9L8DV-O\5ODN;19P=_P$[UHD0*^E("W/I^@D0@._SHS%]Q*[' M5`!%FS,,BBRQ`S5V#'^)3$J=A;&+MFCG+-D6.X8AI<^$_IPQK(>2RHA_`+2F MYKJP"*(\#)_$Q>[->-"T-*GF2PB684W-I6@K#J"[MF4QWE(ZY?']395H')(3 M+YY4TN]@5LM@,NY,QK)_EF='JO$],V"[;[R@CK@`ZMF2PY4[-%:8AM,[K<+ MT;?P:K9R_S;KQP.LSK$QGHT5-%#&,1L]"Z8D6K#)&=BV_51S'\%CP7_.@V)5 MKD`O_Z$Z.UZMUA=.8)D/6A);3\/-[%QS+-`:;B2J?L9FQM3P3=UUC]5LMQ\/ M>K(\[HWZ4437P50CJC6:^,<#51VK\G"\!:KVBV9Z+Z)M+D2T;WBQJI=U3UH^B$F9^>9[,2ICY%7DRVV3*W6@C MH"S05K%S!=Z_VK;N^MEM:3\_A99@\[LIK#<&W>WQ[D_?74 MSGB0DW)PV'E_I0#D#I:!7UJ,[!<-31>J<$S1;EGI*(,^1L'C@5`*3?I:.;AS MM]-=NE8AJD8]'.\!)K5N]'7EU6TO]')''N>R:_)K3AV;)D35:+;0M M0,C,0@.9Y%P3%ML2VS*V?`'!2*7!AO3>?)T*K,,FW-0T(BM`5S]W$^&EE>7) M.XR*QY7]--@2:Q\)OZ\HERWT2-ZP&5CD6>"9XQ>8@,QQ8603V<P)Y-7M?`,+6(X6$RCF$VA:6G6Q&N>*A<:\;[V;,6%[(\"U(R%AN M!:2`@(S5CM+/J;"Q:RG9=-['.7J%8J$IG,LHIFM.*!0U5FDP' MOWD8Z'@RUVO%A,2DKW3ZXYRSGU9.A)P,.P.EC!>RM_M'H6/I2/Z(+RA;V5E[ M%D_=4KZVG#WJWXS0?"O#5\5(6RFZ.XO6UKQ,F3YGOS/LE]D4*UF`G6R5!8][ MRYQLK2FZM@E#$U15,T+\9+V6\.'V\\82N=R7*(ER[NI:ND77* M6)0!^)634O9312O0;-I$G0D4N8D,F?D2KKN<+ZB,Q'>7Z?G)$GG/MID2JWS3 M5*;$'TP"1\R84QT52H+0#$=ZPN8XF!;!M.FC9-/"2?!_^,`#(`PRB75[EBXO ML?,9A?485MO&ZT[\\>.%8V#"@32W=69*SX;W&$^RD)X9RC#&$I\84())6L@D M;0;&^H/F4OI\Y=$:$=(?MJ'"DE&-[WJ0JX\=S;%U5)2)%$2V`U2I2FZ!2 MG0-:\+K"-FN]S7#[GVQ3':YUTJEBHN2DS-2;(;/E]=Q!/^LD^K)-S4,#_$7ZH.8P<6W;>?F8;1$.Q=>BC2@+ MVTS^RY$JG0%OE+8G0XHD;&)/E"9K,?,V0Q^$DTPF7?6] M=(Q6;#='[33S#]J;!H1&6#'6E#[W7(R-*=Z0>)K]F*>3A MSCEN0RUL&D_(7`>O@*,)QM5IX$%7EOYU?G*36C^Y0M5;M4^W,4]714:U*Q_W M`^+%@2A`MRT.,IN^S[7W@13/7N0X&J-R6;G%*!@?.]]'*3WJ>,B'_8-)C]H3 M%N3&O`I#EZ::^RCIPCUR,7R'!9"G]GP.?[I8)U%R#2Q(HDS&2H=7K>8E]\T7 M2;=I(!IQ86J6BV62L=*V[6!=/Q,+0L8GZ$JGMN52CVT8@&I_+UV,[O%&YJ1= M_8>#LM__88Y-%;LQ-(A11\JW%:6R2^\&B:6M>B%I[+5;0^&1SH.XZ[V&A!(+ M]&C`VCC&5#.);HZ!/X#]X(-74A^7["?F2!K6)#=LWHR)%\SURV*S M<+^;H6DEO3#-V6NRKS/W"H_TV:<.XN=BCD,L_%#4%(%&P6]MRP-&SL M0+N)P>46U-T42T:39(&@W>/J4JDMV-'L.9,^F+;K?J1^$E0ZF+:WW-^101$" M'1D$QLT\@MJ!,!ZLL95]5I'GL55UM7%SB[^1>F?5E#^E@ZFTPRB6?YJV%TCO MS2SIQWUYQY8;D[?9,D.-R-[:Y+N(0&Y>(*M!CBU_+%=#%6.S<.WB79.KY/S[ ML5*;+M)*48+2YZKUTJ;!8UDJ'+NM-A%C#=..>,M2Y2QB+V)88:U=&*EOO9*/ M1`^XT3Y4:Y'P3UJKY?%&"N>F+^[6U:Y4N2/WAAVUO^O"P.U:K:],-N@,QN/. M<+)=I>W=J[#,PY]M==76^HFD9?!7>.T4 MXYI@WG@&!HX6#ILQQV$ZUSZ=V(\ZN_

X;IR!5M1,=VDHZGS8Z5<5W/UQDL9#_,U56"N`8S:G-/&JS&W M2UYK]>T"/NY>%N`^_!R`4D?R63D!5`_CE.<=NTP M2E1+J64@$M'P5!X3`MI"W6T?T&U/T,I<#CRT>%!U?4#-BHIO5X#JH77_]-69 M8;E+!SO]K0VBM]T^,VTT-:]!2MOMUD=$]B8QNK83ZXTZOLI7>O3K:Y!BJHMA$85]LPVA5VQQP"X4&;"Y/ M2K!YVQRP%ONIB?#D<-!1AM7U@6PF-%E7M&7KB..ZZ%]6D/'VT7:\.^;,S]B] MEQ5:3'^H#2A6R!_9L<-OV.W1+XO,`L6[Z.U!O&Z%('X`+[,^V$26=.T%[Z8'F4U<=WPX?=0,!X3,UQJ? M;$4-UFT13&=W;;/N0.S M_*^E87G2Y+UT=7&6(DT8M?EC;;[N6Y`?!=3KH#?<$\CW5W[&V-ISC[M/;;GS MW-I+[]$Q]`>V(BUO7#[4=GLI(!ZER72PNXNX(7*B2,J@W5[6B@\:K:-V>UF[ MO2B=OO**MQJWX%!"?W@AL MD59\#K@/>RT=0H40?:Y9?MKVH1E2"8IP;?GVMGMH[5-%EJ2,!CCFYZU;*"7S'6ER^L3 M29O;2ZOBOKGM)HD3?>B/!R4/C[?;)LN<'KZQW?'#0"Y[9+8-X?>_IW9BSVQ; M9UJ^;9:J=/U1#*[/D'WCX[*W=S^TGI7\6PLM-6SYBG M&2:5K+=B&:P:?1?4EZ741(G7I1?IK-D]D7=>&2(MZW72JR;IU8?O^/+\2P!. M/8FPEOWL:(N_'_%_"XM\FOFPZ5A;MH--G=9<[5N5=$>N'<.:&@O-),AB#:G" MV]\%QCD)#6A_D&;H]@K6X%1SG!>_`M3F2_`[MFYO5V"S%7`?MZ3^A>@7M.4P M-YK7KN%F:TC5=+*0NZF%<%K!(B(YO@* M'L;.M_I2UWB:YO^,*R)[QOX'`N8WVZIA23?9/4.8BFQYH\%[ZN9DVN[V0=Q[ M0\_=.9O7`O$=?0\V\>VO*S4M?_U)IZ^D)(KNF0!FWFS:,SAWJR@*;^'J'FSA M)\N'I>OMP2Z^]6VIIF4!D[L/P+3-NEBU9V`>BLC6Z)X7%=E;MO`H8+4OFVYV MFF1UE[@V2<2L>/6'_BI3H:=L:]G)*ZVQ&@!O*MORW5J(I>?U5UEQ2LX>TL4APD M,BTI,I")YB$4N@ZT&\.Z\#W@/3*5JN2:-VH8;W`W.0O[G`S;EF?VZ=U70H(= MJ-EZ#>C\<+;Y.36E+4:@=G78O?P8WO.+R5WYJG M2)/:#39?TFZ2S M>S`1F>>9;$YM#1\.83WPAE*&XWK27TO-@7DPS0L/93O2 M5',?C_E0.CWWS./N:U^E(/W*VPA]]%6736UX+O%N%\@(PRX=:LZH&^YTZ>(U M0^F>F?:SM+1T^/H(E\;U'-MZ(&Z#3TO\(Y[Z[!/OPG673#J#H=#O67.F0$-_ M6OK#?@IGZ6:QQLX+%&S=2"Z]UUNB?1RP&-X\/&,+VS4\WBTN_EUW+(_&V6EL&?_GY[=@37=2`6ST*VR=)V?#ZK?=Z\7:[O7"MGMR"<"'8V4TB`(> M!60#N*ML%Y@']TB93/H%X7[4'/99N`%TY&Y_`@Y;=]!3QULL4MH@>;(RR5$5QRUVQDKA5M7`GN+$^ MD`WR^25\!)QB_.H$C`K]BV8X5-GC!+;J^0+?=CM#29;,-/J$`&Y%TN')>B]5N@K1/'5KIM2<-UR!>6@UNU^_73W M9:9#,U`)%ZR6X>M;J5^N!_]*K$U*%5KR-]M$X8QP;M"'?E5^V',E_/Z]IS4Z79A-/3` MR^S*TK$W;%+2LRGBM9_$ZEM6P&EU6/MV.I%7N3B9JL\O*\7U# MR_HVI+7V9;TQW#^_.(SY)1_K<>/29MF%;/91-F5Y6-=6FH;GJUV\IB60+YXR MJDNSUKAX5WR&7^GHZ<*Z9HYAZ[]BFO5VRY4];D*Z%%D9!"'!;60L,5"P6"[" MYR;/1F3ZGPK6*QO1U[)"\:CM-DN4'"E_C0;M"N6MD%)NA8KING(KU%<'S:_0 M)C$",<'OH#N9_FV)][[QS!E1VBZ4DC/P7N@Y-4W-58QH15)T;6K65ULW9L:4 M7KFPI@Z]H)G1D4YMU]M.K$I,U(0EF')P/P0IK$"L2B":LH8N9:WH5!X;))*^ M"PF?]BM/IU#D\;@[`!S2R965@Y'R6I1$_UXPY]_$XE%BJ6AX]9,V M+3W7TRQL:A%!+/(MAZTO3T8;()3RVAI9[:NC)"818#;&8%(8@T2BR=Y@0$RU MR1JDO+8&`[4_[(%RK6<=BF*16(?26"B3R4"=R"76`@OR/]JFSASW_*\E^/@< MC96O:TZP.AY,)L!$T5/_%1"V@+S&9"N`O-_OC^1M(`?];"YQ<:YMAU2\YSG& M_9)R5._L;[:%`#LV917YKF`&MIL,59NV2\E:D8>Q#*]*X#\`\M:BBEORAMQ; MPSZQ2EZ^2;Q!^M:R@Z78O[1]O4'Z@O8=#S91OBMOY675#4<]>=@;OD'Z3HK2 M-ZE]R]%7'HUZL43@MT)?X-_A0-V$@5=?R[6U>K(\[HW>(HDGA4FO2\Q4^?/CT_/W>?>UW;>?AT=_/I!XZEX,OBSV,O\F97 M]_0C*;S[%;WZ)?X6H-UZFN/%+XM5=-4QO"P?WII3U*YT^]O)S?EO5Y=GYS>W M=(GM;[W)S]+9^9>+TXOS;Z?_2ERTV]M[=O50*+B]2$PK\5"_A-'CS*N(^T^A MIB"YLB3JX$$MI16Z5^I?BM5T>T%W8BT]O""+#YS/%Z;]PI@;X47#85//=B)? MX6NGMN4N30_/Q:25U9$^X&!'^.?1QZYT%MYL]1X=QGCS+E=BE@[SQEM?=V*` M/N#!&SS3IX8XDLW/>K"UEV5;QTQ`*^D^C%@+"`9[!BTIS9:F^2(]T;F0M%S@ M52+776K6E)6"J)<.T8`W&:L*HETSR_ZP[?9+H^#*T.JXQ)B1-3*`6^$52SH] MO\)KU7QQ5/&X6!EC/F>ZH7G,?$%.8?CBH^%*[O+>97\M\<(X;,+&@R4NJ%E2 MK&8W0*699C#KH_;$)->`19;N&(XD$R8ME\'5U:H:3"BMH6*$NV`+L+X8HV;$3!@IGL!XOL.!K/9"C"@F:*VG`(>&),TZ-CW#@PE(0+DWI\/.R\%0:1HY<267B M4C<0XQV6;51E`JZ0RLKDQ6T-I[UAL3^`\##Z7/.-BIEF.-(39@XBQ9@&U!!D MQW6`!QYXZ0S,Q%QB#R58J\]81>CX=@J."@#%'S]>.,84?X:%9"8OVD'C@W-D M/^,/SPR+QJ!A\\3`BF>P[D&JXD]-$YX\.'^2H`&L_/YG251,.KVZO#RYOCW_ M"=N?F]K"9<77`WPQV$3?"Y?ZBI;Q*EKQALHY_7%^\>MO M=SB,6;QTW\J;:_O!BPT"=949;::54%P9/YZC"%:)2%%$"V"UBM0FJ%17]"VM MH-O6E:#C:UU?\4A18ZPT:Y%V#J<'-9U!_K1N++7A6B>=*B9*KTHLFJA1*%3Q MH/\^3@N3S3AX_JURZ<5@II[>$3:IU]^G\%_A%G[2H4S&2H?7NETZ#G"\^2+I M-@U$(RY,C0?T%]J+9#N8-6'B+9[X!%TZ9>1'+N9+1WK&^"`=6U((EK2K_S#M MX1A?_`]S["`%Q.-:?>='7\6S$,0IU'^8'C_Z43K* M:,S/I6('E0;=\D/!"-,`>*I%^'*OHPSDW'>#L\[V^+*"Y("L-40',G\=LM=P M+'?4X>C5+&(]J5O7#ILQ!X]D*4V()B^3N/5JSD5_XSF7R#F#]W@:+LC"60>M M']#\!N\)8"._,G`<.Y(Q`T/*Y<;4,Z:N"%L)]OB7C(/Y#NSZ'GXS6Z*99K(' M#1./M"?-,,F6Q@8"#-@6AN=PX,RPW6,*TW0Y7Z)=\,0BEI[FT52^C?5.Z:H# M-`4DNN5)?VF6M9QWT*"C*43O`C3;[FDJ":4P''$.AM\]"Y$!&2(3D]*BX(/M M-SG@V;!X6CS7=,:3`ES<%!$0').#`!^B=BAO`I%"9P-/^'7&YKSM$`SWC&?, MB"$.!O83P^GA>\Q)D##+E7^)9@[\V\%]OB=+NO82R8@#P]:8PF^"3O[Q]BRJ M@NA7C6;G1](2GF=S>JJ#KG3![0?VA`8`?/EDFTO+PV[4!$_XT33`^-+)K.4Z M[C'DK'5L]2ZV;H;%+>[8"D4HCA1V7>:YF+6$RT5+@.E0X8PQJN]:QO9'VL\Q MS2%@S71&C"X,YL$\V1Z8Y?EZ0CAD^#VQT1.QZY0:=U"J"\7,7,[_*7.B"^:P M![0S'3XS+.MB>6\:4U`1G@,+W&:FA9"<>)0S>`;:F.?WD6TA2W/&,&%)V!AW M%VGI48%NTT(O-2E>N.RT8M('3(P!'2$=W5#4\R/9%3Q;)G*)/U7;H=KU4VS> MR5T9+*"X[A$)N:?\'7[G'C-SD4D"V-`)]-5W7,9Y3A1F48EA\:X`07&/"3O8 M/1.&72$2G_2&OWP&>P=.>2%27OVA@NG%C@#D>7A@8G_3,+T2TS)Q>UB"=:>Y M/`'(P4T,?E7E]X%7E*12JYYRD\.#Y5(&8KVB#"-,6$UZUQ?9L0O8"N%;&W8@ MBQ05US"Q+XF'7-$\A[0+^;TLQA["0%>%\VN1Z0#61]PS)O77KECNBL5N+H2%N? MW3:>O#]:7=RT<$N0.B=X:JL3SF/BSI([DS:=.F`%9VY$F.P?!B?PT,/@&X`1 M&K\BDF]J+F:EOP19ZS/#Q4,1ORUC:C0F8S/N2B>$0SS,'(F'!./0%O=N)'=Z M:J\3WE%ZU^\,U1[_-7BVS"480O+=0.D,0%4&QWIT)8D"+_@SBK7[:#_3I29. M2?X#C\:`&K_'\R)F!D>@$!WHAS+XS'D3%#^T$KY66M=(RK5E:+L-0 M<*K(?,=H.OI'D9BQ$)ZB(H/YF& MLQWFN77+]6NY7J^9ZV_"(Y0TIB>?)OD(MYPTU[6G!K%PH)'?C82C[SUJF)ZD M]^@!G$W*EC/R?,._PA/*RA%^DF(IVWT4P.,YGF"O/)8=[2L7A`[/3N MHIO6U/PW^QE&8_1LZ!*4X8[FSI[ETL^Y%.>".';^H/(Q MYH9^O+`-?KP<>+CWH$7$<)8>?JVY?_H'U%9L%OP[;28>D'W2'(-D)@+"C/%# M@"E9#R[E;\[OF8Y.*JP=F!'DHY,:I4Q$8[9TIJ2E^?E[T;!4`M(@R*V)TRU^ MCH5*V8O<2A?'8"$@OI_[`KJ4VSWI+^)\M*X.6]B\@($>)O5A5/H1*^&';XM= MX]:#I^;BF/\*?`R>HDI5"BQI:0&93(K4/X!^E3[`RKL?<:X(B(;E>LZ2:_1# MU*N[.#Z)LD940#A+AQ'DPKHB:A!,-7.*P29Q`A&4._"R6(N?O+\;*YU)K]?E MEGH(%3<#Q*\9O,D9&H35-6:&2#?C%<5W3>S]6?;H&5$HQ%$O9"5)(I78>"`T M'':4T9#'T<9RIR^/.ZD&Y0:<%#V[7HFLT8S)T]->Q\^#`D#-=LG3EQRM@JB$ M%#[?P'HQX>H77!(0Z*FV=)G0`-D;(:8Z."BKPN3VP45S@XQVON6'+Z*%'XYH M49<;_XS,MR4.Y4"RGC33E6C:GA<'W!MQB:14^P<;ZS/B=3PP0//PB>^G(#PX M2((CN2B1[>503:\.F<)^E2;-3X)Z-^`']5V)ROSQTFVI)[?1!`!N;$>24(-L M2KFKRMRHB[WK)S3Q2(#IVOY`/GAT(8EG&3%)P<3P'%#X!,&K%%:FBTG,F1IN M')RAS(]7).48;\70=8_$^R)H('8H``2]0%Z_E!S]8\,ZGFH+P]/,`Y#Q/;P/ MP'7VZL4`P0.*W!FJ`WJFUXEGQ*RP=':QQZ6%OBAE#(KOI&A#*RJ.V4TW2J(7 M"_H=N3?FAL9P,""A\><0(*36(Q/N17%*["\G_9_C8^D+EE_Y2;K6'MC/,#)> M`YPR`&#\LT1]2'^25"E2I!=>.;?T>/5>&C5:[]?_D%>1.:,>8Z>\I%:=5658^_?/KY>WTD'[NB/)+9U"Z[Y^F>LH@R''8'JMK?@AXI8^Q:9J[HX'@M,>@Q0`-XNCAC M]-((`2-LP!A*&3H0L"5HD-YA)/-J.U4IK)#8KH M]3BL#1`BOU%6,18IU35KM*=T:%8A$V'JU,9;4F.UB=36U%C7EVI_J5%=TYX\ MR2AH`6\J&>5WF)S7=J,[>I-8P^;24.^46,WO.+`1'RRU7J4ZKH-.KU%1UT"G M9E1X7^XE6_YM*W*\#10&NL_]L+1/AI6??%=G#:JY;E)15!5%Z?=&"617(*H` MH:;6#M!9Z==8!SZ@Q!?'L*:79-F@P=HYYY6ZB<6?6KVVCSIJ3 M3)1!:MI\?7_=?O]\>_X_W\^_W4GGO\-_"Z:QO)I2:5>6=+)P#%,:^\DG7YVN M]*NQ=-EBP?`TV["8W?'+PUAX+NXG:&OF'"P5PL5A#S]C\@0=BSO:X@4$](G7 MZ:+T+=/3I!OF,CH4&KNAR-ZX.@CGUS,&4G\=OPWIT%]KV!4:M3+ M^P-J)J*/T_)[QI6,7LGEEL9L#S#J4LXJVMA6-/&=,INQ@3$V8V3U)`6.@=^]F"CQ_P M^H*?34@#'OWJV,L%0A74@EDX6.I'7&T1Y7WHJ0C(U_3,#7_FZ",6F])X/S4R M'#V#,BOOV/31LDV@!?+'A37M`CE.[RZ.)%%MXT@D2,`(8)![/,M#Y+M'LY"" MDL*BP(DGLNA,LQ,66^(9X,"1RYDVI0P\P28BY9K]F)I+%^'2'EB8'D^H=:F\ M4T""J>TL;"I0@^F7MDB[2))&IXQ0SL.*GW6Q@D+?$`%JX($_-5; M'">\!-$-)?)CKOT7&^1-D8__&S^(A1R&J7`&C;I`UKIGWC.N1JS!KKA)02N, M$DK5DT5BN*&+C&*-ET$Z`7VCS\5%2DVZU4RA*@`:5#*6Q]W)$_\2EY"\X#V0 M$5(+6"R23\!+E5HSVYDR7NCPV5Z:.I<4U%=4$0<)XKG^+:]JQ<8G]8-IWP-A M^;65A:FA]J6\98-J4HJGSI>.O6"XHE\-70>E=*YA@3J+`/@&2_(HGY%[>/YZWC/38-C&(9#=<-&PJ!XSZ+">T]["ZSXA[;GB)>@L M'%G2EP`*]H_E92\CE9E()P=F'M9,QP6'$9>@R/'')]N@R[A7W%'I3J@TI7T&ET!G6'E<,IF'^;^P$P>_G/%?+ND7%#H[7M,4T]BQW2=U M[02W8V8X<_^:>6*[YBHHO$R*27>H@!C6>UIZ0JFDJ)(%\J(G&L869J$(]\"6 M:2YU/U.4]$>H/=XH^\234%%KZE%UH@Z$.O$7/)TC.F(;1-K&N"RRMU)=/]C) MO"#A.[@ZC4VU'0#OZR'.!HNUB,4[:>7D]WE@.+]I"[I)S(=;>![N; M5"]F7<]AW\`/@*5M+J/=?\'QY.TA]I<'1>XN89PB[X'N6!Z-XZ&*G.B_YA[;LWBP(OYV3:'^K5&<9$=C`IQZQXHJ M<)KDXQ2/GJEJ)'B6!TCE.*F*.NDJDTE&=DX69BFOY48'HT?*S>$W'I;`3QYA M/2EZJ2Q^ZE`>#3="4/2V/N&MK;_1';"KV9D!*HWYZ95)G,N]4]]Q3'K>U6`P M'@\GO0@URL&[$P+5<[R3GF,LR[VAVI?K)=#*6Y\UUYCFD2?]C7WEGG1H&R?- M/O)-'FE^W(/']Q-.1/BB)J,?@I_FU.*(_6*X=E]51C_!$__U*?X3#?0I'"EU M9+#<6,;0_!,^L-'(@CAY8_-'-AH=\/TW>";_IB$2D_"ZCN*[V*M`>KSY:#O! MCV4)2F]\RALQ,MT9LVSPX_,G7$>*Y(RK@_J_1O#.HI]@?")AA/'[,<8?'O?D M[AA;\F)"+Z9V*+UA(`4)8E,;A9_8!J;(JO*9.P#';Z<'-9E9%4GB:D#&#\6IC$UO*_\4K@.CH"%E[?_?N1+ MX1F[]RZ"PATG/XPPP9V&""#$C[[%.OS$?SSZ9>IYTY_NP+/Y"QP=[\HQ'F`- M3,K7P.MJX$5YD3OM>(L-S0K?PN!@_=>G5&A7ECF.IO]MC-*"(+PAW`J9\(`. M2_[_$BYO,';P6^(E,MM5H>9XE8[[>I1<&62^P/06'E9L@5'"V3M` MR5#KU,1J3#+48Z6/DC'L\KL\$E_U8\*A,/X!,;4,69F/+%;-L7&S*!3S_&,66?Z M%R`%VLI+?F!U-3O7'"QSZUXSAZ?!OZ0/L+'FXSK]-*A"1@;VP;%ES0;T.K94 M1KU#Y\O`83O%FG57,^*#EJMVPU7<+>OUE(-GJZ_:_]K.WHYC(2&UYSH^)/,.K+U_LI?,5RX$F.:QEJQ)L MU8;:WF"H;:<,-^KV575(*FW0[0_Z!\UWUXZM+Z?`,>(VY(:;Z'*!-[28+H:K MX4CCAE$;CVO@CQ>ZUZQ-J3W+YY?H+YN!_SN9D+\;...%-6W%H80X#,:M_O6E MP%YZCXZA/["$KFT9J@Q#*2U#)7R39[O=T>OD.+F-)Q=@PY8'Z^7!5NNU[-84 MN_5;KSG);E8;_JN5X]0NEOJ#/^51CWO0!\QXP!53>)%N5Q,7 M$)?^KP&1.U[KZ2O3C:EFGE'%IZ#`DT+"8]W*FO235=#0H MU#)7">:2V_#F"I==PIL6]OENXYQO5RZ&W4&/*@L MBB:\8*E[ M>NW:GM[O&?L/6O;/8'],2&H%X-4+0+\5@'0!N+):]G_E[)]LVG1@3%]?08>] M+-YP4*PUZO?:>/,:+J.0\PU6_,1.<`7]MC:(_!K$8Z4WUX'*1?6J]X9Y&E;8 M]F\7MTQ5F*E6FK4?*E,M[UU#QVX=_*1MN_N^UX[Q!&MPC47VV_!8*8;BG1;; M"^1)AFIOCF_!3NVFU[)452Q%#>C:RBN55U[Q;_=&VO.U3%F**5.Z(AXJ;SYK MCH['ELUS4QDP*[K:[L/:^AV;\7N_Y?>#XO>VE$,EK'_H]L?N>+YEH[:T]FLH MK7U@_-9ZXFOYK>6GHOP4;<+2/">].EI3I[!(+R"_;]AD'+^AW1;_;NB>=AE\ M7E?I;\&*981#\&N-PA%KE`6?E`$*QR1^L[(5CH;N5[YIX2B[5DA=BW1EE1TE2S.F@O%1_8I>)>>8^Q?D6(E.V2:>' MF82W#TFGA\SO;=+I8?%[Z^E6POJ]WECM]GO#0A3EE5V=.3`V.NC4\_VCM9I(/1>T[HTF;9;*@66IJ)ND;M?,7%%! M5L-[#6T*U.$Q5VG-I=:;`@7@#$/FHD_*$//K^IRY1N/N&/.@*!E*U#0Z5`X[ MQ21EYBR0";YI\PV/!O\P3-/0YLX?F@F#N9>>?C4[U2Q-UZHWNZNMP+1OF5>" M]\I(@V#0&J4A+=M4GO1;57M@JE;9NVS3.',I(7/U6N9Z_\4Z(HDR"5N:U(N.?[H5C#,EPE%GHG7(59;@-Q:_0UF(=5**ZDOKK67C3X MFZKNM];A:Y"&8`/G\`W05Q(;^^DIQ<;BUE]ZC8^@/#'=L"]RE"^-RT4K" M!I)0SMH0S+DC20CVA0,W-_9B1WCE+*6YQ_9,%,<9'"M]C)H'=NH!G5`8P"<: M+$^(23"X^*5*2HFSG!&>?8_`)&OO@T45^&=;<_2K69`D=_JH&66JRTS?U^E[;9 M);,`R5IF2=3.PW:G+<=D<8S"'<%#91B=&3]=L@?-/"=(#[![_6X77VW5Q3XV M7]TI4PPG+5/X3&%;VE]+P_+:#22370;CEEU6@ND)UGA+[*"T[-!0]>;7P2_" M8WD5=S[WOGYK&60.\&;HGG#R*[C9V7+R;N]_[@4GMWOX8533WBFS]%MWL:F. M!*^"7WHMO_C\?EK<68VDSZ?E^4RUW3*(W#)(20:!+]\.@\@\ M8^)0^:.2(TW>RN4K\QYMX(8GY@(S@%GZAIA@/*3_*HECSD/C!EI-,C/`D]"L M3:LE1T>X>[:K#[&T1["5,N^@9=X,YL5TGI9]]YQ]^RW[IK-OX3VX9=[=,"]H MWK9_>-HIR%[TIM\A8PP':LL9J9QQPSP-W$S=[Z/P9EA"&0Z[`Y7J,!TV2RSO M74,W-.>%=T?:[K[&M6,\`8M=F]IT!\TR=\@.\F347M])886^',T.[7;0, MP1E"I7//R>3@[P!_T0SG=\UV M15;#A86]_,#9?.-1">"6ULQ]FZ>6=K;WH=\V[MY M?FDO^A[(1=^F6:--M#Z01.NF&:--M-[[1.NF6:+-K-WC1,K=,$.K'UJ&X`S1 M9M8>6F9MXPRBM@RR`8/TW@J#M%ET>YU%US`W''`67?V4DB?47AB3E'DMIF%W MT!L?[*6%(%_]9<&N9B<8G7M@FT=X+@WMWC#!>V?N]1*4LN:RDP>'[?8:I%BT M.IEB=*P,D2F&[6Y[D+LM+6"=#"*RE,<'WC:T5W.6LAKL1./^85-*K7DG4H[E M(2D=157:W-W#R-T5:U8;3XC>\L@3XX5,XX MQ7-FYBSPX/";-M^P/M4?AFD:VMSY0S-A,/?2TZ]FIYJEZ5KUI:I:7MZ2EY4! M\K(J,G3G,_\/3=`O8^<*X7+1\7)J/E4%S?"SS'J1MD@@P<#(WY%I[ MT>#OG9;XKH0A3,/Z\Z>9;7L6H'4)'Z0?])7WLH"E@\>8I3/]2'SKV&9\0:,D MZWW"GS_A@P&KQ(:/#>TP%X@W9?[0IG;/S+\??1'/_GLPD/]MWIME9O;GH>6% M`:T'P,`Z_GY[],L?3'K4GI@$/TL+S="EJ>8^2E0&`1!T)=N2`!II2G%5R45! MEUS#FC()V%/I2)H%KRQ!"5B>^2+I-@U$(RY@'E?R;!CV1;*!`=G4U!R6F*`K M`0>Y[*\E#="1GIFT=)D.XTK`,&SJP=_^PY(#2DRR9])_F&-+,QC3>V32DV8N M-4Q`<;O_]2E&UBIHK51(ZW/7,^:8.27=:XBCH.VC`61UC*EF$LJ@6H&\7>EW MVP2T3&!_Z5ESPU=2'Y=LD$))DSA72T!/`^@"-,4%0"H%Q#2-&9,,2WIAFE,+ MQ=0**?;91QI1^-Z][4IW#M/B@Y]\`+0"A` M!P]4-.L%<&73)?T&4GCO22[S/)/,`4GSX[V<,L'U%4D'HEH/1)69X0!5_UJ" MA0),!J3""_`=$N1C/I1.SSWS=-&UKW*ED7R;:!EY%;9$&YY+O-N5;AD,NW3@ M$=S4W.G2Q5U-`CK;S](2E+(C'85H3-Y+`94HW57R\UVER-8ET=Y%Y MBV_:T]BZPV<-I-)?UT>PC/Y^]+?X!OM%F[*3.4[-"R"D7)R*=GN#2<8:[@B*7;+"3E%.XRC?8#H(CE+V@J-6H7CU')6% ML?LRB-V!,:`49Z4&I]\Y#S6.:RKS*(?`/!$%&V]UW20+90'Q>ADI M'^-7PD[1?M,[8Z<($&^$G58PKIV=JMZSPY@([MJBT?7N[/`2X.R3O,MC.[JV8,#6NO-%L>.*^=V=;C_GJ8;2\T6QXX;X?9#EZSW1CN MGU\HXJI:,R.2IQSG8) M'^![GI0!?_P_4$L#!!0````(`#UTKT1'$V!B#A```%G(```5`!P`8W1T8RTR M,#$T,#,S,5]C86PN>&UL550)``.5"'53E0AU4W5X"P`!!"4.```$.0$``.U= MW7/B.!)_OZK['WSLR\P#!/,9IG9NCR1DEJI,X"`SN_MT)6P!KC46*]E)V+_^ M6OX``S;(@(RU=_NPF1#C_G7_6NJ6U))^_.E]86NOF#*+.)]+>J5:TK!C$--R M9I]+W\;E[OB^WR]IS$6.B6SBX,\EAY1^^N??__;C/\KE>XJ1BTUMLM*^6XZ+ M9EA[M&SX+M,^E+X_ECZ6R^&32TI,SX!'B:/5JGJC7&V6]:;V+TVO?JHUM>[7 MX$GX[N^?^/\FB&$-L#GLD^&ZQN?2W'67GVYN#+)88M=RK5?L8F-><;![P]]7 MK=?U4OB%]PFU37?]%?YKA=`9/%=MW@1_7#_*9:V??'M[J[S5_6?U3J=SX_]U M_2BSDAZ$E^HWOWY]&AMSO$!ER^&F,C!\BUF?F/_A$S&0Z]LW]O4XJOK-6N74 M)_AOY>BQ,O^HK-?*=;WRSLP(XIXRR4)*8&E-"VQ-B8U'>*KQG]]&_8-VYL_< M=%^19:.)C:>$,F3CKF/V_O`L=S7&AD?A"Y@!'/_=$8.Z9.%)M#0Q=G&B-C7P9>);0Y3#MU'<69AF\.40O<=8A8;3(<4,PS] M.>^UA!!-R#(?-%G8!%"F!%3WQ'$I,EP/V8.);(?1`_19N%09!Q M-8193,F!2K*ER1L$1\:(;9D\G;A#-@^AXSG&KB`\8\*N@FZ(*'CF'+YM(%%3 M`E89C241[!A:#5X`1&A&]XC-'VWR)@J3$6-Z%9QS!"[*^LYX#M:=0X<,Z>D# MGEJ&Y8I#MUAN_AH'/UAB&C0W8:A$`LX'8G@<$<\JH,F[J[X#><9"O$,W$;8D MX'I$%OV.;`]_Q8AY%*SFVTT(TO1U(2/DI4#*TCL",BE)0RP[Z#)FS1QLOI#H MP]70H\8VE(& M6#-DZ@%"*:GZ,W$QY!\K#D8,RU(VC--(7$HB,`9L["T6B*X&TW5G#SV4MUCZ M@3H;6$:FKY)ZHB3`?<#)TTU(+>)_SXH9]%S*!VW,L>G9.(#:M>UPWBLK6"<' M^VY!/=6J.=@T2U^SE-+/#"F!G-9=A1-42^%,8XEP3G"R\`:H9`P,DF!EX`Y0 MN5)0X26R]F:=[CW*AZW0!XH.L)<806.6XU['(6;BUT4-(1LP: M>TMX"8]4R'ZPF&$3/O_!4R+'0&R>N9DPDS@Y.H`@IMSPG#3Z8:8C`R%OOHYK MK_CP`3S0,(CGS_Q#FN+`/XT,TV[40C*FJ\?>A.$_/(#1>Q7-*!D6\"YC,S?R M!+]'SUNN#5]H5#M572MK&W>'7[KW]Z-OO0>M]^NP]SSNC;7N\X,V>/FY-]*> M^MV[_E/_I0^??@AY_1AAX'I(6*$,5,/O+G9,R%5]U2+E8$@5/F6C";8_E^"# M_X028F\,4Y)*L]VJ5?1&I;5MWGAAQ!2QB5\BX+'R#*$EKZ:HWV#;9=$GG(AZ MN:J'Q08_A!^GB]U6Q!\%$AJ1)*+)B*R0O:U'HRE;CUVA0EK$G*U+(X6FE"PR M,^,281,0"AV/7ZS#_RMI;WZ@"3XH:4MJ$6JYJ\\E^,5C@)WX40?9D2A$C2W7 MW:\4"9^X87P:@G^Y;+EXL6T1>"8+IV,$T9I/HEF,UQK%U*K*9C99]'7Y/6X. MM5CN.RZFF+GAM$6DCZZWFO+X319Z)6(%+*`6I7Z82C<$!.>V/&H/"[\2Q1DL MHA;5FTX)T8U"D*KPH<"F:VKGT%.G`KAZ?RUD&B5YAU'!%/MQ"-F/.&Z4=D,V MY2FRK\NV@$$*1_2/-TG#']&!4;5:@Y'0NI(%_KTN=='BM2Y:6/ZD;5=GB0V% MQ*N]LH^!_-G72JO:E-A);BNQ<<5%7:0MI=AWW7#2=(O: M2;4P#>4@1]$ZSA"5CR4)SI%%`:\7ZW^T2AVBM8ML<>J/= M;DG,@HXBR)'AK/8(Z6XH0G?2)%9-K\EC]\*+17Q5D^U,N#9;,L=5B3(OX9!" M5,2F*8ZHKE@2$-?>1M:"[6T7B'1L=/1JTEI@\I*Q^(MSY_`TE17+"W8<]0LF M"P/TJ;:2LH(4"I/><>T6MZ^(8H%>R9J!"Q-ZW`"*A?-XX?C:`O5&7=Z<58+$ MW)D\IG5(8E,1$A\PA:$AGSQ/L,)M0V*YQ"')N;,J:H:0W98R[$XQZ&".,`P= M/5QI=VKR6N>.L"MPF*IL2%M;$=I@'!BH,G:)\?MZ4RM/S1)[UY14)N4UN1,C MHLYZ!*$(1;_P\EL^,^J8(XZ3#3S7/[;*$W_Z-(9?!.CZ]=B[)[14VKK$Z'!`\(6=5I2P M]9*'F$D4&PLGF:!=K\H;;)WHI?)X/6(!Q8;03\29O6"ZB(\_0/EV2V(OE"#R MRIP>M4)APXQ$FQR.UX6UB$#J&ZPVZXW6K;QUO02)EW!RH?XW.4/>UUJQ^?7P M])*-+FV]+F^59%=:[NP=4E>QK*%KFE8@?X@LL^_Y:QC>PO/W@8='W%7T5K4IKS[M.(#<6MT2*[W>G#.HD:G&"\*TK?,>`NT1FLJ$P_U"NQ]E"6_\1D M*^8F:59+\X:R*NX0UO1'76EB;3]HW*C+6YD[#91B#I39SLI[5FQ;%U>LEF=' MDW#DIR)^DF8UQ=S!-Q4_,N*1T`?B3=RI9T>AEF^?;LO;LGI(=*&=0=AF:J4@ M_OF0=\B?8UWP7L]_845O=206H24++33]`G92C'B^[#'P(?!3%,*05]';M9:\ MUI\LM-C$'[>36L0_X"7%AA5>=["TL6]2&%DM"'6M/P._OJTWY:64(@@*[1-9 M3:B6@VQ=)\.M(+%*;$M6H3E/MXI:[,9]=#!]P!.7'S#,TQ@8!"TL;U%I=FX[ M\LHUCHDOM!-D,IY:?A&>I!ZL4>(HS#4Z>N(Q4BF;1A)?4FA&CZNM%HU@(0-C MDSV"Z;;K7)M5B?7;:6(EY),MI/K9#R!5D.'_,,G,T^][[#7.K?VLP/ MA8/F?J-R2N228)/(2;?2PY=?S^\<45F[['(.>PM=D M3&RSTJZWY";``I>/XON]ZGHNLS]61*17\*3\C7L.H"G^*]BW8A?^!3O M&_UNL5&5N/LG2:2Z?G#4@(IM[EVGMM'MD)#$-F7>JK4K3V%7.&BZU%W!!8U7 MJB\/'P0?*_W+Q5$4BPIK=4-/OL,.]@.=+O.,AA2I^?O#8<552SS'V/?+=453 M2^85:MO"+D&=2$#:7#N3JJIB+7"(*2..@^W@M#'FV5LF:'3T6E+"GW;(X\&W MYK:R[X!1QNW[MU33_LP-N;8]&S,EWIY MH9[6M7T.X(4?M0\/_$@VFWW,MO0;+_B+WA^4`6Y>'K[YY*5?WM8V83*Z!+.[ MX/7BE79+XE+P(EUL1S+?CHA:QO M"=J[I]+7.FE&3H"RC**N1.XY!BG>6/#,KK-ZN]]U#D>#86_T\IO6?7[0>O_^ MUA]^[3V_G-I/1OM!XEM!SNT94_>8^$/&9BUQ1^;%-F*DBCYKX)#\UJ`G`I6J M\F;)#PN_1"O-R%]YS'DTCP:#%Y^[HVT^V^C$8\(W?&X]S(^/3#X1\I% M\[7167+A)3O!D7+G!XJXC.WCZM:W^31D[CD00'!.V/!?_H1GR'[$005`/6D? M0OH5EEO?OTQ#/<7DL:MZTC52K),/=8&!O4?YAD>NMM0MHMOB"D-FL@$4*U#Q M%=\VQ\8`58FG0Z8+OC[!@D;YRRW)5!O[\7+4N^_UO_/9II,C8NSPS',#7^Q5 M?"=F1$JS*;$#2I1Y>G"+SH[P12TIB$5UR#HF.:*!;Q(H^+@D*R.9JMIKS=#4(0KMD:A6VC M4`@,_\#_-T$,PR?_!5!+`P04````"``]=*]$D+B..;0X``!WI0,`%0`<`&-T M=&,M,C`Q-#`S,S%?9&5F+GAM;%54"0`#E0AU4Y4(=5-U>`L``00E#@``!#D! M``#L7=USXSAR?T]5_@?&]Y#=!\NBOC6UDXLLR[.JDB7'TLSFGE(P"4O,4J26 MH#RC^^L#D"+U09`$*38)37Q;=1Y1%-#=OP;0:'0W?OO[C[6IO&.'&+;U^4:M MU6\4;&FV;EC+SS=?Y[>#^7`\OE&(BRP=F;:%/]]8]LW?_^-?_^6W?[N]'3H8 MN5A77G?*-\-RT1(KCX9)?TN47VZ^/=[\>GN[?W/CV/I6HZ_:EM*HJZW;>OM6 M;2O_J:CU3XVV,GCRWZ2__?,3^[]71+!":;/()\UUM<\W*]?=?+J[T^SU!KN& M:[QC%VNKFH7=.]9>O=E4;_8_^/'JF+H;_H1]K-G.DKY7;]_Y7X:OLK["-[]_ M_U[[WO3>5?O]_IWW;?@J,7@OTD;5N_]^FLRU%5ZC6\-BHM(P_14Q/A'OX<36 MD.O)]^CGQU0U[T*68]]@GVZ#UV[9HUNU<=M4:S^('I`888;?R0V5M*+XLG9L M$[_@-X7]_?HR3I0S>^=N$X,$[V:^,UV"#+QP-)'?VT-=S?'VM:A/\"$DN.U MO7+PV^<;!M]M`!&C]F_>$X0P48,WW=V&*A8QUAN32NX.F+X'[-)WQ,G4*Z)S MP;X6)],%(5/3G"W61S\VV"*84"IG[@H[$P.]TH$NCC9&MED-?9G09F3"P)U* M9Q:T&9D@<-\C8I#9V[.#":;S.9NUA"AZM3?E4),%34J4#D#5T+9G0Q1-D7=.VCZZ?HL-!LI%5&8191,D*!9*FS`<$H([9IZ,R/N`W0S-<<=(-4IJ^'A,_VV#''V["I-H` M=#[8VI91Q*P*.N3=W=BB=L9:?$+7$38`Z'I$AO,-F5O\A!'9.E1JGMR$2'I[ M7T,L>3$D99D=*64@1L.1=3`@Q%A:6%_8P&]+#+V&=%L_V_9LIXBA\V;[SE(MLJF-8.E[E,(8JI/;1=3^V/'B!&C M90--1CX0-T``'A$VWZ[7R-G-WL+)GLY0V_7&6ZBS$4OLMW>@F8A'$C2RFN?=[9276*D&^)Z3FE6H),LTRUVQ`YIEG MQZ8VK;O;.Z@VPI;&!N&2R,F"&Z4*8F/`(RL#=I0J%X0JO$%&Q.LTW#ILVTKG M0-$-]@8C.IAAU"N=Q$SX>I2"C$L14K-@[E$*,F9?L(:-=W%2'&`BL@#H@&#W M@DVV57]&=(PN'&01I(GOTAV8F36.IDS2VKA`\@K!RZ#2#HB$(-:L^79#&V$K%3(?#**9-O-_ M,)/(TA!991XF1+>M$A5`D*;2Z,FU^R&Z!4$A&[Z6:^[8]H%JH*;96\_S3\T4 MB_Y3R^!V;U\)_FM+R1B]BUJ4!`MH%W*T@)C]/X_I"4_$#[C5[34R\I(8GEM0$I6?R&MJ9[ MN6A/VXFGF+YH6`9;J2;T8_"ZX9KT_5:]75>56^6PPM$/@V^#\61P/QG=/LY> M;N>#R4@93!^4T7]]'2_^H++9WN M4#WF`O9,6]N_1=O$YN<;^N!__'.=!P_:6K]?Z]8Z7(%[PB98JRWM]SL=&RQ< MJLG^P2;8YFU=W0<1_8T^.FGTE#+/F6,[@=P329NZSG;H[#:N37;$Q6LRMK0G M3_EJK;ZJ=J*T\B?\A(:$B#NHQ<`)R'QS['6J`%T["R.V0PT!+WB._>]&V3B& M33'>?;ZA'[:$TF=[=A\*Y^+]D,DY^GV>Z2M"8/AZ]X3=E:V/K7=,^ MNYVL-V^(O'J$;YF85#!:SW M6\(C*;&MZA#ALK-'I2DG*A.\1*;/[N"'06IJLU/K%#'WGC6&9IZ(ZZ][.CC,&A#>J:1U(`_=EL@F\2.VK!/Z9FB#8RP"M]9L-L$E`F(IK40JN MW`*W5'5SP&]W'+^ZL,-=C3K<[P?S\5R9/2K/+Z/Y:+H8+,:S:5[O>GI>V,_D M3?^&-?KJ-X,9]B?^YZ[XK,IMHQRW7RKYVA9;Y_W#_'F_N\>6MEHCYT^?6[753!ZZ^:VFM,[SZU6TY:#= M/4"JVDR9D8IDZ[3S`G0R,VR!EF80C/SSFQ@S0"9_(2CS/3G4E"*X>[.(')'3XQF0KL]$ M:NG'6\?9VZ-A(4LSD'G(Y#_:V/=5NB^/^/YC%*283HLXTKB(DKWWGD+=$6:] MR*X+&"10\$[4')0_XU1U;A!+L5:+8F_0JE#48[2[_*#IM:XK6 M.)A8FQTP*SVNTP+&@@`4@5H+L"Z_P1K';^*V]QI4KQ0&2E$]SLY>@'7I]_G) M/`!M*RZ"C\O&,\7/(,1V=EXR^L'TX^WS8NP!;AN%:U2"B`.]2F5&[EW.LUS;[:!N8AVFL!"B@$ MR)'RI;(O_X(:SS+0BE2J#L+R4+(.8:.?B9 M-K)880=M=D]89_4C'S!K?X&UE66;]G)WR(SHSL2:03#2SZ^%^LM$9ZNJW:5/AN6A,+9<3+OC MQ67=[_PBOW1[4>_5H=:9#(3(YAOE3/`YQ7IED_N!&;76;<`%/29U?`7*("@W MN0^3F--A7^BKUNTVP.S-HWZN`%J^5.3.WSUU'STBNG=:L^HXM6Z'=Q`,X:$[ M='HE&*?(:P]X2T[`C\MI?G%LXO&JBI_Y1WY_!:`E\KR'2])$`X!SU4BZJ2PG MV)D.KX!2@',>7HGF3D"`R)^:SB05&I-M>3-NKS(W&A+1M/QI:C"VI44SWB<+ M-'1S.\EE@#I%6H#;@<(`%_,;`8%?B+M/!D7((,50*:J=TR_*CE.;T>RXX6RZ M>!D,%U\'$V5V/QE_\=+CYEY-.O;=>/IE-!U>4(\NUXU@F9/H)K1GO^DA(GA! M?QX5$%Y!DLWB7:77\6202N%@8PC)8L2Y[A.@'7Y:\O9A)PLVKYUU6QTP+89_"[S:V!H&H@#W0 MVFJG`5;FC-=C$;HG!D:8,I#">+#)E;I*6-RM%?>[XV_\W5R[58>"5)R,\G'. M):(`_*HW-_\O7!P9`17S5:A-F;U3<>LDU**1SV0I%+9$EB'K+14'VCG#D_#L MI]GH@AU7QG>;?]7W[\JRUVO#JX!44YO=G@K%P%EG$*H7CT2@?@DK1]N94:,-,6X'=+OV[M=E5=46W!TI M^6BJ1ADNEU^H(9(NIGQU'^BZX=,T^(XH![JO^71UJO>$)_,L31^^XJ0C.)ZQ`R274J=?"C*LL55`W(&NH`-+$4'`V2RNH>*,I2HPR6"E/0 M"^#B!;=$Q"#_G)E5`D"S4)4*6P)+E2DL9YY-%,-53;#'U`-M-7."R"5=YHN+ M!,3ZDUQ@%,2:?K7(!FO&FX'U@.%N!ZR>36RO^=7I"QW^[N/6TKUR]1HVWK$^ MMJ:&A5V,_;^[1WOK'.TDQ8_;LS5>@`**PQ+H87[^Y590(;[HPR.^.&I[":YA MX_+BRN5?;@])0K0[D,F*<@I!_KA'IG(TK`R M7V'LADHEG`3N-WG8?8RR" MB67#TS_LPMYW9'K7(+E#Y#@[NB[[Q^N='MS58$(4%##VA)`Z%.K-)A:Y[R[W MC2MV.$VF.*Q;I[;;'<#M-*?+LE%,Y5OR^&IV;;9%142M8,L@*ZQ_L6V=A1;V M5+`@('Z?92.7SKGD)1J>';Q!AKX/ZJ=3B9<3`RN#6REH<6P&I2^E1N?`7`/,X7?:4V'PQ)'.Q24*HMP&R=!$ MA%W'Z=I:6#"^#EA'.M+=!9M2[!B8W-.Y[`U3V>M>HWL/5;O>`+L-.*'?`G1. M`)!P5RHD`+GUS^=A&,<#)[^A2!"Y_58!8IH`(#/%B[&QHM2WZG!)#M7CEL*R M]$:QO<&.NWLV$5VS+)UMK3?>77:8;P M+[>9>\RQB8PU>=XZVHI5!%HZV#MO"3AB9^OBL4G"[5:#6BZV)7<%'_'$PJ:9 M];>R359Z@ED1[NY8*&`^15$BBH4]&[\\)8C5&\F'KVTM%]A9']]I4E,;W0Y8 MOAVO1RG`3)'$]0Q>2K5:R@"5`C8^WY+O4@^%RR)UXFM=;HVIHNXUB.U7!C#% MQ"*Y:9[`=UN%.D((FNZBR+`)BCVC:.9OGZG6U15C.W%%?L+W66+') M#(5+>$U(X5N+,"/Y+H&23_5&CS)>:W?APBIC>ZT,PU0A2+XC.'8IA$%HS583 M;)O'Z;`:\%(XE]S@?]@?A.^K6->Z?;B=^5E?U<`5SW!@K5-;JM&6#ZD_D,,2 M_=BNX\58KEPRV[K$15[:7TWMU7E)C<7@EM1S-2"*RB*HOJ[6&H5?K%'(X'., M=\02;3A3?Z_5`D,TJ>.JAJ60*`)`)8WI.(TK"CC9L0,RWDH8=^,!OY5J@!%@ M:0]*3])(#HY"J0VU4<;I@33GMU&^P[,>20V3N!TKF&LYEZ,@WZX[-C@G&L(C MSY%<8:SF<,%*OHE-<2679\0<+BOL&AHR MR:\!<4456CIM_I3U#&67/A+(/Q+(/Q+(*P?Q(X'\(X'\(_#S(_#S(_"SZO.< MC\#/GSGP\SK.%/D^(-.TOS/[_]%V'NSMJ_NV-;VZ;T?%&<.@P7X3K,QH!CI* M/D#-)2#)/7]'/DNZXYLYGCS\NUJ?L3-?T5T@^?6*=,M,KPQY_W6QF:"0*0W.T786),R-9CH`GFG8_ILV+T(HQ7 M[_O+AMQQ%&D7T#!(ZKAB#/DBD#R1\70W'KLPJ*U.!\RE)$9#N>AFE\L>Z,Y5 M`!U9,]16EW=E$P3`U2ZU+BNE'2.OU1!5^A+1>F_)]A+16&])Z64A(6RPD M)'R%*/:;,EPA:XF)8EB*MR[L`V;^73D+P+H@0N30X>QMW]W8.NZ,&^N5(5S$ MC^ZA>\:-;=%N`FQ[73!W,[?'_./Q9SFI%@,BVV&UI+>['GDH]I2K=;CH\DAO MI8.5Q.^5W-&]PLB6LWF"!)>:]L$YX/5<081+B@"N(G:>G!!0WVD#7O?)Z[)T^%(Y#P[VY`3N MBL-\HKD48TLSM\QY^&P['KJNZQBO6Y=-J0M[:EML/::2HRTMQW1E=C!QO?P+ ML,/G8F@LUS%;O%P/,=E2%CWA^)Z[]3:<3E3K=T_D-D"J)V<1J"EVJ2[::SRQ M":FIS0;#-W'X)W(/6X=-%YC2YQ^@>UIWCSPOW)I= MQHL8G53U&EVX]*/,]%0PT>:6UT$9I!RJ,4@2`IU$)7801^: M70E+,@[T_]T2_RZ'A1VSY_&8?#UG\@53(X08+IYCY]W0L"^6%ZS92U_N?HF" M=@\N"A2:^)+#O\N#XJ"4,W*V#F3IGJ%()0(%\4\8%(@R< M6ZU:O]YHMF53(`&O*W2<16ZW<];#:2!&\A]."^JP$#2!.J?Q#QJ,7TPQ,0'& MH0//2M-)($8JU$E.&%H:_R7IY$6A:`D;F!/#H0L6>2Y&@Q3V5()<`H-*TM,> M$6O`RR>E.X$V&-3"5,AG*IT+Y\C^Z=3[K2LK_-2J=^JJ1\C0:S+^^C)[H?]/%7/GE@1V992[T](@,Q]N"/&'$^EC[X7O[ MQG+'Z87-[JM*6\=7R^R[TF=TYZMM'39VZ0M3VW*"C_>(&,0_LU?[_0Y4^$%A M5.9?GT,2[G?A/W\WL$.5:+6;X'=L>LL;E4(/7`J))!0PW.&4(I@E,DOS&B(Z MLC`%9-,5J"+)+(:S$)V#HCWMK;<&NVX`FE,12HH<$]G`C2A\1L%)GX"112Y` MFVL)E1Z:4PF5GN-GR"LX*1(_P,VF@RW=J%-+&"B(N%!*"QA#Q9@4$@NKJ&!M M6!6+#-$"^G+$O08 M8#(>W(\GX\5X-%<&\_GXRW3TH"QFX?-_*,]?7X:_#^8C9?#E9>0=$>0](3B^ M+)$08VEA?6&'QL'SEL*$"!XL'>R!>.G)P8`M0DM?'_QU#!V>+.B_"-*8I(*4 MH"94"_KV[.W($/+9;?8Z4',*M\?\&IC'A@/B#,+:3E9:,?3""+2\ MHI+_V#%!$$#SD`1J#,295&K,F7-SBTKZD)&YML+ZUJ2RR.BR\`\:Z2:SU8[& MV,7LL"_K++^F)X`-%!Z8?ZBFF`P%PQ4H>)J$`(V*XJ\J^_DJ<@&AGK&$%T1. M96'H9Y3,)#S98WXR3MG`="=AIF[R3UZ%@"_*7@DS=+*J%P=CJ.2%R>^GB:6Y M4,@Y'.HEC95'PT*69B!S]FH:2Z].`%G8(SJ;N8:U'#I8-VA3C(]ZGW,&&,.' M8*O5:S_OL"^[1.1VL1Z):&@B8QT]_PBN"V0RX=1*2%?6Y':EA#F75&2O2YR0 MJA@O+,9@AU/I,6[!R]>+E$I0@,3D+NWYC';[9$;>!-;IBR]-"2U)":T@YW(7 M^'S$V*_(L5X;A%GZQ$\^5>OU+EB)PYA.I4190$"5!Y->EIW;J#?.PW*FHX4R MG@YG3R/EE\EL/O]5>1Z]*/3STVRJS'\?O-#G_]?>M34WBBSIO^*WC7U8K=`- M*6)??)'G.*)M.6SO=,PCAI+-C@P>0-VM\^NWBCM2`0544BDW+V=.M]ODYMDA8H^C30QVU ME]UYYDNP5Y6R>)01HNW(2QQRU'4=;(Z-5%;5K\]2"SL-_TK&YLM$@Z4B`%55 MKGR-=^3@\L/=.\%H,=;`/%TI'&);T;RN5I*1P%T=?]2_=*1/X08-'-$Z`ULH MUP[N+(;0%;'7?:+AI9M?FOOQN7,/A(2!Z$VHWJ2`?PDWV*:4*IC]EN.4%ND* M:`*WA3X3CR63N$-(Y^,)V/.5"KH*\133!O*$&L!-&*J@JG\O14F<"4A]JN-, MHM5L('8HZ9HHAAV25HC=WDIKX6CT8E)F\[)^OGB\_.ORZIN<_(L;$/_1.##( MI"5_>NDTS8R43+Q-'%2_.$OJD"P<;"XO8+7RCA?_;TPQO/?K,I$V$)(;L.LD#I ML727CI7T/,L$78@74W>DI@1O>0K"75_Y[.Z#=\^VWLB14)D@1N?H2#"L'<&_\*G`-U]VM0*DO3$JDPWWSSR+QS^^N%[P0[X-= MJ9*'K^,I?'[GE+"LR%86"0(2HF503C0Y(@`)/ZYU)#B2%(5`LMEH[U_-Q<-# MG6@I<5ID*4?YVR$1&WBAX)'6LDYX[>JK#:$#0876($E-L4DL,)O$:VLQ%ZM9 M0VMH24N=(4A03CJ:`*4-A'JALAF.&7M6J_&2J"*3"5;;O'P3O;Y&R,@VDA?3`#':Y72!;9;[F@L M$26D[JB&]K:1RL!DIZPO>\*/D5,-VY'(*5H3_&C=T3W.(W[P1"TN[&QH/=*C ME?[`>",C79^`Q:S%V5"-KJ"*<$>2BR+=&F;RI$M?S,`"_65$52/*%1]WU+DH M0,Y5C?XONP(_>K;)3@T=;OJ@,!>J$193$*0/*0'S?/GW(U4&4U00>/;K/A2L MJF]26`0G'L?I0*E_I"6I)5GO2,%_]%R3$,MG;R[R$H^T^7@,MF.74>T?91'Y M$PB1!N>+6]+_.L8'L]9_$RN).-*M2.OIFLRAKGJ/KE9(4O0WP3G\-1^:O';] MP&?'"NQE.4]-$78E`B=8+4:3.5:L4K.[-P+V*NW`?&PJ`Z\V$V(!YLFJ7GDE M*DA@7(XTAB-N&&\]\L^>..9ALXTZMMIFW.^3^60]W8#+F5`-L9!ZDG)=I%>@ MHD3,6#?;6]NCGCB5S?;8JX]0(A8IF_:TC"NX4`VYF(*2>@:DF,<9UZ@A;/-C;Z\-G8[8ET=XG\6OA<1'U;;[./]X]E>^`15S#?ATT3N25F[S'QT+2-Q MJ0!CA=.K48`5N:\Q*]7#NX6=\H^^DKY$T),R=75VT(85:#LH>Y1;RC_^ROA2 M_D6W\I;ZKV5FXV3/FL9+\0@:]QN23:),43RCX,IQ!BF*F/V7GVZ.??$3GOL- MA3!PY3B#3$/"/BN8S`D@/AFFY"LJH>#+@OMQ:5Z`]:>18U]\;`?W&PJ!X,J! M^^7H]<[P_6$FC#$!+[$%=;8A0ZSL1!S'E8,L0< M>`[8U=$+-05/)6PGREZ.=(PK\)D$052^F9E,7/C!WG,TF'A6^J'^H1`3*D-F M-5Y,YMB0^8-^P&=CA8B_<7@2A58FWB&E]GO]X]1(Q`2NU8BAA6XAK7^Q\6E[ MVW^/1&`:B&UN-8.[VY23[1].(15D,$ZTI8Y[U?$$&FGC!5R?@EKRBA=IG49R MZ*X6RR4V=!F[6;5;7`)'K"Q#%`VUC-(++"T!W\[*9%:MIX6M.8 M^'G_\6%XAPMW>W%KV-Y%F&F\N*2V_A$*YDMI6!Q3V6P9C9!$CL+0Q'AH8ES5 MQ!AY"G-H8HS9\CHU,<:>-#W_)L9#Z]3>6Z]A[Y6ZOI:(&;[ML]\/1Q>]4+?5L?_9$S\+ M)U"CX)PE3:-*&'B)\*ZV'ZJWM&(YI&[LC M*2:3^01L#?!IGJL-U*L0,'3;CR$`Y;6[&`(_.>49CK\E'D/^F7@_;).BRE[5 MG]#Q7^C'??Z/XK#=?#K7H227R:B,=2,(?IKC@M$S^O*!H3M_C]WYD79#J%PK M0&489[!1`DE^3ALEIW(%2,_XJUWD"PX46.S=P+CJBC?#>"^16+G`FV%DI17O'0MY9Z(EW(G MS^M]]H?PBG015V+++>=.Z6RV^9\/%=U#1?=0T8W*\H:*;NQWW"]2T?U@TR/C M<&,>Q05?;SJ?8WK$\*F7%_WWUO6BMN(/A#44GW(:`\*,"2MG`]BJ!<:$ M":E(^=G?-20QJPM)Q&L]"4-<7.Y",.@'Y00BTKV$_6WV\2$`,00@A@`$*LL; M`A#8`Q"#KS?X>BA\O2\2"1MZ&PR]#8H/]]L_U&[\>/E\K$":(=B/RS% M?E@[&0Q!S"&(.00QU5AN,D0XCA(1Z_*5[E"&&C0A0AB1W99:##$POWM?)$ MA"OB4#6QJLFLU^TM84-^(WL3']O4Y--(\!,4'O6"/"Z/V\OJ" M-^,4(@12)*P&8$%5*'_BTS6/IC7,HTDNYRUDT88BWB&')I)#`VD2,^30AAQ: M;0X-V/*&(MZAB/=+%?&^_*3"'V[=O7?O.L'[L6B9.+KX$#2A;RI)*C45%K=_ M-R01>T\B(G4+G]U]\.[9UALY$BJ7"5N*IXBJOZ8D"20N(.[NQ'DO*O5QZ:T' MK)TECZ"L.^BM89+4X9Z!B5!&5((A"L'!OX5RA<=]V.>E_<-S_3"6R3.]L@O: M\>_WC4"E`+@/ZSSKCZX7JB,(//MU'^YE+V[2/^SPN/?,=\,GEV\>"?-]H9#B M2:@.E%3BV4$IN`_G0EI'F\XTL`XCDG-:K:',2XG[.!XFRZB8+(.TW]8P64;% M9)D%;F,8)LOT/UEF,9KC-8FA3+.7,DT=Y[9P_)8SFY7P'(1!X'1J\$C7)SVE MXZO84.LD"RH(][W@J-(@,^:CB='T7--Y&SY(!48Y%VH1%U,/[K._5")6?NEO MMJ<%1/J"-QL=&/@R;M`8@("ZSFFWOV?,VRP%&)`;XIN>';)&S7K>4^RSA`.U M@->K)09Y>6X@/QG.&SNVO(#N70M>+2LTR#D.\(#,5TL,\NHL05X[5G@\<9)D MO4#,Z",#^$@ER&`!$2D^:FAR\#OTV4`8A\9.LH-CS&/ MPU*-'F..A\>8ZBVWD!0V/*K:=Q+8IK'+OPG1.!6S(OEPWO>`K;(N[UTG(IJZ M!C`5<"XWN`MIN%'NOVRRRX_)BYLKT[>)?[WWF'JB MN8QF](?1:@PW#D>0![5&T%Q1Z2 MEV:XS?I)WO2;:SC^$S&)_8-].#MG9U,PUT24!QG.2H%62(@2C(?].&\9T?@" MOUQ-X/V81CQ)6+]M,3_U>=IJ\W@W/UMWJ)$J@3;^/I=/T6R=SA#>9HUM:N'`S,?0IW-BW2LH(,!;53(HO MSAJSU%+7?F!_L'M8.FH\[L%P2?VOCY!%_TA(5FG;H,2L`RD$>,O25&H/.L;U MGDF9M$AA]10?GZY#8MVE+5,X(HIW7VI-!Y4E=-`1;@?VWO@_UXM'7[+=C6II M_<^>LO=,3);HHWY:F&:AF(*U@A#DH?TU1H!`7(1*Q9PK%%-:"XRVL":6WT9C M^)O--](*4,<=;,:N3DPUQLYI/]1&8^AG>G3RU<&K(>1'/KHO>""A92YXT9** M;I`W6!='VCN'00\-5SN0TRMW?^0*^KMU<6D/[#`;X@O/ANAN%L.PB"_W"E&6 M47R%Z1'=^LC.3OO(/JV_7;ZL;RX>+Y]>_KIX>;I\>+Z\?KG;/#RW;1R;;X3W M0O7H&V88?.O:+O:2@?(6YI?\*`]M9'^3)Q3#-M7!^BDV9*7]M2#I?$*M]Z3W M2;9EC<4[X-=_4$8HKQM2R:IM)CSN0[QD4>2BFO/I$BJ)74=<1LZQ;-5?'0H_ MB7T8O8?"XP8<2;#YQ@"?QJW;J?#+%"V+:1!H1X=;(C>V1TSZC^D=Y(=MDNMW MPWLCK&79F)>,+]FV^1_IS6QY-6*U8B%_*Y8OSQ*H==.FLPE856`S7E3"WEYK MB3^%U!PZ;,/@`5C9)QD_`L6JT0OD-B(#>"66RA0PK#]RA43 MX+L=O(<@,CS?[<\7=^T$["%S%.:93Z?CWD2KYD6"18O!5[H=">L*_526"D4` M57E@L..^1%-IQYRBE?:ZPC_CI95L0*X%A!UPA;YR#<_:;!._T*<>H>U]&$X< MJ=/A1*RF#&'9#?%,;%Y419`6+N$97ASJ'6?H"T)!"09!!)H!KK%4(OL='6JL)?&UJA""BW0+T9`TF&RHPY#D]K M56&H^NR6KI^,)\?I^N=_73ZM_[7Y=K-^>OZ/BYOU[=WUW?KA^J_B!-COQ'Y[ M#XAU,8;N]-S&JB"L;Y"FQ+SQ/JD!5EFKHR?&*Q!RC44HQH*62&?'7(_LVC<0@7`:.= M,>!8CSO#R;7J-S%`OESX M=]4CR8"V%@C#@605RG`X.Q=?KO/8AC_Y%X3M,E6`?[ M`B59]E.BYO1)5(ETN"M%[XU?!:[AJI@+E/K"I$0ZY*\MI1L3KUF;+#".]]JS M?2HA2^]@O>`5+N*VM-.V8;G$Q?K7)S$#8MVP:@'B6&R`X4A;K.#ZZX&SCVC5 M\Q[J]HD>;C\01!5_NJS494>%9,J('62JDR7O.3ABB^;*\1N:=BV>R/WJ'G02 M!1Q"G>`[\!K+,=CX*9[*FS+T9^-/MO_WK4=(?J(R.])TL-Y'X.S_1A9=AUYL MR#/$AOQ:KXK7)HN;->'6J`ZT%5QG\_/Z.HF;'+_\3=7CRXSG^9AO]^D:_;;5B%FOMZ]G'6ZMUA7^9]>.@T-72: M^GTZ346M\=+.]_$6I2WA;)1+L;TET@]]N$ZX9]XYYFYOV<[;I679D4H?#=NZ MB'!1E&RXA6"`EXXY4K_;4QR@3\^NDVC@20M7O-`>RFN6C?21J`#YG M;8^A)>!1EFF9?#!.K+)&`>=0>_.%.O>(@2?8D@=B\(IN2'10J:"#UX&+W M"-8@V;K9>_0J\4BH@JW0)_:3>_+AY)8K\GT2ZL%AYX.BJ>\#)$A[WT?03(6@20-.-?+C?W8C(#?4*[_> M31)($(4FR7G&4R<_^@<]<0S8?W'75,Z`'@/7'J'>M>OYX60`3EBEY-"K^%*_ M!YN@2/G#:S[%=GC=DG!6`XM^V#Y#V=\$[V%P8ZR#I29*B/8+GX#D>>CT)3;H MPL#LEG@O[IWS@XKL>@=V:=+%Y]1POM`O!C4BY/2_&D^PZ;_R8OM`?H8_\D>: M/M'!6GN)\8#HPL_52X8SRK'!5?+$>X8^X0V+[@%C!1MG,WVDV"X8N.BP#9F. MA'GT;)-06<*_HR*,Y[#E8#RR/2,I(OW0BP]?$[.A%]_0B^\+F/'0B^_WZ\5W M6NA4VHOO@:F%U2Y);K:7?G?HJ">K;&_HJ#=TU*M?'4-'O=]S=0P=]4Z,[9H- MS27>)QNNPR0(=;6$F]'!H]=^J3R1S^-\[3&!&)+9?*&!->$3Y4*"48O@E38U M::$=_-MYJ0:`=C>E%@O5_0^#Q?*Z!+;0#OXM=F?X_F8;ABN3A.EX`A:F/277 MWEH?*5_$\X@5?BVIG1^O="CF>01EV&`]!&DVM5IDW,-&O`9WCA]X^S0VK$WA_*)3A&@%]/C^&,"HJ.?0ULM`]2HPR[PE80]G!_$ M"^S7'7EP`^(_&@?V\.;EIYN>0F.=XY>5G+QUGY-N9Q6*SYZ^BHN(VP\KDX1" M0G*RB#^_K_\@)L#X8B(OX"D1YM;=>SE9.*58S2#+OH<(,;Z0R-WD9R/L)\P\ M?";Y9ILK64BN]/H4+%153[Y+W,W^803D<6>8A:X5&MP$$CY)&76`S6'*8G$U M:L#M+(N-4`<=#][MYMM^JGL/HDF8?-YPNC07OO0)06M=X4^Y56@"JB@0@2'W M)9I*0^;X?.UUA3X3-_0/'/H'%N\F0__`5L^Y\QFY^+TPW&N`4JH=@BDE&46H MHJ=V*7G!]S6U8*3.7Y74^$/(-0)#-Q*`MSZH`B8%UL>Y5U1*C3Z*_+Q_]6W+ M-KQ#SI^-Y)W`;1RE5#ODW`7=<2B)Y$1-:HQ3&*PT.]]$*_@=MAH%0&V5ZJP5 M2B($ULHK6F^B%?1>62N'$\C9@'#.N4(_N$[B#]S8'C%9MY8T`C\9_C0B;"KEP5S-=O]MDN_Y%S#U[0[G9 M;FV3)%DL;:R!-4VHH(L(5C'M(!^VE$T-96==_(`VZD$63P-=:;/E:>O4LB+1 MNN]UN*A4'^)0'7H[W;B$ARZ+*C^]GP@H(]U;EN/98H6S\>M7F'_>%+OJP>84 M+FTR1]JGM_2E$1!JK5^&@8%7K8$,0UUV"R1I&)85)P)!V+).%`S`2O$!#VOY MO;+Y<4'H3O6M@K1PYZ"`,@"G!,KK6E^>0(;J6M\Z_P\&9IT24B!1=[(_%OI; MVIR-]3D?GTXUJ6KYSO]2ATNT(#K"3$JY[]4/,'?V/Q01:@KVP%60"%^*5.LI`7U`?`QOH3\0BT0#7D*/9\G>ECSNP9B#57P@*.%2>@GPSNY6R*KC%\ M49QO-E6#943RL!\0QXQ.C)[`YC*``^I:W>">)9^;6?EH>!LO]'NM<.AX:K6Z M-@4[2`7HJ\*YF6H`?4@9[0/2*T#T:NR&BK+9/A&3LGUC'.ZI[_%^Z5A_$<,; MK>CQ"?:X5IP/5;"W4U4*OXYQ_L"Q3"^>_?9&O.SZO]EN]H$?&`Z;61OU=$_& MJ;%+RG@E?M?J1`L+Z*T5%-O!'.<RNUH@3'(B+JRL=/H+2"(IW MT6A?NMP'[Y3%?X?^O3[N*09R3!O'[;Q*(RFR*&]L13E*+Z#4T5B`[=MB/.!` M6D1#R-M8\$PWFJS#A%B!7*`MDP3"9Q(BQP?/=D\/>2>(QIN9T1^8%0("6<^`\G4HIIP,ZOE"=M&W M=$_G3Y=-/G^RW]X#/RQ)Z,FAS=/%X>F4:2*#4V=%_-C@?")LVS'IKG-M^"PY MPO[#5/##V+%.+"-MOH++*=515U?L(:Z5!.`%3C^E:*6Y3I2L7ZC/%)//E$3Q M&%;X$*=1F(YX#W]+,D@=J>%8RIV4E)C#$J=34]M[J:SU4M0ZR?^#_L/`OXN+ MH/[P7)\NAL5J#%:="<"P*BL#UGU:EK15/J)!M:5`()CI:8'J/V<[4WFZ$KB6B\\UF/NWK7LK6V&OW+GF%[X M"\8N_Z5KUP_82E38DE""!&>W+;9$)V>KU)E&9ZM9GT(FW_H7DX.,-'T"-S>! M3U.9/=1J((>@/D-7;UTL5[@U3'+YP5X(C_3%K*="CHPHCIH-KA)R*"YG,XPH M9@'O-'^1R704_%[PWC3(PU:<%96(MU)85DX_7N`+D-R0L!V^_8-\LXU7>T>5 M1J\^RRG<>S0N176H5HN?@'=&15:Y:E!64P3G0-00QQ'LJ-0)]EDD3(!H0[G9 M>Y3WR#..1.)?*\-K!)S+V)PAI;>L]KK++$-^6Q,PCR^,EL#&"_#@6ZN!!$*D MG?^X%41>U-HJT@*K%EH`/F.KHX^JMJI4,PG,6+O-5>U##^1G^".?;3UP90!B M/*# MF/U.@\3$9"]SV&!X8[PE5(=N--68V=-)4FMK,X(]M9 M_R*>:?LD7!#I#PO2@4T6;,,0*BL15UYB&CI.TX@Y?R'>1SCE77R^;NXW54%3 MPGRB`L``00E#@``!#D!``#L7>MOXSB2_W[`_0^\W(?=!1+'\DO68%I[[CQF M?.<\+DXWYC`X#!293H26):\DI]O[UQ\?DOS0BY1(F=US&&#:L5"]YA$#J^]^%,ZW3/`/1L?^%XKQ_./LTO)O.KZ?0,A)'E+2S7]^"' M,\\_^[OYK__R\[]=7%P%T(K@`KQLP6?'BZQ7"&X=%]4-P5_//M^>_>WB(BZY M#OS%QD9%?0_TNMK@HCN\T(;@/X#6_:DW!),[6A+5_?(3_M^+%4*`L'GA3]]> M`G<1?3A[BZ+U3Y>7^,^.'[Q>]KK=X27]\2PIBJNF);]^_=KYVB=E-<,P+LFO M:='0R2N(B&J7O]W-YO8;7%D7CH3+F6];$>FNO>K[J/J7*0>% M)?!?%TFQ"_S5A=:[Z&N=;^$B@9AA)K^1,]1Q`-"N"WP7/L$EP/]^>IJFM9=6 M^$)J;L*+5\M:7^("EZ[U`MU+ZYL37L.EM7%Q/Q(R;P%<'G9XA@`:Q/XE=*,0 M?X.IA1?XJXNN%G/Q[SETH^T:"5#HK-8NZM++AL#M-\M[A3/\&37=$PJ^@+98 M!I:!];J"7G3MVQO\+Q$KH6R4MB"'&=)G4I@XH"Q3E/H21:E?GX'C*<"@'"S@ M.H`VGH>+N_Z@JAL$QS7Q#&3@&4@;$>8,SY9.6`GT=64#*UU(>?)2R:@6<_LERQT+,D18.^AX)[ M^YB@\%Y&-BSW1%+1RQF2`D'7Z-XHBY.U3\DJ-T.?XI*88HEI25=&:BWO48;? M(N@MX():G"EMWXY+D58^G*$O_IAZ[S",\*H=3KUK^!)-O,6=%7R!D?7BPIM_ M;)QH.X?V)G`B!X;HQRL81);C/0<6]CTF80BC\-H);="O6N_,R$=-6B]_ M:'?=V7BHC8?#F:$-IM/1K]WA'[)[J=,W]*X^Z@RZ0WV`#"4_6,``>:5G8(VF M:D1M^^$,.:B;$/6AO\:FK)7*OA78%4(=E[BT?>30K:,+-ZLZJ$CNH!S)MRK] MPZ'+65X#&/J;@+BV*Q>QAAU^Z%U\FI\!9Z$.D^;D\V0ZFWRS M&S"YOP8W__UI^OP_8'YSA:;;Y^G-_.?+W1AQS4\Q]@SBES`*+#OJ](S1J(T) MIP*'L"F$F]]D3IB.IW?Z?]U-M;O9*$\,J@B3@1W2@1THK=V".96MIV+A,FL< M^#VA\+^UE4_2>J;_OW$@H3/Q1""[,_YP7]S.8#S0>WTLEP-]3.5RJ.R$<<(> M89]8H@)?IF)V.1UODM;]&7+MW!LO0G@GWYRPH_6KUO80VIU7__UR`1TZ5:`/ MQS,$^NJ8DDQG`U+I/\#.CO:,5$ M)3A72ZI==S!Z\Q=4#R&\@ZL7&'0P&FFF:7&[S62;AQ\F=[2$(!F+'AF+8??[ M$WM^#D_J$C+#-&E)0(N"I"SXG9;F5!"\5[O8N/!A.7FW'!>O2+=^,+=HH7(\]_)&8ES]-GNU%R0\@`\>`F&@=$U!CDKD!U% M-A;@0;>?G!Q`WY03$R^^93C+1'A7C\PK?=JY:@?QN?B0/;/S@"FRGU!YN2)[ M?,I*69G=.[+%+K0#VK_JAIJX^6`7VD7Q"3$QPIN",B<>@-0=CMZL"#AAN($+ M\.Y'CO<*PLBWOX`WZ))3I98''$+.#]#G15(!6+;M;SQ\]!09*&#CH=%"OT$` MJ5ZLJ%X@2R8NB"F_;$F1A%Y'BH+HWXE^,)DE!R-H]&/W3>VM&RX^3F:.%"$R M?T-]!Q[?K&!EV7`3.;;E@BL_6/L!44QALSM6]8>O'N+JS5G?;S#-A^4G\PLT54MB!;S&AP5RWXE,3QL`QKD&XZ^,X7@9:Y]RX<38:XYA&F` ME`B@5,##$E`ZY*=%>VI4VW)25X]8;"RVD8Q=L?$/J4@[YDYGC7$B-9^1H>11 MC4%&5$@U!GVR_=4*K4+42$.65VQOK:T`+57.FJY1/J:([*P]VO+,?K M&(:@_>]]J@VEO@1?[EFTX^:IPQG/9FKO=G/QT>HYL@HP9K*C37_E=$B*]R>. MSY)T1KU^7K14S,8`.XYF(MV$W]+CEQR$R?B-R/B-U-X+%\QIJVK3&*Z9L_D6 MIH7/P=)R`O!NN1LHU#IZA(A)DL+=,?H]>1K'#$.JY53&;:F^L=,EHVK0455[ M-UPLHR?1MKIH"R,'YWNA@UUM\>=2GO&WG8$^.NV9%`)#_GF4`FY+-8Z=+A[: M43RT:N^;BV7T)!I7%RW/.1-2G].RO(^"S56P74=^N`WQ$96I9Z>;'YJ6=]JW MP-DOIM1,4;@0)JI14HGL(-"MX9':^^WL3,@6:68DYOWSTR=P4+31T1"6P6<, M%9]2/K.AWZH>I=N_([7WUMF9:"N4RXRH6E`YHZDL8L`6-3VEH&:BH%4=2@]$ MCM3>Y&9GHI6H)C,<*J12]K!S/+J6CI(JXK_F9NDQDR&)6&BP]&X$S33[_)G:)N9ZF?HZTD7:"F*N@C-A:'";K`TME MK3+#3C(`)<%Y#*PG8ALH(B93%12A4RIA+3:`VZ M`WJ@?DAR=]&PJ6TZU6>J%5.J-KR2N,K\4&TX=82>Q@@?K2TFB/X,-G`QS1X](\=(P.CFWNU2H$?(1%*0RUKM8]2 M]938*KX19$QS\17?*VRQ%Z2OCJVQ8B9-@;@M$#<&]D@#1`J0]@Z^W;4(XB9) MP5VC:%FNO2"WH4AL08L_]V23M07DRJ9A=*ELJKU3VF(OM&-MM,:/.;FZ>OIT M^0\ M._X8P+4?D"S$-;EUFG,O)NXUW$FDYRQW__*^H;SK*4L:;C8K<7%4>CZDG!*2 MC#Z5#+5#=4U9.\D9$'9\C,M_[1LEF>:3Y./V$3'[9H5P\AI`B&_P'4-&L72U"%(8T-M2B#2,'54(C%CJH'J:?TMV"T$$#B4Q;L-R@0LCTW03X.31@6QYX@6!E M+2!IR4K)?L74T$^HPA)]A+RFKC#580[S_0#31%ZXKKD0TEROL=I9V8(Y;2OL M)A!SNIPG3FS!#'$!9H^3ILH8>^(=[&ICR3-D>)V%S8I6MT)NBO4HJ8)W7\?T MF+"A_`X9&P\HGK: MN#>DV>LCQ2_`YV.D38.%#5(JZ7MW[RUAC7-'F,B3O[7X()&A0AT M-2='DIRIH.F]?L_H]+H]/;XQSE![KXN/D38EF0V2F19+=HS$RK!,$Z-=&2XR M*K(5!K&%I_Q!CTKX+1D591C2J38MU,R8F%NN%>R:.MAOQ6.MRY;:,@!"))B/ MPR-I+J^L\!-57#RT)->50%+A3DK*$VF9QH0:(EUD9)16)@;==Q'^8V*C30.# M!5`JX+:_PC$.LM]05\A14_YJY1#K?&]US@N%BQ;OG*9%"3835UF1SJM&]D!U MNG(JGJ+"PT?+0EV-R-P5:&8V5PR_9#/D1$)=8GKD5NO'_:[VZ29V)MHS/BJ0 M[%L?R/_;E6UF89=L/L@4Z/:W4ABO+RS9#1B-!V,Z&FJ;(,T8DRWPC=`Q;L+P MOOZ,5B(81O'IP30"HXV&\JR5_$:;*0$S(ZD*%%08=D?]<4C0-3:N^OL,"7/BM78S"3 M,DF.9DW#@YPK*9[PM4'^R6>#.YY68LD=^JBOT1?5I$ZZH=I.;B0[9$ M\X`QZ4'CG&/(DF5\_*/*^/A8QMG`=0:]?J]K=(9:?]@;4$<^7B?5WED4P1Z[ M1KS#X,6O:YH(@$KUI?;EPYDVR;4Y>_>)(!MIW,;UPQ5`FJE*(X99;R"NHHSO MNAW2^[MZ:H=D!'-Z$C>V-MR#RW*2<_6U'=HZDB?%R559U3+.,`>185_K:P8Y M(!K;QSVU(_B->6O%:6Z*\O#*J5B+;O8C19F$,DZS+GBU/.>?9%_LRO="WW46 MY(^)MWA$#"8Y.@_+6\>S/-NQW#GZAAR2W\M$U7-O_19D_(F`V-!&E--+I4NB MH#:1OSO228YP7VU7J[U..,E"*H,3\^-D/IV#AUOP^'0SO[E_GCQ/'^YK9W@W M@KB[26)O94(>J;Q]%]%P3SA%L'5>&EP1WE3/&(RH4*GMDTKF7'H`1RI\R)M!.Q:V;][KOXE<_*408I1_V>923(.@O"FAH/1N$>,V$&? M7H6H^/W-+?5`*\Y&.[SD&QU\\\,5'CH/V2@8SI,3?MG=PHZDM"?Q;;RREINI M+1]/B09J=]W9>*B-A\.9H0VFT]&OW>$?+&#QJ&A=\C;)H*NVJRZ,1]GKLRB@ MYD%9@`N?UW[B[AJ^1%,/&?3DPHQ;RX;TOHJ.+M.X+FJUF8ZP\\*D'X7D\'`, MZ'5UBJ?6"N'OI'K!"-+$Y<"NX#G`10$MVT0C[JT5C)]/1H9.OR6-V+4J4B/* M>*FA$7OD\&#T-3H8:M\;)H0_A32B$&16(W#1FJ]]7UGNR@K@(ZKY_`8#:[V] M@PO'MMQK^.[8R*:SWSS?]5^WZ>M=73U/5PKN\.$DW]"2:LQ+HBN\E/#;0`9] M[Z&KMI8TY$RV?C2#9\;5`:X/8@(@I@`H";"C4?.UL]IBQG;MU?>A,IF00*V1 M,^C(J7V(O"%GK;CPS3"F>K/&>A/%>K.*]69!]28ZF=XP7BOY?2A.]MK(&F,W M[G;IV*E]G+X9.#D4,-+7S-O@8D6Z&\:#)B5J!M'Q=MR0#8)N2G'QS0B0, M`WDN>U7KHJ6]BK=B:3^JV3/&/3HL:I_9X&.D?6DO05,A[;A\4UG/VP"0LG]Y MXDV-K`]1$2H?T_=W!YK:IPUXV&C'.V`'=/2N<0#?H;>IL?.0G)W7]9Z\^[3V M&FH>32U$G$CG?J&^KJM]I5`6K.Q9--,BB5/6S!JJW/"1DBYTHLVK3(9088UA M?SSJ$Y75Q_0TGZYV[(23$W89;93WPX?*?`P0<`F1#@SY`J*L=PJC)D>S)MAZLXYVC6N;JG>.1(4IRH!^^>L@R M>7/6.\OAX_;1BE-+NV-Y&8?;"K:, M,@2:"3@+GD2,LV6Q(]Z+9R&U`QR5V&7/[54`3%(@N9T%D"+"1(MQ.[(]VUO;@E5`S*EGNYL%-A'P.VL%#PZ3QX5]#S]?_/H:P%PC<(([!`%,^_ M.M$;<#PGPEDY*RO:!/1AJ1>X]?&UX4!Y^9DB7".%5.63+`E=Y@-@[Z/.U8["Z42>TL!E2H8 M%39S/#A%GXD(Y":(%(BDF%:;R;$TSH4D+35CHO+85BVO2,%]4'> MYU':Y^0X[?.A(.WS=TP=$/)MYGKFR#:C6?8CJG76`!0I,+'!HW8^C!R&VS(U MI:`7KM^<1N%CX"\V=O00S&&`#\&1@/2@UY-WXTM>B\TTE8V'1.MR2VO#WIA$ MX`W%WS9@0"][G:N&8,9%Z"5&<;&PUD9&0@GI0D(GS;?1Y!U:*&Q6B*2R<',D MKCE5M+X^'-,N5]N<8V6A)<&MPE$DO;7.2"):^-T#/]@2]RL]:)Y_#KC`',HE MTE@2F7#MB6%.>;*6T9RWL=HI54SX6Q#`2A#FKA"@`=)ZB1P5`\QHB+5DS MN:37>K37U#Y>PX2_+2.6!4RQ"'(:E^3IEX?E?+->NP[$\^YS@*90QWM]P@RX MC]:6WH#FD0=E'I;TZTD8PFA/,')O0B@06`%--A-O.3RGEWX*H$[.DI+7A@<] MM0T'"=S*GN+%0S;I`TK(]TN($L>VK:7!&[;6B[%0Q>OSJ=Q"U*2&BV7D_M M(*X$;ELY#"4>=ZS*_A*$B2KCB$$4DST'`=77=:++Y-T1LL!OQ5`MQQ#+=USH M'*!B=84TO2F_T28*N52?3,1YVQ-%BX_`MAL*N=Q>R#X,(:`9'!G0Z3UO8[63 M0&2R+5T9Y6'?/3*!#$@AFXVD%24F`%9O\@>?`7+\2]'R1/?V=$/M/!>9;+?F M<T0W#@VU$Z:8\,LVLEA`F+00H*7.`2K7J>GS5(PQH^W2OO!EK8F2CJ-[AH;: MF5!,^-M:WUG`E$IAG7!O861%SC.*;<>'#B*R^47)79HZB6PH_%0:$W;IT5(6 M%&;\>]VPY96_6CE1$G!%]B?.<(+(PH1[CY6D+Z-I75WFM8D<4)J)<4.N&=\5 MX6D#OSEGT)1,76WG3A[3L@T/:(D3N;;(1UI MM9T<"=S*7A?%0]ZIXI-87;Q9K5V?[.+?61&>=JZL$#YX<'=QO,%SOJV<7#/U MX8=::E8RX,6#T.O1[)^AVCOOHEAL*UH@"*]Y#2/+<4-\B4\4'S2+?`!3&L!& MM?&=%)@29X3AX<5U7@E[R=OU).DU[_+$HG3?#(5F*L"$J%KJ<\B0;M5IMZJ] M'=Z$K9,X1&S8S%T)D!01)ZZLZ>DMRBO/-%W4>S2U;?0=^O>,;)U^.J[$:$[2 M"X3LQ*A!?^VD&<;U0`!M_]5S_@D7Y^`%3>G8`41O7D/X[]9Y@&`6.'<$%6E#>;OW@(;E_:&)'SCNYL0@_ M?C"4YVS4`]5,!85U!%.,KF9K?6.$_J,2I78\H`7N3QJU$\*"F5`!?TWH_`TX M'MB1`I@66"(%3ZF!'3D^59^A.G2JP98BO7@8/^$J2XNS[3734!;\3,J71PA- MU5J?CHO:;GY#SDZJ-)7PS%T)+/FPUHT1,S\,#\(&L]W5*SU=WJ/:Q>TVE'L. M?MCDOX2@09Y](<.A]J5Z@C@\K3ZPPC1Q27!0M,&=7H?-;J^ME?4*P\E7"XWV MXK/E;B!R.L9]O25-R0,@4F,8&:RA.KF4\<@-1G3DU+Y*2#"G"JD2`]QCE=J> M@[@2B&N=`U*/3[DH#P%L+=I=ODH5&.^!@;U69* M4QMYHCB,!$AV0CRSJ7W[0#V&9*M!+53F7BT05SL'<<6_`%3U?.^U!+DBSY8R MK*+(9S;W><9B2,="[=S>>@RULF%?"YJ9BO@22A9KQM"QBG*=#3'S=':\I*J= MY5"/H;;"RK70Q;+]EQ#+]CD.'Z.6<+38"H&U]UK'.8D?X?CQ&M'>@J]O/EBB MJB&]$-]?K2UOBVJ03Y&#GV*P]E:+-07$&5=FW81FLW]4V"[/V#L,&[!:'.I3 M>T^`(5:AY,)E5'MC,&!4D-V.V5'?QR(AC\GSP'G:00[I:PPC-O.\0/$/[S?-=_]6!(O>.!R,(Z;_;6_3E+A&HF_<<8(&$\U%O)O&-.4DT M@),07GB']`B"XH?DFS$F>VYOA,XDM4%<'23UD6*`A`+]L`681LO*PFC^?P_: MDG4'ZHP;/?B@^*'99HRUY1XT0EE7;3@-_KK"QF9&?0]JDS&SZ@P;M6P53_9H MQE@K9E@CB+'*+&.5"1*5<3R@&<90YLJ"^-J3*XXM`C[J+6A(&2?_U]Z[]S:. M)/FB7R6QV$57`VY?47Q)YP\"+MO5[;NNLH_M[KF#PL&`EM(VS\BDFZ2JRO/I M;SY(BA)?^213/7LOSDZUE8]?)",R(R,B([@D9#<0^4K4INV;[9V6(\P(-:P+ M'<]Y@L8865A4JF$32XN@&G;PW:@IW#?;TR9'F%%J6!=*4;'1H8:U,)M"-6QB ML1%3PPX^&S6R^V;';\@19HX:U@6Q7PUS!$^6CDB1-0V?#S=[,2.8JQ8 MD,+79`X\!5BC.2#OJ\"=WQ)GTJ:Y8G:/9,C[IK8(PZXZ1+VCR8D2-])NV1D8 MBD1U%M=,L_WELJ3IOL)(X@MVK6D>]B*7T>XYEAYF9ZVZ90"WLQP5#&MNTS?( MOMDN<%G2ICL.N'#6#H"WA@!L8UCC?\[=?O]IQP.BIZQK:3D:`\D[9I54K9AI MZEZ!KU".`$UWQH)%3KA^$+=CJ01>)H+X\+8)5\2<]3/2 MOS:09'K`7`9@AM;\.Z\"AM2Y#$V/ZULE*<)55K&N&4@Y+MQ#X\FJ6-QH2UD9 M[$I2*5,CXL+LZ!->4G2?,IQX@JH]J#J`JG:ZH'66F3%8+;*&\''S.LVVVC3\ M;6&VNYN7E+&NRYRXV!A:^&:,C@R8?L-OCYWE&'?B8CY5E^%N^#N.;K2U9D7J MKH79OK0AZ/JWWM[Y@\LLCUZQ$@-J-]?K*'R,-F@9E7&D%AU]/(YL*-8M;5W7 MLUVJDM$X_(79L1&L)(SBSV4$$YRM5ND6,>MFQZRK),MY,Q8)^3@9]5O#/;7- MS97;[T>M70NSW;(R9&G?E,6Q-=)+[+)+[#RO17^1/!-B3,46Y6.Z:#1W><[O MY/O4([(PVP&7S!E2_;>(I]X! M^AM$H#@KP/'D`M*C_1B4[(A52WSZY")?O+Z16*O+_I`A1',;/'I2 M=-$^0AFZ.'ACQ/-@"M9G/`WV^OI+RYU3LQD-IC*\(K0H21.>!8/@@E(*,M)2 M7?9[MNO!F,GO&RS:GF;=]^AS5\.KX`Z#'X7M!F'4:RSLDM%S\EG^`M-=+9]3 MR_87;<\9U6RJ![-),N0@](H;&RTMG]IL#:^(VP]08D@5_R9(M;2W/+H(%EF;;H`>QZ]X0AP`$10.2NO5=,%BU M/LE#&L99N,*KGGU\K_]"LO*CK]R6`4H]E_;C4,>]O/2V(`=2H=`S8C[%8Q#]*%^C[,WN(J>(K@N-SQ\-.@2ANGTO7SVQ;*",%[(PH M%RG,!J>/(3G#@O^`*\0C?T090GL5KW:?W'?93?&M@\@Q(RNNDA/;VY-EL^FR MF6T)9<(_BEF*!4GPQQ]7@EO@V6J%GQUEM^$[?OWW*TQ>5SA'.-?^US:('+^Q MPAHN?MPZDKWT%@ZQ+3N&.^OE"!MKGY1"&91MP!MM=`)^O;SY?,ZY=1[,=$YJ M(N>G2&=UM-UVVN=4ROJ==#!5INL8C'P`\O30,=Q3KX`ZW5JK/,06"7B&,4S# M#:<(9!G,L[/'+$_#57[JS?79J/:GDN3X?MALC+X_!E[?N4W7UVR-5X*J:1F[ M#UI`?Q7AWE)"O)G.?;L^E0KF[43-P;SUO<$NEM)L+5F<*`-8MQU9P;DGH/A9 M!0LOCY*%E[(L[-`U-3OR0)PHCML?CM$6N_T)PRL"PU?T1Q`*[,K/Y)1_0M6Y]J5[)_YB6?X:91E^VAW&:Y!L\RP/:;AV?V#-G>(@+N"I&L,@(<_`A@Q!\27((K/G/?/)X@;-=IG!= MY,4\]9=S?2'(!Y/)2>,@S'%I0_@^)WWA1\ MJ!-^"_LIBJ/L!:Y_39(U3BRWL/3EDVF?5(Z]F0EA8O..T8B:/*-+;W9$G@+J M)F5Z)HA!U>H$EY\F[<`S;LB;O88FO2$I%>>6SDRKNYGDV+T?,A./UX<@IWMA MQS`[)$^4I$FYN1M74/M)`=-JL1;I95H^4U%C)0NCQ1$Z8AE(FMY,U`VN,!*I MX%]TCR8WC9=D@SYAAN_3^3OF$-L=8R=NG5X9I[,2Q\O^[>/B;^23;^0:'C:H ME$Y3=G<6L/4MG]Q7:2M=TJ/[2)A4>H0/CYX/Y=(/=<2>7UXZC3IF6!`'#S;ZXO+N_B=P_,Z+<]8I^U*+U&GUT=H!MGV#VVPA8]?P)715XU M\.$"/D6K*.>TLM9&+SV4:,N?CR)P2KSB3`3P2E'=6>L5G^*('>3#E)DB&>WP MZC(@&/+1QR:Z]3;M?"ZLF^TMMT67^XA]V\.4&:5_M6,\"`G9B-[ZL=?M,)[5 MLAU;GQ.M948YGF[<92)MT>Q_&%Y`FX+:,JA;:X6_3 MPCU'5*ORZ=-,8[&&MAGE&)Z-!B:&;QT*+[M5+/L1^Y!9:)N4Y1D`!E4;0!H) M/@SKY1@M6;-&YOK&FT6QA9\7RN01^Y)9:./0;\3?.LJB#-S_`CONSR2X_P[F M813#]668QE'\G)VM5MO7+Q&M<9V"-B[EDR29:DXO&QQ!-OX+@_@5"G$BK[,XM;9U^ M<-?2:+O5%>G!0P^C//4&"M`TTZYUQ-YI=@HGEAU&F,%^A$9416@4=_.?_Y?2 MC$E:C+P39$QJ&'J[VCN>[_LXM9J]+'8ILUW67'2,8L#E0=1(>J0R<1U;_MBQ M\]8U-NCN[&B%T)OM/6:!KWMK9<"PX[2B$2"M5/(;6V+.L?EM:.9CX\F%$%.PX1L<^5 MAZW)DMIT20O;I]E.2AXR1N11)D!!T0K0/IR7=[Z\95J8V+CL;`TN9^N.(W]M MEWX=^L1S;K9G4H:L4:1``J!@@C5:M!$_@-J53L8/WOWV(L;JTPDO=;$!+>D596ZV;Y&?F'$8FQ=64.M!=.55O8^B1(+:F'N$1(*M;+S7 M$J^K2[>))0WCF9OMVF.D8#2&'<8BE0MP/C]Q//O$M>?#B?P^HU5\*;/X.30/ MX/)DZ_+Q7)WU>WO6S"Z#6[1:A>P@R>/:>0!J<4)AEG:"P1OV,.I*\\&46H8QPY@>$`URT> M78.0W**%_FFV^U"8INE8GPU@1TS@Q19^MU1+_0;1BMK^+S\"W*P\VI MN[#TY='HF%32.,E*22N_#T"C83+%ZIOMP90A2[&/%:0QXM756<0- M=>K-7'WAJ70.%9ZF)LY^3J:=R&.L!5T^L_V>'%1,LS.W02G*5X&OZ$H:;C M;FF9Z)0B,-/Q%F.EE%80T,M&0B]OMPU!5IO&I=I'Z-AD(&D2SA[&U8A9$7!@ MHB'>PFA]2=^&HGOW#7X8NF=413SB^_JL^`P(I-E>@,0A,1@$[0N\N#VT3R0DSP*!L2P0#E@U/0`PYDTG?P15$ MEVJD;&5HFEV:`I>FCM"4AKUE3CDA8"6CE_O;!R&.2AH+XARA7YB)J$GXG059 M4&M$N!M[UL+-)OE.TAFB__A/:V:=6*Z#7S+=HR4LGC+-Z%.F$R(@AR^.;&IFB:^V0:KS+?E=.EOYJ>7;,WT7V^:$ MLKS+0,```S=&(&]MBC4^0G_N,$43,?(`K*#>XB=`VX"S/$^CQVU.$NCF";@- M^4NI]G&)EF4<'V_5QYMB%[RV7 M-,L;38[Q@[D[Y6#1FITQW9F-*,B?8#DFNV`Y:9E=+YG0:4]1E\/ M3X\O-RS7:9S-&.35>8JH2NV:Y.=B)&85MF.`%] M*B)4YW`P5RC;S7&:/*:-6V%O_LQ"&3/;7X;'QN,X#"(JFJHF`G9;F[3 M,&%C+^Q>.R2T-.+&-=O=R$C!*+L@&Q:V^"7!M]*];]&TG.;C/J<;X&#:FA39 M7>!E=V:%FF^V,Y&=B`GXN`?.X4LYC6_D=/&N06_DVGA[N#>^TE(M:T%?,+IF M^Q3%B1J+]\7@Z7K^=@?S,(KA^C),XRA^SLY6J^WK=A/F<'U!G?.GEC=S%]J$ M9!B`G(P($5B*"$MG7.:GN#T7ZJ#9GD9AFD81$%%T0:VA6%C)/41RA#[4!7Q+ M,L(5WE(?VQ_,)ADL-0B]9.A&2W?F>D6]S&(MS?8,LA$P"JLR00G*5H@I23/. M_;G'R^Y:2WUZMZX8$!YZ*J;MCS2@I8D]GZZY9[93CYN6<5B9$U5PWQ;&Q^G6 M^%N8IB%-&WD7/;_DV'`#6CL#D_KJ#H(FHP86,'+0\/IN;QADFZO]MR43B?/+.]TAQ4Z#9-LT,I MV9C>&FEC4&NM-#^$IFOBV/DA]O;H7AC_V#QN3FUO-K?FI^[<]QQZ.5E0FZQG MKJM/DBKM>[86L[5E??;S/T'!W3ZP(1:R#RS?9FJ2=5] MLBC&>U#UNJK:!3Y$,5@GFTV89N`-R1EY'?2SL)21N;,K4M4:\YV^]'<=DRJ3 MIGY*>"5H;S3R:6A4OF>V\U4%>:9(2@_&`^G8K\V.)83^A5,L]KULG8)J.9ZG M+UD1&PB5#ET.0IFDB'%T_$47-%>A9[8S6`.UD\J8$.1#S[+J,VD?U)[L(SY< MZLOXTCVQ2B$;($A`L!K;8ZG&F^UM5D2A00+4`[,I-(J.JK/R3O8I22^2[6/^ MM-T0OWCM`E=>S]VE;6LS,G``D1,G*8I+\>(9Q'+<&7ZZ//,\PS,?2%`UB@U9 M'%]0=05/28K.&-H9A*M5LHUY'8,B+*2GGJ?)0L-8_)-C9**[%X95LP,]5).J M^Y12C/=`W,K.@/0&>[9!H6>WC6+']H8^BP7J, M72.1KU1XDLV.-9$E;1*!8O,>-DWLV+AZ*6)3SKJ M0Q&=FX9`^V:'LDC39H9\=`-L%Y!DUUZ5=:XAJ);CSW36G>B;7+VAH)<:(33?&3KE1[E-DV_1&JX_OO^>P?55?/,&TQ`7Z#Y;Y=$WFO:KBM75F#%7!V!) MR\,82\AD-=>"!''CTB6[N'?,]O8QUF922_T(!`:U.7#NX;2\&&# M9OH9_XS_N$(38N98HY]!4LX$PFHJSK!P3,!9O,;_@T/1OX4;#.8L/P_3]!V- M3!^,>@N'&/BLF99K)`L&R?ND()ELL1],@Y.*`![]]&:;,M43RR[(B*.C!!WD M89J+>0R4@P]P:QRS^`B?HQ@_D\/!C!2G5EFS_CUDS=(E:S[]@F9;/=43RRMK ME_%Z6DFKH%>2!O%C:Y4R=DM&0@=W"L,,7D#ZOX@';8W&40XD.@2.E68)L>N8 M`BLY2ZKD&&Y4U4;SM(&0XL`+$43R1_Y1ZWX"Z`"@'`%\*,?@]5>(L*N6,AJ& MBVBC\H;BK^[0KVZV+5<;S1SQ*^+5.W2A#[[0"V(AB>M2$O&M$%\1>6M\[$]V M%5\4)K([^`W&.&>393OZ7"2#\\L)GPAY3"(W/##^:C1(PO./^-$,-Z&3GG^\ M:(.6(PT+4MD+%-UDA:HL6A)!7';&]OP1!:HVMVIAZB=+4)#J@Y*O5:@H1_R& MAHM(PP2H&VF7\-1Z:)&;71;GOY;@[.A2)3F%TF!V(+(Z(ADD9TDE)X;/^.F* M!LV.![!H+:OF')7CX3Q\BY#*6GD=YK[&QYGL.%3+#SN]@J+4.0'^@EZA/QRQ M#T^<8L..)T;8P?D+F@R_H8F+](W$U+$1KA5Q%><049/?AM$:,1Q.[*]/S'93 MR0I2+VA&6:F-0:ZF=)$71VQ,Z*-I8G[O!$;M=215*0Z[CXJ6G%4C8-[FQ_X4 MQ6&\VO-CGRO$)'&J)D?LLRC8Q^QP MM`E68U(IUT(2W1^>-LGW#&!&!D_E<.(A(QU`L1J;Y1Q`W?ER[.V"$Z.6[4)Z MG62V"^[)\55E2;G)W,Q:$ZV&B=N%'$F-[2(JAQ/?+N[@6_A.0MQNG@XJ82UL M?3'D7=/*R30',4QBVCD>V<:+[W+$C@-6^B85)4:0P:X=CDZAQ:]N18I?#7.1 M'NOF5#+!:=/L_1ZTUJ.W.&)'`"M])E@R&;'N9`.+1HRK&6++RO5DQ%F0I@$I&,T$ESNTD]RQ-9^ M-NHF/3&8(-*T[;\\XF9@56L'?L'_6;UUY2U1@"0=2]+-$U;6/F%=K9;47V-Z MN;Z9):6#BR8V$>D;DGPGBWZG(S;?\]`XK;BP`PW0;66-2RZM`?I7EFRB-2DR M4PU!="]R32'#@*_E0/_'G(=Z>M)E_5L]U&OFW](Q&2ZWX9$J!(Y%P]`79C_- M&7$5..(C)?)[C49/_UL[_,9.UQ.[L]D5-W"S'[GQ$:); M5>5"$]1;8]63<'W9`7PHNG`^@;F`;^C\B?-LF" M0([QQ6@L>9^IM^7._04I1.+8](LMS8X_D:!J%'5,'%]0[TIL?^('PJ]A%&/- M[P9A2*-O:(1O\"I&RMV6:&](.T12EX<_3JV9ZQ/V<;7(""L..3F1H;:4%N8Q MG)F'R]:;+"/Z$V%GQ$(6[Q/'U!OX/SR\L$+WEU6>CON[`,+\7"2H)N38D1 M1T#:@0^TY<^8Q_<;EWJ3-A[7M_^;P>3M.WY_Y[EM68Y_ZEB699MMU.*F9>P= MGP=<@-MB$=CY/-MA=F3.*H4`Q!I%G6D:)#C.N*(^59\-\66Y&L2OGC3GE#;/- M-1JIYC;LB-ET]%$0E,+;PGBU/P MZH.13!`T&FQI=K2$/'&&G(G="+N.OEH/+?(QUF$VMH`('TV-3T3L!?[,[/`Z M>>+,.FBZ@0;"$M'Q/K@E;G8H686^%R5J,,I)F*YUZA5$59-B:_F<\HK9@4\C MKL(DAY\64AJO\14$H^^%UI]:]MQS=8KW;BYI*>V%/21MMZ,LPVC>U MM`3P$#4D!=UC$=M1H1X<87`'#VU320,KP.!CN`9K_%:P\`3Q9GE)5O^\(=\( M'S^%Z^G4\N>>/@EHGU2.]YD)Z>7ZCE'PDCO%7?,(`R#8J)J$TYF@!:05H$N[ MG^%(C.FW;V\T8C[E:"23G99E'C,KA+Q9'&WG94*1Y+(J0HQ,LA9HR_^<`[]<-2'9AD> MQB!(TD32PP0NJ(HFIFJ*)@X6>1I)$(PI:L4@&9UCX$_F>_23.?23&1XW($O; M1++"AW*DNE2:)$5O7:H6=J\U6!A5$DRR0![I+RC=EA!&H)Y3A` M$Z2;B1V@2B$3F29YA]]J,MU6JVW,4FVG-.VKF37:M(BL^,(,B"SSP//YLMCI MS0YE4$KG1,>O$-BAX[<:=*3CEYMEQSQ^CTJ668]?UH')'9]&B5EF1V.H)73* MXU<,\N[X+=/^M]4]'//]%>;*N67HPZLI'URU+,R`N#(//)_;A47.[%@2I71. M=/0*@1TZ>JM!1SIZN5EVS*/WJ&29]>AE'9CP(%[6$3GGTBD%N'KUM MCQR5O''4XO[0_\:QX0`Y;.?8%O'"VBZ-Q[;,#B1A@3^*"X0!".%._&R1DP'1 M.N%@+V*_@67PI+.TK#:5;I7G*\Q>SLPNF`O_I7T020YCQ%5Q6FM[>[FP9O10 MGIL=8,&$7[L&Q``B*!H5QGM8YOY2RG;6W%"^LQH/Z'K6S*-K9K:7EPD_.^.M MDQ5)S]J295N.`2LP%0/NHMFR+,&9E]&A_#W*7]`930(9:D;I/`WC#)_1^%17 MRJF^H8S:/(J[EY:>(7.SPVN8\(]S&#,@J9CTJ=@E5R]A^LRK'=:?M%UEV1:/ M=)/>AQMX\X2?>.;OIY:S],9Y9MD.0(Z)A0@L.9JELSMSS+:0L!.A^_!G1G+P M@K)LBU89X-;X93%MKX_9M=R/3&+VQO;-T-FQ%S/RSM5S7;.577YB1MG8N6$= M2`*ZH+WB:BKDJ5FM@(K$KM_^"ET[^X_YI+Z7U?>ZS"U[X17/'>CKU;G9@5^< ME(S.Y,.81GXMKXNQ)WTMW\;@/=UPU'7Q&8H[C]D!40+4C,7HG+AD'\(C%1]^ M##.X/J^]+SZUO.5LIHVYVR>58VMF0DJ&;N_@XU6VG.+9#36CS\W6QOD(&86- MN2`%I/4OC[CY_BOW7_:T$[49'O0P]@09'O88NS.O`%IP&@UIFZMELX'7SL!, M,%3G9C@GC$X&_0Q?'V%Z:F&=79>-I#&='(\RH"^W7>OS['KA6@O7O5Y:SM65 M]]O,_4Y"5'F&Y#B12Z@#8`E.>_TC;_AU>7+AZNUJ=Q9DO" M)0L]*G1S1EG5F84&)DYO'0JM^H)&S7F&QTA)T\;.[]]@^IB(*B*R.(.JC13S MW\$\C&*XO@S3.(J?LY)U/(T59=OGE!,`5CJ81*!C,++UT$H6AL<6*:!NTFV? M"6)0M@)E,T$9N,_#'-*RSD247I(-^K(9M5'N,C)9GKYJE4P09+5U(2J9!(9M M;/+Y;/KYS(Y44D_LI.(D@AAI5O$:WQ;6.(XV2S;1FH0$5&-AQU0M>P&Y*A<# M_P0NX%.TBG+PM1R=6R0/85[%J\UVC:3\%A>-3N*S/$^CQVV.;:>0"ZQD>5S;!:DR\-B&!FJG5_QY(1>N1]H-T'Z`=CRA!H+L!*#.M`5G'-_9 M>AW13XPSTUW%17[%TM"[T/?2KW=F.2GC(ZH4K?Y>EFTO44?RGHTZRN9F9Y01 M(6>48!$!8$'1!IO$X(\5S&AIJ#`%W\+-%@I:J,_6_W>;Y661JG94I#3]J8LD M6MNYPPQ#5BB$J=U)".L0IL=0<5*B^]#@@Q/4FI-2A54'FEX4"4G1YP207KK% M0M/Y8*A8M!PW:\@BYU,R6C1330O%94,7G^+<(#2MBS`:CGC;5 M0::C2O&_P4XDI(5+S>Q;A5/1['"L4=?!A!N`*F)X[@_UMQKU64]`-2\H M)BYL4J`VM?KMZF_%:]6S&"U"_`VF>?2X@1?P,?];E+_0/Y'W5##,MRF2(O1= M.)($:8"@?YN17Q.>K85W-@<_V33;S*R3;!,V#D'L>_O$0W.?N*KM$^44`,T! M:I,`/`O`TX#=/*"8R*#M@2U%SK_7]B!T!Q+BM>,W%HJ2;YVME=<9<;O]>\M_,(Z>-D3;/8- M0"YKG48:@K-7G+``N^2BHG(?^+`N:O?]3(KP[32'M^*&4>:_^W!V>W7^,T`4 M;#Q)C/'M'YPMEKH_4.12&22 MHL*SS8X&E2=.MT(OC3`XT--_V=WG!1WE-#H,7_^3&&T@%\EK&,6GUH*FCM$B M%:U3RDD#(Q6]8M`^!EE_:L6US4[V)$[4)&S/@BR@C4#5"GRE[7@?1Y%(JIMM MGN7HT$$GT:GEHQGTA1L>SB<96<@`OY>UFP.0,+0Y76>S#3AB!$W"TD.H@C*B MK]9$&2-K>E4S&BCZFAV(*D80+T<+OY$0@B?)S^5K[P/])CO[$64X6%`V-"_,_`5-Q/)3=!\&D&?J2]CWQ(3_$W/@-9G+2$ MD4Z0C:KAKNS,=^3;+EUXQ^R\&&P$C.)"9((2G*U6V]?MAJ2T69?):@2S1_6\ ME.O*_>O//7WEU040:3DJ.)>@2G\L,MK"\^D5SC7;JB]/G.Z#0AHATRO0[F@] M7'@O>0*?DO0)1M@_QGUED6!&?;F7CT8>F^G(!49S'6_A^V33]>GS8-=L=X,Z M(D*2RT$N!#&[3Z%N8XQ*53Y`<:^BDZJS:IUZ1;+%"CRE'$QK;>:6H8="=X M^8QF>Z6DZ#)#AGHQ\HD09UT3=*HF<8P8C@1)%U'+1=&@#->VGB_8WQOVCR;' M_=Q(>W/,,<`E+HT9<0RZOMF&"54DZKXF*<(95*W+@/HRVKZL3Z]'"!B?U9@@ M!AJ2#\S%)Z21# MH,K;4K0Z78KR4VOF^_J> MH-1FDA.'?LA,,E`?`M?D6\[IHIM]DQ8E:5)>[\85D)\`_4T!URZ/CVN74@"S>\%]PKLK]78=!5 M-;>YY^CSIG=,*L?DS)0P\7O7:/A;+!;T6Y@=6ZR"O$EW;S:,@X4&20;U&Z2C MD)MX)EQ3D,)Y"'\4=^V/)"D#VE`MR]:7&[)C5A6BPD(*AZPTAR/7+FJ:6Y@= M?ZR"/`-D90AC@`Z4;Q%)'O*!YA3)?P9/25IJ^7GX@__\H-5QBGD1\WBN3FG8 MFTU6"H:@,W+__C#$`D>-#8LC+@@U0-;$W-Z'+2A_%LLE7!P5-9NJ9;N^OG#[ MQGQR7,T"GXFOFP.1S82:"!9FA\G+$38I;P^A"ZH&X%+(I=7#(%INL>/Q-]^- MMF.A+;K01^C5929L^MOM$,3@`4^LBL%W-P=O,1]O'U=SK>6@1HSM]PJXSZB% M;'&$WEQN`LW:YCM0!H(R@&O"T$L!VA^7MCY;3FTF24;OA5#4C_0KC)%"@X/2SM:O M41QA92:/OL'*N#;#;]ITO0H;F%W2>\I-6BD-0SU=Q_/1AF,O?:>\X)OM3Q4C MB..^*?Z22PA:4/0BX9#A7C_!@&&B_!1B5JGT./;6XP@3;AM$@7+-`*LU^U(G M)KI_T&C3A=G>4#&"V#E7+MQ7"%VA:!>-^-CT/,GRFR=R#MPGF_6I;VM\/'\P MF1PG#R+O32!VV)NL*#4[+B=3#BD%0_)*CME07F@8E%BB8D M6)IM2E%*)X/T+*GTQ/`9QYR(*2XJ,0>_QRD,-]&_T*WU&0V!*Q&MJP%`M!M! MDW:O)WK7".V>[8`9&HY\+VIC6)H=':""O$D.(#Z,ZJ\`U"J*I?<3XK+S),ZC M>!O%S[L8M(_P*4EA%;,#L\L?:$K$"U$/0%5\6SFVOR M[(8$>>_FJT>S/I(90=&>S'D"]F8%9-H3L#\Q*&K,'(V1Q2U3*G`C#!/1 MR[^M8Y`[&77+'*.)B86F2516!F#[;@22,E0E9^N)*1Z9L]EVYN[%+LS?9D?Q M"-,TW3[-@*X()4X(DZ+8/4E#\*FAB_QN,GE]RN#[[ABZFS_#+%A?>N7DJDM:T5*%YRNSTO1@&A'0<$).!ZAED MR5`@V8U%TC[1/W/F>NH`W4!+$[8AIK7UZ59<6+1(*S/9(K+:,3BQ8M!B\K,C M#'62(M8D.65"7.0H'%=&!].":(G=GB;#22-6N[.'[=BS!8T;IK7K9X;';7`1 MPG%W%X_-YH(T9I(230P]1I*2%@8^:.G._>6<+&X1(#8S/*:`B8"1&)8!BFR> MD;;WKEH84N\3W08CUEJABX?C>JY%5XY6TIZ9[?UE0#\*"P[CD'AHV_\^LS67RU\NBN4R MVW7)`G^\O:T?B,SCIJ[7^'KJOX^01J!9\/V@H>W,2_6$UE&>F>UJ9,(_"BNR M()'/!-#AJ=!3(7,$%TNSLN5APX6S\.DRTAJ),[,]@DSX1V%(%B13>4^T\.MQ M>$\:',\]DCM?S.C.8A4?TFP_HQH"1Y$9)5"E'"/_:Q1OR)CR9Y`WA%7VVL?Q M\:$^L^CMV2H43+-=E4KHFU+RN)!*^#K4)#W0(E:C)#W8DXR.F?^Q>=Q0_8'X M@#W+7.MQXZ9C-,9E M151LOQM25*:LY*6VW-TH_#M*N3LF'BXZ[=;:I6MMKOM-@)+)^+@;4Z7!R_!R M?\)#/1:;D;,VMC)Q6Y?=84>]\Y:YKCM>,D9C7T9`,KD7SUYAO,9973YM0G2Y M=8;"MS.X.GU.OOT_:QA1)D7_..1-]*?]<>48LA]B;_;0!A+BH*+JEW.,9:<' M"=+M]1-"%50_`OPK'X=>%-GQ/D79*MR@G3Q*UI_0W[+3^6RHZBY M[-`'N;A[*++42[K49OL0Y8F;C+M9$09E0T!;`MH4D+9B?/^`P)_.K:&GOKRL MCH=5P]VM`)D9FO1&B^@OBT4TV_LH1,_D;-L":L>I^$?..UN<1]CO^4S27<7Y MEQ`'=2U<12S:-KSDU8P%\"#+MHY"5M6GJVJV95B*KLE8F`%<0-N`72.`6XEM MMV?QF@YW%3\EZ2M)75(+[YDMV]Z6=`0=L8RI9@_F1-V=JIEI0++\Q/GE&%ZF M4`V!NIE?"LF''YWODW32O7Y.PS3RWA]$>8XLEG5CM\UA:3G M@Q5XJSCTX:):WYPNO;FF.2F:1F5Z#F!!T:[4L'%+Q.YK@-O*7"WQ0.7M3!5C M=\R@\EK9#;N3K;L&P`M-"QPXAA?EY;WPUW-P/>9"7][N3+:-87K/-?&($3<;'?:AV7%Q8/<1V9:JZG*-QTG!S M%:_AC_^&[^BVILK8USJ^BOOE$.1.'F[O3M2[!5UM]89%,I/HC9QD`%U$TE M!.P0*XF@@72DSPF@O<"-:#P='?13M('I.3HAGI,4[Y=#U0WY)&)O=!4BT`]W M@.?W.Y,U+N[N9C]O$"%G(J[NPU2R,6D#RD9\3/LIC-(_PLT67B`M?9-D6P3U M`?[(/Z(?_WF*??+:\L[T3BW'VYQ4,97K[!_37OHSGVPPOF/V#J^.R$D,Z")( M@T]G5W?@C[/KWR_!Y\NS^]_O+C^C___+P[T.8=$2%#6YL#1>'?1V(['MCDU? M:OE+^B',/A2$Z&$7`8E7!2+(6EE>"<-7MOKYS-57NKEO9O7LWDU3;\:QWJ'( M%N33[V'VTS9IVD;5C00`=@F#L/^HFOLLRV">G<7KZRA\C#81?@S]&888S/HF MOH.K;9JBBP1J\"6)T_(_<8AY=AW%D%2(P$RG+[N?4JB*)$_/JO%I<4HP(#:S MYN3IP,+P/#[3+8H96J(&R@(\.""CGP`Z/O%3UV8`Y12X\F0U"6E5GP:0>0VC&`>`CV`L M8H&B:'L0HYIO"V":@YP[%OW^9KO-]!%MAB@+(*^+:]42?*5M.05R5_VZFOSF M:??'R96="RQ4-0P MTK9TLES?P\]\%K[GVR3?H%/<;8[$4,M+T[C&6DYT`6D)YN`K;2RJJM6FM2ON MF(_+[[8N?N^DJ(_?[=KJX_A$O/HN77V7KK[9CUR$:9J,WUG0%?QN:^1WO1>1 M*?B]H>+T=?*6MD-7VVSW`S,-NA495B![AC_:]@0H8N>/[\UK!1GZ[$>487O3 M0C]G]V)0Q.2<=+*YX?H')=Q8T ML,<]0E>(2MK916]=/&(CC^;5>$84$A+L`KA`^)AL\THZ<01%6`P,\J3X>_X. MWHJQ05@.?JI,D*,6Z/5B.+,Y>[8,P6FTR3$G;:48BXZ(E1J[^,YF>U844:A; MK50#,ZA'*)7C@(=DYVL!Y5"@&DLX5E*:'>7/3(-EK7EF2GSCI5M\8[,=.(HH M'.O\4P-75NC4'7!LRIST`6>PHLISP`TK,A[]Q&8;V151..$!QP%S0-8Z1`V/ M!LAPZDXX-GYDJ_=XG++6<-%*?&)G,:>?V&R'K2(*1W'?JL$:7%^=?;RZOGJX MNKP'9_?W5[]^N;P`#S>@_/O?P>WO=^>_G=U?@K-?[R[)\QMA(6O`*FRHF.<\ M,8VQ8TAELL,!FP]K<' M],\,W9C0]\B$O,>U1#)7\6JSQ9E@SM;KB'[AVS!:7\7GX5N4AYLRSFFVT!>6 MP0U'3JP44%^*'/]0\P6U4BTLLVW[DI3I%C8Y>$$]+1*H!@"[$0`>`D0Q*`81 M=$F+LYJF$H5'(FB-*Q7_4&AO7X!_ M)3I6[?<30%IPLF84A_$J"C9!R!>.EH@+QEM@='D"+MW"P$*ZBZ@5H_;"XN>X*JJV:V M9S,$F\GVS;W>JP38Q51,!=ZTFJY]"Z@1#X*[K"=J6'C6JS,V^]JLB<<*`'!Z<@M%O MUZ()\>294D_4J3$R)QUW>O"EBQW5W#=/*DD<2UU5A%=>^,2#3P<#7[B/MLE# M=?J.J]Z@#^K+GIL=C\-/S(A'$!NB/7YOXVPA]\IM^$ZTQ'8[@+?D4-1ZAI)C M8SZ,)?_V]K(LRS&;8UG@Z^91!@Q!V4:%99GI0[-9DZ=EQH;5>'`ES8X,88$_ MBCV8`4C)D=A<)6CE9?K&C*KTM(S85(@'5]#LF$`6^&,IL@Q8=MOC:[B&[1X( ML-Z29,;89OI&ZG%R*J;WJQ>XWF[@S1.G:DWS,",5T&DKH]S!T'*SR?&\0)BET>1=..J>);QO/DKB&?SU%+! M"#0T8FZVIJ66T+%.0J6HE5S#7?2YZ`C$PZLNRQZJ%'*7PMFJ?$]W9G]'N;'?:LB,+1=$TE<(,O6^PM MP4\OJ12U"V'MT;*"_&R##T#TU#*8Y"U+:_+1CEYE=DL'5U*QK*5GKL`(4*+] M6.+'%-S#]%N$^/L)0I#BM_KH6L7'RY=ABI_U9TCZB.C5:FO/?'VYJ#NGE6-G M#FJ8GMYWCT=J^))MR+?--A6J(5#W]4<)RN#+Y0.X^G)^\_D2?+B^N;__&=Q> MW@'TWY]OOH#[W\[N+E5+AY:M?C+I:%Q:.KO0RNYSAU9VM^@7,-L0P$W+*!<1 M7E3:>;Q*$6CYGK[*WUVSJN7P;EIZ(^L[A\';#0U=\VVS[^)2=.G>[&7`,?"_ M<#;8JWA%RV>&F^+-/+E3G.5Y&CUN9:F M]\B5G8YPBT.YY8C>I6HB?Y(#7"T-;0)_#U/L0#Y'DH]'R2,T)/K`Q2C%1H#? MR=5_7\-'3K_6WV#T_)+#]1D:(WR&U,1X\T0`P<)">;/-LQQ-A3264VLQ*^6\PV-C+RD\Y>T/^+(7Y"C@YL"#YLDBS[&8=(4I/]":ZBLGW%CNHU$?DD5B*N#8P? MPRQ:88ZUK;&%M1V+%E%E)EM$4#L&QQ_?6M*/;_;+5O7$&BBD3,`;(OJ(&_4+ MZO=B/A#2"4N?6[*;:B+]6XL9]J^A?S=LNK(CN[;CSEWJ@S+[2:UB2D>Q!ZO% M+*I%GS14:*)7?R\NYYSI7^(\6AY`6F M)'%GK\DVSD^]F:7/8J`$XJ0WB*Y5*G<>-<-;MC.S9IC3\`Y'.,WL]*I^PWM!S704W)\B_H\IL=Y,)&P"@"P`0EJ!G-)9W(71]94QFN$=BS MI836?D-[;A=J@[D//P9QZ];D^B8/:C^""VZ6NWQ]VR3O$!)#,(VH*HLS+6AV M0"T^S\YI)6-YV:FIHM4[NR`Q=^F=>3$S.Y"`F8:1'(^L>(J7YT4@GV`:P^%O MKB<8?2H.;FRIW5W9ME@!&4S4.=>0>95>_,RT(A7&=]Z$!B(<(7@6KXL@ M8&+#W[TAMCS'TE>V21"5*G>>[%)P.N[XIL,/)UR+!'8:7II\#/(-<<7)T+#G M>`$1W06R\72)]D` MEC2*V_#BZ&H)'<5)H!1R<+Z34BRD7Y!X-B\,?)*)C<(74;9"XKVMIS>P77W. MA?8YY<2*E0ZF<[-C,%),C^:&\8XX>(V-NDE//2:(P9>;A\M[<'OV][./U^(Y M&O;GVHF@[RW:'2]S=8#.2D99>_GP[3/ MS6I9>(1=?"069K.1=(U"]@_J'/7,5G5DR)K$-L&&+<#-P*X=^(I;`M)48-N^ MBM&.3U*&?DKAGUL8K]YOGFC:SVA55%@Y]?WY3*L0L*"0EPHQ6IG5':;AL9'( M+>IFF"T_6NB=7"42`!U4+?&-X:UH"]YH8SZ1^QS^B%ZWKZ6W7F=1];VIY(1G M`#63A!R,L?1M9T97V.S`)'&B)N7U/F1!\:.@3_T.ESHG%F]'9_Q<-8T<[_:@ M9>+;77^\B'91,]3L$$\Q@B;EURY4`?E!S&GRDJ3Y`TQ?\;Y_O7N%:\T>[=!%-SN620%UTWHC6"`&I-4OZ.;\2F).)1[@GF_" M++MY*E+XW:1W.%W(Y0^8KJ(,WJ;1"E8_9L6OV:D_LWU]68T.*[?2\23@N MT6N^;A`9;>XY/OVV9D>9RQ.G^V"31AB0$;!$%[X]H(\3E[.:15:V^S< M4YHHGDX%EL;>+.>VJD1:4"_>?VZY2YQ'3OY;I`;@5'O/\'R39#A39K0^=98S MO\UJTU$AD7\&20%405''$UZ6P=`76WC4>F!XY2MYXK2?EK((&R^&P6Z,0KG= MC0**80`:9SPI8BOR>TQ2-)2G@?DS%ON>V;$Z\L2-,Y,:^0I.Q;YN"49NNMQJASC M6+8_GQLBSA#SE+W0>DPQP5`962!$@J M4D4\;(;.HCQ,<[!&P^B6FQ$"T@V2F]:3AVT(M`,6EVJSH[L$*1KCO.&'1>6B M?JC@GOAN1/J"LC.X%0DEYW[1,,(A8\SKC8$CIF<$:S'WRI`@:M(UO'R:)&43 M'#"\&%4^P-A'D=PRYR M4"\2%!IL20K3V6`G$2OU<7XA]S\1* M!:.?H@Y)V.N$#_SY_-1:NK9#([`=LUVO_,1,H&$QP`J^).@N$A4-I6_K[:PP MANHT+G,/*4=[G6S/I?D`';.#'.`G,6!LSGD\E([?C;V=@TM;V:16/A6.^HZT/^KB;;F/^YEZ+FRCCQ!'T M7ZV<.*#MTN5$+0?S1Y/UIN20$9JHW&/(`"@!_HH7-<] M?\%FY>U)),]*]W=DC(8>BZV:D3>P1NOQ[H['PE%X4\@".XBI^2 M])4F7%[3K(5H_TKA;T!WLB;J"*`?49DL9@ MP':ST?XZ8A,&M=.Y1^#"ZL,^IEFH!T?PD(9Q%J[(#@I_O,$X@YP/;NM37"2O M81230[$ML3'#$4U'4,=CG8C:N*QH3`Z98HF.P+;>"W[,S:X5P:$.2!M):(&' M7U1`#]3-9/VZ8'V9BF/A"+R2O>"GT`=;D>QIA%C!(^_"2MU/0M6[?`N+=*?X M*[AYH)9L$=^,)L M+^S'Y[QVP3>DR'\XQFM!Y!0]BMWNQ-P>7NFA_\$CMQQ&+#_X#U8 MM\*,<`0^DR'\4QR_76"*=]^[A]][1S!(X88$B^8)^?'RSRUV/]^BB5_"#(*S MYQ1"#!!\0-S[L\2!?1/#&G=PI/=I'40=U_;A:F/:77NBZ5`3OGL$OI$A_&,> MV%T@#@YLU$S!AMGRA?D/['$XK_?`/E@TFMG!.QZ'2"?^T0_L+B2'!_9G1.@+ M0(PQU\.&`N?V.'S8?VX?+!]U+WG'XT'IQ#_%N=T%9N_FO/.@X$/ZB3PHW#_' M45OR&UKUYP@MLX(,+"7"!\2<=0YIJP+"P+FU8=3Q;C^V-N:M]\`K;A6#Y:!<4['C]*#P6CG^C=6`[/ M]/]WBY1*14=ZZU<7.-3'8\G^@[VQBO0!B>'%>QDIF.)P[X;3<;R'Z!"/TO7! MX1YNGS&>\OS7<<9_3VJLTA8^P<+&Y2`*F;@'5RL'5^V)-E7L`L?CSNG$/^K) MW@'B\%S_GJC80YM?6.!,'X7S^L_S_44K!/UX'#F=^,<_RSN0')[D9V@]-\J. M\N;G%CG(1^'#@4-\;_DL6@C2.QZ_3B?^20[P#C"=QW<&T8*,^><*XSUY);/G2T5C,IGM>.:[GH:=D_)X^WMPW6V\=Q*[[S!\"$.PWP)&Z M%R12ES92SJU:7H=-R*T-?:&GCV.Y_MP^=2W?]?$NXWF^V98`;EI&T2-X407G M8?92)I)[SO<'\-T89^G609S&[B-CBG%II:'[\/SB_']B+D ME>S/T'#Z^VJP785`I+U: M_I+=KC`XH$(V9L3;RL;M?6>>:YD=Q\).A&XMA!E)0%J"#[3MS^`F!KOFX&97 M0E(;Z[(9)LQAW?X=N&NM/=]L7Q@[$>/ON7UP.C;;HJR:-J9E-&.8P[5-\P;C M%F%V$!8[$6,9.I@1!1?DW2;$MHQ'F'^',*:!"&&4@F_A9DOR')T*@P:ZYW81H@:7B^P#;Z_1*L7$*80P$I7@6OZZ7!$8ID.1\2Q45E5:I5S M#JKF6/BMF][R%DPP%!@+Q:@MY>MJJX?2]J>28>P!U+S\? M]%WZMD/S,_EF!R#S$S,)U_8A"HH?!;V>!LI(LX,=R;QDC+)'MV-)R`_">92 MN%^A.^]V`V^>[E^2E.0_Q#K,`Q$)![^EU\6N?3/+\2\?3;T,W3L4UNCF5*,S MW-DO3=LD+,\!,"C;8@L/:?T+SM-)(@;`5]*#4S"^1#'$FOM[[9)+SHL[^F;U M-DSS]RHVRK+:+#D=QDZ.H>4$08Z&4C!X1L$9_VR:`<$W.^Y5@BK=PB`.+:!= M`>H+:IT!36%;=`>DOZ`^+\12C$X`L^6BZ1C@_D[T6;QO=C2D!%5CN0[$(=;K MT"]G8(WDI%XX?D_-+[,2K%["*'T-X[+2_&,2IFM.IX`0QRW^`E+3N!#S?KME M<24S.Y9=@JJ1+L/B"(-"4)H'BN`14KMUW^(LTTE\EN=I]+@E8S\DUU'X&&W0 MYRT3@51Y0`A?<63OD)A*4E:4TEC)CL2H^)N6^K+9;C*%5&K7U)1!+:H,%&.! M8C!0'PT\)*`:KR5)S@12R*K8';48MBA^DI_=IG[1A=G."X54CJ88*H-<5Q2Q MTO=6"&01E5U3$E]"_-8&-4XIQ6`Q7WO.0 MV'':S6$:P2R\*1[3X1=[L*R4#=4A&[,NJU MQR^73=U6`0]0R\'";*>O4CK'TF]5@BX$%)R)2F@QZB0"RJ:N'K]\-E16:0Y8 M+*DQ?&%V?)%2.D=26U5BWDFGY?X7AX2&RLY0DCU*F'_GK4\;^N548D8EPJJ6 MX@.)E1HY[H')]D2WRF`6 M$=%=EZ+;C.3!HEN^]Q6ZJ#X*LZZWY(A3D)I,A9RJHW-?0H7'M2S+,3OD1PV! MXRB[DBB+H_-Q"@U7FC-YE-MCEL`.E5;FTQM>[UX-@:,JLI)@2QWVXQ3JJS2' M7/9?G&;/GIIN3"1D:Z MH44T_08RB)Z="R5RT`WC&$IT*Y2%CN6+,ZL,3\$ M)?@UQ6D16[+#40;E?>=UGVSSES1:/\,#-:+FV&_+2]7%E_W#23(G-]:*00=Z MDE!JFI]@8?A!SD>)]D.="TZP:]ZX]XG>]%AY@G5C-8*!6[98AH4NOE@G7XVJ+&V(=&_3*66]?&S&@N-(*OFR:_X55':@===<.U"#Y*QC+B M<:&J[\]BV_$#^@)_;B.DOPC'$7H<:>\EIY/C>O6TEE(A.S*)FZ55XA=F/YU5 M3*EN=4\/X)T?LYB?.70^0[1O4YG%],@TJ*GB#N2L"8^A,3$-5YEF:'9PC1 MHUWE%``5T$X`]P*DF[)<2)P\PZHA&L?L+=H>^X>@;XJ79C]8$Z)G-,U-`%Q= M/YL[X)7P?:=^=D*<)[2B#LC>X"IZBG`QG2+?0I2!]99D6@AI_CSP*O)ZE)/K M&/4UXZ2EJ7LQ?[\E]0XLS0YL%Z)G+#U*`%M0"8BJ@X&_KI*6.@K&5I%JB`A_ MA:*Y8_M%ZMREV;D*I&D;271D<3:J1,G(S.]Q^(I/GW_!=7E?0=QC^2/)2LOT M*F6$B;I^V6@;`CLP+.J66YKMN1>F:5)9&,87D)3UY9LF/@$H+M[DDK[^`U=& MO'DZ3U[1R72?)ZM_GH>;#5Q_?"^:$7VCK1Q)AY[$-[HRR(A%#*P4Q^*.L@KNB$I(1"5E1"7E\%XNO%>4K1B/5 M,8A(TVPE\IUHRJVEV3Y).<+&,F1)H3R,,OO6*C5AGH>XF%!9_J&0'?1W\I]Y M]$KZX+?G(5IW3@M6@0S7,B)LYG/K7[BK$FGHP'#`Z:05+K;DV70=S8Z`Z4$] MDL[3,G6ET.#?%/`+EPZBB5^ZM(<=^327V=)L7V\/ZC'/_9;Y`_PWX<&/\/4->WE^NK7^ M[GZV[(N?0+I_FJ+_3%*<\OX)38GY-HDA>(=ABD:(OD%J'T=3X0B!_"5"36&, MZ\KP1O-72]<:^&ZUTO+N;KR M?INY_^@"10J"SK$)R;-LL]VD4G3I/L%EP`6[WP5=/I_"*"4J[1E2+5_)9\HN M?[S!%1(J(N)+;]Z65%,-HP_-+L?X_+0Q"<+@L.0;V?0;F>WC44KGI(+""3;` M[0L;7ZW'"2C["&C-S.SF_X5%J:&A*_AJ#OUJ9KN&E-(YRBU`)>*@DIMC[]>F:[G+30 M:]Q1Q0"Z\\C"?0'N#,K>`'?7+(2C'6(&"*'\H=;]?1?T^YKMR])"KYF''`/R M8"=Q8"KESCZ1>%F%R%V]B/* M3N=S5Z-ZW3ZII-RS4E*);$<'WYD5I@&S'8U,^+4+"@.(H&H$=JW`5]Q.PD"I M4"ROHQA>Y?`5,IEWD(&!"1NXA`T_Z5@/V^9!EG M=!G-#H[A)V:2$Z0/417J*E>_/1:O&6>3XW$-U![6B18>FB1HI;JY M8W;DC&I2=LGM*+)W)L<5/HTB=LP._U%-*KO@ M*BB\IPQVL"^LDY21_IZ(\[';%I4P4$-:=#XE4JN2VL/RT<)#D[VU=CB=H^.91U-%41^K(VK$JW&W% MW^=C%W]7PBS'%GYAZS`[($@UJ>.JQZI@5^KQ?'SU^`%USIY@ MBD$B&-^B510_WSRU!$EE#VAYLO:?+I+7,(I/7=MMR\VAQD^B$JF<[.M=LRI_ MK&HZ())ZVEQ6O4AAF\`+2__V4I+=H M-TK67R!.CFF[&K,$L.*0DU89>DM9Y!C#1CL[_F[NS&R_J2A)NJ5($!=-`;KK M>`+*KN!#V?GG$X"Z:9<6+1$V!DM+(\*&YQ,B1W89J_ M[ZY#5EM\6L?ECV-H.7F0HZ&4")Y12$4)FWX>L[V2$E2-(A/B^(+E#*=9:KER M?3A_":/T-8QQMB:@J]XYCPFFY==]KS32MI4C!WLPJ3Y`A MFMK/C(->MF^9?6MA0#^NWM0&(;A.XN=?2"(SW/@$_)HF6::!89=_089=D%%#S@:?@8^#9-5A"NL[,-81.X/GO, M2,(_?'K;#KN?MW,@.6;DP5>R8GD?CW7;$LP,PVZ]U%6($'9$%0MP=>R M+:<:P/#1V=3BZ9BRH?(.K"--O>2:?:PSTS"*.LN*9L>98=E2.3LRNM>GX\>F M0WQ@^6B0H6?V6SIF&L9R8;,"ZM\M.3W-C4D_PA@^1=@^OBN&]0F&^3:%A"/: MC-BL'-LSMF(FYJ.BDZW[AL$?94']CI[9;]=DR!I=16#'UB8'N]Z@5LNMZ#^& M9`CJ%H9)QK`&,OB9:"B-9[;C1H:L:?04=H`MJLL)D8]O4\J'J+)CF(`PJ$2# M7XJZI#VS734R9$VF.+%C/"S)4]:+3I[0IRC$!_,*^7&-W:)EW1WTES`'W\.: M>($\P0-FVB;*J<)065B-%8XY'&,&E-JVCBOSF)VV4 M\T`29$`+@@-2$;QNSB.=%,D.+KR5X=KCA_9-W_/;@EPTRU`7'$VRQ$[]H$QU M#D4^*JW48'CLN#1MTTH5(\I^L3H!,3ZNL&E=1L(^A2M81:LZ^JI;=V2_KS-@*[G=5TW#I7,SD=OU^NZGC$L=[ZT;;HG41_[S&QK MIS1M$X@(/\K@/,Q>9*H=[@/XC$^>"#]TRC';(*5N'#&ISZM2+/KI:1>#O3Z6 M-W.7#GWG2#TG,[.MG=RT3,#FPZB"L@FX4,C1%S!;I1'Y/I@9QE)O.B#HXO-> M*H=9OM[=V?9=ZBF9F.SBX:='M%N8%U$Q/LR<%@/0Z`:B?4AE`]Y$T M1SSBM?J-1Y$""D&K''11R2@)17>R614Z+77K6V8_!)`ARX0CH@_@X2&1X;9: MCHD#YIGBH!A?1'@/BZ*[[7DTKLLR^_&8`#43'Q@MD!B/#-*34R*V\"&IY<") M8':^35-<")E4(UW1_SA=SCR-KFTV$))2(4II)1>,`UC>S',LLHDMZ:%O&>Y_ MDR)LG.-#!F*`>N.`$)*>"=#D3'JE1,_)8:*4-$\/Q@%(\OPB`\1>K2? M(`*@2BDHNH&BWUCQ'&-D+C,WGH.M[J90B`'2F>DG-MN_K8=@W8*F!750,Q7C M\,;:.\LGD9?,?*Z$D6\U$SE,1`2N:TSR]0I=W&R?N3HB#1`L-J2'PO1:7HSX MK0/UETN[W#6>I4]LVF:4DQ(V&GJ%HGT(M.A$EW`7OMD7?F&:)F%Y!F#!EYN' M2W![]O>SC]>7PGGE]I[E6;9CZ3-QJ7OR.0"Z2JF\UVSN%DE$7+-O%CVH=;-B M]]2!Q+/W]J^E)0.L;A9KI'AMO&JU"_NTV=%$?;`Y##?B*5Q[`!QFFX]YZS'T MGG5:#)4CG]?-W/%MK>!HM+EE=I`/!Q6C&!?9\>`8_K^`+S*-5N*EG2+5L]KP&@P.J8T!6O&T,V=Z7A%W36+RYV<%> MW+2,J2VR`-KG7;#71(LXR5X#I^>92*`[R1+8* M"N>P1'FDUY3Y\5B])*ED$*XE%:X8/F.?MX*S0@IQ<`VS#%S?GA65]?ADJ[6^ M]-\CN*D_,D3\->=(<<\RIIRP"*(NA8*I.]G;Z-NSN=FA5B+DZ%;O!3`%777) M23>PZZ>3P]G4?-,XO*'LLR\_]7G.S8[S$"%G%)5?`%AP%#,E*=9JJ=,X;P+W M,(U@%M[$L!7?81G6L[C*"[>KH.LLV?=YV?GDQ$4#M:4D20]-7!C%GF:VMU(U MJ:.<*XI!!W0\<&8!R_TO@$Z@ELK#8;S+*"M8;KB`_8"$2IQGYZWY#OLE5&)& M)3*JEN(#*94:?.9YAM<;4DCEF+*I`&\EEO8X8OD]$3](7(M?*$7G4R.2"JD] M%$CAH3S49A=O25'"5^IR51(ICHZ]\52 M>%S+LIQC$$99`D<404FHI>!]U"ASR39_2:/U,SQ`53L$VM(==4E5_W"2Y\(4[)HW6%J0B1_0!_ES&\6YN*;C<9A#)*>3 M$P+UM)9"PC=RV*HT%$]B;;.CP!13.HJ0J<4<5,.!I4:-[N$[C//W3XBVSTF< MOQRBW+&DSQ&;RS2HI)`)XJY$B:D_^214R[;-#C03HF<G2')(B`"LI.M`@F^A_2BQP1G]!A M%*]PSK#=(.`K'@:0<3CEI2:2^,GR0TC>_O_(/Z(?_WGJVVY;.6(U4M([M9QH M<%)5"D1_-WMN+>@7,MO!RT&%;N9GAQ+4SP:2(NPK:0UPH'K+>+JY`DL9V`=OC=U(DZ#4C'B MS5-9G`XG;7E]2V)8'#I5L;H#:-A-SU$)5G@B22.40OI:4T7($8<_\-PK/K#9 MUER-5.L^1O1!WTGDS1.H:HJB?^\&HY:R7?E;V7-)`4/5F(;QY=R!IA3 M!C#;^*R1ZE&.1GWX]P[22FRK5^S%(.C;B8KF_4N2YC@'&CG3*Q26YRZ6VBY$ M0].KDDMFXGIS*PV.AS\9+<4Y,]Q`K82^40]!09![O+/[?HD][#%4Y9%L'L[$>4G:+SJ.U1OAIQ800A)S7"E):RPSJ` MA<3/I=_);..T&$&ZI4,(54!Z`=(-2P2Q.V`C&^T*=GW!5]R;4]-CP'21O(91 MC+FG[:7;:')"86B7E"YJ.62E&`)_1I]^1K/#3$5),D!>VG#Q2`SM+WP[VC.< M$_LWPEA9OW?&;Z(HGCJ+I;[4(#FCYKE]LF6:_QU9#H&[) M4X)R3Y'C]A:1`84%\S++HU=\1?L41ND?X6:+_D:]6UFV?24LD+7<[-O,U6@`#P?(>#7+Q&Y( MA89$&5YE?*9[["+9?-8KS0#6C#*`V=Y@E62RRZ3<,V"%F`/TZW83IF`=9:M- MDFU36+X*AI6D/F%)_59**@Q7+V!56B5!$I/6$!U'1RGM#'!MBSGS^&3@-DW>8)J_WR)LI=GH#9_U%]4)6T/BSFU]9>1XH,C)AB31 MI9Q8GV?7"]=:N.XU.JJNKKS?9NX_1*C!WW:VP/Y0UW?-MH!JHUGW#5$7\.#V M[N;V\N[A[^#LRP6X_-^_7]U^OOSRH$@*=WE,YYZ^V-W!Z36)6S=UO;[JX?'( M)[+H)S+;RJF&P$F\U;PH.R1%./&VV"ZN194S_>AJJ'A*ZB>/4\GIQB\0VFCXF(8(BC"^I= MB5TOK/4!\,<;C#/.^]'9:K5]W9+"Q"S`.B7Z%.'4%VNH"J6_0M/<%(%SY`Y M)MYI#JL5_,]6P[18$^PU]*FP;[8-=9+U8-AK5%12F(*VO2UGW:>Y\.TCOX91 M?)UDV4U\'Q9O,W9X=F"LF>?HL^6R@9#;`X0)99)PQM'MI;X%/N!^/^-8`'31KI?-+,>@Q[GH2<[+F%JNU"9*X.)0`IF_(;KF M%1NGV<]RQ0@:X58M#"[`/;"HK(FHA!LL)V^EG."C"HI)2>88RZR M+&U5[/NFUB0<[42)B08>"YW[1=:RV>((WZORT,;AJTCR<"-V>,BB[)2,&*HZ M./8<7Y8^:^LP`$TRTD>@F*08.F1WP@C>W2_@$TQ3 MN#Y/LCP[#]\B=&!&_X+KVQ2^A=$:0;O)7V!ZEF4PS]K<]/YB86D[>631R?K0 M5:\-DR5.>EH2AC0C(1..V7>D4==A4NN=8F*")1C7@_VX/;N M\O;LZ@)<_G^WEU_N+^]),-S-PV^7=^#\][L['&1Z=G]_^7`_BD17X:\(K'&J M@)J(;N4KTWM[E9T-'Q7^DG++$5YM%9,_R;U7+0WL`B\17$Z`7LKF)TC0C1M\&G+*7DX MG1))Z0//(A:[_F3C*M;\"&_`0_1,Y,KM!54Q=M5`O6&((^ MDEN_%X3TO;+[H-04M#+.*;_'AVWGC%OR95=0\RVUF>/4J=F2$@WS'4 MJB@*C4ET$F?A^)Y/DQ@6.Y>Y1EM=Y(ZF,"H&+G["E#6M6A!\@7EE;\;%'#6F MR!N&("=J@E2R)IQB&)O45:;U80V6*SW$3JK`B2`6\:24\^S&)UD(=KSEZ_-Q M]\^M1G18Z>*2F8Y!R=>@&0`=LWTY"JDT0DJ8H`;GX>8U3"'`R6JR6L5#+1*C M1=TS0&(:+LW^?OZIY<\MUZ9)@(IO8:Z329R@4=R?0M`JOL\(WZ>"?'^7O(<; M7+IW-SFIJ&5Q1(BWC"%Y3V<#U7I3[T)$MPV:!-HQ-^FV,#WLG"H7'2X"+JB: M@`]9\@KSZ!57K$VW<8R+Y*7EKR?HJ^#/\0T7ULO@"O$,R,,?,/L98$[?9N$S M_.4QS.`:O(7OF(8,O*(;"WA\!TD,T1_QL_X/N$S??VRB%;92P__X&>0)"&/J M,:K_AACR9_"$IT!_2Z/GEQRW3.+G!(-"C("-WF%,O4LGH`*._Q;%.=QL$,)M MN-GEV_AP=?MSF99SBZL(/H$HKXDF9_&_=NW00XC!=%GC!`YZTQN.<7J#>K9[M#=VXQT_C;M&Y_=&< M5H[93^88T.N^"PQ#J)T?HOI][S=E"R\&-"/HFL/ MX]@Q&TDZ1Y2`S2;YCF._\'_\IS6S3BS7`6$./J,%>`&V=0(PNY"C_P*-^_J( M5(WBKS;OF4\R?=]B3>8A#>,L7)&2I3M_E>OH]+CUSRZK"/#2QF2_&1P6>XV6 M'C%/&QZ-JY3.26TXG&"#N\OKLX?+"W![AJM4/=R=?;D_.W^XNODB[MGK@M!> M`LW7Z%3@0*)'PMA('E#`V8UE(MM,\`2D=@OA8(FXK;_L)>QW%\"J' MKQFZ^=N+L:]?U>Q:],`>VF2L&KMAL8G4H5%",[/50*5TFFC5Z`(;%.T!Z0!J M/03ISGW$.4X[<]5_$Z^A:MM^'F[$>4G;KV7)\`M4XI)S6,5#")2OM8 M1.$H-C2S?8/RQ$TJ%"P(`]((ZWN[9N`K;LC)_6Q7"2V6A>EO2`WKP;#.[165 M1&=FNR'Y"!G%*L`%*9"\O)2S%(-;WEQCCO>]N>3X=@AWE7]]OYT[1W<0[]1: M+ER/IEJ8F>V^9,(_"ENR(&F[7E6BI>@J7Z-=2&7]^+[W"XW"7/AM13Q4)WSB@"0G`(I6H5=.Q.8@>B-U"UIF M^VGU$3V)U*E`OI<>JM/6G9W@]SG[/],J>K*6[[]%^0L9%\_R$KT]))=QCGCF M(GD-H_C4M37&2W""46PMYZ6\5W)Y1R<[-#5]66;[=G60.XFTRF$.ZBWQ/8>V M!5]I:^$CM7RX2IS%)(O(6;S^%,5AO(KBYUV$?3VSH.OK\U-)(%-UOJI8$L9C MEG\J6XRX< M^OI_5ABVS/:5:*!V%)N*>MP'^K&\F&;9]I5\W.SW#*X;67L=>XS\X;THE(D? M)ZDMHM8_@F_3:+?YPNS@$#&"=)]O0JCVQ*'6#^".TH75N7E']\EED)CTG4B] M(]AX0[/(MF8Y]#N:K3C*$3;V.<,/L5.&MEB&\-4NRZ-7G#_E4QBEX(]PLR5- M[U]P!I4;VIA3L'#7CSCKRGGRBE-_DZOD69HBXB!VX'U\WS6YI7E9SKZ'Z1HC M(`!J.''R\%4.UQ?X'@OC]1V"BOATZ7KZ3B[=^"6%>8+E9:NSH1T88FW;(9<: MV_"43&8ME.[3W2AJ`S):D?:I/B6HS8DMS/5VQ;R`3'Q2WPMKDY^`]RBOFWT1,62% MIM_[QB!SE$T/3VR`*OA'@IT3&\3K>//]'/Z(7K>O2%072WU)BL]X&>U/<-;K(D=>L)-[N7KZ^;9)W"._S M9/5/:HPK8U(7,T^;4;IS6CEIYZ"F%.+N+CBCCDTBRVS7[(L0,PVC6)-9T02( MUU\1EY-VI2%8.JAV4#RS+ODL0TP78P3:2L)4Y:U1OEJ,D4*R\^(=E&;CM6=F M/]$8=R$FCB)22\V>9XGED,P&3DF1$-\Q+@E17-UW]672'8\0\PT,G0O>OWV- MAXS<%VUZ7S0[MLJPE9IF`YR*W#9#P@DHVDZXS]U%V3\_I1!>Q4B/A%E>.GU] M?1F-M>,W:%=C7-[Q-K-60(157L9?C/%VES')VEWV-M$W M[B<[$X1M'(]^\Q>)DQE'XVD'X=K6TEE2EJ7V"=?L9#23K\WQZD`<5+9;J%Y' M#761,`P?[19VK);X2;:P`@1AX.+4I<'^KMD)@"9?F[_,%M9'9<<69KB1W?R= MZZB-['KWJ?:Y\:7`ILQ)0TE=LW,=3;4DQ[*FQ7K8L M.#E!5+XTI;1*#XP89C%?4(8Q^Z6.:E)U2[!BO,']]NUM0T[0<`-VS;%THRE^ MP7/LY?(4KL;-<&KH4Z(G.03;E=:N#78Q)U8<9WD$6B8+#>.IA0QH:!Q$5AQ5 M)WA9T0F&4.31LF:3O$%?B<_98@/YKZ^(CYL("1Y M7)30BN$9![#MY9*^@";AR*YG>!2F%%WC"(8$PO*E2$9>BA3:'5+DPM4*?1-T MQ$#P/`$%].T4[0%H%T#[G-`(NNP$D'[Z1&#\PV1D M$>`[1&AGO'_Y+OE,ID>`<1,S_7'1!JLZ(^IZ%7A*4K"!S^@F419%$CL3R(7C M":8/";[?Q(C5WD^=)5*LV4O.M0PAQ\-LF$JF;6N-55++IRJIV?H-`WK=>_,P MA*!L`AX24#52R&B,U>7&Y;1F7;G.E2*7?-?P!YL,Z-E93:ZBW#"4H$JG&689 MQ#7EBBXIM7]&93^L+L?40D/;%-83SN)OO9S`5OEM7.YL'-Z=:[JD8FRVQLJ` M?I3C>1C';C,D!0&(-8_PZ!Y;"JBE+\D&?9[L\L\M^C`X'WIE2'01:7HO99US M*]!&.>AB\V'U#XH]*$MRD?`--X@KI'):;Q8/U.#^M[.[R]]NKB\N[^Y_`A>7 MGZ[.KRZ_G/]=W-S=.OW.P+Z7(MT:6Y!:<.B0*39R]RYZ;&,L?%*$#'T[LQ5I M49)&L7SPXPKJ_7X"M"?`7>NNHZ_B*?SYN4B?/<1(H6FWCC"-X3K>H@@8]HN- MSVSM2Y:T\2PGXB`[#Q[.((F7"#Y=_H"K;1Y]@S=/3]$*5M5N9Y:^$*.>B25C M&W@H8M+0^D;$F7!\FZ:(,_L=A2H2)]7-V'$&I"FHVH*BL6#BLO,$7872#'W` MFR&!NA_R M@,-7D\)CRUGS'3[F5S&Z`Q'+6CUD]O+I">)((QQTL<(FAV=XZON6ONRV7%#D M!$J2:B;YXIL#[XNN1;^NV>]D]!$]J?3)(`^NQ*/';Y$$$0LS$?EZ0H3:=);C M^?HJA;!`D),W02*9Y(QI;/R]E@OZOL6/Q1# MRN&Z3`6B2LJR,I[P`JXVZ'_6F`<7ULB"UD"A0]982)40M^;PY*,6.^01YUL7 M)-=`H1O"'-!N2/*B<(/=F[^TB%YV\.8C%7KTL0_P-DQOTOL\Q`])L0-V%VKM M>!ZIN+S0+XQ=(%3*(@>A`J+8.;J]]!:+.?W,9J=>UT`MNR"BN]=C(FHG5(\\ MJ'K12-T3\!:FX!N)4&B5P4Q*"._@&M+WDP?/'1Q_IN_*QX1!I0BRDRD@@5V# MDWW6H1_VB+W#0L0:=!"R(3Z4.Y!6W8IW)>I/P+JA!Q\&-'O'"*=>?6*58C9` MD(!L[8U(=DJ/?C&S/<2**#3O%.M!VSRY]L*(903ECP0_AKR+GE_RC%Q@%B,= M3?6)50K*`$$"@K(W(MG:B@]CMC=8$84&'3<],&L2WD^\XCH?EW%OX=-W-5O7YB1DEX(8;5G!^>2,:+K`) ML^SFZ6\ASC.4WZ1D]_VRQ2/=/-TC""G)LG`>;C9P_?&]:)<5#;-3?V9[VA1U M27"2XJ%Z92H1DAS8M>9SI&G.9[:[,%R^U%(ZT@U`+>J@_+V61.@-(7@),UA> M"K"+I_8@74G`#_US3F-C'&_LF)_=]%K"?OJHJ^1LL*N-:"+ZJ&7V"S).2G3K M6'QP@EUS4G:/*OM%Z$[51TN0FYY#:?H@M^:1,A@VY<^+#V)V:G\^0L8Z$'A` MM:86V;X1R^F^4755#2O"_'GTN($X$#N[#=]Q& MA*M9=^>#9?=G2[KL9D?T\1,SY?[<#6N/M M'F[N03O$RU57O('0NL^.X2_,>4F9:G?NP-.W-W]/M/.QW+X\-A\S[\GUQ?9G M-&.6X8^]>4F9=#_N`+7'S&^*5._^PX@".HM`&XBY.^_B+(\C1ZW.5Q?AFD_Z^A[&M$PHQY5,%)1YS>2(9>73XO13I635S7*PPN9M^7.A#KWP3;IMVQER`?%0KI^3;%S_+.XC4N M"T/_`W\TG>?Q,`)%W,=%8X,Q^WJ[KDO395AFWXWXB1F-G5D1U3;2HHM&CM=T MY!O%\2U*P7!O=.=:S)=+EYYR=!N:FWVGDB%K-#5"&&*;?A'&:["-W\)(5+DH M8%R$.;QYNH.X:,M%^/XYB?,7A.GO,$PQ%^DKJ,(!1*W`<%'<)3=]@Z"SF_I& MYV8'"@G3-/:YP0JL>7R<`-P7Q\S1WG*R\I!&S\\PW246N7FZV>99CF01Z?HT MHNFVB$M=8X/LDJ,4A=1D:B5$ELXNH>$;E^R!U([7,K5%U$) M^B`'5E*3P?9G$]6SBC7(7\(]J;;;D%,Y?("A,NL10&U<67O"6I*3& MWPE8A6GZCEO39'PA4<9QS\=P0\[\[`7"'*P+`U8(OJ-OF\.XB!F#Y!5T^(Y^ MP)%C)R"*(YQR<_,.UGBXIQR7>8LA>(+J93?X@%8^6A$X]0O&SR<`7RL(AKQXSHK_BSSR(S#Q?]%**6HVCM:X M=;F=8Y)0>XF]H_'H@48NV&;[=%209]SNT8TU^%N?>+/*Y9_HNI#C+2.'^^'M#@VW-#L21IXX\V2P`^E?3`)K>4I)$!JNO^MP.*0. M^\L)&`.:;GEJ="9Y\*A_W#;;RB8/<[N!6(9^S^](Q;_UBD8: M%X9&=FKRIUHJYB<8YEN25#8&/]W&?X\_QQP_R$=(0_PM'O`4KJJK$;Y]H1%P\8-7'+>` M+GXAN85%J"DZ:];A.[$C8J6B6Q M%Q9AE3E-Q&V;_9,&N$=@4K3@KRN_GO[V._MQ&ZY#F6Z>515:T MR--8]01:$<@QOQB)O;+`,B391%WZJI2'J%>VFN M''"VS5\0&_R+)-OW9_JBI/LG5RE:#(1Q2%5C-)*QOMC[S'Y/I8`Z=EF2"I26 M1]I9.2"L>G!6G,?=/V)'^GGR^@;CC`CF&4Y*^DQTRX_ONR:WX3O^$\F5?4,^ M>O8KR5YZ5>BROZ9)EIU:WG*F3V'3@%A.+,=9PEY9U@$!;^,+'+OAV8:7-YYJ M228Y@?7310LG__)(8N7JDX#:+.#Q'=3;%3,!,M4)*"8[`;\6V8U+^PK^"YJ2 M;Y/ZDL2E\_TB2N$*26<]]*'M)4>'O:5[)+D]@`MA*$`?U8MN=A*$/;(Z?Y=O\J4_-1XMB`#+OZZG'# MM-8GOO87<<'876%SN/$DIU-Y&5=!:\G_LB.3H.O"Q66V!UXQI;K5#;5PFR7. M:B.>@&K,@]=FI"T@XY8/TB824L;#Y:\AI?8[:FKYC2L8X_M;"# MSU$ M;L(5L1"7-TW+TU=>KGU.649FHV/'PZWM+6>Q,/WVU0=<_V6J9_:@^!54/PL: MR08^II:2O!,P98O6TKZZ"\];DCKTZ'_--NLR4C"2EL&"I6+:FR>TJ>)M5)1G MDQ6$Z^P3^OI7Q2OYFZ?]3?TL7N\B;LA?D.0LESIW6A%0LDRO:"%V4B$VH(OS M5I`STW2944"?_HU?'F10#@(PMX"K6BZ)`ZL:"4G>C47_J"K(G^UB/%:,?^,0 M:(LT=V8T[[AC=OJ((>BC;/L#(!J1C;7@>Y'DV'>P3&IR5@;V'Y8SN$A>PR@^ M=5Q/7V9C9ABR?"Q,[8Z_68>P/,>?D\=P2]/Y7HPDW9NV(*ZV:ANT':=.=`=Q MIOI5#M?G888S9.+_N?QSBQ2N#7ZE@HZ'I<:,KD/3RXH"-W$[$1CJZKD>34+M MF)WUA9,2_0S/`R?8-0>X(=$ZR#]J73@#;FZ2$-XRQ#\DE&S`O257,_0U_*MF=D,STZ$;EYG1A+@EEC)+AS69$-'_UEK M+[B_UR`0^SQ2N$AT*1*SN:WO-537M,I8>XB8%HX^Z.+//+/-WT/01^3>MOD/ M>99&3J!&-'Q9-9MJ\=E,Q:8-?TUG%]=VT?]WZECVS'!O#2L)(_EJ&.$$E&VK M)W&<;+MZ@>MM-1'-N9%AU21_?\!Y0X@1H:VF8H=)8W!`2,%QLK8G"%;6I\2:G%V_GN]QFR8V+7,9CLX'PRNE^3. MR*,\SVRCY7B+,(K9?S1R@J(#>,8]A%YN/P[#?.R`^0?,T)Q?MMA#C;8]\HP< MJ_Y6VPL,A9N%8L@*=@O]B[BW72B?SI]9I+ZU;7CU@Q&HUZX`:R=!Z>MK.MT) MH!,2*PB9TJ2=1I]:\F^TT[0K)JJGPSKP8D$YU7#C^@CDCZ>,Z"6D4D.^D;8C MW5AN$;F?DW7T%*U(EZMXE9(.X:8^TGF2Y5C_7N@+;1N#A(GN-'*++'W)X9I^ M,7=#)07WV$U";?W]4C,#DCT5#BH M&M%3B]5S9U.J50*(->\V2M:0>7,1F0T=H@MJ/S0\__,(U$^N%4F3$!3.(M)> M-'(JV>8O:;1^AK=AFL=HD[R*KM^J+$N6VY:)L\L-VC.6I.CQH:QDJ*\;\<@M M::BQX<+`089VKF;'$NS:@K(QN(K`]9O@RS8V+F#UV4_,K"V>^H&E]6WIZ*9S=A8@NT]V-2,V[PZN11?7\.L+!QGC M7#O8`=695G!O;<2M7$15Z]G*$G^Y,)8L6=/+W)@>30JQ_!= ME9T*[2H`,Y2@-;0)MP:DN0X>93W^)V72EL-_:%&+QT)FYP3AH&*THY\9TB"W M\A[ZV\&TM M^F+(-3LPFY<4W:HS)YZ@;`^*#@#UP`^S:!]!@QH[:S!:+$SAY*;M@FV]BVW" M;%<;+REC63$X<94L#>Y.$5/C'B>8J4_Q'?&`JSF-&NQ\PN;-,(6K&UX-MA6G MQB/7[&AV7E)&\6YP@N+@:,&[WFWXCM_<7J#!;Y[NX`I]T(OP_3,N38\TG[_# M,,7WJ[8B;8IO@\-`%-T712C&XB&`^!^;QPW]HO1QOVNN+U`1==J%2`W.ZM9: M75I/P!IG(49RE9(QQLT^K*EHP?%E'UZT29S8H.2S.^YB,9_1KU_8+,SU>&JC M=X0+M"[L!TF+#VL`16@*7HO3%_C];+7"=_8H?D;#Q^B?-$5YAB_[+SA2,;N* MZVVB>!6];6!V]ICE:;C*3VW7T9=%4`%`.2G6LD)5I4H%@SLSS_7-%6359.HV M'2C$&MQ=GE]^>;C^.[BZO__]\@*K+K^#V[N8+^O?YY6?4XAY\ M+?ORUG`51_L`?^0?-^3$L>V9OIP-*B!.)L)]BZ1`B&O#S^VEV2Y#E60:+,2' M6`,T%M@U!/NCT3R]=#QL\-YK6`X)ON)!`1EU4OG6$N?$ONLD>[6JLB0#VDYT_8`S^N47P+K\1C*5&X'&":NS.#8:N_^$:_0O] ML?P3^C\XZ0GZR_\/4$L#!!0````(`#UTKT0#A-\U[$L``+#`!``5`!P`8W1T M8RTR,#$T,#,S,5]P&UL550)``.5"'53E0AU4W5X"P`!!"4.```$.0$` M`.Q=67/C.))^WXCY#UK/2_>#95$2=71,[:Q\U2C"96DL5\WLTP9,0A*W*5+- M0U7J7[\`+U'F!9!,'BK/P[A+EH',+P\D$HG$W_[^8Z=V#M@P%5W[="5T>U<= MK$FZK&B;3U=?5]>SU=U\?M4Q+:3)2-4U_.E*TZ_^_E]_^8^__>?U]9V!D87E MSMNQ\TW1++3!G4=%)7]K=GZY^O9X]>OUM??-O:'+MD2^JFN=?D\87O?$:T'L M_'='Z/W6%SNS+^XWR=_^_AO]OS=DX@ZA33-_DRQ+^G2UM:S];S/U!@/ARON#'V^&*EO!G]!_=G5C0[[7$V_<7P9?I7,%W_S^ M_7OW^\#YKC"=3F^*1J&2,/DK4_G-=#Y\ MTB5D.?B&_CQ,U>`F8#GQ&_1?U_[7KNE'UT+_>B!T?YBR3V*$F?A)K@C2G8Z+ MM:&K^`6O._3GUY=Y*L[T.S>S`U)4]*;BM6Z82,4S37[XPU:LXPI+MD'^`)N$ M'&?LK8'7GZZH^*Y]$5%J_^I\@A`V!?^;UG%/%,M4=GN5('<#3-\]MLAWV,F4 M:Z+SE?Z:G4P+A$Q),FPL/_S88\W$)J%R86VQ\:2@-V+H[-+&2%?KH8]+VI1, M&'%GTLDC;4HFB+AOD:F8B_72P"8F_IQZ+2:*WO1]-=3P2),0)0-0=:=KEH$D MRT;JXDU5-@Y=5*+T%V3M(^LGJUE(.I)JHY`'2DHH$)8R-0A*F:FKBDS#B5ND MTB5TM<788B1/>C-KH6Z)#**96_+7$F*%DM`*82RQQ*Z(U>`=(9&8T1TRMX^J M_IV53%.7UK70N45$1@%VB03!^QM:<;'AW^$DWS24V[O3=3G==#Q-IFJ+N)9"=3`IE=TB5 M;-6QYL4ZY7L\&+N,2+K[LVJLGY%!_>8A!\E:U;1R1.HNA2"A^K-N81)_'"DQ M;+3LH*(WA.Z*3A M)@DMPK_GI9GPN8Z1$LDYWMD&WK<0' MLFZP]Q@18X91KVP2N>3K4`IBERRD\LC" M5;I57R)BHZ\&TDPDL>_2#1C/FD03%UI["PBO0'@<*FV`X!3-`V%-.G*09K%-D\2^L;+9$OK,#-M`F;\1IRJ;^'2&(-6ME[\D@=*5"ZKUB2JI.\Q\T M)-(D9&ZYS<24=:U"!6"DJ3)ZO. M2=O)/V;?9O.GV>W3P_7CXN5Z-7MZZ,R>[SL/__PZ?_V?SNKACO#S.G]8^5-3 M\DL])W=YP3\LK,DD.'5X\;DA>RCO6V0PK'ZZ(A_\[UP[8-/RTI1O5LS0LS?3 M.0'J]J>C45?H=\?G`(=+(];(?'.*!&SS>H/0GM93#&ZP:IG^)U04@^N>X)4; M_-7[F(..;-\0<;OQ,8(N)'Y-/F.A.%(T8CWHD4L7@`9 MR/N5P'Q+QOV=@-(CN%0`3:ED,P$9-H&9X8.Z-O1=8!/;RDZN+B>,Y@UED)<#.-P-G=!/KC9@=U;`G]H2\KJKSB[<&_5JZ MTWJWN''[+OCYO_,?Z"=V_8Z`H3401S%LGSEF+N:9#[YLS&NF>/_1;:([?@%YH/P'#: MFPYCA!\?I:0/5JM`XUGRA#JX-*$^6X9]9QSWEFX>"?<[LDY)`?N"$!<6)4@T M>:3*Q,G(C"=+X=)D^80W2'5QFOU0S*XP<#@>%5\YWHU<8/&(2K$$\K@7MBQE MRT(R\!^Q[-08D/'M%5CCVA01-7M?=,HS!4';HVZL2-#VKH"X.QR/1#!6FQ%Z`-[DX'_;B]+E2B(X&,&BV`82?-@)V?*6ECZK*()CW; M=$^Z6#M'9";]6':2#7$6Q)P_R9JA1=J2A8^_EHHMU)NB*>]!_K.YSB]N.4#Y M^>[S,H./H[I<@=;I=&.D_SV>W\*<^!/?--9VXGX-7RTC&=69!Z4I#!5(2S M^I2)"YBY6TWB5RA[N(5O_\1'Z-.9PG]<%X29RV M,G\PC?$'V4AXQCQLP=&\;B&5?;]Y<6LGE>6+?D3JN22'<#FFA$EK7>&R4`@J M3<2FJS-?^L1CG4;\)KU2JIBT\U8(@!ZT&L1/7;LR9"/BJ<2T.QB+EZ02NCYG`O"2(13AOA)Z],"!A#:G!HKO,1-6K/$.6%M8_%+W\HF=PRAN]=QG$M,S@X4F:[V);$4G'QU MNKCRSE/<@(R3*9WE/6CT,*X@GDHDH'858D4GJ`&FH=7E*A0]Z32,[^H#_Y&43HL#ZR5CI`A>Z3 MC0:3217U.QF$U&?P.<'ZB<\'A.CIP.UL-5]U%H^=YT\SLSMQE7`RN MX_Y4+&W?L$2^^DVAT?+9Q;MQW!V"A'1$[""EF&D:=+ZM9;-0H\&T[@9@);?L M&BH)XJEIP;/;YOI%,7^_/=YB3=KND/&[RZPP'(#=HLB:/;^11T?VQ_7D(PB# M++=4)E_GLY>BEORB\Q65!YRVJ6\")R!A7BEBCM\2TP/4%WS`FHV?L>4[^+$K M4)C-;]R40(J:):1@LYL%0XOCPFSY+]9.4S?WQ.#5($@IVN:%(JTNT=$-RS7G MK'VQ=C]V&_&?MVE!?:2XW?RP9\T@H#H]&)7WDP M'O=%L,K`T$2-M(](R6`",JWIUL=='1C9Q9T<@=`=]P';4J3-W$AEB3A35NPN M=7^Z=)X7MQ;&"AL'1<+.EFC8[\-%_'$SYG>#WFA.GL$=S_1V:8.I`->G*G': M%^,U!V!8TD;=F^Q@?;'+UBF;]S>8SK^ M*Y:VFJ[JF^.IG^PX+L^<$'5P#E^F-K(()_"J!5"XU#"5P$BO:.G&T7FF[)0# MC3T;2Y!_["``F;&T9%_([V0PU&RG<\[Q(R)^=D?[!W3'7BT,6#@=-VLCPZ78 MV#H+LZ#XN>D&G!9HLS>]`DD<,K<4%6JX>%##GIS-.U:X)V^(?@#@7.,^N9$0 M9P7C->X,&XD73ZE,CQP5#A6^#"(/WQ=1WB^?7E]G=Z]?94V=Q^S3_[%13NU?" MZ._FSY\?GN^X>]`1R3JGCS92%V^JLG$(^0S84 M!M%+&,Q^(^_%##8/4O2N1CZ]`JJ;KL21/)$5\6QP-P8:]`&?D8F?LT;'$-W7 M9Z+2[(<`GH@%N29RATS\2O[63PD+@(TCDF;-KYT/N[VJ.Y6J7Y!%71D=^/RU M-XZRWO31RKD?PPQ\<%.&G<6+[;U_CIJSKR)XP?G6Z'P%'&B6Q"O@@-/4^)0X M7AR!IV1@OS&^,I-QQL4PGOGW0-79URW/RG_:30_ZXWYUJW^YF5UN&3+!4*?K M9:F3]E,B*PEKB)#FZ*(HC.#$&#ME+1+,9+[A[WB]8)4P("^181U?#:29)#2E MFYO;8_@W;EY;=+N&@DB4G8Y:Q)P/)E_V]>>PVU[?5;8\&0]NA#IZMY6S?,)L MLHHMG_''P4%&Q>_3Y234XQZT23K:C8P`HU,I(`=GKNG,U+D8P!8P!96Q]#:G MH,?-=/SGS!_OT8[P9,YD67%IFGU' MA'[Y&U)MYT2R%]?J+4%V/&/79J:Y`?`->'AQ%IP`21@(H3\9`";P,@EHFKHD M81/LO2].29SVF:.J<7G3BR'FRCUB;L'$R?LB.-M?Q"%VG;=1$U_JS'WN]UPW(>.G#& M/MWL&G$D>!*&*459.<`.#G$8N&KV?;4GPJ9F$OM,8:7'(:"L\>J2%!>?K;E] M\=/=Z0X?FGFT#\4AW'EQ=+Y2%+C(X6GSQ6!P MW<=9H&7L0G[!]^;]HHNOFKG'DK)6L.R#-1[!M0U+G#:_.GXF[L-ZM#79Z9(J M8>6`Y;GV3.)L"V/WY_%1MXW0,L>Q5^`;O10%YA"-K\<%,+A4!6>"A'P8@H3C M+4>^T1NM%O$87&IGIFP48K]^Y[@30 MT-M.NB;3RA*Y<[JR2OYQBU2D2;BSVF)L!3E@YOM-[I#A$;T!S\?COM3D-O7V M7\KT[[Z,`%_(BITQ_\),\];T-@_Y\?"'K1R0ZMSOL>Z081R)1W*/?$83P!M0?`,W%_LG;&E@?=(\1^6]=^5 M/<.O*PS'8\`'8+,IJ$$G>''Q^PE=G(*DPC9M0=AS+K-1;S*LAG)XI9V^5]I$ M5OUF=2W03MU"*J]VGH#IPZ7*SJ*-<9S76HP&@\/2#X@AW"3SL?W MV+".2[+CM,BJ07<3>Z?5**:A9%^`>Q,I;6I`;8T[U&.#P(^I&GJQ=X4EFU)S MC_>ZJ1#21Z,IX$/QY[-5Z5[2&/5EU.`2MC)]"V!44%8@0Y9U<0Q,*Z#V)<0L M8:Y:%$KS!2MW*C+I:X*6+@4O#_9B.[^6E&V+S%>@7`H;"C9OESX^SJ#>.878 MZ\,U&4F9N!0U91'*R5,R@="81AV\6@B3\RU1"V.1'_8`:X[KT+NX9$0JVQ>; MG4H!":1M??D>\R[)64S`F$B9&%IS(VUC&4&HL\LC['?R@ M!UC9DSQO@0A4DN@S"'X?8#_1)(XF<,M'_)SE7`;@$,WI,D`6!)>:C0FCI2)E M9RYM0]K2AET;`SM'^CX8M&Z%H_20>>#:A)Z/]8L]+7QG`Y^QOI/H]9=17!B6 M>.M4@6P@6I29X%.#<'?_X'1S M,!S`=42(F;$VV6=QWZ+3L_Q+>@)8(#L4B-CTGNPT#HA6!,;8\&0XA.,F;>:J M=#KF"3,V./SV3A>X\[KW1O<:7'7'T]A6;&4IP=EDM?FR%*;]!B]B=]07&RUJ M_AJF4';!1^WH/-+(<;4D89C:1,G"EB?3R<6=SS$`!G(`!K$TQ7A@H2_TX2JH MZEN'(L=[&;P'>^06Q%9\AWW_0@:][4/O-K\HFZUE+FS+M)!S]Z,G%#/!TC-!>;CT[!3!0` MJWT:'PZQ`?,S)*QC`:2.*X"-6/^..$:*Z]YQ+@"\M]/6XI"9PDB\@!5&O/-KJT-6'@*VHH2=N$J MO*/SU2.Q6'8;_EY8"O%`L06LK%+8.+]K$7,AZ`+R)V7BE"=.N]C<0P#<8OVH M:(AL0I"ZU-U^R*'@,>,W&+%K,`&3''\%6-?7^3&,X M9S@X]IZ\&(XF55TG*:_=$<^&.?Y\.?WLU6F[C3 MV+[@Q2L3*)@[.`#)\=.C;DNDR'/M#NT5LB/NBA.W$P0((PF35J7%D;HV!A#: MDS#G+FE[P1998+'\@`Q-T3;F3)+LG>WT5[[':T5R;N_W1+@V!=D$U.;?.+'Y MF7/G(,E1")<7E[L<#WK]"IFH2I\C6=P,WEN4XX_D;8NWDAWD:27;^67I\+7% MEB(AU?S59ZVLWK+GPY\#Q]%I]J-/Q$>?B/HWQQ]](C[Z1+0EYOGH$_'1)Z)9 M"LR]M?LXKOXXKJYZB?\XKOXXKBY95O&92U75O]-MTJ-NW.OVF[6V5:>?=JCE M?G#=?CJ`>W^"@Y#J#^?S@?03G-*0;?7"<*"4G9.+)3966T(:/<&`.W5F(`!: M1Z*'K7R@--REA;AQ2#=GMK4E]/V)9<+%$##AD3QQG2)-`Z'.K5L>4.(4/"M)GK%V0"#'7FWKFS7XD+A3`< M/'$CI!F#@=\PH$62/.M],!P+<`^;9,S>")DFH>$WMVFH8#\*HS\*H]M;&%V\ M!F/$5H,1?,7LZ.L.?6*U\ZCJW\MXV/%C'E[_&K2![P7>VP@>D-[)A'"W6LC@5'T M`+NH`A"8M7;-1EA-`7LP18_:0L5)QN\BZTJ&A$SF_53Q]R7`,YW?2IFZ?$C$# M6>>3D+!]]@'A!KKWTZ38,ASK+-;W^,VZ5TQ'?Y8&WBGVKBM.)U,X,+*F;[Q) M1N]1\2#:GE=`N)'M06;KO*4;JX="#VZX;1&%0:C2MU3:/(FJU`B1BVX MZ%R>IF1"";);KV?1?O=J'4T)1QXQHZK0JY)Q%J+J,J-(P%L"IBVZAETT(G[_ MM!"!80C7I#ES_@9K41I2+>JWROF&(+;B-J)>O4!X(^KVL[;)9Q[8NG;:G`Z& M4[BT:CDTYG?B9&()8]E\)`IX_HH!V4_#'8PF35N*"4')/90\SL;L4@\](?,_ MXD]0E/`9*1J=F(1*W2'7"]ZCHU%'E@S@FJJ60V,A.SZ%:U0M`)^7/)L+TLH*2SAD90GH7$#2H6YP@>M;6A"@ M-%Y$^5+D+3B?+C7-G1?N*F.?*A>4`O-3'^L^<=E`<)JX9+$&AGGP]ZL'?I;` MD)91F#PR$-UVOI4F3SB)+'!>Y24!7O69](>M&)A00H:WCO02D3739-J8?$^_ MTA6&@R%@70X[)9`66EP[@E.MG,@V/^8L.>.2%_(JUX[*[+'8_-2QBY5G7!B) M:Z+9LBZL>?"_V(Q+J%=$<"<_U","L.54VLQU!;.18`V$\PH#?HY6(0SB+R=B MC0.Y]@8;52YV52H5Q&)7J5(5`+GA#55+/G"H4JL@#JTJU:H"(#>\MRL33$"O M<4$LZ'0HLL&B/^@FZX!4NA%;8@*Z_#[9V1U-W$2!U)[DD'=O,6-@;%?T,E`ZNPQ`.)-M&2@5EX'2 MII07?QDL3`ZWY>;X_G[P8-0/(8Q+\]FRW_3SZIC#R03.\\$VB0:MYA(P25^A M.K)ZZ!.0,8HM-[^'`<>XVH*T0=TER]1Q MKA"8LG4"-Q(JETL3PX(#-H%KR9DD)6;G*RNA.)0F@WGY7_4R=;IZ M'>%)J3K"K[KY@IR>8?:\$H5!H^S_[%VTH1=57=@GMS23Q*@=[SD*#ON[&ZFK M:)F83%@D>NJ7PP.I9$8E626?-:?A+`@#8-U*&87!U&HWT:E4^A7-73$M'R@0 M\U:PUB;:_`2"4P93#6SV*7(UZ&M>:Z,TSZ$#6DY#.Y]3$--!L,+-]WO#QX^< M_$LSB)L-=XTIG#V72[D&/:0$?+-!$?J.I=\_.:W\-7(Q/FB_T&T37Y2LC,EC$S.X(/M+9FGN#D?2W.N1E)S&+/8J2Y/,F]]#^@7]XG#FDFY5_?@?AAF`.T(J?
A+,-V#.< M`89_')VAX3<*K5-/+B8ABZ+D81-JBOP^L!*:DFW.P(9-RGC#`>*X%3><5)0E M!+KMB1DI%X>98^_#Z%;M=YRTFN3S'$I\VA]..BCQL[(Y&4\J'D)/EYT;UPBO M*<=PT0;9'\8.^<<0J;SS8GJC^.&;D^D8[LX$/?O:KS-UBB.^(,F^EY7I[YMA M2F=U(<76T@SP:L\[H=H5KR)FL2[)ODN*T27_T,@&1@7L!\P_(UFTB1FU6)U& MVJ1;ZA2%O*?-TV3LNUI';8/L*8B.[^=A-O7REGJAD^:!E!D!MG?OD//"B*PF MT\$$&95>/SILCDS@&O\P3T-*,R\%4/C:,N[/U,%LW)U-D06-G[IMZV3AF"2R M^@/A^SO>%$BE_I^&^^K_RNL+CG3W:"-BTHXX^NX"3$%*I:H"8T+_!L/1I%7Z M5SVW8%PFMR!=E$I0%D%6M2N.G`'_V2P:-"Z]JH[AHK$RB%9PH>H'Y`3=T1Y0 MS,58\_NDP9A0=*)"5CRS6"(SJ1@!:>RE4HH(U110K")ZQW4@AE@&,V5(ZYF9 M<0K1QJA%J5)G22$W7:B'39=C6"@L:)VMI3!!*[F M$N#,:UD4J>I%=8FBL]6.(F""7>4+,M&S09A71G"/1!E4FSE862!H3[$?_HX' MM&`]J!K"@L,2N?>+;';;4\>&XK%5^V2/\=5UNLAPW^`E/-$#66.=1DYZG6^R5`ZH%;MRR'?:*003QZ0*L@=20?64TT>!:VZ7HU:34 M*>=T/N.==5`71 MV_9`TU2PJ2LM\J+Q'2$,7IBV/-01YY!#O$/(69F+WV3PH^&\ M^GFO)+.*>,#]%%<8G@HG4)??+/TTP`=-7#Y4VB("YPZS+4">F=+[5^_6VAV# M-+/HG[JY[RU,_+53+]$I*.2$+:TL'&QN[OVA*"-QYY'E#9K8`PL/N48OWEN5Z3[HY/2?%C75<]"N_V)]_-<>&?[BQ/^X7)/X5]3AA2S! MDDA'\47Y;,N=).9/_@:/8NN')5;-W_\7G?#LB^HD\`GM8GQYI);-N.1/YB'W M6_Q7_:$R$"2NY+`R2"F#3^Y[,_^Z@O^`+0U'S!59YG8TK@YRR&)6\_LG-T29#W!G.3C_\B70[TK#" MSKVLHLHB(8/4&-AO\GV1V=JX,P[(OL$3?[%L>3)"$EH1LIN1_J;BG]NW^'?.?WA0-0=().&#-)D M`2`4HNSV9GPRA!R(.A8S*,@G0!KSH?@:-#NK^J^4@4J<5IC%@^4<;81_N)LO MU[T?\_OOB]ZWQ7SS?;WXAO_WL-WP^:[N=,/VJI%^0SH9^X-_L6Y;:>4AA>\S[A7P=K&M>U5 M])MWE+<438A$8(2_#.=TZD_'@+&%ZE'Y84897'IY[Y?S+\O[Y7:YV/3FF\WRZ\/B MMK==1;__L_?X?7WSQWRSZ,V_KA>>!YC/[9LXJ/#A9;R8:+^U(HOX\8A%JSMH M_F(C3_"E_<"<=)*9&0-:4;",J.229,J?"CD$*?3BIPW"%ZWZ##]?>62$;`#B M1!?N!2)`"^,V/^%&,58&Z0>A,EM%V;M%__@\4UG/?[-%O_+ MP>I&:KL'Q\E(@[N!<,Y%R,:2`C3@DRP'VI-8\1Z2,:*0[:*JM"B;!`L`51KK\TBCL!2K3XFZX'VH3ZLP@0I(4M'I.'%T^MZ/"Y+7R(J22 M%")"1F:B#([2![;<9V[E>PNW657/E7.S>T7[XP&+F).T[V+&[(UIL;P9[%6C M)L<%--V041R$7EMK M@7!<> MM=)L#XU!Q&Q0-NC1JV4G!3$G^';2QI1`"'IA2K'T"G)ST(VWM-)J4 M.EOS!Y;U4"J'3(L=_`7^#^(.2?B'GRCH9WYF`TVP43E>PDJ2D56' M1*`6EHSHFD8]ZB?O\DXW]-09AQV?,Y2LFL'*?8.G!VS@"4*.U[;G[>IL_YNL%WYOQ6:==O'D';R-D_R[],'S9CC'R_"B:"IO%%[UG,/+\6>OQ;QG^#5B/\$V3U_0?8\Y/]9-C(D9Y4G)K%ZSOE>U6B1 M0KV;MF-3*-F`&(2[^OLULTNQ8L/F:8NV%,S9DU6E8W,*19C':>%K`>\5?N"Q M?DCL%,[<=6WCZ>@2Y]/6PAO,8>4)BIAZ899.7U'&@*^X%696SSI)N>)$82EY M4G)7;$,V<5DFWAL<[VA]#+<4SV5"1#:#NP96G%U#AJ9(3#O;AJ)T\_(Z+1#0 M?N_";!`FS-K32()FAHBXVY3P0?3^\4#.)G(1@;BS1(-7#F$W76-/M`"/M2%Y MGYYW:_&;!(6B_1U6.?(N>G2#Z]&EYGTYT0?PGU`UN(A)P'F7/Q+I8Y):^4'8 MX61*B]^"1"0F+B:&OD9UB<(`V5&5.^ZO(GBQ.WDRA3,414U2]"IBGL'\S3J: M;E\=*'#6I9`IRK`@LW4J?_55D$9KG!K<'5:)6>X:V$;WVA-I(Y462R$JR^2, M6#M4*0>A#H3Z5;((0*XF0BP"N@_C[?U@G1#R;IV^.R;,$YKZB6\PONPLLH#Z MGR.KZ'F(!8W6:#BW+W>#;!)`=>Z*"`"8#(93,'7((=RL0C`BTII`LD_KWH_# M3BL>CD$8JN:7<8/)(10ZUX;>`.``E^9JR![J#*-S@@Q[QJN\-+#7ZZ$_+ZFUB-PIY["Q0!Q'X5O3KC,V/S:MGN%MEOA$28Z4G-:15]MJ8I MU[%.;O53XI7-.T+6Z*!C`_I1M]U37)[0 M;S-_P5M&[B7'T``*F">24`W+,M_=1YGM+TS\=&<=[6^6Z;Y>XA)CH='>'S,4 M@6G0AE2`G^'N/K]L\:3_/AJFN[*-%P,SX.6G$\."!&-<0I.(HX]1\HN?,*I% M-7)-*8Q`D%J3P,__N&L=W5?;V+^@"T1B%":T%]ZLX@_YPS6D"CQ,MB9;O^0[ MOEY^.4PX;(I*Q)I2$V$`M2:CGUN)UJ3>F'=G&`?172`7H(A,>8/9&R*4S4B% MR\1+$!*BN#D0AYJ:P9LT-=^H`OEFF,;;\2TLYCH"C)4_(R5.*%G:%(HEDT/) M!:/_/ILV8/GH,U(U"B:+0VD<9^SO\BQ.4;K[YM+5([?CYHS/^_B]/^C$`N,` MIM(4'%C!(\!B$)I,`V4W.K=82JBT834<\%N>%2@V:WZ*@BI0#+5[-J@/U%-I MC-39F%>=2A)K5)-$`!1UDNV<$GFH8F!T:C MXF"9I]Z60J:;N(!7-VU@DBG*FS8,[VIW^BY,!=34,5S*4Q95,:N/42QTZYH. M07CO(S)WI]6S7QG:V`6%@;%(AW#-QUEG48?:4^,+>2$*'U[DUWK>>D:^>4W@ M\]ZG-?:JV(D_;42.65,/WS>F?6W2*5F=*^[2Q'^.''>MN\CK)K+'^KLC`+\@ MHKIPF=#L\Y#@6&.%J;O1.,E8WD<,)8$YJ.EF>#7=\AL%*!S^B`JD&E$54="T MI]Q=14O:VVPU=4H[)B`VE\8.EWRVH\>)H>3BKG;"!&Z;6[QKXCN`.JQ+ZF>$ M)1!_)A"1'BC=TH-'V]HAM'=(JFMRC^PKV**"6T\*7&G30O(2V)8%H(2!FR*-Y;C.L1%!'SC M2))K3OA93(?"5OM#R6^=%7>";[I+"B*.[-?K[:-@DT\5SG!$3R>._#ELQ9QH26(Z,((4N*_GOC^7< MBWZ+PA_ZX8C1"(IYD+)DI*$"VG\Y!5_SW'BTPJGY'DC&T9MT4I8!(%0*^6U+ MWF*E!]UQ5L\!SRM[3V MJ*%:5";NXD@_VX;ABL)7G)P\AUDY0$.ED__V7<8C'[J?_A\"!W_E'>Y-FV_9("*)S-RHQ3A`=3CG.(.HAPI<@$BZ86=%Y: M\R9?85%O?UD)SCDNO]1!FI4BG9?61)E6D.+B74]P3BNPR2#%:)!FI4CGI36E M!ZJL19+=E."=5C22937&PS2\'C/X:4W%$$Y9?L70.*1D,')6Y@:Y[L$+U8E= M(IY_C=8Z/D.JA0,V8C?SL1G?QP;JL$OWL<5O%U\_CX;SZG-/T`MR'&9CP*M6 M-MU&M($-AE@+A@J^EG='"VCZ'[!/$DXY[/3LD1J1*R-C<;3SC*SO[@CV;)>C M*7E?&:@JW#(OI-_\WE^(2F+5S]3IM%7*(:)0\JB@4/+F^/:FVZ>>]=R[TPV[ MYSW0]>;8?'KSV[P+*:`<4%D]$QH>B02%:U'EW?\D<4$NR?H.XZX-4CQ1)U3V M*W--7((VUGC\A0?+M,,?2;5^A_R]IPE;+`?3^/N('#\Y=S@8P57SA9RYL+L# M3U'GND31`J??M2ATQXM"MT+YVEL4^EH(MIE"L/*[RTM7!S7+UQY2QARZ5)5> M0\HD%*;6N.W+:M/VEU6AFJK"7_2K++UFM4D,3*UQ.9?6IFL1N8:*R,G_),6M M4T"WL-B_A)6*]@PB]:7XOGIU%)H#9O'['>U(DS^2XSM3`:NB%%$7LBKK5QV: MZZ`(W!8W<"NM8#^L`P:5%!,@M2CZL_&T&54[GT>'E2X;\/84L1*@?VO#^>L. MG[C)2BAX+5*?QN"TCS:+#NI>$=CMJ1120?-`Q=`F/SZ?R=*0IF<\DP"_"%`% MVZ!%SZ+B^+YB[@Q\9SGW10^'$[AN$1E$VZQ0Q3"VIO-!,P@R=4Z0]'5CBV_S M#CZ&"%8;9'\8.XP#29%.*86SQ0,[](\"3\-D--'`5I[(F8I9KJS[3_2X`(2U MW!IVK!MC+PCN$QLA&-%9 M/2<_OP8)\G;@$%JC/8=R(T%ZK%#(OA%?@^RN0792*!^%@QI*EXD(LGLP\(%R MNM5/EX;[&AV\8N>Z[9[B>`R%]N245AZ+C(I!WQ9YEL3*)?M@V^P):>D M*_K:DI,)A,8M]T_6@F=I[FRD.]B$]_][9]E^GYD'1(H%CV@YYC!M.K+GT4@F M6SF86KQUB[BRCHNNK,&N$5Y3>_.#)TX\H)B+:K0KD=_&@U\OJ-<+ZO6">KV@ M7B^HURRP1;WD;A#I'>:K^D<)79YQI9'_*P`M,9>K*H1:1!G-1S2##ZV&[Q03R1' MPR^RJ:E^)ZX9A"F41[DNW9U=ZBXK'*V)^G8M5S\(?X-3.-_@!(>*GKW`70-$ MK^]OU_>WZ_M;B]_?FLB$OP:(7@-$.QX@2G^,_85)G^ZLH_W-,MW72U1B)#2. MNOE,@S:D`/P,=_5F+NR)F5$IVO`.GU87@2!U]4*_L8[NJVWL7]`%'HEG9%KS M]ZQ7POSA&E($'B9;4X:0N[.*J&JRK/U7VE!TE]*G12!,[7&ME-(E`;5DN71) M\I*[6;HD!J9`E]2NZ5+2[Q6Y0O!%%*Z>'8VB*-?`G;Y#D8MU#,=#%E4AFLXF M$KIS@`Y`5V]@2:2^VI;C/0M253?KTGTY0`,"S&>BJS>H7(PF0_DWGN1HCY;M MZ8+KVL;3T3M2ME98N^ST>+1WK[J#YB\V\EK0>0(>TQAE4%-.6O`*'?-`T^A* MT,A_ZYOYRF^B%^(!$Z3^((^D<-J/+;"QHM4R<7AM3KWC9G+:GIMJZN&VMA8, M?/<+V5LP9-XP!$$5W3$FLFM4F?MJY3AP'F62.E`^0X]$`!2HD";_IE2BL7PB MOSVN![YQO;?1^%60%:2N>LDN`K#B912'#C[:Q@XI M&`SJ:042G)8]C<85AA&BKGK",L$@`3_.ZCD=<:JI&EQ^!_=T9-(?%L@^QU'U MC?!MD+`)%]TB9V<;'E-X04WJ?1D;5NOI#CVG;QIJM2 MLS>@=20Q!:ET)`.:0$=FGTQ'%N;>.Y9IT0&U:`B9@'SZ<0E+9YM39>-`-M`F MM$(J94B"$.I`F]^_&BR_(&E,\35SGBMSOIU2E"UU7G1Z>M%V]QE>[A^]>;PB MU]CIAV1FG4)+#6!Y(J4-V+AXB]GLZEL_U:_]IX$.28\D!F+(D;_,,J9P@X15 M4T/QU>6><`V1E7/A7HS!N#E8#NGD9NS)D4?UKF7H`S^%QK6C(BA=W2UN MCVAK)5**#.3<'&TR'[_?W\[_H3\;J(!>>[9)-*Y#)<"*K/KVO3)733@?*47I MYIZY726CW!_@G'>.U/'YSCLCG/"I]][236>-=LCX(`/')L>86I))C/*S3J)\ M^%!\V0E+*Y#'@K=WRT0!W:C4@@?H%D/X!?_B+R^^GZ.D36E"0E9V:6FF4\^K MX-35DR)&9^&XQAM!(6HA&U1T2#03IP#$$U92@99LNE01K^P" M`6TT@0LKR24MA_HPHQ.I1_OLBU(542(,%'4RI67HP99%D4M+N$"*-&78K8VD M6_5_SG3"4PBL&$$+5/,E5H[`4SV=#>'<[^4F)2RJLUS5H-(`REU0Z)O^_RT[ MZ(A+P,%,+?X^XNEMT(X\P^&KJ/>@A,THN!H]C),HOPX8"`31O9A/N.7-/`TA MNEY:M*'RET)-;G475LU"9;IOR%#RHX+N"Z\!(KU^\(,%TG-&[$9!-PT^5^>0 M"H*]MA*I&,M2T?;D.(XNSS.Y-QO>>QJ(32+435R[3I2`4/(F%)^K'8VP;?G3 M]Z>I^JJF#*:7KVJ/Z]7C8KW]LS=_N.TM_OO[\O';XF'+]ZKV:%OO6`*G0+#O MZ6H&'.]JX6"/!]UTDR/&;ZQ#%\OE/F'0YLV,`4S4)4'VQ"7Y\.WJQ2[<(Z\+."-J?OQ^0IQ+F M?OY&Z@?]V_M]YDSZ$TV;P2$@:IHU+XET7280O%N08%6V2!,[UB"%CYHX.!Z0 M2_9&1:F?*TRZYA62JO7$#$N3236@Q9_8P0/Q7@.J_%?=,._QT;\R-WH04!>3 MBKYI,?RQ3:+F99#RBY2`*EP0\FBL[K,2D:DTZ[1%2/3/Z$'[F4O'N=+O*C_W^/B8;/8>"M\M?UCL>[=?%^OR2J?;S:+[89WC:-WW=@O M?K\CT_$>*%;N*[+#]!_'09>->[E:&/HHWEB.Z]SH[P:V(HU_HWU`-"3F4Z&% MQ8T'M`8#HL[#2I,KOU.4))P(DYY.I8-%["8C7'%B`T,<]I]X?QH/-)H/GW&' M*N_6+]ZKJG==O6Y9-./&(W"/7O3#'4)^XW2.N@J7?R_W)I'+;>BI[%RETX#K MI8E!TLT=POAH*EQUP4MRK5`).C@M<%Z7++E!P#K?=8/-EB`UA"LKF$U8;C5A M!*Q%CE_>G"4QP(*\&31]>@8*<4XG5@]-@WP$*IR!5`N+\J;"!V$82M>"%99Z M6JGN%BSO/"CM*2RVS"MZ#J^&>7Z"90;@R9S942V)Q443D6JCR4D]Y@+T$_L" ME,'X#<=JCEUC'97UV2?0KNN;: MO;##3*%X4"^&-#1>)ZH&YVO)IUW_2F7'HL4K,E^7K9-^(-E%,01>=22.?MJ4 M(>J79!$?G76-Y:$$$B@/LAE1SL@'Y,;K$+#4#-,4P!4Z,Z&3&1G)*Z/G,0_B M:A*JIW3TEQ:RWV<>5OSL=#M8O\LIR9]FWUO')?3X>+A=C MM!)GU'=(07L4^T0:,*+*H10V'&Z!UHAW52@45\7]?+NX[3W.2=3D=CU_V,QO MMLO5`[?G(JJ>?,+73]/!LB,5,"O<=N@#QHHQH58>%;4)YE.OLJ731Z9GS&H3 M6C5_6![AG!F\$HW/@G*8M?CV5-F?H5#]&5F+O;Q[(T,R%7T=#S:NU?=0?,7&WETXBI&`UJ2 M=<8=N7A$(2N[JK0B#R8?`')7%\I8&O=Q29S)"*[!7!'U"N&[AHUV^,L;9'\8 M.W3SJMLO7HS8@/J\EJ&9]%$@SYDE8PP5.&:)VZ+N!J$;_=9]'X-G)K3)6&4NQ3*EEP05L]+./H/)JO&^MA>F2#LA^Y""K0'R MF$\:1K=Y91IJ/3-,7;T1AIP'#"OJ$#!^^(R67(J0C4-G@SM(0>#5<\*K%QP0 M4[CZCE224IJ(1=C($Q!1N$38Q!P]N);V\C;NJ*V>4I(7XUTR:23Q3ETQ-Z3= MD:$EBM(G&Z%I<$[T"C.K/QY"%(PMMF>J=S8>7B[SS1_S]>*/U?WM8KWYS][M MXFYYLUP\W/Q911V/ZLCJRIV%&#N%4XJ4=<^,5!@$]0G7^%@9 M#CA6>8ANSWKN_43&RRLV$WOS#V3K+ZB7`/R?92,HZ#M"+-20:$`S0;)RC,4O M?,,E-J#?M6="ZZLF*((B2:G"GD"@^J([).WQC63:!FLI-DN_G.+O/.HGSZ8E MM.,)F'M2?>U!?T/AO6\`>*N!F+&8B(UY5>>;81IOQ[?P(CR:PG7S/2,E M3BA9VA0U@\OB4'+!Z+_/I@WX]'U&JD;!9'$H>=^U1,OSLH=.Z+F;UA'/4'&: M@%90%MW[Z*UV,M``VXM7GI]@MZ]PA6(VC[@DT6#W.^F0S3)/Y3Y<&&_P,*NN MNA]&D(,B)YY*H+Y(!'#<\BS6X+'WP^7^N!5$HP18_C1>O@Z=B%)]XMI4M MLM\4#)\R`XS!`)MX.S0?7F:!RG>NHP?H\W4SFSU4O``5O\7;^\$Z(>0Y_E:> M"H1!\-,!'`B99.M9KT*4(ES!3!"V^`)?O>SN(%VF9G-\?S]XLM`/R4^LY]Z# M9?YKISNO/5J-*<:`J\3H\>"K9Y++CD<64KSJ6K[F6KZFY>5K;O!:N#M8OX)E ML30_L+5LF"_)4/(YAN7#XY?28F`&6$.AZN0J..>Q&J&H$7!_HJB`P09GM(2H MNG"I1J9J)BYR/T3Y#YG$%+!,/%1PGBM!]A>,?4,C65XC\4!OEND9&$MS=SCN MB0CW>\/']-'KVA9T"`E-C\$4+F>&>SI"])I1C*&V5L*LL\[D<`DG;J:*"K>) MI^D)"E/(WZ%3.Q:57;EWK6CN%WKO^!FK._AFC\?][='&E@]FW[#V/BH/Z)?WD8.Q&&IP%3_8)E&_:O!C M$^C)K#^+8T6IIYAFN/,D3MTBQB(U[9X]E@V!WQY5^602S.\CX/9H&S786BAYDB#.2^ M-.1N1*$?^I3R0A/U5FE17!FKM"09N?9E1C@2JWTZF'1GM0=/F,[66N`509R] M-YB206K:8?[5&@+9S@!M7Y+ZB!['EG'@DLV1>->ZS)=ZS*5#D6Z MUF5B"'@XDN#]=U*LE\S?@VH*V+Z"1K#\:EFC]\M[Z"6!0"+CB:K`E7)BG8:8 MN",6F<6])DH@)+G.'G3'63U[9WOH:QH`%NA-TRNOL(_A^>Z-%@8R#F8:V.QI M%,6H(8,8(@=#`=LMKI-;5E6GLJOJ!MFD/QE5=).!O]V`,)%#&%IQIRGK@`V$ M)NO4\RGP![*?+*[6%>C)79KXHG6,?"+*"/`L3=,KK\+G8R7..LP!W/M,%E4A MRLLBCJC;!@/[42^`9C+;'*N)N\,Q[J0;J'"/2[4"_!%A']]4V]B^(]',R,4Q+ MX_X]3L";<+0ISQM+B#Y7$$MD[[/RV^(W@ER!_S0.!T-_LW_J!_*7]^Y^]7RC MF_I>CT&@=@G*$'K1>+((GHOOSFP79&/K++(5#.[L.SZ,6[N]EA?]I?,4UZQ-40AJTW!)>L8+1JPSA?WO`+%#.S* M_=``^C0(XSIM6%9,O\I3H/&!3W>L";NSJB:*"A=R2JC!EG`70MRENB]/`7 M-IRB$V^F8MG+)GDF'#CRXBIL51D>^CWR:[7ZV6O>"N28U.7?UZ<\*>,HEY58 M2S1UHK;2+F+861(0G)>8&&L#N.9K3'.09E=AP2C6ENEX5&\6%[?,[PT,Q%[W M&2(?('-'N%$!V^TQS$`:>1?C(XV]3Y7VEB24TDV M;@X7`A')4%@YK\;[UEJ8+IYNZ.H:C>"<^)R3$2)[1D7. M%#<[7G)[R\LR!N+H@E`$*M:.B31=RR>%-FB*>D&=Q0:_<87^J#"?2 M[;PWKP9Z7OQ&NR-)F5T]/V/[/XS'4P8*7!G"',)R[5F,"'6V;]?QR3'VAFZ? M$J\TOIDR!`R*R23;N,W-!$B\Z`=C=2;;HN=X;X,1KIBGT4(ILZMN)%PN9.0V MJID\!5,FRP/$SWKND_!KA,V/[BN&\-^>0UL;*&"!'OG$Z_/4I*(V.%")"BO5 M?[FO-7'P3M^A^1MY[.IKZABN^6D6U08=^"Q`1+O0=#8=CR56`T[+XYSW;[I[ M)%S=DD:1FC:!<_5ETVW0@DIT_%\_/B'2[(4\/.P+>"V%+ M@?/60-"ZY.%\L4I'GD8T`H?M.=#!7IXD1HEK!?6Y@P,8.K MA))-6)K-(!.-4*3RYY>5NA3X2<2DT&R03HSV\?&8!$4A%C+<&Q'?7!J^0)0# M+=XG M?:N?OEFF^SHW]W\BW<9JKL#5@>.82).;13FX(AW0NM5YY]&V=@CMG3L,*]D@ M=7.'X3@_B$D^5A1"Y?T&'\>S&5R&6KE)-6JX5$8Q-FHZY^F,S^;@V<$_CZ.# M&A_)HS&<-A62;U!QN*`)560L??LO42H2F6RCT:1N_:C=KF55#@HHH6:0G^7N M_L5_([HXKV^.-IF.WU)BY_]`#FJX9S26&32H);P`Q;HR4>L.UJE+5PB_" M'T]&BLR=IRJZQ']8I/O6VGAY=1TO';"NIY,D86D\I)EHQ/J@D8C,+NG#&I&5 ML,,+X49WR$V=_(<`^*$?2'61OC*9*7!^\R+R#>H&%S*AAJC=NV[>(J]6:;>U*>C#'B\P$K:JP*5N%E"7)B0C'Y@\4^$$0]4 MF:_)O`E,97$C=1:_67OCV=AY?[(T=[;W!_HA.=*-Y;@$R"E5 M4$+5QUWJ19ZH]$F@6?PF$*"^H@T!.][0B3:I3L4H)!1`&W>H]!%])7G;/&#U M:RK1!HTN!A1"6TOFU#W_+?/V:&-#T3^T??LQBSVLW\`]N_EFU/064`&_V!2O MOW8B_`;Q5'S4/F48D3^0XZ+]PY%DO^/+KHHPJ44%T^@4<\F%SJAGG2OQ$E<].&B_J4Z'`WA]I(,LDWN'BQ(A'K01'%M MZ%!+OP3^3YTGIK!\.:/_E%'S/";[H]+7!"#!6M]KD MF@S6%`=KJ'SJ)U&^Q6]D[PP'>+T*.;M&)/VU0LED,A!)KHN!%58G]G_]*`8:A^,O_C/I1.`=2V8[D M^(]Z_^K=&L[N8#E'&^$?UHN;QH! M__MF\0U_8Q.R#&!W+1[K5O(M>?^QJ1Y^W#R;]6S'<[4H&&7"UL MR\3_]/ON7"Q\]-M%YA[M_X.A#"KZE34F"=1Z)1=C9VDFOV.8.^/]@)RHI]QH M,H;;!@5,D&GMB$9GBX7PY>`E4XU&`S@/C8@I"ME<0#0IJETK6A`MKG);>>]2 M)I=[U^;[E\WBO[_CW:FW^('_GV^+(J7^T-]'3''QD4HYX=B++L9Q$DTK`6NA M9E$MOVM'Z_AQ```,O&```1`!P`8W1T8RTR,#$T,#,S,2YX^?_O%]&5@/F`O"Z%6C_?:B86'J,9_0^57CSFW:;J?7:UA"(NJC M@%%\U:"L\8^?__RGG_[2;'8X1A+[UG1EW1,JT1Q;71(`K[#>-.Z[C1^:S90R MY,R//"!EU'IWT7[?O/C0;'^P_FFU+SZ]^V#9MPGE=^%_$MX"+Y$E$9]C.4!+ M+$+DP7<74H:?6BV/+4,LB20/6&)O\99BV5(E7EQ>MD'X`"\QE5W&ES=XAJ)` M7C7^B%!`9@3[#0NTI>*3)Z57LKR$X?N4!V3-\?CX^%:EO&5\#J07ERU"505Y M.*.GC-)H62CPHB#^1']30",M8<'Q[*JAFJJ9-<$DA.J"QC^CZLK0%,""S_$Q6F))R`\);Z M<3?N'70+<679#X@`7`(\8UR@`-O4=_Z(B%RYV(LX49HT+.*G%880%NU3I5S+ MF$FYZ?D_MR\^6$WKA@@O8"+B&/ZP[^U>W[[N.\WN<-QT[;YCV8,;R_GUKC?Y M:KE.!_2:]!SWI]9N8;O?B03VA_3G^/>.=4Z94XI#C-MFJCS?+@K+GD6 M@#3F$.G@_6QI:H:0_P9P;K`$FEW\^)4"Z/W%AXOVN1"RWJ0B_E"#R70P353V M+I9DI5BZ/-\866\2^6H@O3"0/(]'V'>^AY@*+`!'0[G`O$_0%$9RN]X,(Q94 M[,X^:@CJ=,9W#D#FMY$S<`$I"C_#R2_.V.KW[.M>OW9FKP$V!;Y,H:=J9_:Q MP)F5`E#MREX-E'1/II!4M2L[TQ#5CLP,&%TC0<1P-LJIF4/,E(75NBW-ZES; M;L^UAEUK-'9<9S"Q)[WAH,:$:9C0W1)`PZ_6)Y5%1^V"#,%)AU%?.1\??@@6 M$%^M:ERC0,WINPN,91XOGC<55>+EXN(=`,2%VHV7+N#W6APK+X^5"F0E$M60 M,1PR(P0B020C"53^+H`J]49`>`Z"K#?;(M96R$!(K5L5_%@'B44W8(_;8!+, MFU6+IA_+H6DCFL5FEA+.BJ6K860XC!:(SK'H47,#P=6XG$%J%67N:_6JG4->+,1MPPQ#S6?M=RL6K!]?X<<&V$JV'T MTC"2''DR0L%P&I!YTB@V5;"2!`P`];:GHSV&O$I']>W+W7%;9SB8C.W.Y,[N M6\/K?N]S/'!+IH)47F_PV1ETZOGHUX$=??"O(%3MZ+]]J8_^2Z.HGA$P!$\W MS(N4AU#KJ@`@N>K1&>/+W6E%'V%2K0N+L9-^//\34=]*)+%RHM0H>5&4=!'A M]RB(\"U&JJLODZ@B!Y#9P[+B]=(?=XU+U^Z-K7N[?^=8MX[MWHV=6_AO,*E= MDI'@T'T08*3J5=$?=1^T%R:USS$$,+D53UL(,J?8G[`L<36*N+>`EK?G',=( MRB$(6B$(4;6&IGVQBZ#\HJ?MNKW/`^?&F@S7Z5^MT=VX\XOM.I;]>>S$Z*HA M]9H@I=NF!%D5FZ?VA6Z>S@%7;;D,@=D`RQZ%7-QG0HPP[[#EDB73BSDL41*$ M7M6[H=_M`FG@3*S>H#.\=:PW_:'K_F"-G#&,LFYOAP/+_<4>.S583`5+9U/7 MP]D!.MU.)=CR6/)OU>'4.]U>'8>9]2:GCIIH!(6L1"-@`9V`!7,K42N9U_ZA MMFCF@W2`N)HO?MB+0EH]_,ZP!:2ZAV.1H"' M22Q&:*4:(X^3L.*!G^[KAA.(RD?V5W6NHP:!,2`XY(G"JKU0N^#DX18P:H=C M.%S<:+E$?#6]!GLU_MCX$HES`!E;82L(64^I`[;J^>P5H<#;AU0 MM84R&D[Z2#ZL>!1_9(A6#]C-`,4HN=MFE5[.$.ZLVH8(5[L6\O==5(S&PY$S MGGQ=7\$PJM=DC42%[FL`'!6?2OR[[F>*\5$[%8.1HCD7`(JL=HJXI!FIO8PI M*,$A(MK]"9V(J\-]MA#;QU=#C&`P4O$J_-]TR#@CNU=X=T+G;CQ6\+%=UZDW M*;X"\!0XIQA#52]S_JW(096$4>VS7A&@=!\6XZGJI<[SC5+MVLP`TQA[F#SL MHH57[+RT^;RQTW%Z]VHD7;LG8P"@>R%>M0-ZKSN@'!1J%V,0**@,5FKE!ONV MY[$H/N,'PR4*/SWM$`XGJ.+;G[0E3(63P:3_U>JYKKHSS.YTAG?QP3XU>AK` M[TY]*,<([`3J"/@(P;!ZPA$5R(N7E/-HJ7BVMMTN<#!]>P(H&=EJ5#T9VP/7 M[L1'0FMX&`F/`N<3RJH7@@K=SSZ@U-[(&,BL0Q1M7,.K'M(<"E7K08L9@-!O MU8'OKW*HJ/9*G79;V^P2[]K]9=B_<<;N7ZT;I]OK])Q!YVL-#`.!<6`3I_!I MQ7=3%!QDV0>6>CNGB1"*PC!YX0H%FU94^U:HA\1B3T0K?$:K]43O+PJ.<.:% MR^?$NU9H4PEHY26LL62@.=KLA?J"R7P!P;#]@#F:']XK+'S!'A&JW%J5=FW; MFZ0RT:U4]GKS\.L!H!9$"[_:]>WR\5(=41L"E&@J\!\1J.@\;&^A$KCBJ1KM MB(M[=^TZO]ZIM2'GOMX\50T4?FKMOB69IFR_.1F_.$F6(>/2HMI#H(>>X4S> M$.VGNZX/L*B_FAE?4R4UV^^:E^VWW]4HK766&&NHG2A&QG>6&'%Y`GMOY^RA MY6.BWC"];%ZTF^H5TSUR%/*H'\T-\XD2:(^/EJR"C$'I_N',RB]^6;6,`'G. M0<*H!/FH&J']XY/%.4^4)\BQU;"$/F`A3\9#CBW]?18J9DA,8\4BT9PC%):6 MHY"QA0,ILI0GRZ/J650D4%S6^?TFJW4OWB?AK53A[TYIKBW&]5_-33'G"J06 MU_CJ9/CD^;(_GEX]0H9<%=D^190U4_RKN6$_W\A_3`(3BN=JN:!Q MU+=G_0HE0?QP3/[:"0 M2!1\47.W0)#<@/R@7EB.C[1-Y1H61(%AVPU^(!Z>P#B4LH#-(7DYQ3Q73R=S[M8!`GW4E=55 MFT2?+4&F,KIO-]VFV480=^8`WP$+3^C\FOAY]<]@/MYO3K,(IW6;G,3YTWI= M%G&]<8_3FMR<6Z<1%V"HRRJX1?QJ-'QDI?7;D!JGG>I&V64$]G>2FP+]IF<] M@_2^_.03D$=UXIYF4Z%XZ,8GJG$3Z[Y'D2S3Z(9P0J1A:T^^T7H,J6X#]N0; MK4>Q-=M+8;8N!79K3[YY>A"./%QQ:'WKVP4]#EE2U%_NSH M/=%%.P?5/8X<]7#K+1WQ9\HH6^7 M4+#E9.LAI@ES(&Q5AS0ZL8%G/.\K2G.8.M/T&9`@U)6NT`;4Q5(FN<-9-E&2 M4[8$K;$^\K,2L!O%GBO9]XP!E0,"!6"<_+OJ0J+69T]E-*X3EU*@:";A5$;C M-#_Q"8F"(.'L$DR+&TY4I`^-JTH5Y]=%KHA75!D%BA0M.)U=@@F+23GA.P$B M2Z$)G*Z(%2M\C,=43Y=301->LWUEB`VT=YZ:`X.A612JU6#LCSCS(T_JHX7C MI.9I!X''YDG,U0U:PHA4;)9Y[$?$?>S'5^[F-3V)[0AX?3Q]F?`E\;8W:+4[ M.YP_]J>U\DEC(@";%Q>BU'7KOB?&.;D-%LC)[-,.G]\A"1@0VT69Z` M0H784D3+,]4QY$6%'@$9"RS567Q!*&T)LC$M>O2.$+[QB!.(),+`X2#:#B2A0+5!@.8\1FFI%1_$Q%\") M*YGW>VX0H%::A3J_EF^AF"C>`Y4N_.5KX*DEO713;\F_CE7V:IBC,#5L3:\K M[.,Y"KIX&Z]:EJ$1V(@S#V-?I,],8+_`WA^@,<[H[XIZC6E\.A0%A_:MGL9F M+AYWM"A^]$W7=IONU:A7L$!V@,9@M99$",97<3-HPY\]^<:-?,;8Q\DQ^5'\ MT9P*>E;ESBA)R9C*B,M6*%"SRYL[F/(2%^4::L)=%*CGLN(;-)(#&!,.31:O M&:KK-+(0%S(4J0H$57)RG:X&MTI*,PZW#4/\/AK,.6(1@T$#_W[AK`Y'@_.[D,LSI9/)1)KRE)MF/MA\5>6H/;&KZ) M!1I27#BMM;OH!?C.XC'=[SRY*/.<3JI2557S/U8O\6;[JBKG28496T./K++Z M.;\H0VMG6E'5G%V.@?6B;PBUETJ;+:7W$YDZB^JR2"XX\>=XIUGT)CU&:5ZC MK25.CXV+'NF'!Q0K(C-/*RV6*5H2/$AEVM1B+&SR;,!-I'B2N8QD]WRI%?RS M2WBFV9+2N_*/[V9[/9O8)HPB@!J8OZ>ZCR>79%[=J`M69YA/F#HN0B7C^?69 MPEQ37<;D$7XGF^,9S:Z5V+2&WICEZ(UKLOMXA]H]B0]>%VR>V9-OG!YIWTBL M8SJ?!B-^:/%DO1,%`?:O5RE93L%3&4U=!D@%G&"^U+5+4E]^TOP+2$#0DG]! M@3H5V)<^5#:BR-`Q0````(`#UTKT36 MZ`Q0````(`#UTKT1'$V!B M#A```%G(```5`!@```````$```"D@>ZA``!C='1C+3(P,30P,S,Q7V-A;"YX M;6Q55`4``Y4(=5-U>`L``00E#@``!#D!``!02P$"'@,4````"``]=*]$D+B. M.;0X``!WI0,`%0`8```````!````I(%+L@``8W1T8RTR,#$T,#,S,5]D968N M>&UL550%``.5"'53=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`/72O1%^. MAZ!3IP``D%`)`!4`&````````0```*2!3NL``&-T=&,M,C`Q-#`S,S%?;&%B M+GAM;%54!0`#E0AU4W5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`#UTKT0# MA-\U[$L``+#`!``5`!@```````$```"D@?"2`0!C='1C+3(P,30P,S,Q7W!R M92YX;6Q55`4``Y4(=5-U>`L``00E#@``!#D!``!02P$"'@,4````"``]=*]$ MJWA^OX<0``#+Q@``$0`8```````!````I($KWP$`8W1T8RTR,#$T,#,S,2YX M`L``00E#@``!#D!``!02P4&``````8`!@`:`@``_>\! #```` ` end XML 37 R22.htm IDEA: XBRL DOCUMENT v2.4.0.8

NET INCOME (LOSS) PER COMMON SHARE (Tables)
3 Months Ended

Mar. 31, 2014

NET INCOME (LOSS) PER COMMON SHARE [Abstract]

Calculation of Net Earnings Per Share

The following sets forth the denominator used in the calculations of basic net income (loss) per share and net income (loss) per share assuming dilution:

Three months
ended Three months
ended

March 31,
2014 March 31,
2013

Denominator for basic net income (loss) per share, weighted average shares outstanding 20,036,240 15,588,693

Dilutive effect of common stock options N/A N/A

Dilutive effect of Series C convertible preferred stock, convertible debt and warrants N/A N/A

Denominator for diluted net income (loss) per share, weighted average shares outstanding 20,036,240 15,588,693

X

- Details

Name: us-gaap_EarningsPerShareAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

+ Details

Name: us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 38 R36.htm IDEA: XBRL DOCUMENT v2.4.0.8

PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details) (USD $)

Mar. 31, 2014

Dec. 31, 2013

PREPAID EXPENSES AND OTHER CURRENT ASSETS [Abstract]

Prepaid insurance $ 15,230 $ 16,802

Other 32,865 48,365

Prepaid expenses and other current assets $ 48,095 $ 65,167

X

- Details

Name: us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (g)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6787-107765

+ Details

Name: us-gaap_OtherPrepaidExpenseCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 8

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

+ Details

Name: us-gaap_PrepaidExpenseAndOtherAssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Current Assets

-URI http://asc.fasb.org/extlink&oid=6509628

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6787-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (g)(1)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 340

-SubTopic 10

-Section 05

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6386993&loc=d3e5865-108316

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 340

-SubTopic 10

-Section 05

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6386993&loc=d3e5879-108316

+ Details

Name: us-gaap_PrepaidInsurance

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 39 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8

PREPAID EXPENSES AND OTHER CURRENT ASSETS (Tables)
3 Months Ended

Mar. 31, 2014

PREPAID EXPENSES AND OTHER CURRENT ASSETS [Abstract]

Schedule of Prepaid Expenses and Other Assets

Prepaid expenses and other current assets consist of the following:

March 31,
2014 December
31,
2013

Prepaid insurance $ 15,230 $ 16,802

Other 32,865 48,365

Prepaid expenses and other current assets $ 48,095 $ 65,167

X

- Details

Name: us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Tabular disclosure of the carrying amounts of other current assets.

+ References

No definition available.

+ Details

Name: us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 40 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 41 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8

BASIS OF PRESENTATION
3 Months Ended

Mar. 31, 2014

BASIS OF PRESENTATION [Abstract]

BASIS OF PRESENTATION

1.    BASIS OF PRESENTATION

The interim condensed consolidated financial information presented in the accompanying condensed consolidated financial statements and notes hereto is unaudited.

Competitive Technologies, Inc. ("CTI") and its majority-owned (56.1%) subsidiary, Vector Vision, Inc. ("VVI"), (collectively, the "Company", "we" or "us") is a biotechnology company developing and commercializing innovative products and technologies. CTI is the licensed distributor of the non-invasive Calmare® pain therapy medical device, which incorporates the biophysical "Scrambler Therapy"® technology developed to treat neuropathic and cancer-derived pain.

These consolidated financial statements include the accounts of CTI and VVI.  Inter-company accounts and transactions have been eliminated in consolidation.

We believe we have made all adjustments necessary, consisting only of normal recurring adjustments, to present the unaudited condensed consolidated financial statements in conformity with accounting principles generally accepted in the U.S.  The results for the three months ended March 31, 2014 are not necessarily indicative of the results that can be expected for the full year ending December 31, 2014.

The interim unaudited condensed consolidated financial statements and notes thereto, should be read in conjunction with our Annual Report on Form 10-K for the year ended December 31, 2013 filed with the Securities and Exchange Commission ("SEC") on April 16, 2014.

During the three months ended March 31, 2014, we had a significant concentration of revenues from our Calmare® pain therapy medical device.  The percentages of gross revenue attributed to sales and rentals of Calmare devices, in the three months ended March 31, 2014, was 98%; and 13% in the three months ended March 31, 2013.  Additionally, the percentage of gross revenue attributed to other Calmare related sales of equipment and training, in the three months ended March 31, 2014, was 1%; and 66% in the three months ended March 31, 2013.  We continue to attempt to expand our sales activities for the Calmare device and expect the majority of our revenues to come from this technology.

The Company has incurred operating losses since fiscal 2006 and has a working capital deficiency at March 31, 2014.  The Company has taken steps to reduce its operating expenses as well as increase revenue from sales of Calmare medical devices.  However, even at the reduced spending levels, should the anticipated increase in revenue from sales of Calmare devices not occur the Company may not have sufficient cash flow to fund operations through 2014.  These conditions raise substantial doubt about the Company's ability to continue as a going concern.  The financial statements do not include adjustments to reflect the possible future effect of the recoverability and classification of assets or amounts and classifications of liabilities that may result from the outcome of this uncertainty.

The Company's continuation as a going concern is dependent upon its developing recurring revenue streams sufficient to cover operating costs.  The Company does not have any significant individual cash or capital requirements in the budget going forward.  If necessary, CTI will meet anticipated operating cash requirements by further reducing costs, issuing debt and/or equity, and/or pursuing sales of certain assets and technologies while we pursue licensing and distribution opportunities for our remaining legacy portfolio of technologies.  There can be no assurance that the Company will be successful in such efforts.  Failure to develop a recurring revenue stream sufficient to cover operating expenses could negatively affect the Company's financial position.

Our liquidity requirements arise principally from our working capital needs, including funds needed to sell our current technologies and obtain new technologies or products, and protect and enforce our intellectual property rights, if necessary. We fund our liquidity requirements with a combination of cash on hand, debt and equity financing, sales of common stock and cash flows from operations, if any, including royalty legal awards. At March 31, 2014, the Company had outstanding debt in the form of promissory notes with a total principal amount of $3,277,000 and a carrying value of $3,117,000.

The Company acquired the exclusive, worldwide rights to the Scrambler Therapy® technology in 2007. The Company's original 2007 agreement with Giuseppe Marineo (the "Scrambler Therapy Agreement"), an inventor of Scrambler Therapy technology, and Delta Research and Development, authorized CTI to manufacture and sell worldwide the device developed from the patented Scrambler Therapy technology. The original agreement was amended in 2011 to provide the Company with exclusive rights to the Scrambler Therapy technology through March 31, 2016. In July 2012, the Company attempted to negotiate a five-year extension to the agreement with Marineo and Delta (the "2012 Amendment"). However, a valid contract was never formed as the 2012 Amendment was not executed by Marineo and Delta. The Scrambler Therapy technology is patented in Italy and in the U.S. Applications for patents have been filed internationally as well and are pending approval. The Calmare device has CE Mark certification from the European Union as well as U.S. FDA 510(k) clearance. CTI's partner, GEOMC Co., Ltd. of Korea, is manufacturing the product commercially under a ten (10) year agreement through 2017. Sales of these devices are expected to provide a significant proportion of the Company's revenue for the next several years.



X

- Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 720

-SubTopic 15

-URI http://asc.fasb.org/subtopic&trid=2122524

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=28200181&loc=SL6228881-111685

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 10

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=7668296&loc=d3e288-107754

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-URI http://asc.fasb.org/subtopic&trid=2197480

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=18733093&loc=d3e5614-111684

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 915

-SubTopic 235

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6472506&loc=d3e38932-110933

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 852

-SubTopic 10

-URI http://asc.fasb.org/subtopic&trid=2209116

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 272

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-URI http://asc.fasb.org/subtopic&trid=2134480

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 10

-URI http://asc.fasb.org/subtopic&trid=2122150

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755

+ Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 42 R3.htm IDEA: XBRL DOCUMENT v2.4.0.8

Condensed Consolidated Balance Sheets (Parentheticals) (USD $)

Mar. 31, 2014

Dec. 31, 2013

Allowance for doubtful accounts $ 101,154 $ 101,154

Common stock, par value (in dollars per share) $ 0.01 $ 0.01

Common stock, shares authorized (in shares) 40,000,000 40,000,000

Common stock, shares issued (in shares) 22,463,532 19,952,907

Common stock, shares outstanding (in shares) 22,463,532 19,952,907

Series B Preferred Stock [Member]

Preferred stock, par value (in dollars per share) $ 0.001 $ 0.001

Preferred stock, shares authorized (in shares) 20,000 20,000

Preferred stock, shares issued (in shares) 0 0

Preferred stock, shares outstanding (in shares) 0 0

Series C convertible preferred stock [Member]

Preferred stock, par value (in dollars per share) $ 1,000 $ 1,000

Preferred stock, shares authorized (in shares) 750 750

Preferred stock, shares issued (in shares) 375 375

Preferred stock, shares outstanding (in shares) 375 375

5% Preferred stock [Member]

Preferred stock, par value (in dollars per share) $ 25 $ 25

Preferred stock, shares authorized (in shares) 35,920 35,920

Preferred stock, shares issued (in shares) 2,427 2,427

Preferred stock, shares outstanding (in shares) 2,427 2,427

X

- Definition

A valuation allowance for doubtful other receivables due to an entity within one year (or the normal operating cycle, whichever is longer) that are expected to be uncollectible and not separately disclosed.

+ References

No definition available.

+ Details

Name: us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Face amount or stated value per share of common stock.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition

The maximum number of common shares permitted to be issued by an entity's charter and bylaws.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

+ Details

Name: us-gaap_PreferredStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition

The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

+ Details

Name: us-gaap_PreferredStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

+ Details

Name: us-gaap_PreferredStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

+ Details

Name: us-gaap_PreferredStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

XML 43 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8

NOTES PAYABLE
3 Months Ended

Mar. 31, 2014

NOTES PAYABLE [Abstract]

NOTES PAYABLE

11.           NOTES PAYABLE

Notes payable consist of the following:

March 31,
2014 December 31,
2013

90 day Convertible Notes (Chairman of the Board) $ 2,498,980 $ 2,518,000

24 month Convertible Notes ($100,000 to Board member) 225,000 225,000

Tonaquint 9% OID Convertible Notes and Warrants 118,536 87,705

Southridge Convertible Note 12,000 12,000

Series A1 15% OID Convertible Notes and Warrants 100,076 81,415

Series A2 15% OID Convertible Notes and Warrants 91,127 69,571

Series A3 15% OID Convertible Notes and Warrants 37,007 -

Series B OID Convertible Notes and Warrants 34,272 -

Notes Payable, gross 3,116,998 2,933,691

Less LPA amount (485,980 ) (505,000 )

Notes Payable, net $ 2,631,018 $ 2,488,691



Details of notes payable as of March 31, 2014 are as follows:

Principal
Amount Carrying
Value Cash
Interest
Rate Common
Stock
Conversion
Price Maturity
Date

90 day Convertible Notes (Chairman of the Board) $ 2,498,980 $ 2,498,980 6 % $ 1.05 Various 2014

24 month Convertible Notes ($100,000 to Board member) 225,000 225,000 6 % 1.05 March 2014 -
June 2014

Tonaquint 9% OID Convertible Notes (1) 112,500 118,536 7 % 0.30 May 2014

Southridge Convertible Note 12,000 12,000 None 75% of closing
bid June 2014

Series A1 15% OID Convertible Notes and Warrants 149,412 100,076 None 0.20 August 2014

Series A2 15% OID Convertible Notes and Warrants 134,236 91,127 None 0.25 September 2014

Series A3 15% OID Convertible Notes and Warrants 64,706 37,007 None 0.25 January 2015

Series B OID Convertible Notes and Warrants 80,000 34,272 None 0.35 March 2017

Notes Payable, gross $ 3,276,834 3,116,998

Less LPA amount (485,980 )

Notes Payable, net $ 2,631,018



  (1) Original terms noted above. The Company executed a debt settlement agreement with Tonaquint during the first quarter of 2014, cash-settled the warrant during the first quarter of 2014 and cash-settled the note during the second quarter of 2014. See further discussion below under "Tonaquint 9% Original Issue Discount Convertible Notes and Warrants".

90 day Convertible Notes

The Company has issued 90-day notes payable to borrow funds from a director, now the chairman of our Board, as follows:

2013 $ 1,188,980

2012 1,210,000

2011 100,000

Total $ 2,498,980



These notes have been extended several times and all bear 6.00% simple interest.  A conversion feature was added to the Notes when they were extended, which allows for conversion of the eligible principal amounts to common stock at any time after the six month anniversary of the effective date -the date the funds are received - at a rate of $1.05 per share.  Additional terms have been added to all Notes to include additional interest payments to all Notes if extended beyond their original maturity dates and to provide the lender with a security interest in unencumbered inventory and intangible assets of the Company other than proceeds relating to the Calmare device and accounts receivable.

A total of $485,980 of the aforementioned notes issued between December 1, 2012 and March 31, 2013 fall under the LPA with ASC Recap, and are expected to be repaid using the process as described in Note 10.  Because there can be no assurance that the Company will be successful in completing this process, the Company retains ultimate responsibility for this debt, until fully paid down.  As a result, the Company continues to accrue interest on these notes and they remain convertible as described above.

24 month Convertible Notes

In March 2012, the Company issued a 24-month convertible promissory note to borrow $100,000. Additional 24-month convertible promissory notes were issued in April 2012 ($25,000) and in June 2012 ($100,000). All of the notes bear 6.00% simple interest. Conversion of the eligible principal amounts to common stock is allowed at any time after the six month anniversary of the effective date of each note at a rate of $1.05 per share.

As of May 14, 2014 the Company has not repaid the principal due on the March 2012 $100,000 note or the April 2012 $25,000 note and as such is in default under the terms of the notes. There is also unpaid interest related to these notes.

Tonaquint 9% Original Issue Discount Convertible Notes and Warrants

During the quarter ended September 30, 2013, the Company entered into a securities purchase agreement with Tonaquint, Inc., under which it was issued a $112,500 convertible promissory note in consideration for $100,000, the difference between the proceeds from the Note and the principal amount consisted of a $10,000 original issue discount and a carried transaction expense of $2,500. The original issue discount was being amortized over the life of the note. The note was convertible at an initial conversion price of $0.30 per share at any time, and contained a "down-round protection" feature that requires the valuation of a derivative liability associated with the note. The note bore interest at 7% and was due in May 2014. Tonaquint was also issued a market-related warrant for $112,500 in shares of common stock with a "cashless" exercise feature. The warrant had a $0.35 exercise price, a 5-year term and included a "down-round protection" feature that required it to be classified as a liability rather than as equity (see Note 6).

During the first quarter of 2014 the Company executed a debt settlement agreement with Tonaquint related to the note and warrant. The warrant was settled during the first quarter of 2014 for a cash payment of $98,000, resulting in a loss of $98,000. The note was settled during the second quarter of 2014 for cash payments totaling $144,000 ($20,000 paid in the first quarter of 2014 and $124,000 paid in the second quarter of 2014). Because the execution of the debt settlement agreement in the first quarter of 2014 resulted in a significant modification of the original terms of the note agreement, the Company adjusted the carrying value of the note in the first quarter of 2014 and recorded a related loss of approximately $34,000.

Southridge

During 2013, the Company issued a six-month $12,000 convertible note payable to Southridge to cover legal expenses as part of the LPA (see Note 10). The convertible note is convertible into the Company's common stock at 75% of the lowest closing bid price during the twenty (20) trading days prior to conversion and is due in June 2014.

Series A 15% Original Issue Discount Convertible Notes and Warrants

During the quarter ended December 31, 2013, the Company did a private offering of two tranches of convertible notes and warrants, under which it issued $283,648 of convertible promissory notes for consideration of $241,100, the difference between the proceeds from the notes and the principal amount consists of $42,548 of original issue discount. During the quarter ended March 31, 2014, the Company did a private offering of a third tranche of convertible notes and warrants, under which it issued $64,706 of convertible promissory notes for consideration of $55,000, the difference between the proceeds from the notes and principal amount consists of $9,706 of original issue discount. The notes are convertible at initial conversion prices ranging from $0.20 to $0.25 per share anytime after issuance thereby having an embedded beneficial conversion feature. The note holders were also issued market-related warrants for 958,179 in shares of common stock. The warrants have exercise prices that range from $0.40 to $0.60 and a 2-year term. The beneficial conversion feature and the warrants were recorded to additional paid-in-capital. The Company allocated the proceeds received to the notes, the beneficial conversion feature and the warrants on a relative fair value basis at the time of issuance. The total debt discount is amortized over the life of the notes to interest expense.

The beneficial conversion feature was valued at the intrinsic value on the issuance date. The intrinsic value represents the difference between the conversion price and the fair value of the common stock multiplied by the number of share into which the note is convertible. We estimated the fair value of the warrants on the issue date using a Black-Scholes pricing model with the following assumptions:

Warrants
(Tranche 1)-
November 15,
2013 Warrants
(Tranche 2)-
December 30,
2013 Warrants
(Tranche 3)-
February 14,
2014

Expected term 2 years 2 years 2 years

Volatility 180.02 % 184.38 % 184.88 %

Risk Free Rate 0.31 % 0.39 % 0.32 %

The proceeds of the Notes issued during the three months ended March 31, 2014 were allocated to the components as follows:

Proceeds allocated
at issue date

Private Offering Notes $ 32,390

Private Offering Warrants 14,845

Beneficial Conversion feature 7,765

Total $ 55,000

Series B Original Issue Discount Convertible Notes and Warrants

During the quarter ended March 31, 2014, the Company did a private offering of convertible notes and warrants, under which it issued $80,000 of convertible promissory notes for consideration of $65,000, the difference between the proceeds from the notes and principal amount consists of $15,000 of original issue discount. The notes are convertible at an initial conversion price of $0.35 per share anytime after issuance thereby having an embedded beneficial conversion feature. The note holders were also issued market-related warrants for 185,714 in shares of common stock. The warrants have an exercise price of $0.45 and a 4-year term. The beneficial conversion feature and the warrants were recorded to additional paid-in-capital. The Company allocated the proceeds received to the notes, the beneficial conversion feature and the warrants on a relative fair value basis at the time of issuance. The total debt discount is amortized over the life of the notes to interest expense.

The beneficial conversion feature was valued at the intrinsic value on the issuance date. The intrinsic value represents the difference between the conversion price and the fair value of the common stock multiplied by the number of share into which the note is convertible. We estimated the fair value of the warrants on the issue date using a Black-Scholes pricing model with the following assumptions:

Warrants
March 20,
2014

Expected term 4 years

Volatility 151.52 %

Risk Free Rate 1.32 %

The proceeds of the Notes were allocated to the components as follows:

Proceeds allocated
at issue date

Private Offering Notes $ 34,272

Private Offering Warrants 26,811

Beneficial Conversion feature 3,917

Total $ 65,000

X

- Details

Name: us-gaap_DebtDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19, 20, 22

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19,20,22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_DebtDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 44 R1.htm IDEA: XBRL DOCUMENT v2.4.0.8

Document and Entity Information
3 Months Ended

Mar. 31, 2014

May 14, 2014

Document and Entity Information [Abstract]

Entity Registrant Name COMPETITIVE TECHNOLOGIES INC

Entity Central Index Key 0000102198

Document Type 10-Q

Document Period End Date Mar. 31, 2014

Amendment Flag false

Current Fiscal Year End Date --12-31

Entity Filer Category Smaller Reporting Company

Entity Common Stock, Shares Outstanding 22,463,532

Document Fiscal Period Focus Q1

Document Fiscal Year Focus 2014

X

- Details

Name: cttc_DocumentAndEntityInformationAbstract

Namespace Prefix: cttc_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

If the value is true, then the document is an amendment to previously-filed/accepted document.

+ References

No definition available.

+ Details

Name: dei_AmendmentFlag

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition

End date of current fiscal year in the format --MM-DD.

+ References

No definition available.

+ Details

Name: dei_CurrentFiscalYearEndDate

Namespace Prefix: dei_

Data Type: xbrli:gMonthDayItemType

Balance Type: na

Period Type: duration

X

- Definition

This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.

+ References

No definition available.

+ Details

Name: dei_DocumentFiscalPeriodFocus

Namespace Prefix: dei_

Data Type: dei:fiscalPeriodItemType

Balance Type: na

Period Type: duration

X

- Definition

This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.

+ References

No definition available.

+ Details

Name: dei_DocumentFiscalYearFocus

Namespace Prefix: dei_

Data Type: xbrli:gYearItemType

Balance Type: na

Period Type: duration

X

- Definition

The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.

+ References

No definition available.

+ Details

Name: dei_DocumentPeriodEndDate

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".

+ References

No definition available.

+ Details

Name: dei_DocumentType

Namespace Prefix: dei_

Data Type: dei:submissionTypeItemType

Balance Type: na

Period Type: duration

X

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation 12B

-Number 240

-Section 12b

-Subsection 1

+ Details

Name: dei_EntityCentralIndexKey

Namespace Prefix: dei_

Data Type: dei:centralIndexKeyItemType

Balance Type: na

Period Type: duration

X

- Definition

Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.

+ References

No definition available.

+ Details

Name: dei_EntityCommonStockSharesOutstanding

Namespace Prefix: dei_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.

+ References

No definition available.

+ Details

Name: dei_EntityFilerCategory

Namespace Prefix: dei_

Data Type: dei:filerCategoryItemType

Balance Type: na

Period Type: duration

X

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation 12B

-Number 240

-Section 12b

-Subsection 1

+ Details

Name: dei_EntityRegistrantName

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

XML 45 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8

SHAREHOLDERS' DEFICIENCY
3 Months Ended

Mar. 31, 2014

SHAREHOLDERS' DEFICIENCY [Abstract]

SHAREHOLDERS' DEFICIENCY

12. SHAREHOLDERS' DEFICIENCY

Stock Option Plan

On May 2, 2011 the Company adopted and executed the Employees' Directors' and Consultants Stock Option Plan (the "Plan"). During the three months ended March 31, 2014, the Company granted 42,500 options to non-employee directors which were fully vested upon issuance. During the three months ended March 31, 2013, the Company granted 50,000 options to non-employee directors which were fully vested upon issuance.

During the three months ended March 31, 2013, the Company granted 1,000,000 stock options to its then CEO of which 200,000 vested immediately. Due to his subsequent resignation in September 2013, all options have since been cancelled.

There were no grants of stock options to employees during the three months ended March 31, 2014.

During the three months ended March 31, 2013 the Board of Directors extended the expiration dates for all options previously granted to one departing Board member in recognition for service. The Company considered the extension as a modification to the option agreements recording incremental compensation expense of $16,920 for the three months ended March 31, 2013.

We estimated the fair value of each option on the grant date using a Black-Scholes option-pricing model with the following weighted average assumptions:

Three
months
Ended Three
months
Ended

March 31,
2014 March 31,
2013

Dividend yield (1) 0.00 % 0.00 %

Expected volatility (2) 118.5 % 99.2% - 100.3 %

Risk-free interest rates (3) 1.72 % 0.63 %

Expected lives (2) 5.0 YEARS 2.0-4.0 YEARS

(1) We have not paid cash dividends on our common stock since 1981, and currently do not have plans to pay or declare cash dividends. Consequently, we used an expected dividend rate of zero for the valuations.

(2) Estimated based on our historical experience. Volatility was based on historical experience over a period equivalent to the expected life in years.

(3) Based on the U.S. Treasury constant maturity interest rate with a term consistent with the expected life of the options granted.

During the three months ended March 31, 2014, the Company recognized expense of $11,178 for stock options issued to directors and expense of $3,150 for stock options issued to employees.

During the three months ended March 31, 2013, the Company recognized expense of $14,250 for stock options issued to directors and expense of $80,267 for stock options issued to employees.

Preferred Stock

Holders of 5% preferred stock are entitled to receive, if, as, and when declared by the Board of Directors, out of funds legally available therefore, preferential non-cumulative dividends at the rate of $1.25 per share per annum, payable quarterly, before any dividends may be declared or paid upon or other distribution made in respect of any share of common stock. The 5% preferred stock is redeemable, in whole at any time or in part from time to time, on 30 days' notice, at the option of the Company, at a redemption price of $25. In the event of voluntary or involuntary liquidation, the holders of preferred stock are entitled to $25 per share in cash before any distribution of assets can be made to holders of common stock.

Each share of 5% preferred stock is entitled to one vote. Holders of 5% preferred stock have no preemptive or conversion rights. The preferred stock is not registered to be publicly traded.

At its December 2, 2010 meeting, the CTI Board of Directors declared a dividend distribution of one right (each, a "Right") for each outstanding share of common stock, par value $0.01, of the Company (the "Common Shares"). The dividend was payable to holders of record as of the close of business on December 2, 2010 (the "Record Date"). Issuance of the dividend may be triggered by an investor purchasing more than 20% of the outstanding shares of common stock.

On December 15, 2010 the Company issued a $400,000 promissory note. The promissory note was scheduled to mature on December 31, 2012 with an annual interest rate of 5%.

On December 15, 2010, the Company's Board of Directors authorized the issuance of 750 shares of Series C Convertible Preferred Stock ($1,000 par value) with a 5% cumulative dividend to William R. Waters, Ltd. of Canada. On December 30, 2010, 750 shares were issued. The Company converted the above $400,000 promissory note into 400 shares and received cash of $350,000 for the remaining 350 shares.

Effective June 16, 2011, William R. Waters, Ltd. of Canada converted one half of its Series C Convertible Preferred Stock, or 375 shares, to 315,126 shares of common stock.

The rights of the Series C Convertible Preferred Stock are as follows:

a)
Dividend rights - The shares of Series C Convertible Preferred Stock accrue a 5% cumulative dividend on a quarterly basis and is payable on the last day of each fiscal quarter when declared by the Company's Board. As of March 31, 2014 dividends declared were $70,323, of which $4,623 were declared during the three months ended March 31, 2014 and $51,575 have not been paid and are shown in accrued and other liabilities at March 31, 2014.

b) Voting rights - Holders of these shares of Series C Convertible Preferred Stock shall have voting rights equivalent to 1,000 votes per $1,000 par value Series C Convertible Preferred share voted together with the shares of Common Stock

c) Liquidation rights - Upon any liquidation these Series C Convertible Preferred Stock shares shall be treated as equivalent to shares of Common stock to which they are convertible.

d) Redemption rights - The redemption rights were associated with the $750,000 that had been held in escrow by the Company in the event that the funds were released and returned to CTI.  However, the funds were withdrawn from escrow and paid out in accordance with the settlement agreement.  Therefore the redemption rights no longer apply to the remaining Series C Convertible Preferred Stock.

e) Conversion rights - Holder has right to convert each share of Series C Convertible Preferred Stock at any time into shares of the Company's common stock at a conversion price for each share of common stock equal to 85% of the lower of (1) the closing market price at the date of notice of conversion or (2) the mid-point of the last bid price and the last ask price on the date of the notice of conversion. The variable conversion feature creates an embedded derivative that was bifurcated from the Series C Convertible Preferred Stock on the date of issuance and was recorded at fair value. The derivative liability will be recorded at fair value on each reporting date with any change recorded in the Statement of Operations as an unrealized gain (loss) on derivative instrument.

On the date of conversion of the 375 shares of Series C Convertible Preferred Stock the Company calculated the value of the derivative liability to be $81,933. Upon conversion, the $81,933 derivative liability was reclassified to equity.

The Company recorded a convertible preferred stock derivative liability of $66,176 and $80,408, associated with the 375 shares of Series C Convertible Preferred Stock outstanding at March 31, 2014 and December 31, 2013, respectively.

The Company has classified the Series C Convertible Preferred Stock as a liability at March 31, 2014 and December 31, 2013 because the variable conversion feature may require the Company to settle the conversion in a variable number of its common shares.

Common Stock



During the quarter ended March 31, 2014, the Company did a private offering of its common stock and warrants, for consideration of $500,000. 2,500,000 shares of common stock were issued at a per share price of $0.20. The common stock holders were also issued warrants to purchase 1,250,000 shares of common stock. The warrants have an exercise price of $0.60 and a 1-year term. The warrants were recorded to additional paid-in-capital.

During the three months ended March 31, 2014 and 2013, the Company issued 10,625 and 3,750 shares of its common stock to non-employee directors under its Director Compensation Plan. The Company recorded expense of $4,038 and $655 for director stock compensation expense in the three months ended March 31, 2014 and 2013.

X

- Details

Name: us-gaap_StockholdersEquityNoteAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(d),(e))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 4

-Subparagraph (SAB TOPIC 4.C)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 4.E)

-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section C

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section E

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Article 4

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Preferred Stock

-URI http://asc.fasb.org/extlink&oid=6521494

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30, 31

-Article 5

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

Reference 16: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 17: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 18: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph d

-Article 4

Reference 19: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 30

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

+ Details

Name: us-gaap_StockholdersEquityNoteDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 46 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8

Condensed Consolidated Statements of Operations (USD $)
3 Months Ended

Mar. 31, 2014

Mar. 31, 2013

Revenue

Product sales $ 221,080

Cost of product sales 70,218 19,348

Gross profit from product sales 150,862 (19,348)

Other Revenue

Retained royalties 2,604 13,376

Other income 3,821 48,679

Total other revenue 6,425 62,055

Expenses

Selling expenses 71,994 68,175

Personnel and consulting expenses 395,023 341,007

General and administrative expenses 193,721 400,759

Interest expense 104,786 32,767

Loss on settlement of note and warrant 132,301

Unrealized gain on derivative instruments (14,232) (18,167)

Total Expenses 883,593 824,541

Loss before income taxes (726,306) (781,834)

Provision (benefit) for income taxes

Net loss $ (726,306) $ (781,834)

Basic loss per share $ (0.04) $ (0.05)

Basic weighted average number of common shares outstanding 20,036,240 15,588,693

Diluted loss per share $ (0.04) $ (0.05)

Diluted weighted average number of common shares outstanding: 20,036,240 15,588,693

X

- Details

Name: cttc_OtherRevenueAbstract

Namespace Prefix: cttc_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

It reprsent as personnel and consulting expenses.

+ References

No definition available.

+ Details

Name: cttc_PersonnelAndConsultingExpenses

Namespace Prefix: cttc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Total costs related to goods produced and sold during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 2

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.2(a))

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_CostOfGoodsSold

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 55

-Paragraph 52

-URI http://asc.fasb.org/extlink&oid=32703322&loc=d3e4984-109258

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.21)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-04.23)

-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 18

-Article 7

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 20

-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 21

-Article 9

+ Details

Name: us-gaap_EarningsPerShareBasic

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.21)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 18

-Article 7

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 20

-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 21

-Article 9

+ Details

Name: us-gaap_EarningsPerShareDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition

Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4A

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5618551-113959

+ Details

Name: us-gaap_GainLossOnDerivativeInstrumentsNetPretax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 50

-Section 40

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6850294&loc=d3e12317-112629

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 50

-Section 40

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6850294&loc=d3e12355-112629

+ Details

Name: us-gaap_GainsLossesOnExtinguishmentOfDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.4)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_GeneralAndAdministrativeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1,2)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_GrossProfit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

This element represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses from ongoing operations, after income or loss from equity method investments, but before income taxes, extraordinary items, and noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 10

-Article 5

+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph h

-Article 4

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Income Tax Expense (or Benefit)

-URI http://asc.fasb.org/extlink&oid=6515339

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 9

-Subparagraph (a),(b)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Amount of the cost of borrowed funds accounted for as interest expense.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-04.9)

-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 9

-Article 9

+ Details

Name: us-gaap_InterestExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=6519514

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=6518256

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=28358780&loc=d3e565-108580

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.

+ References

No definition available.

+ Details

Name: us-gaap_OperatingExpenses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_OperatingExpensesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Reflects the sum of all other revenue and income recognized by the entity in the period not otherwise specified in the income statement.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.4)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 4

-Article 7

+ Details

Name: us-gaap_OtherIncome

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Revenues from the sale of other goods or rendering of other services, not elsewhere specified in the taxonomy; net of (reduced by) sales adjustments, returns, allowances, and discounts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1(a),(d))

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 1

-Article 5

+ Details

Name: us-gaap_OtherSalesRevenueNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Revenue earned during the period from the leasing or otherwise lending to a third party the entity's rights or title to certain property. Royalty revenue is derived from a percentage or stated amount of sales proceeds or revenue generated by the third party using the entity's property. Examples of property from which royalties may be derived include patents and oil and mineral rights.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1(e))

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 1

-Article 5

+ Details

Name: us-gaap_RoyaltyRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Aggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1(a))

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 1

-Article 5

+ Details

Name: us-gaap_SalesRevenueGoodsNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_SalesRevenueNetAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Expenses recognized in the period that are directly related to the selling and distribution of products or services.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.4)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_SellingExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 16

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1505-109256

+ Details

Name: us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1448-109256

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Weighted-Average Number of Common Shares Outstanding

-URI http://asc.fasb.org/extlink&oid=6528421

+ Details

Name: us-gaap_WeightedAverageNumberOfSharesOutstandingBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 47 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8

FAIR VALUE MEASUREMEMENTS
3 Months Ended

Mar. 31, 2014

FAIR VALUE MEASUREMENTS [Abstract]

FAIR VALUE MEASUREMENTS

6.    FAIR VALUE MEASUREMEMENTS

The Company measures fair value in accordance with Topic 820 of the Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC"), Fair Value Measurement ("ASC 820"), which provides a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy under ASC 820 are described as follows:



Level 1 - Inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets that the Company has the ability to access.

Level 2 - Inputs to the valuation methodology include:

● Quoted prices for similar assets or liabilities in active markets;

● Quoted prices for identical or similar assets or liabilities in inactive markets;

● Inputs other than quoted prices that are observable for the asset or liability;

●
Inputs that are derived principally from or corroborated by observable market data by correlation or other means.

If the asset or liability has a specified (contractual) term, the Level 2 input must be observable for substantially the full term of the asset or liability.

Level 3 - Inputs to the valuation methodology are unobservable and significant to the fair value measurement

The asset's or liability's fair value measurement level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Valuation techniques used need to maximize the use of observable inputs and minimize the use of unobservable inputs.

The Company values its derivative liability associated with the variable conversion feature on its Series C Convertible Preferred Stock (Note 12) based on the market price of its common stock.  For each reporting period the Company calculates the amount of potential common stock that the Series C Preferred Stock could convert into based on the conversion formula (incorporating market value of our common stock) and multiplies those converted shares by the market price of its common stock on that reporting date.  The total converted value is subtracted by the consideration paid to determine the fair value of the derivative liability. The Company classified the derivative liability of $66,000 and $80,000 at March 31, 2014 and December 31, 2013, respectively, in Level 2 of the fair value hierarchy.

The warrant issued in connection with the Tonaquint Note (the "Tonaquint Warrants,"see Note 11) were measured at fair value and liability-classified because the Tonaquint Warrants contain "down-round" protection and therefore do not meet the scope exception under FASB ASC 815, Derivatives and Hedging ("ASC 815"). Since "down-round" protection is not an input to the fair value of the warrants, the warrants cannot be considered indexed to the Company's own stock which is a requirement for the scope exception as outlined under ASC 815.  The Company valued the warrants at $8,000 at December 31, 2013, and $26,076 upon issuance July 16, 2013, in Level 3 of the fair value hierarchy. During the first quarter of 2014 the Company executed a debt settlement agreement with Tonaquint related to the note and warrant (see Note 11).

Similarly, the conversion feature of the Tonaquint Note (Note 11) also contained "down-round" protection and therefore did not meet the scope exception under FASB ASC 815.  The Company classified the derivative liability of $0 at December 31, 2013, and $19,024 upon issuance at July 16, 2013, in Level 3 of the fair value hierarchy. During the first quarter of 2014 the Company executed a debt settlement agreement with Tonaquint related to the note and warrant (see Note 11).

The methods described above may produce a fair value calculation that may not be indicative of net realizable value or reflective of future fair values. Furthermore, while the Company believes its valuation method is appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value could result in a different fair value measurement at the reporting date.

The carrying amounts reported in our Condensed Consolidated Balance Sheet for cash, accounts receivable, notes payable, deferred revenue, and preferred stock liability approximate fair value due to the short-term maturity of those financial instruments.



X

- Details

Name: us-gaap_FairValueDisclosuresAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 21

-URI http://asc.fasb.org/extlink&oid=28364263&loc=d3e13537-108611

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=28364263&loc=d3e13433-108611

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14064-108612

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=25499696&loc=d3e19207-110258

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 30

-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14172-108612

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 16

-URI http://asc.fasb.org/extlink&oid=28364263&loc=d3e13504-108611

+ Details

Name: us-gaap_FairValueDisclosuresTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 48 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8

AVAILABLE-FOR-SALE AND EQUITY SECURITIES
3 Months Ended

Mar. 31, 2014

AVAILABLE-FOR-SALE AND EQUITY SECURITIES [Abstract]

AVAILABLE-FOR-SALE AND EQUITY SECURITIES

5.    AVAILABLE-FOR-SALE AND EQUITY SECURITIES

The fair value of the equity securities we held were categorized as available-for-sale securities, which were carried at a fair value of zero, consisted of shares in Security Innovation and Xion Pharmaceutical Corporation ("Xion").  We own 223,317 shares of stock in the privately held Security Innovation, an independent provider of secure software located in Wilmington, MA.

In September 2009 we announced the formation of a joint venture with Xion for the commercialization of our patented melanocortin analogues for treating sexual dysfunction and obesity.  CTI currently owns 60 shares of common stock or 30% of the outstanding stock of privately held Xion.

X

- Details

Name: us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for investments in certain debt and equity securities.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27290-111563

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 50

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27357-111563

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-Glossary Debt Security

-URI http://asc.fasb.org/extlink&oid=6509901

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 30

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6379141&loc=d3e15032-111544

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27232-111563

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 320

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6957658&loc=d3e62557-112803

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27161-111563

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 50

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27405-111563

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-Glossary Equity Security

-URI http://asc.fasb.org/extlink&oid=6511694

+ Details

Name: us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 49 R23.htm IDEA: XBRL DOCUMENT v2.4.0.8

RECEIVABLES (Tables)
3 Months Ended

Mar. 31, 2014

RECEIVABLES [Abstract]

Schedule of Receivables

Receivables consist of the following:

March 31,
2014 December
31,
2013

Calmare® sales receivable $ 86,023 $ 132,850

Royalties, net of allowance of $101,154 at March 31, 2014 and December 31, 2013 - 10,086

Other 294 394

Total receivables $ 86,317 $ 143,330

X

- Details

Name: us-gaap_ReceivablesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.3,4)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 3, 4

-Article 5

+ Details

Name: us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 50 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8

CONTRACTUAL OBLIGATIONS AND CONTINGENCIES
3 Months Ended

Mar. 31, 2014

CONTRACTUAL OBLIGATIONS AND CONTINGENCIES [Abstract]

CONTRACTUAL OBLIGATIONS AND CONTINGENCIES

13.            CONTRACTUAL OBLIGATIONS AND CONTINGENCIES

As of March 31, 2014, CTI and its majority owned subsidiary, VVI, have remaining obligations, contingent upon receipt of certain revenues, to repay up to $165,701 and $198,365, respectively, in consideration of grant funding received in 1994 and 1995.  CTI also is obligated to pay at the rate of 7.5% of its revenues, if any, from transferring rights to certain inventions supported by the grant funds.  VVI is obligated to pay at rates of 1.5% of its net sales of supported products or 15% of its revenues from licensing supported products, if any.

We have engaged R.F. Lafferty & Co. to seek an acquisition partner from a limited number of companies for our nanoparticle bone biomaterial patents, among other assets and/or securities.  The Company would pay Lafferty a 10% finder's fee in the event an acquisition partner is found, which management has deemed to be an immaterial and contingent obligation.

Contingencies - Litigation

Carolina Liquid Chemistries Corporation, et al. (case pending) - On August 29, 2005, we filed a complaint against Carolina Liquid Chemistries Corporation ("Carolina Liquid") in the United States District Court for the District of Colorado, alleging patent infringement of our patent covering homocysteine assays, and seeking monetary damages, punitive damages, attorneys' fees, court costs and other remuneration at the option of the court. As we became aware of other infringers, we amended our complaint to add as defendants Catch, Inc. ("Catch") and the Diazyme Laboratories Division of General Atomics ("Diazyme"). On September 6, 2006, Diazyme filed for declaratory judgment in the Southern District of California for a change in venue and a declaration of non-infringement and invalidity. On September 12, 2006, the District Court in Colorado ruled that both Catch and Diazyme be added as defendants to the Carolina Liquid case.

On October 23, 2006, Diazyme requested the United States Patent and Trademark Office (the "USPTO") to re-evaluate the validity of our patent and this request was granted by the USPTO on December 14, 2006. On July 30, 2009, the U.S. Patent and Trademark Office's Board of Patent Appeals and Interferences ("BPAI") upheld the homocysteine patent. In September 2008, the examiner had denied the patent, but that denial was overruled by the BPAI. While the examiner had appealed that BPAI decision, delaying further action, that appeal was also denied by the BPAI on December 13, 2010. In June 2011, the examiner once again appealed the BPAI decision. In addition to responding to this new appeal, the Company petitioned the Director of the USPTO to help expedite further action on the case within the USPTO, which was to have been handled with special dispatch according to USPTO requirements for handling reexamination proceedings of patents involved in litigation.

On March 13, 2012, the USPTO issued the Ex Parte Reexamination Certificate confirming the patentability of claims examined. The company has begun collecting unpaid amounts from various obligated companies.

Employment matters - former employee (case pending) - In September 2003, a former employee filed a whistleblower complaint with the Occupational Safety and Health Administration of the Department of Labor (OSHA) alleging that the employee had been terminated for engaging in conduct protected under the Sarbanes Oxley Act of 2002 (SOX). In February 2005, OSHA found probable cause to support the employee's complaint and the Secretary of Labor ordered reinstatement and back wages since the date of termination and CTCC requested de novo review and a hearing before an administrative law judge ("ALJ"). In July 2005, after the close of the hearing on CTI's appeal, the U.S. district court for Connecticut enforced the Secretary's preliminary order of reinstatement and back pay under threat of contempt and the Company rehired the employee with back pay.

On October 5, 2005, the ALJ who conducted the hearing on CTI's appeal of the OSHA findings ruled in CTI's favor and recommended dismissal of the employee's complaint. Although the employee abandoned his position upon notice of the ALJ's decision, he nevertheless filed a request for review by the DOL Administrative Review Board ("ARB").

In May 2006, the U.S. Court of Appeals for the Second Circuit vacated the order of the district court enforcing the Secretary's preliminary order of reinstatement and back pay. The employee also filed a new SOX retaliation complaint with OSHA based on alleged black listing action by CTI following his termination. OSHA dismissed the complaint and the employee filed a request for a hearing by an administrative law judge. Ultimately, the employee voluntarily dismissed the appeal.

In March 2008, the ARB issued an order of remand in the employee's appeal of the October 2005 dismissal of his termination complaint, directing the ALJ to clarify her analysis utilizing the burden-shifting standard articulated by the ARB. In January 2009, the ALJ issued a revised decision again recommending dismissal and once again the employee appealed the ruling to the ARB. On September 30, 2011, the ARB issued a final decision and order affirming the ALJ's decision on remand and dismissing the employee's complaint. The employee has appealed the ARB's decision before the U.S. Court of Appeals for the Second Circuit which has ordered the employee to file his opening brief by May 31, 2012. Response briefs by the Solicitor's Office of the U.S. Department of Labor and CTI were submitted in August 2012. In March 2013, the U.S Court of Appeals for the Second Circuit upheld the ARB's decision dismissing the former employee's complaint and denied the employee's appeal from that order. In April 2013, the Second Circuit terminated proceedings in that court.

Summary - We may be a party to other legal actions and proceedings from time to time. We are unable to estimate legal expenses or losses we may incur, if any, or possible damages we may recover, and we have not recorded any potential judgment losses or proceeds in our financial statements to date. We record expenses in connection with these suits as incurred.

We believe that we carry adequate liability insurance, directors and officers insurance, casualty insurance, for owned or leased tangible assets, and other insurance as needed to cover us against potential and actual claims and lawsuits that occur in the ordinary course of our business. However, an unfavorable resolution of any or all matters, and/or our incurrence of significant legal fees and other costs to defend or prosecute any of these actions and proceedings may, depending on the amount and timing, have a material adverse effect on our consolidated financial position, results of operations or cash flows in a particular period.

X

- Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for commitments and contingencies.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.25)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6449706&loc=d3e16207-108621

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 460

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6398077&loc=d3e12565-110249

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 450

-SubTopic 20

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14435-108349

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 440

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6394976&loc=d3e25287-109308

+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 51 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8

ACCRUED EXPENSES AND OTHER LIABILITIES
3 Months Ended

Mar. 31, 2014

ACCRUED EXPENSES AND OTHER LIABILITIES [Abstract]

ACCRUED EXPENSES AND OTHER LIABILITIES

9.           ACCRUED EXPENSES AND OTHER LIABILITIES

Accrued expenses and other liabilities consist of the following:

March 31,
2014 December
31,
2013

Royalties payable $ 155,208 $ 127,708

Accrued compensation 135,000 -

Accrued accounting fees 80,000 82,141

Commissions payable 21,975 21,975

Accrued interest payable 241,487 216,518

Other payables 170,008 134,645

Accrued expenses and other liabilities, net $ 803,678 $ 582,987



Excluded above is approximately $235,000 and $244,000 of accrued expenses and other liabilities at March 31, 2014 and December 31, 2013, respectively, that fall under the Liability Purchase Agreement ("LPA") with ASC Recap, LLC ("ASC Recap"), and are expected to be repaid using the process as described in Note 10.  Because there can be no assurance that the Company will be successful in completing this process, the Company retains ultimate responsibility for these liabilities, until fully paid down.

X

- Definition

The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current and noncurrent at the end of the reporting period.

+ References

No definition available.

+ Details

Name: cttc_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentAndNoncurrentTextBlock

Namespace Prefix: cttc_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_PayablesAndAccrualsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 52 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8

PREPAID EXPENSES AND OTHER CURRENT ASSETS
3 Months Ended

Mar. 31, 2014

PREPAID EXPENSES AND OTHER CURRENT ASSETS [Abstract]

PREPAID EXPENSES AND OTHER CURRENT ASSETS

7.           PREPAID EXPENSES AND OTHER CURRENT ASSETS

Prepaid expenses and other current assets consist of the following:

March 31,
2014 December
31,
2013

Prepaid insurance $ 15,230 $ 16,802

Other 32,865 48,365

Prepaid expenses and other current assets $ 48,095 $ 65,167

X

- Details

Name: us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.17)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 53 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8

PROPERTY AND EQUIPMENT
3 Months Ended

Mar. 31, 2014

PROPERTY AND EQUIPMENT [Abstract]

PROPERTY AND EQUIPMENT

8.           PROPERTY AND EQUIPMENT

Property and equipment, net, consist of the following:

March 31,
2014 December
31, 2013

Property and equipment, gross $ 180,615 $ 177,537

Accumulated depreciation and amortization (171,755 ) (169,931 )

Property and equipment, net $ 8,860 $ 7,606

Depreciation and amortization expense was $1,824 and $2,336 during the three months ended March 31, 2014 and March 31, 2013, respectively.

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6391110&loc=d3e2921-110230

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.13-14)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 54 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8

LIABILITIES ASSIGNED TO LIABILITY PURCHASE AGREEMENT
3 Months Ended

Mar. 31, 2014

Liabilities Assigned To Liability Purchase Agreement [Abstract]

LIABILITIES ASSIGNED TO LIABILITY PURCHASE AGREEMENT

10.          LIABILITIES ASSIGNED TO LIABILITY PURCHASE AGREEMENT

During the third quarter of 2013, the Company negotiated a LPA with Southridge, Partners II, L.P. ("Southridge"). The LPA takes advantage of a provision in the Securities Act of 1933, Section 3(a)(10), that allows the exchange of claims, securities, or property for stock when the arrangement is approved for fairness by a court proceeding. The process, approved by the court in August 2013, has the potential to eliminate nearly $2.1 million of our financial obligations to existing creditors who agreed to participate and executed claims purchase agreements with Southridge's affiliate ASC Recap" accounting for $2,093,303 of existing payables, accrued expenses and other current liabilities, and notes payable. The process began with the issuance in September 2013 of 1,618,235 shares of the Company's common stock to ASC Recap. During September and October 2013, ASC Recap sold the Company's common stock and during the three months ended March 31, 2014 paid creditors approximately $80,000 from the proceeds and retained a service fee of approximately $27,000. As of May 14, 2014, no further shares of the Company's common stock had been issued to ASC Recap to settle creditors' balances.

There can be no assurance that the Company will be successful in completing this process with Southridge, and the Company retains ultimate responsibility for this debt, until fully paid.

X

- Details

Name: cttc_LiabilitiesAssignedToLiabilityPurchaseAgreementAbstract

Namespace Prefix: cttc_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Disclosure about liabilities assigned to liabilty purchase agreement.

+ References

No definition available.

+ Details

Name: cttc_LiabilitiesAssignedToLiabiltyPurchaseAgreementTextBlock

Namespace Prefix: cttc_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 55 R34.htm IDEA: XBRL DOCUMENT v2.4.0.8

AVAILABLE-FOR-SALE AND EQUITY SECURITIES (Details)

Mar. 31, 2014

Security Innovation, Inc. [Member]

Schedule of Available-for-sale Securities [Line Items]

Number of shares held 223,317

Xion Pharmaceutical Corporation [Member]

Schedule of Available-for-sale Securities [Line Items]

Number of shares held 60

Percentage of shares outstanding owned 30.00%

X

- Definition

The number of shares of common stock or equity participation owned in the investee accounted for under the equity method of accounting.

+ References

No definition available.

+ Details

Name: cttc_EquityMethodInvestmentOwnershipNumberOfSharesOwned

Namespace Prefix: cttc_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 50

-Paragraph 3

-Subparagraph (a)(1)

-URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33918-111571

+ Details

Name: us-gaap_EquityMethodInvestmentOwnershipPercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 56 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8

SUBSEQUENT EVENT
3 Months Ended

Mar. 31, 2014

SUBSEQUENT EVENT [Abstract]

SUBSEQUENT EVENT

15.           SUBSEQUENT EVENT

On April 8, 2014, Mr. Giuseppe Marineo, an inventor of the Calmare® pain therapy device, and Delta Research and Development ("Delta"), Mr. Marineo's research company, and Delta International Services and Logistics ("DIS&L"), Delta's commercial arm in which Mr. Marineo is the sole beneficiary of all proceeds as its founder and sole owner (collectively the "Group"), issued a press release (the "Group's Press Release") regarding Competitive Technologies, Inc. ("CTI" or the "Company") stating that the Company did not have authority to sell, distribute and manufacture Calmare as an exclusive agent of the Group. CTI issued a corporate response in a press release dated April 11, 2014 stating that the Group's Press Release was inaccurate and has since been purged by the overseeing body of wire services.

As disclosed in the Company's Annual Report on Form 10-K on April 16, 2014, this dispute between the Company and the Group is over the validity of a 2012 Amendment to a Sales and Representation Agreement (the "Amendment") which, if valid and enforceable, would have compromised its rights to sell, distribute and manufacture Calmare as an exclusive agent of the Group in the global marketplace, especially in the European, Middle Eastern and North African ("EMENA") territory which was responsible for approximately 70% of gross Calmare sales in 2011. However, the Company believes that the Amendment is neither valid nor enforceable as it was never duly signed or authorized and subsequently deemed null and void as disclosed on April 16, 2014 in the Form 10-K filing. Therefore, the parties' rights are determined by an earlier agreement whereby the Company still possesses the authority to sell, distribute and manufacture Calmare as a world-wide exclusive agent of the Group.

On April 16, 2014, counsel for the Group ("Group Counsel") sent a cease and desist letter ("Cease and Desist Letter") to the Company, requesting a confirmation that the Company would no longer hold itself out as an agent of the Group permitted to sell, distribute and manufacture Calmare world-wide including the EMENA territory.

The Company responded on April 25, 2014 to the Cease and Desist Letter, disputing Group Counsel's interpretation of the events surrounding the execution of the Amendment. At this time the Company is pursuing a reasonable and amicable resolution to the situation.

X

- Details

Name: us-gaap_SubsequentEventsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.

+ References

No definition available.

+ Details

Name: us-gaap_SubsequentEventsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 57 R26.htm IDEA: XBRL DOCUMENT v2.4.0.8

ACCRUED EXPENSES AND OTHER LIABILITIES (Tables)
3 Months Ended

Mar. 31, 2014

ACCRUED EXPENSES AND OTHER LIABILITIES [Abstract]

Schedule of Accrued Expenses and Other Liabilities

Accrued expenses and other liabilities consist of the following:

March 31,
2014 December
31,
2013

Royalties payable $ 155,208 $ 127,708

Accrued compensation 135,000 -

Accrued accounting fees 80,000 82,141

Commissions payable 21,975 21,975

Accrued interest payable 241,487 216,518

Other payables 170,008 134,645

Accrued expenses and other liabilities, net $ 803,678 $ 582,987



X

- Details

Name: us-gaap_PayablesAndAccrualsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Tabular disclosure of the components of accrued liabilities.

+ References

No definition available.

+ Details

Name: us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 58 R41.htm IDEA: XBRL DOCUMENT v2.4.0.8

NOTES PAYABLE (Summary of Issuances of Notes Payable) (Details) (90 day Convertible Notes (Chairman of the Board) [Member], USD $)
12 Months Ended 36 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

90 day Convertible Notes (Chairman of the Board) [Member]

Short-term Debt [Line Items]

Notes Payable, amount borrowed during period $ 1,188,980 $ 1,210,000 $ 100,000 $ 2,498,980

X

- Definition

Net increase or decrease in the carrying amount of the debt instrument for the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(f))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph f

-Article 4

+ Details

Name: us-gaap_DebtInstrumentIncreaseDecreaseForPeriodNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_ShortTermDebtLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 59 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8

Condensed Consolidated Statements of Changes in Shareholders' Deficit (USD $)

Total

Preferred Stock [Member]

Common Stock [Member]

Capital in excess of par value [Member]

Accumulated deficit [Member]

Balance at Dec. 31, 2013 $ (5,944,470) $ 60,675 $ 199,529 $ 46,077,394 $ (52,282,068)

Balance, shares at Dec. 31, 2013 2,427 19,952,907

Net loss (726,306)          (726,306)

Common stock issued to directors 4,038    106 3,932

Common stock issued to directors, shares    10,625

Stock option compensation expense 14,328       14,328

Private offering of common stock and warrants 500,000    25,000 475,000

Private offering of common stock and warrants, shares    2,500,000

Warrants and beneficial conversion feature on notes payable 53,338       53,338

Liabilities settled under Liability Purchase Agreement 106,644       106,644

Balance at Mar. 31, 2014 $ (5,992,428) $ 60,675 $ 224,635 $ 46,730,636 $ (53,008,374)

Balance, shares at Mar. 31, 2014 2,427 22,463,532

X

- Definition

Amount of increase (decrease) in additional paid in capital (APIC) resulting from warrants and convertible debt with a beneficial conversion feature.

+ References

No definition available.

+ Details

Name: cttc_AdjustmentsToAdditionalPaidInCapitalWarrantsAndConvertibleDebtWithConversionFeature

Namespace Prefix: cttc_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount of other increase (decrease) in additional paid in capital (APIC).

+ References

No definition available.

+ Details

Name: us-gaap_AdjustmentsToAdditionalPaidInCapitalOther

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

This element represents the amount of recognized equity-based compensation during the period, that is, the amount recognized as expense in the income statement (or as asset if compensation is capitalized). Alternate captions include the words "stock-based compensation".

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 35

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415241&loc=d3e4534-113899

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 20

-Section 55

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=32706628&loc=d3e11149-113907

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 20

-Section 55

-Paragraph 13

-URI http://asc.fasb.org/extlink&oid=32706628&loc=d3e11178-113907

+ Details

Name: us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=6519514

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=6518256

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=28358780&loc=d3e565-108580

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Number of shares issued which are neither cancelled nor held in the treasury.

+ References

No definition available.

+ Details

Name: us-gaap_SharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 15

-URI http://asc.fasb.org/extlink&oid=7656940&loc=SL4568447-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 16

-URI http://asc.fasb.org/extlink&oid=7656940&loc=SL4568740-111683

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4I

-URI http://asc.fasb.org/extlink&oid=31814832&loc=SL4590271-111686

+ Details

Name: us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Number of new stock issued during the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30

-Article 5

+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesNewIssues

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

Number of shares (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP), net of any shares forfeited. Shares issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30

-Article 5

+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30, 31

-Article 5

+ Details

Name: us-gaap_StockIssuedDuringPeriodValueNewIssues

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Value of stock (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP), net of stock value of such awards forfeited. Stock issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (d)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30, 31

-Article 5

+ Details

Name: us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 60 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8

RECEIVABLES
3 Months Ended

Mar. 31, 2014

RECEIVABLES [Abstract]

RECEIVABLES

4.    RECEIVABLES

Receivables consist of the following:

March 31,
2014 December
31,
2013

Calmare® sales receivable $ 86,023 $ 132,850

Royalties, net of allowance of $101,154 at March 31, 2014 and December 31, 2013 - 10,086

Other 294 394

Total receivables $ 86,317 $ 143,330

X

- Definition

The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.3,4)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 3, 4

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=28368275&loc=d3e5074-111524

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=28368275&loc=d3e5066-111524

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 7

-Article 9

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(k))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph k

-Article 4

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section 50

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=28368275&loc=d3e5162-111524

+ Details

Name: us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_ReceivablesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 61 R27.htm IDEA: XBRL DOCUMENT v2.4.0.8

NOTES PAYABLE (Tables)
3 Months Ended

Mar. 31, 2014

Accounts, Notes, Loans and Financing Receivable [Line Items]

Schedule of Notes Payable

Notes payable consist of the following:

March 31,
2014 December 31,
2013

90 day Convertible Notes (Chairman of the Board) $ 2,498,980 $ 2,518,000

24 month Convertible Notes ($100,000 to Board member) 225,000 225,000

Tonaquint 9% OID Convertible Notes and Warrants 118,536 87,705

Southridge Convertible Note 12,000 12,000

Series A1 15% OID Convertible Notes and Warrants 100,076 81,415

Series A2 15% OID Convertible Notes and Warrants 91,127 69,571

Series A3 15% OID Convertible Notes and Warrants 37,007 -

Series B OID Convertible Notes and Warrants 34,272 -

Notes Payable, gross 3,116,998 2,933,691

Less LPA amount (485,980 ) (505,000 )

Notes Payable, net $ 2,631,018 $ 2,488,691



Details of notes payable as of March 31, 2014 are as follows:

Principal
Amount Carrying
Value Cash
Interest
Rate Common
Stock
Conversion
Price Maturity
Date

90 day Convertible Notes (Chairman of the Board) $ 2,498,980 $ 2,498,980 6 % $ 1.05 Various 2014

24 month Convertible Notes ($100,000 to Board member) 225,000 225,000 6 % 1.05 March 2014 -
June 2014

Tonaquint 9% OID Convertible Notes (1) 112,500 118,536 7 % 0.30 May 2014

Southridge Convertible Note 12,000 12,000 None 75% of closing
bid June 2014

Series A1 15% OID Convertible Notes and Warrants 149,412 100,076 None 0.20 August 2014

Series A2 15% OID Convertible Notes and Warrants 134,236 91,127 None 0.25 September 2014

Series A3 15% OID Convertible Notes and Warrants 64,706 37,007 None 0.25 January 2015

Series B OID Convertible Notes and Warrants 80,000 34,272 None 0.35 March 2017

Notes Payable, gross $ 3,276,834 3,116,998

Less LPA amount (485,980 )

Notes Payable, net $ 2,631,018



  (1) Original terms noted above. The Company executed a debt settlement agreement with Tonaquint during the first quarter of 2014, cash-settled the warrant during the first quarter of 2014 and cash-settled the note during the second quarter of 2014. See further discussion below under "Tonaquint 9% Original Issue Discount Convertible Notes and Warrants".

Schedule of 90 day Convertible Notes

The Company has issued 90-day notes payable to borrow funds from a director, now the chairman of our Board, as follows:

2013 $ 1,188,980

2012 1,210,000

2011 100,000

Total $ 2,498,980



Series A 15% Original Issue Discount Convertible Notes and Warrants [Member]

Accounts, Notes, Loans and Financing Receivable [Line Items]

Schedule of Estimated Fair Value of Notes Assumptions

We estimated the fair value of the warrants on the issue date using a Black-Scholes pricing model with the following assumptions:

Warrants
(Tranche 1)-
November 15,
2013 Warrants
(Tranche 2)-
December 30,
2013 Warrants
(Tranche 3)-
February 14,
2014

Expected term 2 years 2 years 2 years

Volatility 180.02 % 184.38 % 184.88 %

Risk Free Rate 0.31 % 0.39 % 0.32 %

Schedule of Proceeds of Notes Allocation

The proceeds of the Notes issued during the three months ended March 31, 2014 were allocated to the components as follows:

Proceeds allocated
at issue date

Private Offering Notes $ 32,390

Private Offering Warrants 14,845

Beneficial Conversion feature 7,765

Total $ 55,000

Series B Original Issue Discount Convertible Notes and Warrants [Member]

Accounts, Notes, Loans and Financing Receivable [Line Items]

Schedule of Estimated Fair Value of Notes Assumptions

We estimated the fair value of the warrants on the issue date using a Black-Scholes pricing model with the following assumptions:

Warrants
March 20,
2014

Expected term 4 years

Volatility 151.52 %

Risk Free Rate 1.32 %

Schedule of Proceeds of Notes Allocation

The proceeds of the Notes were allocated to the components as follows:

Proceeds allocated
at issue date

Private Offering Notes $ 34,272

Private Offering Warrants 26,811

Beneficial Conversion feature 3,917

Total $ 65,000

X

- Definition

Tabular disclosure of the estimated fair value of each component on the issue date and the conversion date using a Black-Scholes pricing model assumptions.

+ References

No definition available.

+ Details

Name: cttc_ScheduleOfEstimatedFairValueOfNotesAssumptionsTableTextBlock

Namespace Prefix: cttc_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

No authoritative reference available.

+ References

No definition available.

+ Details

Name: cttc_ScheduleOfProceedsOfComponentsNoteAllocatedTableTextBlock

Namespace Prefix: cttc_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_AccountsNotesAndLoansReceivableLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Tabular disclosure of borrowings which can be exchanged for a specified number of another security at the option of the issuer or the holder. Disclosures include, but are not limited to, principal amount, amortized premium or discount, and amount of liability and equity components.

+ References

No definition available.

+ Details

Name: us-gaap_ConvertibleDebtTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_ScheduleOfShortTermDebtTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 62 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.8 Html 127 215 1 true 52 0 false 4 false false R1.htm 001 - Document - Document and Entity Information Sheet http://competitivetech.net/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 002 - Statement - Condensed Consolidated Balance Sheets Sheet http://competitivetech.net/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets false false R3.htm 003 - Statement - Condensed Consolidated Balance Sheets (Parentheticals) Sheet http://competitivetech.net/role/CondensedConsolidatedBalanceSheetsParentheticals Condensed Consolidated Balance Sheets (Parentheticals) false false R4.htm 004 - Statement - Condensed Consolidated Statements of Operations Sheet http://competitivetech.net/role/CondensedConsolidatedStatementsOfOperations Condensed Consolidated Statements of Operations false false R5.htm 005 - Statement - Condensed Consolidated Statements of Changes in Shareholders' Deficit Sheet http://competitivetech.net/role/CondensedConsolidatedStatementsOfChangesInShareholdersDeficit Condensed Consolidated Statements of Changes in Shareholders' Deficit false false R6.htm 006 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://competitivetech.net/role/CondensedConsolidatedStatementsOfCashFlows Condensed Consolidated Statements of Cash Flows false false R7.htm 101 - Disclosure - BASIS OF PRESENTATION Sheet http://competitivetech.net/role/BasisOfPresentation BASIS OF PRESENTATION false false R8.htm 102 - Disclosure - NET INCOME (LOSS) PER COMMON SHARE Sheet http://competitivetech.net/role/NetIncomeLossPerCommonShare NET INCOME (LOSS) PER COMMON SHARE false false R9.htm 103 - Disclosure - RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS Sheet http://competitivetech.net/role/RecentlyIssuedAccountingPronouncements RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS false false R10.htm 104 - Disclosure - RECEIVABLES Sheet http://competitivetech.net/role/Receivables RECEIVABLES false false R11.htm 105 - Disclosure - AVAILABLE-FOR-SALE AND EQUITY SECURITIES Sheet http://competitivetech.net/role/AvailableforsaleAndEquitySecurities AVAILABLE-FOR-SALE AND EQUITY SECURITIES false false R12.htm 106 - Disclosure - FAIR VALUE MEASUREMEMENTS Sheet http://competitivetech.net/role/FairValueMeasuremements FAIR VALUE MEASUREMEMENTS false false R13.htm 107 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS Sheet http://competitivetech.net/role/PrepaidExpensesAndOtherCurrentAssets PREPAID EXPENSES AND OTHER CURRENT ASSETS false false R14.htm 108 - Disclosure - PROPERTY AND EQUIPMENT Sheet http://competitivetech.net/role/PropertyAndEquipment PROPERTY AND EQUIPMENT false false R15.htm 109 - Disclosure - ACCRUED EXPENSES AND OTHER LIABILITIES Sheet http://competitivetech.net/role/AccruedExpensesAndOtherLiabilities ACCRUED EXPENSES AND OTHER LIABILITIES false false R16.htm 110 - Disclosure - LIABILITIES ASSIGNED TO LIABILITY PURCHASE AGREEMENT Sheet http://competitivetech.net/role/LiabilitiesAssignedToLiabilityPurchaseAgreement LIABILITIES ASSIGNED TO LIABILITY PURCHASE AGREEMENT false false R17.htm 111 - Disclosure - NOTES PAYABLE Notes http://competitivetech.net/role/NotesPayable NOTES PAYABLE false false R18.htm 112 - Disclosure - SHAREHOLDERS' DEFICIENCY Sheet http://competitivetech.net/role/ShareholdersDeficiency SHAREHOLDERS' DEFICIENCY false false R19.htm 113 - Disclosure - CONTRACTUAL OBLIGATIONS AND CONTINGENCIES Sheet http://competitivetech.net/role/ContractualObligationsAndContingencies CONTRACTUAL OBLIGATIONS AND CONTINGENCIES false false R20.htm 114 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://competitivetech.net/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS false false R21.htm 115 - Disclosure - SUBSEQUENT EVENT Sheet http://competitivetech.net/role/SubsequentEvent SUBSEQUENT EVENT false false R22.htm 302 - Disclosure - NET INCOME (LOSS) PER COMMON SHARE (Tables) Sheet http://competitivetech.net/role/NetIncomeLossPerCommonShareTables NET INCOME (LOSS) PER COMMON SHARE (Tables) false false R23.htm 304 - Disclosure - RECEIVABLES (Tables) Sheet http://competitivetech.net/role/ReceivablesTables RECEIVABLES (Tables) false false R24.htm 307 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS (Tables) Sheet http://competitivetech.net/role/PrepaidExpensesAndOtherCurrentAssetsTables PREPAID EXPENSES AND OTHER CURRENT ASSETS (Tables) false false R25.htm 308 - Disclosure - PROPERTY AND EQUIPMENT (Tables) Sheet http://competitivetech.net/role/PropertyAndEquipmentTables PROPERTY AND EQUIPMENT (Tables) false false R26.htm 309 - Disclosure - ACCRUED EXPENSES AND OTHER LIABILITIES (Tables) Sheet http://competitivetech.net/role/AccruedExpensesAndOtherLiabilitiesTables ACCRUED EXPENSES AND OTHER LIABILITIES (Tables) false false R27.htm 311 - Disclosure - NOTES PAYABLE (Tables) Notes http://competitivetech.net/role/NotesPayableTables NOTES PAYABLE (Tables) false false R28.htm 312 - Disclosure - SHAREHOLDERS' DEFICIENCY (Tables) Sheet http://competitivetech.net/role/ShareholdersDeficiencyTables SHAREHOLDERS' DEFICIENCY (Tables) false false R29.htm 40001 - Disclosure - Supplemental Disclosure of Non-cash Transactions Sheet http://competitivetech.net/role/SupplementalDisclosureOfNoncashTransactions Supplemental Disclosure of Non-cash Transactions false false R30.htm 40101 - Disclosure - BASIS OF PRESENTATION (Details) Sheet http://competitivetech.net/role/BasisOfPresentationDetails BASIS OF PRESENTATION (Details) false false R31.htm 40201 - Disclosure - NET INCOME (LOSS) PER COMMON SHARE (Calculation of Net Income (Loss) Per Common Share) (Details) Sheet http://competitivetech.net/role/NetIncomeLossPerCommonShareCalculationOfNetIncomeLossPerCommonShareDetails NET INCOME (LOSS) PER COMMON SHARE (Calculation of Net Income (Loss) Per Common Share) (Details) false false R32.htm 40202 - Disclosure - NET INCOME (LOSS) PER COMMON SHARE (Narrative) (Details) Sheet http://competitivetech.net/role/NetIncomeLossPerCommonShareNarrativeDetails NET INCOME (LOSS) PER COMMON SHARE (Narrative) (Details) false false R33.htm 40401 - Disclosure - RECEIVABLES (Details) Sheet http://competitivetech.net/role/ReceivablesDetails RECEIVABLES (Details) false false R34.htm 40501 - Disclosure - AVAILABLE-FOR-SALE AND EQUITY SECURITIES (Details) Sheet http://competitivetech.net/role/AvailableforsaleAndEquitySecuritiesDetails AVAILABLE-FOR-SALE AND EQUITY SECURITIES (Details) false false R35.htm 40601 - Disclosure - FAIR VALUE MEASUREMEMENTS (Details) Sheet http://competitivetech.net/role/FairValueMeasuremementsDetails FAIR VALUE MEASUREMEMENTS (Details) false false R36.htm 40701 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details) Sheet http://competitivetech.net/role/PrepaidExpensesAndOtherCurrentAssetsDetails PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details) false false R37.htm 40801 - Disclosure - PROPERTY AND EQUIPMENT (Details) Sheet http://competitivetech.net/role/PropertyAndEquipmentDetails PROPERTY AND EQUIPMENT (Details) false false R38.htm 40901 - Disclosure - ACCRUED EXPENSES AND OTHER LIABILITIES (Details) Sheet http://competitivetech.net/role/AccruedExpensesAndOtherLiabilitiesDetails ACCRUED EXPENSES AND OTHER LIABILITIES (Details) false false R39.htm 41001 - Disclosure - LIABILITIES ASSIGNED TO LIABILITY PURCHASE AGREEMENT (Details) Sheet http://competitivetech.net/role/LiabilitiesAssignedToLiabilityPurchaseAgreementDetails LIABILITIES ASSIGNED TO LIABILITY PURCHASE AGREEMENT (Details) false false R40.htm 41101 - Disclosure - NOTES PAYABLE (Schedule of Notes Payable) (Details) Notes http://competitivetech.net/role/NotesPayableScheduleOfNotesPayableDetails NOTES PAYABLE (Schedule of Notes Payable) (Details) false false R41.htm 41102 - Disclosure - NOTES PAYABLE (Summary of Issuances of Notes Payable) (Details) Notes http://competitivetech.net/role/NotesPayableSummaryOfIssuancesOfNotesPayableDetails NOTES PAYABLE (Summary of Issuances of Notes Payable) (Details) false false R42.htm 41103 - Disclosure - NOTES PAYABLE (Summary of Fair Value Assumptions) (Details) Notes http://competitivetech.net/role/NotesPayableSummaryOfFairValueAssumptionsDetails NOTES PAYABLE (Summary of Fair Value Assumptions) (Details) false false R43.htm 41104 - Disclosure - NOTES PAYABLE (Schedule of Note Allocation) (Details) Notes http://competitivetech.net/role/NotesPayableScheduleOfNoteAllocationDetails NOTES PAYABLE (Schedule of Note Allocation) (Details) false false R44.htm 41105 - Disclosure - NOTES PAYABLE (Narrative) (Details) Notes http://competitivetech.net/role/NotesPayableNarrativeDetails NOTES PAYABLE (Narrative) (Details) false false R45.htm 41201 - Disclosure - SHAREHOLDERS' DEFICIENCY (Narrative) (Details) Sheet http://competitivetech.net/role/ShareholdersDeficiencyNarrativeDetails SHAREHOLDERS' DEFICIENCY (Narrative) (Details) false false R46.htm 41202 - Disclosure - SHAREHOLDERS' DEFICIENCY (Schedule of Weighted Average Assumptions) (Details) Sheet http://competitivetech.net/role/ShareholdersDeficiencyScheduleOfWeightedAverageAssumptionsDetails SHAREHOLDERS' DEFICIENCY (Schedule of Weighted Average Assumptions) (Details) false false R47.htm 41301 - Disclosure - CONTRACTUAL OBLIGATIONS AND CONTINGENCIES (Details) Sheet http://competitivetech.net/role/ContractualObligationsAndContingenciesDetails CONTRACTUAL OBLIGATIONS AND CONTINGENCIES (Details) false false R48.htm 41401 - Disclosure - RELATED PARTY TRANSACTIONS (Details) Sheet http://competitivetech.net/role/RelatedPartyTransactionsDetails RELATED PARTY TRANSACTIONS (Details) false false All Reports Book All Reports Element cttc_PercentageOfRevenuesObligation had a mix of decimals attribute values: 2 3. Element us-gaap_PreferredStockParOrStatedValuePerShare had a mix of decimals attribute values: 0 3. Process Flow-Through: 002 - Statement - Condensed Consolidated Balance Sheets Process Flow-Through: Removing column 'Mar. 31, 2013' Process Flow-Through: Removing column 'Dec. 31, 2012' Process Flow-Through: 003 - Statement - Condensed Consolidated Balance Sheets (Parentheticals) Process Flow-Through: Removing column 'Dec. 30, 2010' Process Flow-Through: 004 - Statement - Condensed Consolidated Statements of Operations Process Flow-Through: 006 - Statement - Condensed Consolidated Statements of Cash Flows cttc-20140331.xml cttc-20140331.xsd cttc-20140331_cal.xml cttc-20140331_def.xml cttc-20140331_lab.xml cttc-20140331_pre.xml true true XML 63 R38.htm IDEA: XBRL DOCUMENT v2.4.0.8

ACCRUED EXPENSES AND OTHER LIABILITIES (Details) (USD $)

Mar. 31, 2014

Dec. 31, 2013

ACCRUED EXPENSES AND OTHER LIABILITIES [Abstract]

Royalties payable $ 155,208 $ 127,708

Accrued compensation 135,000

Accrued accounting fees 80,000 82,141

Commissions payable 21,975 21,975

Accrued interest payable 241,487 216,518

Other 170,008 134,645

Accrued expenses and other liabilities, net 803,678 582,987

Accrued expenses and other liabilities - LPA $ 235,000 $ 244,000

X

- Definition

Amount of accrued and other liabilities that fall under the Liability Purchase Agreement but are still considered a liability since no full assurance can be made the agreement will be fulfilled.

+ References

No definition available.

+ Details

Name: cttc_AccruedLiabilitiesAndOtherLiabilitiesLiabilityPurchaseAgreement

Namespace Prefix: cttc_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 20

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 20

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Current Liabilities

-URI http://asc.fasb.org/extlink&oid=6509677

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6935-107765

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6911-107765

+ Details

Name: us-gaap_AccruedProfessionalFeesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 20

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Current Liabilities

-URI http://asc.fasb.org/extlink&oid=6509677

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6935-107765

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6911-107765

+ Details

Name: us-gaap_AccruedRoyaltiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.15(5))

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.15(a))

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 15

-Subparagraph a

-Article 7

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 15

-Subparagraph 5

-Article 9

+ Details

Name: us-gaap_AccruedSalariesCurrentAndNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 20

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Current Liabilities

-URI http://asc.fasb.org/extlink&oid=6509677

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6935-107765

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6911-107765

+ Details

Name: us-gaap_AccruedSalesCommissionCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 20

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Current Liabilities

-URI http://asc.fasb.org/extlink&oid=6509677

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6935-107765

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e7018-107765

+ Details

Name: us-gaap_InterestPayableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Carrying value as of the balance sheet date of obligations incurred through that date and payable arising from transactions not otherwise specified in the taxonomy. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 20

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Current Liabilities

-URI http://asc.fasb.org/extlink&oid=6509677

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6935-107765

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6911-107765

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e7018-107765

+ Details

Name: us-gaap_OtherAccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_PayablesAndAccrualsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 64 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8

RELATED PARTY TRANSACTIONS
3 Months Ended

Mar. 31, 2014

RELATED PARTY TRANSACTIONS [Abstract]

RELATED PARTY TRANSACTIONS

14.           RELATED PARTY TRANSACTIONS

Our board of directors determined that when a director's services are outside the normal duties of a director, we compensate the director at the rate of $1,000 per day, plus expenses, which is the same amount we pay a director for attending a one-day Board meeting.  We classify these amounts as consulting expenses, included in personnel and consulting expenses.

At March 31, 2014, $2,598,980 of the outstanding were Notes payable to related parties; $2,498,980 to the chairman of our Board and $100,000 to another director.

X

- Details

Name: us-gaap_RelatedPartyTransactionsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39622-107864

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph b

-Article 3A

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(k))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph k

-Article 4

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39678-107864

+ Details

Name: us-gaap_RelatedPartyTransactionsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

NOTES PAYABLE (Schedule of Note Allocation) (Details) (USD $)	Mar. 31, 2014
Series A 15% Original Issue Discount Convertible Notes and Warrants [Member]
Proceeds allocated
Proceeds allocated, Note	$ 32,390
Proceeds allocated, Warrants	14,845
Proceeds allocated, Benevicial Conversion Feature	7,765
Total	55,000
Series B Original Issue Discount Convertible Notes and Warrants [Member]
Proceeds allocated
Proceeds allocated, Note	34,272
Proceeds allocated, Warrants	26,811
Proceeds allocated, Benevicial Conversion Feature	3,917
Total	$ 65,000

PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details) (USD $)	Mar. 31, 2014	Dec. 31, 2013
PREPAID EXPENSES AND OTHER CURRENT ASSETS [Abstract]
Prepaid insurance	$ 15,230	$ 16,802
Other	32,865	48,365
Prepaid expenses and other current assets	$ 48,095	$ 65,167

BASIS OF PRESENTATION	3 Months Ended
BASIS OF PRESENTATION	Mar. 31, 2014
BASIS OF PRESENTATION [Abstract]
BASIS OF PRESENTATION	1. BASIS OF PRESENTATION The interim condensed consolidated financial information presented in the accompanying condensed consolidated financial statements and notes hereto is unaudited. Competitive Technologies, Inc. ("CTI") and its majority-owned (56.1%) subsidiary, Vector Vision, Inc. ("VVI"), (collectively, the "Company", "we" or "us") is a biotechnology company developing and commercializing innovative products and technologies. CTI is the licensed distributor of the non-invasive Calmare® pain therapy medical device, which incorporates the biophysical "Scrambler Therapy"® technology developed to treat neuropathic and cancer-derived pain. These consolidated financial statements include the accounts of CTI and VVI. Inter-company accounts and transactions have been eliminated in consolidation. We believe we have made all adjustments necessary, consisting only of normal recurring adjustments, to present the unaudited condensed consolidated financial statements in conformity with accounting principles generally accepted in the U.S. The results for the three months ended March 31, 2014 are not necessarily indicative of the results that can be expected for the full year ending December 31, 2014. The interim unaudited condensed consolidated financial statements and notes thereto, should be read in conjunction with our Annual Report on Form 10-K for the year ended December 31, 2013 filed with the Securities and Exchange Commission ("SEC") on April 16, 2014. During the three months ended March 31, 2014, we had a significant concentration of revenues from our Calmare® pain therapy medical device. The percentages of gross revenue attributed to sales and rentals of Calmare devices, in the three months ended March 31, 2014, was 98%; and 13% in the three months ended March 31, 2013. Additionally, the percentage of gross revenue attributed to other Calmare related sales of equipment and training, in the three months ended March 31, 2014, was 1%; and 66% in the three months ended March 31, 2013. We continue to attempt to expand our sales activities for the Calmare device and expect the majority of our revenues to come from this technology. The Company has incurred operating losses since fiscal 2006 and has a working capital deficiency at March 31, 2014. The Company has taken steps to reduce its operating expenses as well as increase revenue from sales of Calmare medical devices. However, even at the reduced spending levels, should the anticipated increase in revenue from sales of Calmare devices not occur the Company may not have sufficient cash flow to fund operations through 2014. These conditions raise substantial doubt about the Company's ability to continue as a going concern. The financial statements do not include adjustments to reflect the possible future effect of the recoverability and classification of assets or amounts and classifications of liabilities that may result from the outcome of this uncertainty. The Company's continuation as a going concern is dependent upon its developing recurring revenue streams sufficient to cover operating costs. The Company does not have any significant individual cash or capital requirements in the budget going forward. If necessary, CTI will meet anticipated operating cash requirements by further reducing costs, issuing debt and/or equity, and/or pursuing sales of certain assets and technologies while we pursue licensing and distribution opportunities for our remaining legacy portfolio of technologies. There can be no assurance that the Company will be successful in such efforts. Failure to develop a recurring revenue stream sufficient to cover operating expenses could negatively affect the Company's financial position. Our liquidity requirements arise principally from our working capital needs, including funds needed to sell our current technologies and obtain new technologies or products, and protect and enforce our intellectual property rights, if necessary. We fund our liquidity requirements with a combination of cash on hand, debt and equity financing, sales of common stock and cash flows from operations, if any, including royalty legal awards. At March 31, 2014, the Company had outstanding debt in the form of promissory notes with a total principal amount of $3,277,000 and a carrying value of $3,117,000. The Company acquired the exclusive, worldwide rights to the Scrambler Therapy® technology in 2007. The Company's original 2007 agreement with Giuseppe Marineo (the "Scrambler Therapy Agreement"), an inventor of Scrambler Therapy technology, and Delta Research and Development, authorized CTI to manufacture and sell worldwide the device developed from the patented Scrambler Therapy technology. The original agreement was amended in 2011 to provide the Company with exclusive rights to the Scrambler Therapy technology through March 31, 2016. In July 2012, the Company attempted to negotiate a five-year extension to the agreement with Marineo and Delta (the "2012 Amendment"). However, a valid contract was never formed as the 2012 Amendment was not executed by Marineo and Delta. The Scrambler Therapy technology is patented in Italy and in the U.S. Applications for patents have been filed internationally as well and are pending approval. The Calmare device has CE Mark certification from the European Union as well as U.S. FDA 510(k) clearance. CTI's partner, GEOMC Co., Ltd. of Korea, is manufacturing the product commercially under a ten (10) year agreement through 2017. Sales of these devices are expected to provide a significant proportion of the Company's revenue for the next several years.

Document and Entity Information	3 Months Ended
Document and Entity Information	Mar. 31, 2014	May 14, 2014
Document and Entity Information [Abstract]
Entity Registrant Name	COMPETITIVE TECHNOLOGIES INC
Entity Central Index Key	0000102198
Document Type	10-Q
Document Period End Date	Mar. 31, 2014
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		22,463,532
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2014

Condensed Consolidated Statements of Operations (USD $)	3 Months Ended
Condensed Consolidated Statements of Operations (USD $)	Mar. 31, 2014	Mar. 31, 2013
Revenue
Product sales	$ 221,080
Cost of product sales	70,218	19,348
Gross profit from product sales	150,862	(19,348)
Other Revenue
Retained royalties	2,604	13,376
Other income	3,821	48,679
Total other revenue	6,425	62,055
Expenses
Selling expenses	71,994	68,175
Personnel and consulting expenses	395,023	341,007
General and administrative expenses	193,721	400,759
Interest expense	104,786	32,767
Loss on settlement of note and warrant	132,301
Unrealized gain on derivative instruments	(14,232)	(18,167)
Total Expenses	883,593	824,541
Loss before income taxes	(726,306)	(781,834)
Provision (benefit) for income taxes
Net loss	$ (726,306)	$ (781,834)
Basic loss per share	$ (0.04)	$ (0.05)
Basic weighted average number of common shares outstanding	20,036,240	15,588,693
Diluted loss per share	$ (0.04)	$ (0.05)
Diluted weighted average number of common shares outstanding:	20,036,240	15,588,693

AVAILABLE-FOR-SALE AND EQUITY SECURITIES	3 Months Ended
AVAILABLE-FOR-SALE AND EQUITY SECURITIES	Mar. 31, 2014
AVAILABLE-FOR-SALE AND EQUITY SECURITIES [Abstract]
AVAILABLE-FOR-SALE AND EQUITY SECURITIES	5. AVAILABLE-FOR-SALE AND EQUITY SECURITIES The fair value of the equity securities we held were categorized as available-for-sale securities, which were carried at a fair value of zero, consisted of shares in Security Innovation and Xion Pharmaceutical Corporation ("Xion"). We own 223,317 shares of stock in the privately held Security Innovation, an independent provider of secure software located in Wilmington, MA. In September 2009 we announced the formation of a joint venture with Xion for the commercialization of our patented melanocortin analogues for treating sexual dysfunction and obesity. CTI currently owns 60 shares of common stock or 30% of the outstanding stock of privately held Xion.

AVAILABLE-FOR-SALE AND EQUITY SECURITIES (Details)	Mar. 31, 2014
Security Innovation, Inc. [Member]
Schedule of Available-for-sale Securities [Line Items]
Number of shares held	223,317
Xion Pharmaceutical Corporation [Member]
Schedule of Available-for-sale Securities [Line Items]
Number of shares held	60
Percentage of shares outstanding owned	30.00%

SUBSEQUENT EVENT	3 Months Ended
SUBSEQUENT EVENT	Mar. 31, 2014
SUBSEQUENT EVENT [Abstract]
SUBSEQUENT EVENT	15. SUBSEQUENT EVENT On April 8, 2014, Mr. Giuseppe Marineo, an inventor of the Calmare® pain therapy device, and Delta Research and Development ("Delta"), Mr. Marineo's research company, and Delta International Services and Logistics ("DIS&L"), Delta's commercial arm in which Mr. Marineo is the sole beneficiary of all proceeds as its founder and sole owner (collectively the "Group"), issued a press release (the "Group's Press Release") regarding Competitive Technologies, Inc. ("CTI" or the "Company") stating that the Company did not have authority to sell, distribute and manufacture Calmare as an exclusive agent of the Group. CTI issued a corporate response in a press release dated April 11, 2014 stating that the Group's Press Release was inaccurate and has since been purged by the overseeing body of wire services. As disclosed in the Company's Annual Report on Form 10-K on April 16, 2014, this dispute between the Company and the Group is over the validity of a 2012 Amendment to a Sales and Representation Agreement (the "Amendment") which, if valid and enforceable, would have compromised its rights to sell, distribute and manufacture Calmare as an exclusive agent of the Group in the global marketplace, especially in the European, Middle Eastern and North African ("EMENA") territory which was responsible for approximately 70% of gross Calmare sales in 2011. However, the Company believes that the Amendment is neither valid nor enforceable as it was never duly signed or authorized and subsequently deemed null and void as disclosed on April 16, 2014 in the Form 10-K filing. Therefore, the parties' rights are determined by an earlier agreement whereby the Company still possesses the authority to sell, distribute and manufacture Calmare as a world-wide exclusive agent of the Group. On April 16, 2014, counsel for the Group ("Group Counsel") sent a cease and desist letter ("Cease and Desist Letter") to the Company, requesting a confirmation that the Company would no longer hold itself out as an agent of the Group permitted to sell, distribute and manufacture Calmare world-wide including the EMENA territory. The Company responded on April 25, 2014 to the Cease and Desist Letter, disputing Group Counsel's interpretation of the events surrounding the execution of the Amendment. At this time the Company is pursuing a reasonable and amicable resolution to the situation.

NOTES PAYABLE (Summary of Issuances of Notes Payable) (Details) (90 day Convertible Notes (Chairman of the Board) [Member], USD $)	12 Months Ended			36 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2013
90 day Convertible Notes (Chairman of the Board) [Member]
Short-term Debt [Line Items]
Notes Payable, amount borrowed during period	$ 1,188,980	$ 1,210,000	$ 100,000	$ 2,498,980

Condensed Consolidated Statements of Changes in Shareholders' Deficit (USD $)	Total	Preferred Stock [Member]	Common Stock [Member]	Capital in excess of par value [Member]	Accumulated deficit [Member]
Balance at Dec. 31, 2013	$ (5,944,470)	$ 60,675	$ 199,529	$ 46,077,394	$ (52,282,068)
Balance, shares at Dec. 31, 2013		2,427	19,952,907
Net loss	(726,306)				(726,306)
Common stock issued to directors	4,038		106	3,932
Common stock issued to directors, shares			10,625
Stock option compensation expense	14,328			14,328
Private offering of common stock and warrants	500,000		25,000	475,000
Private offering of common stock and warrants, shares			2,500,000
Warrants and beneficial conversion feature on notes payable	53,338			53,338
Liabilities settled under Liability Purchase Agreement	106,644			106,644
Balance at Mar. 31, 2014	$ (5,992,428)	$ 60,675	$ 224,635	$ 46,730,636	$ (53,008,374)
Balance, shares at Mar. 31, 2014		2,427	22,463,532

ACCRUED EXPENSES AND OTHER LIABILITIES (Details) (USD $)	Mar. 31, 2014	Dec. 31, 2013
ACCRUED EXPENSES AND OTHER LIABILITIES [Abstract]
Royalties payable	$ 155,208	$ 127,708
Accrued compensation	135,000
Accrued accounting fees	80,000	82,141
Commissions payable	21,975	21,975
Accrued interest payable	241,487	216,518
Other	170,008	134,645
Accrued expenses and other liabilities, net	803,678	582,987
Accrued expenses and other liabilities - LPA	$ 235,000	$ 244,000

RELATED PARTY TRANSACTIONS	3 Months Ended
RELATED PARTY TRANSACTIONS	Mar. 31, 2014
RELATED PARTY TRANSACTIONS [Abstract]
RELATED PARTY TRANSACTIONS	14. RELATED PARTY TRANSACTIONS Our board of directors determined that when a director's services are outside the normal duties of a director, we compensate the director at the rate of $1,000 per day, plus expenses, which is the same amount we pay a director for attending a one-day Board meeting. We classify these amounts as consulting expenses, included in personnel and consulting expenses. At March 31, 2014, $2,598,980 of the outstanding were Notes payable to related parties; $2,498,980 to the chairman of our Board and $100,000 to another director.